{"subject": "phosphatase", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "SHP-2", "obj_type": "Gene", "file_name": "PubMed-16371368.json", "snippet": " [CLS] SHP-2 phosphatase [CLS]  that cause hyperactivation of its catalytic activity have been identified in human leukemias, particularly juvenile myelomonocytic leukemia, which is"}
{"subject": "SHP-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "interactions", "obj_type": "Interaction", "file_name": "PubMed-16371368.json", "snippet": " potential of the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2 domain increased  [CLS] interactions of mutant SHP-2 [CLS]  with Grb2, Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite"}
{"subject": "mutant", "sub_type": "Var", "rel": "ThemeOf", "object": "SHP-2", "obj_type": "Gene", "file_name": "PubMed-16371368.json", "snippet": " the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2 domain increased interactions of  [CLS] mutant SHP-2 [CLS]  with Grb2, Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite"}
{"subject": "increased", "sub_type": "PosReg", "rel": "CauseOf", "object": "hyperactivation", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " hematopoietic potential of the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2 domain  [CLS] increased interactions of mutant SHP-2 with Grb2, Gab2, and p85, leading to hyperactivation [CLS]  of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation"}
{"subject": "IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways", "sub_type": "Pathway", "rel": "ThemeOf", "object": "hyperactivation", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " in the N-terminal Src homology 2 domain increased interactions of mutant SHP-2 with Grb2, Gab2, and p85, leading to  [CLS] hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways [CLS] . In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore,"}
{"subject": "catalytic activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial  [CLS] increase in the catalytic activity [CLS] , dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained"}
{"subject": "dephosphorylation of STAT5", "sub_type": "MPA", "rel": "ThemeOf", "object": "dampened", "obj_type": "NegReg", "file_name": "PubMed-16371368.json", "snippet": " hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity,  [CLS] dephosphorylation of STAT5 by SHP-2 E76K was dampened [CLS] . Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to increase the interaction with Gab2"}
{"subject": "E76K", "sub_type": "Var", "rel": "ThemeOf", "object": "SHP-2", "obj_type": "Gene", "file_name": "PubMed-16371368.json", "snippet": " and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by  [CLS] SHP-2 E76K [CLS]  was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to increase the interaction"}
{"subject": "SHP-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "dephosphorylation of STAT5", "obj_type": "MPA", "file_name": "PubMed-16371368.json", "snippet": " hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial increase in the catalytic activity,  [CLS] dephosphorylation of STAT5 by SHP-2 [CLS]  E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to increase the"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2  [CLS] E76K with an additional C459S mutation retained the capability to increase [CLS]  the interaction with Gab2 and to enhance the activation of the PI3K pathway. Taken together, these studies suggest that"}
{"subject": "interaction", "sub_type": "Interaction", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to  [CLS] increase the interaction [CLS]  with Gab2 and to enhance the activation of the PI3K pathway. Taken together, these studies suggest that in addition"}
{"subject": "SHP-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-16371368.json", "snippet": " [CLS] Mutations in SHP-2 [CLS]  phosphatase that cause hyperactivation of its catalytic activity have been identified in human leukemias, particularly juvenile myelomonocytic leukemia, which"}
{"subject": "Gab2", "sub_type": "Protein", "rel": "ThemeOf", "object": "interaction", "obj_type": "Interaction", "file_name": "PubMed-16371368.json", "snippet": " E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional C459S mutation retained the capability to increase the  [CLS] interaction with Gab2 [CLS]  and to enhance the activation of the PI3K pathway. Taken together, these studies suggest that in addition to the"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "enhance", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2  [CLS] E76K with an additional C459S mutation retained the capability to increase the interaction with Gab2 and to enhance [CLS]  the activation of the PI3K pathway. Taken together, these studies suggest that in addition to the elevated catalytic activity,"}
{"subject": "PI3K pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "enhance", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " inactive SHP-2 E76K with an additional C459S mutation retained the capability to increase the interaction with Gab2 and to  [CLS] enhance the activation of the PI3K pathway [CLS] . Taken together, these studies suggest that in addition to the elevated catalytic activity, fundamental changes in physical and functional"}
{"subject": "leukemias", "sub_type": "Disease", "rel": "ThemeOf", "object": "hyperactivation", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " [CLS] hyperactivation of its catalytic activity have been identified in human leukemias [CLS] , particularly juvenile myelomonocytic leukemia, which is characterized by hypersensitivity of myeloid progenitor cells to granulocyte macrophage colony-stimulating factor and"}
{"subject": "juvenile myelomonocytic leukemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "hyperactivation", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " [CLS] hyperactivation of its catalytic activity have been identified in human leukemias, particularly juvenile myelomonocytic leukemia [CLS] , which is characterized by hypersensitivity of myeloid progenitor cells to granulocyte macrophage colony-stimulating factor and interleukin (IL)-3. However, the"}
{"subject": "SHP-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K", "obj_type": "Var", "file_name": "PubMed-16371368.json", "snippet": " despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive  [CLS] SHP-2 E76K [CLS]  with an additional C459S mutation retained the capability to increase the interaction with Gab2 and to enhance the activation"}
{"subject": "C459S", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional  [CLS] C459S mutation retained the capability to increase [CLS]  the interaction with Gab2 and to enhance the activation of the PI3K pathway. Taken together, these studies suggest that"}
{"subject": "SHP-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "C459S", "obj_type": "Var", "file_name": "PubMed-16371368.json", "snippet": " despite the substantial increase in the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive  [CLS] SHP-2 E76K with an additional C459S [CLS]  mutation retained the capability to increase the interaction with Gab2 and to enhance the activation of the PI3K pathway."}
{"subject": "C459S", "sub_type": "Var", "rel": "CauseOf", "object": "enhance", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " the catalytic activity, dephosphorylation of STAT5 by SHP-2 E76K was dampened. Furthermore, catalytically inactive SHP-2 E76K with an additional  [CLS] C459S mutation retained the capability to increase the interaction with Gab2 and to enhance [CLS]  the activation of the PI3K pathway. Taken together, these studies suggest that in addition to the elevated catalytic activity,"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "hyperactivation", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " [CLS] Mutations in SHP-2 phosphatase that cause hyperactivation [CLS]  of its catalytic activity have been identified in human leukemias, particularly juvenile myelomonocytic leukemia, which is characterized by hypersensitivity"}
{"subject": "catalytic activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "hyperactivation", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " [CLS] hyperactivation of its catalytic activity [CLS]  have been identified in human leukemias, particularly juvenile myelomonocytic leukemia, which is characterized by hypersensitivity of myeloid progenitor cells"}
{"subject": "SHP-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K mutation", "obj_type": "Var", "file_name": "PubMed-16371368.json", "snippet": " hematopoietic cell function and IL-3 signal transduction by comparing with those of overexpressed WT SHP-2. Our results showed that  [CLS] SHP-2 E76K mutation [CLS]  caused myeloproliferative disease in mice, while overexpression of WT SHP-2 decreased hematopoietic potential of the transduced cells in recipient"}
{"subject": "E76K mutation", "sub_type": "Var", "rel": "CauseOf", "object": "myeloproliferative disease", "obj_type": "Disease", "file_name": "PubMed-16371368.json", "snippet": " cell function and IL-3 signal transduction by comparing with those of overexpressed WT SHP-2. Our results showed that SHP-2  [CLS] E76K mutation caused myeloproliferative disease [CLS]  in mice, while overexpression of WT SHP-2 decreased hematopoietic potential of the transduced cells in recipient animals. The E76K"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " disease in mice, while overexpression of WT SHP-2 decreased hematopoietic potential of the transduced cells in recipient animals. The  [CLS] E76K mutation in the N-terminal Src homology 2 domain increased [CLS]  interactions of mutant SHP-2 with Grb2, Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K)"}
{"subject": "interactions", "sub_type": "Interaction", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-16371368.json", "snippet": " hematopoietic potential of the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2 domain  [CLS] increased interactions [CLS]  of mutant SHP-2 with Grb2, Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways."}
{"subject": "Grb2", "sub_type": "Protein", "rel": "ThemeOf", "object": "interactions", "obj_type": "Interaction", "file_name": "PubMed-16371368.json", "snippet": " potential of the transduced cells in recipient animals. The E76K mutation in the N-terminal Src homology 2 domain increased  [CLS] interactions of mutant SHP-2 with Grb2 [CLS] , Gab2, and p85, leading to hyperactivation of IL-3-induced Erk and phosphatidylinositol 3-kinase (PI3K) pathways. In addition, despite the substantial"}
{"subject": "bchs", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-17435236.json", "snippet": " to decreased cell viability and are associated with progressive disorders in humans. Previously we have found that loss-of-function (LOF)  [CLS] mutations in the Drosophila gene blue cheese (bchs [CLS] ) lead to reduced adult life span, increased neuronal death, and widespread CNS degeneration that is associated with the formation"}
{"subject": "ubiquitinated protein profiles", "sub_type": "MPA", "rel": "ThemeOf", "object": "changes", "obj_type": "Reg", "file_name": "PubMed-17435236.json", "snippet": " bchs-like phenotypes. Mutations in several lysosomal trafficking genes resulted in significantly decreased adult life spans and several mutants showed  [CLS] changes in ubiquitinated protein profiles [CLS]  as young adults. This work represents a novel approach to examine the role that lysosomal transport and function have"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-17435236.json", "snippet": " to decreased cell viability and are associated with progressive disorders in humans. Previously we have found that loss-of-function (LOF)  [CLS] mutations in the Drosophila gene blue cheese (bchs) lead to reduced [CLS]  adult life span, increased neuronal death, and widespread CNS degeneration that is associated with the formation of ubiquitinated-protein aggregates."}
{"subject": "adult life span", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-17435236.json", "snippet": " in humans. Previously we have found that loss-of-function (LOF) mutations in the Drosophila gene blue cheese (bchs) lead to  [CLS] reduced adult life span [CLS] , increased neuronal death, and widespread CNS degeneration that is associated with the formation of ubiquitinated-protein aggregates. To identify potential"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-17435236.json", "snippet": " to decreased cell viability and are associated with progressive disorders in humans. Previously we have found that loss-of-function (LOF)  [CLS] mutations in the Drosophila gene blue cheese (bchs) lead to reduced adult life span, increased [CLS]  neuronal death, and widespread CNS degeneration that is associated with the formation of ubiquitinated-protein aggregates. To identify potential genes"}
{"subject": "neuronal death", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-17435236.json", "snippet": " have found that loss-of-function (LOF) mutations in the Drosophila gene blue cheese (bchs) lead to reduced adult life span,  [CLS] increased neuronal death [CLS] , and widespread CNS degeneration that is associated with the formation of ubiquitinated-protein aggregates. To identify potential genes that participate"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "degeneration", "obj_type": "NegReg", "file_name": "PubMed-17435236.json", "snippet": " to decreased cell viability and are associated with progressive disorders in humans. Previously we have found that loss-of-function (LOF)  [CLS] mutations in the Drosophila gene blue cheese (bchs) lead to reduced adult life span, increased neuronal death, and widespread CNS degeneration [CLS]  that is associated with the formation of ubiquitinated-protein aggregates. To identify potential genes that participate in the bchs functional"}
{"subject": "widespread CNS", "sub_type": "CPA", "rel": "ThemeOf", "object": "degeneration", "obj_type": "NegReg", "file_name": "PubMed-17435236.json", "snippet": " (LOF) mutations in the Drosophila gene blue cheese (bchs) lead to reduced adult life span, increased neuronal death, and  [CLS] widespread CNS degeneration [CLS]  that is associated with the formation of ubiquitinated-protein aggregates. To identify potential genes that participate in the bchs functional"}
{"subject": "lysosomal trafficking genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-17435236.json", "snippet": " the Bchs gain-of-function (GOF) eye phenotype. Individual mutant alleles that produced viable adults were further examined for bchs-like phenotypes.  [CLS] Mutations in several lysosomal trafficking genes [CLS]  resulted in significantly decreased adult life spans and several mutants showed changes in ubiquitinated protein profiles as young adults."}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-17435236.json", "snippet": " the Bchs gain-of-function (GOF) eye phenotype. Individual mutant alleles that produced viable adults were further examined for bchs-like phenotypes.  [CLS] Mutations in several lysosomal trafficking genes resulted in significantly decreased [CLS]  adult life spans and several mutants showed changes in ubiquitinated protein profiles as young adults. This work represents a"}
{"subject": "adult life spans", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-17435236.json", "snippet": " that produced viable adults were further examined for bchs-like phenotypes. Mutations in several lysosomal trafficking genes resulted in significantly  [CLS] decreased adult life spans [CLS]  and several mutants showed changes in ubiquitinated protein profiles as young adults. This work represents a novel approach to"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "changes", "obj_type": "Reg", "file_name": "PubMed-17435236.json", "snippet": " the Bchs gain-of-function (GOF) eye phenotype. Individual mutant alleles that produced viable adults were further examined for bchs-like phenotypes.  [CLS] Mutations in several lysosomal trafficking genes resulted in significantly decreased adult life spans and several mutants showed changes [CLS]  in ubiquitinated protein profiles as young adults. This work represents a novel approach to examine the role that lysosomal"}
{"subject": "heterotrimeric G proteins", "sub_type": "Protein", "rel": "CauseOf", "object": "stimulation", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " gain-of-function activity.\nRegulator of G protein signaling (RGS) proteins play a crucial role in the adaptation of cells to  [CLS] stimulation by G protein-coupled receptors via heterotrimeric G proteins [CLS] . Alterations in RGS function have been implicated in a wide range of disease states, leading to many researchers focusing"}
{"subject": "RGS4", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " of the serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants,  [CLS] RGS4(S30C/S30F/S30K) demonstrate increased [CLS]  steady state protein levels, however these mutants also demonstrate enhanced GAP activity through an additional mechanism distinct from the"}
{"subject": "protein levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants, RGS4(S30C/S30F/S30K) demonstrate  [CLS] increased steady state protein levels [CLS] , however these mutants also demonstrate enhanced GAP activity through an additional mechanism distinct from the increased protein content. The"}
{"subject": "GAP activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " RGS16. As with previously identified GOF mutants, RGS4(S30C/S30F/S30K) demonstrate increased steady state protein levels, however these mutants also demonstrate  [CLS] enhanced GAP activity [CLS]  through an additional mechanism distinct from the increased protein content. The identification of human RGS mutants with GOF activity"}
{"subject": "RGS4 mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " utilizing inactive mutants or small molecular RGS inhibitors. Here we describe the isolation and characterization of a novel human  [CLS] RGS4 mutant which displays enhanced or gain-of-function [CLS]  (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway and in vitro against the"}
{"subject": "yeast-based signalling pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " RGS inhibitors. Here we describe the isolation and characterization of a novel human RGS4 mutant which displays enhanced or  [CLS] gain-of-function (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway [CLS]  and in vitro against the Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein. Mutational analysis of serine 30 identified"}
{"subject": "Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " RGS inhibitors. Here we describe the isolation and characterization of a novel human RGS4 mutant which displays enhanced or  [CLS] gain-of-function (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway and in vitro against the Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein [CLS] . Mutational analysis of serine 30 identified a number of alternative substitutions that result in GOF activity. GOF activity was"}
{"subject": "RGS", "sub_type": "Protein", "rel": "ThemeOf", "object": "Alterations", "obj_type": "Var", "file_name": "PubMed-18031991.json", "snippet": " play a crucial role in the adaptation of cells to stimulation by G protein-coupled receptors via heterotrimeric G proteins.  [CLS] Alterations in RGS [CLS]  function have been implicated in a wide range of disease states, leading to many researchers focusing on controlling the"}
{"subject": "RGS4", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " of the serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants,  [CLS] RGS4(S30C/S30F/S30K) demonstrate increased steady state protein levels, however these mutants also demonstrate enhanced [CLS]  GAP activity through an additional mechanism distinct from the increased protein content. The identification of human RGS mutants with"}
{"subject": "G protein-coupled receptors", "sub_type": "Protein", "rel": "ThemeOf", "object": "stimulation", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " gain-of-function activity.\nRegulator of G protein signaling (RGS) proteins play a crucial role in the adaptation of cells to  [CLS] stimulation by G protein-coupled receptors [CLS]  via heterotrimeric G proteins. Alterations in RGS function have been implicated in a wide range of disease states, leading"}
{"subject": "S30C", "sub_type": "Var", "rel": "ThemeOf", "object": "RGS4", "obj_type": "Var", "file_name": "PubMed-18031991.json", "snippet": " of the serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants,  [CLS] RGS4(S30C [CLS] /S30F/S30K) demonstrate increased steady state protein levels, however these mutants also demonstrate enhanced GAP activity through an additional mechanism distinct"}
{"subject": "S30F", "sub_type": "Var", "rel": "ThemeOf", "object": "RGS4", "obj_type": "Var", "file_name": "PubMed-18031991.json", "snippet": " of the serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants,  [CLS] RGS4(S30C/S30F [CLS] /S30K) demonstrate increased steady state protein levels, however these mutants also demonstrate enhanced GAP activity through an additional mechanism distinct"}
{"subject": "S30K", "sub_type": "Var", "rel": "ThemeOf", "object": "RGS4", "obj_type": "Var", "file_name": "PubMed-18031991.json", "snippet": " of the serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants,  [CLS] RGS4(S30C/S30F/S30K [CLS] ) demonstrate increased steady state protein levels, however these mutants also demonstrate enhanced GAP activity through an additional mechanism distinct"}
{"subject": "Alterations", "sub_type": "Var", "rel": "CauseOf", "object": "implicated", "obj_type": "Reg", "file_name": "PubMed-18031991.json", "snippet": " play a crucial role in the adaptation of cells to stimulation by G protein-coupled receptors via heterotrimeric G proteins.  [CLS] Alterations in RGS function have been implicated [CLS]  in a wide range of disease states, leading to many researchers focusing on controlling the action of these regulatory"}
{"subject": "disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "implicated", "obj_type": "Reg", "file_name": "PubMed-18031991.json", "snippet": " adaptation of cells to stimulation by G protein-coupled receptors via heterotrimeric G proteins. Alterations in RGS function have been  [CLS] implicated in a wide range of disease [CLS]  states, leading to many researchers focusing on controlling the action of these regulatory proteins. Previous studies have centered on"}
{"subject": "RGS4 mutant", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " utilizing inactive mutants or small molecular RGS inhibitors. Here we describe the isolation and characterization of a novel human  [CLS] RGS4 mutant which displays enhanced [CLS]  or gain-of-function (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway and in vitro"}
{"subject": "yeast-based signalling pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " small molecular RGS inhibitors. Here we describe the isolation and characterization of a novel human RGS4 mutant which displays  [CLS] enhanced or gain-of-function (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway [CLS]  and in vitro against the Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein. Mutational analysis of serine 30 identified"}
{"subject": "Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-18031991.json", "snippet": " small molecular RGS inhibitors. Here we describe the isolation and characterization of a novel human RGS4 mutant which displays  [CLS] enhanced or gain-of-function (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway and in vitro against the Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein [CLS] . Mutational analysis of serine 30 identified a number of alternative substitutions that result in GOF activity. GOF activity was"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "proteins", "obj_type": "Protein", "file_name": "PubMed-18594199.json", "snippet": " [CLS] p53 proteins [CLS]  are thought to have acquired a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we"}
{"subject": "conditional RNA interference", "sub_type": "MPA", "rel": "CauseOf", "object": "inhibiting", "obj_type": "NegReg", "file_name": "PubMed-18594199.json", "snippet": " establishment of a lentiviral-based system for conditional interference with mutant p53 expression. In vivo studies assessed the efficacy of  [CLS] conditional RNA interference in inhibiting [CLS]  gain of function activity of mutant p53 proteins by reducing tumor growth ability. Moreover by using this system, microarray"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "inhibiting", "obj_type": "NegReg", "file_name": "PubMed-18594199.json", "snippet": " system for conditional interference with mutant p53 expression. In vivo studies assessed the efficacy of conditional RNA interference in  [CLS] inhibiting gain of function activity [CLS]  of mutant p53 proteins by reducing tumor growth ability. Moreover by using this system, microarray data were validated in"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "proteins", "obj_type": "Protein", "file_name": "PubMed-18594199.json", "snippet": " expression. In vivo studies assessed the efficacy of conditional RNA interference in inhibiting gain of function activity of mutant  [CLS] p53 proteins [CLS]  by reducing tumor growth ability. Moreover by using this system, microarray data were validated in vitro and in vivo"}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-18594199.json", "snippet": " p53 expression. In vivo studies assessed the efficacy of conditional RNA interference in inhibiting gain of function activity of  [CLS] mutant p53 proteins [CLS]  by reducing tumor growth ability. Moreover by using this system, microarray data were validated in vitro and in vivo"}
{"subject": "mutant", "sub_type": "Var", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-18594199.json", "snippet": " with mutant p53 expression. In vivo studies assessed the efficacy of conditional RNA interference in inhibiting gain of function  [CLS] activity of mutant [CLS]  p53 proteins by reducing tumor growth ability. Moreover by using this system, microarray data were validated in vitro and"}
{"subject": "depletion", "sub_type": "MPA", "rel": "CauseOf", "object": "impacts", "obj_type": "Reg", "file_name": "PubMed-18594199.json", "snippet": " target genes that may contribute to its gain of function effects in cancer were identified. Results are confirmatory that  [CLS] depletion of mutant p53 protein impacts [CLS]  on tumor malignancy and validated the inducible lentiviral-based system as an efficient tool to study the gain of function"}
{"subject": "tumor malignancy", "sub_type": "CPA", "rel": "ThemeOf", "object": "impacts", "obj_type": "Reg", "file_name": "PubMed-18594199.json", "snippet": " to its gain of function effects in cancer were identified. Results are confirmatory that depletion of mutant p53 protein  [CLS] impacts on tumor malignancy [CLS]  and validated the inducible lentiviral-based system as an efficient tool to study the gain of function activity of human"}
{"subject": "mutant", "sub_type": "Var", "rel": "ThemeOf", "object": "depletion", "obj_type": "MPA", "file_name": "PubMed-18594199.json", "snippet": " target genes that may contribute to its gain of function effects in cancer were identified. Results are confirmatory that  [CLS] depletion of mutant [CLS]  p53 protein impacts on tumor malignancy and validated the inducible lentiviral-based system as an efficient tool to study the"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "protein", "obj_type": "Protein", "file_name": "PubMed-18594199.json", "snippet": " may contribute to its gain of function effects in cancer were identified. Results are confirmatory that depletion of mutant  [CLS] p53 protein [CLS]  impacts on tumor malignancy and validated the inducible lentiviral-based system as an efficient tool to study the gain of"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-18594199.json", "snippet": " that may contribute to its gain of function effects in cancer were identified. Results are confirmatory that depletion of  [CLS] mutant p53 protein [CLS]  impacts on tumor malignancy and validated the inducible lentiviral-based system as an efficient tool to study the gain of"}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-18594199.json", "snippet": " [CLS] Mutant p53 proteins [CLS]  are thought to have acquired a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-18594199.json", "snippet": " [CLS] Mutant p53 proteins are thought to have acquired a \"gain of function [CLS] \" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive downregulation of mutant p53 by RNA"}
{"subject": "tumor aggressiveness", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-18594199.json", "snippet": " study mutant p53 oncogenic gain of function on tumor malignancy.\nMutant p53 proteins are thought to have acquired a \" [CLS] gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness [CLS] . Previously we reported that constitutive downregulation of mutant p53 by RNA interference reduces the tumorigenicity of cancer cells in"}
{"subject": "RNA interference", "sub_type": "MPA", "rel": "CauseOf", "object": "downregulation", "obj_type": "NegReg", "file_name": "PubMed-18594199.json", "snippet": " have acquired a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive  [CLS] downregulation of mutant p53 by RNA interference [CLS]  reduces the tumorigenicity of cancer cells in an animal model; however, effects of adaptation to long-term mutant p53 inhibition"}
{"subject": "downregulation", "sub_type": "NegReg", "rel": "CauseOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-18594199.json", "snippet": " have acquired a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive  [CLS] downregulation of mutant p53 by RNA interference reduces [CLS]  the tumorigenicity of cancer cells in an animal model; however, effects of adaptation to long-term mutant p53 inhibition could"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-18594199.json", "snippet": " a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive downregulation of  [CLS] mutant p53 [CLS]  by RNA interference reduces the tumorigenicity of cancer cells in an animal model; however, effects of adaptation to long-term"}
{"subject": "mutant", "sub_type": "Var", "rel": "ThemeOf", "object": "downregulation", "obj_type": "NegReg", "file_name": "PubMed-18594199.json", "snippet": " have acquired a \"gain of function\" (GOF) activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive  [CLS] downregulation of mutant [CLS]  p53 by RNA interference reduces the tumorigenicity of cancer cells in an animal model; however, effects of adaptation to"}
{"subject": "tumorigenicity of cancer cells in an animal model", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-18594199.json", "snippet": " activity that mainly contributes to tumor aggressiveness. Previously we reported that constitutive downregulation of mutant p53 by RNA interference  [CLS] reduces the tumorigenicity of cancer cells in an animal model [CLS] ; however, effects of adaptation to long-term mutant p53 inhibition could not be excluded. To address this point, mimicking more"}
{"subject": "polymorphism", "sub_type": "MPA", "rel": "ThemeOf", "object": "silent", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " p.Val38Met; c.122C>T, p.Ser41Phe; c.383T>C, p.Met128Thr; and c.842A>G, p.Asn281Ser) have not been analyzed for function. p.Asn281Ser corresponds to a functionally  [CLS] silent polymorphism [CLS] . The other mutations are associated with varying degrees of loss of function (LOF), from moderate decreases in coupling to"}
{"subject": "p.Val38Met", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind agonists efficiently. Conversely, LOF of  [CLS] p.Val38Met, p.Ser41Phe, and p.Val51Ala is due to reduced [CLS]  cell surface expression as a consequence of retention in the endoplasmic reticulum (ER). Therefore, LOF of MC1R alleles is"}
{"subject": "cell surface expression", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " cell surface, but are unable to bind agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and p.Val51Ala is due to  [CLS] reduced cell surface expression [CLS]  as a consequence of retention in the endoplasmic reticulum (ER). Therefore, LOF of MC1R alleles is frequently associated with"}
{"subject": "coupling", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreases", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " a functionally silent polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate  [CLS] decreases in coupling [CLS]  to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The"}
{"subject": "functional coupling", "sub_type": "MPA", "rel": "ThemeOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " loss of function (LOF), from moderate decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete  [CLS] absence of functional coupling [CLS]  (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable"}
{"subject": "cAMP pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "decreases", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " a functionally silent polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate  [CLS] decreases in coupling to the cAMP pathway [CLS]  (p.Val38Met and p.Val51Ala) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg"}
{"subject": "p.Val38Met", "sub_type": "Var", "rel": "CauseOf", "object": "decreases", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " a functionally silent polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate  [CLS] decreases in coupling to the cAMP pathway (p.Val38Met [CLS]  and p.Val51Ala) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants"}
{"subject": "p.Val51Ala", "sub_type": "Var", "rel": "CauseOf", "object": "decreases", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " a functionally silent polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate  [CLS] decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala [CLS] ) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked"}
{"subject": "p.Ser41Phe", "sub_type": "Var", "rel": "CauseOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " loss of function (LOF), from moderate decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete  [CLS] absence of functional coupling (p.Ser41Phe [CLS] , p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to"}
{"subject": "p.Met128Thr", "sub_type": "Var", "rel": "CauseOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " loss of function (LOF), from moderate decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete  [CLS] absence of functional coupling (p.Ser41Phe, p.Met128Thr [CLS] , and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind"}
{"subject": "p.Cys289Arg", "sub_type": "Var", "rel": "CauseOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " loss of function (LOF), from moderate decreases in coupling to the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete  [CLS] absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg [CLS] ). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind agonists efficiently."}
{"subject": "p.Cys289Arg", "sub_type": "Var", "rel": "CauseOf", "object": "unable", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " pathway (p.Val38Met and p.Val51Ala) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and  [CLS] p.Cys289Arg mutants are trafficked to the cell surface, but are unable [CLS]  to bind agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and p.Val51Ala is due to reduced cell surface expression as"}
{"subject": "p.Met128Thr", "sub_type": "Var", "rel": "CauseOf", "object": "unable", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " the cAMP pathway (p.Val38Met and p.Val51Ala) to nearly complete absence of functional coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF  [CLS] p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are unable [CLS]  to bind agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and p.Val51Ala is due to reduced cell surface expression as"}
{"subject": "bind", "sub_type": "Interaction", "rel": "ThemeOf", "object": "unable", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " coupling (p.Ser41Phe, p.Met128Thr, and p.Cys289Arg). The LOF p.Met128Thr and p.Cys289Arg mutants are trafficked to the cell surface, but are  [CLS] unable to bind [CLS]  agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and p.Val51Ala is due to reduced cell surface expression as a consequence"}
{"subject": "p.Ser41Phe,", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " p.Cys289Arg mutants are trafficked to the cell surface, but are unable to bind agonists efficiently. Conversely, LOF of p.Val38Met,  [CLS] p.Ser41Phe, and p.Val51Ala is due to reduced [CLS]  cell surface expression as a consequence of retention in the endoplasmic reticulum (ER). Therefore, LOF of MC1R alleles is"}
{"subject": "p.Val51Ala", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " are trafficked to the cell surface, but are unable to bind agonists efficiently. Conversely, LOF of p.Val38Met, p.Ser41Phe, and  [CLS] p.Val51Ala is due to reduced [CLS]  cell surface expression as a consequence of retention in the endoplasmic reticulum (ER). Therefore, LOF of MC1R alleles is"}
{"subject": "p.Asn281Ser", "sub_type": "Var", "rel": "CauseOf", "object": "silent", "obj_type": "NegReg", "file_name": "PubMed-19338054.json", "snippet": " described, and the others (c.112G>A, p.Val38Met; c.122C>T, p.Ser41Phe; c.383T>C, p.Met128Thr; and c.842A>G, p.Asn281Ser) have not been analyzed for function.  [CLS] p.Asn281Ser corresponds to a functionally silent [CLS]  polymorphism. The other mutations are associated with varying degrees of loss of function (LOF), from moderate decreases in coupling"}
{"subject": "p53-R175H expression vector", "sub_type": "Protein", "rel": "ThemeOf", "object": "inducing", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " human endometrial cancer KLE cells, we tested the consequences of up-regulation and down-regulation of p53-R175H in KLE cells by  [CLS] inducing p53-R175H expression vector [CLS]  or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted"}
{"subject": "p53-R175H expression vector", "sub_type": "Protein", "rel": "CauseOf", "object": "tested", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " the relationship between expression of p53 GOF mutation (p53-R175H) and invasive potential of human endometrial cancer KLE cells, we  [CLS] tested the consequences of up-regulation and down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector [CLS]  or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted"}
{"subject": "up-regulation", "sub_type": "PosReg", "rel": "ThemeOf", "object": "tested", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " the relationship between expression of p53 GOF mutation (p53-R175H) and invasive potential of human endometrial cancer KLE cells, we  [CLS] tested the consequences of up-regulation [CLS]  and down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector or suppressing the p53 gene with short"}
{"subject": "down-regulation", "sub_type": "NegReg", "rel": "ThemeOf", "object": "tested", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " the relationship between expression of p53 GOF mutation (p53-R175H) and invasive potential of human endometrial cancer KLE cells, we  [CLS] tested the consequences of up-regulation and down-regulation [CLS]  of p53-R175H in KLE cells by inducing p53-R175H expression vector or suppressing the p53 gene with short hairpin RNA."}
{"subject": "p53 gene", "sub_type": "Gene", "rel": "ThemeOf", "object": "suppressing", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " we tested the consequences of up-regulation and down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector or  [CLS] suppressing the p53 gene [CLS]  with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted cell migration and invasion, and"}
{"subject": "p53 gene", "sub_type": "Gene", "rel": "CauseOf", "object": "tested", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " the relationship between expression of p53 GOF mutation (p53-R175H) and invasive potential of human endometrial cancer KLE cells, we  [CLS] tested the consequences of up-regulation and down-regulation of p53-R175H in KLE cells by inducing p53-R175H expression vector or suppressing the p53 gene [CLS]  with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted cell migration and invasion, and"}
{"subject": "epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly promoted cell migration and invasion, and induced  [CLS] activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway [CLS] . Conversely, suppression of p53-R175H with short hairpin RNA significantly inhibited cell migration and invasion, and resulted in attenuation of"}
{"subject": "short hairpin RNA", "sub_type": "Gene", "rel": "CauseOf", "object": "suppression", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely,  [CLS] suppression of p53-R175H with short hairpin RNA [CLS]  significantly inhibited cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the"}
{"subject": "p53-R175H", "sub_type": "Protein", "rel": "ThemeOf", "object": "suppression", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely,  [CLS] suppression of p53-R175H [CLS]  with short hairpin RNA significantly inhibited cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These"}
{"subject": "p53-R175H", "sub_type": "Protein", "rel": "CauseOf", "object": "inhibited", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of  [CLS] p53-R175H with short hairpin RNA significantly inhibited [CLS]  cell migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time"}
{"subject": "cell migration and invasion", "sub_type": "CPA", "rel": "ThemeOf", "object": "inhibited", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of p53-R175H with short hairpin RNA significantly  [CLS] inhibited cell migration and invasion [CLS] , and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of"}
{"subject": "p53-R175H", "sub_type": "Protein", "rel": "CauseOf", "object": "attenuation", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of  [CLS] p53-R175H with short hairpin RNA significantly inhibited cell migration and invasion, and resulted in attenuation [CLS]  of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert"}
{"subject": "EGFR/PI3K/AKT pathway.", "sub_type": "Pathway", "rel": "ThemeOf", "object": "attenuation", "obj_type": "NegReg", "file_name": "PubMed-19917135.json", "snippet": " (PI3K)/AKT pathway. Conversely, suppression of p53-R175H with short hairpin RNA significantly inhibited cell migration and invasion, and resulted in  [CLS] attenuation of EGFR/PI3K/AKT pathway. [CLS] \nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert gain-of-function activity to"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that  [CLS] elevated expression [CLS]  of p53-R175H mutant may exert gain-of-function activity to activate the EGFR/PI3K/AKT pathway and thus may contribute to the invasive"}
{"subject": "function activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert  [CLS] gain-of-function activity [CLS]  to activate the EGFR/PI3K/AKT pathway and thus may contribute to the invasive phenotype in endometrial cancer."}
{"subject": "EGFR/PI3K/AKT pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "activate", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": "\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert gain-of-function activity to  [CLS] activate the EGFR/PI3K/AKT pathway [CLS]  and thus may contribute to the invasive phenotype in endometrial cancer."}
{"subject": "endometrial cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " time that elevated expression of p53-R175H mutant may exert gain-of-function activity to activate the EGFR/PI3K/AKT pathway and thus may  [CLS] contribute to the invasive phenotype in endometrial cancer [CLS] ."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R175H", "obj_type": "Var", "file_name": "PubMed-19917135.json", "snippet": " and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of  [CLS] p53-R175H [CLS]  mutant may exert gain-of-function activity to activate the EGFR/PI3K/AKT pathway and thus may contribute to the invasive phenotype in"}
{"subject": "R175H", "sub_type": "Var", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " migration and invasion, and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that  [CLS] elevated expression of p53-R175H [CLS]  mutant may exert gain-of-function activity to activate the EGFR/PI3K/AKT pathway and thus may contribute to the invasive phenotype in"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-19917135.json", "snippet": " mutants can gain novel oncogenic functions (gain-of-function, GOF) that actively regulate cancer development and progression. In human endometrial cancer,  [CLS] p53 mutation [CLS]  is more often associated with aggressive nonendometrioid cancer. However, it was unknown if p53 mutants contributed to endometrial cancer"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " can gain novel oncogenic functions (gain-of-function, GOF) that actively regulate cancer development and progression. In human endometrial cancer, p53  [CLS] mutation is more often associated [CLS]  with aggressive nonendometrioid cancer. However, it was unknown if p53 mutants contributed to endometrial cancer progression through the GOF"}
{"subject": "aggressive nonendometrioid cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": " functions (gain-of-function, GOF) that actively regulate cancer development and progression. In human endometrial cancer, p53 mutation is more often  [CLS] associated with aggressive nonendometrioid cancer [CLS] . However, it was unknown if p53 mutants contributed to endometrial cancer progression through the GOF properties.\nMETHODS: To clarify"}
{"subject": "R175H", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " and resulted in attenuation of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53- [CLS] R175H mutant may exert gain [CLS] -of-function activity to activate the EGFR/PI3K/AKT pathway and thus may contribute to the invasive phenotype in endometrial cancer."}
{"subject": "gain", "sub_type": "PosReg", "rel": "CauseOf", "object": "activate", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " of EGFR/PI3K/AKT pathway.\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert  [CLS] gain-of-function activity to activate [CLS]  the EGFR/PI3K/AKT pathway and thus may contribute to the invasive phenotype in endometrial cancer."}
{"subject": "activate", "sub_type": "PosReg", "rel": "CauseOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-19917135.json", "snippet": "\nCONCLUSION: These findings show for the first time that elevated expression of p53-R175H mutant may exert gain-of-function activity to  [CLS] activate the EGFR/PI3K/AKT pathway and thus may contribute [CLS]  to the invasive phenotype in endometrial cancer."}
{"subject": "R175H", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " [CLS] gain-of-function mutation R175H [CLS]  in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.\nBACKGROUND: p53 is the"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R175H", "obj_type": "Var", "file_name": "PubMed-19917135.json", "snippet": " [CLS] p53 gain-of-function mutation R175H [CLS]  in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.\nBACKGROUND: p53 is the"}
{"subject": "EGFR/PI3K/AKT pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " [CLS] gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway [CLS] .\nBACKGROUND: p53 is the most commonly mutated tumor suppressor gene in human cancers. In addition to the loss of"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R175H", "obj_type": "Var", "file_name": "PubMed-19917135.json", "snippet": " p53-R175H expression vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of  [CLS] p53-R175H [CLS]  significantly promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway."}
{"subject": "R175H", "sub_type": "Var", "rel": "CauseOf", "object": "over-expression", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " by inducing p53-R175H expression vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced  [CLS] over-expression of p53-R175H [CLS]  significantly promoted cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway."}
{"subject": "R175H", "sub_type": "Var", "rel": "CauseOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " p53-R175H expression vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53- [CLS] R175H significantly promoted [CLS]  cell migration and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression"}
{"subject": "cell migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly  [CLS] promoted cell migration [CLS]  and invasion, and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of p53-R175H"}
{"subject": "invasion", "sub_type": "CPA", "rel": "ThemeOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-19917135.json", "snippet": " vector or suppressing the p53 gene with short hairpin RNA.\nRESULTS: We found that forced over-expression of p53-R175H significantly  [CLS] promoted cell migration and invasion [CLS] , and induced activation of the epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Conversely, suppression of p53-R175H with short"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-20399956.json", "snippet": " malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by  [CLS] gain-of-function (GOF) mutations [CLS]  of Shp2, loss-of-function (LOF) mutations are thought to be associated with LEOPARD syndrome. Animal models that carry conditional LOF"}
{"subject": "Shp2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-20399956.json", "snippet": " as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by gain-of-function (GOF)  [CLS] mutations of Shp2 [CLS] , loss-of-function (LOF) mutations are thought to be associated with LEOPARD syndrome. Animal models that carry conditional LOF and GOF"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-20399956.json", "snippet": " common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by gain-of-function (GOF) mutations of Shp2,  [CLS] loss-of-function (LOF) mutations [CLS]  are thought to be associated with LEOPARD syndrome. Animal models that carry conditional LOF and GOF mutations have allowed"}
{"subject": "Shp2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-20399956.json", "snippet": " syndromes, two multisymptomatic developmental disorders that are characterized by short stature, craniofacial defects, cardiac defects, and mental retardation. Somatic  [CLS] Shp2 mutations [CLS]  are also associated with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-20399956.json", "snippet": " two multisymptomatic developmental disorders that are characterized by short stature, craniofacial defects, cardiac defects, and mental retardation. Somatic Shp2  [CLS] mutations are also associated [CLS]  with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS"}
{"subject": "juvenile myelomonocytic leukemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-20399956.json", "snippet": " disorders that are characterized by short stature, craniofacial defects, cardiac defects, and mental retardation. Somatic Shp2 mutations are also  [CLS] associated with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia [CLS]  (JMML). Whereas NS and JMML are caused by gain-of-function (GOF) mutations of Shp2, loss-of-function (LOF) mutations are thought to"}
{"subject": "NS", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-20399956.json", "snippet": " associated with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas  [CLS] NS and JMML are caused by gain-of-function [CLS]  (GOF) mutations of Shp2, loss-of-function (LOF) mutations are thought to be associated with LEOPARD syndrome. Animal models that carry"}
{"subject": "JMML", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-20399956.json", "snippet": " several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and  [CLS] JMML are caused by gain-of-function [CLS]  (GOF) mutations of Shp2, loss-of-function (LOF) mutations are thought to be associated with LEOPARD syndrome. Animal models that carry"}
{"subject": "LEOPARD syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-20399956.json", "snippet": " common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by gain-of-function (GOF) mutations of Shp2,  [CLS] loss-of-function (LOF) mutations are thought to be associated with LEOPARD syndrome [CLS] . Animal models that carry conditional LOF and GOF mutations have allowed a better understanding of the mechanism of Shp2"}
{"subject": "Shp2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-20399956.json", "snippet": " most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by gain-of-function (GOF) mutations of  [CLS] Shp2, loss-of-function (LOF) mutations [CLS]  are thought to be associated with LEOPARD syndrome. Animal models that carry conditional LOF and GOF mutations have allowed"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " [CLS] Mutant p53 [CLS]  facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells.\np53 deficiency enhances the efficiency of somatic"}
{"subject": "activities", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " reprogramming to a pluripotent state. As p53 is usually mutated in human tumors and many mutated forms of p53  [CLS] gain novel activities [CLS] , we studied the influence of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a novel gain of"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutated", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in human tumors and many  [CLS] mutated forms of p53 [CLS]  gain novel activities, we studied the influence of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a"}
{"subject": "mut-p53", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " novel activities, we studied the influence of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a novel  [CLS] gain of function (GOF) property for mut-p53 [CLS] , which markedly enhanced the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel activity of mut-p53"}
{"subject": "function", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " novel activities, we studied the influence of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a novel  [CLS] gain of function [CLS]  (GOF) property for mut-p53, which markedly enhanced the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this"}
{"subject": "mut-p53", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a novel gain of function (GOF) property for  [CLS] mut-p53, which markedly enhanced [CLS]  the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel activity of mut-p53 induced alterations in"}
{"subject": "reprogramming process", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " (mut-p53) on somatic cell reprogramming. Our data indicate a novel gain of function (GOF) property for mut-p53, which markedly  [CLS] enhanced the efficiency of the reprogramming process [CLS]  compared with p53 deficiency. Importantly, this novel activity of mut-p53 induced alterations in the characteristics of the reprogrammed cells."}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "mut", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " property for mut-p53, which markedly enhanced the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel  [CLS] activity of mut [CLS] -p53 induced alterations in the characteristics of the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and"}
{"subject": "mut", "sub_type": "Var", "rel": "CauseOf", "object": "alterations", "obj_type": "Reg", "file_name": "PubMed-20696700.json", "snippet": " mut-p53, which markedly enhanced the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel activity of  [CLS] mut-p53 induced alterations [CLS]  in the characteristics of the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained"}
{"subject": "characteristics of the reprogrammed cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "alterations", "obj_type": "Reg", "file_name": "PubMed-20696700.json", "snippet": " markedly enhanced the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel activity of mut-p53 induced  [CLS] alterations in the characteristics of the reprogrammed cells [CLS] . Although p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-20696700.json", "snippet": " p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells expressing  [CLS] mutant p53 lost [CLS]  this capability and gave rise to malignant tumors. This novel GOF of mut-p53 is not attributed to its effect"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "facilitates", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " [CLS] Mutant p53 facilitates [CLS]  somatic cell reprogramming and augments the malignant potential of reprogrammed cells.\np53 deficiency enhances the efficiency of somatic cell"}
{"subject": "pluripotent capacity", "sub_type": "MPA", "rel": "ThemeOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-20696700.json", "snippet": " the characteristics of the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their  [CLS] pluripotent capacity in vivo, reprogrammed cells expressing mutant p53 lost [CLS]  this capability and gave rise to malignant tumors. This novel GOF of mut-p53 is not attributed to its effect"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells expressing  [CLS] mutant p53 [CLS]  lost this capability and gave rise to malignant tumors. This novel GOF of mut-p53 is not attributed to its"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gave rise", "obj_type": "Reg", "file_name": "PubMed-20696700.json", "snippet": " p53 knockout (KO) cells reprogrammed with only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells expressing  [CLS] mutant p53 lost this capability and gave rise [CLS]  to malignant tumors. This novel GOF of mut-p53 is not attributed to its effect on proliferation, as both p53"}
{"subject": "malignant tumors", "sub_type": "CPA", "rel": "ThemeOf", "object": "gave rise", "obj_type": "Reg", "file_name": "PubMed-20696700.json", "snippet": " only Oct4 and Sox2 maintained their pluripotent capacity in vivo, reprogrammed cells expressing mutant p53 lost this capability and  [CLS] gave rise to malignant tumors [CLS] . This novel GOF of mut-p53 is not attributed to its effect on proliferation, as both p53 KO and mut-p53"}
{"subject": "overexpression", "sub_type": "PosReg", "rel": "ThemeOf", "object": "mut", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " KO and mut-p53 cells displayed similar proliferation rates. In addition, we demonstrate an oncogenic activity of Klf4, as its  [CLS] overexpression in either p53 KO or mut [CLS] -p53 cells induced aggressive tumors. Overall, our data show that reprogrammed cells with the capacity to differentiate into the three"}
{"subject": "mut", "sub_type": "Var", "rel": "CauseOf", "object": "induced", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " proliferation rates. In addition, we demonstrate an oncogenic activity of Klf4, as its overexpression in either p53 KO or  [CLS] mut-p53 cells induced [CLS]  aggressive tumors. Overall, our data show that reprogrammed cells with the capacity to differentiate into the three germ layers"}
{"subject": "aggressive tumors", "sub_type": "CPA", "rel": "ThemeOf", "object": "induced", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " In addition, we demonstrate an oncogenic activity of Klf4, as its overexpression in either p53 KO or mut-p53 cells  [CLS] induced aggressive tumors [CLS] . Overall, our data show that reprogrammed cells with the capacity to differentiate into the three germ layers in vitro"}
{"subject": "oncogenic activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "mut", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " effect on proliferation, as both p53 KO and mut-p53 cells displayed similar proliferation rates. In addition, we demonstrate an  [CLS] oncogenic activity of Klf4, as its overexpression in either p53 KO or mut [CLS] -p53 cells induced aggressive tumors. Overall, our data show that reprogrammed cells with the capacity to differentiate into the three"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutated", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " germ layers in vitro can form malignant tumors, suggesting that in genetically unstable cells, such as those in which  [CLS] p53 is mutated [CLS] , reprogramming may result in the generation of cells with malignant tumor-forming potential."}
{"subject": "mutated", "sub_type": "Var", "rel": "CauseOf", "object": "reprogramming", "obj_type": "CPA", "file_name": "PubMed-20696700.json", "snippet": " in vitro can form malignant tumors, suggesting that in genetically unstable cells, such as those in which p53 is  [CLS] mutated, reprogramming [CLS]  may result in the generation of cells with malignant tumor-forming potential."}
{"subject": "somatic cell reprogramming", "sub_type": "CPA", "rel": "ThemeOf", "object": "facilitates", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " [CLS] facilitates somatic cell reprogramming [CLS]  and augments the malignant potential of reprogrammed cells.\np53 deficiency enhances the efficiency of somatic cell reprogramming to a"}
{"subject": "reprogramming", "sub_type": "CPA", "rel": "CauseOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-20696700.json", "snippet": " vitro can form malignant tumors, suggesting that in genetically unstable cells, such as those in which p53 is mutated,  [CLS] reprogramming may result in [CLS]  the generation of cells with malignant tumor-forming potential."}
{"subject": "cells with malignant tumor-forming potential", "sub_type": "CPA", "rel": "ThemeOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-20696700.json", "snippet": " form malignant tumors, suggesting that in genetically unstable cells, such as those in which p53 is mutated, reprogramming may  [CLS] result in the generation of cells with malignant tumor-forming potential [CLS] ."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mut", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " mut-p53, which markedly enhanced the efficiency of the reprogramming process compared with p53 deficiency. Importantly, this novel activity of  [CLS] mut-p53 [CLS]  induced alterations in the characteristics of the reprogrammed cells. Although p53 knockout (KO) cells reprogrammed with only Oct4 and"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mut", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " proliferation rates. In addition, we demonstrate an oncogenic activity of Klf4, as its overexpression in either p53 KO or  [CLS] mut-p53 [CLS]  cells induced aggressive tumors. Overall, our data show that reprogrammed cells with the capacity to differentiate into the three"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "augments", "obj_type": "NegReg", "file_name": "PubMed-20696700.json", "snippet": " [CLS] Mutant p53 facilitates somatic cell reprogramming and augments [CLS]  the malignant potential of reprogrammed cells.\np53 deficiency enhances the efficiency of somatic cell reprogramming to a pluripotent state."}
{"subject": "malignant potential of reprogrammed cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "augments", "obj_type": "NegReg", "file_name": "PubMed-20696700.json", "snippet": " [CLS] augments the malignant potential of reprogrammed cells [CLS] .\np53 deficiency enhances the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "deficiency", "obj_type": "Var", "file_name": "PubMed-20696700.json", "snippet": " [CLS] p53 deficiency [CLS]  enhances the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in human tumors"}
{"subject": "deficiency", "sub_type": "Var", "rel": "CauseOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " [CLS] deficiency enhances [CLS]  the efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in human tumors and"}
{"subject": "somatic cell reprogramming", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " [CLS] enhances the efficiency of somatic cell reprogramming [CLS]  to a pluripotent state. As p53 is usually mutated in human tumors and many mutated forms of p53 gain"}
{"subject": "mutated", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-20696700.json", "snippet": " efficiency of somatic cell reprogramming to a pluripotent state. As p53 is usually mutated in human tumors and many  [CLS] mutated forms of p53 gain [CLS]  novel activities, we studied the influence of mutant p53 (mut-p53) on somatic cell reprogramming. Our data indicate a novel"}
{"subject": "CYP2B6", "sub_type": "Var", "rel": "CauseOf", "object": "bioactivation of cyclophosphamide", "obj_type": "MPA", "file_name": "PubMed-21175440.json", "snippet": " CYP2C19 and CYP2B6 genotype and protein expression we observed that there was a combined role for both CYP2C19 and  [CLS] CYP2B6 in the bioactivation of cyclophosphamide [CLS]  in vitro. The presence of at least one loss of function (LoF) allele at either CYP2C19 or CYP2B6 resulted"}
{"subject": "CYP2B6", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " patients with no LoF alleles at either of these genes.\nCONCLUSIONS: The presence of \u22651 LoF allele(s) at either  [CLS] CYP2B6 or CYP2C19 appeared to result in decreased [CLS]  bioactivation of cyclophosphamide both in vitro and in patients. Further clinical studies to confirm this relationship are warranted."}
{"subject": "CYP2C19", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " no LoF alleles at either of these genes.\nCONCLUSIONS: The presence of \u22651 LoF allele(s) at either CYP2B6 or  [CLS] CYP2C19 appeared to result in decreased [CLS]  bioactivation of cyclophosphamide both in vitro and in patients. Further clinical studies to confirm this relationship are warranted."}
{"subject": "bioactivation of cyclophosphamide", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " of these genes.\nCONCLUSIONS: The presence of \u22651 LoF allele(s) at either CYP2B6 or CYP2C19 appeared to result in  [CLS] decreased bioactivation of cyclophosphamide [CLS]  both in vitro and in patients. Further clinical studies to confirm this relationship are warranted."}
{"subject": "CYP2C19", "sub_type": "Var", "rel": "CauseOf", "object": "bioactivation of cyclophosphamide", "obj_type": "MPA", "file_name": "PubMed-21175440.json", "snippet": " of known CYP2C19 and CYP2B6 genotype and protein expression we observed that there was a combined role for both  [CLS] CYP2C19 and CYP2B6 in the bioactivation of cyclophosphamide [CLS]  in vitro. The presence of at least one loss of function (LoF) allele at either CYP2C19 or CYP2B6 resulted"}
{"subject": "combined", "sub_type": "Interaction", "rel": "ThemeOf", "object": "bioactivation of cyclophosphamide", "obj_type": "MPA", "file_name": "PubMed-21175440.json", "snippet": " 16)\nRESULTS: In livers of known CYP2C19 and CYP2B6 genotype and protein expression we observed that there was a  [CLS] combined role for both CYP2C19 and CYP2B6 in the bioactivation of cyclophosphamide [CLS]  in vitro. The presence of at least one loss of function (LoF) allele at either CYP2C19 or CYP2B6 resulted"}
{"subject": "CYP2C19", "sub_type": "Var", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " the bioactivation of cyclophosphamide in vitro. The presence of at least one loss of function (LoF) allele at either  [CLS] CYP2C19 or CYP2B6 resulted in a significant decrease [CLS]  in both V(max) (P= 0.028) and CL(int) (P= 0.0017) compared with livers with no LoF alleles. This dual genotype"}
{"subject": "CYP2B6", "sub_type": "Var", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " of cyclophosphamide in vitro. The presence of at least one loss of function (LoF) allele at either CYP2C19 or  [CLS] CYP2B6 resulted in a significant decrease [CLS]  in both V(max) (P= 0.028) and CL(int) (P= 0.0017) compared with livers with no LoF alleles. This dual genotype"}
{"subject": "V(max) (P= 0.028) and CL(int) (P= 0.0017)", "sub_type": "MPA", "rel": "ThemeOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " presence of at least one loss of function (LoF) allele at either CYP2C19 or CYP2B6 resulted in a significant  [CLS] decrease in both V(max) (P= 0.028) and CL(int) (P= 0.0017) [CLS]  compared with livers with no LoF alleles. This dual genotype relationship was also observed in a preliminary clinical study,"}
{"subject": "CYP2C19", "sub_type": "Var", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " genotype relationship was also observed in a preliminary clinical study, with patients who had \u22651 LoF allele at either  [CLS] CYP2C19 or CYP2B6 also displaying significantly (P= 0.0316) lower [CLS]  bioactivation of cyclophosphamide. The mean 4-OHCP : CP bioactivation ratio was 0.0014 (95% CI 0.0007, 0.002) compared with 0.0071"}
{"subject": "CYP2B6", "sub_type": "Var", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " was also observed in a preliminary clinical study, with patients who had \u22651 LoF allele at either CYP2C19 or  [CLS] CYP2B6 also displaying significantly (P= 0.0316) lower [CLS]  bioactivation of cyclophosphamide. The mean 4-OHCP : CP bioactivation ratio was 0.0014 (95% CI 0.0007, 0.002) compared with 0.0071"}
{"subject": "bioactivation of cyclophosphamide", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-21175440.json", "snippet": " clinical study, with patients who had \u22651 LoF allele at either CYP2C19 or CYP2B6 also displaying significantly (P= 0.0316)  [CLS] lower bioactivation of cyclophosphamide [CLS] . The mean 4-OHCP : CP bioactivation ratio was 0.0014 (95% CI 0.0007, 0.002) compared with 0.0071 (95% CI 0.0001,"}
{"subject": "TP53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-21187651.json", "snippet": " in vitro invasiveness of human lung cancer NCI-H1299 cells.\nMore than half of all human cancers are associated with  [CLS] mutations of the TP53 [CLS]  gene. In regard to the functional interaction with the remaining wild-type (WT) p53 allele, p53 mutations are classified into"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-21187651.json", "snippet": " R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells.\nMore than half of all human cancers are  [CLS] associated with mutations [CLS]  of the TP53 gene. In regard to the functional interaction with the remaining wild-type (WT) p53 allele, p53 mutations"}
{"subject": "human cancers", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-21187651.json", "snippet": " R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells.\nMore than half of all  [CLS] human cancers are associated [CLS]  with mutations of the TP53 gene. In regard to the functional interaction with the remaining wild-type (WT) p53 allele,"}
{"subject": "dominant-negative (DN) mutations", "sub_type": "Var", "rel": "CauseOf", "object": "over the remaining WT allele", "obj_type": "PosReg", "file_name": "PubMed-21187651.json", "snippet": " the functional interaction with the remaining wild-type (WT) p53 allele, p53 mutations are classified into two types, recessive and  [CLS] dominant-negative (DN) mutations. The latter mutant protein has a DN activity over the remaining WT allele [CLS] . We previously showed that the DN p53 mutant was useful as a predictor of poor outcome or a risk"}
{"subject": "DN activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "over the remaining WT allele", "obj_type": "PosReg", "file_name": "PubMed-21187651.json", "snippet": " allele, p53 mutations are classified into two types, recessive and dominant-negative (DN) mutations. The latter mutant protein has a  [CLS] DN activity over the remaining WT allele [CLS] . We previously showed that the DN p53 mutant was useful as a predictor of poor outcome or a risk"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "DN", "obj_type": "Var", "file_name": "PubMed-21187651.json", "snippet": " of cancers, regardless of the presence or absence of loss of heterozygosity (LOH) of WT p53, suggesting that the  [CLS] DN p53 [CLS]  had 'gain-of-function (GOF)' activity besides the transdominance function. In this study, we investigated GOF activity of two DN p53"}
{"subject": "DN", "sub_type": "Var", "rel": "CauseOf", "object": "'gain-of-function (GOF)' activity", "obj_type": "PosReg", "file_name": "PubMed-21187651.json", "snippet": " of cancers, regardless of the presence or absence of loss of heterozygosity (LOH) of WT p53, suggesting that the  [CLS] DN p53 had 'gain-of-function (GOF)' activity [CLS]  besides the transdominance function. In this study, we investigated GOF activity of two DN p53 mutants which had a"}
{"subject": "R248Q-transfectants", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-21187651.json", "snippet": " from that of parent or Mock transfectants. Meanwhile, in vitro invasions of Matrigel and type I collagen gel by  [CLS] R248Q-transfectants were significantly higher [CLS]  than those by R248W-transfectants or the control cells. However, there were no differences in cell motile activities, expressions of"}
{"subject": "vitro invasions of Matrigel and type I collagen gel", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-21187651.json", "snippet": " of the transfectants with the two mutants was not different from that of parent or Mock transfectants. Meanwhile, in  [CLS] vitro invasions of Matrigel and type I collagen gel by R248Q-transfectants were significantly higher [CLS]  than those by R248W-transfectants or the control cells. However, there were no differences in cell motile activities, expressions of"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "upregulates", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " [CLS] mutant p53 upregulates [CLS]  CXC chemokines and enhances cell migration.\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous"}
{"subject": "p53 -R175H, -R273H and -D281G", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " and metastasis. Here, we examined potential mechanisms through which gain-of-function (GOF) p53 proteins can induce motility. Cells expressing GOF  [CLS] p53 -R175H, -R273H and -D281G showed enhanced [CLS]  migration, which was reversed by RNA interference (RNAi) or transactivation-deficient mutants. In cells with engineered or endogenous p53 mutants,"}
{"subject": "migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " mechanisms through which gain-of-function (GOF) p53 proteins can induce motility. Cells expressing GOF p53 -R175H, -R273H and -D281G showed  [CLS] enhanced migration [CLS] , which was reversed by RNA interference (RNAi) or transactivation-deficient mutants. In cells with engineered or endogenous p53 mutants, enhanced"}
{"subject": "GOF p53", "sub_type": "Var", "rel": "CauseOf", "object": "upregulate", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " endogenous p53 mutants, enhanced migration was reduced by downregulation of nuclear factor-kappaB2, a GOF p53 target. We found that  [CLS] GOF p53 proteins upregulate [CLS]  CXC-chemokine expression, the inflammatory mediators that contribute to multiple aspects of tumorigenesis. Elevated expression of CXCL5, CXCL8 and CXCL12"}
{"subject": "CXC-chemokine expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "upregulate", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " enhanced migration was reduced by downregulation of nuclear factor-kappaB2, a GOF p53 target. We found that GOF p53 proteins  [CLS] upregulate CXC-chemokine expression [CLS] , the inflammatory mediators that contribute to multiple aspects of tumorigenesis. Elevated expression of CXCL5, CXCL8 and CXCL12 was found"}
{"subject": "oncogenic p53", "sub_type": "Var", "rel": "CauseOf", "object": "Elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " We found that GOF p53 proteins upregulate CXC-chemokine expression, the inflammatory mediators that contribute to multiple aspects of tumorigenesis.  [CLS] Elevated expression of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53 [CLS] . Transcription was elevated as CXCL5 and CXCL8 promoter activity was higher in cells expressing GOF p53, whereas wild-type p53"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "Elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " We found that GOF p53 proteins upregulate CXC-chemokine expression, the inflammatory mediators that contribute to multiple aspects of tumorigenesis.  [CLS] Elevated expression [CLS]  of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53. Transcription was elevated as CXCL5 and CXCL8"}
{"subject": "GOF p53", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " and CXCL12 was found in cells expressing oncogenic p53. Transcription was elevated as CXCL5 and CXCL8 promoter activity was  [CLS] higher in cells expressing GOF p53 [CLS] , whereas wild-type p53 repressed promoter activity. Chromatin immunoprecipitation assays revealed enhanced presence of acetylated histone H3 on the CXCL5"}
{"subject": "CXCL5 and CXCL8 promoter activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " tumorigenesis. Elevated expression of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53. Transcription was elevated as  [CLS] CXCL5 and CXCL8 promoter activity was higher [CLS]  in cells expressing GOF p53, whereas wild-type p53 repressed promoter activity. Chromatin immunoprecipitation assays revealed enhanced presence of acetylated"}
{"subject": "CXCL5 and CXCL8 promoter activity", "sub_type": "MPA", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " aspects of tumorigenesis. Elevated expression of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53. Transcription was  [CLS] elevated as CXCL5 and CXCL8 promoter activity [CLS]  was higher in cells expressing GOF p53, whereas wild-type p53 repressed promoter activity. Chromatin immunoprecipitation assays revealed enhanced presence"}
{"subject": "CXC chemokines", "sub_type": "MPA", "rel": "ThemeOf", "object": "upregulates", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " [CLS] upregulates CXC chemokines [CLS]  and enhances cell migration.\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested"}
{"subject": "Transcription", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " to multiple aspects of tumorigenesis. Elevated expression of CXCL5, CXCL8 and CXCL12 was found in cells expressing oncogenic p53.  [CLS] Transcription was elevated [CLS]  as CXCL5 and CXCL8 promoter activity was higher in cells expressing GOF p53, whereas wild-type p53 repressed promoter activity."}
{"subject": "endogenous mutant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-22114072.json", "snippet": " transcriptional activity of the promoter, whereas RNAi-mediated repression of CXCL5 inhibited cell migration. Consistent with this, knockdown of the  [CLS] endogenous mutant p53 in lung cancer or melanoma cells reduced [CLS]  CXCL5 expression and cell migration. Furthermore, short hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells reduced expression of"}
{"subject": "CXCL5 expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-22114072.json", "snippet": " CXCL5 inhibited cell migration. Consistent with this, knockdown of the endogenous mutant p53 in lung cancer or melanoma cells  [CLS] reduced CXCL5 expression [CLS]  and cell migration. Furthermore, short hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells reduced expression of a number"}
{"subject": "cell migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-22114072.json", "snippet": " CXCL5 inhibited cell migration. Consistent with this, knockdown of the endogenous mutant p53 in lung cancer or melanoma cells  [CLS] reduced CXCL5 expression and cell migration [CLS] . Furthermore, short hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells reduced expression of a number of key targets,"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "endogenous mutant", "obj_type": "Var", "file_name": "PubMed-22114072.json", "snippet": " transcriptional activity of the promoter, whereas RNAi-mediated repression of CXCL5 inhibited cell migration. Consistent with this, knockdown of the  [CLS] endogenous mutant p53 [CLS]  in lung cancer or melanoma cells reduced CXCL5 expression and cell migration. Furthermore, short hairpin RNA knockdown of mutant"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-22114072.json", "snippet": " p53 in lung cancer or melanoma cells reduced CXCL5 expression and cell migration. Furthermore, short hairpin RNA knockdown of  [CLS] mutant p53 in MDA-MB-231 cells reduced [CLS]  expression of a number of key targets, including several chemokines and other inflammatory mediators. Finally, CXCL5 expression was also"}
{"subject": "expression of a number of key targets", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-22114072.json", "snippet": " melanoma cells reduced CXCL5 expression and cell migration. Furthermore, short hairpin RNA knockdown of mutant p53 in MDA-MB-231 cells  [CLS] reduced expression of a number of key targets [CLS] , including several chemokines and other inflammatory mediators. Finally, CXCL5 expression was also elevated in lung tumor samples containing GOF"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-22114072.json", "snippet": " p53 in lung cancer or melanoma cells reduced CXCL5 expression and cell migration. Furthermore, short hairpin RNA knockdown of  [CLS] mutant p53 [CLS]  in MDA-MB-231 cells reduced expression of a number of key targets, including several chemokines and other inflammatory mediators. Finally,"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-22114072.json", "snippet": " [CLS] mutant p53 [CLS]  upregulates CXC chemokines and enhances cell migration.\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our"}
{"subject": "GOF p53", "sub_type": "Var", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " expression of a number of key targets, including several chemokines and other inflammatory mediators. Finally, CXCL5 expression was also  [CLS] elevated in lung tumor samples containing GOF p53 [CLS] , indicating relevance to human cancer. The data suggest a mechanistic link between GOF p53 proteins and chemokines in enhanced"}
{"subject": "CXCL5 expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " in MDA-MB-231 cells reduced expression of a number of key targets, including several chemokines and other inflammatory mediators. Finally,  [CLS] CXCL5 expression was also elevated [CLS]  in lung tumor samples containing GOF p53, indicating relevance to human cancer. The data suggest a mechanistic link between"}
{"subject": "lung tumor", "sub_type": "Disease", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " expression of a number of key targets, including several chemokines and other inflammatory mediators. Finally, CXCL5 expression was also  [CLS] elevated in lung tumor [CLS]  samples containing GOF p53, indicating relevance to human cancer. The data suggest a mechanistic link between GOF p53 proteins"}
{"subject": "CXC chemokines", "sub_type": "MPA", "rel": "CauseOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " [CLS] CXC chemokines and enhances [CLS]  cell migration.\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested that aberrant"}
{"subject": "cell migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " [CLS] enhances cell migration [CLS] .\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested that aberrant p53 proteins"}
{"subject": "aberrant", "sub_type": "Var", "rel": "CauseOf", "object": "enhance", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " enhances cell migration.\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested that  [CLS] aberrant p53 proteins can enhance [CLS]  tumorigenesis and metastasis. Here, we examined potential mechanisms through which gain-of-function (GOF) p53 proteins can induce motility. Cells expressing"}
{"subject": "tumorigenesis and metastasis", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhance", "obj_type": "PosReg", "file_name": "PubMed-22114072.json", "snippet": " role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested that aberrant p53 proteins can  [CLS] enhance tumorigenesis and metastasis [CLS] . Here, we examined potential mechanisms through which gain-of-function (GOF) p53 proteins can induce motility. Cells expressing GOF p53 -R175H,"}
{"subject": "p53 proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "aberrant", "obj_type": "Var", "file_name": "PubMed-22114072.json", "snippet": " enhances cell migration.\nThe role of dominant transforming p53 in carcinogenesis is poorly understood. Our previous data suggested that  [CLS] aberrant p53 proteins [CLS]  can enhance tumorigenesis and metastasis. Here, we examined potential mechanisms through which gain-of-function (GOF) p53 proteins can induce motility."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-22989750.json", "snippet": " [CLS] p53 mutants [CLS]  in lung cancer cells.\np53 mutations are mostly single amino acid changes resulting in expression of a stable mutant"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " of function of wild-type p53. Knock-down of mutant p53 in human lung cancer cell lines with different endogenous p53  [CLS] mutants results in loss [CLS]  of GOF activity as shown by lowering of cell growth rate. Two lung cancer cell lines, ABC1 and H1437,"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " wild-type p53. Knock-down of mutant p53 in human lung cancer cell lines with different endogenous p53 mutants results in  [CLS] loss of GOF activity [CLS]  as shown by lowering of cell growth rate. Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "lowering", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " of function of wild-type p53. Knock-down of mutant p53 in human lung cancer cell lines with different endogenous p53  [CLS] mutants results in loss of GOF activity as shown by lowering [CLS]  of cell growth rate. Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show"}
{"subject": "cell growth rate", "sub_type": "CPA", "rel": "ThemeOf", "object": "lowering", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " human lung cancer cell lines with different endogenous p53 mutants results in loss of GOF activity as shown by  [CLS] lowering of cell growth rate [CLS] . Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show reduction in growth rate"}
{"subject": "mutants p53-P278S and -R267P", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " activity as shown by lowering of cell growth rate. Two lung cancer cell lines, ABC1 and H1437, carrying endogenous  [CLS] mutants p53-P278S and -R267P, show reduction [CLS]  in growth rate on knock-down on p53 levels. However, whereas reduction of the p53 level induces loss of tumorigenicity"}
{"subject": "growth rate", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " of cell growth rate. Two lung cancer cell lines, ABC1 and H1437, carrying endogenous mutants p53-P278S and -R267P, show  [CLS] reduction in growth rate [CLS]  on knock-down on p53 levels. However, whereas reduction of the p53 level induces loss of tumorigenicity in nude mice"}
{"subject": "tumorigenicity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " -R267P, show reduction in growth rate on knock-down on p53 levels. However, whereas reduction of the p53 level induces  [CLS] loss of tumorigenicity [CLS]  in nude mice for ABC1 cells, it escalates tumorigenicity for H1437 cells. We have tested their transactivation potential on"}
{"subject": "reduction", "sub_type": "NegReg", "rel": "ThemeOf", "object": "p53", "obj_type": "Var", "file_name": "PubMed-22989750.json", "snippet": " H1437, carrying endogenous mutants p53-P278S and -R267P, show reduction in growth rate on knock-down on p53 levels. However, whereas  [CLS] reduction of the p53 [CLS]  level induces loss of tumorigenicity in nude mice for ABC1 cells, it escalates tumorigenicity for H1437 cells. We have"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] gain-of-function activity of p53 mutants [CLS]  in lung cancer cells.\np53 mutations are mostly single amino acid changes resulting in expression of a stable mutant"}
{"subject": "p53", "sub_type": "Var", "rel": "CauseOf", "object": "escalates", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " mutants p53-P278S and -R267P, show reduction in growth rate on knock-down on p53 levels. However, whereas reduction of the  [CLS] p53 level induces loss of tumorigenicity in nude mice for ABC1 cells, it escalates [CLS]  tumorigenicity for H1437 cells. We have tested their transactivation potential on p53 target gene promoters by performing transient transcriptional"}
{"subject": "tumorigenicity", "sub_type": "MPA", "rel": "ThemeOf", "object": "escalates", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " levels. However, whereas reduction of the p53 level induces loss of tumorigenicity in nude mice for ABC1 cells, it  [CLS] escalates tumorigenicity [CLS]  for H1437 cells. We have tested their transactivation potential on p53 target gene promoters by performing transient transcriptional assays"}
{"subject": "p53", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-22989750.json", "snippet": " mutants p53-P278S and -R267P, show reduction in growth rate on knock-down on p53 levels. However, whereas reduction of the  [CLS] p53 level induces loss [CLS]  of tumorigenicity in nude mice for ABC1 cells, it escalates tumorigenicity for H1437 cells. We have tested their transactivation"}
{"subject": "lung cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] gain-of-function activity of p53 mutants in lung cancer [CLS]  cells.\np53 mutations are mostly single amino acid changes resulting in expression of a stable mutant protein with \"gain"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] gain-of-function activity [CLS]  of p53 mutants in lung cancer cells.\np53 mutations are mostly single amino acid changes resulting in expression of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "resulting in", "obj_type": "Reg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] mutations are mostly single amino acid changes resulting in [CLS]  expression of a stable mutant protein with \"gain of function\" (GOF) activity having a dominant oncogenic role rather than"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "resulting in", "obj_type": "Reg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] resulting in expression [CLS]  of a stable mutant protein with \"gain of function\" (GOF) activity having a dominant oncogenic role rather than simple"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-22989750.json", "snippet": " [CLS] p53 mutations [CLS]  are mostly single amino acid changes resulting in expression of a stable mutant protein with \"gain of function\" (GOF)"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " [CLS] mutations are mostly single amino acid changes resulting in expression of a stable mutant protein with \"gain of function [CLS] \" (GOF) activity having a dominant oncogenic role rather than simple loss of function of wild-type p53. Knock-down of mutant"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-22989750.json", "snippet": " cancer cells.\np53 mutations are mostly single amino acid changes resulting in expression of a stable mutant protein with \" [CLS] gain of function\" (GOF) activity [CLS]  having a dominant oncogenic role rather than simple loss of function of wild-type p53. Knock-down of mutant p53 in"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-22989750.json", "snippet": " loss of function of wild-type p53. Knock-down of mutant p53 in human lung cancer cell lines with different endogenous  [CLS] p53 mutants [CLS]  results in loss of GOF activity as shown by lowering of cell growth rate. Two lung cancer cell lines,"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-23264849.json", "snippet": " with p53 mutations, in general, grow more aggressively than those with wild-type p53 or no p53. Expression of tumor-derived  [CLS] mutant p53 [CLS]  in cells leads to up-regulated expression of genes that may affect cell growth and oncogenesis. In our study of"}
{"subject": "expression of genes", "sub_type": "MPA", "rel": "CauseOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " aggressively than those with wild-type p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to up-regulated  [CLS] expression of genes that may affect [CLS]  cell growth and oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor protein tyrosine kinase"}
{"subject": "cell growth", "sub_type": "CPA", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to up-regulated expression of genes that may  [CLS] affect cell growth [CLS]  and oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor protein tyrosine kinase Axl, which"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "up-regulated", "obj_type": "PosReg", "file_name": "PubMed-23264849.json", "snippet": " oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor protein tyrosine kinase Axl, which is  [CLS] up-regulated by p53 mutants [CLS]  at both RNA and protein levels in H1299 lung cancer cells expressing mutants p53-R175H, -R273H, and -D281G. Knockdown of"}
{"subject": "tyrosine kinase Axl", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "up-regulated", "obj_type": "PosReg", "file_name": "PubMed-23264849.json", "snippet": " may affect cell growth and oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor protein  [CLS] tyrosine kinase Axl, which is up-regulated [CLS]  by p53 mutants at both RNA and protein levels in H1299 lung cancer cells expressing mutants p53-R175H, -R273H, and"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-23264849.json", "snippet": " our study of this aggressive phenotype, we have investigated the receptor protein tyrosine kinase Axl, which is up-regulated by  [CLS] p53 mutants [CLS]  at both RNA and protein levels in H1299 lung cancer cells expressing mutants p53-R175H, -R273H, and -D281G. Knockdown of"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-23264849.json", "snippet": " immunoprecipitation (ChIP) assays carried out with acetylated histone antibodies demonstrated induced histone acetylation on the Axl promoter region by  [CLS] mutant p53 [CLS] . Direct mutant p53 nucleation on the Axl promoter was demonstrated by ChIP assays using antibodies against p53. The Axl"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "histone", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " in the up-regulation of Axl gene expression. Chromatin immunoprecipitation (ChIP) assays carried out with acetylated histone antibodies demonstrated induced  [CLS] histone acetylation on the Axl promoter region by mutant [CLS]  p53. Direct mutant p53 nucleation on the Axl promoter was demonstrated by ChIP assays using antibodies against p53. The"}
{"subject": "acetylation on the Axl promoter region", "sub_type": "MPA", "rel": "ThemeOf", "object": "histone", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " in the up-regulation of Axl gene expression. Chromatin immunoprecipitation (ChIP) assays carried out with acetylated histone antibodies demonstrated induced  [CLS] histone acetylation on the Axl promoter region [CLS]  by mutant p53. Direct mutant p53 nucleation on the Axl promoter was demonstrated by ChIP assays using antibodies against"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-23264849.json", "snippet": " and motility rate in lung cancer cells expressing mutant p53. This indicates that for lung cancer cell lines with  [CLS] mutant p53 [CLS] , GOF activities are mediated in part through Axl."}
{"subject": "mutant", "sub_type": "Var", "rel": "ThemeOf", "object": "Axl", "obj_type": "Protein", "file_name": "PubMed-23264849.json", "snippet": " and motility rate in lung cancer cells expressing mutant p53. This indicates that for lung cancer cell lines with  [CLS] mutant p53, GOF activities are mediated in part through Axl [CLS] ."}
{"subject": "Axl", "sub_type": "Protein", "rel": "CauseOf", "object": "mediated", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " cancer cells expressing mutant p53. This indicates that for lung cancer cell lines with mutant p53, GOF activities are  [CLS] mediated in part through Axl [CLS] ."}
{"subject": "activities", "sub_type": "MPA", "rel": "ThemeOf", "object": "mediated", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " in lung cancer cells expressing mutant p53. This indicates that for lung cancer cell lines with mutant p53, GOF  [CLS] activities are mediated [CLS]  in part through Axl."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "aggressively", "obj_type": "PosReg", "file_name": "PubMed-23264849.json", "snippet": " Protein Tyrosine Kinase Axl.\np53 mutations are present in up to 70% of lung cancer. Cancer cells with p53  [CLS] mutations, in general, grow more aggressively [CLS]  than those with wild-type p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to up-regulated expression"}
{"subject": "grow", "sub_type": "CPA", "rel": "ThemeOf", "object": "aggressively", "obj_type": "PosReg", "file_name": "PubMed-23264849.json", "snippet": " Axl.\np53 mutations are present in up to 70% of lung cancer. Cancer cells with p53 mutations, in general,  [CLS] grow more aggressively [CLS]  than those with wild-type p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to up-regulated expression"}
{"subject": "oncogenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-23264849.json", "snippet": " p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to up-regulated expression of genes that may  [CLS] affect cell growth and oncogenesis [CLS] . In our study of this aggressive phenotype, we have investigated the receptor protein tyrosine kinase Axl, which is up-regulated"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23264849.json", "snippet": " Receptor Protein Tyrosine Kinase Axl.\np53 mutations are present in up to 70% of lung cancer. Cancer cells with  [CLS] p53 mutations [CLS] , in general, grow more aggressively than those with wild-type p53 or no p53. Expression of tumor-derived mutant p53 in"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "up-regulated", "obj_type": "PosReg", "file_name": "PubMed-23264849.json", "snippet": " with p53 mutations, in general, grow more aggressively than those with wild-type p53 or no p53. Expression of tumor-derived  [CLS] mutant p53 in cells leads to up-regulated [CLS]  expression of genes that may affect cell growth and oncogenesis. In our study of this aggressive phenotype, we have"}
{"subject": "expression of genes", "sub_type": "MPA", "rel": "ThemeOf", "object": "up-regulated", "obj_type": "PosReg", "file_name": "PubMed-23264849.json", "snippet": " more aggressively than those with wild-type p53 or no p53. Expression of tumor-derived mutant p53 in cells leads to  [CLS] up-regulated expression of genes [CLS]  that may affect cell growth and oncogenesis. In our study of this aggressive phenotype, we have investigated the receptor"}
{"subject": "virulence", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " of gain-of-function (GOF) mutations in CgPDR1 have been found to lead not only to azole resistance but also to  [CLS] enhanced virulence [CLS] . This implicates CgPDR1 in the regulation of the interaction of C. glabrata with the host. To identify specific CgPDR1-regulated"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-23460523.json", "snippet": " marrow-derived macrophages and human acute monocytic leukemia cell line (THP-1)-derived macrophages, as well as different epithelial cell lines. GOF  [CLS] mutations in CgPDR1 did not influence survival and replication within macrophages following phagocytosis but led to decreased [CLS]  adherence to and uptake by macrophages. This may allow evasion from the host's innate cellular immune response. The interaction"}
{"subject": "adherence to and uptake by macrophages", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-23460523.json", "snippet": " cell lines. GOF mutations in CgPDR1 did not influence survival and replication within macrophages following phagocytosis but led to  [CLS] decreased adherence to and uptake by macrophages [CLS] . This may allow evasion from the host's innate cellular immune response. The interaction with epithelial cells revealed an opposite"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " from the host's innate cellular immune response. The interaction with epithelial cells revealed an opposite trend, suggesting that GOF  [CLS] mutations in CgPDR1 may favor epithelial colonization of the host by C. glabrata through increased [CLS]  adherence to epithelial cell layers. These data reveal that GOF mutations in CgPDR1 modulate the interaction with host cells"}
{"subject": "adherence", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " opposite trend, suggesting that GOF mutations in CgPDR1 may favor epithelial colonization of the host by C. glabrata through  [CLS] increased adherence [CLS]  to epithelial cell layers. These data reveal that GOF mutations in CgPDR1 modulate the interaction with host cells in"}
{"subject": "epithelial colonization", "sub_type": "CPA", "rel": "ThemeOf", "object": "favor", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " cellular immune response. The interaction with epithelial cells revealed an opposite trend, suggesting that GOF mutations in CgPDR1 may  [CLS] favor epithelial colonization [CLS]  of the host by C. glabrata through increased adherence to epithelial cell layers. These data reveal that GOF mutations"}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23460523.json", "snippet": " from the host's innate cellular immune response. The interaction with epithelial cells revealed an opposite trend, suggesting that GOF  [CLS] mutations in CgPDR1 [CLS]  may favor epithelial colonization of the host by C. glabrata through increased adherence to epithelial cell layers. These data"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-23460523.json", "snippet": " colonization of the host by C. glabrata through increased adherence to epithelial cell layers. These data reveal that GOF  [CLS] mutations in CgPDR1 modulate [CLS]  the interaction with host cells in ways that may contribute to increased virulence."}
{"subject": "interaction", "sub_type": "Interaction", "rel": "ThemeOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-23460523.json", "snippet": " host by C. glabrata through increased adherence to epithelial cell layers. These data reveal that GOF mutations in CgPDR1  [CLS] modulate the interaction [CLS]  with host cells in ways that may contribute to increased virulence."}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23460523.json", "snippet": " colonization of the host by C. glabrata through increased adherence to epithelial cell layers. These data reveal that GOF  [CLS] mutations in CgPDR1 [CLS]  modulate the interaction with host cells in ways that may contribute to increased virulence."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " colonization of the host by C. glabrata through increased adherence to epithelial cell layers. These data reveal that GOF  [CLS] mutations in CgPDR1 modulate the interaction with host cells in ways that may contribute to increased [CLS]  virulence."}
{"subject": "virulence", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " data reveal that GOF mutations in CgPDR1 modulate the interaction with host cells in ways that may contribute to  [CLS] increased virulence [CLS] ."}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23460523.json", "snippet": " to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF)  [CLS] mutations in CgPDR1 have been found to lead not only to azole resistance but also to enhanced virulence. This implicates CgPDR1 [CLS]  in the regulation of the interaction of C. glabrata with the host. To identify specific CgPDR1-regulated steps of the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "implicates", "obj_type": "Reg", "file_name": "PubMed-23460523.json", "snippet": " to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF)  [CLS] mutations in CgPDR1 have been found to lead not only to azole resistance but also to enhanced virulence. This implicates [CLS]  CgPDR1 in the regulation of the interaction of C. glabrata with the host. To identify specific CgPDR1-regulated steps of"}
{"subject": "regulation", "sub_type": "MPA", "rel": "ThemeOf", "object": "implicates", "obj_type": "Reg", "file_name": "PubMed-23460523.json", "snippet": " mutations in CgPDR1 have been found to lead not only to azole resistance but also to enhanced virulence. This  [CLS] implicates CgPDR1 in the regulation [CLS]  of the interaction of C. glabrata with the host. To identify specific CgPDR1-regulated steps of the host-pathogen interaction, we"}
{"subject": "interaction", "sub_type": "Interaction", "rel": "ThemeOf", "object": "regulation", "obj_type": "MPA", "file_name": "PubMed-23460523.json", "snippet": " been found to lead not only to azole resistance but also to enhanced virulence. This implicates CgPDR1 in the  [CLS] regulation of the interaction [CLS]  of C. glabrata with the host. To identify specific CgPDR1-regulated steps of the host-pathogen interaction, we investigated in this"}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23460523.json", "snippet": " marrow-derived macrophages and human acute monocytic leukemia cell line (THP-1)-derived macrophages, as well as different epithelial cell lines. GOF  [CLS] mutations in CgPDR1 [CLS]  did not influence survival and replication within macrophages following phagocytosis but led to decreased adherence to and uptake by"}
{"subject": "increased", "sub_type": "PosReg", "rel": "CauseOf", "object": "favor", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " cellular immune response. The interaction with epithelial cells revealed an opposite trend, suggesting that GOF mutations in CgPDR1 may  [CLS] favor epithelial colonization of the host by C. glabrata through increased [CLS]  adherence to epithelial cell layers. These data reveal that GOF mutations in CgPDR1 modulate the interaction with host cells"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " drugs due to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of  [CLS] gain-of-function (GOF) mutations [CLS]  in CgPDR1 have been found to lead not only to azole resistance but also to enhanced virulence. This implicates"}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23460523.json", "snippet": " to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF)  [CLS] mutations in CgPDR1 [CLS]  have been found to lead not only to azole resistance but also to enhanced virulence. This implicates CgPDR1 in"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF)  [CLS] mutations in CgPDR1 have been found to lead [CLS]  not only to azole resistance but also to enhanced virulence. This implicates CgPDR1 in the regulation of the interaction"}
{"subject": "azole resistance", "sub_type": "MPA", "rel": "ThemeOf", "object": "lead", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF) mutations in CgPDR1 have been found to  [CLS] lead not only to azole resistance [CLS]  but also to enhanced virulence. This implicates CgPDR1 in the regulation of the interaction of C. glabrata with the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-23460523.json", "snippet": " to increased drug efflux. The mechanism consists of CgPDR1-mediated upregulation of ATP-binding cassette transporters. A range of gain-of-function (GOF)  [CLS] mutations in CgPDR1 have been found to lead not only to azole resistance but also to enhanced [CLS]  virulence. This implicates CgPDR1 in the regulation of the interaction of C. glabrata with the host. To identify specific"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "accumulation", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that progress to invasive carcinoma with  [CLS] mutp53 accumulation [CLS]  and augmented NF-\u03baB activation, faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These findings might explain"}
{"subject": "NF-\u03baB", "sub_type": "Protein", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " is manifested by rapid onset of flat dysplastic lesions that progress to invasive carcinoma with mutp53 accumulation and augmented  [CLS] NF-\u03baB activation [CLS] , faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These findings might explain the early appearance of"}
{"subject": "activation", "sub_type": "PosReg", "rel": "CauseOf", "object": "progress", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " highly prone to inflammation-associated colon cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that  [CLS] progress to invasive carcinoma with mutp53 accumulation and augmented NF-\u03baB activation [CLS] , faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These findings might explain the early appearance of"}
{"subject": "invasive carcinoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "progress", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " highly prone to inflammation-associated colon cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that  [CLS] progress to invasive carcinoma [CLS]  with mutp53 accumulation and augmented NF-\u03baB activation, faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These"}
{"subject": "accumulation", "sub_type": "PosReg", "rel": "CauseOf", "object": "progress", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " highly prone to inflammation-associated colon cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that  [CLS] progress to invasive carcinoma with mutp53 accumulation [CLS]  and augmented NF-\u03baB activation, faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These findings might explain"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that progress to invasive carcinoma with  [CLS] mutp53 accumulation and augmented NF-\u03baB activation [CLS] , faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These findings might explain the early appearance of"}
{"subject": "colitis-associated colorectal cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "progress", "obj_type": "PosReg", "file_name": "PubMed-23680148.json", "snippet": " highly prone to inflammation-associated colon cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that  [CLS] progress to invasive carcinoma with mutp53 accumulation and augmented NF-\u03baB activation, faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer [CLS]  (CAC). These findings might explain the early appearance of p53 mutations in human CAC."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " hotspots, and at CpG sites, and resulted in mutp53 with higher functional severity (FS) scores. Clinically, patients with GOF  [CLS] mutations showed a higher [CLS]  frequency of platinum resistance (22/58, 37.9%) than patients with NE-GOF mutations (12/56, 21.4%) (p=0.054). Furthermore, patients with GOF mutations"}
{"subject": "platinum resistance", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " CpG sites, and resulted in mutp53 with higher functional severity (FS) scores. Clinically, patients with GOF mutations showed a  [CLS] higher frequency of platinum resistance [CLS]  (22/58, 37.9%) than patients with NE-GOF mutations (12/56, 21.4%) (p=0.054). Furthermore, patients with GOF mutations were more likely to"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "develop", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " higher frequency of platinum resistance (22/58, 37.9%) than patients with NE-GOF mutations (12/56, 21.4%) (p=0.054). Furthermore, patients with GOF  [CLS] mutations were more likely to develop [CLS]  distant metastasis (36/55, 65.5%) than local recurrence (19/55, 34.5%), whereas patients with NE-GOF mutations showed a higher frequency of"}
{"subject": "distant metastasis", "sub_type": "CPA", "rel": "ThemeOf", "object": "develop", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " (22/58, 37.9%) than patients with NE-GOF mutations (12/56, 21.4%) (p=0.054). Furthermore, patients with GOF mutations were more likely to  [CLS] develop distant metastasis [CLS]  (36/55, 65.5%) than local recurrence (19/55, 34.5%), whereas patients with NE-GOF mutations showed a higher frequency of locoregional recurrence"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23967324.json", "snippet": " is a major genetic alteration in a subset of human cancer. In spite of growing evidence that gain-of-function (GOF)  [CLS] mutations of p53 [CLS]  also have oncogenic activity, little is known about the clinical relevance of these mutations.\nMETHODS: The clinicopathological features of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " exons 4-9, is a major genetic alteration in a subset of human cancer. In spite of growing evidence that  [CLS] gain-of-function (GOF) mutations [CLS]  of p53 also have oncogenic activity, little is known about the clinical relevance of these mutations.\nMETHODS: The clinicopathological"}
{"subject": "oncogenic activity", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " exons 4-9, is a major genetic alteration in a subset of human cancer. In spite of growing evidence that  [CLS] gain-of-function (GOF) mutations of p53 also have oncogenic activity [CLS] , little is known about the clinical relevance of these mutations.\nMETHODS: The clinicopathological features of high-grade serous ovarian carcinoma"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " in overall or progression-free survival between patients with GOF or NE-GOF mutp53.\nCONCLUSION: This study demonstrates that patient with  [CLS] GOF mutp53 [CLS]  is characterized by a greater likelihood of platinum treatment resistance and distant metastatic properties in HGS-OvCa."}
{"subject": "HGS-OvCa", "sub_type": "Disease", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " in overall or progression-free survival between patients with GOF or NE-GOF mutp53.\nCONCLUSION: This study demonstrates that patient with  [CLS] GOF mutp53 is characterized by a greater likelihood of platinum treatment resistance and distant metastatic properties in HGS-OvCa [CLS] ."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-23967324.json", "snippet": " [CLS] mutations of p53 [CLS]  in high-grade serous ovarian carcinoma.\nPURPOSE: Inactivation of TP53, which occurs predominantly by missense mutations in exons 4-9, is"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " [CLS] gain-of-function mutations [CLS]  of p53 in high-grade serous ovarian carcinoma.\nPURPOSE: Inactivation of TP53, which occurs predominantly by missense mutations in exons"}
{"subject": "high-grade serous ovarian carcinoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " [CLS] gain-of-function mutations of p53 in high-grade serous ovarian carcinoma [CLS] .\nPURPOSE: Inactivation of TP53, which occurs predominantly by missense mutations in exons 4-9, is a major genetic alteration in"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "greater", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " overall or progression-free survival between patients with GOF or NE-GOF mutp53.\nCONCLUSION: This study demonstrates that patient with GOF  [CLS] mutp53 is characterized by a greater [CLS]  likelihood of platinum treatment resistance and distant metastatic properties in HGS-OvCa."}
{"subject": "platinum treatment resistance", "sub_type": "CPA", "rel": "ThemeOf", "object": "greater", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " patients with GOF or NE-GOF mutp53.\nCONCLUSION: This study demonstrates that patient with GOF mutp53 is characterized by a  [CLS] greater likelihood of platinum treatment resistance [CLS]  and distant metastatic properties in HGS-OvCa."}
{"subject": "distant metastatic properties", "sub_type": "CPA", "rel": "ThemeOf", "object": "greater", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " patients with GOF or NE-GOF mutp53.\nCONCLUSION: This study demonstrates that patient with GOF mutp53 is characterized by a  [CLS] greater likelihood of platinum treatment resistance and distant metastatic properties [CLS]  in HGS-OvCa."}
{"subject": "p53 protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-23967324.json", "snippet": " sequencing, mRNA expression, and protein expression profiles obtained from the Cancer Genome Atlas (TCGA).\nRESULTS: Patients with a mutant  [CLS] p53 protein (mutp53) with a GOF mutation [CLS]  showed higher p53 mRNA and protein expression levels than patients with p53 mutation with no evidence of GOF (NE-GOF)."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " profiles obtained from the Cancer Genome Atlas (TCGA).\nRESULTS: Patients with a mutant p53 protein (mutp53) with a GOF  [CLS] mutation showed higher [CLS]  p53 mRNA and protein expression levels than patients with p53 mutation with no evidence of GOF (NE-GOF). GOF mutations"}
{"subject": "p53 mRNA and protein expression levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-23967324.json", "snippet": " from the Cancer Genome Atlas (TCGA).\nRESULTS: Patients with a mutant p53 protein (mutp53) with a GOF mutation showed  [CLS] higher p53 mRNA and protein expression levels [CLS]  than patients with p53 mutation with no evidence of GOF (NE-GOF). GOF mutations were more likely to occur within"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24356649.json", "snippet": " tumours, which promotes mutp53 accumulation and tumorigenesis. Thus, overexpression of MDM2 isoforms promotes mutp53 accumulation in tumours, contributing to  [CLS] mutp53 GOF [CLS]  in tumorigenesis. This may be an important mechanism by which MDM2 isoforms promote tumorigenesis."}
{"subject": "tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24356649.json", "snippet": " which promotes mutp53 accumulation and tumorigenesis. Thus, overexpression of MDM2 isoforms promotes mutp53 accumulation in tumours, contributing to mutp53  [CLS] GOF in tumorigenesis [CLS] . This may be an important mechanism by which MDM2 isoforms promote tumorigenesis."}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24356649.json", "snippet": " new activities in promoting tumorigenesis, defined as gain-of-function (GOF). Mutp53 can accumulate to high levels in tumours, which promotes  [CLS] mutp53 GOF [CLS]  in tumorigenesis. The mechanism of mutp53 accumulation is poorly understood. Here we find that MDM2 isoforms promote mutp53 accumulation"}
{"subject": "tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24356649.json", "snippet": " activities in promoting tumorigenesis, defined as gain-of-function (GOF). Mutp53 can accumulate to high levels in tumours, which promotes mutp53  [CLS] GOF in tumorigenesis [CLS] . The mechanism of mutp53 accumulation is poorly understood. Here we find that MDM2 isoforms promote mutp53 accumulation in tumours."}
{"subject": "promoting tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain new activities", "obj_type": "PosReg", "file_name": "PubMed-24356649.json", "snippet": " accumulation and gain-of-function in tumorigenesis.\nThe tumour suppressor p53 is frequently mutated in tumours. Mutant p53 (Mutp53) proteins often  [CLS] gain new activities in promoting tumorigenesis [CLS] , defined as gain-of-function (GOF). Mutp53 can accumulate to high levels in tumours, which promotes mutp53 GOF in tumorigenesis. The"}
{"subject": "p53", "sub_type": "Protein", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-24356649.json", "snippet": " MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis.\nThe tumour suppressor p53 is frequently mutated in tumours.  [CLS] Mutant p53 [CLS]  (Mutp53) proteins often gain new activities in promoting tumorigenesis, defined as gain-of-function (GOF). Mutp53 can accumulate to high levels"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain new activities", "obj_type": "PosReg", "file_name": "PubMed-24356649.json", "snippet": " MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis.\nThe tumour suppressor p53 is frequently mutated in tumours.  [CLS] Mutant p53 (Mutp53) proteins often gain new activities [CLS]  in promoting tumorigenesis, defined as gain-of-function (GOF). Mutp53 can accumulate to high levels in tumours, which promotes mutp53 GOF"}
{"subject": "p53-R248W/P72R", "sub_type": "Var", "rel": "CauseOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-24373920.json", "snippet": " it strongly decreased the levels of stemness and invasiveness genes. We have also found that the ectopic expression of  [CLS] p53-R248W/P72R in MG63 cells promoted [CLS]  cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly"}
{"subject": "cancer stem-like features", "sub_type": "CPA", "rel": "ThemeOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-24373920.json", "snippet": " levels of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells  [CLS] promoted cancer stem-like features [CLS] , as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly increased the levels"}
{"subject": "p53-R248W/P72R", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-24373920.json", "snippet": " it strongly decreased the levels of stemness and invasiveness genes. We have also found that the ectopic expression of  [CLS] p53-R248W/P72R in MG63 cells promoted cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly increased [CLS]  the levels of stemness proteins. Overall, the findings suggest the involvement of p53-R248W/P72R at the origin of the aberrant"}
{"subject": "levels of stemness proteins", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-24373920.json", "snippet": " cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly  [CLS] increased the levels of stemness proteins [CLS] . Overall, the findings suggest the involvement of p53-R248W/P72R at the origin of the aberrant characters of the 3AB-OS cells"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-24373920.json", "snippet": " [CLS] Mutant p53 [CLS]  gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-24373920.json", "snippet": " [CLS] Mutant p53 gain of function [CLS]  can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.\nOsteosarcoma is"}
{"subject": "human osteosarcoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-24373920.json", "snippet": " [CLS] gain of function can be at the root of dedifferentiation of human osteosarcoma [CLS]  MG63 cells into 3AB-OS cancer stem cells.\nOsteosarcoma is a highly metastatic tumor affecting adolescents, for which there is"}
{"subject": "high proliferation rate", "sub_type": "CPA", "rel": "ThemeOf", "object": "cancer stem-like features", "obj_type": "CPA", "file_name": "PubMed-24373920.json", "snippet": " of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells promoted  [CLS] cancer stem-like features, as high proliferation rate [CLS] , sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall,"}
{"subject": "sphere formation", "sub_type": "CPA", "rel": "ThemeOf", "object": "cancer stem-like features", "obj_type": "CPA", "file_name": "PubMed-24373920.json", "snippet": " of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells promoted  [CLS] cancer stem-like features, as high proliferation rate, sphere formation [CLS] , clonogenic growth, high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings"}
{"subject": "clonogenic growth", "sub_type": "CPA", "rel": "ThemeOf", "object": "cancer stem-like features", "obj_type": "CPA", "file_name": "PubMed-24373920.json", "snippet": " of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells promoted  [CLS] cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth [CLS] , high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the"}
{"subject": "high migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "cancer stem-like features", "obj_type": "CPA", "file_name": "PubMed-24373920.json", "snippet": " of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells promoted  [CLS] cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration [CLS]  and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the involvement of"}
{"subject": "invasive ability", "sub_type": "CPA", "rel": "ThemeOf", "object": "cancer stem-like features", "obj_type": "CPA", "file_name": "PubMed-24373920.json", "snippet": " of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells promoted  [CLS] cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability [CLS] ; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the involvement of p53-R248W/P72R at the"}
{"subject": "p53-R248W/P72R", "sub_type": "Var", "rel": "CauseOf", "object": "involvement", "obj_type": "Reg", "file_name": "PubMed-24373920.json", "snippet": " high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the  [CLS] involvement of p53-R248W/P72R [CLS]  at the origin of the aberrant characters of the 3AB-OS cells with the hypothesis that its GOF can be"}
{"subject": "origin of the aberrant characters of the 3AB-OS cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "involvement", "obj_type": "Reg", "file_name": "PubMed-24373920.json", "snippet": " high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the  [CLS] involvement of p53-R248W/P72R at the origin of the aberrant characters of the 3AB-OS cells [CLS]  with the hypothesis that its GOF can be at the root of the dedifferentiation of MG63 cells into CSCs."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " patient survival, but such association was not evident for other hotspot GOF mutations. Gene set enrichment analysis on these  [CLS] mutations revealed higher [CLS]  activity of drug-metabolizing enzymes, including the CYP3A4 cytochrome P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " but such association was not evident for other hotspot GOF mutations. Gene set enrichment analysis on these mutations revealed  [CLS] higher activity [CLS]  of drug-metabolizing enzymes, including the CYP3A4 cytochrome P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant R282W", "obj_type": "Var", "file_name": "PubMed-24603336.json", "snippet": " enrichment analysis on these mutations revealed higher activity of drug-metabolizing enzymes, including the CYP3A4 cytochrome P450. Ectopic expression of  [CLS] p53 mutant R282W [CLS]  in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53"}
{"subject": "mutant R282W", "sub_type": "Var", "rel": "ThemeOf", "object": "Ectopic expression", "obj_type": "MPA", "file_name": "PubMed-24603336.json", "snippet": " mutations. Gene set enrichment analysis on these mutations revealed higher activity of drug-metabolizing enzymes, including the CYP3A4 cytochrome P450.  [CLS] Ectopic expression of p53 mutant R282W [CLS]  in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53"}
{"subject": "Ectopic expression", "sub_type": "MPA", "rel": "CauseOf", "object": "upregulated", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " mutations. Gene set enrichment analysis on these mutations revealed higher activity of drug-metabolizing enzymes, including the CYP3A4 cytochrome P450.  [CLS] Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated [CLS]  CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53 mutations display higher CYP3A4 expression and resistance"}
{"subject": "CYP3A4 mRNA and protein levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "upregulated", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " drug-metabolizing enzymes, including the CYP3A4 cytochrome P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly  [CLS] upregulated CYP3A4 mRNA and protein levels [CLS] , and cancer cell lines bearing mortality-associated p53 mutations display higher CYP3A4 expression and resistance to several CYP3A4-metabolized chemotherapeutic drugs."}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53 mutations display  [CLS] higher CYP3A4 expression [CLS]  and resistance to several CYP3A4-metabolized chemotherapeutic drugs. Our results suggest that p53 mutations have unequal GOF activities in human"}
{"subject": "resistance", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53 mutations display  [CLS] higher CYP3A4 expression and resistance [CLS]  to several CYP3A4-metabolized chemotherapeutic drugs. Our results suggest that p53 mutations have unequal GOF activities in human cancers, and"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-24603336.json", "snippet": " R282W in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated  [CLS] p53 mutations [CLS]  display higher CYP3A4 expression and resistance to several CYP3A4-metabolized chemotherapeutic drugs. Our results suggest that p53 mutations have unequal"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-24603336.json", "snippet": " in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53  [CLS] mutations display higher [CLS]  CYP3A4 expression and resistance to several CYP3A4-metabolized chemotherapeutic drugs. Our results suggest that p53 mutations have unequal GOF activities"}
{"subject": "drug-metabolizing enzymes", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-24603336.json", "snippet": " such association was not evident for other hotspot GOF mutations. Gene set enrichment analysis on these mutations revealed higher  [CLS] activity of drug-metabolizing enzymes [CLS] , including the CYP3A4 cytochrome P450. Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated CYP3A4"}
{"subject": "CYP3A4 cytochrome P450", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "drug-metabolizing enzymes", "obj_type": "Enzyme", "file_name": "PubMed-24603336.json", "snippet": " was not evident for other hotspot GOF mutations. Gene set enrichment analysis on these mutations revealed higher activity of  [CLS] drug-metabolizing enzymes, including the CYP3A4 cytochrome P450 [CLS] . Ectopic expression of p53 mutant R282W in H1299 and SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and"}
{"subject": "CYP3A4", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-24603336.json", "snippet": " SaOS2 cells significantly upregulated CYP3A4 mRNA and protein levels, and cancer cell lines bearing mortality-associated p53 mutations display higher  [CLS] CYP3A4 expression [CLS]  and resistance to several CYP3A4-metabolized chemotherapeutic drugs. Our results suggest that p53 mutations have unequal GOF activities in human"}
{"subject": "\u03b2-catenin", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-24632946.json", "snippet": " URS epithelia. We modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both  [CLS] \u03b2-catenin loss- and gain-of-function (LOF and GOF) mutants [CLS]  displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The mutants also displayed reduced cell"}
{"subject": "expression levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " \u03b2-catenin GOF mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in  [CLS] reduced expression levels [CLS]  of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The expression of bone morphogenetic protein"}
{"subject": "expression", "sub_type": "MPA", "rel": "CauseOf", "object": "induced", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " resulted in reduced expression levels of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The  [CLS] expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was also ectopically induced [CLS]  in the epithelia of the URS in the \u03b2-catenin GOF mutants. The expression of the Msx2 gene and phosphorylated-Smad1/5/8,"}
{"subject": "\u03b2-catenin", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-24632946.json", "snippet": " (Bmp) genes, such as Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS in the  [CLS] \u03b2-catenin GOF mutants [CLS] . The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also increased in the mutants."}
{"subject": "mutants", "sub_type": "Var", "rel": "ThemeOf", "object": "induced", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " the perineal epithelia. The expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was also ectopically  [CLS] induced in the epithelia of the URS in the \u03b2-catenin GOF mutants [CLS] . The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also increased in the mutants."}
{"subject": "Msx2 gene", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-24632946.json", "snippet": " Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS in the \u03b2-catenin GOF mutants. The  [CLS] expression of the Msx2 gene [CLS]  and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also increased in the mutants. Moreover, we introduced an additional mutation"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS in the \u03b2-catenin GOF mutants. The  [CLS] expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also increased [CLS]  in the mutants. Moreover, we introduced an additional mutation for a Bmp receptor gene: BmprIA. The Shh(CreERT2/+); \u03b2-catenin(flox(ex3)/+); BmprIA(flox/-)"}
{"subject": "readouts of Bmp signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " the epithelia of the URS in the \u03b2-catenin GOF mutants. The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible  [CLS] readouts of Bmp signaling, was also increased [CLS]  in the mutants. Moreover, we introduced an additional mutation for a Bmp receptor gene: BmprIA. The Shh(CreERT2/+); \u03b2-catenin(flox(ex3)/+); BmprIA(flox/-)"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " the \u03b2-catenin GOF mutants. The expression of the Msx2 gene and phosphorylated-Smad1/5/8, possible readouts of Bmp signaling, was also  [CLS] increased in the mutants [CLS] . Moreover, we introduced an additional mutation for a Bmp receptor gene: BmprIA. The Shh(CreERT2/+); \u03b2-catenin(flox(ex3)/+); BmprIA(flox/-) mutants displayed partial"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin loss- and  [CLS] gain-of-function (LOF and GOF) mutants [CLS]  displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The mutants also displayed reduced cell"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " epithelia. We modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin  [CLS] loss- and gain-of-function (LOF and GOF) mutants [CLS]  displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The mutants also displayed reduced cell"}
{"subject": "clefts in the perineal region", "sub_type": "CPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " epithelia. We modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin  [CLS] loss- and gain-of-function (LOF and GOF) mutants displayed abnormal clefts in the perineal region [CLS]  and hypoplastic elongation of the URS. The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition,"}
{"subject": "hypoplastic elongation of the URS", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin loss- and  [CLS] gain-of-function (LOF and GOF) mutants displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS [CLS] . The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF mutants displayed reduced"}
{"subject": "hypoplastic elongation of the URS", "sub_type": "CPA", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " epithelia. We modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin  [CLS] loss- and gain-of-function (LOF and GOF) mutants displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS [CLS] . The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF mutants displayed reduced"}
{"subject": "clefts in the perineal region", "sub_type": "CPA", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " modulated the \u03b2-catenin gene conditionally in endodermal epithelia by utilizing tamoxifen-inducible Cre driver line (Shh(CreERT2)). Both \u03b2-catenin loss- and  [CLS] gain-of-function (LOF and GOF) mutants displayed abnormal clefts in the perineal region [CLS]  and hypoplastic elongation of the URS. The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition,"}
{"subject": "keratin 1", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression levels", "obj_type": "MPA", "file_name": "PubMed-24632946.json", "snippet": " GOF mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced  [CLS] expression levels of differentiation markers, such as keratin 1 [CLS]  and filaggrin, in the perineal epithelia. The expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7,"}
{"subject": "filaggrin", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression levels", "obj_type": "MPA", "file_name": "PubMed-24632946.json", "snippet": " GOF mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced  [CLS] expression levels of differentiation markers, such as keratin 1 and filaggrin [CLS] , in the perineal epithelia. The expression of bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7, was also"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " of the URS. The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF  [CLS] mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced [CLS]  expression levels of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The expression of bone"}
{"subject": "bone morphogenetic protein (Bmp) genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-24632946.json", "snippet": " resulted in reduced expression levels of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The  [CLS] expression of bone morphogenetic protein (Bmp) genes [CLS] , such as Bmp4 and Bmp7, was also ectopically induced in the epithelia of the URS in the \u03b2-catenin GOF"}
{"subject": "Bmp4", "sub_type": "Gene", "rel": "ThemeOf", "object": "bone morphogenetic protein (Bmp) genes", "obj_type": "Gene", "file_name": "PubMed-24632946.json", "snippet": " reduced expression levels of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The expression of  [CLS] bone morphogenetic protein (Bmp) genes, such as Bmp4 [CLS]  and Bmp7, was also ectopically induced in the epithelia of the URS in the \u03b2-catenin GOF mutants. The expression"}
{"subject": "Bmp7", "sub_type": "Gene", "rel": "ThemeOf", "object": "bone morphogenetic protein (Bmp) genes", "obj_type": "Gene", "file_name": "PubMed-24632946.json", "snippet": " reduced expression levels of differentiation markers, such as keratin 1 and filaggrin, in the perineal epithelia. The expression of  [CLS] bone morphogenetic protein (Bmp) genes, such as Bmp4 and Bmp7 [CLS] , was also ectopically induced in the epithelia of the URS in the \u03b2-catenin GOF mutants. The expression of the"}
{"subject": "ARM", "sub_type": "Disease", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " BmprIA(flox/-) mutants displayed partial restoration of URS elongation compared with the \u03b2-catenin GOF mutants. These results indicate that some  [CLS] ARM phenotypes in the \u03b2-catenin GOF [CLS]  mutants were caused by abnormal Bmp signaling. The current analysis revealed the close relation of endodermal \u03b2-catenin signaling to"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-24632946.json", "snippet": " URS elongation compared with the \u03b2-catenin GOF mutants. These results indicate that some ARM phenotypes in the \u03b2-catenin GOF  [CLS] mutants were caused by [CLS]  abnormal Bmp signaling. The current analysis revealed the close relation of endodermal \u03b2-catenin signaling to the ARM phenotypes. These"}
{"subject": "Bmp signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-24632946.json", "snippet": " compared with the \u03b2-catenin GOF mutants. These results indicate that some ARM phenotypes in the \u03b2-catenin GOF mutants were  [CLS] caused by abnormal Bmp signaling [CLS] . The current analysis revealed the close relation of endodermal \u03b2-catenin signaling to the ARM phenotypes. These results are considered"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " gain-of-function (LOF and GOF) mutants displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The  [CLS] mutants also displayed reduced [CLS]  cell proliferation in the URS mesenchyme. In addition, the \u03b2-catenin GOF mutants displayed reduced apoptosis and subsequently increased apoptosis"}
{"subject": "\u03b2-catenin", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-24632946.json", "snippet": " restoration of URS elongation compared with the \u03b2-catenin GOF mutants. These results indicate that some ARM phenotypes in the  [CLS] \u03b2-catenin GOF mutants [CLS]  were caused by abnormal Bmp signaling. The current analysis revealed the close relation of endodermal \u03b2-catenin signaling to the"}
{"subject": "caused by", "sub_type": "Reg", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24632946.json", "snippet": " of URS elongation compared with the \u03b2-catenin GOF mutants. These results indicate that some ARM phenotypes in the \u03b2-catenin  [CLS] GOF mutants were caused by [CLS]  abnormal Bmp signaling. The current analysis revealed the close relation of endodermal \u03b2-catenin signaling to the ARM phenotypes. These"}
{"subject": "cell proliferation in the URS mesenchyme", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-24632946.json", "snippet": " GOF) mutants displayed abnormal clefts in the perineal region and hypoplastic elongation of the URS. The mutants also displayed  [CLS] reduced cell proliferation in the URS mesenchyme [CLS] . In addition, the \u03b2-catenin GOF mutants displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability"}
{"subject": "\u03b2-catenin", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-24632946.json", "snippet": " hypoplastic elongation of the URS. The mutants also displayed reduced cell proliferation in the URS mesenchyme. In addition, the  [CLS] \u03b2-catenin GOF mutants [CLS]  displayed reduced apoptosis and subsequently increased apoptosis in the URS epithelium. This instability possibly resulted in reduced expression levels"}
{"subject": "endodermal \u03b2-catenin", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-24632949.json", "snippet": " associated with excessive endodermal apoptosis and septation defects in Shh(-/-) mutants. Furthermore, apoptotic cells were markedly reduced in the  [CLS] endodermal \u03b2-catenin GOF mutant [CLS]  embryos, which counteracted the inhibitory effects of Wif1. Taken altogether, these data suggest that regulated expression of Wif1 is"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-24632949.json", "snippet": " excessive endodermal apoptosis and septation defects in Shh(-/-) mutants. Furthermore, apoptotic cells were markedly reduced in the endodermal \u03b2-catenin  [CLS] GOF mutant [CLS]  embryos, which counteracted the inhibitory effects of Wif1. Taken altogether, these data suggest that regulated expression of Wif1 is"}
{"subject": "GOF", "sub_type": "PosReg", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-24632949.json", "snippet": " urs and cm associated with excessive endodermal apoptosis and septation defects in Shh(-/-) mutants. Furthermore, apoptotic cells were markedly  [CLS] reduced in the endodermal \u03b2-catenin GOF [CLS]  mutant embryos, which counteracted the inhibitory effects of Wif1. Taken altogether, these data suggest that regulated expression of Wif1"}
{"subject": "apoptotic cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-24632949.json", "snippet": " ectopically expressed in the urs and cm associated with excessive endodermal apoptosis and septation defects in Shh(-/-) mutants. Furthermore,  [CLS] apoptotic cells were markedly reduced [CLS]  in the endodermal \u03b2-catenin GOF mutant embryos, which counteracted the inhibitory effects of Wif1. Taken altogether, these data suggest"}
{"subject": "MC1R", "sub_type": "Protein", "rel": "ThemeOf", "object": "LOF", "obj_type": "Var", "file_name": "PubMed-24730569.json", "snippet": " propose that \u03b1-MSH increases UV-induced \u03b3H2AX to facilitate formation of DNA repair complexes and repair of DNA photoproducts, and  [CLS] LOF of MC1R [CLS]  compromises the DDR and genomic stability of melanocytes."}
{"subject": "LOF", "sub_type": "Var", "rel": "CauseOf", "object": "compromises", "obj_type": "NegReg", "file_name": "PubMed-24730569.json", "snippet": " propose that \u03b1-MSH increases UV-induced \u03b3H2AX to facilitate formation of DNA repair complexes and repair of DNA photoproducts, and  [CLS] LOF of MC1R compromises [CLS]  the DDR and genomic stability of melanocytes."}
{"subject": "genomic stability of melanocytes", "sub_type": "CPA", "rel": "ThemeOf", "object": "compromises", "obj_type": "NegReg", "file_name": "PubMed-24730569.json", "snippet": " increases UV-induced \u03b3H2AX to facilitate formation of DNA repair complexes and repair of DNA photoproducts, and LOF of MC1R  [CLS] compromises the DDR and genomic stability of melanocytes [CLS] ."}
{"subject": "DDR", "sub_type": "MPA", "rel": "ThemeOf", "object": "compromises", "obj_type": "NegReg", "file_name": "PubMed-24730569.json", "snippet": " increases UV-induced \u03b3H2AX to facilitate formation of DNA repair complexes and repair of DNA photoproducts, and LOF of MC1R  [CLS] compromises the DDR [CLS]  and genomic stability of melanocytes."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-24808909.json", "snippet": " medical record and genomics (eMERGE) consortium to determine the effects of rare LOFs. Here, we show that two hypocholesterolemia-associated  [CLS] LOF mutations [CLS]  in the PCSK9 gene can be accurately imputed into large-scale GWAS datasets which raises the possibility of assessing LOFs"}
{"subject": "hypocholesterolemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-24808909.json", "snippet": " electronic medical record and genomics (eMERGE) consortium to determine the effects of rare LOFs. Here, we show that two  [CLS] hypocholesterolemia-associated LOF [CLS]  mutations in the PCSK9 gene can be accurately imputed into large-scale GWAS datasets which raises the possibility of assessing"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-24808909.json", "snippet": " record and genomics (eMERGE) consortium to determine the effects of rare LOFs. Here, we show that two hypocholesterolemia-associated LOF  [CLS] mutations in the PCSK9 [CLS]  gene can be accurately imputed into large-scale GWAS datasets which raises the possibility of assessing LOFs through genomics-linked medical"}
{"subject": "PDGF", "sub_type": "Protein", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-24946076.json", "snippet": " and as such, they exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or ectopic  [CLS] PDGF activity [CLS]  may also cause or contribute to diseases such as cancer and tissue fibrosis. Until recently, no loss-of-function (LOF) mutations"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-24946076.json", "snippet": " genes were reported as causally linked to a human disease. This changed in 2013 when reports appeared on presumed  [CLS] LOF mutations [CLS]  in the genes encoding PDGF-B and its receptor PDGF receptor-beta (PDGF-R\u03b2) in familial idiopathic basal ganglia calcification (IBGC), a"}
{"subject": "familial idiopathic basal ganglia calcification", "sub_type": "Disease", "rel": "ThemeOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-24946076.json", "snippet": " genes were reported as causally linked to a human disease. This changed in 2013 when reports appeared on presumed  [CLS] LOF mutations in the genes encoding PDGF-B and its receptor PDGF receptor-beta (PDGF-R\u03b2) in familial idiopathic basal ganglia calcification [CLS]  (IBGC), a brain disease characterized by anatomically localized calcifications in or near the blood microvessels. Here, we review PDGF-B"}
{"subject": "PDGF-R\u03b2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-24946076.json", "snippet": " were reported as causally linked to a human disease. This changed in 2013 when reports appeared on presumed LOF  [CLS] mutations in the genes encoding PDGF-B and its receptor PDGF receptor-beta (PDGF-R\u03b2 [CLS] ) in familial idiopathic basal ganglia calcification (IBGC), a brain disease characterized by anatomically localized calcifications in or near the"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "ectopic", "obj_type": "Var", "file_name": "PubMed-24946076.json", "snippet": " cells, and as such, they exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or  [CLS] ectopic PDGF activity [CLS]  may also cause or contribute to diseases such as cancer and tissue fibrosis. Until recently, no loss-of-function (LOF) mutations"}
{"subject": "ectopic", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-24946076.json", "snippet": " cells, and as such, they exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or  [CLS] ectopic PDGF activity may also cause [CLS]  or contribute to diseases such as cancer and tissue fibrosis. Until recently, no loss-of-function (LOF) mutations in PDGF or"}
{"subject": "ectopic", "sub_type": "Var", "rel": "CauseOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-24946076.json", "snippet": " cells, and as such, they exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or  [CLS] ectopic PDGF activity may also cause or contribute [CLS]  to diseases such as cancer and tissue fibrosis. Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor"}
{"subject": "cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-24946076.json", "snippet": " functions during organogenesis in mammalian embryonic and early postnatal development. Increased or ectopic PDGF activity may also cause or  [CLS] contribute to diseases such as cancer [CLS]  and tissue fibrosis. Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally"}
{"subject": "tissue fibrosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-24946076.json", "snippet": " functions during organogenesis in mammalian embryonic and early postnatal development. Increased or ectopic PDGF activity may also cause or  [CLS] contribute to diseases such as cancer and tissue fibrosis [CLS] . Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally linked to a"}
{"subject": "cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-24946076.json", "snippet": " exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or ectopic PDGF activity may also  [CLS] cause or contribute to diseases such as cancer [CLS]  and tissue fibrosis. Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally"}
{"subject": "tissue fibrosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-24946076.json", "snippet": " exert critical functions during organogenesis in mammalian embryonic and early postnatal development. Increased or ectopic PDGF activity may also  [CLS] cause or contribute to diseases such as cancer and tissue fibrosis [CLS] . Until recently, no loss-of-function (LOF) mutations in PDGF or PDGF receptor genes were reported as causally linked to a"}
{"subject": "PDGF-B", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-24946076.json", "snippet": " were reported as causally linked to a human disease. This changed in 2013 when reports appeared on presumed LOF  [CLS] mutations in the genes encoding PDGF-B [CLS]  and its receptor PDGF receptor-beta (PDGF-R\u03b2) in familial idiopathic basal ganglia calcification (IBGC), a brain disease characterized by anatomically"}
{"subject": "TP53 tumor-suppressor gene", "sub_type": "Gene", "rel": "ThemeOf", "object": "Missense mutations", "obj_type": "Var", "file_name": "PubMed-24998848.json", "snippet": " [CLS] TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations [CLS]  can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that mutant (mut) p53 promotes tumor"}
{"subject": "sIL-1Ra production", "sub_type": "MPA", "rel": "ThemeOf", "object": "suppresses", "obj_type": "NegReg", "file_name": "PubMed-24998848.json", "snippet": " occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that mutp53 but not wild-type (wt) p53  [CLS] suppresses the sIL-1Ra production [CLS]  in conditioned media of cancer cells. Moreover, mutp53, but not wtp53, binds physically the sIL-1Ra promoter and the protein-protein"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-24998848.json", "snippet": " [CLS] Mutant p53 [CLS]  gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist.\nThe TP53 tumor-suppressor gene"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "promoting", "obj_type": "PosReg", "file_name": "PubMed-24998848.json", "snippet": " [CLS] Mutant p53 gains new function in promoting [CLS]  inflammatory signals by repression of the secreted interleukin-1 receptor antagonist.\nThe TP53 tumor-suppressor gene is frequently mutated in human"}
{"subject": "inflammatory signals", "sub_type": "MPA", "rel": "ThemeOf", "object": "promoting", "obj_type": "PosReg", "file_name": "PubMed-24998848.json", "snippet": " [CLS] promoting inflammatory signals [CLS]  by repression of the secreted interleukin-1 receptor antagonist.\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "repression", "obj_type": "NegReg", "file_name": "PubMed-24998848.json", "snippet": " [CLS] Mutant p53 gains new function in promoting inflammatory signals by repression [CLS]  of the secreted interleukin-1 receptor antagonist.\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can"}
{"subject": "Missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-24998848.json", "snippet": " signals by repression of the secreted interleukin-1 receptor antagonist.\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer.  [CLS] Missense mutations can add novel functions (gain-of-function, GOF) that promote [CLS]  tumor malignancy. Here we report that mutant (mut) p53 promotes tumor malignancy by suppressing the expression of a natural"}
{"subject": "tumor malignancy", "sub_type": "CPA", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-24998848.json", "snippet": "\nThe TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that  [CLS] promote tumor malignancy [CLS] . Here we report that mutant (mut) p53 promotes tumor malignancy by suppressing the expression of a natural occurring anti-inflammatory"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-24998848.json", "snippet": " in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that  [CLS] mutant (mut) p53 [CLS]  promotes tumor malignancy by suppressing the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra,"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "suppressing", "obj_type": "NegReg", "file_name": "PubMed-24998848.json", "snippet": " in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that  [CLS] mutant (mut) p53 promotes tumor malignancy by suppressing [CLS]  the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that mutp53"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "suppressing", "obj_type": "NegReg", "file_name": "PubMed-24998848.json", "snippet": " novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that mutant (mut) p53 promotes tumor malignancy by  [CLS] suppressing the expression [CLS]  of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that mutp53 but not"}
{"subject": "suppressing", "sub_type": "NegReg", "rel": "CauseOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-24998848.json", "snippet": " Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that mutant (mut) p53  [CLS] promotes tumor malignancy by suppressing [CLS]  the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that mutp53"}
{"subject": "tumor malignancy", "sub_type": "CPA", "rel": "ThemeOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-24998848.json", "snippet": " Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that mutant (mut) p53  [CLS] promotes tumor malignancy [CLS]  by suppressing the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "suppresses", "obj_type": "NegReg", "file_name": "PubMed-24998848.json", "snippet": " suppressing the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that  [CLS] mutp53 but not wild-type (wt) p53 suppresses [CLS]  the sIL-1Ra production in conditioned media of cancer cells. Moreover, mutp53, but not wtp53, binds physically the sIL-1Ra promoter"}
{"subject": "PPARG", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-25157153.json", "snippet": " master transcriptional regulator of adipocyte differentiation and a canonical target of antidiabetic thiazolidinedione medications. In rare families, loss-of-function (LOF)  [CLS] mutations in PPARG [CLS]  are known to cosegregate with lipodystrophy and insulin resistance; in the general population, the common P12A variant is associated"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-25157153.json", "snippet": " of large-scale DNA sequencing and functional testing in the laboratory reveals that approximately 1 in 1,000 individuals carries a  [CLS] variant in PPARG that reduces function in a human adipocyte differentiation assay and is associated [CLS]  with a substantial risk of T2D."}
{"subject": "T2D", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-25157153.json", "snippet": " in 1,000 individuals carries a variant in PPARG that reduces function in a human adipocyte differentiation assay and is  [CLS] associated with a substantial risk of T2D [CLS] ."}
{"subject": "PPARG", "sub_type": "Gene", "rel": "ThemeOf", "object": "P12A", "obj_type": "Var", "file_name": "PubMed-25157153.json", "snippet": " regulator of adipocyte differentiation and a canonical target of antidiabetic thiazolidinedione medications. In rare families, loss-of-function (LOF) mutations in  [CLS] PPARG are known to cosegregate with lipodystrophy and insulin resistance; in the general population, the common P12A [CLS]  variant is associated with a decreased risk of type 2 diabetes (T2D). Whether and how rare variants in PPARG"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " is a master transcriptional regulator of adipocyte differentiation and a canonical target of antidiabetic thiazolidinedione medications. In rare families,  [CLS] loss-of-function (LOF) mutations [CLS]  in PPARG are known to cosegregate with lipodystrophy and insulin resistance; in the general population, the common P12A variant"}
{"subject": "lipodystrophy", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " is a master transcriptional regulator of adipocyte differentiation and a canonical target of antidiabetic thiazolidinedione medications. In rare families,  [CLS] loss-of-function (LOF) mutations in PPARG are known to cosegregate with lipodystrophy [CLS]  and insulin resistance; in the general population, the common P12A variant is associated with a decreased risk of type"}
{"subject": "insulin resistance", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " is a master transcriptional regulator of adipocyte differentiation and a canonical target of antidiabetic thiazolidinedione medications. In rare families,  [CLS] loss-of-function (LOF) mutations in PPARG are known to cosegregate with lipodystrophy and insulin resistance [CLS] ; in the general population, the common P12A variant is associated with a decreased risk of type 2 diabetes (T2D)."}
{"subject": "P12A", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " (LOF) mutations in PPARG are known to cosegregate with lipodystrophy and insulin resistance; in the general population, the common  [CLS] P12A variant is associated with a decreased [CLS]  risk of type 2 diabetes (T2D). Whether and how rare variants in PPARG and defects in adipocyte differentiation influence"}
{"subject": "type 2 diabetes", "sub_type": "Disease", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " to cosegregate with lipodystrophy and insulin resistance; in the general population, the common P12A variant is associated with a  [CLS] decreased risk of type 2 diabetes [CLS]  (T2D). Whether and how rare variants in PPARG and defects in adipocyte differentiation influence risk of T2D in the"}
{"subject": "PPARG", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-25157153.json", "snippet": " of large-scale DNA sequencing and functional testing in the laboratory reveals that approximately 1 in 1,000 individuals carries a  [CLS] variant in PPARG [CLS]  that reduces function in a human adipocyte differentiation assay and is associated with a substantial risk of T2D."}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " of large-scale DNA sequencing and functional testing in the laboratory reveals that approximately 1 in 1,000 individuals carries a  [CLS] variant in PPARG that reduces [CLS]  function in a human adipocyte differentiation assay and is associated with a substantial risk of T2D."}
{"subject": "function in a human adipocyte differentiation assay", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-25157153.json", "snippet": " and functional testing in the laboratory reveals that approximately 1 in 1,000 individuals carries a variant in PPARG that  [CLS] reduces function in a human adipocyte differentiation assay [CLS]  and is associated with a substantial risk of T2D."}
{"subject": "SHROOM3", "sub_type": "Gene", "rel": "ThemeOf", "object": "DNMs", "obj_type": "Var", "file_name": "PubMed-25805808.json", "snippet": " showing a higher rate of LoF DNM in our cohort compared with control cohorts. Notably, we identified two protein-truncating  [CLS] DNMs in two independent cases in SHROOM3 [CLS] , previously associated with NTDs only in animal models. We have demonstrated a significant enrichment of LoF DNMs in this"}
{"subject": "DNMs", "sub_type": "Var", "rel": "CauseOf", "object": "truncating", "obj_type": "NegReg", "file_name": "PubMed-25805808.json", "snippet": " (LoF) showing a higher rate of LoF DNM in our cohort compared with control cohorts. Notably, we identified two protein- [CLS] truncating DNMs [CLS]  in two independent cases in SHROOM3, previously associated with NTDs only in animal models. We have demonstrated a significant"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "truncating", "obj_type": "NegReg", "file_name": "PubMed-25805808.json", "snippet": " (LoF) showing a higher rate of LoF DNM in our cohort compared with control cohorts. Notably, we identified two  [CLS] protein-truncating [CLS]  DNMs in two independent cases in SHROOM3, previously associated with NTDs only in animal models. We have demonstrated a"}
{"subject": "DNMs", "sub_type": "Var", "rel": "CauseOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-25805808.json", "snippet": " PAX3 and two potentially causative missense DNMs in GRHL3 and PTPRS.\nCONCLUSIONS: Our study demonstrates an important role of  [CLS] LoF DNMs [CLS]  in the development of NTDs and strongly implicates SHROOM3 in its aetiology."}
{"subject": "NTDs", "sub_type": "Disease", "rel": "ThemeOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-25805808.json", "snippet": " PAX3 and two potentially causative missense DNMs in GRHL3 and PTPRS.\nCONCLUSIONS: Our study demonstrates an important role of  [CLS] LoF DNMs in the development of NTDs [CLS]  and strongly implicates SHROOM3 in its aetiology."}
{"subject": "SHROOM3", "sub_type": "Gene", "rel": "ThemeOf", "object": "DNMs", "obj_type": "Var", "file_name": "PubMed-25805808.json", "snippet": " and two potentially causative missense DNMs in GRHL3 and PTPRS.\nCONCLUSIONS: Our study demonstrates an important role of LoF  [CLS] DNMs in the development of NTDs and strongly implicates SHROOM3 [CLS]  in its aetiology."}
{"subject": "SHROOM3", "sub_type": "Gene", "rel": "ThemeOf", "object": "DNMs", "obj_type": "Var", "file_name": "PubMed-25805808.json", "snippet": " DNM in our cohort compared with control cohorts. Notably, we identified two protein-truncating DNMs in two independent cases in  [CLS] SHROOM3, previously associated with NTDs only in animal models. We have demonstrated a significant enrichment of LoF DNMs [CLS]  in this gene in NTDs compared with the gene specific DNM rate and to the DNM rate estimated from"}
{"subject": "DNMs", "sub_type": "Var", "rel": "CauseOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-25805808.json", "snippet": " independent cases in SHROOM3, previously associated with NTDs only in animal models. We have demonstrated a significant enrichment of  [CLS] LoF DNMs [CLS]  in this gene in NTDs compared with the gene specific DNM rate and to the DNM rate estimated from"}
{"subject": "NTDs", "sub_type": "Disease", "rel": "ThemeOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-25805808.json", "snippet": " independent cases in SHROOM3, previously associated with NTDs only in animal models. We have demonstrated a significant enrichment of  [CLS] LoF DNMs in this gene in NTDs [CLS]  compared with the gene specific DNM rate and to the DNM rate estimated from control cohorts. We also identified"}
{"subject": "TXNDC5", "sub_type": "Gene", "rel": "ThemeOf", "object": "variation", "obj_type": "Var", "file_name": "PubMed-25915599.json", "snippet": " and APOC3) and identified eight new loci. Previously unknown relationships included elevated fasting glucose in carriers of heterozygous LOF  [CLS] variation in TXNDC5 [CLS] , which encodes a biomarker for type 1 diabetes progression, and apparent recessive effects of C1QTNF8 on serum magnesium levels."}
{"subject": "variation", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-25915599.json", "snippet": " (PCSK9 and APOC3) and identified eight new loci. Previously unknown relationships included elevated fasting glucose in carriers of heterozygous  [CLS] LOF variation [CLS]  in TXNDC5, which encodes a biomarker for type 1 diabetes progression, and apparent recessive effects of C1QTNF8 on serum"}
{"subject": "LOF", "sub_type": "NegReg", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-25915599.json", "snippet": " size verified two relationships in well-studied genes (PCSK9 and APOC3) and identified eight new loci. Previously unknown relationships included  [CLS] elevated fasting glucose in carriers of heterozygous LOF [CLS]  variation in TXNDC5, which encodes a biomarker for type 1 diabetes progression, and apparent recessive effects of C1QTNF8 on"}
{"subject": "glucose", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-25915599.json", "snippet": " size verified two relationships in well-studied genes (PCSK9 and APOC3) and identified eight new loci. Previously unknown relationships included  [CLS] elevated fasting glucose [CLS]  in carriers of heterozygous LOF variation in TXNDC5, which encodes a biomarker for type 1 diabetes progression, and apparent"}
{"subject": "C1QTNF8", "sub_type": "Gene", "rel": "CauseOf", "object": "recessive effects", "obj_type": "NegReg", "file_name": "PubMed-25915599.json", "snippet": " in carriers of heterozygous LOF variation in TXNDC5, which encodes a biomarker for type 1 diabetes progression, and apparent  [CLS] recessive effects of C1QTNF8 [CLS]  on serum magnesium levels. These data demonstrate the utility of functional-variant annotation within a large sample of deeply phenotyped"}
{"subject": "serum magnesium levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "recessive effects", "obj_type": "NegReg", "file_name": "PubMed-25915599.json", "snippet": " in carriers of heterozygous LOF variation in TXNDC5, which encodes a biomarker for type 1 diabetes progression, and apparent  [CLS] recessive effects of C1QTNF8 on serum magnesium levels [CLS] . These data demonstrate the utility of functional-variant annotation within a large sample of deeply phenotyped individuals for gene discovery."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "proteins", "obj_type": "Protein", "file_name": "PubMed-25954247.json", "snippet": " cells. Not surprisingly, mutations in the p53 gene are the most frequent genetic alteration in human cancers. Importantly, mutant  [CLS] p53 (mutp53) proteins [CLS]  not only lose their wild-type tumor suppressor activity but also can actively promote tumor development. Two main mechanisms accounting"}
{"subject": "resistant", "sub_type": "CPA", "rel": "ThemeOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " GOF, which relies on its oncogenic cooperation with the heat shock machinery. This coordinated adaptive mechanism renders cancer cells  [CLS] more resistant [CLS]  to proteotoxic stress and provides both, a strong survival advantage to cancer cells and a promising means for therapeutic"}
{"subject": "survival advantage", "sub_type": "CPA", "rel": "ThemeOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " GOF, which relies on its oncogenic cooperation with the heat shock machinery. This coordinated adaptive mechanism renders cancer cells  [CLS] more resistant to proteotoxic stress and provides both, a strong survival advantage [CLS]  to cancer cells and a promising means for therapeutic intervention."}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-25954247.json", "snippet": " damaged cells. Not surprisingly, mutations in the p53 gene are the most frequent genetic alteration in human cancers. Importantly,  [CLS] mutant p53 (mutp53) proteins [CLS]  not only lose their wild-type tumor suppressor activity but also can actively promote tumor development. Two main mechanisms accounting"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "lose", "obj_type": "NegReg", "file_name": "PubMed-25954247.json", "snippet": " damaged cells. Not surprisingly, mutations in the p53 gene are the most frequent genetic alteration in human cancers. Importantly,  [CLS] mutant p53 (mutp53) proteins not only lose [CLS]  their wild-type tumor suppressor activity but also can actively promote tumor development. Two main mechanisms accounting for mutp53 proto-oncogenic"}
{"subject": "tumor suppressor activity", "sub_type": "CPA", "rel": "ThemeOf", "object": "lose", "obj_type": "NegReg", "file_name": "PubMed-25954247.json", "snippet": " the p53 gene are the most frequent genetic alteration in human cancers. Importantly, mutant p53 (mutp53) proteins not only  [CLS] lose their wild-type tumor suppressor activity [CLS]  but also can actively promote tumor development. Two main mechanisms accounting for mutp53 proto-oncogenic activity are inhibition of the"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " damaged cells. Not surprisingly, mutations in the p53 gene are the most frequent genetic alteration in human cancers. Importantly,  [CLS] mutant p53 (mutp53) proteins not only lose their wild-type tumor suppressor activity but also can actively promote [CLS]  tumor development. Two main mechanisms accounting for mutp53 proto-oncogenic activity are inhibition of the wild-type p53 in a dominant-negative"}
{"subject": "tumor development", "sub_type": "CPA", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " human cancers. Importantly, mutant p53 (mutp53) proteins not only lose their wild-type tumor suppressor activity but also can actively  [CLS] promote tumor development [CLS] . Two main mechanisms accounting for mutp53 proto-oncogenic activity are inhibition of the wild-type p53 in a dominant-negative fashion and"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " only lose their wild-type tumor suppressor activity but also can actively promote tumor development. Two main mechanisms accounting for  [CLS] mutp53 proto-oncogenic activity are inhibition of the wild-type p53 in a dominant-negative fashion and gain [CLS]  of additional oncogenic activities known as gain-of-function (GOF). Here, we discuss a novel mechanism of mutp53 GOF, which relies"}
{"subject": "oncogenic activities", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " Two main mechanisms accounting for mutp53 proto-oncogenic activity are inhibition of the wild-type p53 in a dominant-negative fashion and  [CLS] gain of additional oncogenic activities [CLS]  known as gain-of-function (GOF). Here, we discuss a novel mechanism of mutp53 GOF, which relies on its oncogenic cooperation"}
{"subject": "mutp53", "sub_type": "Var", "rel": "CauseOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-25954247.json", "snippet": " dominant-negative fashion and gain of additional oncogenic activities known as gain-of-function (GOF). Here, we discuss a novel mechanism of  [CLS] mutp53 GOF, which relies on its oncogenic cooperation with the heat shock machinery. This coordinated adaptive mechanism renders cancer cells more [CLS]  resistant to proteotoxic stress and provides both, a strong survival advantage to cancer cells and a promising means for"}
{"subject": "MC1R", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Tyr298*", "obj_type": "Var", "file_name": "PubMed-26197705.json", "snippet": " including a p.Val174del in-frame deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells.  [CLS] p.Tyr298* MC1R [CLS]  showed no agonist-induced signaling to the cAMP or ERK pathways, nor detectable agonist binding. Conversely, signaling was comparable for"}
{"subject": "plasma membrane expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " cells overexpressing the proteins, but binding analysis suggested impaired cell surface expression. Flow cytometry and confocal imaging studies revealed  [CLS] reduced plasma membrane expression [CLS]  of p.Val174del and p.Tyr298*. Therefore, p.Tyr298* was a total loss-of-function (LOF) allele, while p.Val174del displayed a partial LOF attribute."}
{"subject": "p.Val174del", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " cells overexpressing the proteins, but binding analysis suggested impaired cell surface expression. Flow cytometry and confocal imaging studies revealed  [CLS] reduced plasma membrane expression of p.Val174del [CLS]  and p.Tyr298*. Therefore, p.Tyr298* was a total loss-of-function (LOF) allele, while p.Val174del displayed a partial LOF attribute."}
{"subject": "p.Tyr298*", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " cells overexpressing the proteins, but binding analysis suggested impaired cell surface expression. Flow cytometry and confocal imaging studies revealed  [CLS] reduced plasma membrane expression of p.Val174del and p.Tyr298* [CLS] . Therefore, p.Tyr298* was a total loss-of-function (LOF) allele, while p.Val174del displayed a partial LOF attribute."}
{"subject": "p.Tyr298*", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " cell surface expression. Flow cytometry and confocal imaging studies revealed reduced plasma membrane expression of p.Val174del and p.Tyr298*. Therefore,  [CLS] p.Tyr298* was a total loss-of-function [CLS]  (LOF) allele, while p.Val174del displayed a partial LOF attribute."}
{"subject": "p.Val174del", "sub_type": "Var", "rel": "CauseOf", "object": "partial LOF", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " studies revealed reduced plasma membrane expression of p.Val174del and p.Tyr298*. Therefore, p.Tyr298* was a total loss-of-function (LOF) allele, while  [CLS] p.Val174del displayed a partial LOF [CLS]  attribute."}
{"subject": "p.Tyr298*", "sub_type": "Var", "rel": "CauseOf", "object": "no", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " including a p.Val174del in-frame deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells.  [CLS] p.Tyr298* MC1R showed no [CLS]  agonist-induced signaling to the cAMP or ERK pathways, nor detectable agonist binding. Conversely, signaling was comparable for p.Val174del and"}
{"subject": "p.Tyr298*", "sub_type": "Var", "rel": "CauseOf", "object": "nor", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " including a p.Val174del in-frame deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells.  [CLS] p.Tyr298* MC1R showed no agonist-induced signaling to the cAMP or ERK pathways, nor [CLS]  detectable agonist binding. Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding"}
{"subject": "agonist binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "nor", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " analyzed for function in heterologous HEK293 cells. p.Tyr298* MC1R showed no agonist-induced signaling to the cAMP or ERK pathways,  [CLS] nor detectable agonist binding [CLS] . Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested impaired"}
{"subject": "no", "sub_type": "NegReg", "rel": "ThemeOf", "object": "agonist-induced signaling", "obj_type": "MPA", "file_name": "PubMed-26197705.json", "snippet": " in-frame deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells. p.Tyr298* MC1R showed  [CLS] no agonist-induced signaling [CLS]  to the cAMP or ERK pathways, nor detectable agonist binding. Conversely, signaling was comparable for p.Val174del and wild-type in"}
{"subject": "cAMP", "sub_type": "Pathway", "rel": "ThemeOf", "object": "agonist-induced signaling", "obj_type": "MPA", "file_name": "PubMed-26197705.json", "snippet": " deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells. p.Tyr298* MC1R showed no  [CLS] agonist-induced signaling to the cAMP [CLS]  or ERK pathways, nor detectable agonist binding. Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing"}
{"subject": "ERK pathways", "sub_type": "Pathway", "rel": "ThemeOf", "object": "agonist-induced signaling", "obj_type": "MPA", "file_name": "PubMed-26197705.json", "snippet": " deletion and a p.Tyr298* nonsense mutation, that were analyzed for function in heterologous HEK293 cells. p.Tyr298* MC1R showed no  [CLS] agonist-induced signaling to the cAMP or ERK pathways [CLS] , nor detectable agonist binding. Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but"}
{"subject": "p.Val174del", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " showed no agonist-induced signaling to the cAMP or ERK pathways, nor detectable agonist binding. Conversely, signaling was comparable for  [CLS] p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested impaired [CLS]  cell surface expression. Flow cytometry and confocal imaging studies revealed reduced plasma membrane expression of p.Val174del and p.Tyr298*. Therefore,"}
{"subject": "cell surface expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-26197705.json", "snippet": " binding. Conversely, signaling was comparable for p.Val174del and wild-type in HEK cells overexpressing the proteins, but binding analysis suggested  [CLS] impaired cell surface expression [CLS] . Flow cytometry and confocal imaging studies revealed reduced plasma membrane expression of p.Val174del and p.Tyr298*. Therefore, p.Tyr298* was a"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutations", "obj_type": "Var", "file_name": "PubMed-26331536.json", "snippet": " drive cancer growth.\nTP53 (which encodes p53 protein) is the most frequently mutated gene among all human cancers. Prevalent  [CLS] p53 missense mutations [CLS]  abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53"}
{"subject": "MLL2", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "chromatin regulatory genes", "obj_type": "Gene", "file_name": "PubMed-26331536.json", "snippet": " lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate  [CLS] chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 [CLS]  (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide increases of histone"}
{"subject": "acetyltransferase MOZ", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "chromatin regulatory genes", "obj_type": "Gene", "file_name": "PubMed-26331536.json", "snippet": " lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate  [CLS] chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ [CLS]  (also known as KAT6A or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " cancer growth.\nTP53 (which encodes p53 protein) is the most frequently mutated gene among all human cancers. Prevalent p53  [CLS] missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes [CLS]  cancer. Here we show that p53 GOF mutants bind to and upregulate chromatin regulatory genes, including the methyltransferases MLL1"}
{"subject": "cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " all human cancers. Prevalent p53 missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that  [CLS] promotes cancer [CLS] . Here we show that p53 GOF mutants bind to and upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also"}
{"subject": "upregulate", "sub_type": "PosReg", "rel": "CauseOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and  [CLS] upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide increases [CLS]  of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific upregulation of MLL1, MLL2, and MOZ"}
{"subject": "histone methylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide  [CLS] increases of histone methylation [CLS]  and acetylation. Analysis of The Cancer Genome Atlas shows specific upregulation of MLL1, MLL2, and MOZ in p53 GOF"}
{"subject": "acetylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide  [CLS] increases of histone methylation and acetylation [CLS] . Analysis of The Cancer Genome Atlas shows specific upregulation of MLL1, MLL2, and MOZ in p53 GOF patient-derived tumours,"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "GOF", "obj_type": "Var", "file_name": "PubMed-26331536.json", "snippet": " histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific upregulation of MLL1, MLL2, and MOZ in  [CLS] p53 GOF [CLS]  patient-derived tumours, but not in wild-type p53 or p53 null tumours. Cancer cell proliferation is markedly lowered by genetic"}
{"subject": "GOF", "sub_type": "Var", "rel": "CauseOf", "object": "upregulation", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific  [CLS] upregulation of MLL1, MLL2, and MOZ in p53 GOF [CLS]  patient-derived tumours, but not in wild-type p53 or p53 null tumours. Cancer cell proliferation is markedly lowered by genetic"}
{"subject": "MLL1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "upregulation", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific  [CLS] upregulation of MLL1 [CLS] , MLL2, and MOZ in p53 GOF patient-derived tumours, but not in wild-type p53 or p53 null tumours. Cancer cell"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "abrogate", "obj_type": "NegReg", "file_name": "PubMed-26331536.json", "snippet": " cancer growth.\nTP53 (which encodes p53 protein) is the most frequently mutated gene among all human cancers. Prevalent p53  [CLS] missense mutations abrogate [CLS]  its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF"}
{"subject": "MLL2", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "upregulation", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific  [CLS] upregulation of MLL1, MLL2 [CLS] , and MOZ in p53 GOF patient-derived tumours, but not in wild-type p53 or p53 null tumours. Cancer cell proliferation"}
{"subject": "MOZ", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "upregulation", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific  [CLS] upregulation of MLL1, MLL2, and MOZ [CLS]  in p53 GOF patient-derived tumours, but not in wild-type p53 or p53 null tumours. Cancer cell proliferation is markedly"}
{"subject": "tumour suppressive function", "sub_type": "CPA", "rel": "ThemeOf", "object": "abrogate", "obj_type": "NegReg", "file_name": "PubMed-26331536.json", "snippet": "\nTP53 (which encodes p53 protein) is the most frequently mutated gene among all human cancers. Prevalent p53 missense mutations  [CLS] abrogate its tumour suppressive function [CLS]  and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " cancer growth.\nTP53 (which encodes p53 protein) is the most frequently mutated gene among all human cancers. Prevalent p53  [CLS] missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function [CLS] ' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate chromatin regulatory genes, including"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-26331536.json", "snippet": " mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that  [CLS] p53 GOF mutants [CLS]  bind to and upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53  [CLS] GOF mutants [CLS]  bind to and upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "upregulate", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF  [CLS] mutants bind to and upregulate [CLS]  chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ"}
{"subject": "chromatin regulatory genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "upregulate", "obj_type": "PosReg", "file_name": "PubMed-26331536.json", "snippet": " and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and  [CLS] upregulate chromatin regulatory genes [CLS] , including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as"}
{"subject": "methyltransferases MLL1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "chromatin regulatory genes", "obj_type": "Gene", "file_name": "PubMed-26331536.json", "snippet": " lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate  [CLS] chromatin regulatory genes, including the methyltransferases MLL1 [CLS]  (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-26494468.json", "snippet": " hub prediction identified EFNB2 as a possible GOF mutant p53 target gene, responsible for chemoresistance. We show that the  [CLS] mutant p53 [CLS] -NF-Y complex transcriptionally upregulates EFNB2 expression in response to DNA damage. Moreover, the acetylated form of mutant p53 protein is"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "regulates", "obj_type": "Reg", "file_name": "PubMed-26494468.json", "snippet": " to DNA damage. Moreover, the acetylated form of mutant p53 protein is recruited on the EFNB2 promoter and positively  [CLS] regulates its expression [CLS]  in conjunction with coactivator p300. In vitro cell line and in vivo nude mice data show that EFNB2 silencing"}
{"subject": "ABCG2", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-26494468.json", "snippet": " the disease. In the course of deciphering the drug resistance mechanism, we also show that ephrin-B2 reverse signaling induces  [CLS] ABCG2 expression [CLS]  after drug treatment that involves JNK-c-Jun signaling in mutant p53 cells. Moreover, 5-fluorouracil-induced ephrin-B2 reverse signaling promotes tumorigenesis through"}
{"subject": "JNK-c-Jun signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " of the disease. In the course of deciphering the drug resistance mechanism, we also show that ephrin-B2 reverse signaling  [CLS] induces ABCG2 expression after drug treatment that involves JNK-c-Jun signaling [CLS]  in mutant p53 cells. Moreover, 5-fluorouracil-induced ephrin-B2 reverse signaling promotes tumorigenesis through the Src-ERK pathway, and drives EMT via"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " of the disease. In the course of deciphering the drug resistance mechanism, we also show that ephrin-B2 reverse signaling  [CLS] induces ABCG2 expression [CLS]  after drug treatment that involves JNK-c-Jun signaling in mutant p53 cells. Moreover, 5-fluorouracil-induced ephrin-B2 reverse signaling promotes tumorigenesis through"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-26494468.json", "snippet": " mechanism, we also show that ephrin-B2 reverse signaling induces ABCG2 expression after drug treatment that involves JNK-c-Jun signaling in  [CLS] mutant p53 [CLS]  cells. Moreover, 5-fluorouracil-induced ephrin-B2 reverse signaling promotes tumorigenesis through the Src-ERK pathway, and drives EMT via the Src-FAK pathway."}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " of the disease. In the course of deciphering the drug resistance mechanism, we also show that ephrin-B2 reverse signaling  [CLS] induces ABCG2 expression after drug treatment that involves JNK-c-Jun signaling in mutant [CLS]  p53 cells. Moreover, 5-fluorouracil-induced ephrin-B2 reverse signaling promotes tumorigenesis through the Src-ERK pathway, and drives EMT via the Src-FAK"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "upregulates", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " hub prediction identified EFNB2 as a possible GOF mutant p53 target gene, responsible for chemoresistance. We show that the  [CLS] mutant p53-NF-Y complex transcriptionally upregulates [CLS]  EFNB2 expression in response to DNA damage. Moreover, the acetylated form of mutant p53 protein is recruited on the"}
{"subject": "EFNB2", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-26494468.json", "snippet": " a possible GOF mutant p53 target gene, responsible for chemoresistance. We show that the mutant p53-NF-Y complex transcriptionally upregulates  [CLS] EFNB2 expression [CLS]  in response to DNA damage. Moreover, the acetylated form of mutant p53 protein is recruited on the EFNB2 promoter"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "upregulates", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " as a possible GOF mutant p53 target gene, responsible for chemoresistance. We show that the mutant p53-NF-Y complex transcriptionally  [CLS] upregulates EFNB2 expression [CLS]  in response to DNA damage. Moreover, the acetylated form of mutant p53 protein is recruited on the EFNB2 promoter"}
{"subject": "response to DNA damage", "sub_type": "MPA", "rel": "ThemeOf", "object": "upregulates", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " as a possible GOF mutant p53 target gene, responsible for chemoresistance. We show that the mutant p53-NF-Y complex transcriptionally  [CLS] upregulates EFNB2 expression in response to DNA damage [CLS] . Moreover, the acetylated form of mutant p53 protein is recruited on the EFNB2 promoter and positively regulates its expression"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "recruited", "obj_type": "PosReg", "file_name": "PubMed-26494468.json", "snippet": " that the mutant p53-NF-Y complex transcriptionally upregulates EFNB2 expression in response to DNA damage. Moreover, the acetylated form of  [CLS] mutant p53 protein is recruited [CLS]  on the EFNB2 promoter and positively regulates its expression in conjunction with coactivator p300. In vitro cell line and"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "protein", "obj_type": "Protein", "file_name": "PubMed-26494468.json", "snippet": " the mutant p53-NF-Y complex transcriptionally upregulates EFNB2 expression in response to DNA damage. Moreover, the acetylated form of mutant  [CLS] p53 protein [CLS]  is recruited on the EFNB2 promoter and positively regulates its expression in conjunction with coactivator p300. In vitro cell"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-26494468.json", "snippet": " that the mutant p53-NF-Y complex transcriptionally upregulates EFNB2 expression in response to DNA damage. Moreover, the acetylated form of  [CLS] mutant p53 protein [CLS]  is recruited on the EFNB2 promoter and positively regulates its expression in conjunction with coactivator p300. In vitro cell"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "regulates", "obj_type": "Reg", "file_name": "PubMed-26494468.json", "snippet": " that the mutant p53-NF-Y complex transcriptionally upregulates EFNB2 expression in response to DNA damage. Moreover, the acetylated form of  [CLS] mutant p53 protein is recruited on the EFNB2 promoter and positively regulates [CLS]  its expression in conjunction with coactivator p300. In vitro cell line and in vivo nude mice data show that"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-26586530.json", "snippet": " PCSK9-mediated autosomal dominant hypercholesterolemia.\nProprotein convertase subtilisin kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas  [CLS] PCSK9 gain-of-function (GOF) mutations [CLS]  are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, PCSK9 loss-of-function (LOF) mutations have a cardio-protective effect and"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-26586530.json", "snippet": " autosomal dominant hypercholesterolemia.\nProprotein convertase subtilisin kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas PCSK9  [CLS] gain-of-function (GOF) mutations [CLS]  are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, PCSK9 loss-of-function (LOF) mutations have a cardio-protective effect and"}
{"subject": "autosomal dominant hypercholesterolemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-26586530.json", "snippet": " autosomal dominant hypercholesterolemia.\nProprotein convertase subtilisin kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas PCSK9  [CLS] gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia [CLS]  (ADH) and premature atherosclerosis, PCSK9 loss-of-function (LOF) mutations have a cardio-protective effect and in some cases can lead to"}
{"subject": "premature atherosclerosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-26586530.json", "snippet": " autosomal dominant hypercholesterolemia.\nProprotein convertase subtilisin kexin type 9 (PCSK9) is a critical modulator of cholesterol homeostasis. Whereas PCSK9  [CLS] gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis [CLS] , PCSK9 loss-of-function (LOF) mutations have a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However,"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-26586530.json", "snippet": " modulator of cholesterol homeostasis. Whereas PCSK9 gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis,  [CLS] PCSK9 loss-of-function (LOF) mutations [CLS]  have a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However, limitations of the currently"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-26586530.json", "snippet": " of cholesterol homeostasis. Whereas PCSK9 gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, PCSK9  [CLS] loss-of-function (LOF) mutations [CLS]  have a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However, limitations of the currently"}
{"subject": "familial hypobetalipoproteinemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-26586530.json", "snippet": " of cholesterol homeostasis. Whereas PCSK9 gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, PCSK9  [CLS] loss-of-function (LOF) mutations have a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia [CLS]  (FHBL). However, limitations of the currently available cellular models preclude deciphering the consequences of PCSK9 mutation further. We aimed"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "have", "obj_type": "PosReg", "file_name": "PubMed-26586530.json", "snippet": " homeostasis. Whereas PCSK9 gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, PCSK9 loss-of-function (LOF)  [CLS] mutations have [CLS]  a cardio-protective effect and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However, limitations of the currently available"}
{"subject": "cardio-protective effect", "sub_type": "CPA", "rel": "ThemeOf", "object": "have", "obj_type": "PosReg", "file_name": "PubMed-26586530.json", "snippet": " Whereas PCSK9 gain-of-function (GOF) mutations are associated with autosomal dominant hypercholesterolemia (ADH) and premature atherosclerosis, PCSK9 loss-of-function (LOF) mutations  [CLS] have a cardio-protective effect [CLS]  and in some cases can lead to familial hypobetalipoproteinemia (FHBL). However, limitations of the currently available cellular models preclude"}
{"subject": "MLK4", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-26637668.json", "snippet": " [CLS] MLK4 Loss-of-Function Mutations [CLS]  Suppress JNK Signaling to Promote Colon Tumorigenesis.\nMLK4 is a member of the mixed-lineage family of kinases that regulate"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " the cyclin-dependent kinase inhibitors CDKN1A and CDKN2B. Our work indicates that MLK4 is a novel tumor-suppressing kinase harboring frequent  [CLS] LOF mutations [CLS]  that lead to diminished signaling in the JNK pathway and enhanced proliferation in colon cancer. Cancer Res; 76(3); 1-12."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "diminished", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " cyclin-dependent kinase inhibitors CDKN1A and CDKN2B. Our work indicates that MLK4 is a novel tumor-suppressing kinase harboring frequent LOF  [CLS] mutations that lead to diminished [CLS]  signaling in the JNK pathway and enhanced proliferation in colon cancer. Cancer Res; 76(3); 1-12. \u00a92015 AACR."}
{"subject": "signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "diminished", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " and CDKN2B. Our work indicates that MLK4 is a novel tumor-suppressing kinase harboring frequent LOF mutations that lead to  [CLS] diminished signaling [CLS]  in the JNK pathway and enhanced proliferation in colon cancer. Cancer Res; 76(3); 1-12. \u00a92015 AACR."}
{"subject": "signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "JNK pathway", "obj_type": "Pathway", "file_name": "PubMed-26637668.json", "snippet": " CDKN2B. Our work indicates that MLK4 is a novel tumor-suppressing kinase harboring frequent LOF mutations that lead to diminished  [CLS] signaling in the JNK pathway [CLS]  and enhanced proliferation in colon cancer. Cancer Res; 76(3); 1-12. \u00a92015 AACR."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-26637668.json", "snippet": " cyclin-dependent kinase inhibitors CDKN1A and CDKN2B. Our work indicates that MLK4 is a novel tumor-suppressing kinase harboring frequent LOF  [CLS] mutations that lead to diminished signaling in the JNK pathway and enhanced [CLS]  proliferation in colon cancer. Cancer Res; 76(3); 1-12. \u00a92015 AACR."}
{"subject": "proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-26637668.json", "snippet": " is a novel tumor-suppressing kinase harboring frequent LOF mutations that lead to diminished signaling in the JNK pathway and  [CLS] enhanced proliferation [CLS]  in colon cancer. Cancer Res; 76(3); 1-12. \u00a92015 AACR."}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " [CLS] Loss-of-Function Mutations [CLS]  Suppress JNK Signaling to Promote Colon Tumorigenesis.\nMLK4 is a member of the mixed-lineage family of kinases that regulate"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Suppress", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " [CLS] Mutations Suppress [CLS]  JNK Signaling to Promote Colon Tumorigenesis.\nMLK4 is a member of the mixed-lineage family of kinases that regulate the"}
{"subject": "JNK Signaling", "sub_type": "Pathway", "rel": "ThemeOf", "object": "Suppress", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " [CLS] Suppress JNK Signaling [CLS]  to Promote Colon Tumorigenesis.\nMLK4 is a member of the mixed-lineage family of kinases that regulate the JNK, p38,"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Promote", "obj_type": "PosReg", "file_name": "PubMed-26637668.json", "snippet": " [CLS] Mutations Suppress JNK Signaling to Promote [CLS]  Colon Tumorigenesis.\nMLK4 is a member of the mixed-lineage family of kinases that regulate the JNK, p38, and ERK"}
{"subject": "Colon Tumorigenesis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Promote", "obj_type": "PosReg", "file_name": "PubMed-26637668.json", "snippet": " [CLS] Promote Colon Tumorigenesis [CLS] .\nMLK4 is a member of the mixed-lineage family of kinases that regulate the JNK, p38, and ERK kinase signaling"}
{"subject": "MLK4", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-26637668.json", "snippet": " study, we assessed the functional consequences of MLK4 mutations in colon tumorigenesis. Biochemical data indicated that a majority of  [CLS] MLK4 mutations [CLS]  are loss-of-function (LOF) mutations that can exert dominant-negative effects. In seeking to understand the abrogated activity of these mutants,"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-26637668.json", "snippet": " we assessed the functional consequences of MLK4 mutations in colon tumorigenesis. Biochemical data indicated that a majority of MLK4  [CLS] mutations are loss-of-function [CLS]  (LOF) mutations that can exert dominant-negative effects. In seeking to understand the abrogated activity of these mutants, we elucidated"}
{"subject": "MLK4", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-26637668.json", "snippet": " pathway and its downstream targets, cJUN, ATF3, and the cyclin-dependent kinase inhibitors CDKN1A and CDKN2B. Our work indicates that  [CLS] MLK4 is a novel tumor-suppressing kinase harboring frequent LOF mutations [CLS]  that lead to diminished signaling in the JNK pathway and enhanced proliferation in colon cancer. Cancer Res; 76(3); 1-12."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutants", "obj_type": "Var", "file_name": "PubMed-27114909.json", "snippet": " cells harboring GOF mutant p53.\nMutation in TP53 is a common genetic alteration in human cancers. Certain tumor associated  [CLS] p53 missense mutants [CLS]  acquire gain-of-function (GOF) properties and confer oncogenic phenotypes including enhanced chemoresistance. The colorectal cancers (CRC) harboring mutant p53 are"}
{"subject": "missense mutants", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-27114909.json", "snippet": " harboring GOF mutant p53.\nMutation in TP53 is a common genetic alteration in human cancers. Certain tumor associated p53  [CLS] missense mutants acquire gain-of-function [CLS]  (GOF) properties and confer oncogenic phenotypes including enhanced chemoresistance. The colorectal cancers (CRC) harboring mutant p53 are generally aggressive"}
{"subject": "chemoresistance", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-27114909.json", "snippet": " alteration in human cancers. Certain tumor associated p53 missense mutants acquire gain-of-function (GOF) properties and confer oncogenic phenotypes including  [CLS] enhanced chemoresistance [CLS] . The colorectal cancers (CRC) harboring mutant p53 are generally aggressive in nature and difficult to treat. To identify a"}
{"subject": "missense mutants", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-27114909.json", "snippet": " harboring GOF mutant p53.\nMutation in TP53 is a common genetic alteration in human cancers. Certain tumor associated p53  [CLS] missense mutants acquire gain-of-function (GOF) properties and confer oncogenic phenotypes including enhanced [CLS]  chemoresistance. The colorectal cancers (CRC) harboring mutant p53 are generally aggressive in nature and difficult to treat. To identify"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-27114909.json", "snippet": " pathways upon FUdR treatment in SW480 cells. Our data suggest that in response to chemotherapeutics treatment, cancer cells with  [CLS] GOF mutant [CLS]  p53 can modulate key cellular pathways to withstand the cytotoxic effect of the drugs. The genes and pathways identified"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-27114909.json", "snippet": " upon FUdR treatment in SW480 cells. Our data suggest that in response to chemotherapeutics treatment, cancer cells with GOF  [CLS] mutant p53 [CLS]  can modulate key cellular pathways to withstand the cytotoxic effect of the drugs. The genes and pathways identified in"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-27114909.json", "snippet": " upon FUdR treatment in SW480 cells. Our data suggest that in response to chemotherapeutics treatment, cancer cells with GOF  [CLS] mutant p53 can modulate [CLS]  key cellular pathways to withstand the cytotoxic effect of the drugs. The genes and pathways identified in the present"}
{"subject": "key cellular pathways", "sub_type": "Pathway", "rel": "ThemeOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-27114909.json", "snippet": " in SW480 cells. Our data suggest that in response to chemotherapeutics treatment, cancer cells with GOF mutant p53 can  [CLS] modulate key cellular pathways [CLS]  to withstand the cytotoxic effect of the drugs. The genes and pathways identified in the present study can be"}
{"subject": "withstand the cytotoxic effect of the drugs", "sub_type": "CPA", "rel": "ThemeOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-27114909.json", "snippet": " in SW480 cells. Our data suggest that in response to chemotherapeutics treatment, cancer cells with GOF mutant p53 can  [CLS] modulate key cellular pathways to withstand the cytotoxic effect of the drugs [CLS] . The genes and pathways identified in the present study can be further validated and targeted for better chemotherapy response"}
{"subject": "TBR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-27325115.json", "snippet": " autism risk genes in the developing neocortex.\nExome sequencing studies have identified multiple genes harboring de novo loss-of-function (LoF)  [CLS] variants in individuals with autism spectrum disorders (ASD), including TBR1 [CLS] , a master regulator of cortical development. We performed ChIP-seq for TBR1 during mouse cortical neurogenesis and show that TBR1-bound"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27325115.json", "snippet": " [CLS] loss-of-function (LoF) variants [CLS]  in individuals with autism spectrum disorders (ASD), including TBR1, a master regulator of cortical development. We performed ChIP-seq for"}
{"subject": "autism spectrum disorders", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27325115.json", "snippet": " [CLS] loss-of-function (LoF) variants in individuals with autism spectrum disorders [CLS]  (ASD), including TBR1, a master regulator of cortical development. We performed ChIP-seq for TBR1 during mouse cortical neurogenesis and"}
{"subject": "TNFAIP8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-27341992.json", "snippet": " [CLS] mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 [CLS]  induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur"}
{"subject": "tumor suppressive functions", "sub_type": "CPA", "rel": "ThemeOf", "object": "blocking", "obj_type": "NegReg", "file_name": "PubMed-27341992.json", "snippet": " in human cancer and often result in single amino acid substitutions (missense mutations) in the DNA binding domain (DBD),  [CLS] blocking normal tumor suppressive functions [CLS] . In addition to the loss of canonical functions, some missense mutations in p53 confer gain-of-function (GOF) activities to tumor"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " the DNA binding domain (DBD), blocking normal tumor suppressive functions. In addition to the loss of canonical functions, some  [CLS] missense mutations in p53 confer gain-of-function [CLS]  (GOF) activities to tumor cells. While many missense mutations in p53 cluster at six \"hotspot\" amino acids, the majority"}
{"subject": "activities to tumor cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " blocking normal tumor suppressive functions. In addition to the loss of canonical functions, some missense mutations in p53 confer  [CLS] gain-of-function (GOF) activities to tumor cells [CLS] . While many missense mutations in p53 cluster at six \"hotspot\" amino acids, the majority of mutations in human cancer"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutations", "obj_type": "Var", "file_name": "PubMed-27341992.json", "snippet": " the DNA binding domain (DBD), blocking normal tumor suppressive functions. In addition to the loss of canonical functions, some  [CLS] missense mutations in p53 [CLS]  confer gain-of-function (GOF) activities to tumor cells. While many missense mutations in p53 cluster at six \"hotspot\" amino acids,"}
{"subject": "mutations at K120", "sub_type": "Var", "rel": "CauseOf", "object": "confer", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " mutations in human cancer occur elsewhere in the DBD and at a much lower frequency. We report here that  [CLS] mutations at K120, a non-hotspot DNA contact residue, confer [CLS]  p53 with the previously unrecognized ability to bind and activate the transcription of the pro-survival TNFAIP8 gene. Mutant K120"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations at K120", "obj_type": "Var", "file_name": "PubMed-27341992.json", "snippet": " mutations in human cancer occur elsewhere in the DBD and at a much lower frequency. We report here that  [CLS] mutations at K120, a non-hotspot DNA contact residue, confer p53 [CLS]  with the previously unrecognized ability to bind and activate the transcription of the pro-survival TNFAIP8 gene. Mutant K120 p53"}
{"subject": "ability", "sub_type": "MPA", "rel": "ThemeOf", "object": "confer", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " DBD and at a much lower frequency. We report here that mutations at K120, a non-hotspot DNA contact residue,  [CLS] confer p53 with the previously unrecognized ability [CLS]  to bind and activate the transcription of the pro-survival TNFAIP8 gene. Mutant K120 p53 binds the TNFAIP8 locus at"}
{"subject": "bind", "sub_type": "Interaction", "rel": "ThemeOf", "object": "ability", "obj_type": "MPA", "file_name": "PubMed-27341992.json", "snippet": " frequency. We report here that mutations at K120, a non-hotspot DNA contact residue, confer p53 with the previously unrecognized  [CLS] ability to bind [CLS]  and activate the transcription of the pro-survival TNFAIP8 gene. Mutant K120 p53 binds the TNFAIP8 locus at a cryptic"}
{"subject": "mutations at K120", "sub_type": "Var", "rel": "CauseOf", "object": "activate", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " mutations in human cancer occur elsewhere in the DBD and at a much lower frequency. We report here that  [CLS] mutations at K120, a non-hotspot DNA contact residue, confer p53 with the previously unrecognized ability to bind and activate [CLS]  the transcription of the pro-survival TNFAIP8 gene. Mutant K120 p53 binds the TNFAIP8 locus at a cryptic p53 response"}
{"subject": "transcription", "sub_type": "MPA", "rel": "ThemeOf", "object": "activate", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " that mutations at K120, a non-hotspot DNA contact residue, confer p53 with the previously unrecognized ability to bind and  [CLS] activate the transcription [CLS]  of the pro-survival TNFAIP8 gene. Mutant K120 p53 binds the TNFAIP8 locus at a cryptic p53 response element that"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "confers", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " [CLS] mutation in cancer confers [CLS]  p53 gain-of-function and tumor cell survival via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor."}
{"subject": "TNFAIP8", "sub_type": "Gene", "rel": "ThemeOf", "object": "transcription", "obj_type": "MPA", "file_name": "PubMed-27341992.json", "snippet": " at K120, a non-hotspot DNA contact residue, confer p53 with the previously unrecognized ability to bind and activate the  [CLS] transcription of the pro-survival TNFAIP8 [CLS]  gene. Mutant K120 p53 binds the TNFAIP8 locus at a cryptic p53 response element that is not occupied by"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " tumor cells expressing the K120R variant of p53. These findings identify induction of pro-survival targets as a mechanism of  [CLS] gain-of-function activity for mutant [CLS]  p53 and will likely broaden our understanding of this phenomenon beyond the limited number of GOF activities currently reported"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " tumor cells expressing the K120R variant of p53. These findings identify induction of pro-survival targets as a mechanism of  [CLS] gain-of-function activity [CLS]  for mutant p53 and will likely broaden our understanding of this phenomenon beyond the limited number of GOF activities"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-27341992.json", "snippet": " cells expressing the K120R variant of p53. These findings identify induction of pro-survival targets as a mechanism of gain-of-function  [CLS] activity for mutant p53 [CLS]  and will likely broaden our understanding of this phenomenon beyond the limited number of GOF activities currently reported for"}
{"subject": "binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-27341992.json", "snippet": " encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur frequently in human cancer and often  [CLS] result in single amino acid substitutions (missense mutations) in the DNA binding [CLS]  domain (DBD), blocking normal tumor suppressive functions. In addition to the loss of canonical functions, some missense mutations in"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "ThemeOf", "object": "confers", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " [CLS] confers p53 gain-of-function [CLS]  and tumor cell survival via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " [CLS] p53 gain-of-function [CLS]  and tumor cell survival via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in"}
{"subject": "tumor cell survival", "sub_type": "CPA", "rel": "ThemeOf", "object": "confers", "obj_type": "PosReg", "file_name": "PubMed-27341992.json", "snippet": " [CLS] confers p53 gain-of-function and tumor cell survival [CLS]  via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in the coding sequence of"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-27341992.json", "snippet": " p53 gain-of-function and tumor cell survival via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor.  [CLS] Mutations in the coding sequence of p53 [CLS]  occur frequently in human cancer and often result in single amino acid substitutions (missense mutations) in the DNA binding"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-27341992.json", "snippet": " p53 gain-of-function and tumor cell survival via TNFAIP8 induction.\nThe p53 tumor suppressor gene encodes a sequence-specific transcription factor.  [CLS] Mutations in the coding sequence of p53 occur frequently in human cancer and often result in [CLS]  single amino acid substitutions (missense mutations) in the DNA binding domain (DBD), blocking normal tumor suppressive functions. In addition"}
{"subject": "substitutions", "sub_type": "Var", "rel": "ThemeOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-27341992.json", "snippet": " encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur frequently in human cancer and often  [CLS] result in single amino acid substitutions [CLS]  (missense mutations) in the DNA binding domain (DBD), blocking normal tumor suppressive functions. In addition to the loss of"}
{"subject": "blocking", "sub_type": "NegReg", "rel": "ThemeOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-27341992.json", "snippet": " encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur frequently in human cancer and often  [CLS] result in single amino acid substitutions (missense mutations) in the DNA binding domain (DBD), blocking [CLS]  normal tumor suppressive functions. In addition to the loss of canonical functions, some missense mutations in p53 confer gain-of-function"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27545680.json", "snippet": " mechanisms explaining the diseases, are often lacking. Here, we report on an ID syndrome caused by de novo heterozygous  [CLS] loss-of-function (LoF) mutations [CLS]  in SON. The syndrome is characterized by ID and/or DD, malformations of the cerebral cortex, epilepsy, vision problems, musculoskeletal"}
{"subject": "Intellectual-Disability Syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "Causing", "obj_type": "Reg", "file_name": "PubMed-27545680.json", "snippet": " [CLS] Causing an Intellectual-Disability Syndrome [CLS] .\nThe overall understanding of the molecular etiologies of intellectual disability (ID) and developmental delay (DD) is increasing as next-generation"}
{"subject": "SON", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-27545680.json", "snippet": " [CLS] Mutations in SON [CLS]  Disrupt RNA Splicing of Genes Essential for Brain Development and Metabolism, Causing an Intellectual-Disability Syndrome.\nThe overall understanding of"}
{"subject": "ID syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27545680.json", "snippet": " variants, as well as the underlying molecular mechanisms explaining the diseases, are often lacking. Here, we report on an  [CLS] ID syndrome caused by de novo heterozygous loss-of-function [CLS]  (LoF) mutations in SON. The syndrome is characterized by ID and/or DD, malformations of the cerebral cortex, epilepsy, vision"}
{"subject": "SON", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-27545680.json", "snippet": " the diseases, are often lacking. Here, we report on an ID syndrome caused by de novo heterozygous loss-of-function (LoF)  [CLS] mutations in SON [CLS] . The syndrome is characterized by ID and/or DD, malformations of the cerebral cortex, epilepsy, vision problems, musculoskeletal abnormalities, and"}
{"subject": "erroneous SON-mediated RNA splicing", "sub_type": "Var", "rel": "CauseOf", "object": "accumulation", "obj_type": "PosReg", "file_name": "PubMed-27545680.json", "snippet": " FLNA, PNKP, WDR62, PSMD3, and\u00a0HDAC6) and metabolism (PCK2, PFKL, IDH2, ACY1, and ADA) are significantly downregulated because of the  [CLS] accumulation of mis-spliced transcripts resulting from erroneous SON-mediated RNA splicing [CLS] . Our data highlight SON as a master regulator governing neurodevelopment and demonstrate the importance of SON-mediated RNA splicing in"}
{"subject": "accumulation", "sub_type": "PosReg", "rel": "CauseOf", "object": "downregulated", "obj_type": "NegReg", "file_name": "PubMed-27545680.json", "snippet": " and cortex organization (TUBG1, FLNA, PNKP, WDR62, PSMD3, and\u00a0HDAC6) and metabolism (PCK2, PFKL, IDH2, ACY1, and ADA) are significantly  [CLS] downregulated because of the accumulation [CLS]  of mis-spliced transcripts resulting from erroneous SON-mediated RNA splicing. Our data highlight SON as a master regulator governing neurodevelopment"}
{"subject": "cortex organization", "sub_type": "CPA", "rel": "ThemeOf", "object": "downregulated", "obj_type": "NegReg", "file_name": "PubMed-27545680.json", "snippet": " spine, brain, and eyes. Importantly, analyses of RNA from affected individuals revealed that genes critical for neuronal migration and  [CLS] cortex organization (TUBG1, FLNA, PNKP, WDR62, PSMD3, and\u00a0HDAC6) and metabolism (PCK2, PFKL, IDH2, ACY1, and ADA) are significantly downregulated [CLS]  because of the accumulation of mis-spliced transcripts resulting from erroneous SON-mediated RNA splicing. Our data highlight SON as a"}
{"subject": "metabolism", "sub_type": "CPA", "rel": "ThemeOf", "object": "downregulated", "obj_type": "NegReg", "file_name": "PubMed-27545680.json", "snippet": " affected individuals revealed that genes critical for neuronal migration and cortex organization (TUBG1, FLNA, PNKP, WDR62, PSMD3, and\u00a0HDAC6) and  [CLS] metabolism (PCK2, PFKL, IDH2, ACY1, and ADA) are significantly downregulated [CLS]  because of the accumulation of mis-spliced transcripts resulting from erroneous SON-mediated RNA splicing. Our data highlight SON as a"}
{"subject": "neuronal migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "downregulated", "obj_type": "NegReg", "file_name": "PubMed-27545680.json", "snippet": " malformation of the spine, brain, and eyes. Importantly, analyses of RNA from affected individuals revealed that genes critical for  [CLS] neuronal migration and cortex organization (TUBG1, FLNA, PNKP, WDR62, PSMD3, and\u00a0HDAC6) and metabolism (PCK2, PFKL, IDH2, ACY1, and ADA) are significantly downregulated [CLS]  because of the accumulation of mis-spliced transcripts resulting from erroneous SON-mediated RNA splicing. Our data highlight SON as a"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Causing", "obj_type": "Reg", "file_name": "PubMed-27545680.json", "snippet": " [CLS] Mutations in SON Disrupt RNA Splicing of Genes Essential for Brain Development and Metabolism, Causing [CLS]  an Intellectual-Disability Syndrome.\nThe overall understanding of the molecular etiologies of intellectual disability (ID) and developmental delay (DD) is"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-27662822.json", "snippet": " [CLS] PCSK9 loss-of-function variants [CLS] .\nOBJECTIVE: To determine the effect of (1) an oral fat load and (2) pro-protein convertase subtilisin/kexin type (PCSK) 9"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The  [CLS] absence of anti-adipogenic action of PBMC from PCSK9 LOF variant [CLS]  subjects points to a novel role for PCSK9 in PBMC-adipose cell interactions."}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "novel role", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The absence of anti-adipogenic action of PBMC from PCSK9 LOF  [CLS] variant subjects points to a novel role [CLS]  for PCSK9 in PBMC-adipose cell interactions."}
{"subject": "interactions", "sub_type": "Interaction", "rel": "ThemeOf", "object": "novel role", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " from non-variant controls.\nCONCLUSIONS: The absence of anti-adipogenic action of PBMC from PCSK9 LOF variant subjects points to a  [CLS] novel role for PCSK9 in PBMC-adipose cell interactions [CLS] ."}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-27662822.json", "snippet": " PBMC-CM-PP from non-variant controls inhibited adipogenesis of human preadipocytes more than did PBMC-CM-F. In contrast, PBMC-CM-F or -PP from  [CLS] PCSK9 LOF variant [CLS]  subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " from non-variant controls inhibited adipogenesis of human preadipocytes more than did PBMC-CM-F. In contrast, PBMC-CM-F or -PP from PCSK9  [CLS] LOF variant [CLS]  subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant"}
{"subject": "adipogenesis", "sub_type": "MPA", "rel": "ThemeOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " from non-variant controls inhibited adipogenesis of human preadipocytes more than did PBMC-CM-F. In contrast, PBMC-CM-F or -PP from PCSK9  [CLS] LOF variant subjects had no effect on adipogenesis [CLS] . After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant increases in mRNA levels of interleukin-1\u03b2,"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-27662822.json", "snippet": " or -PP from PCSK9 LOF variant subjects had no effect on adipogenesis. After the oral fat load, PBMC from  [CLS] PCSK9 LOF variant [CLS]  subjects showed significant increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36, and"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " -PP from PCSK9 LOF variant subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9  [CLS] LOF variant [CLS]  subjects showed significant increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36, and"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " from PCSK9 LOF variant subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF  [CLS] variant subjects showed significant increases [CLS]  in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1),"}
{"subject": "mRNA levels of interleukin-1\u03b2", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant  [CLS] increases in mRNA levels of interleukin-1\u03b2 [CLS] , tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " [CLS] loss-of-function variants [CLS] .\nOBJECTIVE: To determine the effect of (1) an oral fat load and (2) pro-protein convertase subtilisin/kexin type (PCSK) 9"}
{"subject": "tumor necrosis factor-\u03b1", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant  [CLS] increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1 [CLS] , sterol regulatory element binding protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from"}
{"subject": "sterol regulatory element binding protein-1c", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant  [CLS] increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c [CLS] , CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The absence"}
{"subject": "CD36", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-27662822.json", "snippet": " subjects had no effect on adipogenesis. After the oral fat load, PBMC from PCSK9 LOF variant subjects showed significant  [CLS] increases in mRNA levels of interleukin-1\u03b2, tumor necrosis factor-\u03b1, sterol regulatory element binding protein-1c, CD36 [CLS] , and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The absence of"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "absent", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " [CLS] absent with PCSK9 loss-of-function [CLS]  variants.\nOBJECTIVE: To determine the effect of (1) an oral fat load and (2) pro-protein convertase subtilisin/kexin type (PCSK)"}
{"subject": "anti-adipogenic effect", "sub_type": "MPA", "rel": "ThemeOf", "object": "absent", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " [CLS] anti-adipogenic effect of peripheral blood mononuclear cells is absent [CLS]  with PCSK9 loss-of-function variants.\nOBJECTIVE: To determine the effect of (1) an oral fat load and (2) pro-protein convertase"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": "\nOBJECTIVE: To determine the effect of (1) an oral fat load and (2) pro-protein convertase subtilisin/kexin type (PCSK) 9  [CLS] loss-of-function (LOF) variant [CLS]  status on the ability of peripheral blood mononuclear cells (PBMC) to inhibit human adipogenesis.\nMETHODS: PBMC from subjects with"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "inhibit", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": "\nOBJECTIVE: To determine the effect of (1) an oral fat load and (2) pro-protein convertase subtilisin/kexin type (PCSK) 9  [CLS] loss-of-function (LOF) variant status on the ability of peripheral blood mononuclear cells (PBMC) to inhibit [CLS]  human adipogenesis.\nMETHODS: PBMC from subjects with one or more PCSK9 LOF variants versus non-variant controls were compared in"}
{"subject": "human adipogenesis", "sub_type": "MPA", "rel": "ThemeOf", "object": "inhibit", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " convertase subtilisin/kexin type (PCSK) 9 loss-of-function (LOF) variant status on the ability of peripheral blood mononuclear cells (PBMC) to  [CLS] inhibit human adipogenesis [CLS] .\nMETHODS: PBMC from subjects with one or more PCSK9 LOF variants versus non-variant controls were compared in the fasting"}
{"subject": "anti-adipogenic action", "sub_type": "MPA", "rel": "ThemeOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-27662822.json", "snippet": " protein-1c, CD36, and monocyte chemoattractant protein-1 (MCP-1), only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The  [CLS] absence of anti-adipogenic action [CLS]  of PBMC from PCSK9 LOF variant subjects points to a novel role for PCSK9 in PBMC-adipose cell interactions."}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-27662822.json", "snippet": " only MCP-1 mRNA levels increased in PBMC from non-variant controls.\nCONCLUSIONS: The absence of anti-adipogenic action of PBMC from  [CLS] PCSK9 LOF variant [CLS]  subjects points to a novel role for PCSK9 in PBMC-adipose cell interactions."}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "extensive genetic variation", "obj_type": "Var", "file_name": "PubMed-27678121.json", "snippet": " in Filaggrin Hitchhike Hornerin Selective Sweep.\nHuman skin has evolved rapidly, leaving evolutionary signatures in the genome. The filaggrin ( [CLS] FLG) gene is widely studied for its skin-barrier function in humans. The extensive genetic variation [CLS]  in this gene, especially common loss-of-function (LoF) mutations, has been established as primary risk factors for atopic dermatitis. To"}
{"subject": "extensive genetic variation", "sub_type": "Var", "rel": "CauseOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-27678121.json", "snippet": " evolutionary signatures in the genome. The filaggrin (FLG) gene is widely studied for its skin-barrier function in humans. The  [CLS] extensive genetic variation in this gene, especially common loss-of-function (LoF) mutations [CLS] , has been established as primary risk factors for atopic dermatitis. To investigate the evolution of this gene, we analyzed"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-27678121.json", "snippet": " gene is widely studied for its skin-barrier function in humans. The extensive genetic variation in this gene, especially common  [CLS] loss-of-function (LoF) mutations [CLS] , has been established as primary risk factors for atopic dermatitis. To investigate the evolution of this gene, we analyzed"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "ThemeOf", "object": "atopic dermatitis", "obj_type": "Disease", "file_name": "PubMed-27678121.json", "snippet": " gene is widely studied for its skin-barrier function in humans. The extensive genetic variation in this gene, especially common  [CLS] loss-of-function (LoF) mutations, has been established as primary risk factors for atopic dermatitis [CLS] . To investigate the evolution of this gene, we analyzed 2,504 human genomes and genotyped the copy number variation of"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "dyshomeostasis", "obj_type": "Reg", "file_name": "PubMed-27975164.json", "snippet": " initiation codon) in 11.06% (50/452) AD patients, which were absent in 163 controls (P=2.5\u00d710(-5)). Transcriptome sequencing revealed that identified  [CLS] variants induced dyshomeostasis [CLS]  in expression of collagens-TIMPs/MMPs systems. The Col5a2 (-/-) rats manifested growth retardation and aortic dysplasia. Our study provides a"}
{"subject": "expression of collagens-TIMPs/MMPs systems", "sub_type": "CPA", "rel": "ThemeOf", "object": "dyshomeostasis", "obj_type": "Reg", "file_name": "PubMed-27975164.json", "snippet": " in 11.06% (50/452) AD patients, which were absent in 163 controls (P=2.5\u00d710(-5)). Transcriptome sequencing revealed that identified variants induced  [CLS] dyshomeostasis in expression of collagens-TIMPs/MMPs systems [CLS] . The Col5a2 (-/-) rats manifested growth retardation and aortic dysplasia. Our study provides a first comprehensive map of genetic"}
{"subject": "Col5a2", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-27975164.json", "snippet": " initiation codon) in 11.06% (50/452) AD patients, which were absent in 163 controls (P=2.5\u00d710(-5)). Transcriptome sequencing revealed that identified  [CLS] variants induced dyshomeostasis in expression of collagens-TIMPs/MMPs systems. The Col5a2 [CLS]  (-/-) rats manifested growth retardation and aortic dysplasia. Our study provides a first comprehensive map of genetic alterations in"}
{"subject": "growth retardation", "sub_type": "CPA", "rel": "ThemeOf", "object": "dyshomeostasis", "obj_type": "Reg", "file_name": "PubMed-27975164.json", "snippet": " in 11.06% (50/452) AD patients, which were absent in 163 controls (P=2.5\u00d710(-5)). Transcriptome sequencing revealed that identified variants induced  [CLS] dyshomeostasis in expression of collagens-TIMPs/MMPs systems. The Col5a2 (-/-) rats manifested growth retardation [CLS]  and aortic dysplasia. Our study provides a first comprehensive map of genetic alterations in collagens-MMPs/TIMPs system in sporadic AD"}
{"subject": "aortic dysplasia", "sub_type": "CPA", "rel": "ThemeOf", "object": "dyshomeostasis", "obj_type": "Reg", "file_name": "PubMed-27975164.json", "snippet": " in 11.06% (50/452) AD patients, which were absent in 163 controls (P=2.5\u00d710(-5)). Transcriptome sequencing revealed that identified variants induced  [CLS] dyshomeostasis in expression of collagens-TIMPs/MMPs systems. The Col5a2 (-/-) rats manifested growth retardation and aortic dysplasia [CLS] . Our study provides a first comprehensive map of genetic alterations in collagens-MMPs/TIMPs system in sporadic AD patients and suggests"}
{"subject": "Germline heterozygous mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28011069.json", "snippet": " [CLS] Germline heterozygous mutations in human signal transducer and activator of transcription 1 (STAT1) can cause loss of function [CLS]  (LOF), as in patients with Mendelian susceptibility to mycobacterial diseases, or gain of function (GOF), as in patients with"}
{"subject": "coiled-coil domain", "sub_type": "MPA", "rel": "ThemeOf", "object": "domains", "obj_type": "MPA", "file_name": "PubMed-28011069.json", "snippet": " as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare and can affect the same  [CLS] domains of STAT1, especially the coiled-coil domain [CLS]  (CCD) and DNA-binding domain (DBD). Moreover, 6% of patients with chronic mucocutaneous candidiasis with a GOF STAT1 mutation have"}
{"subject": "DNA-binding domain", "sub_type": "MPA", "rel": "ThemeOf", "object": "domains", "obj_type": "MPA", "file_name": "PubMed-28011069.json", "snippet": " as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare and can affect the same  [CLS] domains of STAT1, especially the coiled-coil domain (CCD) and DNA-binding domain [CLS]  (DBD). Moreover, 6% of patients with chronic mucocutaneous candidiasis with a GOF STAT1 mutation have mycobacterial disease, obscuring the"}
{"subject": "signal transducer", "sub_type": "Gene", "rel": "ThemeOf", "object": "Germline heterozygous mutations", "obj_type": "Var", "file_name": "PubMed-28011069.json", "snippet": " [CLS] Germline heterozygous mutations in human signal transducer [CLS]  and activator of transcription 1 (STAT1) can cause loss of function (LOF), as in patients with Mendelian susceptibility to"}
{"subject": "Germline heterozygous mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-28011069.json", "snippet": " [CLS] Germline heterozygous mutations in human signal transducer and activator of transcription 1 (STAT1) can cause loss of function (LOF), as in patients with Mendelian susceptibility to mycobacterial diseases, or gain of function [CLS]  (GOF), as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare and can affect the"}
{"subject": "chronic mucocutaneous candidiasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-28011069.json", "snippet": " transcription 1 (STAT1) can cause loss of function (LOF), as in patients with Mendelian susceptibility to mycobacterial diseases, or  [CLS] gain of function (GOF), as in patients with chronic mucocutaneous candidiasis [CLS] . LOF and GOF mutations are equally rare and can affect the same domains of STAT1, especially the coiled-coil domain"}
{"subject": "mycobacterial diseases", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28011069.json", "snippet": " or gain-of-function variants.\nBACKGROUND: Germline heterozygous mutations in human signal transducer and activator of transcription 1 (STAT1) can cause  [CLS] loss of function (LOF), as in patients with Mendelian susceptibility to mycobacterial diseases [CLS] , or gain of function (GOF), as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare"}
{"subject": "activator of transcription 1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Germline heterozygous mutations", "obj_type": "Var", "file_name": "PubMed-28011069.json", "snippet": " [CLS] Germline heterozygous mutations in human signal transducer and activator of transcription 1 [CLS]  (STAT1) can cause loss of function (LOF), as in patients with Mendelian susceptibility to mycobacterial diseases, or gain of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28011069.json", "snippet": " susceptibility to mycobacterial diseases, or gain of function (GOF), as in patients with chronic mucocutaneous candidiasis. LOF and GOF  [CLS] mutations are equally rare and can affect [CLS]  the same domains of STAT1, especially the coiled-coil domain (CCD) and DNA-binding domain (DBD). Moreover, 6% of patients with"}
{"subject": "domains", "sub_type": "MPA", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28011069.json", "snippet": " of function (GOF), as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare and can  [CLS] affect the same domains [CLS]  of STAT1, especially the coiled-coil domain (CCD) and DNA-binding domain (DBD). Moreover, 6% of patients with chronic mucocutaneous candidiasis"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "domains", "obj_type": "MPA", "file_name": "PubMed-28011069.json", "snippet": " as in patients with chronic mucocutaneous candidiasis. LOF and GOF mutations are equally rare and can affect the same  [CLS] domains of STAT1 [CLS] , especially the coiled-coil domain (CCD) and DNA-binding domain (DBD). Moreover, 6% of patients with chronic mucocutaneous candidiasis with a"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28139313.json", "snippet": " controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.\nBACKGROUND: Gain-of-function (GOF)  [CLS] mutations in the human signal transducer and activator of transcription 1 (STAT1) manifest in immunodeficiency and autoimmunity with impaired [CLS]  TH17\u00a0cell differentiation and exaggerated responsiveness to type I and II interferons. Allogeneic bone marrow transplantation has been attempted in"}
{"subject": "TH17\u00a0cell responses", "sub_type": "CPA", "rel": "ThemeOf", "object": "suppressed", "obj_type": "NegReg", "file_name": "PubMed-28139313.json", "snippet": " and chronic mucocutaneous candidiasis. Naive lymphocytes from the affected patient displayed increased TH1 and follicular T helper cell and  [CLS] suppressed TH17\u00a0cell responses [CLS] . The mutation augmented cytokine-induced STAT1 phosphorylation without affecting dephosphorylation kinetics. Treatment with the Janus kinase 1/2 inhibitor ruxolitinib reduced"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " Naive lymphocytes from the affected patient displayed increased TH1 and follicular T helper cell and suppressed TH17\u00a0cell responses. The  [CLS] mutation augmented [CLS]  cytokine-induced STAT1 phosphorylation without affecting dephosphorylation kinetics. Treatment with the Janus kinase 1/2 inhibitor ruxolitinib reduced hyperresponsiveness to type"}
{"subject": "cytokine-induced STAT1 phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " lymphocytes from the affected patient displayed increased TH1 and follicular T helper cell and suppressed TH17\u00a0cell responses. The mutation  [CLS] augmented cytokine-induced STAT1 phosphorylation [CLS]  without affecting dephosphorylation kinetics. Treatment with the Janus kinase 1/2 inhibitor ruxolitinib reduced hyperresponsiveness to type I and II"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation in the linker domain", "obj_type": "Var", "file_name": "PubMed-28139313.json", "snippet": " as well as phenotypic and functional analysis of STAT1-mutated patient cells.\nRESULTS: We report a child with a novel  [CLS] mutation in the linker domain of STAT1 [CLS]  who had life-threatening autoimmune cytopenias and chronic mucocutaneous candidiasis. Naive lymphocytes from the affected patient displayed increased TH1 and"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " improved TH17 differentiation, cured mucocutaneous candidiasis, and maintained remission of immune-mediated cytopenias.\nCONCLUSIONS: Autoimmunity and infection caused by STAT1  [CLS] GOF mutations [CLS]  are the result of dysregulated T helper cell responses. Janus kinase inhibitor therapy could represent an effective targeted treatment"}
{"subject": "T helper cell responses", "sub_type": "CPA", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " improved TH17 differentiation, cured mucocutaneous candidiasis, and maintained remission of immune-mediated cytopenias.\nCONCLUSIONS: Autoimmunity and infection caused by STAT1  [CLS] GOF mutations are the result of dysregulated T helper cell responses [CLS] . Janus kinase inhibitor therapy could represent an effective targeted treatment for long-term disease control in severely affected patients for"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28139313.json", "snippet": " responses, improved TH17 differentiation, cured mucocutaneous candidiasis, and maintained remission of immune-mediated cytopenias.\nCONCLUSIONS: Autoimmunity and infection caused by  [CLS] STAT1 GOF mutations [CLS]  are the result of dysregulated T helper cell responses. Janus kinase inhibitor therapy could represent an effective targeted treatment"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.\nBACKGROUND:  [CLS] Gain-of-function (GOF) mutations [CLS]  in the human signal transducer and activator of transcription 1 (STAT1) manifest in immunodeficiency and autoimmunity with impaired TH17\u00a0cell"}
{"subject": "human signal transducer and activator of transcription 1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28139313.json", "snippet": " controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.\nBACKGROUND: Gain-of-function (GOF)  [CLS] mutations in the human signal transducer and activator of transcription 1 [CLS]  (STAT1) manifest in immunodeficiency and autoimmunity with impaired TH17\u00a0cell differentiation and exaggerated responsiveness to type I and II interferons."}
{"subject": "TH17\u00a0cell differentiation", "sub_type": "CPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28139313.json", "snippet": " (GOF) mutations in the human signal transducer and activator of transcription 1 (STAT1) manifest in immunodeficiency and autoimmunity with  [CLS] impaired TH17\u00a0cell differentiation [CLS]  and exaggerated responsiveness to type I and II interferons. Allogeneic bone marrow transplantation has been attempted in severely affected"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "exaggerated", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.\nBACKGROUND: Gain-of-function (GOF)  [CLS] mutations in the human signal transducer and activator of transcription 1 (STAT1) manifest in immunodeficiency and autoimmunity with impaired TH17\u00a0cell differentiation and exaggerated [CLS]  responsiveness to type I and II interferons. Allogeneic bone marrow transplantation has been attempted in severely affected patients, but"}
{"subject": "responsiveness to type I and II interferons", "sub_type": "Interaction", "rel": "ThemeOf", "object": "exaggerated", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " human signal transducer and activator of transcription 1 (STAT1) manifest in immunodeficiency and autoimmunity with impaired TH17\u00a0cell differentiation and  [CLS] exaggerated responsiveness to type I and II interferons [CLS] . Allogeneic bone marrow transplantation has been attempted in severely affected patients, but outcomes have been poor.\nOBJECTIVE: We sought"}
{"subject": "mutation in the linker domain", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " as well as phenotypic and functional analysis of STAT1-mutated patient cells.\nRESULTS: We report a child with a novel  [CLS] mutation in the linker domain of STAT1 who had life-threatening autoimmune cytopenias and chronic mucocutaneous candidiasis. Naive lymphocytes from the affected patient displayed increased [CLS]  TH1 and follicular T helper cell and suppressed TH17\u00a0cell responses. The mutation augmented cytokine-induced STAT1 phosphorylation without affecting dephosphorylation"}
{"subject": "TH1 and follicular T helper cell", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28139313.json", "snippet": " domain of STAT1 who had life-threatening autoimmune cytopenias and chronic mucocutaneous candidiasis. Naive lymphocytes from the affected patient displayed  [CLS] increased TH1 and follicular T helper cell [CLS]  and suppressed TH17\u00a0cell responses. The mutation augmented cytokine-induced STAT1 phosphorylation without affecting dephosphorylation kinetics. Treatment with the Janus kinase"}
{"subject": "mutation in the linker domain", "sub_type": "Var", "rel": "CauseOf", "object": "suppressed", "obj_type": "NegReg", "file_name": "PubMed-28139313.json", "snippet": " as well as phenotypic and functional analysis of STAT1-mutated patient cells.\nRESULTS: We report a child with a novel  [CLS] mutation in the linker domain of STAT1 who had life-threatening autoimmune cytopenias and chronic mucocutaneous candidiasis. Naive lymphocytes from the affected patient displayed increased TH1 and follicular T helper cell and suppressed [CLS]  TH17\u00a0cell responses. The mutation augmented cytokine-induced STAT1 phosphorylation without affecting dephosphorylation kinetics. Treatment with the Janus kinase 1/2 inhibitor"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28157721.json", "snippet": " of mechanisms among human proprotein convertase subtilisin-kexin type 9 variants.\nPURPOSE OF REVIEW: There are many reports of human  [CLS] variants in proprotein convertase subtilisin-kexin type 9 (PCSK9) that are either gain-of-function [CLS]  (GOF) or loss-of-function (LOF), with downstream effects on LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular"}
{"subject": "LDL receptor", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-28157721.json", "snippet": " been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare, affect all domains of the protein, act to reduce  [CLS] LDL receptor expression [CLS]  through several mechanisms, are a minor cause of familial hypercholesterolemia, have been reported mainly within families, have variable LDL"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduce", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare, affect all domains of the protein, act to  [CLS] reduce LDL receptor expression [CLS]  through several mechanisms, are a minor cause of familial hypercholesterolemia, have been reported mainly within families, have variable LDL"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF  [CLS] variants are individually ultrarare, affect all domains of the protein, act to reduce LDL receptor expression through several mechanisms, are a minor cause [CLS]  of familial hypercholesterolemia, have been reported mainly within families, have variable LDL cholesterol-raising effects, and are associated with increased"}
{"subject": "familial hypercholesterolemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " ultrarare, affect all domains of the protein, act to reduce LDL receptor expression through several mechanisms, are a minor  [CLS] cause of familial hypercholesterolemia [CLS] , have been reported mainly within families, have variable LDL cholesterol-raising effects, and are associated with increased CVD risk mainly"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " effects, and are associated with increased CVD risk mainly through observational studies in families and small cohorts. In contrast,  [CLS] LOF variants [CLS]  can be either ultrarare mutations or relatively more common polymorphisms seen in populations, affect all domains of the protein,"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " and are associated with increased CVD risk mainly through observational studies in families and small cohorts. In contrast, LOF  [CLS] variants can be either ultrarare mutations or relatively more common polymorphisms seen in populations, affect [CLS]  all domains of the protein, act to increase LDL receptor expression through several mechanisms, have variable LDL cholesterol-lowering effects,"}
{"subject": "affect", "sub_type": "Reg", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28157721.json", "snippet": " small cohorts. In contrast, LOF variants can be either ultrarare mutations or relatively more common polymorphisms seen in populations,  [CLS] affect all domains of the protein, act to increase [CLS]  LDL receptor expression through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with decreased CVD risk"}
{"subject": "domains of the protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " small cohorts. In contrast, LOF variants can be either ultrarare mutations or relatively more common polymorphisms seen in populations,  [CLS] affect all domains of the protein [CLS] , act to increase LDL receptor expression through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "lowering", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " and are associated with increased CVD risk mainly through observational studies in families and small cohorts. In contrast, LOF  [CLS] variants can be either ultrarare mutations or relatively more common polymorphisms seen in populations, affect all domains of the protein, act to increase LDL receptor expression through several mechanisms, have variable LDL cholesterol-lowering [CLS]  effects, and have been associated with decreased CVD risk mainly through Mendelian randomization studies in epidemiologic populations.\nSUMMARY: There"}
{"subject": "LDL cholesterol", "sub_type": "MPA", "rel": "ThemeOf", "object": "lowering", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " in populations, affect all domains of the protein, act to increase LDL receptor expression through several mechanisms, have variable  [CLS] LDL cholesterol-lowering [CLS]  effects, and have been associated with decreased CVD risk mainly through Mendelian randomization studies in epidemiologic populations.\nSUMMARY: There"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " of mechanisms among human proprotein convertase subtilisin-kexin type 9 variants.\nPURPOSE OF REVIEW: There are many reports of human  [CLS] variants in proprotein convertase subtilisin-kexin type 9 (PCSK9) that are either gain-of-function (GOF) or loss-of-function [CLS]  (LOF), with downstream effects on LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only"}
{"subject": "CVD", "sub_type": "Disease", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " act to increase LDL receptor expression through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with  [CLS] decreased CVD [CLS]  risk mainly through Mendelian randomization studies in epidemiologic populations.\nSUMMARY: There is considerable complexity underlying the clinical concept of"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " and are associated with increased CVD risk mainly through observational studies in families and small cohorts. In contrast, LOF  [CLS] variants can be either ultrarare mutations or relatively more common polymorphisms seen in populations, affect all domains of the protein, act to increase LDL receptor expression through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with decreased [CLS]  CVD risk mainly through Mendelian randomization studies in epidemiologic populations.\nSUMMARY: There is considerable complexity underlying the clinical concept"}
{"subject": "LDL receptor", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-28157721.json", "snippet": " ultrarare mutations or relatively more common polymorphisms seen in populations, affect all domains of the protein, act to increase  [CLS] LDL receptor expression [CLS]  through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with decreased CVD risk mainly through Mendelian"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28157721.json", "snippet": " either ultrarare mutations or relatively more common polymorphisms seen in populations, affect all domains of the protein, act to  [CLS] increase LDL receptor expression [CLS]  through several mechanisms, have variable LDL cholesterol-lowering effects, and have been associated with decreased CVD risk mainly through Mendelian"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28157721.json", "snippet": " of mechanisms among human proprotein convertase subtilisin-kexin type 9 variants.\nPURPOSE OF REVIEW: There are many reports of human  [CLS] variants in proprotein convertase subtilisin-kexin type 9 (PCSK9 [CLS] ) that are either gain-of-function (GOF) or loss-of-function (LOF), with downstream effects on LDL cholesterol and cardiovascular disease (CVD) risk."}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "effects", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " of mechanisms among human proprotein convertase subtilisin-kexin type 9 variants.\nPURPOSE OF REVIEW: There are many reports of human  [CLS] variants in proprotein convertase subtilisin-kexin type 9 (PCSK9) that are either gain-of-function (GOF) or loss-of-function (LOF), with downstream effects [CLS]  on LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT"}
{"subject": "LDL cholesterol", "sub_type": "Disease", "rel": "ThemeOf", "object": "effects", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " human variants in proprotein convertase subtilisin-kexin type 9 (PCSK9) that are either gain-of-function (GOF) or loss-of-function (LOF), with downstream  [CLS] effects on LDL cholesterol [CLS]  and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants"}
{"subject": "cardiovascular disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "effects", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " human variants in proprotein convertase subtilisin-kexin type 9 (PCSK9) that are either gain-of-function (GOF) or loss-of-function (LOF), with downstream  [CLS] effects on LDL cholesterol and cardiovascular disease [CLS]  (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare,"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF  [CLS] variants are individually ultrarare, affect [CLS]  all domains of the protein, act to reduce LDL receptor expression through several mechanisms, are a minor cause of"}
{"subject": "domains of the protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28157721.json", "snippet": " (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare,  [CLS] affect all domains of the protein [CLS] , act to reduce LDL receptor expression through several mechanisms, are a minor cause of familial hypercholesterolemia, have been reported"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-28157721.json", "snippet": " LDL cholesterol and cardiovascular disease (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS:  [CLS] GOF variants [CLS]  are individually ultrarare, affect all domains of the protein, act to reduce LDL receptor expression through several mechanisms, are"}
{"subject": "affect", "sub_type": "Reg", "rel": "CauseOf", "object": "reduce", "obj_type": "NegReg", "file_name": "PubMed-28157721.json", "snippet": " (CVD) risk. However, data on particular mechanisms have only been minimally curated.\nRECENT FINDINGS: GOF variants are individually ultrarare,  [CLS] affect all domains of the protein, act to reduce [CLS]  LDL receptor expression through several mechanisms, are a minor cause of familial hypercholesterolemia, have been reported mainly within families,"}
{"subject": "DAT", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28167616.json", "snippet": " pharmacological approach metabotropic glutamate receptor mGluR2/3 antagonism, in DAT mutants in a comparative way with standard medications. Loss of  [CLS] DAT functionality in mutant [CLS]  rats not only elevated subcortical extracellular dopamine concentration but also altered the balance of monoaminergic transmission. DAT mutant rats"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-28167616.json", "snippet": " glutamate receptor mGluR2/3 antagonism, in DAT mutants in a comparative way with standard medications. Loss of DAT functionality in  [CLS] mutant rats not only elevated [CLS]  subcortical extracellular dopamine concentration but also altered the balance of monoaminergic transmission. DAT mutant rats showed deficits in all"}
{"subject": "subcortical extracellular dopamine concentration", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-28167616.json", "snippet": " in DAT mutants in a comparative way with standard medications. Loss of DAT functionality in mutant rats not only  [CLS] elevated subcortical extracellular dopamine concentration [CLS]  but also altered the balance of monoaminergic transmission. DAT mutant rats showed deficits in all five RDoC domains. Thus,"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-28167616.json", "snippet": " glutamate receptor mGluR2/3 antagonism, in DAT mutants in a comparative way with standard medications. Loss of DAT functionality in  [CLS] mutant rats not only elevated subcortical extracellular dopamine concentration but also altered [CLS]  the balance of monoaminergic transmission. DAT mutant rats showed deficits in all five RDoC domains. Thus, mutant rats failed"}
{"subject": "balance of monoaminergic transmission", "sub_type": "MPA", "rel": "ThemeOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-28167616.json", "snippet": " with standard medications. Loss of DAT functionality in mutant rats not only elevated subcortical extracellular dopamine concentration but also  [CLS] altered the balance of monoaminergic transmission [CLS] . DAT mutant rats showed deficits in all five RDoC domains. Thus, mutant rats failed to show conditioned fear responses,"}
{"subject": "DAT", "sub_type": "Gene", "rel": "CauseOf", "object": "Loss", "obj_type": "NegReg", "file_name": "PubMed-28167616.json", "snippet": " a novel pharmacological approach metabotropic glutamate receptor mGluR2/3 antagonism, in DAT mutants in a comparative way with standard medications.  [CLS] Loss of DAT [CLS]  functionality in mutant rats not only elevated subcortical extracellular dopamine concentration but also altered the balance of monoaminergic transmission."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28167755.json", "snippet": " PI3K\u03b4 regulation by immunodeficiency mutations in PIK3CD and PIK3R1.\nActivated PI3K Delta Syndrome (APDS) is a primary immunodeficiency disease  [CLS] caused by activating mutations [CLS]  in either the leukocyte-restricted p110\u03b4 catalytic (PIK3CD) subunit or the ubiquitously expressed p85\u03b1 regulatory (PIK3R1) subunit of class IA"}
{"subject": "Activated PI3K Delta Syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28167755.json", "snippet": " [CLS] Activated PI3K Delta Syndrome (APDS) is a primary immunodeficiency disease caused [CLS]  by activating mutations in either the leukocyte-restricted p110\u03b4 catalytic (PIK3CD) subunit or the ubiquitously expressed p85\u03b1 regulatory (PIK3R1) subunit"}
{"subject": "PIK3CD", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28167755.json", "snippet": " immunodeficiency mutations in PIK3CD and PIK3R1.\nActivated PI3K Delta Syndrome (APDS) is a primary immunodeficiency disease caused by activating  [CLS] mutations in either the leukocyte-restricted p110\u03b4 catalytic (PIK3CD [CLS] ) subunit or the ubiquitously expressed p85\u03b1 regulatory (PIK3R1) subunit of class IA phosphoinositide 3-kinases (PI3Ks). There are two classes"}
{"subject": "APDS2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28167755.json", "snippet": " of APDS mutations using a combination of biochemical assays and hydrogen-deuterium exchange mass spectrometry. Intriguingly, we find that an  [CLS] APDS2 mutation [CLS]  in p85\u03b1 leads to substantial basal activation of p110\u03b4 (>300-fold) and disrupts inhibitory interactions from the nSH2, iSH2, and"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-28167755.json", "snippet": " APDS mutations using a combination of biochemical assays and hydrogen-deuterium exchange mass spectrometry. Intriguingly, we find that an APDS2  [CLS] mutation in p85\u03b1 leads to substantial basal activation [CLS]  of p110\u03b4 (>300-fold) and disrupts inhibitory interactions from the nSH2, iSH2, and cSH2 domains of p85, whereas p110\u03b1 is"}
{"subject": "p110\u03b4 (>300-fold)", "sub_type": "MPA", "rel": "ThemeOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-28167755.json", "snippet": " assays and hydrogen-deuterium exchange mass spectrometry. Intriguingly, we find that an APDS2 mutation in p85\u03b1 leads to substantial basal  [CLS] activation of p110\u03b4 (>300-fold) [CLS]  and disrupts inhibitory interactions from the nSH2, iSH2, and cSH2 domains of p85, whereas p110\u03b1 is only minimally basally"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "disrupts", "obj_type": "NegReg", "file_name": "PubMed-28167755.json", "snippet": " APDS mutations using a combination of biochemical assays and hydrogen-deuterium exchange mass spectrometry. Intriguingly, we find that an APDS2  [CLS] mutation in p85\u03b1 leads to substantial basal activation of p110\u03b4 (>300-fold) and disrupts [CLS]  inhibitory interactions from the nSH2, iSH2, and cSH2 domains of p85, whereas p110\u03b1 is only minimally basally activated (\u223c2-fold)"}
{"subject": "inhibitory interactions", "sub_type": "MPA", "rel": "ThemeOf", "object": "disrupts", "obj_type": "NegReg", "file_name": "PubMed-28167755.json", "snippet": " spectrometry. Intriguingly, we find that an APDS2 mutation in p85\u03b1 leads to substantial basal activation of p110\u03b4 (>300-fold) and  [CLS] disrupts inhibitory interactions [CLS]  from the nSH2, iSH2, and cSH2 domains of p85, whereas p110\u03b1 is only minimally basally activated (\u223c2-fold) when associated"}
{"subject": "Cdh2", "sub_type": "Gene", "rel": "ThemeOf", "object": "deletion", "obj_type": "Var", "file_name": "PubMed-28240364.json", "snippet": " tested the hypothesis that N-cadherin has different effects on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage  [CLS] Cdh2 deletion [CLS]  in mice results in defective growth, low bone mass, and reduced osteoprogenitor number. These abnormalities are prevented by delaying"}
{"subject": "deletion", "sub_type": "Var", "rel": "CauseOf", "object": "defective", "obj_type": "NegReg", "file_name": "PubMed-28240364.json", "snippet": " the hypothesis that N-cadherin has different effects on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage Cdh2  [CLS] deletion in mice results in defective [CLS]  growth, low bone mass, and reduced osteoprogenitor number. These abnormalities are prevented by delaying Cdh2 ablation until 1 month"}
{"subject": "growth", "sub_type": "MPA", "rel": "ThemeOf", "object": "defective", "obj_type": "NegReg", "file_name": "PubMed-28240364.json", "snippet": " different effects on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage Cdh2 deletion in mice results in  [CLS] defective growth [CLS] , low bone mass, and reduced osteoprogenitor number. These abnormalities are prevented by delaying Cdh2 ablation until 1 month of"}
{"subject": "deletion", "sub_type": "Var", "rel": "CauseOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-28240364.json", "snippet": " the hypothesis that N-cadherin has different effects on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage Cdh2  [CLS] deletion in mice results in defective growth, low [CLS]  bone mass, and reduced osteoprogenitor number. These abnormalities are prevented by delaying Cdh2 ablation until 1 month of age,"}
{"subject": "bone mass", "sub_type": "MPA", "rel": "ThemeOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-28240364.json", "snippet": " on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage Cdh2 deletion in mice results in defective growth,  [CLS] low bone mass [CLS] , and reduced osteoprogenitor number. These abnormalities are prevented by delaying Cdh2 ablation until 1 month of age, thus targeting"}
{"subject": "deletion", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28240364.json", "snippet": " the hypothesis that N-cadherin has different effects on osteolineage cells depending upon their differentiation stage. Embryonic conditional osteolineage Cdh2  [CLS] deletion in mice results in defective growth, low bone mass, and reduced [CLS]  osteoprogenitor number. These abnormalities are prevented by delaying Cdh2 ablation until 1 month of age, thus targeting only committed"}
{"subject": "osteoprogenitor number", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28240364.json", "snippet": " upon their differentiation stage. Embryonic conditional osteolineage Cdh2 deletion in mice results in defective growth, low bone mass, and  [CLS] reduced osteoprogenitor number [CLS] . These abnormalities are prevented by delaying Cdh2 ablation until 1 month of age, thus targeting only committed and mature"}
{"subject": "KIT", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28270683.json", "snippet": " [CLS] KIT, PDGFRA, NF1 and SDH mutations [CLS]  are alternate initiating events, fostering hyperplasia in gastrointestinal stromal tumours (GISTs), and additional genetic alterations are required for progression"}
{"subject": "SDH", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28270683.json", "snippet": " [CLS] SDH mutations [CLS]  are alternate initiating events, fostering hyperplasia in gastrointestinal stromal tumours (GISTs), and additional genetic alterations are required for progression"}
{"subject": "NF1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28270683.json", "snippet": " [CLS] NF1 and SDH mutations [CLS]  are alternate initiating events, fostering hyperplasia in gastrointestinal stromal tumours (GISTs), and additional genetic alterations are required for progression"}
{"subject": "PDGFRA", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28270683.json", "snippet": " [CLS] PDGFRA, NF1 and SDH mutations [CLS]  are alternate initiating events, fostering hyperplasia in gastrointestinal stromal tumours (GISTs), and additional genetic alterations are required for progression"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "fostering", "obj_type": "Reg", "file_name": "PubMed-28270683.json", "snippet": " inactivation is an early event in GIST development that regulates p16 and cell proliferation.\nKIT, PDGFRA, NF1 and SDH  [CLS] mutations are alternate initiating events, fostering [CLS]  hyperplasia in gastrointestinal stromal tumours (GISTs), and additional genetic alterations are required for progression to malignancy. The most frequent"}
{"subject": "gastrointestinal stromal tumours", "sub_type": "MPA", "rel": "ThemeOf", "object": "fostering", "obj_type": "Reg", "file_name": "PubMed-28270683.json", "snippet": " in GIST development that regulates p16 and cell proliferation.\nKIT, PDGFRA, NF1 and SDH mutations are alternate initiating events,  [CLS] fostering hyperplasia in gastrointestinal stromal tumours [CLS]  (GISTs), and additional genetic alterations are required for progression to malignancy. The most frequent secondary alteration, demonstrated in \u223c70%"}
{"subject": "ATR", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-28273450.json", "snippet": " [CLS] ATR Mutations [CLS]  Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.\nMelanomas accumulate a high burden of mutations that"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28273450.json", "snippet": " mutations in ATR, a kinase that recognizes and repairs UV-induced DNA damage and is required for cellular proliferation. ATR  [CLS] mutant tumors exhibit both the accumulation of multiple mutations and the altered expression of inflammatory genes, resulting in decreased [CLS]  T\u00a0cell recruitment and increased recruitment of macrophages known to spur tumor invasion. Taken together, these studies identify a mechanism"}
{"subject": "T\u00a0cell recruitment", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28273450.json", "snippet": " ATR mutant tumors exhibit both the accumulation of multiple mutations and the altered expression of inflammatory genes, resulting in  [CLS] decreased T\u00a0cell recruitment [CLS]  and increased recruitment of macrophages known to spur tumor invasion. Taken together, these studies identify a mechanism by which"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28273450.json", "snippet": " mutations in ATR, a kinase that recognizes and repairs UV-induced DNA damage and is required for cellular proliferation. ATR  [CLS] mutant tumors exhibit both the accumulation of multiple mutations and the altered expression of inflammatory genes, resulting in decreased T\u00a0cell recruitment and increased [CLS]  recruitment of macrophages known to spur tumor invasion. Taken together, these studies identify a mechanism by which melanoma cells"}
{"subject": "recruitment of macrophages", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28273450.json", "snippet": " both the accumulation of multiple mutations and the altered expression of inflammatory genes, resulting in decreased T\u00a0cell recruitment and  [CLS] increased recruitment of macrophages [CLS]  known to spur tumor invasion. Taken together, these studies identify a mechanism by which melanoma cells modulate the immune"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Promote", "obj_type": "PosReg", "file_name": "PubMed-28273450.json", "snippet": " [CLS] Mutations Promote [CLS]  the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.\nMelanomas accumulate a high burden of mutations that could"}
{"subject": "Growth", "sub_type": "MPA", "rel": "ThemeOf", "object": "Promote", "obj_type": "PosReg", "file_name": "PubMed-28273450.json", "snippet": " [CLS] Promote the Growth [CLS]  of Melanoma Tumors by Modulating the Immune Microenvironment.\nMelanomas accumulate a high burden of mutations that could potentially generate"}
{"subject": "Melanoma Tumors", "sub_type": "Disease", "rel": "ThemeOf", "object": "Growth", "obj_type": "MPA", "file_name": "PubMed-28273450.json", "snippet": " [CLS] Growth of Melanoma Tumors [CLS]  by Modulating the Immune Microenvironment.\nMelanomas accumulate a high burden of mutations that could potentially generate neoantigens, yet somehow"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "generate", "obj_type": "Reg", "file_name": "PubMed-28273450.json", "snippet": " [CLS] mutations that could potentially generate [CLS]  neoantigens, yet somehow suppress the immune response to facilitate continued growth. In this study, we identify a subset of"}
{"subject": "neoantigens", "sub_type": "MPA", "rel": "ThemeOf", "object": "generate", "obj_type": "Reg", "file_name": "PubMed-28273450.json", "snippet": " Growth of Melanoma Tumors by Modulating the Immune Microenvironment.\nMelanomas accumulate a high burden of mutations that could potentially  [CLS] generate neoantigens [CLS] , yet somehow suppress the immune response to facilitate continued growth. In this study, we identify a subset of human"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "suppress", "obj_type": "NegReg", "file_name": "PubMed-28273450.json", "snippet": " [CLS] mutations that could potentially generate neoantigens, yet somehow suppress [CLS]  the immune response to facilitate continued growth. In this study, we identify a subset of human melanomas that have"}
{"subject": "immune response to facilitate continued growth", "sub_type": "MPA", "rel": "ThemeOf", "object": "suppress", "obj_type": "NegReg", "file_name": "PubMed-28273450.json", "snippet": " by Modulating the Immune Microenvironment.\nMelanomas accumulate a high burden of mutations that could potentially generate neoantigens, yet somehow  [CLS] suppress the immune response to facilitate continued growth [CLS] . In this study, we identify a subset of human melanomas that have loss-of-function mutations in ATR, a kinase that"}
{"subject": "ATR", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28273450.json", "snippet": " loss-of-function mutations in ATR, a kinase that recognizes and repairs UV-induced DNA damage and is required for cellular proliferation.  [CLS] ATR mutant [CLS]  tumors exhibit both the accumulation of multiple mutations and the altered expression of inflammatory genes, resulting in decreased T\u00a0cell"}
{"subject": "BDNF", "sub_type": "Gene", "rel": "ThemeOf", "object": "polymorphism", "obj_type": "Var", "file_name": "PubMed-28277116.json", "snippet": " role of Val66Met, a single-nucleotide polymorphism of the BDNF gene, in regulating endometrial cells proliferation. The results showed that  [CLS] BDNF(V66M) polymorphism [CLS]  is a loss-of-function polymorphism in the regulation of endometrial cells growth. Given the correlation between endometriosis and infertility, it"}
{"subject": "polymorphism", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28277116.json", "snippet": " of Val66Met, a single-nucleotide polymorphism of the BDNF gene, in regulating endometrial cells proliferation. The results showed that BDNF(V66M)  [CLS] polymorphism is a loss-of-function [CLS]  polymorphism in the regulation of endometrial cells growth. Given the correlation between endometriosis and infertility, it is important to"}
{"subject": "regulation of endometrial cells growth", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28277116.json", "snippet": " single-nucleotide polymorphism of the BDNF gene, in regulating endometrial cells proliferation. The results showed that BDNF(V66M) polymorphism is a  [CLS] loss-of-function polymorphism in the regulation of endometrial cells growth [CLS] . Given the correlation between endometriosis and infertility, it is important to understand the role of BDNF in regulating endometrial"}
{"subject": "polymorphism", "sub_type": "Var", "rel": "ThemeOf", "object": "regulation of endometrial cells growth", "obj_type": "MPA", "file_name": "PubMed-28277116.json", "snippet": " polymorphism of the BDNF gene, in regulating endometrial cells proliferation. The results showed that BDNF(V66M) polymorphism is a loss-of-function  [CLS] polymorphism in the regulation of endometrial cells growth [CLS] . Given the correlation between endometriosis and infertility, it is important to understand the role of BDNF in regulating endometrial"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28283687.json", "snippet": " [CLS] gain-of-function mutations [CLS]  in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis.\nLRP5 loss-of-function mutations have been shown"}
{"subject": "LRP5", "sub_type": "Gene", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28283687.json", "snippet": " lipid metabolism. We hypothesized that gain-of-function mutations in LRP5 would also affect these parameters. We therefore studied individuals with  [CLS] LRP5 gain-of-function [CLS]  mutations exhibiting high bone mass (HBM) phenotypes and found that while there was no detected change in insulin sensitivity,"}
{"subject": "LRP5", "sub_type": "Gene", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-28283687.json", "snippet": " lipid metabolism. We hypothesized that gain-of-function mutations in LRP5 would also affect these parameters. We therefore studied individuals with  [CLS] LRP5 gain-of-function mutations exhibiting high bone mass (HBM) phenotypes and found that while there was no detected change in insulin sensitivity, there was a significant reduction [CLS]  in serum LDL.\nINTRODUCTION: Wnt signaling through LRP5 represents a newly appreciated metabolic pathway, which potentially represents a target"}
{"subject": "serum LDL", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-28283687.json", "snippet": " mass (HBM) phenotypes and found that while there was no detected change in insulin sensitivity, there was a significant  [CLS] reduction in serum LDL [CLS] .\nINTRODUCTION: Wnt signaling through LRP5 represents a newly appreciated metabolic pathway, which potentially represents a target for drug discovery"}
{"subject": "LRP5", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28283687.json", "snippet": " that HBM-causing LRP5 mutations, associated with increased Wnt signaling, improve glucose metabolism in humans. However, it does appear that  [CLS] LRP5 variants [CLS]  may affect LDL metabolism, a major risk factor for coronary artery disease. The molecular mechanisms underpinning this effect warrant"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28283687.json", "snippet": " HBM-causing LRP5 mutations, associated with increased Wnt signaling, improve glucose metabolism in humans. However, it does appear that LRP5  [CLS] variants may affect [CLS]  LDL metabolism, a major risk factor for coronary artery disease. The molecular mechanisms underpinning this effect warrant further study."}
{"subject": "LDL metabolism", "sub_type": "MPA", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-28283687.json", "snippet": " mutations, associated with increased Wnt signaling, improve glucose metabolism in humans. However, it does appear that LRP5 variants may  [CLS] affect LDL metabolism [CLS] , a major risk factor for coronary artery disease. The molecular mechanisms underpinning this effect warrant further study."}
{"subject": "LRP5", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28283687.json", "snippet": " [CLS] mutations in the low-density lipoprotein receptor-related protein 5 (LRP5 [CLS] ) on glucose and lipid homeostasis.\nLRP5 loss-of-function mutations have been shown to cause profound osteoporosis and have been associated"}
{"subject": "glucose and lipid homeostasis", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28283687.json", "snippet": " [CLS] gain-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis [CLS] .\nLRP5 loss-of-function mutations have been shown to cause profound osteoporosis and have been associated with impaired insulin sensitivity and"}
{"subject": "LRP5", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28283687.json", "snippet": " [CLS] LRP5 loss-of-function mutations [CLS]  have been shown to cause profound osteoporosis and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28283687.json", "snippet": " [CLS] loss-of-function mutations [CLS]  have been shown to cause profound osteoporosis and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism."}
{"subject": "profound osteoporosis", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28283687.json", "snippet": " [CLS] loss-of-function mutations have been shown to cause profound osteoporosis [CLS]  and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism. We hypothesized that gain-of-function mutations in LRP5"}
{"subject": "impaired insulin sensitivity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28283687.json", "snippet": " [CLS] loss-of-function mutations have been shown to cause profound osteoporosis and have been associated with impaired insulin sensitivity [CLS]  and dysregulated lipid metabolism. We hypothesized that gain-of-function mutations in LRP5 would also affect these parameters. We therefore studied"}
{"subject": "dysregulated lipid metabolism", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28283687.json", "snippet": " [CLS] loss-of-function mutations have been shown to cause profound osteoporosis and have been associated with impaired insulin sensitivity and dysregulated lipid metabolism [CLS] . We hypothesized that gain-of-function mutations in LRP5 would also affect these parameters. We therefore studied individuals with LRP5 gain-of-function"}
{"subject": "LRP5", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28283687.json", "snippet": " lipid metabolism. We hypothesized that gain-of-function mutations in LRP5 would also affect these parameters. We therefore studied individuals with  [CLS] LRP5 gain-of-function mutations [CLS]  exhibiting high bone mass (HBM) phenotypes and found that while there was no detected change in insulin sensitivity, there"}
{"subject": "knockdown", "sub_type": "Var", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-28314794.json", "snippet": " positive regulator of both root hair initiation and tip growth in Arabidopsis. Both loss of function of ROP2 and  [CLS] knockdown of MAP18 lead to a decrease [CLS]  in root hair length, whereas overexpression of either MAP18 or ROP2 causes multiple tips or a branching hair phenotype."}
{"subject": "root hair length", "sub_type": "MPA", "rel": "ThemeOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-28314794.json", "snippet": " initiation and tip growth in Arabidopsis. Both loss of function of ROP2 and knockdown of MAP18 lead to a  [CLS] decrease in root hair length [CLS] , whereas overexpression of either MAP18 or ROP2 causes multiple tips or a branching hair phenotype. However, it is unclear"}
{"subject": "MAP18", "sub_type": "Gene", "rel": "ThemeOf", "object": "knockdown", "obj_type": "Var", "file_name": "PubMed-28314794.json", "snippet": " positive regulator of both root hair initiation and tip growth in Arabidopsis. Both loss of function of ROP2 and  [CLS] knockdown of MAP18 [CLS]  lead to a decrease in root hair length, whereas overexpression of either MAP18 or ROP2 causes multiple tips or"}
{"subject": "Deletion", "sub_type": "Var", "rel": "CauseOf", "object": "affects", "obj_type": "Reg", "file_name": "PubMed-28322269.json", "snippet": " interacts with P. blakesleeanus Ras homologs in yeast two-hybrid assays, indicating that MadC is a regulator of Ras signaling.  [CLS] Deletion of the homolog in the filamentous ascomycete Neurospora crassa affects [CLS]  the circadian clock output, yielding a pattern of asexual conidiation similar to a ras-1 mutant that is used in"}
{"subject": "circadian clock output", "sub_type": "MPA", "rel": "ThemeOf", "object": "affects", "obj_type": "Reg", "file_name": "PubMed-28322269.json", "snippet": " indicating that MadC is a regulator of Ras signaling. Deletion of the homolog in the filamentous ascomycete Neurospora crassa  [CLS] affects the circadian clock output [CLS] , yielding a pattern of asexual conidiation similar to a ras-1 mutant that is used in circadian studies in N."}
{"subject": "Deletion", "sub_type": "Var", "rel": "CauseOf", "object": "yielding", "obj_type": "Reg", "file_name": "PubMed-28322269.json", "snippet": " interacts with P. blakesleeanus Ras homologs in yeast two-hybrid assays, indicating that MadC is a regulator of Ras signaling.  [CLS] Deletion of the homolog in the filamentous ascomycete Neurospora crassa affects the circadian clock output, yielding [CLS]  a pattern of asexual conidiation similar to a ras-1 mutant that is used in circadian studies in N. crassa."}
{"subject": "asexual conidiation", "sub_type": "MPA", "rel": "ThemeOf", "object": "yielding", "obj_type": "Reg", "file_name": "PubMed-28322269.json", "snippet": " regulator of Ras signaling. Deletion of the homolog in the filamentous ascomycete Neurospora crassa affects the circadian clock output,  [CLS] yielding a pattern of asexual conidiation [CLS]  similar to a ras-1 mutant that is used in circadian studies in N. crassa. Thus, MadC is unlikely to"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "escaped", "obj_type": "NegReg", "file_name": "PubMed-28338294.json", "snippet": " Here, we report a heterozygous frameshift mutation of PROKR2 identified in a 3.5-year-old girl with central precocious puberty. The  [CLS] mutant mRNA escaped [CLS]  nonsense-mediated decay and generated a GPCR lacking two transmembrane domains and the carboxyl-terminal tail. The mutant protein had no"}
{"subject": "nonsense-mediated decay", "sub_type": "MPA", "rel": "ThemeOf", "object": "escaped", "obj_type": "NegReg", "file_name": "PubMed-28338294.json", "snippet": " report a heterozygous frameshift mutation of PROKR2 identified in a 3.5-year-old girl with central precocious puberty. The mutant mRNA  [CLS] escaped nonsense-mediated decay [CLS]  and generated a GPCR lacking two transmembrane domains and the carboxyl-terminal tail. The mutant protein had no in vitro"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "lacking", "obj_type": "NegReg", "file_name": "PubMed-28338294.json", "snippet": " Here, we report a heterozygous frameshift mutation of PROKR2 identified in a 3.5-year-old girl with central precocious puberty. The  [CLS] mutant mRNA escaped nonsense-mediated decay and generated a GPCR lacking [CLS]  two transmembrane domains and the carboxyl-terminal tail. The mutant protein had no in vitro signal transduction activity; however, cells"}
{"subject": "two transmembrane domains", "sub_type": "MPA", "rel": "ThemeOf", "object": "lacking", "obj_type": "NegReg", "file_name": "PubMed-28338294.json", "snippet": " identified in a 3.5-year-old girl with central precocious puberty. The mutant mRNA escaped nonsense-mediated decay and generated a GPCR  [CLS] lacking two transmembrane domains [CLS]  and the carboxyl-terminal tail. The mutant protein had no in vitro signal transduction activity; however, cells co-expressing the mutant"}
{"subject": "PROKR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28338294.json", "snippet": " cells co-expressing the mutant and wild-type PROKR2 exhibited markedly exaggerated ligand-induced Ca(2+) responses. The results indicate that certain inactive  [CLS] PROKR2 mutants [CLS]  can cause early puberty by enhancing the functional property of coexisting wild-type proteins. Considering the structural similarity among GPCRs,"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "enhancing", "obj_type": "PosReg", "file_name": "PubMed-28338294.json", "snippet": " co-expressing the mutant and wild-type PROKR2 exhibited markedly exaggerated ligand-induced Ca(2+) responses. The results indicate that certain inactive PROKR2  [CLS] mutants can cause early puberty by enhancing [CLS]  the functional property of coexisting wild-type proteins. Considering the structural similarity among GPCRs, this paradoxical gain-of-function mechanism may underlie"}
{"subject": "functional", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhancing", "obj_type": "PosReg", "file_name": "PubMed-28338294.json", "snippet": " exhibited markedly exaggerated ligand-induced Ca(2+) responses. The results indicate that certain inactive PROKR2 mutants can cause early puberty by  [CLS] enhancing the functional [CLS]  property of coexisting wild-type proteins. Considering the structural similarity among GPCRs, this paradoxical gain-of-function mechanism may underlie various human"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "disrupted", "obj_type": "NegReg", "file_name": "PubMed-28339550.json", "snippet": " whether these physiological functions required ion flux through a mechanically gated channel provided by MSL8. We introduced two point  [CLS] mutations into the predicted pore-lining domain of MSL8 that disrupted [CLS]  normal channel function in different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving"}
{"subject": "MSL8", "sub_type": "Gene", "rel": "ThemeOf", "object": "Phe720Leu mutation", "obj_type": "Var", "file_name": "PubMed-28339550.json", "snippet": " different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and the  [CLS] Phe720Leu mutation severely disrupted the MSL8 [CLS]  channel. Both of these mutations impaired the ability of MSL8 to preserve pollen viability during hydration and to maintain"}
{"subject": "channel", "sub_type": "Pathway", "rel": "ThemeOf", "object": "disrupted", "obj_type": "NegReg", "file_name": "PubMed-28339550.json", "snippet": " Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely  [CLS] disrupted the MSL8 channel [CLS] . Both of these mutations impaired the ability of MSL8 to preserve pollen viability during hydration and to maintain the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28339550.json", "snippet": " the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these  [CLS] mutations impaired [CLS]  the ability of MSL8 to preserve pollen viability during hydration and to maintain the integrity of the pollen tube"}
{"subject": "ability", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28339550.json", "snippet": " MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these mutations  [CLS] impaired the ability [CLS]  of MSL8 to preserve pollen viability during hydration and to maintain the integrity of the pollen tube when expressed"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "maintain", "obj_type": "Reg", "file_name": "PubMed-28339550.json", "snippet": " the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these  [CLS] mutations impaired the ability of MSL8 to preserve pollen viability during hydration and to maintain [CLS]  the integrity of the pollen tube when expressed at endogenous levels. When overexpressed in an msl8-4 null background, MSL8I711S"}
{"subject": "integrity", "sub_type": "MPA", "rel": "ThemeOf", "object": "maintain", "obj_type": "Reg", "file_name": "PubMed-28339550.json", "snippet": " MSL8 channel. Both of these mutations impaired the ability of MSL8 to preserve pollen viability during hydration and to  [CLS] maintain the integrity [CLS]  of the pollen tube when expressed at endogenous levels. When overexpressed in an msl8-4 null background, MSL8I711S could partially"}
{"subject": "normal channel function", "sub_type": "MPA", "rel": "ThemeOf", "object": "disrupted", "obj_type": "NegReg", "file_name": "PubMed-28339550.json", "snippet": " mechanically gated channel provided by MSL8. We introduced two point mutations into the predicted pore-lining domain of MSL8 that  [CLS] disrupted normal channel function [CLS]  in different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and"}
{"subject": "MSL8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28339550.json", "snippet": " whether these physiological functions required ion flux through a mechanically gated channel provided by MSL8. We introduced two point  [CLS] mutations into the predicted pore-lining domain of MSL8 [CLS]  that disrupted normal channel function in different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel"}
{"subject": "Ile711Ser", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28339550.json", "snippet": " two point mutations into the predicted pore-lining domain of MSL8 that disrupted normal channel function in different ways. The  [CLS] Ile711Ser mutation increased [CLS]  the tension threshold of the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8"}
{"subject": "tension threshold", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28339550.json", "snippet": " mutations into the predicted pore-lining domain of MSL8 that disrupted normal channel function in different ways. The Ile711Ser mutation  [CLS] increased the tension threshold [CLS]  of the MSL8 channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of"}
{"subject": "MSL8", "sub_type": "Gene", "rel": "ThemeOf", "object": "Ile711Ser", "obj_type": "Var", "file_name": "PubMed-28339550.json", "snippet": " two point mutations into the predicted pore-lining domain of MSL8 that disrupted normal channel function in different ways. The  [CLS] Ile711Ser mutation increased the tension threshold of the MSL8 [CLS]  channel while leaving conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these mutations impaired"}
{"subject": "Ile711Ser", "sub_type": "Var", "rel": "CauseOf", "object": "leaving", "obj_type": "Reg", "file_name": "PubMed-28339550.json", "snippet": " two point mutations into the predicted pore-lining domain of MSL8 that disrupted normal channel function in different ways. The  [CLS] Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving [CLS]  conductance unchanged, and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these mutations impaired the ability of"}
{"subject": "conductance unchanged", "sub_type": "MPA", "rel": "ThemeOf", "object": "leaving", "obj_type": "Reg", "file_name": "PubMed-28339550.json", "snippet": " disrupted normal channel function in different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while  [CLS] leaving conductance unchanged [CLS] , and the Phe720Leu mutation severely disrupted the MSL8 channel. Both of these mutations impaired the ability of MSL8 to"}
{"subject": "Phe720Leu mutation", "sub_type": "Var", "rel": "CauseOf", "object": "disrupted", "obj_type": "NegReg", "file_name": "PubMed-28339550.json", "snippet": " different ways. The Ile711Ser mutation increased the tension threshold of the MSL8 channel while leaving conductance unchanged, and the  [CLS] Phe720Leu mutation severely disrupted [CLS]  the MSL8 channel. Both of these mutations impaired the ability of MSL8 to preserve pollen viability during hydration and"}
{"subject": "Rack1", "sub_type": "Gene", "rel": "ThemeOf", "object": "knock-down", "obj_type": "Var", "file_name": "PubMed-28343944.json", "snippet": " proposed. Here, we used a genetic approach to test this hypothesis in vivo in the mouse. We show that  [CLS] Rack1 knock-down [CLS]  in the mouse melanoma cell line B16 reduces invasiveness and induces cell differentiation. We have developed the first mouse"}
{"subject": "knock-down", "sub_type": "Var", "rel": "CauseOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28343944.json", "snippet": " Here, we used a genetic approach to test this hypothesis in vivo in the mouse. We show that Rack1  [CLS] knock-down in the mouse melanoma cell line B16 reduces [CLS]  invasiveness and induces cell differentiation. We have developed the first mouse model for RACK1 gain of function, Tyr::Rack1-HA transgenic"}
{"subject": "invasiveness", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28343944.json", "snippet": " this hypothesis in vivo in the mouse. We show that Rack1 knock-down in the mouse melanoma cell line B16  [CLS] reduces invasiveness [CLS]  and induces cell differentiation. We have developed the first mouse model for RACK1 gain of function, Tyr::Rack1-HA transgenic mice,"}
{"subject": "knock-down", "sub_type": "Var", "rel": "CauseOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-28343944.json", "snippet": " Here, we used a genetic approach to test this hypothesis in vivo in the mouse. We show that Rack1  [CLS] knock-down in the mouse melanoma cell line B16 reduces invasiveness and induces [CLS]  cell differentiation. We have developed the first mouse model for RACK1 gain of function, Tyr::Rack1-HA transgenic mice, targeting RACK1"}
{"subject": "cell differentiation", "sub_type": "MPA", "rel": "ThemeOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-28343944.json", "snippet": " vivo in the mouse. We show that Rack1 knock-down in the mouse melanoma cell line B16 reduces invasiveness and  [CLS] induces cell differentiation [CLS] . We have developed the first mouse model for RACK1 gain of function, Tyr::Rack1-HA transgenic mice, targeting RACK1 to melanocytes"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " DGAT1 missense mutation associated with congenital diarrhea.\nAcyl-CoA:diacylglycerol acyltransferase (DGAT)1 and DGAT2 catalyze triglyceride (TG) biosynthesis in humans. Biallelic  [CLS] loss-of-function mutations [CLS]  in human DGAT1 result in severe congenital diarrhea and protein-losing enteropathy. Additionally, pharmacologic inhibition of DGAT1 led to dose-related"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " a homozygous recessive mutation in DGAT1, c.314T>C, p.L105P. We show here that the p.L105P DGAT1 enzyme produced from the  [CLS] mutant allele is less abundant, resulting in partial loss of TG synthesis activity and decreased [CLS]  formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the"}
{"subject": "formation of lipid droplets", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " DGAT1 enzyme produced from the mutant allele is less abundant, resulting in partial loss of TG synthesis activity and  [CLS] decreased formation of lipid droplets [CLS]  in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the p.L105P missense allele partially"}
{"subject": "p.L105P missense", "sub_type": "Var", "rel": "CauseOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the  [CLS] p.L105P missense allele partially reduces [CLS]  TG synthesis activity and causes a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1"}
{"subject": "TG synthesis activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the p.L105P missense allele partially  [CLS] reduces TG synthesis activity [CLS]  and causes a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1 deficiency as a"}
{"subject": "p.L105P missense", "sub_type": "Var", "rel": "CauseOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of DGAT1, the  [CLS] p.L105P missense allele partially reduces TG synthesis activity and causes [CLS]  a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1 deficiency as a cause of"}
{"subject": "less severe clinical phenotype", "sub_type": "MPA", "rel": "ThemeOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " Thus, in contrast with complete loss-of-function alleles of DGAT1, the p.L105P missense allele partially reduces TG synthesis activity and  [CLS] causes a less severe clinical phenotype [CLS] . Our findings add to the growing recognition of DGAT1 deficiency as a cause of congenital diarrhea with protein-losing enteropathy"}
{"subject": "DGAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "deficiency", "obj_type": "Var", "file_name": "PubMed-28373485.json", "snippet": " reduces TG synthesis activity and causes a less severe clinical phenotype. Our findings add to the growing recognition of  [CLS] DGAT1 deficiency [CLS]  as a cause of congenital diarrhea with protein-losing enteropathy and indicate that DGAT1 mutations result in a spectrum of"}
{"subject": "deficiency", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " TG synthesis activity and causes a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1  [CLS] deficiency as a cause [CLS]  of congenital diarrhea with protein-losing enteropathy and indicate that DGAT1 mutations result in a spectrum of diseases."}
{"subject": "congenital diarrhea", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " and causes a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1 deficiency as a  [CLS] cause of congenital diarrhea [CLS]  with protein-losing enteropathy and indicate that DGAT1 mutations result in a spectrum of diseases."}
{"subject": "congenital diarrhea", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " DGAT1 missense mutation associated with congenital diarrhea.\nAcyl-CoA:diacylglycerol acyltransferase (DGAT)1 and DGAT2 catalyze triglyceride (TG) biosynthesis in humans. Biallelic  [CLS] loss-of-function mutations in human DGAT1 result in severe congenital diarrhea [CLS]  and protein-losing enteropathy. Additionally, pharmacologic inhibition of DGAT1 led to dose-related diarrhea in human clinical trials. Here we identify"}
{"subject": "protein-losing enteropathy", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " and causes a less severe clinical phenotype. Our findings add to the growing recognition of DGAT1 deficiency as a  [CLS] cause of congenital diarrhea with protein-losing enteropathy [CLS]  and indicate that DGAT1 mutations result in a spectrum of diseases."}
{"subject": "DGAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28373485.json", "snippet": " to the growing recognition of DGAT1 deficiency as a cause of congenital diarrhea with protein-losing enteropathy and indicate that  [CLS] DGAT1 mutations [CLS]  result in a spectrum of diseases."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " the growing recognition of DGAT1 deficiency as a cause of congenital diarrhea with protein-losing enteropathy and indicate that DGAT1  [CLS] mutations result in [CLS]  a spectrum of diseases."}
{"subject": "spectrum of diseases", "sub_type": "Disease", "rel": "ThemeOf", "object": "result in", "obj_type": "Reg", "file_name": "PubMed-28373485.json", "snippet": " growing recognition of DGAT1 deficiency as a cause of congenital diarrhea with protein-losing enteropathy and indicate that DGAT1 mutations  [CLS] result in a spectrum of diseases [CLS] ."}
{"subject": "DGAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.L105P", "obj_type": "Var", "file_name": "PubMed-28373485.json", "snippet": " failure to thrive. Exome sequencing revealed a homozygous recessive mutation in DGAT1, c.314T>C, p.L105P. We show here that the  [CLS] p.L105P DGAT1 [CLS]  enzyme produced from the mutant allele is less abundant, resulting in partial loss of TG synthesis activity and decreased"}
{"subject": "protein-losing enteropathy", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " DGAT1 missense mutation associated with congenital diarrhea.\nAcyl-CoA:diacylglycerol acyltransferase (DGAT)1 and DGAT2 catalyze triglyceride (TG) biosynthesis in humans. Biallelic  [CLS] loss-of-function mutations in human DGAT1 result in severe congenital diarrhea and protein-losing enteropathy [CLS] . Additionally, pharmacologic inhibition of DGAT1 led to dose-related diarrhea in human clinical trials. Here we identify a previously unknown"}
{"subject": "DGAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28373485.json", "snippet": " missense mutation associated with congenital diarrhea.\nAcyl-CoA:diacylglycerol acyltransferase (DGAT)1 and DGAT2 catalyze triglyceride (TG) biosynthesis in humans. Biallelic loss-of-function  [CLS] mutations in human DGAT1 [CLS]  result in severe congenital diarrhea and protein-losing enteropathy. Additionally, pharmacologic inhibition of DGAT1 led to dose-related diarrhea in human"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "less", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " a homozygous recessive mutation in DGAT1, c.314T>C, p.L105P. We show here that the p.L105P DGAT1 enzyme produced from the  [CLS] mutant allele is less [CLS]  abundant, resulting in partial loss of TG synthesis activity and decreased formation of lipid droplets in patient-derived primary dermal"}
{"subject": "p.L105P", "sub_type": "Var", "rel": "ThemeOf", "object": "less", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " failure to thrive. Exome sequencing revealed a homozygous recessive mutation in DGAT1, c.314T>C, p.L105P. We show here that the  [CLS] p.L105P DGAT1 enzyme produced from the mutant allele is less [CLS]  abundant, resulting in partial loss of TG synthesis activity and decreased formation of lipid droplets in patient-derived primary dermal"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " a homozygous recessive mutation in DGAT1, c.314T>C, p.L105P. We show here that the p.L105P DGAT1 enzyme produced from the  [CLS] mutant allele is less abundant, resulting in partial loss [CLS]  of TG synthesis activity and decreased formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with"}
{"subject": "TG synthesis activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28373485.json", "snippet": " We show here that the p.L105P DGAT1 enzyme produced from the mutant allele is less abundant, resulting in partial  [CLS] loss of TG synthesis activity [CLS]  and decreased formation of lipid droplets in patient-derived primary dermal fibroblasts. Thus, in contrast with complete loss-of-function alleles of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28460636.json", "snippet": " [CLS] caused by mutations [CLS]  in the MPDZ gene.\nCongenital hydrocephalus is considered as either acquired due to haemorrhage, infection or neoplasia or as"}
{"subject": "Hydrocephalus", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28460636.json", "snippet": " [CLS] Hydrocephalus due to multiple ependymal malformations is caused by [CLS]  mutations in the MPDZ gene.\nCongenital hydrocephalus is considered as either acquired due to haemorrhage, infection or neoplasia or"}
{"subject": "MPDZ", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28460636.json", "snippet": " [CLS] mutations in the MPDZ [CLS]  gene.\nCongenital hydrocephalus is considered as either acquired due to haemorrhage, infection or neoplasia or as of developmental nature"}
{"subject": "L1CAM", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28460636.json", "snippet": " in the latter no cause is found in more than half of the patients. In patients with isolated hydrocephalus,  [CLS] L1CAM mutations [CLS]  represent the most common aetiology. More recently, a founder mutation has also been reported in the MPDZ gene in"}
{"subject": "isolated hydrocephalus", "sub_type": "Disease", "rel": "ThemeOf", "object": "common", "obj_type": "Reg", "file_name": "PubMed-28460636.json", "snippet": " non-syndromic, and in the latter no cause is found in more than half of the patients. In patients with  [CLS] isolated hydrocephalus, L1CAM mutations represent the most common [CLS]  aetiology. More recently, a founder mutation has also been reported in the MPDZ gene in foetuses presenting massive hydrocephalus,"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "common", "obj_type": "Reg", "file_name": "PubMed-28460636.json", "snippet": " the latter no cause is found in more than half of the patients. In patients with isolated hydrocephalus, L1CAM  [CLS] mutations represent the most common [CLS]  aetiology. More recently, a founder mutation has also been reported in the MPDZ gene in foetuses presenting massive hydrocephalus,"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "perturb", "obj_type": "Reg", "file_name": "PubMed-28464429.json", "snippet": " while PntP1 is constitutively active, PntP2 is only active after being phosphorylated by MAPK in the RTK pathway. As  [CLS] mutations in pnt perturb [CLS]  the development of several tissues, we wanted to examine the effect and efficacy of using RNAi to target Pnt."}
{"subject": "development of several tissues", "sub_type": "CPA", "rel": "ThemeOf", "object": "perturb", "obj_type": "Reg", "file_name": "PubMed-28464429.json", "snippet": " constitutively active, PntP2 is only active after being phosphorylated by MAPK in the RTK pathway. As mutations in pnt  [CLS] perturb the development of several tissues [CLS] , we wanted to examine the effect and efficacy of using RNAi to target Pnt. We have expressed pnt RNAi"}
{"subject": "pnt", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28464429.json", "snippet": " while PntP1 is constitutively active, PntP2 is only active after being phosphorylated by MAPK in the RTK pathway. As  [CLS] mutations in pnt [CLS]  perturb the development of several tissues, we wanted to examine the effect and efficacy of using RNAi to target"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " [CLS] gain-of-function mutation [CLS]  shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy.\nCACNA1D encodes the pore-forming \u03b11-subunit of Cav1.3,"}
{"subject": "autism spectrum disorders", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " [CLS] gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders [CLS]  and epilepsy.\nCACNA1D encodes the pore-forming \u03b11-subunit of Cav1.3, an L-type voltage-gated Ca2+-channel. Despite the recent discovery of two"}
{"subject": "epilepsy", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " [CLS] gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy [CLS] .\nCACNA1D encodes the pore-forming \u03b11-subunit of Cav1.3, an L-type voltage-gated Ca2+-channel. Despite the recent discovery of two de novo"}
{"subject": "CACNA1D", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28472301.json", "snippet": " [CLS] mutation shows CACNA1D [CLS]  as recurrently mutated gene in autism spectrum disorders and epilepsy.\nCACNA1D encodes the pore-forming \u03b11-subunit of Cav1.3, an L-type"}
{"subject": "current densities", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " mutant channel complexes in tsA-201 cells and performed whole-cell patch-clamp recordings.Mutation V401L, localized within the channel's activation gate, significantly  [CLS] enhanced current densities [CLS] , shifted voltage dependence of activation and inactivation to more negative voltages and reduced channel inactivation in both Cav1.3 splice"}
{"subject": "Ca2+-influx through the channel", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " voltages and reduced channel inactivation in both Cav1.3 splice variants. Altogether these gating changes are expected to result in  [CLS] enhanced Ca2+-influx through the channel [CLS] , thus representing a strong gain-of-function phenotype. Additionally, we also found that mutant channels retained full sensitivity towards the clinically"}
{"subject": "V401L", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " and short Cav1.3 splice variants, expressed wild-type or mutant channel complexes in tsA-201 cells and performed whole-cell patch-clamp recordings.Mutation  [CLS] V401L, localized within the channel's activation gate, significantly enhanced [CLS]  current densities, shifted voltage dependence of activation and inactivation to more negative voltages and reduced channel inactivation in both"}
{"subject": "changes", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28472301.json", "snippet": " activation and inactivation to more negative voltages and reduced channel inactivation in both Cav1.3 splice variants. Altogether these gating  [CLS] changes are expected to result in enhanced [CLS]  Ca2+-influx through the channel, thus representing a strong gain-of-function phenotype. Additionally, we also found that mutant channels retained full"}
{"subject": "Null mutations", "sub_type": "Var", "rel": "CauseOf", "object": "predispose", "obj_type": "Reg", "file_name": "PubMed-28479159.json", "snippet": " identifies molecular signatures characteristic of atopic eczema.\nBACKGROUND: Atopic eczema (AE) is characterized by skin barrier and immune dysfunction.  [CLS] Null mutations in filaggrin (FLG), a key epidermal barrier protein, strongly predispose [CLS]  to AE; however, the precise role of FLG deficiency in AE pathogenesis remains incompletely understood.\nOBJECTIVES: We sought to"}
{"subject": "AE", "sub_type": "Disease", "rel": "ThemeOf", "object": "predispose", "obj_type": "Reg", "file_name": "PubMed-28479159.json", "snippet": " is characterized by skin barrier and immune dysfunction. Null mutations in filaggrin (FLG), a key epidermal barrier protein, strongly  [CLS] predispose to AE [CLS] ; however, the precise role of FLG deficiency in AE pathogenesis remains incompletely understood.\nOBJECTIVES: We sought to identify global"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "Null mutations", "obj_type": "Var", "file_name": "PubMed-28479159.json", "snippet": " identifies molecular signatures characteristic of atopic eczema.\nBACKGROUND: Atopic eczema (AE) is characterized by skin barrier and immune dysfunction.  [CLS] Null mutations in filaggrin (FLG [CLS] ), a key epidermal barrier protein, strongly predispose to AE; however, the precise role of FLG deficiency in AE pathogenesis"}
{"subject": "Molecular pathways", "sub_type": "Pathway", "rel": "ThemeOf", "object": "overrepresented", "obj_type": "PosReg", "file_name": "PubMed-28479159.json", "snippet": " 0.9-fold), and cofilin-1 (CFL1, 1.3-fold). Differential protein expression was confirmed in shNT/shFLG LSEs; however, only KLK7 was transcriptionally dysregulated.  [CLS] Molecular pathways overrepresented [CLS]  after FLG knockdown included inflammation, protease activity, cell structure, and stress. Furthermore, KLK7 (1.8-fold) and PPIA (0.65-fold) proteins were"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "knockdown", "obj_type": "Var", "file_name": "PubMed-28479159.json", "snippet": " 1.3-fold). Differential protein expression was confirmed in shNT/shFLG LSEs; however, only KLK7 was transcriptionally dysregulated. Molecular pathways overrepresented after  [CLS] FLG knockdown [CLS]  included inflammation, protease activity, cell structure, and stress. Furthermore, KLK7 (1.8-fold) and PPIA (0.65-fold) proteins were differentially expressed in"}
{"subject": "knockdown", "sub_type": "Var", "rel": "CauseOf", "object": "overrepresented", "obj_type": "PosReg", "file_name": "PubMed-28479159.json", "snippet": " cofilin-1 (CFL1, 1.3-fold). Differential protein expression was confirmed in shNT/shFLG LSEs; however, only KLK7 was transcriptionally dysregulated. Molecular pathways  [CLS] overrepresented after FLG knockdown [CLS]  included inflammation, protease activity, cell structure, and stress. Furthermore, KLK7 (1.8-fold) and PPIA (0.65-fold) proteins were differentially expressed in"}
{"subject": "loss", "sub_type": "Var", "rel": "CauseOf", "object": "alter", "obj_type": "Reg", "file_name": "PubMed-28479159.json", "snippet": " lesional biopsy specimens from patients with AE relative to normal skin.\nCONCLUSIONS: For the first time, we show that  [CLS] loss of FLG in the absence of inflammation is sufficient to alter [CLS]  the expression level of proteins relevant to the pathogenesis of AE. These include proteins regulating inflammatory, proteolytic, and cytoskeletal"}
{"subject": "expression level of proteins", "sub_type": "MPA", "rel": "ThemeOf", "object": "alter", "obj_type": "Reg", "file_name": "PubMed-28479159.json", "snippet": "\nCONCLUSIONS: For the first time, we show that loss of FLG in the absence of inflammation is sufficient to  [CLS] alter the expression level of proteins [CLS]  relevant to the pathogenesis of AE. These include proteins regulating inflammatory, proteolytic, and cytoskeletal functions. We identify PPIA as"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss", "obj_type": "Var", "file_name": "PubMed-28479159.json", "snippet": " lesional biopsy specimens from patients with AE relative to normal skin.\nCONCLUSIONS: For the first time, we show that  [CLS] loss of FLG [CLS]  in the absence of inflammation is sufficient to alter the expression level of proteins relevant to the pathogenesis of"}
{"subject": "TREM2", "sub_type": "Gene", "rel": "ThemeOf", "object": "variations", "obj_type": "Var", "file_name": "PubMed-28483841.json", "snippet": " [CLS] variations in the triggering receptor expressed on myeloid cells 2 (TREM2 [CLS] ) have been linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "affecting", "obj_type": "Reg", "file_name": "PubMed-28483841.json", "snippet": " as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2  [CLS] variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing binding of lipoproteins and affecting [CLS]  shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among"}
{"subject": "lipid sensing", "sub_type": "MPA", "rel": "ThemeOf", "object": "impairing", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis,  [CLS] impairing lipid sensing [CLS] , preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of"}
{"subject": "binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " in microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing,  [CLS] preventing binding [CLS]  of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on"}
{"subject": "lipoproteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "binding", "obj_type": "Interaction", "file_name": "PubMed-28483841.json", "snippet": " microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing  [CLS] binding of lipoproteins [CLS]  and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia"}
{"subject": "shielding of amyloid plaques", "sub_type": "MPA", "rel": "ThemeOf", "object": "affecting", "obj_type": "Reg", "file_name": "PubMed-28483841.json", "snippet": " variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing binding of lipoproteins and  [CLS] affecting shielding of amyloid plaques [CLS] . We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the differentially expressed messenger"}
{"subject": "loss", "sub_type": "Var", "rel": "CauseOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " Trem2(-/-) microglia, gene clusters are identified which represent gene functions in chemotaxis, migration and mobility. Functional analyses confirm that  [CLS] loss of TREM2 impairs [CLS]  appropriate microglial responses to injury and signals that normally evoke chemotaxis on multiple levels. In an ex vivo organotypic"}
{"subject": "TREM2", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss", "obj_type": "Var", "file_name": "PubMed-28483841.json", "snippet": " Trem2(-/-) microglia, gene clusters are identified which represent gene functions in chemotaxis, migration and mobility. Functional analyses confirm that  [CLS] loss of TREM2 [CLS]  impairs appropriate microglial responses to injury and signals that normally evoke chemotaxis on multiple levels. In an ex vivo"}
{"subject": "microglial responses to injury and signals", "sub_type": "CPA", "rel": "ThemeOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " clusters are identified which represent gene functions in chemotaxis, migration and mobility. Functional analyses confirm that loss of TREM2  [CLS] impairs appropriate microglial responses to injury and signals [CLS]  that normally evoke chemotaxis on multiple levels. In an ex vivo organotypic brain slice assay, absence of TREM2 reduces"}
{"subject": "variations", "sub_type": "Var", "rel": "CauseOf", "object": "linked to", "obj_type": "Reg", "file_name": "PubMed-28483841.json", "snippet": " [CLS] variations in the triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to [CLS]  an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is"}
{"subject": "Alzheimer's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "linked to", "obj_type": "Reg", "file_name": "PubMed-28483841.json", "snippet": " microglial responses to neuronal injury.\nSequence variations in the triggering receptor expressed on myeloid cells 2 (TREM2) have been  [CLS] linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease [CLS]  and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in"}
{"subject": "frontotemporal lobar degeneration", "sub_type": "Disease", "rel": "ThemeOf", "object": "linked to", "obj_type": "Reg", "file_name": "PubMed-28483841.json", "snippet": " microglial responses to neuronal injury.\nSequence variations in the triggering receptor expressed on myeloid cells 2 (TREM2) have been  [CLS] linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration [CLS] . In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function"}
{"subject": "TREM2", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28483841.json", "snippet": " such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated  [CLS] TREM2 variants [CLS]  result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing binding of lipoproteins and affecting"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "reducing", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2  [CLS] variants result in a loss of function by reducing [CLS]  microglial phagocytosis, impairing lipid sensing, preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the"}
{"subject": "microglial phagocytosis", "sub_type": "CPA", "rel": "ThemeOf", "object": "reducing", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by  [CLS] reducing microglial phagocytosis [CLS] , impairing lipid sensing, preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "impairing", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2  [CLS] variants result in a loss of function by reducing microglial phagocytosis, impairing [CLS]  lipid sensing, preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28483841.json", "snippet": " as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2  [CLS] variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing [CLS]  binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28488085.json", "snippet": " [CLS] loss of function mutation [CLS]  in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell"}
{"subject": "KRIT1 protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28488085.json", "snippet": " This deletion leads to a frameshift with a premature stop codon at nucleotide position 1553 and a highly likely  [CLS] loss of function of the KRIT1 protein [CLS] .\nCONCLUSION: We describe a patient with a novel heterozygous germ line loss of function mutation in KRIT1, which is"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28488085.json", "snippet": " likely loss of function of the KRIT1 protein.\nCONCLUSION: We describe a patient with a novel heterozygous germ line  [CLS] loss of function mutation [CLS]  in KRIT1, which is associated with rapid-onset and highly progressive CCMs after radiochemotherapy for a malignant brain tumor."}
{"subject": "KRIT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28488085.json", "snippet": " function of the KRIT1 protein.\nCONCLUSION: We describe a patient with a novel heterozygous germ line loss of function  [CLS] mutation in KRIT1 [CLS] , which is associated with rapid-onset and highly progressive CCMs after radiochemotherapy for a malignant brain tumor."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": " function of the KRIT1 protein.\nCONCLUSION: We describe a patient with a novel heterozygous germ line loss of function  [CLS] mutation in KRIT1, which is associated with [CLS]  rapid-onset and highly progressive CCMs after radiochemotherapy for a malignant brain tumor."}
{"subject": "CCMs", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": "\nCONCLUSION: We describe a patient with a novel heterozygous germ line loss of function mutation in KRIT1, which is  [CLS] associated with rapid-onset and highly progressive CCMs [CLS]  after radiochemotherapy for a malignant brain tumor."}
{"subject": "KRIT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28488085.json", "snippet": " [CLS] mutation in KRIT1 [CLS] /CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor.\nPURPOSE:"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": " [CLS] mutation in KRIT1/CCM1 is associated with [CLS]  distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor.\nPURPOSE: Cerebrospinal cavernous malformations"}
{"subject": "cerebral and spinal cavernous malformations", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": " [CLS] associated with distinctly progressive cerebral and spinal cavernous malformations [CLS]  after radiochemotherapy for intracranial malignant germ cell tumor.\nPURPOSE: Cerebrospinal cavernous malformations (CCMs) are vascular lesions characterized by dilated"}
{"subject": "c.1535_1536delTG", "sub_type": "Var", "rel": "CauseOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": " cavernous malformations that progressed with subsequent follow-up imaging. Genetic analysis demonstrated a novel heterozygous KRIT1/CCM1 two base pair deletion ( [CLS] c.1535_1536delTG) in exon 14. This deletion leads to [CLS]  a frameshift with a premature stop codon at nucleotide position 1553 and a highly likely loss of function of"}
{"subject": "frameshift", "sub_type": "Var", "rel": "ThemeOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": " follow-up imaging. Genetic analysis demonstrated a novel heterozygous KRIT1/CCM1 two base pair deletion (c.1535_1536delTG) in exon 14. This deletion  [CLS] leads to a frameshift [CLS]  with a premature stop codon at nucleotide position 1553 and a highly likely loss of function of the KRIT1"}
{"subject": "premature stop codon", "sub_type": "MPA", "rel": "ThemeOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-28488085.json", "snippet": " follow-up imaging. Genetic analysis demonstrated a novel heterozygous KRIT1/CCM1 two base pair deletion (c.1535_1536delTG) in exon 14. This deletion  [CLS] leads to a frameshift with a premature stop codon [CLS]  at nucleotide position 1553 and a highly likely loss of function of the KRIT1 protein.\nCONCLUSION: We describe a"}
{"subject": "KRIT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1535_1536delTG", "obj_type": "Var", "file_name": "PubMed-28488085.json", "snippet": " and spinal microhemorrhages and pronounced cavernous malformations that progressed with subsequent follow-up imaging. Genetic analysis demonstrated a novel heterozygous  [CLS] KRIT1/CCM1 two base pair deletion (c.1535_1536delTG [CLS] ) in exon 14. This deletion leads to a frameshift with a premature stop codon at nucleotide position 1553 and"}
{"subject": "c.1535_1536delTG", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28488085.json", "snippet": " cavernous malformations that progressed with subsequent follow-up imaging. Genetic analysis demonstrated a novel heterozygous KRIT1/CCM1 two base pair deletion ( [CLS] c.1535_1536delTG) in exon 14. This deletion leads to a frameshift with a premature stop codon at nucleotide position 1553 and a highly likely loss of function [CLS]  of the KRIT1 protein.\nCONCLUSION: We describe a patient with a novel heterozygous germ line loss of function mutation"}
{"subject": "EGFR", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutation", "obj_type": "Var", "file_name": "PubMed-28507206.json", "snippet": " [CLS] EGFR Mutation [CLS] -Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.\nBACKGROUND: This study aimed to identify independent prognostic factors"}
{"subject": "Mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Positive", "obj_type": "Reg", "file_name": "PubMed-28507206.json", "snippet": " [CLS] Mutation-Positive [CLS]  Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.\nBACKGROUND: This study aimed to identify independent prognostic factors"}
{"subject": "Non-Small Cell Lung Cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "Positive", "obj_type": "Reg", "file_name": "PubMed-28507206.json", "snippet": " [CLS] Positive Advanced Non-Small Cell Lung Cancer [CLS]  Patients Treated with First-Line Gefitinib.\nBACKGROUND: This study aimed to identify independent prognostic factors for overall survival (OS) of"}
{"subject": "Loss", "sub_type": "Var", "rel": "CauseOf", "object": "leads", "obj_type": "Reg", "file_name": "PubMed-28512217.json", "snippet": " [CLS] Loss of the homologous recombination gene rad51 leads [CLS]  to Fanconi anemia-like symptoms in zebrafish.\nRAD51 is an indispensable homologous recombination protein, necessary for strand invasion and crossing"}
{"subject": "Fanconi anemia-like symptoms", "sub_type": "Disease", "rel": "ThemeOf", "object": "leads", "obj_type": "Reg", "file_name": "PubMed-28512217.json", "snippet": " [CLS] leads to Fanconi anemia-like symptoms [CLS]  in zebrafish.\nRAD51 is an indispensable homologous recombination protein, necessary for strand invasion and crossing over. It has recently"}
{"subject": "rad51", "sub_type": "Gene", "rel": "ThemeOf", "object": "Loss", "obj_type": "Var", "file_name": "PubMed-28512217.json", "snippet": " [CLS] Loss of the homologous recombination gene rad51 [CLS]  leads to Fanconi anemia-like symptoms in zebrafish.\nRAD51 is an indispensable homologous recombination protein, necessary for strand invasion and"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28512217.json", "snippet": " marrow failure, and cancer predisposition. In this report, we describe a viable vertebrate model of RAD51 loss. Zebrafish rad51  [CLS] loss-of-function mutants [CLS]  developed key features of FA, including hypocellular kidney marrow, sensitivity to cross-linking agents, and decreased size. We show that"}
{"subject": "FA", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28512217.json", "snippet": " marrow failure, and cancer predisposition. In this report, we describe a viable vertebrate model of RAD51 loss. Zebrafish rad51  [CLS] loss-of-function mutants developed key features of FA [CLS] , including hypocellular kidney marrow, sensitivity to cross-linking agents, and decreased size. We show that some of these symptoms stem"}
{"subject": "rad51", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28512217.json", "snippet": " bone marrow failure, and cancer predisposition. In this report, we describe a viable vertebrate model of RAD51 loss. Zebrafish  [CLS] rad51 loss-of-function mutants [CLS]  developed key features of FA, including hypocellular kidney marrow, sensitivity to cross-linking agents, and decreased size. We show that"}
{"subject": "CAG repeat expansion", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28525545.json", "snippet": " Identifying Modules and Functionally Enriched Pathways in SCA2.\nSpinocerebellar ataxia type 2 (SCA2) is an autosomal dominant neurodegenerative disease  [CLS] caused by CAG repeat expansion [CLS]  in the ATXN2 gene. The repeat resides in an encoded region of the gene resulting in polyglutamine (polyQ) expansion"}
{"subject": "ATXN2", "sub_type": "Gene", "rel": "ThemeOf", "object": "CAG repeat expansion", "obj_type": "Var", "file_name": "PubMed-28525545.json", "snippet": " and Functionally Enriched Pathways in SCA2.\nSpinocerebellar ataxia type 2 (SCA2) is an autosomal dominant neurodegenerative disease caused by  [CLS] CAG repeat expansion in the ATXN2 [CLS]  gene. The repeat resides in an encoded region of the gene resulting in polyglutamine (polyQ) expansion which has been"}
{"subject": "Spinocerebellar ataxia type 2", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28525545.json", "snippet": " [CLS] Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant neurodegenerative disease caused by [CLS]  CAG repeat expansion in the ATXN2 gene. The repeat resides in an encoded region of the gene resulting in"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28525834.json", "snippet": " protein that is important for normal skin barrier functions. Up to 10% of Europeans and Asians carry filaggrin gene ( [CLS] FLG) loss-of function mutations [CLS]  that appear to facilitate trans-epidermal penetration of certain chemicals. We previously showed that mutation carriers have higher internal exposure"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of function", "obj_type": "NegReg", "file_name": "PubMed-28525834.json", "snippet": " that is important for normal skin barrier functions. Up to 10% of Europeans and Asians carry filaggrin gene (FLG)  [CLS] loss-of function mutations [CLS]  that appear to facilitate trans-epidermal penetration of certain chemicals. We previously showed that mutation carriers have higher internal exposure"}
{"subject": "trans-epidermal penetration", "sub_type": "CPA", "rel": "ThemeOf", "object": "facilitate", "obj_type": "PosReg", "file_name": "PubMed-28525834.json", "snippet": " barrier functions. Up to 10% of Europeans and Asians carry filaggrin gene (FLG) loss-of function mutations that appear to  [CLS] facilitate trans-epidermal penetration [CLS]  of certain chemicals. We previously showed that mutation carriers have higher internal exposure to certain phthalates, compared to controls,"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "facilitate", "obj_type": "PosReg", "file_name": "PubMed-28525834.json", "snippet": " important for normal skin barrier functions. Up to 10% of Europeans and Asians carry filaggrin gene (FLG) loss-of function  [CLS] mutations that appear to facilitate [CLS]  trans-epidermal penetration of certain chemicals. We previously showed that mutation carriers have higher internal exposure to certain phthalates, compared"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-28533163.json", "snippet": " [CLS] gain of function mutations [CLS]  in GRIN2B encoding the GluN2B subunit of the N-methyl-d-aspartate (NMDA) receptor have been linked with epileptic encephalopathies, including infantile"}
{"subject": "epileptic encephalopathies", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-28533163.json", "snippet": " [CLS] gain of function mutations in GRIN2B encoding the GluN2B subunit of the N-methyl-d-aspartate (NMDA) receptor have been linked with epileptic encephalopathies [CLS] , including infantile spasms. We investigated the effects of radiprodil, a selective GluN2B negative allosteric modulator and other non-selective NMDA"}
{"subject": "infantile spasms", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-28533163.json", "snippet": " [CLS] gain of function mutations in GRIN2B encoding the GluN2B subunit of the N-methyl-d-aspartate (NMDA) receptor have been linked with epileptic encephalopathies, including infantile spasms [CLS] . We investigated the effects of radiprodil, a selective GluN2B negative allosteric modulator and other non-selective NMDA receptor inhibitors on"}
{"subject": "GRIN2B", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28533163.json", "snippet": " function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.\nDe novo gain of function  [CLS] mutations in GRIN2B [CLS]  encoding the GluN2B subunit of the N-methyl-d-aspartate (NMDA) receptor have been linked with epileptic encephalopathies, including infantile spasms. We"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-28543872.json", "snippet": " [CLS] variants promote [CLS]  airway fibrosis and are associated with asthma and with worse lung function in subjects with asthma.\nOBJECTIVE: We sought"}
{"subject": "airway fibrosis", "sub_type": "CPA", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-28543872.json", "snippet": " [CLS] promote airway fibrosis [CLS]  and are associated with asthma and with worse lung function in subjects with asthma.\nOBJECTIVE: We sought to determine"}
{"subject": "PAI-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28543872.json", "snippet": " [CLS] PAI-1 gain-of-function variants [CLS]  promote airway fibrosis and are associated with asthma and with worse lung function in subjects with asthma.\nOBJECTIVE: We"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28543872.json", "snippet": " [CLS] variants promote airway fibrosis and are associated with [CLS]  asthma and with worse lung function in subjects with asthma.\nOBJECTIVE: We sought to determine whether the association of"}
{"subject": "asthma", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28543872.json", "snippet": " increasing PAI-1 levels, and airway obstruction: The GALA II Cohort.\nBACKGROUND: PAI-1 gain-of-function variants promote airway fibrosis and are  [CLS] associated with asthma [CLS]  and with worse lung function in subjects with asthma.\nOBJECTIVE: We sought to determine whether the association of a"}
{"subject": "E396V", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " [CLS] loss-of-function lipoprotein lipase gene mutations (C310R/E396V [CLS] ) in a Chinese family associated with recurrent acute pancreatitis.\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28548960.json", "snippet": " magnitude to the wild-type. However, few LPL were detected in the culture medium for the mutants, suggesting that both  [CLS] mutations caused [CLS]  aberrant triglyceride catabolism. More specifically, E396V and double mutations dampened the transport of LPL to the cell surface, while"}
{"subject": "triglyceride catabolism", "sub_type": "MPA", "rel": "ThemeOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28548960.json", "snippet": " to the wild-type. However, few LPL were detected in the culture medium for the mutants, suggesting that both mutations  [CLS] caused aberrant triglyceride catabolism [CLS] . More specifically, E396V and double mutations dampened the transport of LPL to the cell surface, while for the C310R"}
{"subject": "E396V", "sub_type": "Var", "rel": "CauseOf", "object": "dampened", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " were detected in the culture medium for the mutants, suggesting that both mutations caused aberrant triglyceride catabolism. More specifically,  [CLS] E396V and double mutations dampened [CLS]  the transport of LPL to the cell surface, while for the C310R mutation, reducing LPL protein level might be"}
{"subject": "double mutations", "sub_type": "Var", "rel": "CauseOf", "object": "dampened", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " in the culture medium for the mutants, suggesting that both mutations caused aberrant triglyceride catabolism. More specifically, E396V and  [CLS] double mutations dampened [CLS]  the transport of LPL to the cell surface, while for the C310R mutation, reducing LPL protein level might be"}
{"subject": "transport of LPL to the cell surface", "sub_type": "MPA", "rel": "ThemeOf", "object": "dampened", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " culture medium for the mutants, suggesting that both mutations caused aberrant triglyceride catabolism. More specifically, E396V and double mutations  [CLS] dampened the transport of LPL to the cell surface [CLS] , while for the C310R mutation, reducing LPL protein level might be involved. By characterizing these two novel LPL mutations,"}
{"subject": "C310R", "sub_type": "Var", "rel": "CauseOf", "object": "reducing", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " catabolism. More specifically, E396V and double mutations dampened the transport of LPL to the cell surface, while for the  [CLS] C310R mutation, reducing [CLS]  LPL protein level might be involved. By characterizing these two novel LPL mutations, this study has expanded our understanding"}
{"subject": "LPL protein level", "sub_type": "MPA", "rel": "ThemeOf", "object": "reducing", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " specifically, E396V and double mutations dampened the transport of LPL to the cell surface, while for the C310R mutation,  [CLS] reducing LPL protein level [CLS]  might be involved. By characterizing these two novel LPL mutations, this study has expanded our understanding on the pathogenesis"}
{"subject": "C310R", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " [CLS] loss-of-function lipoprotein lipase gene mutations (C310R [CLS] /E396V) in a Chinese family associated with recurrent acute pancreatitis.\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac"}
{"subject": "E396V", "sub_type": "Var", "rel": "CauseOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28548960.json", "snippet": " [CLS] E396V) in a Chinese family associated with [CLS]  recurrent acute pancreatitis.\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac muscles as well as adipose tissue"}
{"subject": "C310R", "sub_type": "Var", "rel": "CauseOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28548960.json", "snippet": " [CLS] C310R/E396V) in a Chinese family associated with [CLS]  recurrent acute pancreatitis.\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac muscles as well as adipose tissue"}
{"subject": "lipoprotein lipase", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "C310R", "obj_type": "Var", "file_name": "PubMed-28548960.json", "snippet": " [CLS] lipoprotein lipase gene mutations (C310R [CLS] /E396V) in a Chinese family associated with recurrent acute pancreatitis.\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac"}
{"subject": "recurrent acute pancreatitis", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-28548960.json", "snippet": " [CLS] associated with recurrent acute pancreatitis [CLS] .\nLipoprotein lipase (LPL) is widely expressed in skeletal muscles, cardiac muscles as well as adipose tissue and involved in"}
{"subject": "hypertriglyceridemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " [CLS] hypertriglyceridemia due to two novel loss-of-function [CLS]  lipoprotein lipase gene mutations (C310R/E396V) in a Chinese family associated with recurrent acute pancreatitis.\nLipoprotein lipase (LPL) is widely"}
{"subject": "C310R", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " exon 8 of the LPL gene. Furthermore, COS-1 cells were transfected with lentiviruses containing the mutant LPL genes. While  [CLS] C310R markedly reduced [CLS]  the overall LPL protein level, COS-1 cells carrying E396V or double mutations contained similar overall LPL protein levels to"}
{"subject": "LPL protein level", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28548960.json", "snippet": " of the LPL gene. Furthermore, COS-1 cells were transfected with lentiviruses containing the mutant LPL genes. While C310R markedly  [CLS] reduced the overall LPL protein level [CLS] , COS-1 cells carrying E396V or double mutations contained similar overall LPL protein levels to the wild-type. The specific activity"}
{"subject": "WNT10A", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28589954.json", "snippet": " [CLS] WNT10A mutation [CLS]  causes ectodermal dysplasia by impairing progenitor cell proliferation and KLF4-mediated differentiation.\nHuman WNT10A mutations are associated with developmental tooth"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "impairing", "obj_type": "NegReg", "file_name": "PubMed-28589954.json", "snippet": " [CLS] mutation causes ectodermal dysplasia by impairing [CLS]  progenitor cell proliferation and KLF4-mediated differentiation.\nHuman WNT10A mutations are associated with developmental tooth abnormalities and adolescent onset of"}
{"subject": "progenitor cell proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "impairing", "obj_type": "NegReg", "file_name": "PubMed-28589954.json", "snippet": " [CLS] impairing progenitor cell proliferation [CLS]  and KLF4-mediated differentiation.\nHuman WNT10A mutations are associated with developmental tooth abnormalities and adolescent onset of a broad range"}
{"subject": "KLF4-mediated differentiation", "sub_type": "CPA", "rel": "ThemeOf", "object": "impairing", "obj_type": "NegReg", "file_name": "PubMed-28589954.json", "snippet": " [CLS] impairing progenitor cell proliferation and KLF4-mediated differentiation [CLS] .\nHuman WNT10A mutations are associated with developmental tooth abnormalities and adolescent onset of a broad range of ectodermal defects."}
{"subject": "impairing", "sub_type": "NegReg", "rel": "CauseOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-28589954.json", "snippet": " [CLS] causes ectodermal dysplasia by impairing [CLS]  progenitor cell proliferation and KLF4-mediated differentiation.\nHuman WNT10A mutations are associated with developmental tooth abnormalities and adolescent onset of"}
{"subject": "ectodermal dysplasia", "sub_type": "Disease", "rel": "ThemeOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-28589954.json", "snippet": " [CLS] causes ectodermal dysplasia [CLS]  by impairing progenitor cell proliferation and KLF4-mediated differentiation.\nHuman WNT10A mutations are associated with developmental tooth abnormalities and adolescent"}
{"subject": "ROBO1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Loss of function", "obj_type": "Var", "file_name": "PubMed-28592524.json", "snippet": " [CLS] Loss of function in ROBO1 [CLS]  is associated with tetralogy of Fallot and septal defects.\nBACKGROUND: Congenital heart disease (CHD) is a common birth defect"}
{"subject": "Loss of function", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28592524.json", "snippet": " [CLS] Loss of function in ROBO1 is associated [CLS]  with tetralogy of Fallot and septal defects.\nBACKGROUND: Congenital heart disease (CHD) is a common birth defect affecting approximately"}
{"subject": "tetralogy of Fallot", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28592524.json", "snippet": " [CLS] associated with tetralogy of Fallot [CLS]  and septal defects.\nBACKGROUND: Congenital heart disease (CHD) is a common birth defect affecting approximately 1% of newborns. Great"}
{"subject": "septal defects", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28592524.json", "snippet": " [CLS] associated with tetralogy of Fallot and septal defects [CLS] .\nBACKGROUND: Congenital heart disease (CHD) is a common birth defect affecting approximately 1% of newborns. Great progress has been"}
{"subject": "NFKBIA", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28597146.json", "snippet": " [CLS] mutations of NFKBIA [CLS] , encoding I\u03baB\u03b1, cause an autosomal dominant (AD) form of anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID). Fourteen unrelated patients have"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28597146.json", "snippet": " [CLS] gain-of-function (GOF) mutations [CLS]  of NFKBIA, encoding I\u03baB\u03b1, cause an autosomal dominant (AD) form of anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID). Fourteen unrelated"}
{"subject": "anhidrotic ectodermal dysplasia with immunodeficiency", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28597146.json", "snippet": " [CLS] gain-of-function (GOF) mutations of NFKBIA, encoding I\u03baB\u03b1, cause an autosomal dominant (AD) form of anhidrotic ectodermal dysplasia with immunodeficiency [CLS]  (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first case in 2003. All mutations enhanced"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28597146.json", "snippet": " with immunodeficiency (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first case in 2003. All  [CLS] mutations enhanced the inhibitory activity of I\u03baB\u03b1, by preventing [CLS]  its phosphorylation on serine 32 or 36 and its subsequent degradation. The mutation certainly or probably occurred de novo"}
{"subject": "preventing", "sub_type": "NegReg", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28597146.json", "snippet": " immunodeficiency (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first case in 2003. All mutations  [CLS] enhanced the inhibitory activity of I\u03baB\u03b1, by preventing [CLS]  its phosphorylation on serine 32 or 36 and its subsequent degradation. The mutation certainly or probably occurred de novo"}
{"subject": "I\u03baB\u03b1", "sub_type": "Protein", "rel": "ThemeOf", "object": "inhibitory activity", "obj_type": "MPA", "file_name": "PubMed-28597146.json", "snippet": " Fourteen unrelated patients have been reported since the identification of the first case in 2003. All mutations enhanced the  [CLS] inhibitory activity of I\u03baB\u03b1 [CLS] , by preventing its phosphorylation on serine 32 or 36 and its subsequent degradation. The mutation certainly or probably occurred"}
{"subject": "inhibitory activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28597146.json", "snippet": " immunodeficiency (EDA-ID). Fourteen unrelated patients have been reported since the identification of the first case in 2003. All mutations  [CLS] enhanced the inhibitory activity [CLS]  of I\u03baB\u03b1, by preventing its phosphorylation on serine 32 or 36 and its subsequent degradation. The mutation certainly or"}
{"subject": "degradation", "sub_type": "MPA", "rel": "ThemeOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28597146.json", "snippet": " reported since the identification of the first case in 2003. All mutations enhanced the inhibitory activity of I\u03baB\u03b1, by  [CLS] preventing its phosphorylation on serine 32 or 36 and its subsequent degradation [CLS] . The mutation certainly or probably occurred de novo in 13 patients, whereas it was inherited from a parent with"}
{"subject": "phosphorylation on serine 32 or 36", "sub_type": "MPA", "rel": "ThemeOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28597146.json", "snippet": " reported since the identification of the first case in 2003. All mutations enhanced the inhibitory activity of I\u03baB\u03b1, by  [CLS] preventing its phosphorylation on serine 32 or 36 [CLS]  and its subsequent degradation. The mutation certainly or probably occurred de novo in 13 patients, whereas it was inherited"}
{"subject": "ARX", "sub_type": "Gene", "rel": "ThemeOf", "object": "polyalanine expansion mutations", "obj_type": "Var", "file_name": "PubMed-28627419.json", "snippet": " developing mouse brains. Data from our study demonstrated that cortical calbindin interneuron development and migration is negatively affected by  [CLS] ARX polyalanine expansion mutations [CLS] . Understanding the cellular pathogenesis contributing to disease manifestation is necessary to screen efficacy of potential therapeutic interventions."}
{"subject": "developmental deficit of calbindin-positive cortical GABAergic interneurons", "sub_type": "CPA", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-28627419.json", "snippet": " [CLS] lead to migration impediment in the rostral cortex coupled with a developmental deficit of calbindin-positive cortical GABAergic interneurons [CLS] .\nThe Aristaless-related homeobox gene (ARX) is indispensable for interneuron development. Patients with ARX polyalanine expansion mutations of the first"}
{"subject": "polyalanine expansion mutations", "sub_type": "Var", "rel": "CauseOf", "object": "negatively", "obj_type": "NegReg", "file_name": "PubMed-28627419.json", "snippet": " profiles within the developing mouse brains. Data from our study demonstrated that cortical calbindin interneuron development and migration is  [CLS] negatively affected by ARX polyalanine expansion mutations [CLS] . Understanding the cellular pathogenesis contributing to disease manifestation is necessary to screen efficacy of potential therapeutic interventions."}
{"subject": "cortical calbindin interneuron", "sub_type": "CPA", "rel": "ThemeOf", "object": "development", "obj_type": "CPA", "file_name": "PubMed-28627419.json", "snippet": " including Arx protein reduction and overlapping transcriptome profiles within the developing mouse brains. Data from our study demonstrated that  [CLS] cortical calbindin interneuron development [CLS]  and migration is negatively affected by ARX polyalanine expansion mutations. Understanding the cellular pathogenesis contributing to disease manifestation is"}
{"subject": "cortical calbindin interneuron", "sub_type": "CPA", "rel": "ThemeOf", "object": "migration", "obj_type": "CPA", "file_name": "PubMed-28627419.json", "snippet": " including Arx protein reduction and overlapping transcriptome profiles within the developing mouse brains. Data from our study demonstrated that  [CLS] cortical calbindin interneuron development and migration [CLS]  is negatively affected by ARX polyalanine expansion mutations. Understanding the cellular pathogenesis contributing to disease manifestation is necessary to"}
{"subject": "migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "negatively", "obj_type": "NegReg", "file_name": "PubMed-28627419.json", "snippet": " overlapping transcriptome profiles within the developing mouse brains. Data from our study demonstrated that cortical calbindin interneuron development and  [CLS] migration is negatively [CLS]  affected by ARX polyalanine expansion mutations. Understanding the cellular pathogenesis contributing to disease manifestation is necessary to screen efficacy"}
{"subject": "development", "sub_type": "CPA", "rel": "ThemeOf", "object": "negatively", "obj_type": "NegReg", "file_name": "PubMed-28627419.json", "snippet": " reduction and overlapping transcriptome profiles within the developing mouse brains. Data from our study demonstrated that cortical calbindin interneuron  [CLS] development and migration is negatively [CLS]  affected by ARX polyalanine expansion mutations. Understanding the cellular pathogenesis contributing to disease manifestation is necessary to screen efficacy"}
{"subject": "ARX", "sub_type": "Gene", "rel": "ThemeOf", "object": "polyalanine expansion mutations", "obj_type": "Var", "file_name": "PubMed-28627419.json", "snippet": " [CLS] ARX polyalanine expansion mutations [CLS]  lead to migration impediment in the rostral cortex coupled with a developmental deficit of calbindin-positive cortical GABAergic interneurons.\nThe"}
{"subject": "polyalanine expansion mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-28627419.json", "snippet": " [CLS] polyalanine expansion mutations lead to [CLS]  migration impediment in the rostral cortex coupled with a developmental deficit of calbindin-positive cortical GABAergic interneurons.\nThe Aristaless-related homeobox"}
{"subject": "migration impediment in the rostral cortex coupled", "sub_type": "CPA", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-28627419.json", "snippet": " [CLS] lead to migration impediment in the rostral cortex coupled [CLS]  with a developmental deficit of calbindin-positive cortical GABAergic interneurons.\nThe Aristaless-related homeobox gene (ARX) is indispensable for interneuron development."}
{"subject": "FGFR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28650109.json", "snippet": " promotes bone formation after bone marrow ablation.\nApert syndrome is one of the most severe craniosynostoses, resulting from gain-of-function  [CLS] mutations in fibroblast growth factor receptor 2 (FGFR2 [CLS] ). Previous studies have shown that gain-of-function mutations of FGFR2 (S252W or P253R) cause skull malformation of human Apert syndrome"}
{"subject": "bone marrow stromal cell", "sub_type": "CPA", "rel": "ThemeOf", "object": "proliferation", "obj_type": "CPA", "file_name": "PubMed-28650109.json", "snippet": " MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase in  [CLS] bone marrow stromal cell recruitment and proliferation [CLS] , osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular"}
{"subject": "osteoblast", "sub_type": "CPA", "rel": "ThemeOf", "object": "proliferation", "obj_type": "CPA", "file_name": "PubMed-28650109.json", "snippet": " and decreased bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation,  [CLS] osteoblast proliferation [CLS]  and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation"}
{"subject": "osteoblast", "sub_type": "CPA", "rel": "ThemeOf", "object": "differentiation", "obj_type": "CPA", "file_name": "PubMed-28650109.json", "snippet": " and decreased bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation,  [CLS] osteoblast proliferation and differentiation [CLS] , and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " mutant FGFR2 (P253R) at the adult stage. Mechanical bone marrow ablation (BMX) was performed in both wild-type and Fgfr2  [CLS] mutant (MT) mice. Changes in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase [CLS]  in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " mutant FGFR2 (P253R) at the adult stage. Mechanical bone marrow ablation (BMX) was performed in both wild-type and Fgfr2  [CLS] mutant (MT) mice. Changes in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation, and enhanced [CLS]  Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption"}
{"subject": "Wnt/?-catenin activity", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation, and  [CLS] enhanced Wnt/?-catenin activity [CLS] . Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased bone resorption in MT"}
{"subject": "recruitment", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable  [CLS] increase in bone marrow stromal cell recruitment [CLS]  and proliferation, osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the"}
{"subject": "proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable  [CLS] increase in bone marrow stromal cell recruitment and proliferation [CLS] , osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular"}
{"subject": "proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable  [CLS] increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation [CLS]  and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation"}
{"subject": "differentiation", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " found that MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable  [CLS] increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation [CLS] , and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the increased trabecular bone formation and decreased"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " mice promotes bone formation after bone marrow ablation.\nApert syndrome is one of the most severe craniosynostoses, resulting from  [CLS] gain-of-function mutations [CLS]  in fibroblast growth factor receptor 2 (FGFR2). Previous studies have shown that gain-of-function mutations of FGFR2 (S252W or P253R)"}
{"subject": "FGFR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28650109.json", "snippet": " the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that gain-of-function  [CLS] mutation in FGFR2 [CLS]  exerts a Wnt/\u03b2-catenin-dependent anabolic effect on trabecular bone by promoting bone formation and inhibiting bone resorption at the adult"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that  [CLS] gain-of-function mutation [CLS]  in FGFR2 exerts a Wnt/\u03b2-catenin-dependent anabolic effect on trabecular bone by promoting bone formation and inhibiting bone resorption at"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "promoting", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that  [CLS] gain-of-function mutation in FGFR2 exerts a Wnt/\u03b2-catenin-dependent anabolic effect on trabecular bone by promoting [CLS]  bone formation and inhibiting bone resorption at the adult stage. This article is protected by copyright. All rights reserved."}
{"subject": "bone formation", "sub_type": "CPA", "rel": "ThemeOf", "object": "promoting", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " after BMX. Our data demonstrate that gain-of-function mutation in FGFR2 exerts a Wnt/\u03b2-catenin-dependent anabolic effect on trabecular bone by  [CLS] promoting bone formation [CLS]  and inhibiting bone resorption at the adult stage. This article is protected by copyright. All rights reserved."}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "inhibiting", "obj_type": "NegReg", "file_name": "PubMed-28650109.json", "snippet": " reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that  [CLS] gain-of-function mutation in FGFR2 exerts a Wnt/\u03b2-catenin-dependent anabolic effect on trabecular bone by promoting bone formation and inhibiting [CLS]  bone resorption at the adult stage. This article is protected by copyright. All rights reserved."}
{"subject": "bone resorption at the adult stage", "sub_type": "CPA", "rel": "ThemeOf", "object": "inhibiting", "obj_type": "NegReg", "file_name": "PubMed-28650109.json", "snippet": " demonstrate that gain-of-function mutation in FGFR2 exerts a Wnt/\u03b2-catenin-dependent anabolic effect on trabecular bone by promoting bone formation and  [CLS] inhibiting bone resorption at the adult stage [CLS] . This article is protected by copyright. All rights reserved."}
{"subject": "exerts a Wnt/\u03b2-catenin-dependent anabolic effect", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " reverse the increased trabecular bone formation and decreased bone resorption in MT mice after BMX. Our data demonstrate that  [CLS] gain-of-function mutation in FGFR2 exerts a Wnt/\u03b2-catenin-dependent anabolic effect [CLS]  on trabecular bone by promoting bone formation and inhibiting bone resorption at the adult stage. This article is protected"}
{"subject": "Apert syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " [CLS] Apert syndrome is one of the most severe craniosynostoses, resulting from gain-of-function [CLS]  mutations in fibroblast growth factor receptor 2 (FGFR2). Previous studies have shown that gain-of-function mutations of FGFR2 (S252W or"}
{"subject": "Fgfr2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28650109.json", "snippet": " of mutant FGFR2 (P253R) at the adult stage. Mechanical bone marrow ablation (BMX) was performed in both wild-type and  [CLS] Fgfr2 mutant [CLS]  (MT) mice. Changes in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " mutant FGFR2 (P253R) at the adult stage. Mechanical bone marrow ablation (BMX) was performed in both wild-type and Fgfr2  [CLS] mutant (MT) mice. Changes in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased [CLS]  trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28650109.json", "snippet": " mutant FGFR2 (P253R) at the adult stage. Mechanical bone marrow ablation (BMX) was performed in both wild-type and Fgfr2  [CLS] mutant (MT) mice. Changes in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and decreased [CLS]  bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation"}
{"subject": "trabecular bone formation", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28650109.json", "snippet": " in newly formed trabecular bone were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited  [CLS] increased trabecular bone formation [CLS]  and decreased bone resorption after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation,"}
{"subject": "bone resorption", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28650109.json", "snippet": " were assessed by micro-computed tomography and bone histomorphometry. We found that MT mice exhibited increased trabecular bone formation and  [CLS] decreased bone resorption [CLS]  after BMX accompanied with a remarkable increase in bone marrow stromal cell recruitment and proliferation, osteoblast proliferation and differentiation,"}
{"subject": "bone marrow stromal cell", "sub_type": "CPA", "rel": "ThemeOf", "object": "recruitment", "obj_type": "CPA", "file_name": "PubMed-28650109.json", "snippet": " MT mice exhibited increased trabecular bone formation and decreased bone resorption after BMX accompanied with a remarkable increase in  [CLS] bone marrow stromal cell recruitment [CLS]  and proliferation, osteoblast proliferation and differentiation, and enhanced Wnt/?-catenin activity. Furthermore, pharmacologically inhibiting Wnt/\u03b2-catenin signaling can partially reverse the"}
{"subject": "TNFAIP3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28659290.json", "snippet": " [CLS] mutation in TNFAIP3 [CLS]  (A20).\n"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28659290.json", "snippet": " [CLS] loss-of-function mutation [CLS]  in TNFAIP3 (A20).\n"}
{"subject": "Early-onset autoimmune disease", "sub_type": "Disease", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28659290.json", "snippet": " [CLS] Early-onset autoimmune disease due to a heterozygous loss-of-function [CLS]  mutation in TNFAIP3 (A20).\n"}
{"subject": "TgRON4", "sub_type": "Gene", "rel": "ThemeOf", "object": "null mutation", "obj_type": "Var", "file_name": "PubMed-28662729.json", "snippet": " In this study, we used the CRISPR-Cas9 system to generate a derivative of T. gondii strain RH with a  [CLS] null mutation in TgRON4 [CLS] , thought to be an essential MJ component. Deficiency of TgRON4 moderately decreased invasion ability relative to that of the"}
{"subject": "null mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Deficiency", "obj_type": "NegReg", "file_name": "PubMed-28662729.json", "snippet": " In this study, we used the CRISPR-Cas9 system to generate a derivative of T. gondii strain RH with a  [CLS] null mutation in TgRON4, thought to be an essential MJ component. Deficiency [CLS]  of TgRON4 moderately decreased invasion ability relative to that of the wild-type parasite. In addition, expression of the endogenous"}
{"subject": "TgRON4", "sub_type": "Protein", "rel": "ThemeOf", "object": "Deficiency", "obj_type": "NegReg", "file_name": "PubMed-28662729.json", "snippet": " derivative of T. gondii strain RH with a null mutation in TgRON4, thought to be an essential MJ component.  [CLS] Deficiency of TgRON4 [CLS]  moderately decreased invasion ability relative to that of the wild-type parasite. In addition, expression of the endogenous N-terminal fragment"}
{"subject": "Deficiency", "sub_type": "NegReg", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28662729.json", "snippet": " derivative of T. gondii strain RH with a null mutation in TgRON4, thought to be an essential MJ component.  [CLS] Deficiency of TgRON4 moderately decreased [CLS]  invasion ability relative to that of the wild-type parasite. In addition, expression of the endogenous N-terminal fragment of RON5"}
{"subject": "invasion ability", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28662729.json", "snippet": " strain RH with a null mutation in TgRON4, thought to be an essential MJ component. Deficiency of TgRON4 moderately  [CLS] decreased invasion ability [CLS]  relative to that of the wild-type parasite. In addition, expression of the endogenous N-terminal fragment of RON5 decreased in"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28662729.json", "snippet": " invasion ability relative to that of the wild-type parasite. In addition, expression of the endogenous N-terminal fragment of RON5  [CLS] decreased in the mutant [CLS] . Together, the results improve our understanding of the assembly mechanism of the MJ complex of T. gondii and raise"}
{"subject": "expression of the endogenous N-terminal fragment", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28662729.json", "snippet": " essential MJ component. Deficiency of TgRON4 moderately decreased invasion ability relative to that of the wild-type parasite. In addition,  [CLS] expression of the endogenous N-terminal fragment of RON5 decreased [CLS]  in the mutant. Together, the results improve our understanding of the assembly mechanism of the MJ complex of T."}
{"subject": "RON5", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression of the endogenous N-terminal fragment", "obj_type": "MPA", "file_name": "PubMed-28662729.json", "snippet": " essential MJ component. Deficiency of TgRON4 moderately decreased invasion ability relative to that of the wild-type parasite. In addition,  [CLS] expression of the endogenous N-terminal fragment of RON5 [CLS]  decreased in the mutant. Together, the results improve our understanding of the assembly mechanism of the MJ complex of"}
{"subject": "SlMBP21", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28667273.json", "snippet": " [CLS] mutations in SlMBP21 [CLS]  MADS-box gene led to jointless-2 phenotype in tomato.\nAbscission is the mechanism by which plants disconnect unfertilized flowers, ripe"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28667273.json", "snippet": " [CLS] loss of function mutations [CLS]  in SlMBP21 MADS-box gene led to jointless-2 phenotype in tomato.\nAbscission is the mechanism by which plants disconnect unfertilized"}
{"subject": "jointless-2 phenotype", "sub_type": "CPA", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28667273.json", "snippet": " [CLS] loss of function mutations in SlMBP21 MADS-box gene led to jointless-2 phenotype [CLS]  in tomato.\nAbscission is the mechanism by which plants disconnect unfertilized flowers, ripe fruits, senescent or diseased organs from"}
{"subject": "LAMB2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28683731.json", "snippet": " [CLS] LAMB2 mutations [CLS] .\nBACKGROUND: Congenital nephrotic syndrome (CNS) is a rare disorder caused by various structural and developmental defects of glomeruli. It"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28683731.json", "snippet": " [CLS] caused by null LAMB2 mutations [CLS] .\nBACKGROUND: Congenital nephrotic syndrome (CNS) is a rare disorder caused by various structural and developmental defects of glomeruli. It"}
{"subject": "extrarenal features", "sub_type": "CPA", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28683731.json", "snippet": " [CLS] extrarenal features in a child with congenital nephrotic syndrome caused by [CLS]  null LAMB2 mutations.\nBACKGROUND: Congenital nephrotic syndrome (CNS) is a rare disorder caused by various structural and developmental defects"}
{"subject": "Nephron development", "sub_type": "CPA", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28683731.json", "snippet": " [CLS] Nephron development and extrarenal features in a child with congenital nephrotic syndrome caused by [CLS]  null LAMB2 mutations.\nBACKGROUND: Congenital nephrotic syndrome (CNS) is a rare disorder caused by various structural and developmental defects"}
{"subject": "SGCD", "sub_type": "Gene", "rel": "ThemeOf", "object": "deletions", "obj_type": "Var", "file_name": "PubMed-28697784.json", "snippet": " [CLS] SGCD deletions [CLS]  causing limb girdle muscular dystrophy in Boston terriers.\nBACKGROUND: Limb-girdle muscular dystrophies (LGMDs) are a heterogeneous group of inherited"}
{"subject": "limb girdle muscular dystrophy", "sub_type": "Disease", "rel": "ThemeOf", "object": "causing", "obj_type": "Reg", "file_name": "PubMed-28697784.json", "snippet": " [CLS] causing limb girdle muscular dystrophy [CLS]  in Boston terriers.\nBACKGROUND: Limb-girdle muscular dystrophies (LGMDs) are a heterogeneous group of inherited autosomal myopathies that preferentially affect"}
{"subject": "deletions", "sub_type": "Var", "rel": "CauseOf", "object": "causing", "obj_type": "Reg", "file_name": "PubMed-28697784.json", "snippet": " [CLS] deletions causing [CLS]  limb girdle muscular dystrophy in Boston terriers.\nBACKGROUND: Limb-girdle muscular dystrophies (LGMDs) are a heterogeneous group of inherited autosomal"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-28697784.json", "snippet": " the family was discovered, and a deletion encompassing exons 7 and 8 was found in the unrelated dog. Both  [CLS] mutations are predicted to cause an absence [CLS]  of SGCD protein, confirmed by immunohistochemistry. The mutations are private to each family.\nCONCLUSIONS: Here, we describe the first"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "absence", "obj_type": "NegReg", "file_name": "PubMed-28697784.json", "snippet": " deletion encompassing exons 7 and 8 was found in the unrelated dog. Both mutations are predicted to cause an  [CLS] absence of SGCD protein [CLS] , confirmed by immunohistochemistry. The mutations are private to each family.\nCONCLUSIONS: Here, we describe the first cases of canine"}
{"subject": "SGCD", "sub_type": "Gene", "rel": "ThemeOf", "object": "protein", "obj_type": "Protein", "file_name": "PubMed-28697784.json", "snippet": " exons 7 and 8 was found in the unrelated dog. Both mutations are predicted to cause an absence of  [CLS] SGCD protein [CLS] , confirmed by immunohistochemistry. The mutations are private to each family.\nCONCLUSIONS: Here, we describe the first cases of canine"}
{"subject": "SGCD", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28697784.json", "snippet": " five Boston terriers: one affected dog and its three family members and one unrelated affected dog.\nRESULTS: Within sarcoglycan-\u03b4 ( [CLS] SGCD), a two base pair deletion segregating with LGMD in the family was discovered, and a deletion encompassing exons 7 and 8 was found in the unrelated dog. Both mutations [CLS]  are predicted to cause an absence of SGCD protein, confirmed by immunohistochemistry. The mutations are private to each family."}
{"subject": "aca10", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28701352.json", "snippet": " positively regulates stomatal closure. We found that BON1 interacts with the autoinhibitory domains of ACA10 and ACA8, and the  [CLS] aca10 loss of function (LOF) mutants [CLS]  have an autoimmune phenotype similar to that of the bon1 LOF mutants. Genetic evidences indicate that BON1 positively regulates"}
{"subject": "bon1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28701352.json", "snippet": " bon1 mutants in guard cells. In addition, calcium and pathogen induced stomatal closure was compromised in the aca10 and  [CLS] bon1 mutants [CLS] . Taken together, this study indicates that ACA10/8 and BON1 physically interact on plasma membrane and function in the generation"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "compromised", "obj_type": "NegReg", "file_name": "PubMed-28701352.json", "snippet": " altered in aca10, aca8, and bon1 mutants in guard cells. In addition, calcium and pathogen induced stomatal closure was  [CLS] compromised in the aca10 and bon1 mutants [CLS] . Taken together, this study indicates that ACA10/8 and BON1 physically interact on plasma membrane and function in the generation"}
{"subject": "calcium and pathogen induced stomatal closure", "sub_type": "CPA", "rel": "ThemeOf", "object": "compromised", "obj_type": "NegReg", "file_name": "PubMed-28701352.json", "snippet": " oscillation imposed by external calcium treatment was altered in aca10, aca8, and bon1 mutants in guard cells. In addition,  [CLS] calcium and pathogen induced stomatal closure was compromised [CLS]  in the aca10 and bon1 mutants. Taken together, this study indicates that ACA10/8 and BON1 physically interact on plasma"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28701352.json", "snippet": " regulates stomatal closure. We found that BON1 interacts with the autoinhibitory domains of ACA10 and ACA8, and the aca10  [CLS] loss of function (LOF) mutants [CLS]  have an autoimmune phenotype similar to that of the bon1 LOF mutants. Genetic evidences indicate that BON1 positively regulates"}
{"subject": "bon1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28701352.json", "snippet": " and ACA8, and the aca10 loss of function (LOF) mutants have an autoimmune phenotype similar to that of the  [CLS] bon1 LOF mutants [CLS] . Genetic evidences indicate that BON1 positively regulates the activities of ACA10 and ACA8. Consistent with this idea, the steady"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-28701352.json", "snippet": " ACA8, and the aca10 loss of function (LOF) mutants have an autoimmune phenotype similar to that of the bon1  [CLS] LOF mutants [CLS] . Genetic evidences indicate that BON1 positively regulates the activities of ACA10 and ACA8. Consistent with this idea, the steady"}
{"subject": "bon1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28701352.json", "snippet": " ACA10 and ACA8. Consistent with this idea, the steady level of calcium concentration is increased in both aca10 and  [CLS] bon1 mutants [CLS] . Most strikingly, cytosolic calcium oscillation imposed by external calcium treatment was altered in aca10, aca8, and bon1 mutants in"}
{"subject": "aca10", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28701352.json", "snippet": " activities of ACA10 and ACA8. Consistent with this idea, the steady level of calcium concentration is increased in both  [CLS] aca10 and bon1 mutants [CLS] . Most strikingly, cytosolic calcium oscillation imposed by external calcium treatment was altered in aca10, aca8, and bon1 mutants in"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28701352.json", "snippet": " positively regulates the activities of ACA10 and ACA8. Consistent with this idea, the steady level of calcium concentration is  [CLS] increased in both aca10 and bon1 mutants [CLS] . Most strikingly, cytosolic calcium oscillation imposed by external calcium treatment was altered in aca10, aca8, and bon1 mutants in"}
{"subject": "steady level of calcium concentration", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28701352.json", "snippet": " mutants. Genetic evidences indicate that BON1 positively regulates the activities of ACA10 and ACA8. Consistent with this idea, the  [CLS] steady level of calcium concentration is increased [CLS]  in both aca10 and bon1 mutants. Most strikingly, cytosolic calcium oscillation imposed by external calcium treatment was altered in"}
{"subject": "aca10", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28701352.json", "snippet": " aca8, and bon1 mutants in guard cells. In addition, calcium and pathogen induced stomatal closure was compromised in the  [CLS] aca10 and bon1 mutants [CLS] . Taken together, this study indicates that ACA10/8 and BON1 physically interact on plasma membrane and function in the generation"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-28708837.json", "snippet": " loss of function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent  [CLS] LoF mutation [CLS]  in human cancers is Adenomatous polyposis coli (APC), causing aberrant activation of the Wnt pathway. In nearly all colon"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-28708837.json", "snippet": " of function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent LoF  [CLS] mutation in human cancers is Adenomatous polyposis coli (APC), causing aberrant activation [CLS]  of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated, but still retains partial"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "retains partial", "obj_type": "NegReg", "file_name": "PubMed-28708837.json", "snippet": " of function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent LoF  [CLS] mutation in human cancers is Adenomatous polyposis coli (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated, but still retains partial [CLS]  binding abilities.\nOBJECTIVE & METHODS: Here, we tested the hypothesis that extracellular inhibitors of the Wnt pathway, although acting"}
{"subject": "Wnt pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-28708837.json", "snippet": " translated to the clinic. The most frequent LoF mutation in human cancers is Adenomatous polyposis coli (APC), causing aberrant  [CLS] activation of the Wnt pathway [CLS] . In nearly all colon cancer tumors, the APC protein is truncated, but still retains partial binding abilities.\nOBJECTIVE &"}
{"subject": "APC protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "abilities", "obj_type": "MPA", "file_name": "PubMed-28708837.json", "snippet": " is Adenomatous polyposis coli (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors, the  [CLS] APC protein is truncated, but still retains partial binding abilities [CLS] .\nOBJECTIVE & METHODS: Here, we tested the hypothesis that extracellular inhibitors of the Wnt pathway, although acting upstream of"}
{"subject": "binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "abilities", "obj_type": "MPA", "file_name": "PubMed-28708837.json", "snippet": " of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated, but still retains partial  [CLS] binding abilities [CLS] .\nOBJECTIVE & METHODS: Here, we tested the hypothesis that extracellular inhibitors of the Wnt pathway, although acting upstream of"}
{"subject": "abilities", "sub_type": "MPA", "rel": "ThemeOf", "object": "retains partial", "obj_type": "NegReg", "file_name": "PubMed-28708837.json", "snippet": " aberrant activation of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated, but still  [CLS] retains partial binding abilities [CLS] .\nOBJECTIVE & METHODS: Here, we tested the hypothesis that extracellular inhibitors of the Wnt pathway, although acting upstream of"}
{"subject": "Adenomatous polyposis coli", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28708837.json", "snippet": " of function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent LoF  [CLS] mutation in human cancers is Adenomatous polyposis coli [CLS]  (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors, the APC protein is truncated,"}
{"subject": "colon cancer tumors", "sub_type": "Disease", "rel": "ThemeOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-28708837.json", "snippet": " loss of function (LoF) mutations in tumor suppressor genes has been successfully translated to the clinic. The most frequent  [CLS] LoF mutation in human cancers is Adenomatous polyposis coli (APC), causing aberrant activation of the Wnt pathway. In nearly all colon cancer tumors [CLS] , the APC protein is truncated, but still retains partial binding abilities.\nOBJECTIVE & METHODS: Here, we tested the hypothesis"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28711549.json", "snippet": " [CLS] PCSK9 loss-of-function mutation [CLS]  and polymorphisms predisposing to nonalcoholic fatty liver disease.\nWe report a new case of hypobetalipoproteinemia in a 44-year-old man"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28711549.json", "snippet": " [CLS] loss-of-function mutation [CLS]  and polymorphisms predisposing to nonalcoholic fatty liver disease.\nWe report a new case of hypobetalipoproteinemia in a 44-year-old man"}
{"subject": "hypocholesterolemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28711549.json", "snippet": " [CLS] hypocholesterolemia and steatosis in a carrier of a PCSK9 loss-of-function [CLS]  mutation and polymorphisms predisposing to nonalcoholic fatty liver disease.\nWe report a new case of hypobetalipoproteinemia in a 44-year-old"}
{"subject": "steatosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28711549.json", "snippet": " [CLS] steatosis in a carrier of a PCSK9 loss-of-function [CLS]  mutation and polymorphisms predisposing to nonalcoholic fatty liver disease.\nWe report a new case of hypobetalipoproteinemia in a 44-year-old"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.946\u00a0G>T", "obj_type": "Var", "file_name": "PubMed-28711549.json", "snippet": " report a new case of hypobetalipoproteinemia in a 44-year-old man of Peruvian origin exhibiting a heterozygous PCSK9 missense mutation ( [CLS] c.946\u00a0G>T, p. Gly316Cys). In\u00a0vitro functional studies demonstrated that this mutation leads to a loss of function of PCSK9 [CLS]  on low-density lipoprotein receptor degradation. This patient exhibited liver steatosis; he was neither diabetic, nor obese or alcoholic, but"}
{"subject": "c.946\u00a0G>T", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28711549.json", "snippet": " report a new case of hypobetalipoproteinemia in a 44-year-old man of Peruvian origin exhibiting a heterozygous PCSK9 missense mutation ( [CLS] c.946\u00a0G>T, p. Gly316Cys). In\u00a0vitro functional studies demonstrated that this mutation leads to a loss of function [CLS]  of PCSK9 on low-density lipoprotein receptor degradation. This patient exhibited liver steatosis; he was neither diabetic, nor obese or"}
{"subject": "low-density lipoprotein receptor degradation", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28711549.json", "snippet": " exhibiting a heterozygous PCSK9 missense mutation (c.946\u00a0G>T, p. Gly316Cys). In\u00a0vitro functional studies demonstrated that this mutation leads to a  [CLS] loss of function of PCSK9 on low-density lipoprotein receptor degradation [CLS] . This patient exhibited liver steatosis; he was neither diabetic, nor obese or alcoholic, but is a carrier of 2"}
{"subject": "Ovarian aromatase", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28711606.json", "snippet": " [CLS] Ovarian aromatase loss-of-function mutant [CLS]  medaka undergo ovary degeneration and partial female-to-male sex reversal after puberty.\nAlthough estrogens have been generally considered to play"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28711606.json", "snippet": " [CLS] loss-of-function mutant [CLS]  medaka undergo ovary degeneration and partial female-to-male sex reversal after puberty.\nAlthough estrogens have been generally considered to play"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "undergo", "obj_type": "Reg", "file_name": "PubMed-28711606.json", "snippet": " [CLS] loss-of-function mutant medaka undergo [CLS]  ovary degeneration and partial female-to-male sex reversal after puberty.\nAlthough estrogens have been generally considered to play a critical"}
{"subject": "ovary degeneration", "sub_type": "CPA", "rel": "ThemeOf", "object": "undergo", "obj_type": "Reg", "file_name": "PubMed-28711606.json", "snippet": " [CLS] undergo ovary degeneration [CLS]  and partial female-to-male sex reversal after puberty.\nAlthough estrogens have been generally considered to play a critical role in"}
{"subject": "partial female-to-male sex reversal", "sub_type": "CPA", "rel": "ThemeOf", "object": "undergo", "obj_type": "Reg", "file_name": "PubMed-28711606.json", "snippet": " [CLS] undergo ovary degeneration and partial female-to-male sex reversal [CLS]  after puberty.\nAlthough estrogens have been generally considered to play a critical role in ovarian differentiation in non-mammalian vertebrates,"}
{"subject": "ALMS1", "sub_type": "Gene", "rel": "ThemeOf", "object": "protein", "obj_type": "Protein", "file_name": "PubMed-28717663.json", "snippet": " real-time PCR, immunoblotting, or immunostaining of fixed cells after stimulation.\nRESULTS: In 16 of the patient cell lines examined,  [CLS] ALMS1 protein [CLS]  was undetectable (14 with biallelic loss-of-function (LoF) mutations), and in two, ALMS1 staining was equivocal (one with biallelic LoF"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "undetectable", "obj_type": "NegReg", "file_name": "PubMed-28717663.json", "snippet": " PCR, immunoblotting, or immunostaining of fixed cells after stimulation.\nRESULTS: In 16 of the patient cell lines examined, ALMS1  [CLS] protein was undetectable [CLS]  (14 with biallelic loss-of-function (LoF) mutations), and in two, ALMS1 staining was equivocal (one with biallelic LoF mutations). In"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28717663.json", "snippet": " cells after stimulation.\nRESULTS: In 16 of the patient cell lines examined, ALMS1 protein was undetectable (14 with biallelic  [CLS] loss-of-function (LoF) mutations [CLS] ), and in two, ALMS1 staining was equivocal (one with biallelic LoF mutations). In five lines, ALMS1 expression was normal"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "undetectable", "obj_type": "NegReg", "file_name": "PubMed-28717663.json", "snippet": " or immunostaining of fixed cells after stimulation.\nRESULTS: In 16 of the patient cell lines examined, ALMS1 protein was  [CLS] undetectable (14 with biallelic loss-of-function (LoF) mutations [CLS] ), and in two, ALMS1 staining was equivocal (one with biallelic LoF mutations). In five lines, ALMS1 expression was normal"}
{"subject": "loss-of-function", "sub_type": "Var", "rel": "CauseOf", "object": "activated", "obj_type": "PosReg", "file_name": "PubMed-28720827.json", "snippet": " further genetic screens and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that  [CLS] loss-of-function (LOF) CG17259 activated [CLS]  eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or"}
{"subject": "phosphorylation", "sub_type": "CPA", "rel": "ThemeOf", "object": "down-regulation", "obj_type": "NegReg", "file_name": "PubMed-28720827.json", "snippet": " found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically,  [CLS] down-regulation of eIF2\u03b1 phosphorylation [CLS] , Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect"}
{"subject": "Hsp26", "sub_type": "Protein", "rel": "ThemeOf", "object": "down-regulation", "obj_type": "NegReg", "file_name": "PubMed-28720827.json", "snippet": " found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically,  [CLS] down-regulation of eIF2\u03b1 phosphorylation, Hsp26 [CLS] /Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of"}
{"subject": "autophagy", "sub_type": "CPA", "rel": "ThemeOf", "object": "down-regulation", "obj_type": "NegReg", "file_name": "PubMed-28720827.json", "snippet": " found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically,  [CLS] down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy [CLS]  reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of these protein"}
{"subject": "down-regulation", "sub_type": "NegReg", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28720827.json", "snippet": " found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically,  [CLS] down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced [CLS]  the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of these protein degradation"}
{"subject": "CG17259", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "Var", "file_name": "PubMed-28720827.json", "snippet": " further genetic screens and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that  [CLS] loss-of-function (LOF) CG17259 [CLS]  activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27"}
{"subject": "protective effect", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28720827.json", "snippet": " phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy  [CLS] reduced the protective effect [CLS]  of LOF CG17259, indicating they function downstream of CG17259. The protective effect of these protein degradation pathways indicated activation"}
{"subject": "CG17259", "sub_type": "Gene", "rel": "ThemeOf", "object": "LOF", "obj_type": "Var", "file_name": "PubMed-28720827.json", "snippet": " chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of  [CLS] LOF CG17259 [CLS] , indicating they function downstream of CG17259. The protective effect of these protein degradation pathways indicated activation of a toxic"}
{"subject": "LOF", "sub_type": "Var", "rel": "ThemeOf", "object": "protective effect", "obj_type": "CPA", "file_name": "PubMed-28720827.json", "snippet": " subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the  [CLS] protective effect of LOF [CLS]  CG17259, indicating they function downstream of CG17259. The protective effect of these protein degradation pathways indicated activation of a"}
{"subject": "Hsp27", "sub_type": "Protein", "rel": "ThemeOf", "object": "down-regulation", "obj_type": "NegReg", "file_name": "PubMed-28720827.json", "snippet": " found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically,  [CLS] down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 [CLS]  or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect of"}
{"subject": "loss-of-function", "sub_type": "Var", "rel": "CauseOf", "object": "up-regulation", "obj_type": "PosReg", "file_name": "PubMed-28720827.json", "snippet": " further genetic screens and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that  [CLS] loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation [CLS]  of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect"}
{"subject": "phosphorylation", "sub_type": "CPA", "rel": "ThemeOf", "object": "activated", "obj_type": "PosReg", "file_name": "PubMed-28720827.json", "snippet": " and identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259  [CLS] activated eIF2\u03b1 phosphorylation [CLS]  and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced"}
{"subject": "eIF2\u03b1", "sub_type": "Protein", "rel": "ThemeOf", "object": "phosphorylation", "obj_type": "CPA", "file_name": "PubMed-28720827.json", "snippet": " identified a suppressor of neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated  [CLS] eIF2\u03b1 phosphorylation [CLS]  and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced"}
{"subject": "Hsp26", "sub_type": "Protein", "rel": "ThemeOf", "object": "chaperons", "obj_type": "CPA", "file_name": "PubMed-28720827.json", "snippet": " CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of  [CLS] chaperons (Hsp26 [CLS]  and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259,"}
{"subject": "Hsp27", "sub_type": "Protein", "rel": "ThemeOf", "object": "chaperons", "obj_type": "CPA", "file_name": "PubMed-28720827.json", "snippet": " CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of  [CLS] chaperons (Hsp26 and Hsp27 [CLS] ) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they"}
{"subject": "chaperons", "sub_type": "CPA", "rel": "ThemeOf", "object": "up-regulation", "obj_type": "PosReg", "file_name": "PubMed-28720827.json", "snippet": " neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent  [CLS] up-regulation of chaperons [CLS]  (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF"}
{"subject": "autophagy", "sub_type": "CPA", "rel": "ThemeOf", "object": "up-regulation", "obj_type": "PosReg", "file_name": "PubMed-28720827.json", "snippet": " neuronal necrosis, CG17259, which encodes a seryl-tRNA synthetase. We found that loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent  [CLS] up-regulation of chaperons (Hsp26 and Hsp27) and autophagy [CLS] . Genetically, down-regulation of eIF2\u03b1 phosphorylation, Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream"}
{"subject": "eIF2\u03b1", "sub_type": "Protein", "rel": "ThemeOf", "object": "phosphorylation", "obj_type": "CPA", "file_name": "PubMed-28720827.json", "snippet": " loss-of-function (LOF) CG17259 activated eIF2\u03b1 phosphorylation and subsequent up-regulation of chaperons (Hsp26 and Hsp27) and autophagy. Genetically, down-regulation of  [CLS] eIF2\u03b1 phosphorylation [CLS] , Hsp26/Hsp27 or autophagy reduced the protective effect of LOF CG17259, indicating they function downstream of CG17259. The protective effect"}
{"subject": "PTPN2", "sub_type": "Gene", "rel": "ThemeOf", "object": "deletion", "obj_type": "Var", "file_name": "PubMed-28723893.json", "snippet": " of genes involved in several diverse pathways, including NF-\u03baB signalling, antigen presentation and the unfolded protein response. In addition,  [CLS] deletion of the protein tyrosine phosphatase PTPN2 [CLS]  in tumour cells increased the efficacy of immunotherapy by enhancing interferon-\u03b3-mediated effects on antigen presentation and growth suppression. In"}
{"subject": "deletion", "sub_type": "Var", "rel": "CauseOf", "object": "enhancing", "obj_type": "PosReg", "file_name": "PubMed-28723893.json", "snippet": " of genes involved in several diverse pathways, including NF-\u03baB signalling, antigen presentation and the unfolded protein response. In addition,  [CLS] deletion of the protein tyrosine phosphatase PTPN2 in tumour cells increased the efficacy of immunotherapy by enhancing [CLS]  interferon-\u03b3-mediated effects on antigen presentation and growth suppression. In vivo genetic screens in tumour models can identify new immunotherapy"}
{"subject": "interferon-\u03b3-mediated effects on antigen presentation", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhancing", "obj_type": "PosReg", "file_name": "PubMed-28723893.json", "snippet": " response. In addition, deletion of the protein tyrosine phosphatase PTPN2 in tumour cells increased the efficacy of immunotherapy by  [CLS] enhancing interferon-\u03b3-mediated effects on antigen presentation [CLS]  and growth suppression. In vivo genetic screens in tumour models can identify new immunotherapy targets in unanticipated pathways."}
{"subject": "growth suppression", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhancing", "obj_type": "PosReg", "file_name": "PubMed-28723893.json", "snippet": " response. In addition, deletion of the protein tyrosine phosphatase PTPN2 in tumour cells increased the efficacy of immunotherapy by  [CLS] enhancing interferon-\u03b3-mediated effects on antigen presentation and growth suppression [CLS] . In vivo genetic screens in tumour models can identify new immunotherapy targets in unanticipated pathways."}
{"subject": "enhancing", "sub_type": "PosReg", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28723893.json", "snippet": " antigen presentation and the unfolded protein response. In addition, deletion of the protein tyrosine phosphatase PTPN2 in tumour cells  [CLS] increased the efficacy of immunotherapy by enhancing [CLS]  interferon-\u03b3-mediated effects on antigen presentation and growth suppression. In vivo genetic screens in tumour models can identify new immunotherapy"}
{"subject": "efficacy of immunotherapy", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28723893.json", "snippet": " antigen presentation and the unfolded protein response. In addition, deletion of the protein tyrosine phosphatase PTPN2 in tumour cells  [CLS] increased the efficacy of immunotherapy [CLS]  by enhancing interferon-\u03b3-mediated effects on antigen presentation and growth suppression. In vivo genetic screens in tumour models can identify"}
{"subject": "PDGFRB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.N666H", "obj_type": "Var", "file_name": "PubMed-28726812.json", "snippet": " activating mutations in PDGFRB cause Kosaki and Penttinen syndromes and myofibromatosis. We describe a 10-year-old child with a germ-line  [CLS] PDGFRB p.N666H [CLS]  mutation who responded to the tyrosine kinase inhibitor imatinib by inhibition of PDGFRB.MethodsThe impact of p.N666H on PDGFRB function"}
{"subject": "p.N666H", "sub_type": "Var", "rel": "CauseOf", "object": "inhibition", "obj_type": "NegReg", "file_name": "PubMed-28726812.json", "snippet": " mutations in PDGFRB cause Kosaki and Penttinen syndromes and myofibromatosis. We describe a 10-year-old child with a germ-line PDGFRB  [CLS] p.N666H mutation who responded to the tyrosine kinase inhibitor imatinib by inhibition [CLS]  of PDGFRB.MethodsThe impact of p.N666H on PDGFRB function and sensitivity to imatinib was studied in cell culture.ResultsCells expressing the"}
{"subject": "PDGFRB", "sub_type": "Gene", "rel": "ThemeOf", "object": "inhibition", "obj_type": "NegReg", "file_name": "PubMed-28726812.json", "snippet": " describe a 10-year-old child with a germ-line PDGFRB p.N666H mutation who responded to the tyrosine kinase inhibitor imatinib by  [CLS] inhibition of PDGFRB [CLS] .MethodsThe impact of p.N666H on PDGFRB function and sensitivity to imatinib was studied in cell culture.ResultsCells expressing the p.N666H mutation"}
{"subject": "inhibition", "sub_type": "NegReg", "rel": "CauseOf", "object": "responded to the tyrosine kinase inhibitor imatinib", "obj_type": "MPA", "file_name": "PubMed-28726812.json", "snippet": " cause Kosaki and Penttinen syndromes and myofibromatosis. We describe a 10-year-old child with a germ-line PDGFRB p.N666H mutation who  [CLS] responded to the tyrosine kinase inhibitor imatinib by inhibition [CLS]  of PDGFRB.MethodsThe impact of p.N666H on PDGFRB function and sensitivity to imatinib was studied in cell culture.ResultsCells expressing the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28726812.json", "snippet": " [CLS] mutations in PDGFRB cause [CLS]  Kosaki and Penttinen syndromes and myofibromatosis. We describe a 10-year-old child with a germ-line PDGFRB p.N666H mutation who responded"}
{"subject": "PDGFRB", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28726812.json", "snippet": " [CLS] mutations in PDGFRB [CLS]  cause Kosaki and Penttinen syndromes and myofibromatosis. We describe a 10-year-old child with a germ-line PDGFRB p.N666H mutation who"}
{"subject": "Kosaki and Penttinen syndromes", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28726812.json", "snippet": " patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib.\nPurposeHeterozygous germ-line activating mutations in PDGFRB  [CLS] cause Kosaki and Penttinen syndromes [CLS]  and myofibromatosis. We describe a 10-year-old child with a germ-line PDGFRB p.N666H mutation who responded to the tyrosine kinase"}
{"subject": "myofibromatosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28726812.json", "snippet": " patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib.\nPurposeHeterozygous germ-line activating mutations in PDGFRB  [CLS] cause Kosaki and Penttinen syndromes and myofibromatosis [CLS] . We describe a 10-year-old child with a germ-line PDGFRB p.N666H mutation who responded to the tyrosine kinase inhibitor imatinib"}
{"subject": "PIEZO1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28728825.json", "snippet": "\nMutations in the genes encoding the mechanosensitive cation channels PIEZO1 and\u00a0PIEZO2 are responsible for multiple hereditary human diseases. Loss-of-function  [CLS] mutations in the human PIEZO1 [CLS]  gene cause autosomal recessive congenital lymphatic dysplasia. Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic"}
{"subject": "hereditary xerocytosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28728825.json", "snippet": " responsible for multiple hereditary human diseases. Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia.  [CLS] Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis [CLS]  (also known as dehydrated stomatocytosis). Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular"}
{"subject": "dehydrated stomatocytosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28728825.json", "snippet": " responsible for multiple hereditary human diseases. Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia.  [CLS] Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis [CLS] ). Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress,"}
{"subject": "autosomal recessive syndrome of muscular atrophy", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28728825.json", "snippet": " mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis).  [CLS] Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy [CLS]  with perinatal respiratory distress, arthrogryposis, and scoliosis. Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of"}
{"subject": "arthrogryposis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28728825.json", "snippet": " mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis).  [CLS] Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis [CLS] , and scoliosis. Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis. This"}
{"subject": "scoliosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28728825.json", "snippet": " mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis).  [CLS] Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis [CLS] . Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis. This chapter will"}
{"subject": "autosomal dominant distal arthrogryposis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28728825.json", "snippet": " the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.  [CLS] Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis [CLS] . This chapter will review the hereditary diseases caused by mutations in the PIEZO genes\u00a0and will discuss additional physiological systems"}
{"subject": "autosomal recessive congenital lymphatic dysplasia", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28728825.json", "snippet": " Dysfunction.\nMutations in the genes encoding the mechanosensitive cation channels PIEZO1 and\u00a0PIEZO2 are responsible for multiple hereditary human diseases.  [CLS] Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia [CLS] . Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated"}
{"subject": "autosomal dominant hemolytic anemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28728825.json", "snippet": " responsible for multiple hereditary human diseases. Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia.  [CLS] Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia [CLS] , hereditary xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28728825.json", "snippet": " Dysfunction.\nMutations in the genes encoding the mechanosensitive cation channels PIEZO1 and\u00a0PIEZO2 are responsible for multiple hereditary human diseases.  [CLS] Loss-of-function mutations [CLS]  in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia. Gain-of-function mutations in the human PIEZO1 gene cause"}
{"subject": "PIEZO1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28728825.json", "snippet": " for multiple hereditary human diseases. Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia. Gain-of-function  [CLS] mutations in the human PIEZO1 [CLS]  gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function mutations in the human"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28728825.json", "snippet": " responsible for multiple hereditary human diseases. Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia.  [CLS] Gain-of-function mutations [CLS]  in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function"}
{"subject": "PIEZO2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28728825.json", "snippet": " in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis). Loss-of-function  [CLS] mutations in the human PIEZO2 [CLS]  gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis. Gain-of-function mutations in"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28728825.json", "snippet": " mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis).  [CLS] Loss-of-function mutations [CLS]  in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and"}
{"subject": "PIEZO2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28728825.json", "snippet": " human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis. Gain-of-function  [CLS] mutations in the human PIEZO2 [CLS]  gene cause three clinical types of autosomal dominant distal arthrogryposis. This chapter will review the hereditary diseases caused by"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28728825.json", "snippet": " the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.  [CLS] Gain-of-function mutations [CLS]  in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis. This chapter will review the"}
{"subject": "SCN5a", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28734073.json", "snippet": " [CLS] SCN5a mutations [CLS]  may express gain-of-function (Long QT Syndrome-3), loss-of-function (Brugada Syndrome 1) or both (mixed syndromes), depending on the mutation and"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28734073.json", "snippet": " [CLS] mutations may express gain-of-function [CLS]  (Long QT Syndrome-3), loss-of-function (Brugada Syndrome 1) or both (mixed syndromes), depending on the mutation and environmental triggers. One"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28734073.json", "snippet": " [CLS] mutations may express gain-of-function (Long QT Syndrome-3), loss-of-function [CLS]  (Brugada Syndrome 1) or both (mixed syndromes), depending on the mutation and environmental triggers. One such trigger may be"}
{"subject": "Long QT Syndrome-3", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28734073.json", "snippet": " [CLS] gain-of-function (Long QT Syndrome-3 [CLS] ), loss-of-function (Brugada Syndrome 1) or both (mixed syndromes), depending on the mutation and environmental triggers. One such trigger may"}
{"subject": "Brugada Syndrome 1", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28734073.json", "snippet": " [CLS] loss-of-function (Brugada Syndrome 1 [CLS] ) or both (mixed syndromes), depending on the mutation and environmental triggers. One such trigger may be an increase in"}
{"subject": "activation kinetics", "sub_type": "MPA", "rel": "ThemeOf", "object": "D242N KV7.1 channels", "obj_type": "MPA", "file_name": "PubMed-28739325.json", "snippet": " show that, unexpectedly, the mutation did not disrupt the voltage-dependent activation but it removed the inactivation and slowed the  [CLS] activation kinetics of D242N KV7.1 channels [CLS] . Biotinylation of cell-surface protein and co-immunoprecipitation experiments revealed that neither plasma membrane targeting nor co-assembly between KV7.1 and KCNE1"}
{"subject": "conserved charge balance of this region", "sub_type": "MPA", "rel": "ThemeOf", "object": "disrupting", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " the LQTS. The mutation is located in the S4 transmembrane segment, within the voltage sensor of the KV7.1 channel,  [CLS] disrupting the conserved charge balance of this region [CLS] . Perforated patch-clamp experiments show that, unexpectedly, the mutation did not disrupt the voltage-dependent activation but it removed the inactivation"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28739325.json", "snippet": " the most important repolarizing currents of the cardiac action potential. Its relevance is underscored by the identification of >500  [CLS] mutations in KV7.1 and, at least, 36 in KCNE1, that cause [CLS]  Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the"}
{"subject": "Long QT Syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28739325.json", "snippet": " Its relevance is underscored by the identification of >500 mutations in KV7.1 and, at least, 36 in KCNE1, that  [CLS] cause Long QT Syndrome [CLS]  (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the D242N KV7.1 mutation"}
{"subject": "mutations", "sub_type": "Var", "rel": "ThemeOf", "object": "KCNE1", "obj_type": "Gene", "file_name": "PubMed-28739325.json", "snippet": " the most important repolarizing currents of the cardiac action potential. Its relevance is underscored by the identification of >500  [CLS] mutations in KV7.1 and, at least, 36 in KCNE1 [CLS] , that cause Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences"}
{"subject": "D242N", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " relevant membrane potentials. Both functional and computational analysis suggest that the clinical phenotype of the LQTS patients carrying the  [CLS] D242N mutation is due to impaired [CLS]  action potential adaptation to exercise and, in particular, to increase in heart rate. Moreover, our data identify D242 aminoacidic"}
{"subject": "action potential adaptation to exercise", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " and computational analysis suggest that the clinical phenotype of the LQTS patients carrying the D242N mutation is due to  [CLS] impaired action potential adaptation to exercise [CLS]  and, in particular, to increase in heart rate. Moreover, our data identify D242 aminoacidic position as a potential residue"}
{"subject": "D242N", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28739325.json", "snippet": " relevant membrane potentials. Both functional and computational analysis suggest that the clinical phenotype of the LQTS patients carrying the  [CLS] D242N mutation is due to impaired action potential adaptation to exercise and, in particular, to increase [CLS]  in heart rate. Moreover, our data identify D242 aminoacidic position as a potential residue involved in the KCNE1-mediated regulation"}
{"subject": "heart rate", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28739325.json", "snippet": " LQTS patients carrying the D242N mutation is due to impaired action potential adaptation to exercise and, in particular, to  [CLS] increase in heart rate [CLS] . Moreover, our data identify D242 aminoacidic position as a potential residue involved in the KCNE1-mediated regulation of the voltage"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "removed", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " of the KV7.1 channel, disrupting the conserved charge balance of this region. Perforated patch-clamp experiments show that, unexpectedly, the  [CLS] mutation did not disrupt the voltage-dependent activation but it removed [CLS]  the inactivation and slowed the activation kinetics of D242N KV7.1 channels. Biotinylation of cell-surface protein and co-immunoprecipitation experiments revealed"}
{"subject": "KV7.1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28739325.json", "snippet": " the most important repolarizing currents of the cardiac action potential. Its relevance is underscored by the identification of >500  [CLS] mutations in KV7.1 [CLS]  and, at least, 36 in KCNE1, that cause Long QT Syndrome (LQTS). The aim of this study was to"}
{"subject": "KCNE1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28739325.json", "snippet": " the most important repolarizing currents of the cardiac action potential. Its relevance is underscored by the identification of >500  [CLS] mutations in KV7.1 and, at least, 36 in KCNE1 [CLS] , that cause Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences"}
{"subject": "KV7.1", "sub_type": "Gene", "rel": "ThemeOf", "object": "D242N", "obj_type": "Var", "file_name": "PubMed-28739325.json", "snippet": " Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the  [CLS] D242N KV7.1 [CLS]  mutation associated with the LQTS. The mutation is located in the S4 transmembrane segment, within the voltage sensor of"}
{"subject": "D242N", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28739325.json", "snippet": " Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the  [CLS] D242N KV7.1 mutation associated [CLS]  with the LQTS. The mutation is located in the S4 transmembrane segment, within the voltage sensor of the KV7.1"}
{"subject": "inactivation", "sub_type": "MPA", "rel": "ThemeOf", "object": "removed", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " of this region. Perforated patch-clamp experiments show that, unexpectedly, the mutation did not disrupt the voltage-dependent activation but it  [CLS] removed the inactivation [CLS]  and slowed the activation kinetics of D242N KV7.1 channels. Biotinylation of cell-surface protein and co-immunoprecipitation experiments revealed that neither"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "slowed", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " of the KV7.1 channel, disrupting the conserved charge balance of this region. Perforated patch-clamp experiments show that, unexpectedly, the  [CLS] mutation did not disrupt the voltage-dependent activation but it removed the inactivation and slowed [CLS]  the activation kinetics of D242N KV7.1 channels. Biotinylation of cell-surface protein and co-immunoprecipitation experiments revealed that neither plasma membrane"}
{"subject": "activation kinetics", "sub_type": "MPA", "rel": "ThemeOf", "object": "slowed", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " patch-clamp experiments show that, unexpectedly, the mutation did not disrupt the voltage-dependent activation but it removed the inactivation and  [CLS] slowed the activation kinetics [CLS]  of D242N KV7.1 channels. Biotinylation of cell-surface protein and co-immunoprecipitation experiments revealed that neither plasma membrane targeting nor co-assembly"}
{"subject": "LQTS", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28739325.json", "snippet": " (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the D242N KV7.1 mutation  [CLS] associated with the LQTS [CLS] . The mutation is located in the S4 transmembrane segment, within the voltage sensor of the KV7.1 channel, disrupting the"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "disrupting", "obj_type": "NegReg", "file_name": "PubMed-28739325.json", "snippet": " study was to characterize the biophysical and cellular consequences of the D242N KV7.1 mutation associated with the LQTS. The  [CLS] mutation is located in the S4 transmembrane segment, within the voltage sensor of the KV7.1 channel, disrupting [CLS]  the conserved charge balance of this region. Perforated patch-clamp experiments show that, unexpectedly, the mutation did not disrupt the"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28739660.json", "snippet": " renal agenesis can lead to future health issues including end stage renal disease. Genetic investigations have identified several gene  [CLS] variants which cause [CLS]  RA, including EYA1, LHX1, and WT1 However, whereas compound null mutations of genes encoding \u03b1 and \u03b3 retinoic acid"}
{"subject": "kidney agenesis phenotypes", "sub_type": "MPA", "rel": "ThemeOf", "object": "revealed", "obj_type": "Reg", "file_name": "PubMed-28739660.json", "snippet": " revealed defects in the pronephric kidney just prior to death, and F0 CRISPR/Cas9 mutagenesis of Greb1l in the mouse  [CLS] revealed kidney agenesis phenotypes [CLS] , implicating Greb1l in this disorder. GREB1L resides in a chromatin complex with RAR members, and our data implicate GREB1L"}
{"subject": "RA", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28739660.json", "snippet": " can lead to future health issues including end stage renal disease. Genetic investigations have identified several gene variants which  [CLS] cause RA [CLS] , including EYA1, LHX1, and WT1 However, whereas compound null mutations of genes encoding \u03b1 and \u03b3 retinoic acid receptors"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28739660.json", "snippet": " inheritance of an RA phenotype, and in both identified a single candidate gene, GREB1L Analysis of a zebrafish greb1l  [CLS] loss-of-function mutant [CLS]  revealed defects in the pronephric kidney just prior to death, and F0 CRISPR/Cas9 mutagenesis of Greb1l in the mouse"}
{"subject": "pronephric kidney just prior to death", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28739660.json", "snippet": " inheritance of an RA phenotype, and in both identified a single candidate gene, GREB1L Analysis of a zebrafish greb1l  [CLS] loss-of-function mutant revealed defects in the pronephric kidney just prior to death [CLS] , and F0 CRISPR/Cas9 mutagenesis of Greb1l in the mouse revealed kidney agenesis phenotypes, implicating Greb1l in this disorder. GREB1L"}
{"subject": "mutagenesis", "sub_type": "Var", "rel": "CauseOf", "object": "revealed", "obj_type": "Reg", "file_name": "PubMed-28739660.json", "snippet": " of a zebrafish greb1l loss-of-function mutant revealed defects in the pronephric kidney just prior to death, and F0 CRISPR/Cas9  [CLS] mutagenesis of Greb1l in the mouse revealed [CLS]  kidney agenesis phenotypes, implicating Greb1l in this disorder. GREB1L resides in a chromatin complex with RAR members, and our"}
{"subject": "missense variant", "sub_type": "Var", "rel": "CauseOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " [CLS] missense variant in the FOXP2 and FOXP1 transcription factors causes [CLS]  distinct neurodevelopmental disorders.\nThe closely related paralogues FOXP2 and FOXP1 encode transcription factors with shared functions in the development"}
{"subject": "global developmental delay", "sub_type": "Disease", "rel": "ThemeOf", "object": "includes", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " FOXP2 lead to a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of FOXP1 variants  [CLS] includes a broader neurodevelopmental phenotype with global developmental delay [CLS] , intellectual disability, and speech/language impairment. Using clinical whole-exome sequencing, we report an identical de novo missense FOXP1 variant identified"}
{"subject": "intellectual disability", "sub_type": "Disease", "rel": "ThemeOf", "object": "includes", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " FOXP2 lead to a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of FOXP1 variants  [CLS] includes a broader neurodevelopmental phenotype with global developmental delay, intellectual disability [CLS] , and speech/language impairment. Using clinical whole-exome sequencing, we report an identical de novo missense FOXP1 variant identified in three"}
{"subject": "speech/language impairment", "sub_type": "Disease", "rel": "ThemeOf", "object": "includes", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " FOXP2 lead to a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of FOXP1 variants  [CLS] includes a broader neurodevelopmental phenotype with global developmental delay, intellectual disability, and speech/language impairment [CLS] . Using clinical whole-exome sequencing, we report an identical de novo missense FOXP1 variant identified in three unrelated patients. The"}
{"subject": "neurodevelopmental disorders", "sub_type": "Disease", "rel": "ThemeOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " [CLS] causes distinct neurodevelopmental disorders [CLS] .\nThe closely related paralogues FOXP2 and FOXP1 encode transcription factors with shared functions in the development of many tissues,"}
{"subject": "FOXP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense variant", "obj_type": "Var", "file_name": "PubMed-28741757.json", "snippet": " [CLS] missense variant in the FOXP2 [CLS]  and FOXP1 transcription factors causes distinct neurodevelopmental disorders.\nThe closely related paralogues FOXP2 and FOXP1 encode transcription factors with"}
{"subject": "FOXP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense variant", "obj_type": "Var", "file_name": "PubMed-28741757.json", "snippet": " [CLS] missense variant in the FOXP2 and FOXP1 [CLS]  transcription factors causes distinct neurodevelopmental disorders.\nThe closely related paralogues FOXP2 and FOXP1 encode transcription factors with shared functions"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " and FOXP1 encode transcription factors with shared functions in the development of many tissues, including the brain. However, while  [CLS] mutations in FOXP2 lead to [CLS]  a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of FOXP1 variants includes a broader"}
{"subject": "FOXP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28741757.json", "snippet": " and FOXP1 encode transcription factors with shared functions in the development of many tissues, including the brain. However, while  [CLS] mutations in FOXP2 [CLS]  lead to a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of FOXP1 variants includes"}
{"subject": "childhood apraxia of speech", "sub_type": "Disease", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " transcription factors with shared functions in the development of many tissues, including the brain. However, while mutations in FOXP2  [CLS] lead to a speech/language disorder characterized by childhood apraxia of speech [CLS]  (CAS), the clinical profile of FOXP1 variants includes a broader neurodevelopmental phenotype with global developmental delay, intellectual disability, and"}
{"subject": "FOXP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28741757.json", "snippet": " mutations in FOXP2 lead to a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of  [CLS] FOXP1 variants [CLS]  includes a broader neurodevelopmental phenotype with global developmental delay, intellectual disability, and speech/language impairment. Using clinical whole-exome sequencing, we"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "includes", "obj_type": "Reg", "file_name": "PubMed-28741757.json", "snippet": " in FOXP2 lead to a speech/language disorder characterized by childhood apraxia of speech (CAS), the clinical profile of FOXP1  [CLS] variants includes [CLS]  a broader neurodevelopmental phenotype with global developmental delay, intellectual disability, and speech/language impairment. Using clinical whole-exome sequencing, we report"}
{"subject": "Leu191Phe", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28742244.json", "snippet": " Enzyme activity analysis confirmed superactivity of PRPP synthetase. Analysis of the crystal structure of human PRPPS suggests that the  [CLS] Leu191Phe mutation [CLS]  affects the architecture of both allosteric sites, thereby preventing the allosteric inhibition of the enzyme. The family reported here"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "affects", "obj_type": "Reg", "file_name": "PubMed-28742244.json", "snippet": " activity analysis confirmed superactivity of PRPP synthetase. Analysis of the crystal structure of human PRPPS suggests that the Leu191Phe  [CLS] mutation affects [CLS]  the architecture of both allosteric sites, thereby preventing the allosteric inhibition of the enzyme. The family reported here broadens"}
{"subject": "architecture", "sub_type": "MPA", "rel": "ThemeOf", "object": "affects", "obj_type": "Reg", "file_name": "PubMed-28742244.json", "snippet": " analysis confirmed superactivity of PRPP synthetase. Analysis of the crystal structure of human PRPPS suggests that the Leu191Phe mutation  [CLS] affects the architecture [CLS]  of both allosteric sites, thereby preventing the allosteric inhibition of the enzyme. The family reported here broadens the clinical"}
{"subject": "architecture", "sub_type": "MPA", "rel": "CauseOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28742244.json", "snippet": " superactivity of PRPP synthetase. Analysis of the crystal structure of human PRPPS suggests that the Leu191Phe mutation affects the  [CLS] architecture of both allosteric sites, thereby preventing [CLS]  the allosteric inhibition of the enzyme. The family reported here broadens the clinical spectrum of PRPPS superactivity and indicates"}
{"subject": "allosteric inhibition", "sub_type": "MPA", "rel": "ThemeOf", "object": "preventing", "obj_type": "NegReg", "file_name": "PubMed-28742244.json", "snippet": " the crystal structure of human PRPPS suggests that the Leu191Phe mutation affects the architecture of both allosteric sites, thereby  [CLS] preventing the allosteric inhibition [CLS]  of the enzyme. The family reported here broadens the clinical spectrum of PRPPS superactivity and indicates that this rare"}
{"subject": "enzyme", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "allosteric inhibition", "obj_type": "MPA", "file_name": "PubMed-28742244.json", "snippet": " structure of human PRPPS suggests that the Leu191Phe mutation affects the architecture of both allosteric sites, thereby preventing the  [CLS] allosteric inhibition of the enzyme [CLS] . The family reported here broadens the clinical spectrum of PRPPS superactivity and indicates that this rare metabolic disorder might"}
{"subject": "Variation", "sub_type": "Var", "rel": "CauseOf", "object": "Contributes", "obj_type": "Reg", "file_name": "PubMed-28743761.json", "snippet": " [CLS] Variation at Ugt86Dd Contributes [CLS]  to Nicotine Resistance in Drosophila melanogaster.\nIdentifying the sequence polymorphisms underlying complex trait variation is a key goal of"}
{"subject": "Ugt86Dd", "sub_type": "Gene", "rel": "ThemeOf", "object": "lesions", "obj_type": "Var", "file_name": "PubMed-28743761.json", "snippet": " event explains the bulk of the effect of the mapped locus. CRISPR/Cas9 editing a relatively resistant genotype to generate  [CLS] lesions in Ugt86Dd [CLS]  that recapitulate the naturally-occurring putative loss-of-function allele leads to a large reduction in resistance. Despite this major effect of"}
{"subject": "Ugt86Dd", "sub_type": "Gene", "rel": "ThemeOf", "object": "Variation", "obj_type": "Var", "file_name": "PubMed-28743761.json", "snippet": " [CLS] Variation at Ugt86Dd [CLS]  Contributes to Nicotine Resistance in Drosophila melanogaster.\nIdentifying the sequence polymorphisms underlying complex trait variation is a key goal"}
{"subject": "Nicotine Resistance in Drosophila melanogaster", "sub_type": "MPA", "rel": "ThemeOf", "object": "Contributes", "obj_type": "Reg", "file_name": "PubMed-28743761.json", "snippet": " [CLS] Contributes to Nicotine Resistance in Drosophila melanogaster [CLS] .\nIdentifying the sequence polymorphisms underlying complex trait variation is a key goal of genetics research, since knowing the precise"}
{"subject": "frameshift deletion", "sub_type": "Var", "rel": "CauseOf", "object": "eliminates", "obj_type": "NegReg", "file_name": "PubMed-28743761.json", "snippet": " are more resistant to nicotine, and anterior midgut-specific RNAi of this gene reduced resistance. We discovered a segregating 22-bp  [CLS] frameshift deletion in Ugt86Dd, and accounting for the InDel during mapping largely eliminates [CLS]  the QTL, implying the event explains the bulk of the effect of the mapped locus. CRISPR/Cas9 editing a relatively"}
{"subject": "QTL", "sub_type": "MPA", "rel": "ThemeOf", "object": "eliminates", "obj_type": "NegReg", "file_name": "PubMed-28743761.json", "snippet": " reduced resistance. We discovered a segregating 22-bp frameshift deletion in Ugt86Dd, and accounting for the InDel during mapping largely  [CLS] eliminates the QTL [CLS] , implying the event explains the bulk of the effect of the mapped locus. CRISPR/Cas9 editing a relatively resistant genotype"}
{"subject": "Ugt86Dd", "sub_type": "Gene", "rel": "ThemeOf", "object": "frameshift deletion", "obj_type": "Var", "file_name": "PubMed-28743761.json", "snippet": " are more resistant to nicotine, and anterior midgut-specific RNAi of this gene reduced resistance. We discovered a segregating 22-bp  [CLS] frameshift deletion in Ugt86Dd [CLS] , and accounting for the InDel during mapping largely eliminates the QTL, implying the event explains the bulk of the"}
{"subject": "lesions", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28743761.json", "snippet": " event explains the bulk of the effect of the mapped locus. CRISPR/Cas9 editing a relatively resistant genotype to generate  [CLS] lesions in Ugt86Dd that recapitulate the naturally-occurring putative loss-of-function [CLS]  allele leads to a large reduction in resistance. Despite this major effect of the deletion, the allele appears to"}
{"subject": "lesions", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-28743761.json", "snippet": " event explains the bulk of the effect of the mapped locus. CRISPR/Cas9 editing a relatively resistant genotype to generate  [CLS] lesions in Ugt86Dd that recapitulate the naturally-occurring putative loss-of-function allele leads to a large reduction [CLS]  in resistance. Despite this major effect of the deletion, the allele appears to be very rare in wild-caught populations,"}
{"subject": "resistance", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-28743761.json", "snippet": " relatively resistant genotype to generate lesions in Ugt86Dd that recapitulate the naturally-occurring putative loss-of-function allele leads to a large  [CLS] reduction in resistance [CLS] . Despite this major effect of the deletion, the allele appears to be very rare in wild-caught populations, and likely"}
{"subject": "Sequence exchange", "sub_type": "Var", "rel": "CauseOf", "object": "converts", "obj_type": "Reg", "file_name": "PubMed-28747428.json", "snippet": " [CLS] Sequence exchange between R genes converts [CLS]  virus resistance into nematode resistance, and vice versa.\nPlants have evolved a limited repertoire of NB-LRR disease resistance (R)"}
{"subject": "mild nematode resistance in the roots", "sub_type": "MPA", "rel": "ThemeOf", "object": "convert", "obj_type": "Reg", "file_name": "PubMed-28747428.json", "snippet": " G. pallida in the roots. These data demonstrate that exchanging the recognition moiety in the LRR is sufficient to  [CLS] convert extreme virus resistance in the leaves into mild nematode resistance in the roots [CLS] , and vice versa. In addition, we show that the CC-NB-ARC can operate independently of the recognition specificities defined by"}
{"subject": "nematode resistance", "sub_type": "MPA", "rel": "ThemeOf", "object": "converts", "obj_type": "Reg", "file_name": "PubMed-28747428.json", "snippet": " [CLS] converts virus resistance into nematode resistance [CLS] , and vice versa.\nPlants have evolved a limited repertoire of NB-LRR disease resistance (R) genes to protect themselves against"}
{"subject": "R", "sub_type": "Gene", "rel": "ThemeOf", "object": "Sequence exchange", "obj_type": "Var", "file_name": "PubMed-28747428.json", "snippet": " [CLS] Sequence exchange between R [CLS]  genes converts virus resistance into nematode resistance, and vice versa.\nPlants have evolved a limited repertoire of NB-LRR disease"}
{"subject": "changes", "sub_type": "Var", "rel": "CauseOf", "object": "alter", "obj_type": "Reg", "file_name": "PubMed-28747428.json", "snippet": " pathogens. This limitation is thought to be counterbalanced by the rapid evolution of NB-LRR proteins, as only few sequence  [CLS] changes have been shown to be sufficient to alter [CLS]  resistance specificities towards novel strains of a pathogen. However, little is known about the flexibility of NB-LRR genes to"}
{"subject": "resistance specificities towards novel strains of a pathogen", "sub_type": "MPA", "rel": "ThemeOf", "object": "alter", "obj_type": "Reg", "file_name": "PubMed-28747428.json", "snippet": " by the rapid evolution of NB-LRR proteins, as only few sequence changes have been shown to be sufficient to  [CLS] alter resistance specificities towards novel strains of a pathogen [CLS] . However, little is known about the flexibility of NB-LRR genes to switch resistance specificities between phylogenetically unrelated pathogens. To"}
{"subject": "exchange", "sub_type": "Var", "rel": "CauseOf", "object": "regain", "obj_type": "PosReg", "file_name": "PubMed-28747428.json", "snippet": " activation response including extreme resistance to PVX in potato shoots. The reciprocal construct (Rx1CN/Gpa2L) showed a loss-of-function phenotype, but  [CLS] exchange of the first 3 LRR repeats of Rx1 was sufficient to regain [CLS]  a wild type resistance response to G. pallida in the roots. These data demonstrate that exchanging the recognition moiety"}
{"subject": "wild type resistance response to G. pallida in the roots", "sub_type": "MPA", "rel": "ThemeOf", "object": "regain", "obj_type": "PosReg", "file_name": "PubMed-28747428.json", "snippet": " construct (Rx1CN/Gpa2L) showed a loss-of-function phenotype, but exchange of the first 3 LRR repeats of Rx1 was sufficient to  [CLS] regain a wild type resistance response to G. pallida in the roots [CLS] . These data demonstrate that exchanging the recognition moiety in the LRR is sufficient to convert extreme virus resistance in"}
{"subject": "Rx1", "sub_type": "Gene", "rel": "ThemeOf", "object": "exchange", "obj_type": "Var", "file_name": "PubMed-28747428.json", "snippet": " activation response including extreme resistance to PVX in potato shoots. The reciprocal construct (Rx1CN/Gpa2L) showed a loss-of-function phenotype, but  [CLS] exchange of the first 3 LRR repeats of Rx1 [CLS]  was sufficient to regain a wild type resistance response to G. pallida in the roots. These data demonstrate that"}
{"subject": "exchanging", "sub_type": "Var", "rel": "CauseOf", "object": "convert", "obj_type": "Reg", "file_name": "PubMed-28747428.json", "snippet": " was sufficient to regain a wild type resistance response to G. pallida in the roots. These data demonstrate that  [CLS] exchanging the recognition moiety in the LRR is sufficient to convert [CLS]  extreme virus resistance in the leaves into mild nematode resistance in the roots, and vice versa. In addition, we"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " [CLS] mutations in the K(+) channels Kir4.1 (KCNJ10) and SLACK (KCNT1) associated [CLS]  with severe-disabling seizures and neurodevelopmental delay.\nA 2-year-old boy presented profound developmental delay, failure to thrive, ataxia, hypotonia and"}
{"subject": "protein expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28747464.json", "snippet": " KCNJ10 expression yielded robust Kir currents, while currents from oocytes expressing the mutation were reduced. Western Blot analysis revealed  [CLS] reduced protein expression [CLS]  by the mutation. Kir5.1 subunits display selective heteromultimerization with Kir4.1 constituting channels with unique kinetics. The effect of the"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28747464.json", "snippet": " was twofold: a reduction in current amplitudes and an increase in the pH-dependent inhibition. We thus report a novel  [CLS] loss-of-function mutation [CLS]  in Kir4.1 found in a patient with a co-exiting mutation in SLACK channels that results in a fatal disease."}
{"subject": "mutation", "sub_type": "Var", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28747464.json", "snippet": " twofold: a reduction in current amplitudes and an increase in the pH-dependent inhibition. We thus report a novel loss-of-function  [CLS] mutation in Kir4.1 found in a patient with a co-exiting mutation [CLS]  in SLACK channels that results in a fatal disease."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "results in", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " twofold: a reduction in current amplitudes and an increase in the pH-dependent inhibition. We thus report a novel loss-of-function  [CLS] mutation in Kir4.1 found in a patient with a co-exiting mutation in SLACK channels that results in [CLS]  a fatal disease."}
{"subject": "fatal disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "results in", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " report a novel loss-of-function mutation in Kir4.1 found in a patient with a co-exiting mutation in SLACK channels that  [CLS] results in a fatal disease [CLS] ."}
{"subject": "seizures", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " [CLS] associated with severe-disabling seizures [CLS]  and neurodevelopmental delay.\nA 2-year-old boy presented profound developmental delay, failure to thrive, ataxia, hypotonia and tonic-clonic seizures that"}
{"subject": "KCNJ10", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28747464.json", "snippet": " [CLS] mutations in the K(+) channels Kir4.1 (KCNJ10 [CLS] ) and SLACK (KCNT1) associated with severe-disabling seizures and neurodevelopmental delay.\nA 2-year-old boy presented profound developmental delay, failure to"}
{"subject": "KCNT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28747464.json", "snippet": " [CLS] mutations in the K(+) channels Kir4.1 (KCNJ10) and SLACK (KCNT1 [CLS] ) associated with severe-disabling seizures and neurodevelopmental delay.\nA 2-year-old boy presented profound developmental delay, failure to thrive, ataxia, hypotonia"}
{"subject": "neurodevelopmental delay", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " [CLS] associated with severe-disabling seizures and neurodevelopmental delay [CLS] .\nA 2-year-old boy presented profound developmental delay, failure to thrive, ataxia, hypotonia and tonic-clonic seizures that caused the death"}
{"subject": "KCNJ10", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28747464.json", "snippet": " and heterologously expressed in Xenopus laevis oocytes, and whole-cell K(+) currents were measured using the two-electrode voltage-clamp technique. The  [CLS] KCNJ10 mutation [CLS]  c.652C>T resulted in a p.L218F substitution at a highly conserved residue site. Wild-type KCNJ10 expression yielded robust Kir currents,"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "resulted in", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " heterologously expressed in Xenopus laevis oocytes, and whole-cell K(+) currents were measured using the two-electrode voltage-clamp technique. The KCNJ10  [CLS] mutation c.652C>T resulted in [CLS]  a p.L218F substitution at a highly conserved residue site. Wild-type KCNJ10 expression yielded robust Kir currents, while currents from"}
{"subject": "substitution", "sub_type": "Var", "rel": "ThemeOf", "object": "resulted in", "obj_type": "Reg", "file_name": "PubMed-28747464.json", "snippet": " in Xenopus laevis oocytes, and whole-cell K(+) currents were measured using the two-electrode voltage-clamp technique. The KCNJ10 mutation c.652C>T  [CLS] resulted in a p.L218F substitution [CLS]  at a highly conserved residue site. Wild-type KCNJ10 expression yielded robust Kir currents, while currents from oocytes expressing the"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28747464.json", "snippet": " KCNJ10 expression yielded robust Kir currents, while currents from oocytes expressing the mutation were reduced. Western Blot analysis revealed  [CLS] reduced protein expression by the mutation [CLS] . Kir5.1 subunits display selective heteromultimerization with Kir4.1 constituting channels with unique kinetics. The effect of the mutation on Kir4.1/5.1"}
{"subject": "LQTS", "sub_type": "Disease", "rel": "ThemeOf", "object": "pathogenic", "obj_type": "Reg", "file_name": "PubMed-28749435.json", "snippet": " more severe phenotypes when combined with disease-causing alleles. Our results indicate that the novel KCNH2-C108Y variant can be a  [CLS] pathogenic LQTS [CLS]  mutation, whereas KCNQ1-p.R583H, KCNH2-p.K897T, and KCNE1-p.G38S could be LQTS modifiers."}
{"subject": "KCNH2", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.C108Y", "obj_type": "Var", "file_name": "PubMed-28749435.json", "snippet": " using the whole-cell patch clamp technique. We found that KCNQ1-p.R583H was not associated with a severe functional impairment, whereas  [CLS] KCNH2-p.C108Y [CLS] , a novel variant, encoded a non-functional channel that exerts dominant-negative effects on the wild-type. Notably, the common variants KCNH2-p.K897T"}
{"subject": "p.C108Y", "sub_type": "Var", "rel": "CauseOf", "object": "encoded", "obj_type": "Reg", "file_name": "PubMed-28749435.json", "snippet": " using the whole-cell patch clamp technique. We found that KCNQ1-p.R583H was not associated with a severe functional impairment, whereas KCNH2- [CLS] p.C108Y, a novel variant, encoded [CLS]  a non-functional channel that exerts dominant-negative effects on the wild-type. Notably, the common variants KCNH2-p.K897T and KCNE1-p.G38S were previously"}
{"subject": "non-functional channel", "sub_type": "Pathway", "rel": "ThemeOf", "object": "encoded", "obj_type": "Reg", "file_name": "PubMed-28749435.json", "snippet": " clamp technique. We found that KCNQ1-p.R583H was not associated with a severe functional impairment, whereas KCNH2-p.C108Y, a novel variant,  [CLS] encoded a non-functional channel [CLS]  that exerts dominant-negative effects on the wild-type. Notably, the common variants KCNH2-p.K897T and KCNE1-p.G38S were previously reported to produce"}
{"subject": "non-functional channel", "sub_type": "Pathway", "rel": "CauseOf", "object": "dominant-negative", "obj_type": "NegReg", "file_name": "PubMed-28749435.json", "snippet": " We found that KCNQ1-p.R583H was not associated with a severe functional impairment, whereas KCNH2-p.C108Y, a novel variant, encoded a  [CLS] non-functional channel that exerts dominant-negative [CLS]  effects on the wild-type. Notably, the common variants KCNH2-p.K897T and KCNE1-p.G38S were previously reported to produce more severe phenotypes"}
{"subject": "effects", "sub_type": "MPA", "rel": "ThemeOf", "object": "dominant-negative", "obj_type": "NegReg", "file_name": "PubMed-28749435.json", "snippet": " was not associated with a severe functional impairment, whereas KCNH2-p.C108Y, a novel variant, encoded a non-functional channel that exerts  [CLS] dominant-negative effects [CLS]  on the wild-type. Notably, the common variants KCNH2-p.K897T and KCNE1-p.G38S were previously reported to produce more severe phenotypes when"}
{"subject": "KCNH2", "sub_type": "Gene", "rel": "ThemeOf", "object": "C108Y", "obj_type": "Var", "file_name": "PubMed-28749435.json", "snippet": " were previously reported to produce more severe phenotypes when combined with disease-causing alleles. Our results indicate that the novel  [CLS] KCNH2-C108Y [CLS]  variant can be a pathogenic LQTS mutation, whereas KCNQ1-p.R583H, KCNH2-p.K897T, and KCNE1-p.G38S could be LQTS modifiers."}
{"subject": "C108Y", "sub_type": "Var", "rel": "CauseOf", "object": "pathogenic", "obj_type": "Reg", "file_name": "PubMed-28749435.json", "snippet": " were previously reported to produce more severe phenotypes when combined with disease-causing alleles. Our results indicate that the novel KCNH2- [CLS] C108Y variant can be a pathogenic [CLS]  LQTS mutation, whereas KCNQ1-p.R583H, KCNH2-p.K897T, and KCNE1-p.G38S could be LQTS modifiers."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28751317.json", "snippet": " However, it is unclear how OsHRZ1 transmits signals. In this study, we reveal that OsPRI1 interacts with OsHRZ1. A  [CLS] loss-of-function mutation [CLS]  to OsPRI1 increased the sensitivity of plants to Fe-deficient conditions and downregulated the expression of Fe-deficiency-responsive genes. Yeast one-hybrid"}
{"subject": "pri1-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28751317.json", "snippet": " suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the  [CLS] pri1-1 mutation [CLS]  was introduced into hrz1-2 mutants, the pri1hrz1 double mutant was more sensitive to Fe deficiency than the hrz1-2 mutant."}
{"subject": "mutation", "sub_type": "Var", "rel": "ThemeOf", "object": "introduced", "obj_type": "Interaction", "file_name": "PubMed-28751317.json", "snippet": " OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1  [CLS] mutation was introduced [CLS]  into hrz1-2 mutants, the pri1hrz1 double mutant was more sensitive to Fe deficiency than the hrz1-2 mutant. Additionally, the"}
{"subject": "mutants", "sub_type": "Var", "rel": "ThemeOf", "object": "introduced", "obj_type": "Interaction", "file_name": "PubMed-28751317.json", "snippet": " responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1 mutation was  [CLS] introduced into hrz1-2 mutants [CLS] , the pri1hrz1 double mutant was more sensitive to Fe deficiency than the hrz1-2 mutant. Additionally, the expression levels of"}
{"subject": "hrz1-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-28751317.json", "snippet": " the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1 mutation was introduced into  [CLS] hrz1-2 mutants [CLS] , the pri1hrz1 double mutant was more sensitive to Fe deficiency than the hrz1-2 mutant. Additionally, the expression levels of"}
{"subject": "hrz1-2", "sub_type": "Gene", "rel": "CauseOf", "object": "introduced", "obj_type": "Interaction", "file_name": "PubMed-28751317.json", "snippet": " responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1 mutation was  [CLS] introduced into hrz1-2 [CLS]  mutants, the pri1hrz1 double mutant was more sensitive to Fe deficiency than the hrz1-2 mutant. Additionally, the expression levels"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-28751317.json", "snippet": " instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the pri1-1 mutation was introduced into hrz1-2  [CLS] mutants, the pri1hrz1 double mutant was more [CLS]  sensitive to Fe deficiency than the hrz1-2 mutant. Additionally, the expression levels of Fe-deficiency-responsive genes were lower in the"}
{"subject": "sensitive to Fe deficiency", "sub_type": "MPA", "rel": "ThemeOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-28751317.json", "snippet": " were insensitive to Fe-deficient conditions. When the pri1-1 mutation was introduced into hrz1-2 mutants, the pri1hrz1 double mutant was  [CLS] more sensitive to Fe deficiency [CLS]  than the hrz1-2 mutant. Additionally, the expression levels of Fe-deficiency-responsive genes were lower in the hrz1pri1 double mutant than"}
{"subject": "OsPRI1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28751317.json", "snippet": " it is unclear how OsHRZ1 transmits signals. In this study, we reveal that OsPRI1 interacts with OsHRZ1. A loss-of-function  [CLS] mutation to OsPRI1 [CLS]  increased the sensitivity of plants to Fe-deficient conditions and downregulated the expression of Fe-deficiency-responsive genes. Yeast one-hybrid and electrophoretic"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28751317.json", "snippet": " it is unclear how OsHRZ1 transmits signals. In this study, we reveal that OsPRI1 interacts with OsHRZ1. A loss-of-function  [CLS] mutation to OsPRI1 increased [CLS]  the sensitivity of plants to Fe-deficient conditions and downregulated the expression of Fe-deficiency-responsive genes. Yeast one-hybrid and electrophoretic mobility"}
{"subject": "sensitivity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28751317.json", "snippet": " how OsHRZ1 transmits signals. In this study, we reveal that OsPRI1 interacts with OsHRZ1. A loss-of-function mutation to OsPRI1  [CLS] increased the sensitivity [CLS]  of plants to Fe-deficient conditions and downregulated the expression of Fe-deficiency-responsive genes. Yeast one-hybrid and electrophoretic mobility shift assay"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "downregulated", "obj_type": "NegReg", "file_name": "PubMed-28751317.json", "snippet": " it is unclear how OsHRZ1 transmits signals. In this study, we reveal that OsPRI1 interacts with OsHRZ1. A loss-of-function  [CLS] mutation to OsPRI1 increased the sensitivity of plants to Fe-deficient conditions and downregulated [CLS]  the expression of Fe-deficiency-responsive genes. Yeast one-hybrid and electrophoretic mobility shift assay results suggested that OsPRI1 binds to the"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "downregulated", "obj_type": "NegReg", "file_name": "PubMed-28751317.json", "snippet": " that OsPRI1 interacts with OsHRZ1. A loss-of-function mutation to OsPRI1 increased the sensitivity of plants to Fe-deficient conditions and  [CLS] downregulated the expression [CLS]  of Fe-deficiency-responsive genes. Yeast one-hybrid and electrophoretic mobility shift assay results suggested that OsPRI1 binds to the OsIRO2 and"}
{"subject": "hrz1-2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28751317.json", "snippet": " OsHRZ1. Cell-free degradation assays revealed that the stability of OsPRI1 decreased in wild type roots, but increased in the  [CLS] hrz1-2 mutant [CLS] , suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28751317.json", "snippet": " is ubiquitinated by OsHRZ1. Cell-free degradation assays revealed that the stability of OsPRI1 decreased in wild type roots, but  [CLS] increased in the hrz1-2 mutant [CLS] , suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to Fe-deficient conditions. When the"}
{"subject": "stability", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28751317.json", "snippet": " OsIRO3 promoters. In vitro ubiquitination experiments indicated that OsPRI1 is ubiquitinated by OsHRZ1. Cell-free degradation assays revealed that the  [CLS] stability of OsPRI1 decreased in wild type roots, but increased [CLS]  in the hrz1-2 mutant, suggesting OsHRZ1 is responsible for the instability of OsPRI1. The hrz1-2 seedlings were insensitive to"}
{"subject": "IKZF1", "sub_type": "Gene", "rel": "ThemeOf", "object": "deletions", "obj_type": "Var", "file_name": "PubMed-28751559.json", "snippet": " [CLS] IKZF1 deletions [CLS]  are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia.\nGenetic alterations of the transcription factor IKZF1"}
{"subject": "deletions", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " [CLS] Loss-of-function but not dominant-negative intragenic IKZF1 deletions [CLS]  are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia.\nGenetic alterations of the transcription factor IKZF1"}
{"subject": "acute lymphoblastic leukemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " [CLS] Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia [CLS] .\nGenetic alterations of the transcription factor IKZF1 (\"IKAROS\") are detected in around 15-30% of cases of BCR-ABL-negative B-cell precursor"}
{"subject": "deletions", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " are detected in around 15-30% of cases of BCR-ABL-negative B-cell precursor acute lymphoblastic leukemia (ALL). Different types of intragenic  [CLS] deletions have been observed, resulting in a functionally inactivated allele (\"loss-of-function [CLS] \") or in \"dominant-negative\" isoforms. The prognostic impact of these alterations especially in adult acute lymphoblastic leukemia is not well"}
{"subject": "functionally inactivated allele", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " of BCR-ABL-negative B-cell precursor acute lymphoblastic leukemia (ALL). Different types of intragenic deletions have been observed, resulting in a  [CLS] functionally inactivated allele (\"loss-of-function [CLS] \") or in \"dominant-negative\" isoforms. The prognostic impact of these alterations especially in adult acute lymphoblastic leukemia is not well"}
{"subject": "deletions", "sub_type": "Var", "rel": "CauseOf", "object": "dominant-negative", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " are detected in around 15-30% of cases of BCR-ABL-negative B-cell precursor acute lymphoblastic leukemia (ALL). Different types of intragenic  [CLS] deletions have been observed, resulting in a functionally inactivated allele (\"loss-of-function\") or in \"dominant-negative [CLS] \" isoforms. The prognostic impact of these alterations especially in adult acute lymphoblastic leukemia is not well defined. We analyzed"}
{"subject": "isoforms", "sub_type": "MPA", "rel": "ThemeOf", "object": "dominant-negative", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " leukemia (ALL). Different types of intragenic deletions have been observed, resulting in a functionally inactivated allele (\"loss-of-function\") or in \" [CLS] dominant-negative\" isoforms [CLS] . The prognostic impact of these alterations especially in adult acute lymphoblastic leukemia is not well defined. We analyzed 482"}
{"subject": "high deletion load", "sub_type": "Var", "rel": "CauseOf", "object": "shorter", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " subclones (\"low deletion load\"). Some patients showed more than one IKZF1 alteration (8%). Patients exhibiting a loss-of-function isoform with  [CLS] high deletion load had a shorter [CLS]  overall survival (OS at 5 years 28% vs. 59%, p<0.0001), also significant in a subgroup analysis of standard risk"}
{"subject": "overall survival", "sub_type": "MPA", "rel": "ThemeOf", "object": "shorter", "obj_type": "NegReg", "file_name": "PubMed-28751559.json", "snippet": " patients showed more than one IKZF1 alteration (8%). Patients exhibiting a loss-of-function isoform with high deletion load had a  [CLS] shorter overall survival [CLS]  (OS at 5 years 28% vs. 59%, p<0.0001), also significant in a subgroup analysis of standard risk patients according"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-28754659.json", "snippet": " damage response pathway. Loss of function mutants of atl-1 had no defect in UVC induced SIS but a partial  [CLS] loss of function mutant [CLS]  of cep-1, gk138, had decreased movement quiescence following UVC irradiation. Germline ablation experiments and tissue-specific RNA interference experiments showed"}
{"subject": "cep-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28754659.json", "snippet": " Loss of function mutants of atl-1 had no defect in UVC induced SIS but a partial loss of function  [CLS] mutant of cep-1 [CLS] , gk138, had decreased movement quiescence following UVC irradiation. Germline ablation experiments and tissue-specific RNA interference experiments showed that cep-1"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28754659.json", "snippet": " Loss of function mutants of atl-1 had no defect in UVC induced SIS but a partial loss of function  [CLS] mutant of cep-1, gk138, had decreased [CLS]  movement quiescence following UVC irradiation. Germline ablation experiments and tissue-specific RNA interference experiments showed that cep-1 is required somatically"}
{"subject": "movement quiescence", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28754659.json", "snippet": " atl-1 had no defect in UVC induced SIS but a partial loss of function mutant of cep-1, gk138, had  [CLS] decreased movement quiescence [CLS]  following UVC irradiation. Germline ablation experiments and tissue-specific RNA interference experiments showed that cep-1 is required somatically in neurons"}
{"subject": "cep-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28754659.json", "snippet": " and tissue-specific RNA interference experiments showed that cep-1 is required somatically in neurons for its effect on SIS. The  [CLS] cep-1(gk138) mutant [CLS]  suppressed body movement quiescence controlled by EGF, indicating that CEP-1 acts downstream or in parallel to ALA activation to"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "suppressed", "obj_type": "NegReg", "file_name": "PubMed-28754659.json", "snippet": " tissue-specific RNA interference experiments showed that cep-1 is required somatically in neurons for its effect on SIS. The cep-1(gk138)  [CLS] mutant suppressed [CLS]  body movement quiescence controlled by EGF, indicating that CEP-1 acts downstream or in parallel to ALA activation to promote"}
{"subject": "body movement quiescence controlled by EGF", "sub_type": "MPA", "rel": "ThemeOf", "object": "suppressed", "obj_type": "NegReg", "file_name": "PubMed-28754659.json", "snippet": " RNA interference experiments showed that cep-1 is required somatically in neurons for its effect on SIS. The cep-1(gk138) mutant  [CLS] suppressed body movement quiescence controlled by EGF [CLS] , indicating that CEP-1 acts downstream or in parallel to ALA activation to promote quiescence in response to ultraviolet light."}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "deficiency", "obj_type": "Var", "file_name": "PubMed-28758421.json", "snippet": " [CLS] PCSK9 deficiency [CLS]  results in increased ectopic fat accumulation in experimental models and in humans.\nBackground Proprotein convertase subtilisin kexin type 9"}
{"subject": "deficiency", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28758421.json", "snippet": " [CLS] deficiency results in increased [CLS]  ectopic fat accumulation in experimental models and in humans.\nBackground Proprotein convertase subtilisin kexin type 9 (PCSK9) regulates low-density"}
{"subject": "ectopic fat accumulation", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28758421.json", "snippet": " [CLS] increased ectopic fat accumulation [CLS]  in experimental models and in humans.\nBackground Proprotein convertase subtilisin kexin type 9 (PCSK9) regulates low-density lipoprotein and very"}
{"subject": "R46L", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-28758421.json", "snippet": " levels, higher body mass index and increased percentage of total and android fat masses compared with non-carriers ( n\u2009=\u2009521).  [CLS] R46L variant [CLS]  associated with a two-fold increase prevalence of hepatic steatosis and higher epicardial fat thickness. These observations were replicated in"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28758421.json", "snippet": " higher body mass index and increased percentage of total and android fat masses compared with non-carriers ( n\u2009=\u2009521). R46L  [CLS] variant associated with a two-fold increase [CLS]  prevalence of hepatic steatosis and higher epicardial fat thickness. These observations were replicated in PCSK9 KO mice, which showed"}
{"subject": "hepatic steatosis and higher epicardial fat thickness", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28758421.json", "snippet": " increased percentage of total and android fat masses compared with non-carriers ( n\u2009=\u2009521). R46L variant associated with a two-fold  [CLS] increase prevalence of hepatic steatosis and higher epicardial fat thickness [CLS] . These observations were replicated in PCSK9 KO mice, which showed increased visceral adipose tissue (but not subcutaneous adipose tissue)"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "deficiency", "obj_type": "Var", "file_name": "PubMed-28758421.json", "snippet": " chow or high-fat diet for 20 weeks, compared with wild type mice. Conclusions These data suggest that genetically determined  [CLS] PCSK9 deficiency [CLS]  might be associated with ectopic fat accumulation."}
{"subject": "deficiency", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28758421.json", "snippet": " or high-fat diet for 20 weeks, compared with wild type mice. Conclusions These data suggest that genetically determined PCSK9  [CLS] deficiency might be associated [CLS]  with ectopic fat accumulation."}
{"subject": "ectopic fat accumulation", "sub_type": "MPA", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28758421.json", "snippet": " for 20 weeks, compared with wild type mice. Conclusions These data suggest that genetically determined PCSK9 deficiency might be  [CLS] associated with ectopic fat accumulation [CLS] ."}
{"subject": "Braf", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28783725.json", "snippet": " [CLS] Braf kinase-inactive mutant [CLS]  induces lung adenocarcinoma.\nThe initiating oncogenic event in almost half of human lung adenocarcinomas is still unknown, a fact"}
{"subject": "Kras", "sub_type": "Gene", "rel": "ThemeOf", "object": "G12V", "obj_type": "Var", "file_name": "PubMed-28783725.json", "snippet": " oncogenesis. Moreover, inactivating BRAF mutations have also been identified in a subset of KRAS-driven human lung tumours. Co-expression of  [CLS] Kras(G12V [CLS] ) and Braf(D631A) in mouse lung cells markedly enhances tumour initiation, a phenomenon mediated by Craf kinase activity, and effectively"}
{"subject": "Braf", "sub_type": "Gene", "rel": "ThemeOf", "object": "D631A", "obj_type": "Var", "file_name": "PubMed-28783725.json", "snippet": " inactivating BRAF mutations have also been identified in a subset of KRAS-driven human lung tumours. Co-expression of Kras(G12V) and  [CLS] Braf(D631A [CLS] ) in mouse lung cells markedly enhances tumour initiation, a phenomenon mediated by Craf kinase activity, and effectively accelerates tumour"}
{"subject": "tumour initiation", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-28783725.json", "snippet": " identified in a subset of KRAS-driven human lung tumours. Co-expression of Kras(G12V) and Braf(D631A) in mouse lung cells markedly  [CLS] enhances tumour initiation [CLS] , a phenomenon mediated by Craf kinase activity, and effectively accelerates tumour progression when activated in advanced lung adenocarcinomas. We"}
{"subject": "G12V", "sub_type": "Var", "rel": "CauseOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-28783725.json", "snippet": " oncogenesis. Moreover, inactivating BRAF mutations have also been identified in a subset of KRAS-driven human lung tumours. Co-expression of Kras( [CLS] G12V) and Braf(D631A) in mouse lung cells markedly enhances [CLS]  tumour initiation, a phenomenon mediated by Craf kinase activity, and effectively accelerates tumour progression when activated in advanced lung"}
{"subject": "D631A", "sub_type": "Var", "rel": "CauseOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-28783725.json", "snippet": " inactivating BRAF mutations have also been identified in a subset of KRAS-driven human lung tumours. Co-expression of Kras(G12V) and Braf( [CLS] D631A) in mouse lung cells markedly enhances [CLS]  tumour initiation, a phenomenon mediated by Craf kinase activity, and effectively accelerates tumour progression when activated in advanced lung"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-28783725.json", "snippet": " [CLS] mutant induces [CLS]  lung adenocarcinoma.\nThe initiating oncogenic event in almost half of human lung adenocarcinomas is still unknown, a fact that"}
{"subject": "lung adenocarcinoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-28783725.json", "snippet": " [CLS] induces lung adenocarcinoma [CLS] .\nThe initiating oncogenic event in almost half of human lung adenocarcinomas is still unknown, a fact that complicates the"}
{"subject": "Braf", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss", "obj_type": "Var", "file_name": "PubMed-28783725.json", "snippet": " in oncogenic toxicity; this effect can be abolished by pharmacological inhibition of Mek to restore tumour growth. However, the  [CLS] loss of wild-type Braf [CLS]  also induces transdifferentiation of club cells, which leads to the rapid development of lethal intrabronchiolar lesions. These observations indicate"}
{"subject": "loss", "sub_type": "Var", "rel": "CauseOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-28783725.json", "snippet": " in oncogenic toxicity; this effect can be abolished by pharmacological inhibition of Mek to restore tumour growth. However, the  [CLS] loss of wild-type Braf also induces [CLS]  transdifferentiation of club cells, which leads to the rapid development of lethal intrabronchiolar lesions. These observations indicate that the"}
{"subject": "transdifferentiation", "sub_type": "CPA", "rel": "ThemeOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-28783725.json", "snippet": " can be abolished by pharmacological inhibition of Mek to restore tumour growth. However, the loss of wild-type Braf also  [CLS] induces transdifferentiation [CLS]  of club cells, which leads to the rapid development of lethal intrabronchiolar lesions. These observations indicate that the signal"}
{"subject": "transdifferentiation", "sub_type": "CPA", "rel": "CauseOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-28783725.json", "snippet": " be abolished by pharmacological inhibition of Mek to restore tumour growth. However, the loss of wild-type Braf also induces  [CLS] transdifferentiation of club cells, which leads to [CLS]  the rapid development of lethal intrabronchiolar lesions. These observations indicate that the signal intensity of the MAPK pathway is"}
{"subject": "rapid development of lethal intrabronchiolar lesions", "sub_type": "MPA", "rel": "ThemeOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-28783725.json", "snippet": " of Mek to restore tumour growth. However, the loss of wild-type Braf also induces transdifferentiation of club cells, which  [CLS] leads to the rapid development of lethal intrabronchiolar lesions [CLS] . These observations indicate that the signal intensity of the MAPK pathway is a critical determinant not only in tumour"}
{"subject": "Loss-of-function", "sub_type": "Var", "rel": "CauseOf", "object": "exhibited", "obj_type": "Reg", "file_name": "PubMed-28798354.json", "snippet": " human aging. Here we show that ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) is required for Klotho expression under phosphate overload conditions.  [CLS] Loss-of-function Enpp1 (ttw/ttw) mice under phosphate overload conditions exhibited [CLS]  phenotypes resembling human aging and Klotho mutants, such as short life span, arteriosclerosis and osteoporosis, with elevated serum 1,25(OH)2D3"}
{"subject": "arteriosclerosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "exhibited", "obj_type": "Reg", "file_name": "PubMed-28798354.json", "snippet": " 1 (Enpp1) is required for Klotho expression under phosphate overload conditions. Loss-of-function Enpp1 (ttw/ttw) mice under phosphate overload conditions  [CLS] exhibited phenotypes resembling human aging and Klotho mutants, such as short life span, arteriosclerosis [CLS]  and osteoporosis, with elevated serum 1,25(OH)2D3 levels. Enpp1 (ttw/ttw) mice also exhibited significantly reduced renal Klotho expression under phosphate"}
{"subject": "osteoporosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "exhibited", "obj_type": "Reg", "file_name": "PubMed-28798354.json", "snippet": " 1 (Enpp1) is required for Klotho expression under phosphate overload conditions. Loss-of-function Enpp1 (ttw/ttw) mice under phosphate overload conditions  [CLS] exhibited phenotypes resembling human aging and Klotho mutants, such as short life span, arteriosclerosis and osteoporosis [CLS] , with elevated serum 1,25(OH)2D3 levels. Enpp1 (ttw/ttw) mice also exhibited significantly reduced renal Klotho expression under phosphate overload conditions,"}
{"subject": "Enpp1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "Var", "file_name": "PubMed-28798354.json", "snippet": " human aging. Here we show that ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) is required for Klotho expression under phosphate overload conditions.  [CLS] Loss-of-function Enpp1 [CLS]  (ttw/ttw) mice under phosphate overload conditions exhibited phenotypes resembling human aging and Klotho mutants, such as short life span,"}
{"subject": "serum 1,25(OH)2D3 levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-28798354.json", "snippet": " overload conditions exhibited phenotypes resembling human aging and Klotho mutants, such as short life span, arteriosclerosis and osteoporosis, with  [CLS] elevated serum 1,25(OH)2D3 levels [CLS] . Enpp1 (ttw/ttw) mice also exhibited significantly reduced renal Klotho expression under phosphate overload conditions, and aging phenotypes in these"}
{"subject": "Loss-of-function", "sub_type": "Var", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-28798354.json", "snippet": " human aging. Here we show that ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) is required for Klotho expression under phosphate overload conditions.  [CLS] Loss-of-function Enpp1 (ttw/ttw) mice under phosphate overload conditions exhibited phenotypes resembling human aging and Klotho mutants, such as short life span, arteriosclerosis and osteoporosis, with elevated [CLS]  serum 1,25(OH)2D3 levels. Enpp1 (ttw/ttw) mice also exhibited significantly reduced renal Klotho expression under phosphate overload conditions, and aging"}
{"subject": "BmATG8", "sub_type": "Gene", "rel": "ThemeOf", "object": "Deletion", "obj_type": "Var", "file_name": "PubMed-28800850.json", "snippet": " maydis, we constructed null mutants of BmATG8, an orthologue of the Saccharomyces cerevisiae autophagy gene ATG8 in B. maydis.  [CLS] Deletion of BmATG8 [CLS]  impaired localization of cytosolic components to the vacuole under nitrogen starvation, suggesting that autophagy was deficient in the null"}
{"subject": "Deletion", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28800850.json", "snippet": " maydis, we constructed null mutants of BmATG8, an orthologue of the Saccharomyces cerevisiae autophagy gene ATG8 in B. maydis.  [CLS] Deletion of BmATG8 impaired [CLS]  localization of cytosolic components to the vacuole under nitrogen starvation, suggesting that autophagy was deficient in the null mutants."}
{"subject": "localization", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-28800850.json", "snippet": " null mutants of BmATG8, an orthologue of the Saccharomyces cerevisiae autophagy gene ATG8 in B. maydis. Deletion of BmATG8  [CLS] impaired localization [CLS]  of cytosolic components to the vacuole under nitrogen starvation, suggesting that autophagy was deficient in the null mutants. Additionally,"}
{"subject": "Deletion", "sub_type": "Var", "rel": "CauseOf", "object": "deficient", "obj_type": "NegReg", "file_name": "PubMed-28800850.json", "snippet": " maydis, we constructed null mutants of BmATG8, an orthologue of the Saccharomyces cerevisiae autophagy gene ATG8 in B. maydis.  [CLS] Deletion of BmATG8 impaired localization of cytosolic components to the vacuole under nitrogen starvation, suggesting that autophagy was deficient [CLS]  in the null mutants. Additionally, fluorescent microscopic observations on a eGFP-fused BmATG8 expressing strain showed that BmATG8 is associated"}
{"subject": "autophagy", "sub_type": "CPA", "rel": "ThemeOf", "object": "deficient", "obj_type": "NegReg", "file_name": "PubMed-28800850.json", "snippet": " in B. maydis. Deletion of BmATG8 impaired localization of cytosolic components to the vacuole under nitrogen starvation, suggesting that  [CLS] autophagy was deficient [CLS]  in the null mutants. Additionally, fluorescent microscopic observations on a eGFP-fused BmATG8 expressing strain showed that BmATG8 is associated"}
{"subject": "\u0394", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-28800850.json", "snippet": " microscopic observations on a eGFP-fused BmATG8 expressing strain showed that BmATG8 is associated with autophagy-related structures. In vegetative growth,  [CLS] \u0394BmATG8 strains showed a reduction [CLS]  in conidiation and aerial mycelial growth. Interestingly, the mutant conidia indicated loss of the germination rate under starvation conditions"}
{"subject": "BmATG8", "sub_type": "Gene", "rel": "ThemeOf", "object": "\u0394", "obj_type": "Var", "file_name": "PubMed-28800850.json", "snippet": " microscopic observations on a eGFP-fused BmATG8 expressing strain showed that BmATG8 is associated with autophagy-related structures. In vegetative growth,  [CLS] \u0394BmATG8 [CLS]  strains showed a reduction in conidiation and aerial mycelial growth. Interestingly, the mutant conidia indicated loss of the germination"}
{"subject": "conidiation and aerial mycelial growth", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-28800850.json", "snippet": " eGFP-fused BmATG8 expressing strain showed that BmATG8 is associated with autophagy-related structures. In vegetative growth, \u0394BmATG8 strains showed a  [CLS] reduction in conidiation and aerial mycelial growth [CLS] . Interestingly, the mutant conidia indicated loss of the germination rate under starvation conditions and affected longevity. However, germinated mutant"}
{"subject": "haploinsufficiency", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " TCF4.\nPitt-Hopkins syndrome is a neurodevelopmental disorder characterized by severe intellectual disability and a distinctive facial gestalt. It is  [CLS] caused by haploinsufficiency [CLS]  of the TCF4 gene. The TCF4 protein has different functional domains, with the NLS (nuclear localization signal) domain coded"}
{"subject": "partial gene deletion", "sub_type": "Var", "rel": "CauseOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " certain loss-of-function variants disrupting TCF4 are associated with mild ID, but not with typical PTHS. We describe a frameshift-causing  [CLS] partial gene deletion encompassing exons 4-6 of TCF4 in an adult patient with [CLS]  mild ID and nonspecific facial dysmorphisms but without the typical features of PTHS, and a c.520C\u00a0>\u00a0T nonsense variant within"}
{"subject": "mild ID", "sub_type": "Disease", "rel": "ThemeOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " with typical PTHS. We describe a frameshift-causing partial gene deletion encompassing exons 4-6 of TCF4 in an adult patient  [CLS] with mild ID [CLS]  and nonspecific facial dysmorphisms but without the typical features of PTHS, and a c.520C\u00a0>\u00a0T nonsense variant within exon 8"}
{"subject": "c.520C\u00a0>\u00a0T", "sub_type": "Var", "rel": "CauseOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " an adult patient with mild ID and nonspecific facial dysmorphisms but without the typical features of PTHS, and a  [CLS] c.520C\u00a0>\u00a0T nonsense variant within exon 8 in a child presenting with [CLS]  a severe phenotype largely mimicking PTHS, but lacking the typical facial dysmorphism. Investigation on mRNA, along with literature review,"}
{"subject": "PTHS", "sub_type": "Disease", "rel": "ThemeOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " but without the typical features of PTHS, and a c.520C\u00a0>\u00a0T nonsense variant within exon 8 in a child presenting  [CLS] with a severe phenotype largely mimicking PTHS [CLS] , but lacking the typical facial dysmorphism. Investigation on mRNA, along with literature review, led us to suggest a preliminary"}
{"subject": "Pitt-Hopkins syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " [CLS] Pitt-Hopkins syndrome is a neurodevelopmental disorder characterized by severe intellectual disability and a distinctive facial gestalt. It is caused by [CLS]  haploinsufficiency of the TCF4 gene. The TCF4 protein has different functional domains, with the NLS (nuclear localization signal) domain"}
{"subject": "TCF4", "sub_type": "Gene", "rel": "ThemeOf", "object": "haploinsufficiency", "obj_type": "Var", "file_name": "PubMed-28807867.json", "snippet": " syndrome is a neurodevelopmental disorder characterized by severe intellectual disability and a distinctive facial gestalt. It is caused by  [CLS] haploinsufficiency of the TCF4 [CLS]  gene. The TCF4 protein has different functional domains, with the NLS (nuclear localization signal) domain coded by exons 7-8"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "disrupting", "obj_type": "NegReg", "file_name": "PubMed-28807867.json", "snippet": " of the remaining domains contributes to the final phenotype is not clear. There is recent evidence that certain loss-of-function  [CLS] variants disrupting [CLS]  TCF4 are associated with mild ID, but not with typical PTHS. We describe a frameshift-causing partial gene deletion encompassing"}
{"subject": "TCF4", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28807867.json", "snippet": " of the remaining domains contributes to the final phenotype is not clear. There is recent evidence that certain loss-of-function  [CLS] variants disrupting TCF4 [CLS]  are associated with mild ID, but not with typical PTHS. We describe a frameshift-causing partial gene deletion encompassing exons"}
{"subject": "mild ID", "sub_type": "Disease", "rel": "ThemeOf", "object": "disrupting", "obj_type": "NegReg", "file_name": "PubMed-28807867.json", "snippet": " the remaining domains contributes to the final phenotype is not clear. There is recent evidence that certain loss-of-function variants  [CLS] disrupting TCF4 are associated with mild ID [CLS] , but not with typical PTHS. We describe a frameshift-causing partial gene deletion encompassing exons 4-6 of TCF4 in an"}
{"subject": "frameshift", "sub_type": "Var", "rel": "CauseOf", "object": "causing", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " that certain loss-of-function variants disrupting TCF4 are associated with mild ID, but not with typical PTHS. We describe a  [CLS] frameshift-causing [CLS]  partial gene deletion encompassing exons 4-6 of TCF4 in an adult patient with mild ID and nonspecific facial dysmorphisms"}
{"subject": "partial gene deletion", "sub_type": "Var", "rel": "ThemeOf", "object": "causing", "obj_type": "Reg", "file_name": "PubMed-28807867.json", "snippet": " that certain loss-of-function variants disrupting TCF4 are associated with mild ID, but not with typical PTHS. We describe a frameshift- [CLS] causing partial gene deletion [CLS]  encompassing exons 4-6 of TCF4 in an adult patient with mild ID and nonspecific facial dysmorphisms but without the"}
{"subject": "TCF4", "sub_type": "Gene", "rel": "ThemeOf", "object": "partial gene deletion", "obj_type": "Var", "file_name": "PubMed-28807867.json", "snippet": " certain loss-of-function variants disrupting TCF4 are associated with mild ID, but not with typical PTHS. We describe a frameshift-causing  [CLS] partial gene deletion encompassing exons 4-6 of TCF4 [CLS]  in an adult patient with mild ID and nonspecific facial dysmorphisms but without the typical features of PTHS, and"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-28817352.json", "snippet": " a cleft at birth. Collectively, our data demonstrate that ARHGAP29 is required for embryonic survival and that heterozygosity for  [CLS] LoF variants [CLS]  of Arhgap29 increases the incidence and length of oral adhesions at a critical time point during orofacial development. In"}
{"subject": "Arhgap29", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28817352.json", "snippet": " cleft at birth. Collectively, our data demonstrate that ARHGAP29 is required for embryonic survival and that heterozygosity for LoF  [CLS] variants of Arhgap29 [CLS]  increases the incidence and length of oral adhesions at a critical time point during orofacial development. In conclusion, we"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-28817352.json", "snippet": " cleft at birth. Collectively, our data demonstrate that ARHGAP29 is required for embryonic survival and that heterozygosity for LoF  [CLS] variants of Arhgap29 increases [CLS]  the incidence and length of oral adhesions at a critical time point during orofacial development. In conclusion, we validate"}
{"subject": "incidence and length of oral adhesions at a critical time point during orofacial development", "sub_type": "CPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-28817352.json", "snippet": " Collectively, our data demonstrate that ARHGAP29 is required for embryonic survival and that heterozygosity for LoF variants of Arhgap29  [CLS] increases the incidence and length of oral adhesions at a critical time point during orofacial development [CLS] . In conclusion, we validate the LoF nature of the human K326X mutation in vivo and reveal a previously unknown"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28817352.json", "snippet": " Epithelial Adhesions.\nNonsyndromic cleft lip and/or palate (NSCL/P) is a prevalent birth defect of complex etiology. Previous studies identified  [CLS] mutations in ARHGAP29 associated [CLS]  with an increased risk for NSCL/P. To investigate the effects of ARHGAP29 in vivo, we generated a novel murine"}
{"subject": "NSCL/P", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28817352.json", "snippet": " cleft lip and/or palate (NSCL/P) is a prevalent birth defect of complex etiology. Previous studies identified mutations in ARHGAP29  [CLS] associated with an increased risk for NSCL/P [CLS] . To investigate the effects of ARHGAP29 in vivo, we generated a novel murine allele by inserting a point mutation"}
{"subject": "ARHGAP29", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28817352.json", "snippet": " Epithelial Adhesions.\nNonsyndromic cleft lip and/or palate (NSCL/P) is a prevalent birth defect of complex etiology. Previous studies identified  [CLS] mutations in ARHGAP29 [CLS]  associated with an increased risk for NSCL/P. To investigate the effects of ARHGAP29 in vivo, we generated a novel"}
{"subject": "single-nucleotide variation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28817352.json", "snippet": " vivo, we generated a novel murine allele by inserting a point mutation identified in a patient with NSCL/P. This  [CLS] single-nucleotide variation of ARHGAP29 translates to an early nonsense mutation (K326X), presumably resulting in loss-of-function [CLS]  (LoF). Embryos from Arhgap29(K326X/+) intercrosses were harvested at various time points. No homozygous Arhgap29(K326X) animals were found in the"}
{"subject": "K326X", "sub_type": "Var", "rel": "ThemeOf", "object": "single-nucleotide variation", "obj_type": "Var", "file_name": "PubMed-28817352.json", "snippet": " vivo, we generated a novel murine allele by inserting a point mutation identified in a patient with NSCL/P. This  [CLS] single-nucleotide variation of ARHGAP29 translates to an early nonsense mutation (K326X [CLS] ), presumably resulting in loss-of-function (LoF). Embryos from Arhgap29(K326X/+) intercrosses were harvested at various time points. No homozygous Arhgap29(K326X) animals"}
{"subject": "ARHGAP29", "sub_type": "Gene", "rel": "ThemeOf", "object": "single-nucleotide variation", "obj_type": "Var", "file_name": "PubMed-28817352.json", "snippet": " vivo, we generated a novel murine allele by inserting a point mutation identified in a patient with NSCL/P. This  [CLS] single-nucleotide variation of ARHGAP29 [CLS]  translates to an early nonsense mutation (K326X), presumably resulting in loss-of-function (LoF). Embryos from Arhgap29(K326X/+) intercrosses were harvested at"}
{"subject": "K326X mutation", "sub_type": "Var", "rel": "CauseOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-28817352.json", "snippet": " incidence and length of oral adhesions at a critical time point during orofacial development. In conclusion, we validate the  [CLS] LoF nature of the human K326X mutation [CLS]  in vivo and reveal a previously unknown effect of Arhgap29 in murine craniofacial development."}
{"subject": "craniofacial development", "sub_type": "CPA", "rel": "ThemeOf", "object": "LoF", "obj_type": "NegReg", "file_name": "PubMed-28817352.json", "snippet": " incidence and length of oral adhesions at a critical time point during orofacial development. In conclusion, we validate the  [CLS] LoF nature of the human K326X mutation in vivo and reveal a previously unknown effect of Arhgap29 in murine craniofacial development [CLS] ."}
{"subject": "Arhgap29", "sub_type": "Gene", "rel": "ThemeOf", "object": "K326X mutation", "obj_type": "Var", "file_name": "PubMed-28817352.json", "snippet": " adhesions at a critical time point during orofacial development. In conclusion, we validate the LoF nature of the human  [CLS] K326X mutation in vivo and reveal a previously unknown effect of Arhgap29 [CLS]  in murine craniofacial development."}
{"subject": "SLC40A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutations", "obj_type": "Var", "file_name": "PubMed-28826751.json", "snippet": " [CLS] SLC40A1 missense mutations [CLS]  found in suspected hemochromatosis type 4 patients.\nGenetic medicine applied to the study of hemochromatosis has identified the systemic"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-28826751.json", "snippet": " [CLS] missense mutations found [CLS]  in suspected hemochromatosis type 4 patients.\nGenetic medicine applied to the study of hemochromatosis has identified the systemic loop"}
{"subject": "hemochromatosis type 4", "sub_type": "Disease", "rel": "ThemeOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-28826751.json", "snippet": " [CLS] found in suspected hemochromatosis type 4 [CLS]  patients.\nGenetic medicine applied to the study of hemochromatosis has identified the systemic loop controlling iron homeostasis, centered on"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28833578.json", "snippet": " [CLS] mutations in filaggrin gene (FLG [CLS] ) have been suggested to increase the susceptibility of skin malignancies due to reduced levels of epidermal filaggrin and its"}
{"subject": "skin malignancies", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28833578.json", "snippet": " [CLS] Loss-of-function mutations in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies [CLS]  due to reduced levels of epidermal filaggrin and its degradation products, urocanic acid, which may be protective against ultraviolet"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28833578.json", "snippet": " [CLS] Loss-of-function mutations [CLS]  in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies due to reduced levels of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28833578.json", "snippet": " [CLS] mutations in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies due to reduced [CLS]  levels of epidermal filaggrin and its degradation products, urocanic acid, which may be protective against ultraviolet irradiation.\nOBJECTIVE: We"}
{"subject": "levels of epidermal filaggrin", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28833578.json", "snippet": "\nBACKGROUND: Loss-of-function mutations in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies due to  [CLS] reduced levels of epidermal filaggrin [CLS]  and its degradation products, urocanic acid, which may be protective against ultraviolet irradiation.\nOBJECTIVE: We aimed to investigate the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "degradation products", "obj_type": "MPA", "file_name": "PubMed-28833578.json", "snippet": " [CLS] mutations in filaggrin gene (FLG) have been suggested to increase the susceptibility of skin malignancies due to reduced levels of epidermal filaggrin and its degradation products [CLS] , urocanic acid, which may be protective against ultraviolet irradiation.\nOBJECTIVE: We aimed to investigate the association between FLG mutation"}
{"subject": "urocanic acid", "sub_type": "MPA", "rel": "ThemeOf", "object": "degradation products", "obj_type": "MPA", "file_name": "PubMed-28833578.json", "snippet": " have been suggested to increase the susceptibility of skin malignancies due to reduced levels of epidermal filaggrin and its  [CLS] degradation products, urocanic acid [CLS] , which may be protective against ultraviolet irradiation.\nOBJECTIVE: We aimed to investigate the association between FLG mutation status and"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " [CLS] gain-of-function mutation [CLS]  in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia.\nBACKGROUND: Most immune thrombocytopenia (ITP) is"}
{"subject": "\"cytokine-cytokine receptor interaction\" signal", "sub_type": "MPA", "rel": "ThemeOf", "object": "upregulated", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " potential pathologic p.G76S heterozygous mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring G76S mutation displayed  [CLS] upregulated \"cytokine-cytokine receptor interaction\" signal [CLS] , increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and enhanced binding capacity of APRIL ligand to B cells. Additionally,"}
{"subject": "serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " on the TNFRSF13B gene in familial ITP patients. ITP patients harboring G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal,  [CLS] increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels [CLS] , and enhanced binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the G76S mutation could"}
{"subject": "binding capacity of APRIL ligand to B cells", "sub_type": "Interaction", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " patients harboring G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal, increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and  [CLS] enhanced binding capacity of APRIL ligand to B cells [CLS] . Additionally, EBV-transformed B cells with the G76S mutation could induce human megakaryocyte line (Meg-01) apoptosis significantly.\nCONCLUSION: p.G76S mutation"}
{"subject": "human megakaryocyte line (Meg-01) apoptosis", "sub_type": "CPA", "rel": "ThemeOf", "object": "induce", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " and enhanced binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the G76S mutation could  [CLS] induce human megakaryocyte line (Meg-01) apoptosis [CLS]  significantly.\nCONCLUSION: p.G76S mutation on TNFRSF13B gene is responsible for ITP, and is a genetic predisposing factor for familial"}
{"subject": "G76S", "sub_type": "Var", "rel": "CauseOf", "object": "induce", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " and BAFF levels, and enhanced binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the  [CLS] G76S mutation could induce [CLS]  human megakaryocyte line (Meg-01) apoptosis significantly.\nCONCLUSION: p.G76S mutation on TNFRSF13B gene is responsible for ITP, and is a"}
{"subject": "p.G76S", "sub_type": "Var", "rel": "CauseOf", "object": "responsible", "obj_type": "Reg", "file_name": "PubMed-28834165.json", "snippet": " B cells. Additionally, EBV-transformed B cells with the G76S mutation could induce human megakaryocyte line (Meg-01) apoptosis significantly.\nCONCLUSION:  [CLS] p.G76S mutation on TNFRSF13B gene is responsible [CLS]  for ITP, and is a genetic predisposing factor for familial or sporadic ITP. This article is protected by copyright."}
{"subject": "ITP", "sub_type": "Disease", "rel": "ThemeOf", "object": "responsible", "obj_type": "Reg", "file_name": "PubMed-28834165.json", "snippet": " with the G76S mutation could induce human megakaryocyte line (Meg-01) apoptosis significantly.\nCONCLUSION: p.G76S mutation on TNFRSF13B gene is  [CLS] responsible for ITP [CLS] , and is a genetic predisposing factor for familial or sporadic ITP. This article is protected by copyright. All rights"}
{"subject": "TNFRSF13B", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.G76S", "obj_type": "Var", "file_name": "PubMed-28834165.json", "snippet": " B cells. Additionally, EBV-transformed B cells with the G76S mutation could induce human megakaryocyte line (Meg-01) apoptosis significantly.\nCONCLUSION:  [CLS] p.G76S mutation on TNFRSF13B [CLS]  gene is responsible for ITP, and is a genetic predisposing factor for familial or sporadic ITP. This article is"}
{"subject": "TNFRSF13B", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28834165.json", "snippet": " [CLS] mutation in TNFRSF13B [CLS]  is a candidate for predisposition to familial or sporadic immune thrombocytopenia.\nBACKGROUND: Most immune thrombocytopenia (ITP) is sporadic but"}
{"subject": "familial or sporadic immune thrombocytopenia", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " [CLS] gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia [CLS] .\nBACKGROUND: Most immune thrombocytopenia (ITP) is sporadic but a positive family history of ITP in some patients suggests that"}
{"subject": "TNFRSF13B", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.G76S", "obj_type": "Var", "file_name": "PubMed-28834165.json", "snippet": " the influence of potential pathogenic mutation on immune function and megakaryocyte apoptosis.\nRESULTS: Whole-exome sequencing identified a potential pathologic  [CLS] p.G76S heterozygous mutation on the TNFRSF13B [CLS]  gene in familial ITP patients. ITP patients harboring G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal, increased serum TNF\u03b1,"}
{"subject": "familial ITP", "sub_type": "Disease", "rel": "ThemeOf", "object": "pathologic", "obj_type": "Reg", "file_name": "PubMed-28834165.json", "snippet": " evaluated the influence of potential pathogenic mutation on immune function and megakaryocyte apoptosis.\nRESULTS: Whole-exome sequencing identified a potential  [CLS] pathologic p.G76S heterozygous mutation on the TNFRSF13B gene in familial ITP [CLS]  patients. ITP patients harboring G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal, increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF"}
{"subject": "p.G76S", "sub_type": "Var", "rel": "CauseOf", "object": "pathologic", "obj_type": "Reg", "file_name": "PubMed-28834165.json", "snippet": " evaluated the influence of potential pathogenic mutation on immune function and megakaryocyte apoptosis.\nRESULTS: Whole-exome sequencing identified a potential  [CLS] pathologic p.G76S [CLS]  heterozygous mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring G76S mutation displayed upregulated \"cytokine-cytokine receptor"}
{"subject": "G76S", "sub_type": "Var", "rel": "CauseOf", "object": "upregulated", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " sequencing identified a potential pathologic p.G76S heterozygous mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring  [CLS] G76S mutation displayed upregulated [CLS]  \"cytokine-cytokine receptor interaction\" signal, increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and enhanced binding capacity of APRIL ligand"}
{"subject": "G76S", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " sequencing identified a potential pathologic p.G76S heterozygous mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring  [CLS] G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal, increased [CLS]  serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and enhanced binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed"}
{"subject": "G76S", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28834165.json", "snippet": " sequencing identified a potential pathologic p.G76S heterozygous mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring  [CLS] G76S mutation displayed upregulated \"cytokine-cytokine receptor interaction\" signal, increased serum TNF\u03b1, IL-17\u03b1, IFN\u03b3 and BAFF levels, and enhanced [CLS]  binding capacity of APRIL ligand to B cells. Additionally, EBV-transformed B cells with the G76S mutation could induce human"}
{"subject": "S148C", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28836768.json", "snippet": " a lower energy concerted acyl substitution (TES148C), accounting for the gain-of-function and improved reaction kinetics. Finally, we introduced the  [CLS] S148C mutation into a polyketide synthase module (PikAIII-TE) to impart increased [CLS]  substrate flexibility, enabling the production of diastereomeric macrolactones."}
{"subject": "substrate flexibility", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28836768.json", "snippet": " gain-of-function and improved reaction kinetics. Finally, we introduced the S148C mutation into a polyketide synthase module (PikAIII-TE) to impart  [CLS] increased substrate flexibility [CLS] , enabling the production of diastereomeric macrolactones."}
{"subject": "production of diastereomeric macrolactones", "sub_type": "MPA", "rel": "ThemeOf", "object": "enabling", "obj_type": "PosReg", "file_name": "PubMed-28836768.json", "snippet": " reaction kinetics. Finally, we introduced the S148C mutation into a polyketide synthase module (PikAIII-TE) to impart increased substrate flexibility,  [CLS] enabling the production of diastereomeric macrolactones [CLS] ."}
{"subject": "S148C", "sub_type": "Var", "rel": "CauseOf", "object": "enabling", "obj_type": "PosReg", "file_name": "PubMed-28836768.json", "snippet": " a lower energy concerted acyl substitution (TES148C), accounting for the gain-of-function and improved reaction kinetics. Finally, we introduced the  [CLS] S148C mutation into a polyketide synthase module (PikAIII-TE) to impart increased substrate flexibility, enabling [CLS]  the production of diastereomeric macrolactones."}
{"subject": "rs151291296", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " 0.5% in a given population or located in close proximity to the CES1 active site. Five nsSNPs including L40Ter ( [CLS] rs151291296), G142E (rs121912777), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be loss-of-function [CLS]  variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and"}
{"subject": "rs151291296", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " and T290M (rs202001817) decreased CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter ( [CLS] rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly reduced [CLS]  CES1 protein and/or mRNA expressions in the transfected cells. Functions of the common nonsynonymous haplotypes D203E-A269S and S75N-D203E-A269S were"}
{"subject": "rs146456965", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " (rs202001817) decreased CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C ( [CLS] rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly reduced [CLS]  CES1 protein and/or mRNA expressions in the transfected cells. Functions of the common nonsynonymous haplotypes D203E-A269S and S75N-D203E-A269S were"}
{"subject": "rs148947808", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D ( [CLS] rs148947808), and R171C (rs201065375) significantly reduced [CLS]  CES1 protein and/or mRNA expressions in the transfected cells. Functions of the common nonsynonymous haplotypes D203E-A269S and S75N-D203E-A269S were"}
{"subject": "rs201065375", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C ( [CLS] rs201065375) significantly reduced [CLS]  CES1 protein and/or mRNA expressions in the transfected cells. Functions of the common nonsynonymous haplotypes D203E-A269S and S75N-D203E-A269S were"}
{"subject": "metabolizing", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " site. Five nsSNPs including L40Ter (rs151291296), G142E (rs121912777), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be  [CLS] loss-of-function variants for metabolizing [CLS]  the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased"}
{"subject": "CES1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "metabolizing", "obj_type": "MPA", "file_name": "PubMed-28838926.json", "snippet": " including L40Ter (rs151291296), G142E (rs121912777), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be loss-of-function variants for  [CLS] metabolizing the CES1 [CLS]  substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased CES1 activity"}
{"subject": "CES1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-28838926.json", "snippet": " the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased  [CLS] CES1 activity [CLS]  to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817)  [CLS] decreased CES1 activity [CLS]  to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and"}
{"subject": "CES1 protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly  [CLS] reduced CES1 protein [CLS]  and/or mRNA expressions in the transfected cells. Functions of the common nonsynonymous haplotypes D203E-A269S and S75N-D203E-A269S were evaluated using"}
{"subject": "mRNA expressions", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) significantly  [CLS] reduced CES1 protein and/or mRNA expressions [CLS]  in the transfected cells. Functions of the common nonsynonymous haplotypes D203E-A269S and S75N-D203E-A269S were evaluated using cells stably expressing"}
{"subject": "rs121912777", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " a given population or located in close proximity to the CES1 active site. Five nsSNPs including L40Ter (rs151291296), G142E ( [CLS] rs121912777), G147C (rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be loss-of-function [CLS]  variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and"}
{"subject": "rs146456965", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " population or located in close proximity to the CES1 active site. Five nsSNPs including L40Ter (rs151291296), G142E (rs121912777), G147C ( [CLS] rs146456965), Y170D (rs148947808), and R171C (rs201065375) were found to be loss-of-function [CLS]  variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and"}
{"subject": "rs148947808", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " located in close proximity to the CES1 active site. Five nsSNPs including L40Ter (rs151291296), G142E (rs121912777), G147C (rs146456965), Y170D ( [CLS] rs148947808), and R171C (rs201065375) were found to be loss-of-function [CLS]  variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and"}
{"subject": "rs201065375", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " proximity to the CES1 active site. Five nsSNPs including L40Ter (rs151291296), G142E (rs121912777), G147C (rs146456965), Y170D (rs148947808), and R171C ( [CLS] rs201065375) were found to be loss-of-function [CLS]  variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and"}
{"subject": "rs202121317", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " (rs201065375) were found to be loss-of-function variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V ( [CLS] rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased [CLS]  CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D"}
{"subject": "rs2307243", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " found to be loss-of-function variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H ( [CLS] rs2307243), E220G (rs200707504), and T290M (rs202001817) decreased [CLS]  CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D"}
{"subject": "rs200707504", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " be loss-of-function variants for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G ( [CLS] rs200707504), and T290M (rs202001817) decreased [CLS]  CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D"}
{"subject": "rs202001817", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28838926.json", "snippet": " for metabolizing the CES1 substrates clopidogrel, enalapril, and sacubitril. Additionally, the A158V (rs202121317), R199H (rs2307243), E220G (rs200707504), and T290M ( [CLS] rs202001817) decreased [CLS]  CES1 activity to a lesser extent in a substrate-dependent manner. Several nsSNPs including the L40Ter (rs151291296), G147C (rs146456965), Y170D"}
{"subject": "Progranulin", "sub_type": "Protein", "rel": "ThemeOf", "object": "haploinsufficiency", "obj_type": "Var", "file_name": "PubMed-28845019.json", "snippet": " [CLS] Progranulin haploinsufficiency [CLS]  reduces amyloid beta deposition in Alzheimer's disease model mice.\nGranulin (Grn) mutations were identified in familial frontotemporal lobar degeneration"}
{"subject": "Grn", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28845019.json", "snippet": " of functional progranulin (PGRN) protein. Thus, these mutations are strongly involved in FTLD pathogenesis. Moreover, recent findings indicate that  [CLS] Grn mutations [CLS]  are associated with other neurodegenerative disorders with tau pathology, including Alzheimer's disease. To investigate the influence of PGRN on"}
{"subject": "Alzheimer's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28845019.json", "snippet": " (PGRN) protein. Thus, these mutations are strongly involved in FTLD pathogenesis. Moreover, recent findings indicate that Grn mutations are  [CLS] associated with other neurodegenerative disorders with tau pathology, including Alzheimer's disease [CLS] . To investigate the influence of PGRN on amyloid beta (A\u03b2) accumulation, amyloid precursor protein (APP) transgenic mice were interbred"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-28845019.json", "snippet": " functional progranulin (PGRN) protein. Thus, these mutations are strongly involved in FTLD pathogenesis. Moreover, recent findings indicate that Grn  [CLS] mutations are associated [CLS]  with other neurodegenerative disorders with tau pathology, including Alzheimer's disease. To investigate the influence of PGRN on amyloid beta"}
{"subject": "PGRN", "sub_type": "Protein", "rel": "ThemeOf", "object": "haploinsufficiency", "obj_type": "Var", "file_name": "PubMed-28845019.json", "snippet": " the sarkosyl-insoluble fraction of 16-18-month-old APP/Grn+/- mice as compared with that of APP transgenic mice. Our data suggest that  [CLS] PGRN haploinsufficiency [CLS]  may decrease accumulation of A\u03b2."}
{"subject": "accumulation of A\u03b2", "sub_type": "MPA", "rel": "ThemeOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " of 16-18-month-old APP/Grn+/- mice as compared with that of APP transgenic mice. Our data suggest that PGRN haploinsufficiency may  [CLS] decrease accumulation of A\u03b2 [CLS] ."}
{"subject": "haploinsufficiency", "sub_type": "Var", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " sarkosyl-insoluble fraction of 16-18-month-old APP/Grn+/- mice as compared with that of APP transgenic mice. Our data suggest that PGRN  [CLS] haploinsufficiency may decrease [CLS]  accumulation of A\u03b2."}
{"subject": "amyloid beta deposition", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " [CLS] reduces amyloid beta deposition [CLS]  in Alzheimer's disease model mice.\nGranulin (Grn) mutations were identified in familial frontotemporal lobar degeneration (FTLD) patients with TAR"}
{"subject": "Alzheimer's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " [CLS] reduces amyloid beta deposition in Alzheimer's disease [CLS]  model mice.\nGranulin (Grn) mutations were identified in familial frontotemporal lobar degeneration (FTLD) patients with TAR DNA-binding protein of"}
{"subject": "haploinsufficiency", "sub_type": "Var", "rel": "CauseOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " [CLS] haploinsufficiency reduces [CLS]  amyloid beta deposition in Alzheimer's disease model mice.\nGranulin (Grn) mutations were identified in familial frontotemporal lobar degeneration (FTLD)"}
{"subject": "Grn", "sub_type": "Protein", "rel": "ThemeOf", "object": "haploinsufficiency", "obj_type": "Var", "file_name": "PubMed-28845019.json", "snippet": " mutations were identified in familial frontotemporal lobar degeneration (FTLD) patients with TAR DNA-binding protein of 43 kd (TDP-43) pathology.  [CLS] Grn transcript haploinsufficiency [CLS]  is proposed as a disease mechanism that leads to the loss of functional progranulin (PGRN) protein. Thus, these mutations"}
{"subject": "PGRN", "sub_type": "Protein", "rel": "ThemeOf", "object": "loss of functional", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " protein of 43 kd (TDP-43) pathology. Grn transcript haploinsufficiency is proposed as a disease mechanism that leads to the  [CLS] loss of functional progranulin (PGRN [CLS] ) protein. Thus, these mutations are strongly involved in FTLD pathogenesis. Moreover, recent findings indicate that Grn mutations are associated"}
{"subject": "FTLD", "sub_type": "Disease", "rel": "ThemeOf", "object": "involved", "obj_type": "Reg", "file_name": "PubMed-28845019.json", "snippet": " as a disease mechanism that leads to the loss of functional progranulin (PGRN) protein. Thus, these mutations are strongly  [CLS] involved in FTLD [CLS]  pathogenesis. Moreover, recent findings indicate that Grn mutations are associated with other neurodegenerative disorders with tau pathology, including Alzheimer's"}
{"subject": "haploinsufficiency", "sub_type": "Var", "rel": "CauseOf", "object": "loss of functional", "obj_type": "NegReg", "file_name": "PubMed-28845019.json", "snippet": " identified in familial frontotemporal lobar degeneration (FTLD) patients with TAR DNA-binding protein of 43 kd (TDP-43) pathology. Grn transcript  [CLS] haploinsufficiency is proposed as a disease mechanism that leads to the loss of functional [CLS]  progranulin (PGRN) protein. Thus, these mutations are strongly involved in FTLD pathogenesis. Moreover, recent findings indicate that Grn mutations"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "involved", "obj_type": "Reg", "file_name": "PubMed-28845019.json", "snippet": " haploinsufficiency is proposed as a disease mechanism that leads to the loss of functional progranulin (PGRN) protein. Thus, these  [CLS] mutations are strongly involved [CLS]  in FTLD pathogenesis. Moreover, recent findings indicate that Grn mutations are associated with other neurodegenerative disorders with tau pathology,"}
{"subject": "CUL3", "sub_type": "Gene", "rel": "ThemeOf", "object": "deleted", "obj_type": "Var", "file_name": "PubMed-28860350.json", "snippet": " and ZFP36L2, were validated as important tumour-suppressors specific to the OSCC subtype. We further identified their additional loss-of-function mechanisms.  [CLS] CUL3 was homozygously deleted [CLS]  specifically in OSCC and other squamous cell cancers (SCCs). Notably, ZFP36L2 is associated with super-enhancer in healthy oesophageal mucosa;"}
{"subject": "deleted", "sub_type": "Var", "rel": "CauseOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-28860350.json", "snippet": " validated as important tumour-suppressors specific to the OSCC subtype. We further identified their additional loss-of-function mechanisms. CUL3 was homozygously  [CLS] deleted specifically in [CLS]  OSCC and other squamous cell cancers (SCCs). Notably, ZFP36L2 is associated with super-enhancer in healthy oesophageal mucosa; DNA hypermethylation"}
{"subject": "OSCC", "sub_type": "Disease", "rel": "ThemeOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-28860350.json", "snippet": " important tumour-suppressors specific to the OSCC subtype. We further identified their additional loss-of-function mechanisms. CUL3 was homozygously deleted specifically  [CLS] in OSCC [CLS]  and other squamous cell cancers (SCCs). Notably, ZFP36L2 is associated with super-enhancer in healthy oesophageal mucosa; DNA hypermethylation in"}
{"subject": "squamous cell cancers", "sub_type": "Disease", "rel": "ThemeOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-28860350.json", "snippet": " important tumour-suppressors specific to the OSCC subtype. We further identified their additional loss-of-function mechanisms. CUL3 was homozygously deleted specifically  [CLS] in OSCC and other squamous cell cancers [CLS]  (SCCs). Notably, ZFP36L2 is associated with super-enhancer in healthy oesophageal mucosa; DNA hypermethylation in its super-enhancer reduced active histone"}
{"subject": "PIK3CA", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.3140 A\u00a0>\u00a0G", "obj_type": "Var", "file_name": "PubMed-28867506.json", "snippet": " the lower limb showed a lipoblastoma of the right thigh. A mosaic gain-of-function mutation in the catalytic domain of  [CLS] PIK3CA (c.3140 A\u00a0>\u00a0G [CLS] ; p.His1047Arg) was detected in the adipose tissue and in skin cultured fibroblasts from the macrodactyly but not in blood."}
{"subject": "PIK3CA", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.His1047Arg", "obj_type": "Var", "file_name": "PubMed-28867506.json", "snippet": " the lower limb showed a lipoblastoma of the right thigh. A mosaic gain-of-function mutation in the catalytic domain of  [CLS] PIK3CA (c.3140 A\u00a0>\u00a0G; p.His1047Arg [CLS] ) was detected in the adipose tissue and in skin cultured fibroblasts from the macrodactyly but not in blood. The"}
{"subject": "c.3140 A\u00a0>\u00a0G", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28867506.json", "snippet": " foot, and mild intellectual disability. Imaging of the lower limb showed a lipoblastoma of the right thigh. A mosaic  [CLS] gain-of-function mutation in the catalytic domain of PIK3CA (c.3140 A\u00a0>\u00a0G [CLS] ; p.His1047Arg) was detected in the adipose tissue and in skin cultured fibroblasts from the macrodactyly but not in blood."}
{"subject": "p.His1047Arg", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28867506.json", "snippet": " foot, and mild intellectual disability. Imaging of the lower limb showed a lipoblastoma of the right thigh. A mosaic  [CLS] gain-of-function mutation in the catalytic domain of PIK3CA (c.3140 A\u00a0>\u00a0G; p.His1047Arg [CLS] ) was detected in the adipose tissue and in skin cultured fibroblasts from the macrodactyly but not in blood. The"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "damaged", "obj_type": "NegReg", "file_name": "PubMed-28886269.json", "snippet": " However, 4 of the 5 mutations were present in unaffected mothers, indicating that their penetrance is incomplete. Interestingly, 1  [CLS] mutation damaged [CLS]  a predicted sumoylation site, and another disrupted a predicted CK1 phosphorylation site. Overexpression assays in zebrafish and reporter assays"}
{"subject": "sumoylation site", "sub_type": "MPA", "rel": "ThemeOf", "object": "damaged", "obj_type": "NegReg", "file_name": "PubMed-28886269.json", "snippet": " 4 of the 5 mutations were present in unaffected mothers, indicating that their penetrance is incomplete. Interestingly, 1 mutation  [CLS] damaged a predicted sumoylation site [CLS] , and another disrupted a predicted CK1 phosphorylation site. Overexpression assays in zebrafish and reporter assays in vitro indicated that"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "disrupted", "obj_type": "NegReg", "file_name": "PubMed-28886269.json", "snippet": " However, 4 of the 5 mutations were present in unaffected mothers, indicating that their penetrance is incomplete. Interestingly, 1  [CLS] mutation damaged a predicted sumoylation site, and another disrupted [CLS]  a predicted CK1 phosphorylation site. Overexpression assays in zebrafish and reporter assays in vitro indicated that 4 variants were"}
{"subject": "CK1 phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "disrupted", "obj_type": "NegReg", "file_name": "PubMed-28886269.json", "snippet": " in unaffected mothers, indicating that their penetrance is incomplete. Interestingly, 1 mutation damaged a predicted sumoylation site, and another  [CLS] disrupted a predicted CK1 phosphorylation [CLS]  site. Overexpression assays in zebrafish and reporter assays in vitro indicated that 4 variants were functionally null or hypomorphic,"}
{"subject": "GRHL3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28886269.json", "snippet": " were functionally null or hypomorphic, while 1 was dominant negative. This study provides evidence that, as in Caucasian populations,  [CLS] mutations in GRHL3 [CLS]  contribute to the risk of nonsyndromic CPO in the African population."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "risk", "obj_type": "Reg", "file_name": "PubMed-28886269.json", "snippet": " were functionally null or hypomorphic, while 1 was dominant negative. This study provides evidence that, as in Caucasian populations,  [CLS] mutations in GRHL3 contribute to the risk [CLS]  of nonsyndromic CPO in the African population."}
{"subject": "CPO", "sub_type": "Disease", "rel": "ThemeOf", "object": "risk", "obj_type": "Reg", "file_name": "PubMed-28886269.json", "snippet": " 1 was dominant negative. This study provides evidence that, as in Caucasian populations, mutations in GRHL3 contribute to the  [CLS] risk of nonsyndromic CPO [CLS]  in the African population."}
{"subject": "apolipoprotein C-III", "sub_type": "Protein", "rel": "ThemeOf", "object": "Gln38Lys", "obj_type": "Var", "file_name": "PubMed-28887372.json", "snippet": " [CLS] apolipoprotein C-III (Gln38Lys [CLS] ) variant associated with human hypertriglyceridemia is a gain-of-function mutation.\nRecent cell culture and animal studies have suggested that expression"}
{"subject": "C3QK", "sub_type": "Var", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " increase in DNL and expression of lipogenic genes as compared with that in C3WT mice. These results suggest that  [CLS] C3QK variant is a gain-of-function mutation that can stimulate VLDL1 production, through enhanced [CLS]  DNL."}
{"subject": "Gln38Lys", "sub_type": "Var", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " [CLS] Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function [CLS]  mutation.\nRecent cell culture and animal studies have suggested that expression of human apo C-III in the liver has"}
{"subject": "human hypertriglyceridemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " [CLS] human hypertriglyceridemia is a gain-of-function [CLS]  mutation.\nRecent cell culture and animal studies have suggested that expression of human apo C-III in the liver has"}
{"subject": "DNL", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " and FA were increased in C3QK mice as compared with C3WT mice. Liver of C3QK mice also displayed an  [CLS] increase in DNL [CLS]  and expression of lipogenic genes as compared with that in C3WT mice. These results suggest that C3QK variant is"}
{"subject": "lipogenic genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-28887372.json", "snippet": " in C3QK mice as compared with C3WT mice. Liver of C3QK mice also displayed an increase in DNL and  [CLS] expression of lipogenic genes [CLS]  as compared with that in C3WT mice. These results suggest that C3QK variant is a gain-of-function mutation that can"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " and FA were increased in C3QK mice as compared with C3WT mice. Liver of C3QK mice also displayed an  [CLS] increase in DNL and expression [CLS]  of lipogenic genes as compared with that in C3WT mice. These results suggest that C3QK variant is a gain-of-function"}
{"subject": "VLDL1 production", "sub_type": "MPA", "rel": "ThemeOf", "object": "stimulate", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " as compared with that in C3WT mice. These results suggest that C3QK variant is a gain-of-function mutation that can  [CLS] stimulate VLDL1 production [CLS] , through enhanced DNL."}
{"subject": "DNL", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " in C3WT mice. These results suggest that C3QK variant is a gain-of-function mutation that can stimulate VLDL1 production, through  [CLS] enhanced DNL [CLS] ."}
{"subject": "C3QK", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " of TAG, cholesterol, cholesteryl ester, and FA were increased in C3QK mice as compared with C3WT mice. Liver of  [CLS] C3QK mice also displayed an increase [CLS]  in DNL and expression of lipogenic genes as compared with that in C3WT mice. These results suggest that C3QK"}
{"subject": "C3QK", "sub_type": "Var", "rel": "ThemeOf", "object": "stimulate", "obj_type": "PosReg", "file_name": "PubMed-28887372.json", "snippet": " increase in DNL and expression of lipogenic genes as compared with that in C3WT mice. These results suggest that  [CLS] C3QK variant is a gain-of-function mutation that can stimulate [CLS]  VLDL1 production, through enhanced DNL."}
{"subject": "KCNK3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28889099.json", "snippet": " Heterozygous KCNK3 Mutations Associated With Pulmonary Arterial Hypertension on Channel Function and Pharmacological Recovery.\nBACKGROUND: Heterozygous loss of function  [CLS] mutations in the KCNK3 [CLS]  gene cause hereditary pulmonary arterial hypertension (PAH). KCNK3 encodes an acid-sensitive potassium channel, which contributes to the resting potential"}
{"subject": "pulmonary arterial hypertension", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28889099.json", "snippet": " Pulmonary Arterial Hypertension on Channel Function and Pharmacological Recovery.\nBACKGROUND: Heterozygous loss of function mutations in the KCNK3 gene  [CLS] cause hereditary pulmonary arterial hypertension [CLS]  (PAH). KCNK3 encodes an acid-sensitive potassium channel, which contributes to the resting potential of human pulmonary artery smooth muscle"}
{"subject": "channel function", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28889099.json", "snippet": " of select KCNK3 mutations when the 2 channel subunits co-assemble.\nCONCLUSIONS: Heterozygous KCNK3 mutations in PAH lead to variable  [CLS] loss of channel function [CLS]  via distinct mechanisms. Homomeric and heterodimeric mutant KCNK3 channels represent novel therapeutic substrates in PAH. Pharmacological and pH-dependent activation"}
{"subject": "KCNK3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28889099.json", "snippet": " functional studies that KCNK9 minimizes the impact of select KCNK3 mutations when the 2 channel subunits co-assemble.\nCONCLUSIONS: Heterozygous  [CLS] KCNK3 mutations [CLS]  in PAH lead to variable loss of channel function via distinct mechanisms. Homomeric and heterodimeric mutant KCNK3 channels represent"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28889099.json", "snippet": " Heterozygous KCNK3 Mutations Associated With Pulmonary Arterial Hypertension on Channel Function and Pharmacological Recovery.\nBACKGROUND: Heterozygous loss of function  [CLS] mutations in the KCNK3 gene cause [CLS]  hereditary pulmonary arterial hypertension (PAH). KCNK3 encodes an acid-sensitive potassium channel, which contributes to the resting potential of human"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28889099.json", "snippet": " studies that KCNK9 minimizes the impact of select KCNK3 mutations when the 2 channel subunits co-assemble.\nCONCLUSIONS: Heterozygous KCNK3  [CLS] mutations in PAH lead to variable loss [CLS]  of channel function via distinct mechanisms. Homomeric and heterodimeric mutant KCNK3 channels represent novel therapeutic substrates in PAH. Pharmacological"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28890134.json", "snippet": " [CLS] loss-of-function (LOF) mutations [CLS]  in the human progranulin gene (GRN) cause frontotemporal lobar degeneration (FTLD) by a mechanism of haploinsufficiency. Patients present most"}
{"subject": "GRN", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28890134.json", "snippet": " [CLS] mutations in the human progranulin gene (GRN [CLS] ) cause frontotemporal lobar degeneration (FTLD) by a mechanism of haploinsufficiency. Patients present most frequently with frontotemporal dementia, which is"}
{"subject": "frontotemporal lobar degeneration", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28890134.json", "snippet": " [CLS] loss-of-function (LOF) mutations in the human progranulin gene (GRN) cause frontotemporal lobar degeneration [CLS]  (FTLD) by a mechanism of haploinsufficiency. Patients present most frequently with frontotemporal dementia, which is the second most common"}
{"subject": "SETD5", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-28905509.json", "snippet": " [CLS] SETD5 loss-of-function variant [CLS]  as a cause for intellectual disability in a 10-year old boy with an aberrant blind ending bronchus.\nAlthough rare,"}
{"subject": "intellectual disability", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28905509.json", "snippet": " [CLS] loss-of-function variant as a cause for intellectual disability [CLS]  in a 10-year old boy with an aberrant blind ending bronchus.\nAlthough rare, 3p microdeletion cases have been well"}
{"subject": "ID", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-28905509.json", "snippet": " and recent Whole Exome Sequencing (WES) studies have suggested that the SETD5 gene contributes significantly to the 3p25 phenotype.  [CLS] Loss-of-Function (LoF) variants in SETD5 are now considered a likely cause of ID [CLS] . We report here a patient with a frameshift LoF variant in exon 12 of SETD5. This patient has features"}
{"subject": "SETD5", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28905509.json", "snippet": " Whole Exome Sequencing (WES) studies have suggested that the SETD5 gene contributes significantly to the 3p25 phenotype. Loss-of-Function (LoF)  [CLS] variants in SETD5 [CLS]  are now considered a likely cause of ID. We report here a patient with a frameshift LoF variant in"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28905509.json", "snippet": " [CLS] loss-of-function variant [CLS]  as a cause for intellectual disability in a 10-year old boy with an aberrant blind ending bronchus.\nAlthough rare,"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-28905509.json", "snippet": " and recent Whole Exome Sequencing (WES) studies have suggested that the SETD5 gene contributes significantly to the 3p25 phenotype.  [CLS] Loss-of-Function (LoF) variants [CLS]  in SETD5 are now considered a likely cause of ID. We report here a patient with a frameshift LoF"}
{"subject": "STAT", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28914637.json", "snippet": " and activator of transcription gain-of-function primary immunodeficiency/immunodysregulation disorders.\nPURPOSE OF REVIEW: To describe primary immunodeficiencies caused by gain-of-function (GOF)  [CLS] mutations of signal transducer and activator of transcription (STAT [CLS] ) genes, a group of genetically determined disorders characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT"}
{"subject": "primary immunodeficiencies", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28914637.json", "snippet": " [CLS] primary immunodeficiencies caused by gain-of-function [CLS]  (GOF) mutations of signal transducer and activator of transcription (STAT) genes, a group of genetically determined disorders characterized by"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28914637.json", "snippet": " group of genetically determined disorders characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT FINDINGS: GOF  [CLS] mutations affecting STAT1 [CLS]  result in increased STAT tyrosine phosphorylation and secondarily increased response to STAT1-signaling cytokines, such as interferons. In contrast, STAT3"}
{"subject": "STAT tyrosine phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28914637.json", "snippet": " characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT FINDINGS: GOF mutations affecting STAT1 result in  [CLS] increased STAT tyrosine phosphorylation [CLS]  and secondarily increased response to STAT1-signaling cytokines, such as interferons. In contrast, STAT3 hyperactivity is not usually related to"}
{"subject": "response to STAT1-signaling cytokines", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28914637.json", "snippet": " in many cases, autoimmune manifestations.\nRECENT FINDINGS: GOF mutations affecting STAT1 result in increased STAT tyrosine phosphorylation and secondarily  [CLS] increased response to STAT1-signaling cytokines [CLS] , such as interferons. In contrast, STAT3 hyperactivity is not usually related to hyperphosphorylation but rather to increased STAT3-mediated transcriptional"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28914637.json", "snippet": " [CLS] gain-of-function (GOF) mutations [CLS]  of signal transducer and activator of transcription (STAT) genes, a group of genetically determined disorders characterized by susceptibility to"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28914637.json", "snippet": " group of genetically determined disorders characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT FINDINGS: GOF  [CLS] mutations affecting STAT1 result in increased [CLS]  STAT tyrosine phosphorylation and secondarily increased response to STAT1-signaling cytokines, such as interferons. In contrast, STAT3 hyperactivity is not"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28914637.json", "snippet": " group of genetically determined disorders characterized by susceptibility to infections and, in many cases, autoimmune manifestations.\nRECENT FINDINGS: GOF  [CLS] mutations affecting STAT1 result in increased STAT tyrosine phosphorylation and secondarily increased [CLS]  response to STAT1-signaling cytokines, such as interferons. In contrast, STAT3 hyperactivity is not usually related to hyperphosphorylation but rather"}
{"subject": "GNPTAB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.D76G", "obj_type": "Var", "file_name": "PubMed-28918368.json", "snippet": " GlcNAc-1-phosphotransferase, 13 Brazilian patients clinically and biochemical diagnosed for MLII or III alpha/beta were studied. By sequencing of genomic  [CLS] GNPTAB of the MLII and MLIII alpha/beta patients we identified six novel mutations: p.D76G [CLS] , p.S385L, p.Q278Kfs*3, p.H588Qfs*27, p.N642Lfs*10 and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28918368.json", "snippet": " whereas the mutant p.S385L is correctly transported to the cis-Golgi apparatus and proteolytically processed. Both mutations lead to complete  [CLS] loss of GlcNAc-1-phosphotransferase activity [CLS] , consistent with the severe clinical MLII phenotype of the patients. Our study expands the genotypic spectrum of MLII and"}
{"subject": "GNPTAB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.S385L", "obj_type": "Var", "file_name": "PubMed-28918368.json", "snippet": " GlcNAc-1-phosphotransferase, 13 Brazilian patients clinically and biochemical diagnosed for MLII or III alpha/beta were studied. By sequencing of genomic  [CLS] GNPTAB of the MLII and MLIII alpha/beta patients we identified six novel mutations: p.D76G, p.S385L [CLS] , p.Q278Kfs*3, p.H588Qfs*27, p.N642Lfs*10 and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor"}
{"subject": "GNPTAB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Q278Kfs*3", "obj_type": "Var", "file_name": "PubMed-28918368.json", "snippet": " GlcNAc-1-phosphotransferase, 13 Brazilian patients clinically and biochemical diagnosed for MLII or III alpha/beta were studied. By sequencing of genomic  [CLS] GNPTAB of the MLII and MLIII alpha/beta patients we identified six novel mutations: p.D76G, p.S385L, p.Q278Kfs*3 [CLS] , p.H588Qfs*27, p.N642Lfs*10 and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor p.D76G"}
{"subject": "GNPTAB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.H588Qfs*27", "obj_type": "Var", "file_name": "PubMed-28918368.json", "snippet": " GlcNAc-1-phosphotransferase, 13 Brazilian patients clinically and biochemical diagnosed for MLII or III alpha/beta were studied. By sequencing of genomic  [CLS] GNPTAB of the MLII and MLIII alpha/beta patients we identified six novel mutations: p.D76G, p.S385L, p.Q278Kfs*3, p.H588Qfs*27 [CLS] , p.N642Lfs*10 and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor p.D76G is"}
{"subject": "GNPTAB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.N642Lfs*10", "obj_type": "Var", "file_name": "PubMed-28918368.json", "snippet": " GlcNAc-1-phosphotransferase, 13 Brazilian patients clinically and biochemical diagnosed for MLII or III alpha/beta were studied. By sequencing of genomic  [CLS] GNPTAB of the MLII and MLIII alpha/beta patients we identified six novel mutations: p.D76G, p.S385L, p.Q278Kfs*3, p.H588Qfs*27, p.N642Lfs*10 [CLS]  and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor p.D76G is retained"}
{"subject": "GNPTAB", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Y1111*", "obj_type": "Var", "file_name": "PubMed-28918368.json", "snippet": " GlcNAc-1-phosphotransferase, 13 Brazilian patients clinically and biochemical diagnosed for MLII or III alpha/beta were studied. By sequencing of genomic  [CLS] GNPTAB of the MLII and MLIII alpha/beta patients we identified six novel mutations: p.D76G, p.S385L, p.Q278Kfs*3, p.H588Qfs*27, p.N642Lfs*10 and p.Y1111* [CLS] . Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor p.D76G is retained in the"}
{"subject": "p.D76G", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28918368.json", "snippet": " p.Q278Kfs*3, p.H588Qfs*27, p.N642Lfs*10 and p.Y1111*. Expression analysis by western blotting and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor  [CLS] p.D76G is retained in the endoplasmic reticulum whereas the mutant p.S385L is correctly transported to the cis-Golgi apparatus and proteolytically processed. Both mutations lead to complete loss [CLS]  of GlcNAc-1-phosphotransferase activity, consistent with the severe clinical MLII phenotype of the patients. Our study expands the genotypic spectrum"}
{"subject": "p.S385L", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-28918368.json", "snippet": " and immunofluorescence microscopy revealed that the mutant \u03b1\u2044\u03b2-subunit precursor p.D76G is retained in the endoplasmic reticulum whereas the mutant  [CLS] p.S385L is correctly transported to the cis-Golgi apparatus and proteolytically processed. Both mutations lead to complete loss [CLS]  of GlcNAc-1-phosphotransferase activity, consistent with the severe clinical MLII phenotype of the patients. Our study expands the genotypic spectrum"}
{"subject": "GlcNAc-1-phosphotransferase", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-28918368.json", "snippet": " mutant p.S385L is correctly transported to the cis-Golgi apparatus and proteolytically processed. Both mutations lead to complete loss of  [CLS] GlcNAc-1-phosphotransferase activity [CLS] , consistent with the severe clinical MLII phenotype of the patients. Our study expands the genotypic spectrum of MLII and"}
{"subject": "CACNA1C", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28921675.json", "snippet": " to schizophrenia, bipolar disorder and major depressive disorder: psychopathologies in which serotonin signaling has been implicated. Additionally, a gain-of-function  [CLS] mutation in CACNA1C [CLS]  is responsible for the neurodevelopmental disorder Timothy syndrome that presents with prominent behavioral features on the autism spectrum. Given"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28921675.json", "snippet": " linkages to schizophrenia, bipolar disorder and major depressive disorder: psychopathologies in which serotonin signaling has been implicated. Additionally, a  [CLS] gain-of-function mutation [CLS]  in CACNA1C is responsible for the neurodevelopmental disorder Timothy syndrome that presents with prominent behavioral features on the autism"}
{"subject": "Timothy syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28921675.json", "snippet": " linkages to schizophrenia, bipolar disorder and major depressive disorder: psychopathologies in which serotonin signaling has been implicated. Additionally, a  [CLS] gain-of-function mutation in CACNA1C is responsible for the neurodevelopmental disorder Timothy syndrome [CLS]  that presents with prominent behavioral features on the autism spectrum. Given an emerging role for serotonin in the etiology"}
{"subject": "Cdc7", "sub_type": "Gene", "rel": "ThemeOf", "object": "point mutation", "obj_type": "Var", "file_name": "PubMed-28924058.json", "snippet": " genome, which may be necessary to initiate other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead  [CLS] Cdc7 point mutation [CLS]  increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable to bind Dbf4, reduces"}
{"subject": "55-amino acid C-terminal truncation", "sub_type": "MPA", "rel": "ThemeOf", "object": "Cdc7", "obj_type": "Gene", "file_name": "PubMed-28924058.json", "snippet": " meiotic recombination and translesion synthesis. A kinase dead Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a  [CLS] 55-amino acid C-terminal truncation of Cdc7 [CLS] , unable to bind Dbf4, reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S"}
{"subject": "Cdc7", "sub_type": "Gene", "rel": "ThemeOf", "object": "bind", "obj_type": "Interaction", "file_name": "PubMed-28924058.json", "snippet": " A kinase dead Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of  [CLS] Cdc7, unable to bind [CLS]  Dbf4, reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation"}
{"subject": "point mutation", "sub_type": "Var", "rel": "CauseOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-28924058.json", "snippet": " which may be necessary to initiate other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead Cdc7  [CLS] point mutation increases [CLS]  the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable to bind Dbf4, reduces Cdc7"}
{"subject": "point mutation", "sub_type": "Var", "rel": "CauseOf", "object": "unable", "obj_type": "NegReg", "file_name": "PubMed-28924058.json", "snippet": " which may be necessary to initiate other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead Cdc7  [CLS] point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable [CLS]  to bind Dbf4, reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase."}
{"subject": "bind", "sub_type": "Interaction", "rel": "ThemeOf", "object": "unable", "obj_type": "NegReg", "file_name": "PubMed-28924058.json", "snippet": " kinase dead Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7,  [CLS] unable to bind [CLS]  Dbf4, reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation"}
{"subject": "Dbf4", "sub_type": "Gene", "rel": "ThemeOf", "object": "bind", "obj_type": "Interaction", "file_name": "PubMed-28924058.json", "snippet": " Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable to  [CLS] bind Dbf4 [CLS] , reduces Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates"}
{"subject": "unable", "sub_type": "NegReg", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28924058.json", "snippet": " kinase dead Cdc7 point mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7,  [CLS] unable to bind Dbf4, reduces [CLS]  Cdc7 binding suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates that"}
{"subject": "Cdc7", "sub_type": "Gene", "rel": "ThemeOf", "object": "binding", "obj_type": "Interaction", "file_name": "PubMed-28924058.json", "snippet": " increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable to bind Dbf4, reduces  [CLS] Cdc7 binding [CLS]  suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates that Cdc7 binding"}
{"subject": "binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "reduces", "obj_type": "NegReg", "file_name": "PubMed-28924058.json", "snippet": " mutation increases the Ty5 retrotransposon integration efficiency and a 55-amino acid C-terminal truncation of Cdc7, unable to bind Dbf4,  [CLS] reduces Cdc7 binding [CLS]  suggesting a requirement for Dbf4 to stabilize Cdc7 on chromatin during S phase. Chromatin immunoprecipitation demonstrates that Cdc7 binding"}
{"subject": "Ty5 retrotransposon integration efficiency", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-28924058.json", "snippet": " be necessary to initiate other cellular processes, including meiotic recombination and translesion synthesis. A kinase dead Cdc7 point mutation  [CLS] increases the Ty5 retrotransposon integration efficiency [CLS]  and a 55-amino acid C-terminal truncation of Cdc7, unable to bind Dbf4, reduces Cdc7 binding suggesting a requirement for"}
{"subject": "PTPN11", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28929581.json", "snippet": " [CLS] mutation in PTPN11 [CLS]  in histiocytic sarcomas of Bernese Mountain Dogs.\nHistiocytic sarcoma (HS) is an aggressive malignant neoplasm of dendritic cell origin"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28929581.json", "snippet": " [CLS] Gain-of-function mutation [CLS]  in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs.\nHistiocytic sarcoma (HS) is an aggressive malignant neoplasm of dendritic"}
{"subject": "histiocytic sarcomas", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28929581.json", "snippet": " [CLS] Gain-of-function mutation in PTPN11 in histiocytic sarcomas [CLS]  of Bernese Mountain Dogs.\nHistiocytic sarcoma (HS) is an aggressive malignant neoplasm of dendritic cell origin that is common"}
{"subject": "PTPN11", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K", "obj_type": "Var", "file_name": "PubMed-28929581.json", "snippet": " date, causative genetic events have not been reported. In addition, no driver mutations have been identified in tumours. Recently,  [CLS] E76K gain-of-function mutation in SHP2 encoded by the PTPN11 [CLS]  gene has been described in human histiocytic malignancies. In our study, we identified the PTPN11E76K in HS of BMDs."}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28929581.json", "snippet": " date, causative genetic events have not been reported. In addition, no driver mutations have been identified in tumours. Recently,  [CLS] E76K gain-of-function [CLS]  mutation in SHP2 encoded by the PTPN11 gene has been described in human histiocytic malignancies. In our study, we"}
{"subject": "histiocytic malignancies", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28929581.json", "snippet": " causative genetic events have not been reported. In addition, no driver mutations have been identified in tumours. Recently, E76K  [CLS] gain-of-function mutation in SHP2 encoded by the PTPN11 gene has been described in human histiocytic malignancies [CLS] . In our study, we identified the PTPN11E76K in HS of BMDs. Amplification of exon 3 of the PTPN11 gene"}
{"subject": "KIDINS220", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28934391.json", "snippet": " [CLS] KIDINS220 loss-of-function variants [CLS]  in fetuses with cerebral ventriculomegaly and limb contractures.\nHeterozygous mutations in KIDINS220 were recently suggested a cause of spastic"}
{"subject": "obesity", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28934391.json", "snippet": " KIDINS220 loss-of-function variants in fetuses with cerebral ventriculomegaly and limb contractures.\nHeterozygous mutations in KIDINS220 were recently suggested a  [CLS] cause of spastic paraplegia, intellectual disability, nystagmus and obesity [CLS] . All patients carried terminal nonsense de novo mutations that seemed to escape nonsense-mediated mRNA decay. The mechanism for pathogenicity"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28934391.json", "snippet": " [CLS] loss-of-function variants [CLS]  in fetuses with cerebral ventriculomegaly and limb contractures.\nHeterozygous mutations in KIDINS220 were recently suggested a cause of spastic"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "cerebral ventriculomegaly", "obj_type": "CPA", "file_name": "PubMed-28934391.json", "snippet": " [CLS] loss-of-function variants in fetuses with cerebral ventriculomegaly [CLS]  and limb contractures.\nHeterozygous mutations in KIDINS220 were recently suggested a cause of spastic paraplegia, intellectual disability, nystagmus and"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "limb contractures", "obj_type": "CPA", "file_name": "PubMed-28934391.json", "snippet": " [CLS] loss-of-function variants in fetuses with cerebral ventriculomegaly and limb contractures [CLS] .\nHeterozygous mutations in KIDINS220 were recently suggested a cause of spastic paraplegia, intellectual disability, nystagmus and obesity. All patients"}
{"subject": "KIDINS220", "sub_type": "Gene", "rel": "ThemeOf", "object": "Heterozygous mutations", "obj_type": "Var", "file_name": "PubMed-28934391.json", "snippet": " [CLS] Heterozygous mutations in KIDINS220 [CLS]  were recently suggested a cause of spastic paraplegia, intellectual disability, nystagmus and obesity. All patients carried terminal nonsense de"}
{"subject": "Heterozygous mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28934391.json", "snippet": " [CLS] Heterozygous mutations in KIDINS220 were recently suggested a cause [CLS]  of spastic paraplegia, intellectual disability, nystagmus and obesity. All patients carried terminal nonsense de novo mutations that seemed to"}
{"subject": "spastic paraplegia", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28934391.json", "snippet": " KIDINS220 loss-of-function variants in fetuses with cerebral ventriculomegaly and limb contractures.\nHeterozygous mutations in KIDINS220 were recently suggested a  [CLS] cause of spastic paraplegia [CLS] , intellectual disability, nystagmus and obesity. All patients carried terminal nonsense de novo mutations that seemed to escape nonsense-mediated mRNA"}
{"subject": "intellectual disability", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28934391.json", "snippet": " KIDINS220 loss-of-function variants in fetuses with cerebral ventriculomegaly and limb contractures.\nHeterozygous mutations in KIDINS220 were recently suggested a  [CLS] cause of spastic paraplegia, intellectual disability [CLS] , nystagmus and obesity. All patients carried terminal nonsense de novo mutations that seemed to escape nonsense-mediated mRNA decay. The"}
{"subject": "nystagmus", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28934391.json", "snippet": " KIDINS220 loss-of-function variants in fetuses with cerebral ventriculomegaly and limb contractures.\nHeterozygous mutations in KIDINS220 were recently suggested a  [CLS] cause of spastic paraplegia, intellectual disability, nystagmus [CLS]  and obesity. All patients carried terminal nonsense de novo mutations that seemed to escape nonsense-mediated mRNA decay. The mechanism"}
{"subject": "GNAS", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutation", "obj_type": "Var", "file_name": "PubMed-28939416.json", "snippet": " variants on HSC function must be validated. One variant that has been identified recurrently in CHIP is a gain-of-function  [CLS] missense mutation in the imprinted gene GNAS [CLS]  (Guanine Nucleotide Binding Protein, Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC"}
{"subject": "missense mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28939416.json", "snippet": " CHIP variants on HSC function must be validated. One variant that has been identified recurrently in CHIP is a  [CLS] gain-of-function missense mutation [CLS]  in the imprinted gene GNAS (Guanine Nucleotide Binding Protein, Alpha Stimulating). In this study, we examined the effect of"}
{"subject": "GNAS", "sub_type": "Gene", "rel": "ThemeOf", "object": "R201C", "obj_type": "Var", "file_name": "PubMed-28939416.json", "snippet": " Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression of  [CLS] GNASR201C [CLS]  supported transplantable HSC activity and improved lymphoid output in secondary recipients. Because declining lymphoid output is a hallmark of"}
{"subject": "CHIP", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28939416.json", "snippet": " biological impact of CHIP variants on HSC function must be validated. One variant that has been identified recurrently in  [CLS] CHIP is a gain-of-function [CLS]  missense mutation in the imprinted gene GNAS (Guanine Nucleotide Binding Protein, Alpha Stimulating). In this study, we examined the"}
{"subject": "R201C", "sub_type": "Var", "rel": "CauseOf", "object": "supported", "obj_type": "PosReg", "file_name": "PubMed-28939416.json", "snippet": " Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression of GNAS [CLS] R201C supported [CLS]  transplantable HSC activity and improved lymphoid output in secondary recipients. Because declining lymphoid output is a hallmark of aging,"}
{"subject": "transplantable HSC activity", "sub_type": "CPA", "rel": "ThemeOf", "object": "supported", "obj_type": "PosReg", "file_name": "PubMed-28939416.json", "snippet": " Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression of GNASR201C  [CLS] supported transplantable HSC activity [CLS]  and improved lymphoid output in secondary recipients. Because declining lymphoid output is a hallmark of aging, GNASR201C mutations may"}
{"subject": "lymphoid output", "sub_type": "CPA", "rel": "ThemeOf", "object": "improved", "obj_type": "PosReg", "file_name": "PubMed-28939416.json", "snippet": " examined the effect of the GNASR201C variant on HSC function. Ectopic expression of GNASR201C supported transplantable HSC activity and  [CLS] improved lymphoid output [CLS]  in secondary recipients. Because declining lymphoid output is a hallmark of aging, GNASR201C mutations may sustain lymphoid-biased HSCs over"}
{"subject": "R201C", "sub_type": "Var", "rel": "CauseOf", "object": "improved", "obj_type": "PosReg", "file_name": "PubMed-28939416.json", "snippet": " Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression of GNAS [CLS] R201C supported transplantable HSC activity and improved [CLS]  lymphoid output in secondary recipients. Because declining lymphoid output is a hallmark of aging, GNASR201C mutations may sustain lymphoid-biased"}
{"subject": "SCN4A", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutations", "obj_type": "Var", "file_name": "PubMed-28940424.json", "snippet": " of human skeletal muscle sodium channel causes paramyotonia congenita.\nKEY POINTS: Paramyotonia congenita is a hereditary channelopathy caused by  [CLS] missense mutations in the SCN4A [CLS]  gene, which encodes the \u03b1 subunit of the human skeletal muscle voltage-gated sodium channel NaV1.4. Affected individuals suffered from"}
{"subject": "N1366S", "sub_type": "Var", "rel": "CauseOf", "object": "accelerated", "obj_type": "PosReg", "file_name": "PubMed-28940424.json", "snippet": " recording revealed that the N1366S mutation led to significant alterations in the gating process of the NaV1.4 channel. The  [CLS] N1366S mutant displayed a cold-induced hyperpolarizing shift in the voltage dependence of activation and a depolarizing shift in fast inactivation, as well as a reduced rate of fast inactivation and accelerated [CLS]  recovery from fast inactivation. In addition, homology modelling and molecular dynamic simulation of N1366S and wild-type NaV1.4 channels indicated"}
{"subject": "fast inactivation", "sub_type": "MPA", "rel": "ThemeOf", "object": "rate", "obj_type": "MPA", "file_name": "PubMed-28940424.json", "snippet": " shift in the voltage dependence of activation and a depolarizing shift in fast inactivation, as well as a reduced  [CLS] rate of fast inactivation [CLS]  and accelerated recovery from fast inactivation. In addition, homology modelling and molecular dynamic simulation of N1366S and wild-type NaV1.4"}
{"subject": "rate", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28940424.json", "snippet": " hyperpolarizing shift in the voltage dependence of activation and a depolarizing shift in fast inactivation, as well as a  [CLS] reduced rate [CLS]  of fast inactivation and accelerated recovery from fast inactivation. In addition, homology modelling and molecular dynamic simulation of N1366S"}
{"subject": "fast inactivation", "sub_type": "MPA", "rel": "ThemeOf", "object": "recovery", "obj_type": "MPA", "file_name": "PubMed-28940424.json", "snippet": " activation and a depolarizing shift in fast inactivation, as well as a reduced rate of fast inactivation and accelerated  [CLS] recovery from fast inactivation [CLS] . In addition, homology modelling and molecular dynamic simulation of N1366S and wild-type NaV1.4 channels indicated that the arginine-to-serine substitution"}
{"subject": "recovery", "sub_type": "MPA", "rel": "ThemeOf", "object": "accelerated", "obj_type": "PosReg", "file_name": "PubMed-28940424.json", "snippet": " of activation and a depolarizing shift in fast inactivation, as well as a reduced rate of fast inactivation and  [CLS] accelerated recovery [CLS]  from fast inactivation. In addition, homology modelling and molecular dynamic simulation of N1366S and wild-type NaV1.4 channels indicated that"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28940424.json", "snippet": " [CLS] caused by missense mutations [CLS]  in the SCN4A gene, which encodes the \u03b1 subunit of the human skeletal muscle voltage-gated sodium channel NaV1.4. Affected"}
{"subject": "Paramyotonia congenita", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28940424.json", "snippet": " [CLS] Paramyotonia congenita is a hereditary channelopathy caused [CLS]  by missense mutations in the SCN4A gene, which encodes the \u03b1 subunit of the human skeletal muscle voltage-gated sodium"}
{"subject": "SCN4A", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutations", "obj_type": "Var", "file_name": "PubMed-28940424.json", "snippet": " pronounced paramyotonia congenita symptoms of these patients.\nABSTRACT: Paramyotonia congenita is an autosomal dominant skeletal muscle channelopathy caused by  [CLS] missense mutations in SCN4A [CLS] , the gene encoding the \u03b1 subunit of the human skeletal muscle voltage-gated sodium channel NaV1.4. We report a three-generation"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28940424.json", "snippet": " for the pronounced paramyotonia congenita symptoms of these patients.\nABSTRACT: Paramyotonia congenita is an autosomal dominant skeletal muscle channelopathy  [CLS] caused by missense mutations [CLS]  in SCN4A, the gene encoding the \u03b1 subunit of the human skeletal muscle voltage-gated sodium channel NaV1.4. We report"}
{"subject": "Paramyotonia congenita", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-28940424.json", "snippet": " temperature-sensitive alteration of N1366S channel activity may be responsible for the pronounced paramyotonia congenita symptoms of these patients.\nABSTRACT:  [CLS] Paramyotonia congenita is an autosomal dominant skeletal muscle channelopathy caused [CLS]  by missense mutations in SCN4A, the gene encoding the \u03b1 subunit of the human skeletal muscle voltage-gated sodium channel"}
{"subject": "N1366S", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28940424.json", "snippet": " indicated that the arginine-to-serine substitution disrupted the hydrogen bond formed between N1366 and R1454. Together, our results suggest that  [CLS] N1366S is a gain-of-function [CLS]  mutation of NaV1.4 at low temperature and the mutation may be responsible for the clinical symptoms of paramyotonia congenita"}
{"subject": "paramyotonia congenita", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28940424.json", "snippet": " arginine-to-serine substitution disrupted the hydrogen bond formed between N1366 and R1454. Together, our results suggest that N1366S is a  [CLS] gain-of-function mutation of NaV1.4 at low temperature and the mutation may be responsible for the clinical symptoms of paramyotonia congenita [CLS]  in the affected family and constitute a basis for studies into its pathogenesis."}
{"subject": "N1366S", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28940424.json", "snippet": " recording revealed that the N1366S mutation led to significant alterations in the gating process of the NaV1.4 channel. The  [CLS] N1366S mutant displayed a cold-induced hyperpolarizing shift in the voltage dependence of activation and a depolarizing shift in fast inactivation, as well as a reduced [CLS]  rate of fast inactivation and accelerated recovery from fast inactivation. In addition, homology modelling and molecular dynamic simulation of"}
{"subject": "NFIA", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-28941020.json", "snippet": " [CLS] variants in NFIA [CLS]  provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: A four patient series.\nThe association"}
{"subject": "1p32-p31 deletion syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28941020.json", "snippet": " [CLS] Loss-of-function variants in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome [CLS] : A four patient series.\nThe association between 1p32-p31 contiguous gene deletions and a distinct phenotype that includes anomalies of"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28941020.json", "snippet": " [CLS] Loss-of-function variants [CLS]  in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: A four patient series."}
{"subject": "CLCN7", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28942122.json", "snippet": " [CLS] mutations in CLCN7 [CLS] , which encodes a homodimeric chloride channel needed for matrix acidification by osteoclasts, cause Albers-Sch\u00f6nberg disease (also known as autosomal"}
{"subject": "p.F318L", "sub_type": "Var", "rel": "CauseOf", "object": "non", "obj_type": "NegReg", "file_name": "PubMed-28942122.json", "snippet": " negative mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout mice, which indicate that  [CLS] p.F318L mutant protein is non [CLS] -functional and p.F318L and p.G213R mutant proteins do not complement one another. Since it has been reported that treatment with"}
{"subject": "functional", "sub_type": "MPA", "rel": "ThemeOf", "object": "non", "obj_type": "NegReg", "file_name": "PubMed-28942122.json", "snippet": " Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout mice, which indicate that p.F318L mutant protein is  [CLS] non-functional [CLS]  and p.F318L and p.G213R mutant proteins do not complement one another. Since it has been reported that treatment with"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "p.F318L", "obj_type": "Var", "file_name": "PubMed-28942122.json", "snippet": " negative mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout mice, which indicate that  [CLS] p.F318L mutant protein [CLS]  is non-functional and p.F318L and p.G213R mutant proteins do not complement one another. Since it has been reported that"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "negative", "obj_type": "NegReg", "file_name": "PubMed-28942122.json", "snippet": " [CLS] negative mutations [CLS]  in CLCN7, which encodes a homodimeric chloride channel needed for matrix acidification by osteoclasts, cause Albers-Sch\u00f6nberg disease (also known"}
{"subject": "Albers-Sch\u00f6nberg disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "negative", "obj_type": "NegReg", "file_name": "PubMed-28942122.json", "snippet": " [CLS] negative mutations in CLCN7, which encodes a homodimeric chloride channel needed for matrix acidification by osteoclasts, cause Albers-Sch\u00f6nberg disease [CLS]  (also known as autosomal dominant osteopetrosis type 2). More than 25 different CLCN7 mutations have been identified in patients"}
{"subject": "Clcn7", "sub_type": "Gene", "rel": "ThemeOf", "object": "F318L", "obj_type": "Var", "file_name": "PubMed-28942122.json", "snippet": " different osteopetrosis-causing mutation (Clcn7F318L). Compared to Clcn7+/+ mice, 12-week-old Clcn7F318L/+ mice have significantly increased trabecular bone volume, consistent with  [CLS] Clcn7F318L [CLS]  acting as a dominant negative mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout"}
{"subject": "F318L", "sub_type": "Var", "rel": "CauseOf", "object": "negative", "obj_type": "NegReg", "file_name": "PubMed-28942122.json", "snippet": " different osteopetrosis-causing mutation (Clcn7F318L). Compared to Clcn7+/+ mice, 12-week-old Clcn7F318L/+ mice have significantly increased trabecular bone volume, consistent with Clcn7 [CLS] F318L acting as a dominant negative [CLS]  mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout mice, which indicate that p.F318L"}
{"subject": "negative", "sub_type": "NegReg", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28942122.json", "snippet": " we describe a mouse with a different osteopetrosis-causing mutation (Clcn7F318L). Compared to Clcn7+/+ mice, 12-week-old Clcn7F318L/+ mice have significantly  [CLS] increased trabecular bone volume, consistent with Clcn7F318L acting as a dominant negative [CLS]  mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and resemble Clcn7 knockout mice, which indicate that p.F318L"}
{"subject": "trabecular bone volume", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-28942122.json", "snippet": " we describe a mouse with a different osteopetrosis-causing mutation (Clcn7F318L). Compared to Clcn7+/+ mice, 12-week-old Clcn7F318L/+ mice have significantly  [CLS] increased trabecular bone volume [CLS] , consistent with Clcn7F318L acting as a dominant negative mutation. Clcn7F318L/F318L and Clcn7F318L/G213R mice die by 1month of age and"}
{"subject": "IL-36Ra", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28967976.json", "snippet": " be another driving force in the pathogenesis of psoriasis. This was first highlighted by the discovery that a loss-of-function  [CLS] mutation of the IL-36R antagonist (IL-36Ra [CLS] ) causes pustular psoriasis. Although the TNF-?/IL-23/IL-17/IL-22 axis and the functional activation of IL-36R are fundamentally involved in plaque psoriasis"}
{"subject": "pustular psoriasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28967976.json", "snippet": " to be another driving force in the pathogenesis of psoriasis. This was first highlighted by the discovery that a  [CLS] loss-of-function mutation of the IL-36R antagonist (IL-36Ra) causes pustular psoriasis [CLS] . Although the TNF-?/IL-23/IL-17/IL-22 axis and the functional activation of IL-36R are fundamentally involved in plaque psoriasis and pustular psoriasis,"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28967976.json", "snippet": " to be another driving force in the pathogenesis of psoriasis. This was first highlighted by the discovery that a  [CLS] loss-of-function mutation [CLS]  of the IL-36R antagonist (IL-36Ra) causes pustular psoriasis. Although the TNF-?/IL-23/IL-17/IL-22 axis and the functional activation of IL-36R are"}
{"subject": "TNF\u03b1", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-28969941.json", "snippet": " 0.29-0.83; p-value 0.01) and aggressive (OR 0.46; 95% CI 0.22-0.94; p-value 0.03) periodontitis. Further, heterozygous subjects exhibited significantly decreased  [CLS] expression of TNF\u03b1 [CLS]  in periodontal tissues, pointing to a functional effect of the mutation in periodontal tissues during the progression of the"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28969941.json", "snippet": " CI 0.29-0.83; p-value 0.01) and aggressive (OR 0.46; 95% CI 0.22-0.94; p-value 0.03) periodontitis. Further, heterozygous subjects exhibited significantly  [CLS] decreased expression [CLS]  of TNF\u03b1 in periodontal tissues, pointing to a functional effect of the mutation in periodontal tissues during the progression"}
{"subject": "host response", "sub_type": "CPA", "rel": "ThemeOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-28969941.json", "snippet": " contributing to pro-inflammatory response and osteoclastogenesis. CCR5\u039432 (rs333) is a loss-of-function mutation in the CCR5 gene, which can potentially  [CLS] modulate the host response [CLS]  and, consequently periodontitis outcome. Thus, we investigated the effect of the CCR5\u039432 mutation over the risk to suffer periodontitis"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "modulate", "obj_type": "Reg", "file_name": "PubMed-28969941.json", "snippet": " receptor CCR5 play an important role in disease pathogenesis, contributing to pro-inflammatory response and osteoclastogenesis. CCR5\u039432 (rs333) is a  [CLS] loss-of-function mutation in the CCR5 gene, which can potentially modulate [CLS]  the host response and, consequently periodontitis outcome. Thus, we investigated the effect of the CCR5\u039432 mutation over the risk"}
{"subject": "CCR5", "sub_type": "Gene", "rel": "ThemeOf", "object": "rs333", "obj_type": "Var", "file_name": "PubMed-28969941.json", "snippet": " infection. The chemokine receptor CCR5 play an important role in disease pathogenesis, contributing to pro-inflammatory response and osteoclastogenesis. CCR5\u039432 ( [CLS] rs333) is a loss-of-function mutation in the CCR5 [CLS]  gene, which can potentially modulate the host response and, consequently periodontitis outcome. Thus, we investigated the effect of the"}
{"subject": "rs333", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28969941.json", "snippet": " infection. The chemokine receptor CCR5 play an important role in disease pathogenesis, contributing to pro-inflammatory response and osteoclastogenesis. CCR5\u039432 ( [CLS] rs333) is a loss-of-function [CLS]  mutation in the CCR5 gene, which can potentially modulate the host response and, consequently periodontitis outcome. Thus, we investigated"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-28969941.json", "snippet": " CI 0.29-0.83; p-value 0.01) and aggressive (OR 0.46; 95% CI 0.22-0.94; p-value 0.03) periodontitis. Further, heterozygous subjects exhibited significantly  [CLS] decreased expression of TNF\u03b1 in periodontal tissues, pointing to a functional effect of the mutation [CLS]  in periodontal tissues during the progression of the disease. Conversely, no significant changes were observed in the presence or"}
{"subject": "(BMP9)-ALK1-Smad1/5/8 signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28973643.json", "snippet": " arising from endothelial cell (EC) proliferation and hypervascularization, for which no cure exists. Because HHT is caused by loss-of-function  [CLS] mutations in bone morphogenetic protein 9 (BMP9)-ALK1-Smad1/5/8 signaling [CLS] , interventions aimed at activating this pathway are of therapeutic value. We interrogated the whole-transcriptome in human umbilical vein ECs"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28973643.json", "snippet": " disorder arising from endothelial cell (EC) proliferation and hypervascularization, for which no cure exists. Because HHT is caused by  [CLS] loss-of-function mutations [CLS]  in bone morphogenetic protein 9 (BMP9)-ALK1-Smad1/5/8 signaling, interventions aimed at activating this pathway are of therapeutic value. We interrogated"}
{"subject": "HHT", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28973643.json", "snippet": " and life-threatening genetic vascular disorder arising from endothelial cell (EC) proliferation and hypervascularization, for which no cure exists. Because  [CLS] HHT is caused by loss-of-function [CLS]  mutations in bone morphogenetic protein 9 (BMP9)-ALK1-Smad1/5/8 signaling, interventions aimed at activating this pathway are of therapeutic value. We"}
{"subject": "ORC1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " Division Cycle 6 (Cdc6) is a component of pre-replicative complex (preRC) forming on DNA replication origins in eukaryotes. Recessive  [CLS] mutations in ORC1 [CLS] , ORC4, ORC6, CDT1 or CDC6 of the preRC in human cause Meier-Gorlin syndrome (MGS) that is characterized by impaired"}
{"subject": "cell cycle arrest at the S phase", "sub_type": "CPA", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " MGS have not been reported. Through N-ethyl-N-nitrosourea mutagenesis and Cas9 knockout, we generate several cdc6 mutant lines in zebrafish.  [CLS] Loss-of-function mutations of cdc6, as manifested by cdc6tsu4305 and cdc6tsu7cd mutants, lead to embryonic lethality due to cell cycle arrest at the S phase [CLS]  and extensive apoptosis. Embryos homozygous for a cdc6 hypomorphic mutation, cdc6tsu21cd, develop normally during embryogenesis. Later on, compared with"}
{"subject": "apoptosis", "sub_type": "CPA", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " MGS have not been reported. Through N-ethyl-N-nitrosourea mutagenesis and Cas9 knockout, we generate several cdc6 mutant lines in zebrafish.  [CLS] Loss-of-function mutations of cdc6, as manifested by cdc6tsu4305 and cdc6tsu7cd mutants, lead to embryonic lethality due to cell cycle arrest at the S phase and extensive apoptosis [CLS] . Embryos homozygous for a cdc6 hypomorphic mutation, cdc6tsu21cd, develop normally during embryogenesis. Later on, compared with their wild-type (WT)"}
{"subject": "Loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "embryonic lethality", "obj_type": "CPA", "file_name": "PubMed-28985365.json", "snippet": " MGS have not been reported. Through N-ethyl-N-nitrosourea mutagenesis and Cas9 knockout, we generate several cdc6 mutant lines in zebrafish.  [CLS] Loss-of-function mutations of cdc6, as manifested by cdc6tsu4305 and cdc6tsu7cd mutants, lead to embryonic lethality [CLS]  due to cell cycle arrest at the S phase and extensive apoptosis. Embryos homozygous for a cdc6 hypomorphic mutation,"}
{"subject": "body weight and length", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " normally during embryogenesis. Later on, compared with their wild-type (WT) siblings, cdc6tsu21cd mutant fish show growth retardation, and their  [CLS] body weight and length in adulthood are greatly reduced [CLS] , which resemble human MGS. Surprisingly, cdc6tsu21cd mutant fish become males with a short life and fail to mate with"}
{"subject": "cdc6tsu21cd mutant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " homozygous for a cdc6 hypomorphic mutation, cdc6tsu21cd, develop normally during embryogenesis. Later on, compared with their wild-type (WT) siblings,  [CLS] cdc6tsu21cd mutant fish show growth retardation, and their body weight and length in adulthood are greatly reduced [CLS] , which resemble human MGS. Surprisingly, cdc6tsu21cd mutant fish become males with a short life and fail to mate with"}
{"subject": "cdc6tsu21cd mutant", "sub_type": "Var", "rel": "CauseOf", "object": "defective", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " show growth retardation, and their body weight and length in adulthood are greatly reduced, which resemble human MGS. Surprisingly,  [CLS] cdc6tsu21cd mutant fish become males with a short life and fail to mate with WT females, suggesting defective [CLS]  reproduction. Overexpression of Cdc6 mutant forms, which mimic human CDC6(T323R) mutation found in a MGS patient, in zebrafish cdc6tsu4305"}
{"subject": "reproduction", "sub_type": "CPA", "rel": "ThemeOf", "object": "defective", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " MGS. Surprisingly, cdc6tsu21cd mutant fish become males with a short life and fail to mate with WT females, suggesting  [CLS] defective reproduction [CLS] . Overexpression of Cdc6 mutant forms, which mimic human CDC6(T323R) mutation found in a MGS patient, in zebrafish cdc6tsu4305 mutant"}
{"subject": "CDC6", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " life and fail to mate with WT females, suggesting defective reproduction. Overexpression of Cdc6 mutant forms, which mimic human  [CLS] CDC6(T323R) mutation [CLS]  found in a MGS patient, in zebrafish cdc6tsu4305 mutant embryos partially represses cell death phenotype, suggesting that the human"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "represses", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " and fail to mate with WT females, suggesting defective reproduction. Overexpression of Cdc6 mutant forms, which mimic human CDC6(T323R)  [CLS] mutation found in a MGS patient, in zebrafish cdc6tsu4305 mutant embryos partially represses [CLS]  cell death phenotype, suggesting that the human CDC6(T323R) mutation is a hypomorph. cdc6tsu21cd mutant fish will be useful to"}
{"subject": "cell death phenotype", "sub_type": "CPA", "rel": "ThemeOf", "object": "represses", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " Cdc6 mutant forms, which mimic human CDC6(T323R) mutation found in a MGS patient, in zebrafish cdc6tsu4305 mutant embryos partially  [CLS] represses cell death phenotype [CLS] , suggesting that the human CDC6(T323R) mutation is a hypomorph. cdc6tsu21cd mutant fish will be useful to detect more tissue"}
{"subject": "ORC4", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " Division Cycle 6 (Cdc6) is a component of pre-replicative complex (preRC) forming on DNA replication origins in eukaryotes. Recessive  [CLS] mutations in ORC1, ORC4 [CLS] , ORC6, CDT1 or CDC6 of the preRC in human cause Meier-Gorlin syndrome (MGS) that is characterized by impaired post-natal"}
{"subject": "ORC6", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " Division Cycle 6 (Cdc6) is a component of pre-replicative complex (preRC) forming on DNA replication origins in eukaryotes. Recessive  [CLS] mutations in ORC1, ORC4, ORC6 [CLS] , CDT1 or CDC6 of the preRC in human cause Meier-Gorlin syndrome (MGS) that is characterized by impaired post-natal growth,"}
{"subject": "CDT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " Division Cycle 6 (Cdc6) is a component of pre-replicative complex (preRC) forming on DNA replication origins in eukaryotes. Recessive  [CLS] mutations in ORC1, ORC4, ORC6, CDT1 [CLS]  or CDC6 of the preRC in human cause Meier-Gorlin syndrome (MGS) that is characterized by impaired post-natal growth, short"}
{"subject": "CDC6", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " Division Cycle 6 (Cdc6) is a component of pre-replicative complex (preRC) forming on DNA replication origins in eukaryotes. Recessive  [CLS] mutations in ORC1, ORC4, ORC6, CDT1 or CDC6 [CLS]  of the preRC in human cause Meier-Gorlin syndrome (MGS) that is characterized by impaired post-natal growth, short stature and"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28985365.json", "snippet": " Division Cycle 6 (Cdc6) is a component of pre-replicative complex (preRC) forming on DNA replication origins in eukaryotes. Recessive  [CLS] mutations in ORC1, ORC4, ORC6, CDT1 or CDC6 of the preRC in human cause [CLS]  Meier-Gorlin syndrome (MGS) that is characterized by impaired post-natal growth, short stature and microcephaly. However, vertebrate models of MGS"}
{"subject": "Meier-Gorlin syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28985365.json", "snippet": " DNA replication origins in eukaryotes. Recessive mutations in ORC1, ORC4, ORC6, CDT1 or CDC6 of the preRC in human  [CLS] cause Meier-Gorlin syndrome [CLS]  (MGS) that is characterized by impaired post-natal growth, short stature and microcephaly. However, vertebrate models of MGS have not"}
{"subject": "cdc6", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28985365.json", "snippet": " have not been reported. Through N-ethyl-N-nitrosourea mutagenesis and Cas9 knockout, we generate several cdc6 mutant lines in zebrafish. Loss-of-function  [CLS] mutations of cdc6 [CLS] , as manifested by cdc6tsu4305 and cdc6tsu7cd mutants, lead to embryonic lethality due to cell cycle arrest at the S"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-28985365.json", "snippet": " MGS have not been reported. Through N-ethyl-N-nitrosourea mutagenesis and Cas9 knockout, we generate several cdc6 mutant lines in zebrafish.  [CLS] Loss-of-function mutations [CLS]  of cdc6, as manifested by cdc6tsu4305 and cdc6tsu7cd mutants, lead to embryonic lethality due to cell cycle arrest at"}
{"subject": "KCNT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28987752.json", "snippet": " [CLS] KCNT1 mutations [CLS]  are gain-of-function mutations in potassium channels resulting in severe infantile epilepsy. Herein we describe 3 infants with malignant migrating"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28987752.json", "snippet": " [CLS] mutations are gain-of-function [CLS]  mutations in potassium channels resulting in severe infantile epilepsy. Herein we describe 3 infants with malignant migrating partial seizures"}
{"subject": "infantile epilepsy", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28987752.json", "snippet": " of KCNT1 Mutations: Malignant Migrating Partial Seizures in Infancy with Massive Systemic to Pulmonary Collateral Arteries.\nKCNT1 mutations are  [CLS] gain-of-function mutations in potassium channels resulting in severe infantile epilepsy [CLS] . Herein we describe 3 infants with malignant migrating partial seizures with KCNT1 mutations accompanied by massive systemic to pulmonary"}
{"subject": "CDH11", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28988429.json", "snippet": " addition, cell proliferation rate was slow and osteogenic differentiation potential was delayed. We consider that this study reveals loss-of-function  [CLS] mutations in CDH11 [CLS]  as a probable cause of this phenotype. Next generation sequencing in further patients would both prove this gene as"}
{"subject": "Elsahy-Waters syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28988429.json", "snippet": " [CLS] cause of Elsahy-Waters syndrome [CLS] .\nTwo sisters from a consanguineous couple were seen in genetics department for facial dysmorphic features and glaucoma. They both"}
{"subject": "cell proliferation rate", "sub_type": "CPA", "rel": "ThemeOf", "object": "slow", "obj_type": "NegReg", "file_name": "PubMed-28988429.json", "snippet": " the heterozygous parent and another healthy donor. Immunostaining showed absence of the protein expression in patient fibroblasts. In addition,  [CLS] cell proliferation rate was slow [CLS]  and osteogenic differentiation potential was delayed. We consider that this study reveals loss-of-function mutations in CDH11 as a probable"}
{"subject": "osteogenic differentiation potential", "sub_type": "CPA", "rel": "ThemeOf", "object": "delayed", "obj_type": "NegReg", "file_name": "PubMed-28988429.json", "snippet": " donor. Immunostaining showed absence of the protein expression in patient fibroblasts. In addition, cell proliferation rate was slow and  [CLS] osteogenic differentiation potential was delayed [CLS] . We consider that this study reveals loss-of-function mutations in CDH11 as a probable cause of this phenotype. Next generation"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "slow", "obj_type": "NegReg", "file_name": "PubMed-28988429.json", "snippet": " another healthy donor. Immunostaining showed absence of the protein expression in patient fibroblasts. In addition, cell proliferation rate was  [CLS] slow and osteogenic differentiation potential was delayed. We consider that this study reveals loss-of-function mutations [CLS]  in CDH11 as a probable cause of this phenotype. Next generation sequencing in further patients would both prove this"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "delayed", "obj_type": "NegReg", "file_name": "PubMed-28988429.json", "snippet": " of the protein expression in patient fibroblasts. In addition, cell proliferation rate was slow and osteogenic differentiation potential was  [CLS] delayed. We consider that this study reveals loss-of-function mutations [CLS]  in CDH11 as a probable cause of this phenotype. Next generation sequencing in further patients would both prove this"}
{"subject": "CDH11", "sub_type": "Gene", "rel": "ThemeOf", "object": "Homozygous indel mutation", "obj_type": "Var", "file_name": "PubMed-28988429.json", "snippet": " [CLS] Homozygous indel mutation in CDH11 [CLS]  as the probable cause of Elsahy-Waters syndrome.\nTwo sisters from a consanguineous couple were seen in genetics department for"}
{"subject": "Homozygous indel mutation", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-28988429.json", "snippet": " [CLS] Homozygous indel mutation in CDH11 as the probable cause [CLS]  of Elsahy-Waters syndrome.\nTwo sisters from a consanguineous couple were seen in genetics department for facial dysmorphic features and"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "Effect", "obj_type": "Reg", "file_name": "PubMed-28993478.json", "snippet": " [CLS] Effect of Mutant [CLS]  p53 Proteins on Glycolysis and Mitochondrial Metabolism.\nTP53 is one of the most commonly mutated genes in human cancers."}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28993478.json", "snippet": " loss-of-function mutations, the majority of TP53 mutations in tumors are missense substitutions, which lead to the expression of full-length  [CLS] mutant proteins [CLS]  that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53"}
{"subject": "activities", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " substitutions, which lead to the expression of full-length mutant proteins that accumulate in cancer cells and may confer unique  [CLS] gain-of-function (GOF) activities [CLS]  to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF"}
{"subject": "accumulate", "sub_type": "PosReg", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " majority of TP53 mutations in tumors are missense substitutions, which lead to the expression of full-length mutant proteins that  [CLS] accumulate in cancer cells and may confer unique gain-of-function [CLS]  (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " substitutions, which lead to the expression of full-length mutant proteins that accumulate in cancer cells and may confer unique  [CLS] gain-of-function (GOF) activities to promote [CLS]  tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF to promote"}
{"subject": "tumorigenic events", "sub_type": "CPA", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " the expression of full-length mutant proteins that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to  [CLS] promote tumorigenic events [CLS] . Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF to promote tumor development."}
{"subject": "tumor development", "sub_type": "CPA", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF to  [CLS] promote tumor development [CLS] . There is a strong rationale that the GOF activities, including alterations in cellular metabolism, might vary between the different"}
{"subject": "GOF", "sub_type": "PosReg", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " activities to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate metabolic changes as a novel  [CLS] GOF to promote [CLS]  tumor development. There is a strong rationale that the GOF activities, including alterations in cellular metabolism, might vary between"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " mutant proteins that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently,  [CLS] mutant p53 proteins have been shown to mediate metabolic changes as a novel GOF [CLS]  to promote tumor development. There is a strong rationale that the GOF activities, including alterations in cellular metabolism, might"}
{"subject": "metabolic changes", "sub_type": "CPA", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins have been shown to mediate  [CLS] metabolic changes as a novel GOF [CLS]  to promote tumor development. There is a strong rationale that the GOF activities, including alterations in cellular metabolism, might"}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-28993478.json", "snippet": " mutant proteins that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently,  [CLS] mutant p53 proteins [CLS]  have been shown to mediate metabolic changes as a novel GOF to promote tumor development. There is a strong"}
{"subject": "Glycolysis", "sub_type": "MPA", "rel": "ThemeOf", "object": "Effect", "obj_type": "Reg", "file_name": "PubMed-28993478.json", "snippet": " [CLS] Effect of Mutant p53 Proteins on Glycolysis [CLS]  and Mitochondrial Metabolism.\nTP53 is one of the most commonly mutated genes in human cancers. Unlike other tumor suppressors"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "proteins", "obj_type": "Protein", "file_name": "PubMed-28993478.json", "snippet": " proteins that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant  [CLS] p53 proteins [CLS]  have been shown to mediate metabolic changes as a novel GOF to promote tumor development. There is a strong"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Proteins", "obj_type": "Protein", "file_name": "PubMed-28993478.json", "snippet": " [CLS] p53 Proteins [CLS]  on Glycolysis and Mitochondrial Metabolism.\nTP53 is one of the most commonly mutated genes in human cancers. Unlike other"}
{"subject": "Mitochondrial Metabolism", "sub_type": "MPA", "rel": "ThemeOf", "object": "Effect", "obj_type": "Reg", "file_name": "PubMed-28993478.json", "snippet": " [CLS] Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism [CLS] .\nTP53 is one of the most commonly mutated genes in human cancers. Unlike other tumor suppressors that are frequently"}
{"subject": "Proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-28993478.json", "snippet": " [CLS] Mutant p53 Proteins [CLS]  on Glycolysis and Mitochondrial Metabolism.\nTP53 is one of the most commonly mutated genes in human cancers. Unlike other"}
{"subject": "TP53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28993478.json", "snippet": " genes in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations, the majority of  [CLS] TP53 mutations [CLS]  in tumors are missense substitutions, which lead to the expression of full-length mutant proteins that accumulate in cancer cells"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "accumulate", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations, the majority of TP53  [CLS] mutations in tumors are missense substitutions, which lead to the expression of full-length mutant proteins that accumulate [CLS]  in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins have"}
{"subject": "missense substitutions", "sub_type": "Var", "rel": "CauseOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-28993478.json", "snippet": " in human cancers. Unlike other tumor suppressors that are frequently deleted or acquire loss-of-function mutations, the majority of TP53  [CLS] mutations in tumors are missense substitutions [CLS] , which lead to the expression of full-length mutant proteins that accumulate in cancer cells and may confer unique gain-of-function"}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-28993478.json", "snippet": " deleted or acquire loss-of-function mutations, the majority of TP53 mutations in tumors are missense substitutions, which lead to the  [CLS] expression of full-length mutant proteins [CLS]  that accumulate in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "accumulate", "obj_type": "PosReg", "file_name": "PubMed-28993478.json", "snippet": " deleted or acquire loss-of-function mutations, the majority of TP53 mutations in tumors are missense substitutions, which lead to the  [CLS] expression of full-length mutant proteins that accumulate [CLS]  in cancer cells and may confer unique gain-of-function (GOF) activities to promote tumorigenic events. Recently, mutant p53 proteins have"}
{"subject": "Mparf1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29016901.json", "snippet": " and MpARF3, two 'repressor' ARFs. Genetic screens for auxin-resistant mutants revealed that loss of MpARF1 function conferred auxin insensitivity.  [CLS] Mparf1 mutants [CLS]  showed reduced auxin-inducible gene expression and various developmental defects, including thallus twisting and gemma malformation. We further investigated the"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29016901.json", "snippet": " MpARF3, two 'repressor' ARFs. Genetic screens for auxin-resistant mutants revealed that loss of MpARF1 function conferred auxin insensitivity. Mparf1  [CLS] mutants showed reduced [CLS]  auxin-inducible gene expression and various developmental defects, including thallus twisting and gemma malformation. We further investigated the role of"}
{"subject": "auxin-inducible gene", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-29016901.json", "snippet": " ARFs. Genetic screens for auxin-resistant mutants revealed that loss of MpARF1 function conferred auxin insensitivity. Mparf1 mutants showed reduced  [CLS] auxin-inducible gene expression [CLS]  and various developmental defects, including thallus twisting and gemma malformation. We further investigated the role of MpARF1 in gemma"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29016901.json", "snippet": " 'repressor' ARFs. Genetic screens for auxin-resistant mutants revealed that loss of MpARF1 function conferred auxin insensitivity. Mparf1 mutants showed  [CLS] reduced auxin-inducible gene expression [CLS]  and various developmental defects, including thallus twisting and gemma malformation. We further investigated the role of MpARF1 in gemma"}
{"subject": "developmental defects", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29016901.json", "snippet": " 'repressor' ARFs. Genetic screens for auxin-resistant mutants revealed that loss of MpARF1 function conferred auxin insensitivity. Mparf1 mutants showed  [CLS] reduced auxin-inducible gene expression and various developmental defects [CLS] , including thallus twisting and gemma malformation. We further investigated the role of MpARF1 in gemma development, which is traceable"}
{"subject": "Tas1R3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29019082.json", "snippet": " this phenotype remains unclear. Here, we independently corroborate the increased thickness of cortical bone in femurs of 20-week-old male  [CLS] Tas1R3 mutant [CLS]  mice and confirm that Tas1R3 is expressed in the bone environment. Tas1R3 is expressed in undifferentiated bone marrow stromal"}
{"subject": "cortical bone mass", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29019082.json", "snippet": " member 2 (TAS1R2), respectively. It was recently reported that deletion of TAS1R3 expression in Tas1R3 mutant mice leads to  [CLS] increased cortical bone mass [CLS]  but the underlying cellular mechanism leading to this phenotype remains unclear. Here, we independently corroborate the increased thickness of"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29019082.json", "snippet": " and their expression levels positively correlate with differentiation status. Collectively, these findings suggest that high bone mass in Tas1R3  [CLS] mutant mice is due to uncoupled bone remodeling with reduced [CLS]  osteoclast function and provide rationale for future experiments examining the cell-type-dependent role for TAS1R family members in nutrient sensing"}
{"subject": "osteoclast function", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29019082.json", "snippet": " Collectively, these findings suggest that high bone mass in Tas1R3 mutant mice is due to uncoupled bone remodeling with  [CLS] reduced osteoclast function [CLS]  and provide rationale for future experiments examining the cell-type-dependent role for TAS1R family members in nutrient sensing in postnatal"}
{"subject": "reduced", "sub_type": "NegReg", "rel": "CauseOf", "object": "high", "obj_type": "PosReg", "file_name": "PubMed-29019082.json", "snippet": " are expressed in primary osteoclasts and their expression levels positively correlate with differentiation status. Collectively, these findings suggest that  [CLS] high bone mass in Tas1R3 mutant mice is due to uncoupled bone remodeling with reduced [CLS]  osteoclast function and provide rationale for future experiments examining the cell-type-dependent role for TAS1R family members in nutrient sensing"}
{"subject": "bone mass", "sub_type": "CPA", "rel": "ThemeOf", "object": "high", "obj_type": "PosReg", "file_name": "PubMed-29019082.json", "snippet": " are expressed in primary osteoclasts and their expression levels positively correlate with differentiation status. Collectively, these findings suggest that  [CLS] high bone mass [CLS]  in Tas1R3 mutant mice is due to uncoupled bone remodeling with reduced osteoclast function and provide rationale for future"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29019082.json", "snippet": " cortical bone mass but the underlying cellular mechanism leading to this phenotype remains unclear. Here, we independently corroborate the  [CLS] increased thickness of cortical bone in femurs of 20-week-old male Tas1R3 mutant [CLS]  mice and confirm that Tas1R3 is expressed in the bone environment. Tas1R3 is expressed in undifferentiated bone marrow stromal"}
{"subject": "thickness of cortical bone", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29019082.json", "snippet": " cortical bone mass but the underlying cellular mechanism leading to this phenotype remains unclear. Here, we independently corroborate the  [CLS] increased thickness of cortical bone [CLS]  in femurs of 20-week-old male Tas1R3 mutant mice and confirm that Tas1R3 is expressed in the bone environment. Tas1R3"}
{"subject": "Tas1R3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29019082.json", "snippet": " controls. In contrast, levels of the bone resorption marker collagen type I C-telopeptide are reduced greater than 60% in  [CLS] Tas1R3 mutant [CLS]  mice. Consistent with this, Tas1R3 and its putative signaling partner Tas1R2 are expressed in primary osteoclasts and their expression"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29019082.json", "snippet": " mutant mice as compared to controls. In contrast, levels of the bone resorption marker collagen type I C-telopeptide are  [CLS] reduced greater than 60% in Tas1R3 mutant [CLS]  mice. Consistent with this, Tas1R3 and its putative signaling partner Tas1R2 are expressed in primary osteoclasts and their expression"}
{"subject": "levels of the bone resorption marker collagen type I C-telopeptide", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29019082.json", "snippet": " N-terminal propeptide (PINP) are unchanged in the serum of 20-week-old Tas1R3 mutant mice as compared to controls. In contrast,  [CLS] levels of the bone resorption marker collagen type I C-telopeptide are reduced [CLS]  greater than 60% in Tas1R3 mutant mice. Consistent with this, Tas1R3 and its putative signaling partner Tas1R2 are expressed"}
{"subject": "Tas1R3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29019082.json", "snippet": " osteoclasts and their expression levels positively correlate with differentiation status. Collectively, these findings suggest that high bone mass in  [CLS] Tas1R3 mutant [CLS]  mice is due to uncoupled bone remodeling with reduced osteoclast function and provide rationale for future experiments examining the"}
{"subject": "TAS1R3", "sub_type": "Gene", "rel": "ThemeOf", "object": "deletion", "obj_type": "Var", "file_name": "PubMed-29019082.json", "snippet": " fructose when dimerized with TAS1R member 1 (TAS1R1) or TAS1R member 2 (TAS1R2), respectively. It was recently reported that  [CLS] deletion of TAS1R3 [CLS]  expression in Tas1R3 mutant mice leads to increased cortical bone mass but the underlying cellular mechanism leading to this"}
{"subject": "deletion", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29019082.json", "snippet": " fructose when dimerized with TAS1R member 1 (TAS1R1) or TAS1R member 2 (TAS1R2), respectively. It was recently reported that  [CLS] deletion of TAS1R3 expression in Tas1R3 mutant mice leads to increased [CLS]  cortical bone mass but the underlying cellular mechanism leading to this phenotype remains unclear. Here, we independently corroborate the"}
{"subject": "FGF5", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.499C>T", "obj_type": "Var", "file_name": "PubMed-29024003.json", "snippet": " found together with the insertion forming a haplotype and producing a putative truncated protein of 123 amino acids. The  [CLS] c.499C>T mutation also leads to a premature stop codon at position 168. In both cases, critical functional domains of FGF5 [CLS] , including one heparin binding site, are lost. All animals analyzed were homozygous for one of the deleterious mutations or"}
{"subject": "FGF5", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.348delA", "obj_type": "Var", "file_name": "PubMed-29024003.json", "snippet": " absent. DNA variation analysis showed four polymorphisms in the coding region: a synonymous SNP (c.210A>G), a single base deletion ( [CLS] c.348delA), a 12-bp insertion (c.351_352insCATATAACATAG) and a non-sense mutation (c.499C>T). The deletion was always found together with the insertion forming a haplotype and producing a putative truncated protein of 123 amino acids. The c.499C>T mutation also leads to a premature stop codon at position 168. In both cases, critical functional domains of FGF5 [CLS] , including one heparin binding site, are lost. All animals analyzed were homozygous for one of the deleterious mutations or"}
{"subject": "c.348delA", "sub_type": "Var", "rel": "CauseOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-29024003.json", "snippet": " absent. DNA variation analysis showed four polymorphisms in the coding region: a synonymous SNP (c.210A>G), a single base deletion ( [CLS] c.348delA), a 12-bp insertion (c.351_352insCATATAACATAG) and a non-sense mutation (c.499C>T). The deletion was always found together with the insertion forming a haplotype and producing a putative truncated protein of 123 amino acids. The c.499C>T mutation also leads to a premature stop codon at position 168. In both cases, critical functional domains of FGF5, including one heparin binding site, are lost [CLS] . All animals analyzed were homozygous for one of the deleterious mutations or compound heterozygous for both (i.e. c.348delA, c.351_352insCATATAACATAG/c.499T)."}
{"subject": "c.499C>T", "sub_type": "Var", "rel": "CauseOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-29024003.json", "snippet": " found together with the insertion forming a haplotype and producing a putative truncated protein of 123 amino acids. The  [CLS] c.499C>T mutation also leads to a premature stop codon at position 168. In both cases, critical functional domains of FGF5, including one heparin binding site, are lost [CLS] . All animals analyzed were homozygous for one of the deleterious mutations or compound heterozygous for both (i.e. c.348delA, c.351_352insCATATAACATAG/c.499T)."}
{"subject": "heparin binding site", "sub_type": "MPA", "rel": "ThemeOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-29024003.json", "snippet": " leads to a premature stop codon at position 168. In both cases, critical functional domains of FGF5, including one  [CLS] heparin binding site, are lost [CLS] . All animals analyzed were homozygous for one of the deleterious mutations or compound heterozygous for both (i.e. c.348delA, c.351_352insCATATAACATAG/c.499T)."}
{"subject": "critical functional domains", "sub_type": "MPA", "rel": "ThemeOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-29024003.json", "snippet": " 123 amino acids. The c.499C>T mutation also leads to a premature stop codon at position 168. In both cases,  [CLS] critical functional domains of FGF5, including one heparin binding site, are lost [CLS] . All animals analyzed were homozygous for one of the deleterious mutations or compound heterozygous for both (i.e. c.348delA, c.351_352insCATATAACATAG/c.499T)."}
{"subject": "FLNA", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29024177.json", "snippet": " [CLS] mutations in the X-linked gene FLNA [CLS]  can lead to abnormal neuronal migration, vascular and cardiac defects, and congenital intestinal pseudo-obstruction (CIPO), the latter characterized by"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29024177.json", "snippet": " [CLS] Loss-of-function mutations [CLS]  in the X-linked gene FLNA can lead to abnormal neuronal migration, vascular and cardiac defects, and congenital intestinal pseudo-obstruction"}
{"subject": "abnormal neuronal migration", "sub_type": "CPA", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29024177.json", "snippet": " [CLS] Loss-of-function mutations in the X-linked gene FLNA can lead to abnormal neuronal migration [CLS] , vascular and cardiac defects, and congenital intestinal pseudo-obstruction (CIPO), the latter characterized by anomalous intestinal smooth muscle layering. Survival"}
{"subject": "vascular and cardiac defects", "sub_type": "CPA", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29024177.json", "snippet": " [CLS] Loss-of-function mutations in the X-linked gene FLNA can lead to abnormal neuronal migration, vascular and cardiac defects [CLS] , and congenital intestinal pseudo-obstruction (CIPO), the latter characterized by anomalous intestinal smooth muscle layering. Survival in male hemizygotes for"}
{"subject": "congenital intestinal pseudo-obstruction", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29024177.json", "snippet": " [CLS] Loss-of-function mutations in the X-linked gene FLNA can lead to abnormal neuronal migration, vascular and cardiac defects, and congenital intestinal pseudo-obstruction [CLS]  (CIPO), the latter characterized by anomalous intestinal smooth muscle layering. Survival in male hemizygotes for such mutations is dependent"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "confer", "obj_type": "Reg", "file_name": "PubMed-29036710.json", "snippet": " proteins but non-S-specific factors, namely modifiers, are also required. In apricot, Prunus armeniaca (Rosaceae), we previously mapped two pollen-part  [CLS] mutations that confer [CLS]  self-compatibility in cultivars Canino and Katy at the distal end of chromosome 3 (M-locus) unlinked to the S-locus. Here,"}
{"subject": "self-compatibility", "sub_type": "MPA", "rel": "ThemeOf", "object": "confer", "obj_type": "Reg", "file_name": "PubMed-29036710.json", "snippet": " non-S-specific factors, namely modifiers, are also required. In apricot, Prunus armeniaca (Rosaceae), we previously mapped two pollen-part mutations that  [CLS] confer self-compatibility [CLS]  in cultivars Canino and Katy at the distal end of chromosome 3 (M-locus) unlinked to the S-locus. Here, we"}
{"subject": "MITE", "sub_type": "Gene", "rel": "ThemeOf", "object": "insertion", "obj_type": "Var", "file_name": "PubMed-29036710.json", "snippet": " strong candidate gene required for SI. ParM-7 encodes a disulfide bond A-like oxidoreductase protein, which we named ParMDO. The  [CLS] MITE insertion [CLS]  truncates the ParMDO ORF and produces a loss of SI function, suggesting that pollen rejection in Prunus is dependent"}
{"subject": "insertion", "sub_type": "Var", "rel": "CauseOf", "object": "truncates", "obj_type": "NegReg", "file_name": "PubMed-29036710.json", "snippet": " candidate gene required for SI. ParM-7 encodes a disulfide bond A-like oxidoreductase protein, which we named ParMDO. The MITE  [CLS] insertion truncates [CLS]  the ParMDO ORF and produces a loss of SI function, suggesting that pollen rejection in Prunus is dependent on"}
{"subject": "ParMDO ORF", "sub_type": "MPA", "rel": "ThemeOf", "object": "truncates", "obj_type": "NegReg", "file_name": "PubMed-29036710.json", "snippet": " gene required for SI. ParM-7 encodes a disulfide bond A-like oxidoreductase protein, which we named ParMDO. The MITE insertion  [CLS] truncates the ParMDO ORF [CLS]  and produces a loss of SI function, suggesting that pollen rejection in Prunus is dependent on redox regulation. Based"}
{"subject": "insertion", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29036710.json", "snippet": " candidate gene required for SI. ParM-7 encodes a disulfide bond A-like oxidoreductase protein, which we named ParMDO. The MITE  [CLS] insertion truncates the ParMDO ORF and produces a loss [CLS]  of SI function, suggesting that pollen rejection in Prunus is dependent on redox regulation. Based on phylogentic analyses we"}
{"subject": "SI function", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29036710.json", "snippet": " disulfide bond A-like oxidoreductase protein, which we named ParMDO. The MITE insertion truncates the ParMDO ORF and produces a  [CLS] loss of SI function [CLS] , suggesting that pollen rejection in Prunus is dependent on redox regulation. Based on phylogentic analyses we also suggest that"}
{"subject": "Variant", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-Function", "obj_type": "PosReg", "file_name": "PubMed-29038237.json", "snippet": " [CLS] Gain-of-Function Integrin \u03b23 Pro33 Variant [CLS]  Alters the Serotonin System in the Mouse Brain.\nEngagement of integrins by the extracellular matrix initiates signaling cascades that"}
{"subject": "Itgb3", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29038237.json", "snippet": " associations between the Pro33 allele and attention-deficit hyperactivity disorder and ASDs. Here, we used knock-in (KI) mice expressing an  [CLS] Itgb3 variant [CLS]  that phenocopies the human Pro33 variant to elucidate the consequences of constitutively enhanced \u03b1v\u03b23 signaling to the 5-HT system"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29038237.json", "snippet": " between the Pro33 allele and attention-deficit hyperactivity disorder and ASDs. Here, we used knock-in (KI) mice expressing an Itgb3  [CLS] variant that phenocopies the human Pro33 variant to elucidate the consequences of constitutively enhanced [CLS]  \u03b1v\u03b23 signaling to the 5-HT system in the brain. KI mice displayed deficits in multiple behaviors, including anxiety, repetitive,"}
{"subject": "\u03b1v\u03b23 signaling to the 5-HT system", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29038237.json", "snippet": " knock-in (KI) mice expressing an Itgb3 variant that phenocopies the human Pro33 variant to elucidate the consequences of constitutively  [CLS] enhanced \u03b1v\u03b23 signaling to the 5-HT system [CLS]  in the brain. KI mice displayed deficits in multiple behaviors, including anxiety, repetitive, and social behaviors. Anatomical studies revealed"}
{"subject": "Serotonin System", "sub_type": "MPA", "rel": "ThemeOf", "object": "Gain-of-Function", "obj_type": "PosReg", "file_name": "PubMed-29038237.json", "snippet": " [CLS] Gain-of-Function Integrin \u03b23 Pro33 Variant Alters the Serotonin System [CLS]  in the Mouse Brain.\nEngagement of integrins by the extracellular matrix initiates signaling cascades that drive a variety of"}
{"subject": "ITGB3", "sub_type": "Gene", "rel": "ThemeOf", "object": "Leu33Pro", "obj_type": "Var", "file_name": "PubMed-29038237.json", "snippet": " the integrin \u03b23 subunit with the serotonin (5-HT) system, likely via its modulation of the 5-HT transporter (SERT). The  [CLS] ITGB3 coding polymorphism Leu33Pro [CLS]  (rs5918, PlA2) produces hyperactive \u03b1v\u03b23 receptors that influence whole-blood 5-HT levels and may influence the risk for autism spectrum"}
{"subject": "Leu33Pro", "sub_type": "Var", "rel": "CauseOf", "object": "hyperactive", "obj_type": "PosReg", "file_name": "PubMed-29038237.json", "snippet": " subunit with the serotonin (5-HT) system, likely via its modulation of the 5-HT transporter (SERT). The ITGB3 coding polymorphism  [CLS] Leu33Pro (rs5918, PlA2) produces hyperactive [CLS]  \u03b1v\u03b23 receptors that influence whole-blood 5-HT levels and may influence the risk for autism spectrum disorder (ASD). Using a"}
{"subject": "\u03b1v\u03b23 receptors", "sub_type": "Protein", "rel": "ThemeOf", "object": "hyperactive", "obj_type": "PosReg", "file_name": "PubMed-29038237.json", "snippet": " (5-HT) system, likely via its modulation of the 5-HT transporter (SERT). The ITGB3 coding polymorphism Leu33Pro (rs5918, PlA2) produces  [CLS] hyperactive \u03b1v\u03b23 receptors [CLS]  that influence whole-blood 5-HT levels and may influence the risk for autism spectrum disorder (ASD). Using a phenome-wide scan"}
{"subject": "\u03b1v\u03b23 receptors", "sub_type": "Protein", "rel": "CauseOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29038237.json", "snippet": " system, likely via its modulation of the 5-HT transporter (SERT). The ITGB3 coding polymorphism Leu33Pro (rs5918, PlA2) produces hyperactive  [CLS] \u03b1v\u03b23 receptors that influence [CLS]  whole-blood 5-HT levels and may influence the risk for autism spectrum disorder (ASD). Using a phenome-wide scan of psychiatric"}
{"subject": "whole-blood 5-HT levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29038237.json", "snippet": " its modulation of the 5-HT transporter (SERT). The ITGB3 coding polymorphism Leu33Pro (rs5918, PlA2) produces hyperactive \u03b1v\u03b23 receptors that  [CLS] influence whole-blood 5-HT levels [CLS]  and may influence the risk for autism spectrum disorder (ASD). Using a phenome-wide scan of psychiatric diagnoses, we found"}
{"subject": "Leu33Pro", "sub_type": "Var", "rel": "CauseOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29038237.json", "snippet": " subunit with the serotonin (5-HT) system, likely via its modulation of the 5-HT transporter (SERT). The ITGB3 coding polymorphism  [CLS] Leu33Pro (rs5918, PlA2) produces hyperactive \u03b1v\u03b23 receptors that influence whole-blood 5-HT levels and may influence [CLS]  the risk for autism spectrum disorder (ASD). Using a phenome-wide scan of psychiatric diagnoses, we found significant, male-specific associations"}
{"subject": "autism spectrum disorder", "sub_type": "Disease", "rel": "ThemeOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29038237.json", "snippet": " (SERT). The ITGB3 coding polymorphism Leu33Pro (rs5918, PlA2) produces hyperactive \u03b1v\u03b23 receptors that influence whole-blood 5-HT levels and may  [CLS] influence the risk for autism spectrum disorder [CLS]  (ASD). Using a phenome-wide scan of psychiatric diagnoses, we found significant, male-specific associations between the Pro33 allele and attention-deficit"}
{"subject": "Parkin", "sub_type": "Gene", "rel": "ThemeOf", "object": "absence", "obj_type": "Var", "file_name": "PubMed-29040870.json", "snippet": " [CLS] Parkin absence [CLS]  accelerates microtubule aging in dopaminergic neurons.\nLoss-of-function caused by mutations in the parkin gene (PARK2) lead to early-onset familial"}
{"subject": "loss", "sub_type": "Var", "rel": "CauseOf", "object": "affects", "obj_type": "Reg", "file_name": "PubMed-29040870.json", "snippet": " in PARK2 knockout mice, changes of MT stability preceded the alteration of mitochondria transport. Moreover, in-cell experiments confirmed that  [CLS] loss of parkin affects [CLS]  mitochondria mobility and showed that this defect depends on MT system as it is rescued by paclitaxel, a well-known"}
{"subject": "mitochondria mobility", "sub_type": "MPA", "rel": "ThemeOf", "object": "affects", "obj_type": "Reg", "file_name": "PubMed-29040870.json", "snippet": " mice, changes of MT stability preceded the alteration of mitochondria transport. Moreover, in-cell experiments confirmed that loss of parkin  [CLS] affects mitochondria mobility [CLS]  and showed that this defect depends on MT system as it is rescued by paclitaxel, a well-known MT-targeted agent."}
{"subject": "parkin", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss", "obj_type": "Var", "file_name": "PubMed-29040870.json", "snippet": " in PARK2 knockout mice, changes of MT stability preceded the alteration of mitochondria transport. Moreover, in-cell experiments confirmed that  [CLS] loss of parkin [CLS]  affects mitochondria mobility and showed that this defect depends on MT system as it is rescued by paclitaxel, a"}
{"subject": "absence", "sub_type": "Var", "rel": "CauseOf", "object": "accelerates", "obj_type": "PosReg", "file_name": "PubMed-29040870.json", "snippet": " [CLS] absence accelerates [CLS]  microtubule aging in dopaminergic neurons.\nLoss-of-function caused by mutations in the parkin gene (PARK2) lead to early-onset familial Parkinson's"}
{"subject": "microtubule aging in dopaminergic neurons", "sub_type": "MPA", "rel": "ThemeOf", "object": "accelerates", "obj_type": "PosReg", "file_name": "PubMed-29040870.json", "snippet": " [CLS] accelerates microtubule aging in dopaminergic neurons [CLS] .\nLoss-of-function caused by mutations in the parkin gene (PARK2) lead to early-onset familial Parkinson's disease. Recently, mechanistic studies proved"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29040870.json", "snippet": " [CLS] Loss-of-function caused by mutations [CLS]  in the parkin gene (PARK2) lead to early-onset familial Parkinson's disease. Recently, mechanistic studies proved the ability of parkin"}
{"subject": "early-onset familial Parkinson's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29040870.json", "snippet": " [CLS] Loss-of-function caused by mutations in the parkin gene (PARK2) lead to early-onset familial Parkinson's disease [CLS] . Recently, mechanistic studies proved the ability of parkin in regulating mitochondria homeostasis and microtubule (MT) stability. Looking at these"}
{"subject": "PARK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29040870.json", "snippet": " [CLS] mutations in the parkin gene (PARK2 [CLS] ) lead to early-onset familial Parkinson's disease. Recently, mechanistic studies proved the ability of parkin in regulating mitochondria homeostasis and"}
{"subject": "loss", "sub_type": "Var", "rel": "CauseOf", "object": "accelerated", "obj_type": "PosReg", "file_name": "PubMed-29040870.json", "snippet": " mitochondria homeostasis and microtubule (MT) stability. Looking at these systems during aging of PARK2 knockout mice, we found that  [CLS] loss of parkin induced an accelerated [CLS]  (over)acetylation of MT system both in dopaminergic neuron cell bodies and fibers, localized in the substantia nigra and corpus"}
{"subject": "acetylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "accelerated", "obj_type": "PosReg", "file_name": "PubMed-29040870.json", "snippet": " stability. Looking at these systems during aging of PARK2 knockout mice, we found that loss of parkin induced an  [CLS] accelerated (over)acetylation [CLS]  of MT system both in dopaminergic neuron cell bodies and fibers, localized in the substantia nigra and corpus striatum,"}
{"subject": "parkin", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss", "obj_type": "Var", "file_name": "PubMed-29040870.json", "snippet": " mitochondria homeostasis and microtubule (MT) stability. Looking at these systems during aging of PARK2 knockout mice, we found that  [CLS] loss of parkin [CLS]  induced an accelerated (over)acetylation of MT system both in dopaminergic neuron cell bodies and fibers, localized in the substantia"}
{"subject": "LRRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-29054882.json", "snippet": " [CLS] LRRK2 Hyperactive Kinase Mutant [CLS]  Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.\nParkinson's disease (PD) is characterized pathologically by the selective loss of"}
{"subject": "SV endocytosis in ventral midbrain (MB) neurons, including DA neurons", "sub_type": "MPA", "rel": "ThemeOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " LRRK2 mutants contribute to nigral vulnerability remains unclear. Here we show that the most common PD mutation LRRK2 G2019S  [CLS] impairs SV endocytosis in ventral midbrain (MB) neurons, including DA neurons [CLS] , and the slowed endocytosis can be rescued by inhibition of LRRK2 kinase activity. A similar endocytic defect, however, was"}
{"subject": "SYNJ1", "sub_type": "Gene", "rel": "ThemeOf", "object": "deletion", "obj_type": "Var", "file_name": "PubMed-29054882.json", "snippet": " brain region-specific vulnerability to the G2019S mutation. Additionally, we found MB-specific impairment of SV endocytosis in neurons carrying heterozygous  [CLS] deletion of SYNJ1 [CLS]  (PARK20), a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis"}
{"subject": "deletion", "sub_type": "Var", "rel": "CauseOf", "object": "impairment", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " (hereafter, cortical neurons) or the hippocampus, suggesting a brain region-specific vulnerability to the G2019S mutation. Additionally, we found MB-specific  [CLS] impairment of SV endocytosis in neurons carrying heterozygous deletion [CLS]  of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and LRRK2 G2019S does not exacerbate"}
{"subject": "SV endocytosis in neurons", "sub_type": "MPA", "rel": "ThemeOf", "object": "impairment", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " (hereafter, cortical neurons) or the hippocampus, suggesting a brain region-specific vulnerability to the G2019S mutation. Additionally, we found MB-specific  [CLS] impairment of SV endocytosis in neurons [CLS]  carrying heterozygous deletion of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and LRRK2 G2019S"}
{"subject": "SYNJ1+/-", "sub_type": "Var", "rel": "CauseOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " SV endocytosis in neurons carrying heterozygous deletion of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining  [CLS] SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis but impairs [CLS]  sustained exocytosis in MB neurons and alters specific motor functions of 1-year-old male mice. Interestingly, we show that LRRK2"}
{"subject": "sustained exocytosis in MB neurons", "sub_type": "MPA", "rel": "ThemeOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis but  [CLS] impairs sustained exocytosis in MB neurons [CLS]  and alters specific motor functions of 1-year-old male mice. Interestingly, we show that LRRK2 directly phosphorylates synaptojanin1 in vitro,"}
{"subject": "LRRK2 G2019S", "sub_type": "Var", "rel": "CauseOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " in neurons carrying heterozygous deletion of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and  [CLS] LRRK2 G2019S does not exacerbate SV endocytosis but impairs [CLS]  sustained exocytosis in MB neurons and alters specific motor functions of 1-year-old male mice. Interestingly, we show that LRRK2"}
{"subject": "SYNJ1+/-", "sub_type": "Var", "rel": "CauseOf", "object": "alters", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " SV endocytosis in neurons carrying heterozygous deletion of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining  [CLS] SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis but impairs sustained exocytosis in MB neurons and alters [CLS]  specific motor functions of 1-year-old male mice. Interestingly, we show that LRRK2 directly phosphorylates synaptojanin1 in vitro, resulting in"}
{"subject": "LRRK2 G2019S", "sub_type": "Var", "rel": "CauseOf", "object": "alters", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " in neurons carrying heterozygous deletion of SYNJ1 (PARK20), a gene that is associated with recessive Parkinsonism. Combining SYNJ1+/- and  [CLS] LRRK2 G2019S does not exacerbate SV endocytosis but impairs sustained exocytosis in MB neurons and alters [CLS]  specific motor functions of 1-year-old male mice. Interestingly, we show that LRRK2 directly phosphorylates synaptojanin1 in vitro, resulting in"}
{"subject": "specific motor functions", "sub_type": "MPA", "rel": "ThemeOf", "object": "alters", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " Parkinsonism. Combining SYNJ1+/- and LRRK2 G2019S does not exacerbate SV endocytosis but impairs sustained exocytosis in MB neurons and  [CLS] alters specific motor functions [CLS]  of 1-year-old male mice. Interestingly, we show that LRRK2 directly phosphorylates synaptojanin1 in vitro, resulting in the disruption of"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "Disrupts", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " [CLS] Mutant Disrupts [CLS]  Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.\nParkinson's disease (PD) is characterized pathologically by the selective loss of substantia"}
{"subject": "G2019S", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29054882.json", "snippet": " neurons but not cortical neurons caused by two PARK genes: LRRK2 (PARK8) and SYNJ1 (PARK20). We demonstrate that the  [CLS] enhanced kinase activity resulting from the most frequent G2019S [CLS]  mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2 G2019S and SYNJ1 loss"}
{"subject": "kinase activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29054882.json", "snippet": " neurons but not cortical neurons caused by two PARK genes: LRRK2 (PARK8) and SYNJ1 (PARK20). We demonstrate that the  [CLS] enhanced kinase activity [CLS]  resulting from the most frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting"}
{"subject": "LRRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "G2019S", "obj_type": "Var", "file_name": "PubMed-29054882.json", "snippet": " PARK genes: LRRK2 (PARK8) and SYNJ1 (PARK20). We demonstrate that the enhanced kinase activity resulting from the most frequent  [CLS] G2019S mutation in LRRK2 [CLS]  is the key to this impairment. We provide evidence suggesting that LRRK2 G2019S and SYNJ1 loss of function share"}
{"subject": "G2019S", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " the most frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2  [CLS] G2019S and SYNJ1 loss of function [CLS]  share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis and that they play additive roles in facilitating"}
{"subject": "SYNJ1", "sub_type": "Gene", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2 G2019S and  [CLS] SYNJ1 loss of function [CLS]  share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis and that they play additive roles in facilitating"}
{"subject": "deregulating DAergic neuron SV endocytosis", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2 G2019S and SYNJ1  [CLS] loss of function share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis [CLS]  and that they play additive roles in facilitating each other's pathogenic functions in PD."}
{"subject": "SYNJ1", "sub_type": "Gene", "rel": "CauseOf", "object": "play additive roles", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2 G2019S and  [CLS] SYNJ1 loss of function share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis and that they play additive roles [CLS]  in facilitating each other's pathogenic functions in PD."}
{"subject": "G2019S", "sub_type": "Var", "rel": "CauseOf", "object": "play additive roles", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " the most frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that LRRK2  [CLS] G2019S and SYNJ1 loss of function share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis and that they play additive roles [CLS]  in facilitating each other's pathogenic functions in PD."}
{"subject": "PD", "sub_type": "Disease", "rel": "ThemeOf", "object": "play additive roles", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " and SYNJ1 loss of function share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis and that they  [CLS] play additive roles in facilitating each other's pathogenic functions in PD [CLS] ."}
{"subject": "LRRK2", "sub_type": "Var", "rel": "CauseOf", "object": "resulting in", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " impairs sustained exocytosis in MB neurons and alters specific motor functions of 1-year-old male mice. Interestingly, we show that  [CLS] LRRK2 directly phosphorylates synaptojanin1 in vitro, resulting in [CLS]  the disruption of endophilin-synaptojanin1 interaction required for SV endocytosis. Our work suggests a merge of LRRK2 and SYNJ1 pathogenic"}
{"subject": "Synaptic Vesicle Trafficking in Ventral Midbrain Neurons", "sub_type": "MPA", "rel": "ThemeOf", "object": "Disrupts", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " [CLS] Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons [CLS] .\nParkinson's disease (PD) is characterized pathologically by the selective loss of substantia nigra (SN) dopaminergic (DAergic) neurons. Recent evidence"}
{"subject": "disruption of endophilin-synaptojanin1 interaction required for SV endocytosis", "sub_type": "MPA", "rel": "ThemeOf", "object": "resulting in", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " and alters specific motor functions of 1-year-old male mice. Interestingly, we show that LRRK2 directly phosphorylates synaptojanin1 in vitro,  [CLS] resulting in the disruption of endophilin-synaptojanin1 interaction required for SV endocytosis [CLS] . Our work suggests a merge of LRRK2 and SYNJ1 pathogenic pathways in deregulating SV trafficking in MB neurons as"}
{"subject": "LRRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "G2019S", "obj_type": "Var", "file_name": "PubMed-29054882.json", "snippet": " from the most frequent G2019S mutation in LRRK2 is the key to this impairment. We provide evidence suggesting that  [CLS] LRRK2 G2019S [CLS]  and SYNJ1 loss of function share a similar pathogenic pathway in deregulating DAergic neuron SV endocytosis and that they"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "Parkinson's Disease", "obj_type": "Disease", "file_name": "PubMed-29054882.json", "snippet": " [CLS] Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant [CLS]  Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.\nParkinson's disease (PD) is characterized pathologically by the selective loss of"}
{"subject": "LRRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29054882.json", "snippet": " of LRRK2, linked to the most frequent familial PD, in regulating synaptic vesicle (SV) trafficking. However, the mechanism whereby  [CLS] LRRK2 mutants [CLS]  contribute to nigral vulnerability remains unclear. Here we show that the most common PD mutation LRRK2 G2019S impairs SV"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " LRRK2, linked to the most frequent familial PD, in regulating synaptic vesicle (SV) trafficking. However, the mechanism whereby LRRK2  [CLS] mutants contribute [CLS]  to nigral vulnerability remains unclear. Here we show that the most common PD mutation LRRK2 G2019S impairs SV endocytosis"}
{"subject": "nigral vulnerability", "sub_type": "MPA", "rel": "ThemeOf", "object": "contribute", "obj_type": "Reg", "file_name": "PubMed-29054882.json", "snippet": " linked to the most frequent familial PD, in regulating synaptic vesicle (SV) trafficking. However, the mechanism whereby LRRK2 mutants  [CLS] contribute to nigral vulnerability [CLS]  remains unclear. Here we show that the most common PD mutation LRRK2 G2019S impairs SV endocytosis in ventral midbrain"}
{"subject": "LRRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29054882.json", "snippet": " the mechanism whereby LRRK2 mutants contribute to nigral vulnerability remains unclear. Here we show that the most common PD  [CLS] mutation LRRK2 [CLS]  G2019S impairs SV endocytosis in ventral midbrain (MB) neurons, including DA neurons, and the slowed endocytosis can be rescued"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29054882.json", "snippet": " the mechanism whereby LRRK2 mutants contribute to nigral vulnerability remains unclear. Here we show that the most common PD  [CLS] mutation LRRK2 G2019S impairs [CLS]  SV endocytosis in ventral midbrain (MB) neurons, including DA neurons, and the slowed endocytosis can be rescued by inhibition"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "inactivation", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " mutational inactivation to aberrant gain-of-function: Unraveling the structural basis of mutant p53 oncogenic transition.\nVarious evidence has revealed that  [CLS] mutations in p53 exert activities that go beyond simply inactivation [CLS]  of wildtype functions but rather elicits downstream interactions that promote malignancy described as mutant p53 gain-of-function (GOF). Here we"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R273C", "obj_type": "Var", "file_name": "PubMed-29058783.json", "snippet": " mutation-induced structural transition of native p53 to an aberrant gain-of-function state, studying the wildtype (WT) and high incidence contact ( [CLS] R273C) and structural (R175H) mutant p53 [CLS]  (mutp53) through molecular dynamics simulation. Result analysis revealed that both mutants exhibited structural distortion and reduced flexibility, indicative of"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R175H", "obj_type": "Var", "file_name": "PubMed-29058783.json", "snippet": " of native p53 to an aberrant gain-of-function state, studying the wildtype (WT) and high incidence contact (R273C) and structural ( [CLS] R175H) mutant p53 [CLS]  (mutp53) through molecular dynamics simulation. Result analysis revealed that both mutants exhibited structural distortion and reduced flexibility, indicative of"}
{"subject": "R273C", "sub_type": "Var", "rel": "CauseOf", "object": "exhibited", "obj_type": "Reg", "file_name": "PubMed-29058783.json", "snippet": " mutation-induced structural transition of native p53 to an aberrant gain-of-function state, studying the wildtype (WT) and high incidence contact ( [CLS] R273C) and structural (R175H) mutant p53 (mutp53) through molecular dynamics simulation. Result analysis revealed that both mutants exhibited [CLS]  structural distortion and reduced flexibility, indicative of rigidity and kinetic stability. In addition, surface analysis revealed an increase in"}
{"subject": "structural distortion", "sub_type": "Var", "rel": "ThemeOf", "object": "exhibited", "obj_type": "Reg", "file_name": "PubMed-29058783.json", "snippet": " incidence contact (R273C) and structural (R175H) mutant p53 (mutp53) through molecular dynamics simulation. Result analysis revealed that both mutants  [CLS] exhibited structural distortion [CLS]  and reduced flexibility, indicative of rigidity and kinetic stability. In addition, surface analysis revealed an increase in the accessible"}
{"subject": "R273C", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " mutation-induced structural transition of native p53 to an aberrant gain-of-function state, studying the wildtype (WT) and high incidence contact ( [CLS] R273C) and structural (R175H) mutant p53 (mutp53) through molecular dynamics simulation. Result analysis revealed that both mutants exhibited structural distortion and reduced [CLS]  flexibility, indicative of rigidity and kinetic stability. In addition, surface analysis revealed an increase in the accessible surface area"}
{"subject": "flexibility", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " structural (R175H) mutant p53 (mutp53) through molecular dynamics simulation. Result analysis revealed that both mutants exhibited structural distortion and  [CLS] reduced flexibility [CLS] , indicative of rigidity and kinetic stability. In addition, surface analysis revealed an increase in the accessible surface area in"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "induced", "obj_type": "Reg", "file_name": "PubMed-29058783.json", "snippet": " the mutants but dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between  [CLS] mutation-induced [CLS]  structural distortion, loss of flexibility, rigidity, enhanced stability, protein unfolding and ultimately, exposure of binding surfaces as conformational attributes"}
{"subject": "structural distortion", "sub_type": "Var", "rel": "ThemeOf", "object": "induced", "obj_type": "Reg", "file_name": "PubMed-29058783.json", "snippet": " the mutants but dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between mutation- [CLS] induced structural distortion [CLS] , loss of flexibility, rigidity, enhanced stability, protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize"}
{"subject": "flexibility", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between mutation-induced structural distortion,  [CLS] loss of flexibility [CLS] , rigidity, enhanced stability, protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize mutP53 structure-GOF activities."}
{"subject": "rigidity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between mutation-induced structural distortion,  [CLS] loss of flexibility, rigidity [CLS] , enhanced stability, protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize mutP53 structure-GOF activities. This"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29058783.json", "snippet": " mutational inactivation to aberrant gain-of-function: Unraveling the structural basis of mutant p53 oncogenic transition.\nVarious evidence has revealed that  [CLS] mutations in p53 [CLS]  exert activities that go beyond simply inactivation of wildtype functions but rather elicits downstream interactions that promote malignancy described"}
{"subject": "stability", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29058783.json", "snippet": " Taken together, this study complements experimental findings and reveals the interplay between mutation-induced structural distortion, loss of flexibility, rigidity,  [CLS] enhanced stability [CLS] , protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize mutP53 structure-GOF activities. This insight is,"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29058783.json", "snippet": " the mutants but dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between  [CLS] mutation-induced structural distortion, loss of flexibility, rigidity, enhanced [CLS]  stability, protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize mutP53 structure-GOF activities. This insight"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " the mutants but dissimilar to the WT. Taken together, this study complements experimental findings and reveals the interplay between  [CLS] mutation-induced structural distortion, loss [CLS]  of flexibility, rigidity, enhanced stability, protein unfolding and ultimately, exposure of binding surfaces as conformational attributes that characterize mutP53"}
{"subject": "wildtype functions", "sub_type": "MPA", "rel": "ThemeOf", "object": "inactivation", "obj_type": "NegReg", "file_name": "PubMed-29058783.json", "snippet": " of mutant p53 oncogenic transition.\nVarious evidence has revealed that mutations in p53 exert activities that go beyond simply  [CLS] inactivation of wildtype functions [CLS]  but rather elicits downstream interactions that promote malignancy described as mutant p53 gain-of-function (GOF). Here we report the first"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "elicits", "obj_type": "Reg", "file_name": "PubMed-29058783.json", "snippet": " mutational inactivation to aberrant gain-of-function: Unraveling the structural basis of mutant p53 oncogenic transition.\nVarious evidence has revealed that  [CLS] mutations in p53 exert activities that go beyond simply inactivation of wildtype functions but rather elicits [CLS]  downstream interactions that promote malignancy described as mutant p53 gain-of-function (GOF). Here we report the first account of the"}
{"subject": "interactions", "sub_type": "Interaction", "rel": "ThemeOf", "object": "elicits", "obj_type": "Reg", "file_name": "PubMed-29058783.json", "snippet": " evidence has revealed that mutations in p53 exert activities that go beyond simply inactivation of wildtype functions but rather  [CLS] elicits downstream interactions [CLS]  that promote malignancy described as mutant p53 gain-of-function (GOF). Here we report the first account of the dynamics of"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-29058783.json", "snippet": " mutations in p53 exert activities that go beyond simply inactivation of wildtype functions but rather elicits downstream interactions that  [CLS] promote malignancy described as mutant [CLS]  p53 gain-of-function (GOF). Here we report the first account of the dynamics of mutation-induced structural transition of native p53"}
{"subject": "malignancy", "sub_type": "Disease", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-29058783.json", "snippet": " mutations in p53 exert activities that go beyond simply inactivation of wildtype functions but rather elicits downstream interactions that  [CLS] promote malignancy [CLS]  described as mutant p53 gain-of-function (GOF). Here we report the first account of the dynamics of mutation-induced structural transition"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29058783.json", "snippet": " activities that go beyond simply inactivation of wildtype functions but rather elicits downstream interactions that promote malignancy described as  [CLS] mutant p53 [CLS]  gain-of-function (GOF). Here we report the first account of the dynamics of mutation-induced structural transition of native p53 to"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29058783.json", "snippet": " activities that go beyond simply inactivation of wildtype functions but rather elicits downstream interactions that promote malignancy described as  [CLS] mutant p53 gain-of-function [CLS]  (GOF). Here we report the first account of the dynamics of mutation-induced structural transition of native p53 to an"}
{"subject": "p.S632W", "sub_type": "Var", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " in a patient with photo-sensitive GGE and his father diagnosed with juvenile myoclonic epilepsy. Functional studies revealed that both  [CLS] p.S632W and p.V246M had an identical functional impact including a depolarizing shift in the voltage dependence of activation [CLS]  that is consistent with a gain-of-function. In contrast, no biophysical changes resulted from the introduction of common population variants,"}
{"subject": "p.V246M", "sub_type": "Var", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " patient with photo-sensitive GGE and his father diagnosed with juvenile myoclonic epilepsy. Functional studies revealed that both p.S632W and  [CLS] p.V246M had an identical functional impact including a depolarizing shift in the voltage dependence of activation [CLS]  that is consistent with a gain-of-function. In contrast, no biophysical changes resulted from the introduction of common population variants,"}
{"subject": "depolarizing shift in the voltage dependence", "sub_type": "MPA", "rel": "ThemeOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " with juvenile myoclonic epilepsy. Functional studies revealed that both p.S632W and p.V246M had an identical functional impact including a  [CLS] depolarizing shift in the voltage dependence of activation [CLS]  that is consistent with a gain-of-function. In contrast, no biophysical changes resulted from the introduction of common population variants,"}
{"subject": "HCN2", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29064616.json", "snippet": " p.E280K and p.A705T, and the p.R756C variant from EPGP that did not segregate with disease. Our data suggest that  [CLS] HCN2 variants [CLS]  can confer susceptibility to GGE via a gain-of-function mechanism."}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " and p.A705T, and the p.R756C variant from EPGP that did not segregate with disease. Our data suggest that HCN2  [CLS] variants can confer susceptibility to GGE via a gain-of-function [CLS]  mechanism."}
{"subject": "susceptibility", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " the p.R756C variant from EPGP that did not segregate with disease. Our data suggest that HCN2 variants can confer  [CLS] susceptibility to GGE via a gain-of-function [CLS]  mechanism."}
{"subject": "HCN2", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29064616.json", "snippet": " [CLS] HCN2 variants [CLS]  in genetic epilepsy.\nGenetic generalized epilepsy (GGE) is a common epilepsy syndrome that encompasses seizure disorders characterized by spike-and-wave"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " [CLS] Gain-of-function HCN2 variants [CLS]  in genetic epilepsy.\nGenetic generalized epilepsy (GGE) is a common epilepsy syndrome that encompasses seizure disorders characterized by spike-and-wave"}
{"subject": "epilepsy", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29064616.json", "snippet": " [CLS] Gain-of-function HCN2 variants in genetic epilepsy [CLS] .\nGenetic generalized epilepsy (GGE) is a common epilepsy syndrome that encompasses seizure disorders characterized by spike-and-wave discharges (SWDs). Pacemaker"}
{"subject": "Polymorphisms", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29067933.json", "snippet": " factor in the pathogenesis of many diseases including psoriasis. Glutathione S-transferases (GSTs) protect against oxidative stress, inflammation, and genotoxicity.  [CLS] Polymorphisms in the GST genes may lead to [CLS]  an imbalance in pro- and antioxidant systems resulting in the increased production of reactive oxygen species that could influence"}
{"subject": "GSTT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "presence", "obj_type": "Var", "file_name": "PubMed-29067933.json", "snippet": " and GSTM1 (OR = 1.58) alone or in combination with tobacco use (P < 0.001) and psoriasis risk. The  [CLS] presence of both null genotypes of GSTM1 and GSTT1 [CLS]  further increased the risk of psoriasis (OR = 3.52) when compared with the positive genotypes of GSTM1 and GSTT1."}
{"subject": "GSTM1", "sub_type": "Gene", "rel": "ThemeOf", "object": "presence", "obj_type": "Var", "file_name": "PubMed-29067933.json", "snippet": " and GSTM1 (OR = 1.58) alone or in combination with tobacco use (P < 0.001) and psoriasis risk. The  [CLS] presence of both null genotypes of GSTM1 [CLS]  and GSTT1 further increased the risk of psoriasis (OR = 3.52) when compared with the positive genotypes of GSTM1"}
{"subject": "imbalance in pro- and antioxidant systems", "sub_type": "MPA", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29067933.json", "snippet": " diseases including psoriasis. Glutathione S-transferases (GSTs) protect against oxidative stress, inflammation, and genotoxicity. Polymorphisms in the GST genes may  [CLS] lead to an imbalance in pro- and antioxidant systems [CLS]  resulting in the increased production of reactive oxygen species that could influence the pathogenesis of psoriasis.\nAIM: The aim"}
{"subject": "GST", "sub_type": "Gene", "rel": "ThemeOf", "object": "Polymorphisms", "obj_type": "Var", "file_name": "PubMed-29067933.json", "snippet": " factor in the pathogenesis of many diseases including psoriasis. Glutathione S-transferases (GSTs) protect against oxidative stress, inflammation, and genotoxicity.  [CLS] Polymorphisms in the GST [CLS]  genes may lead to an imbalance in pro- and antioxidant systems resulting in the increased production of reactive oxygen"}
{"subject": "imbalance in pro- and antioxidant systems", "sub_type": "MPA", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29067933.json", "snippet": " Glutathione S-transferases (GSTs) protect against oxidative stress, inflammation, and genotoxicity. Polymorphisms in the GST genes may lead to an  [CLS] imbalance in pro- and antioxidant systems resulting in the increased [CLS]  production of reactive oxygen species that could influence the pathogenesis of psoriasis.\nAIM: The aim of this study was"}
{"subject": "production of reactive oxygen species", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29067933.json", "snippet": " genotoxicity. Polymorphisms in the GST genes may lead to an imbalance in pro- and antioxidant systems resulting in the  [CLS] increased production of reactive oxygen species [CLS]  that could influence the pathogenesis of psoriasis.\nAIM: The aim of this study was to investigate the association between"}
{"subject": "production of reactive oxygen species", "sub_type": "MPA", "rel": "CauseOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29067933.json", "snippet": " Polymorphisms in the GST genes may lead to an imbalance in pro- and antioxidant systems resulting in the increased  [CLS] production of reactive oxygen species that could influence [CLS]  the pathogenesis of psoriasis.\nAIM: The aim of this study was to investigate the association between GSTs (GSTM1 and"}
{"subject": "psoriasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29067933.json", "snippet": " to an imbalance in pro- and antioxidant systems resulting in the increased production of reactive oxygen species that could  [CLS] influence the pathogenesis of psoriasis [CLS] .\nAIM: The aim of this study was to investigate the association between GSTs (GSTM1 and GSTT1) gene polymorphism in"}
{"subject": "presence", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29067933.json", "snippet": " and GSTM1 (OR = 1.58) alone or in combination with tobacco use (P < 0.001) and psoriasis risk. The  [CLS] presence of both null genotypes of GSTM1 and GSTT1 further increased [CLS]  the risk of psoriasis (OR = 3.52) when compared with the positive genotypes of GSTM1 and GSTT1.\nLIMITATIONS: A"}
{"subject": "psoriasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29067933.json", "snippet": " tobacco use (P < 0.001) and psoriasis risk. The presence of both null genotypes of GSTM1 and GSTT1 further  [CLS] increased the risk of psoriasis [CLS]  (OR = 3.52) when compared with the positive genotypes of GSTM1 and GSTT1.\nLIMITATIONS: A major limitation of this"}
{"subject": "Fix- mutants", "sub_type": "Var", "rel": "CauseOf", "object": "indicating", "obj_type": "Reg", "file_name": "PubMed-29086445.json", "snippet": " nodules when inoculated with the Mesorhizobium loti strain TONO. In these nodules, infected cells disintegrated and successively became necrotic,  [CLS] indicating premature senescence typical of Fix- mutants [CLS] . However, it formed effective nodules when inoculated with the M. loti strain MAFF303099. Among nine different M. loti strains"}
{"subject": "premature senescence", "sub_type": "MPA", "rel": "ThemeOf", "object": "indicating", "obj_type": "Reg", "file_name": "PubMed-29086445.json", "snippet": " nodules when inoculated with the Mesorhizobium loti strain TONO. In these nodules, infected cells disintegrated and successively became necrotic,  [CLS] indicating premature senescence [CLS]  typical of Fix- mutants. However, it formed effective nodules when inoculated with the M. loti strain MAFF303099. Among nine"}
{"subject": "Null-mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29087092.json", "snippet": " [CLS] Null-mutations which cause loss of function [CLS]  of the gene encoding filaggrin (FLG) have been strongly linked to the\ndevelopment of atopic disorders, predominantly atopic eczema/dermatitis"}
{"subject": "Null-mutations", "sub_type": "Var", "rel": "CauseOf", "object": "linked", "obj_type": "Reg", "file_name": "PubMed-29087092.json", "snippet": " [CLS] Null-mutations which cause loss of function of the gene encoding filaggrin (FLG) have been strongly linked [CLS]  to the\ndevelopment of atopic disorders, predominantly atopic eczema/dermatitis syndrome (AEDS). Filaggrin plays a key role in\nepidermal barrier"}
{"subject": "atopic eczema/dermatitis syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "linked", "obj_type": "Reg", "file_name": "PubMed-29087092.json", "snippet": " NULL-MUTATIONS AND ATOPIC DISEASES].\nNull-mutations which cause loss of function of the gene encoding filaggrin (FLG) have been strongly  [CLS] linked to the\ndevelopment of atopic disorders, predominantly atopic eczema/dermatitis syndrome [CLS]  (AEDS). Filaggrin plays a key role in\nepidermal barrier function by upholding epidermal structure and moisturization. Up to now,"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "null-mutations", "obj_type": "Var", "file_name": "PubMed-29087092.json", "snippet": " defect of epidermal\nbarrier function, which allows greater skin penetration of various hazards. Epidemiological studies indicate an association\nof  [CLS] FLG null-mutations [CLS]  with AEDS, whereas results regarding an association of FLG null-mutations with sensitization to\ncommon inhalant allergens and development of"}
{"subject": "null-mutations", "sub_type": "Var", "rel": "CauseOf", "object": "association", "obj_type": "Interaction", "file_name": "PubMed-29087092.json", "snippet": " to their defect of epidermal\nbarrier function, which allows greater skin penetration of various hazards. Epidemiological studies indicate an  [CLS] association\nof FLG null-mutations [CLS]  with AEDS, whereas results regarding an association of FLG null-mutations with sensitization to\ncommon inhalant allergens and development of"}
{"subject": "AEDS", "sub_type": "Disease", "rel": "ThemeOf", "object": "association", "obj_type": "Interaction", "file_name": "PubMed-29087092.json", "snippet": " to their defect of epidermal\nbarrier function, which allows greater skin penetration of various hazards. Epidemiological studies indicate an  [CLS] association\nof FLG null-mutations with AEDS [CLS] , whereas results regarding an association of FLG null-mutations with sensitization to\ncommon inhalant allergens and development of rhinitis and"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "null-mutation", "obj_type": "Var", "file_name": "PubMed-29087092.json", "snippet": " a latitude dependent distribution of common FLG null-mutations\nwith a decreasing north-south gradient of R501X and 2282del4 mutation frequencies.  [CLS] FLG null-mutation [CLS]  carriers are prone\nto develop unspecific skin symptoms related to atopic and non-atopic skin disorders due to their defect"}
{"subject": "null-mutation", "sub_type": "Var", "rel": "CauseOf", "object": "develop", "obj_type": "PosReg", "file_name": "PubMed-29087092.json", "snippet": " latitude dependent distribution of common FLG null-mutations\nwith a decreasing north-south gradient of R501X and 2282del4 mutation frequencies. FLG  [CLS] null-mutation carriers are prone\nto develop [CLS]  unspecific skin symptoms related to atopic and non-atopic skin disorders due to their defect of epidermal\nbarrier function, which"}
{"subject": "unspecific skin symptoms", "sub_type": "Disease", "rel": "ThemeOf", "object": "develop", "obj_type": "PosReg", "file_name": "PubMed-29087092.json", "snippet": " FLG null-mutations\nwith a decreasing north-south gradient of R501X and 2282del4 mutation frequencies. FLG null-mutation carriers are prone\nto  [CLS] develop unspecific skin symptoms [CLS]  related to atopic and non-atopic skin disorders due to their defect of epidermal\nbarrier function, which allows greater skin"}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "Null-mutations", "obj_type": "Var", "file_name": "PubMed-29087092.json", "snippet": " [CLS] Null-mutations which cause loss of function of the gene encoding filaggrin (FLG [CLS] ) have been strongly linked to the\ndevelopment of atopic disorders, predominantly atopic eczema/dermatitis syndrome (AEDS). Filaggrin plays a key"}
{"subject": "Deleting", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29097598.json", "snippet": " of many neurological diseases. We found that excessive glutamate transmission upregulated mRNA expression of Fgfrs and their ligands Fgfs  [CLS] Deleting Fgfr1/2/3 not only impaired [CLS]  bSC dendritogenesis but also abolished glutamate transmission-induced dendritic overgrowth. Overexpressing FGF9 or FGF10 in cortical glutamatergic neurons results in"}
{"subject": "bSC dendritogenesis", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29097598.json", "snippet": " We found that excessive glutamate transmission upregulated mRNA expression of Fgfrs and their ligands Fgfs Deleting Fgfr1/2/3 not only  [CLS] impaired bSC dendritogenesis [CLS]  but also abolished glutamate transmission-induced dendritic overgrowth. Overexpressing FGF9 or FGF10 in cortical glutamatergic neurons results in excessive dendritic"}
{"subject": "Deleting", "sub_type": "Var", "rel": "CauseOf", "object": "abolished", "obj_type": "NegReg", "file_name": "PubMed-29097598.json", "snippet": " of many neurological diseases. We found that excessive glutamate transmission upregulated mRNA expression of Fgfrs and their ligands Fgfs  [CLS] Deleting Fgfr1/2/3 not only impaired bSC dendritogenesis but also abolished [CLS]  glutamate transmission-induced dendritic overgrowth. Overexpressing FGF9 or FGF10 in cortical glutamatergic neurons results in excessive dendritic outgrowth within 24"}
{"subject": "glutamate transmission-induced dendritic overgrowth", "sub_type": "MPA", "rel": "ThemeOf", "object": "abolished", "obj_type": "NegReg", "file_name": "PubMed-29097598.json", "snippet": " transmission upregulated mRNA expression of Fgfrs and their ligands Fgfs Deleting Fgfr1/2/3 not only impaired bSC dendritogenesis but also  [CLS] abolished glutamate transmission-induced dendritic overgrowth [CLS] . Overexpressing FGF9 or FGF10 in cortical glutamatergic neurons results in excessive dendritic outgrowth within 24 h, resembling the changes"}
{"subject": "Fgfr1/2/3", "sub_type": "Gene", "rel": "ThemeOf", "object": "Deleting", "obj_type": "Var", "file_name": "PubMed-29097598.json", "snippet": " of many neurological diseases. We found that excessive glutamate transmission upregulated mRNA expression of Fgfrs and their ligands Fgfs  [CLS] Deleting Fgfr1/2/3 [CLS]  not only impaired bSC dendritogenesis but also abolished glutamate transmission-induced dendritic overgrowth. Overexpressing FGF9 or FGF10 in cortical glutamatergic"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "regulates", "obj_type": "Reg", "file_name": "PubMed-29099487.json", "snippet": " missense mutant proteins that span ~190 different codons localized in the DNA-binding domain of the gene and protein. These  [CLS] mutations produce a protein with a reduced capacity to bind to a specific DNA sequence that regulates [CLS]  the p53 transcriptional pathway. Eight of these mutations are localized in codons that account for ~28% of the total"}
{"subject": "p53 transcriptional pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "regulates", "obj_type": "Reg", "file_name": "PubMed-29099487.json", "snippet": " and protein. These mutations produce a protein with a reduced capacity to bind to a specific DNA sequence that  [CLS] regulates the p53 transcriptional pathway [CLS] . Eight of these mutations are localized in codons that account for ~28% of the total p53 mutations and these"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29099487.json", "snippet": " hotspot mutations in the p53 gene in human cancers?' Four possible reasons for this are considered; (1) the hotspot  [CLS] mutant alleles produce a protein that has a highly altered [CLS]  structure, (2) environmental mutagens produce allele-specific changes in the p53 gene, (3) these mutations arise at selected sites in"}
{"subject": "structure", "sub_type": "MPA", "rel": "ThemeOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29099487.json", "snippet": " Four possible reasons for this are considered; (1) the hotspot mutant alleles produce a protein that has a highly  [CLS] altered structure [CLS] , (2) environmental mutagens produce allele-specific changes in the p53 gene, (3) these mutations arise at selected sites in the"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29099487.json", "snippet": " with the observed change in mutant p53 proteins, which produce a loss of function (DNA binding and transcription), some  [CLS] mutant proteins have an allele-specific gain of function [CLS]  that promotes cancer. Evidence is presented that demonstrates the first three possibilities all contribute some property to this list"}
{"subject": "cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29099487.json", "snippet": " mutant p53 proteins, which produce a loss of function (DNA binding and transcription), some mutant proteins have an allele-specific  [CLS] gain of function that promotes cancer [CLS] . Evidence is presented that demonstrates the first three possibilities all contribute some property to this list of hotspot mutations."}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29099487.json", "snippet": " with the observed change in mutant p53 proteins, which produce a loss of function (DNA binding and transcription), some  [CLS] mutant proteins [CLS]  have an allele-specific gain of function that promotes cancer. Evidence is presented that demonstrates the first three possibilities all"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "changes", "obj_type": "Reg", "file_name": "PubMed-29099488.json", "snippet": " [CLS] Mutant p53 proteins impart changes [CLS]  in cellular behavior and function through interactions with proteins that alter gene expression. The milieu of intracellular proteins available"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29099488.json", "snippet": " interact with mutant p53 is context specific and changes with disease, cell type, and environmental conditions. Varying conformations of  [CLS] mutant p53 [CLS]  largely dictate protein-protein interactions as different point mutations within protein-coding regions greatly alter the extent and array of gain-of-function"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-29099488.json", "snippet": " to blunt or ablate mutant p53 GOF for therapy? In this article, we review known proteins that interact with  [CLS] mutant p53 and result in the activation [CLS]  of genes that contribute to p53 GOF with particular emphasis on context dependency and an evolving appreciation of GOF"}
{"subject": "genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "activation", "obj_type": "PosReg", "file_name": "PubMed-29099488.json", "snippet": " GOF for therapy? In this article, we review known proteins that interact with mutant p53 and result in the  [CLS] activation of genes [CLS]  that contribute to p53 GOF with particular emphasis on context dependency and an evolving appreciation of GOF mechanisms."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29099488.json", "snippet": " to blunt or ablate mutant p53 GOF for therapy? In this article, we review known proteins that interact with  [CLS] mutant p53 [CLS]  and result in the activation of genes that contribute to p53 GOF with particular emphasis on context dependency and"}
{"subject": "cellular behavior", "sub_type": "MPA", "rel": "ThemeOf", "object": "changes", "obj_type": "Reg", "file_name": "PubMed-29099488.json", "snippet": " [CLS] changes in cellular behavior [CLS]  and function through interactions with proteins that alter gene expression. The milieu of intracellular proteins available to interact with"}
{"subject": "function", "sub_type": "MPA", "rel": "ThemeOf", "object": "changes", "obj_type": "Reg", "file_name": "PubMed-29099488.json", "snippet": " [CLS] changes in cellular behavior and function [CLS]  through interactions with proteins that alter gene expression. The milieu of intracellular proteins available to interact with mutant p53"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "interactions", "obj_type": "Interaction", "file_name": "PubMed-29099488.json", "snippet": " [CLS] Mutant p53 proteins impart changes in cellular behavior and function through interactions [CLS]  with proteins that alter gene expression. The milieu of intracellular proteins available to interact with mutant p53 is context"}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "interactions", "obj_type": "Interaction", "file_name": "PubMed-29099488.json", "snippet": " [CLS] interactions with proteins [CLS]  that alter gene expression. The milieu of intracellular proteins available to interact with mutant p53 is context specific and"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-29099488.json", "snippet": " [CLS] Mutant p53 [CLS]  proteins impart changes in cellular behavior and function through interactions with proteins that alter gene expression. The milieu of"}
{"subject": "proteins", "sub_type": "Protein", "rel": "ThemeOf", "object": "p53", "obj_type": "Gene", "file_name": "PubMed-29099488.json", "snippet": " [CLS] p53 proteins [CLS]  impart changes in cellular behavior and function through interactions with proteins that alter gene expression. The milieu of intracellular"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "dictate", "obj_type": "Reg", "file_name": "PubMed-29099488.json", "snippet": " interact with mutant p53 is context specific and changes with disease, cell type, and environmental conditions. Varying conformations of  [CLS] mutant p53 largely dictate [CLS]  protein-protein interactions as different point mutations within protein-coding regions greatly alter the extent and array of gain-of-function (GOF) activities."}
{"subject": "protein-protein interactions", "sub_type": "MPA", "rel": "ThemeOf", "object": "dictate", "obj_type": "Reg", "file_name": "PubMed-29099488.json", "snippet": " p53 is context specific and changes with disease, cell type, and environmental conditions. Varying conformations of mutant p53 largely  [CLS] dictate protein-protein interactions [CLS]  as different point mutations within protein-coding regions greatly alter the extent and array of gain-of-function (GOF) activities. Given such"}
{"subject": "MTOR", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29118224.json", "snippet": " in all tumor regions, with similar allele frequency as the VHL mutation, and in vitro functional assessment of the  [CLS] MTOR variant [CLS]  demonstrated that it increased mTORC1 activity. Consistently, immunohistochemistry in the tumor samples demonstrated increased levels of phospho-S6. In conclusion,"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29118224.json", "snippet": " all tumor regions, with similar allele frequency as the VHL mutation, and in vitro functional assessment of the MTOR  [CLS] variant demonstrated that it increased [CLS]  mTORC1 activity. Consistently, immunohistochemistry in the tumor samples demonstrated increased levels of phospho-S6. In conclusion, multiregion WES identified a"}
{"subject": "mTORC1 activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29118224.json", "snippet": " similar allele frequency as the VHL mutation, and in vitro functional assessment of the MTOR variant demonstrated that it  [CLS] increased mTORC1 activity [CLS] . Consistently, immunohistochemistry in the tumor samples demonstrated increased levels of phospho-S6. In conclusion, multiregion WES identified a novel MTOR"}
{"subject": "MTOR", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29118224.json", "snippet": " activity. Consistently, immunohistochemistry in the tumor samples demonstrated increased levels of phospho-S6. In conclusion, multiregion WES identified a novel  [CLS] MTOR mutation [CLS]  acquired early during tumor development as the event leading to a high sensitivity to temsirolimus treatment. This study supports"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "leading to", "obj_type": "Reg", "file_name": "PubMed-29118224.json", "snippet": " Consistently, immunohistochemistry in the tumor samples demonstrated increased levels of phospho-S6. In conclusion, multiregion WES identified a novel MTOR  [CLS] mutation acquired early during tumor development as the event leading to [CLS]  a high sensitivity to temsirolimus treatment. This study supports tumor multiregion sequencing to detect truncal mutations in the mTOR"}
{"subject": "high sensitivity to temsirolimus treatment", "sub_type": "MPA", "rel": "ThemeOf", "object": "leading to", "obj_type": "Reg", "file_name": "PubMed-29118224.json", "snippet": " of phospho-S6. In conclusion, multiregion WES identified a novel MTOR mutation acquired early during tumor development as the event  [CLS] leading to a high sensitivity to temsirolimus treatment [CLS] . This study supports tumor multiregion sequencing to detect truncal mutations in the mTOR pathway to identify patients sensitive to"}
{"subject": "frameshift mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29121062.json", "snippet": " Atlas and Cancer Cell Line Encyclopedia data to confirm and extend our findings by analyzing gene expression patterns. Recurrent  [CLS] frameshift mutations in JAK1 were associated [CLS]  with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including endometrial, colorectal, stomach, and"}
{"subject": "colorectal", "sub_type": "Disease", "rel": "ThemeOf", "object": "carcinomas", "obj_type": "Disease", "file_name": "PubMed-29121062.json", "snippet": " JAK1 were associated with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including endometrial,  [CLS] colorectal, stomach, and prostate carcinomas [CLS] . Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1 frameshift exhibited reduced expression"}
{"subject": "stomach", "sub_type": "Disease", "rel": "ThemeOf", "object": "carcinomas", "obj_type": "Disease", "file_name": "PubMed-29121062.json", "snippet": " were associated with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including endometrial, colorectal,  [CLS] stomach, and prostate carcinomas [CLS] . Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1 frameshift exhibited reduced expression"}
{"subject": "prostate", "sub_type": "Disease", "rel": "ThemeOf", "object": "carcinomas", "obj_type": "Disease", "file_name": "PubMed-29121062.json", "snippet": " with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including endometrial, colorectal, stomach, and  [CLS] prostate carcinomas [CLS] . Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1 frameshift exhibited reduced expression"}
{"subject": "JAK1", "sub_type": "Gene", "rel": "ThemeOf", "object": "frameshift mutations", "obj_type": "Var", "file_name": "PubMed-29121062.json", "snippet": " Atlas and Cancer Cell Line Encyclopedia data to confirm and extend our findings by analyzing gene expression patterns. Recurrent  [CLS] frameshift mutations in JAK1 [CLS]  were associated with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including endometrial, colorectal,"}
{"subject": "high mutation burden", "sub_type": "MPA", "rel": "ThemeOf", "object": "frameshift mutations", "obj_type": "Var", "file_name": "PubMed-29121062.json", "snippet": " Atlas and Cancer Cell Line Encyclopedia data to confirm and extend our findings by analyzing gene expression patterns. Recurrent  [CLS] frameshift mutations in JAK1 were associated with high mutation burden [CLS]  and microsatellite instability. These mutations occurred in multiple tumor types including endometrial, colorectal, stomach, and prostate carcinomas. Analyzing gene"}
{"subject": "microsatellite instability", "sub_type": "MPA", "rel": "ThemeOf", "object": "frameshift mutations", "obj_type": "Var", "file_name": "PubMed-29121062.json", "snippet": " Atlas and Cancer Cell Line Encyclopedia data to confirm and extend our findings by analyzing gene expression patterns. Recurrent  [CLS] frameshift mutations in JAK1 were associated with high mutation burden and microsatellite instability [CLS] . These mutations occurred in multiple tumor types including endometrial, colorectal, stomach, and prostate carcinomas. Analyzing gene expression signatures in"}
{"subject": "JAK1", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29121062.json", "snippet": " that represent a potential pan-cancer adaptation to immune responses against tumors with microsatellite instability; 2) The mechanism by which  [CLS] JAK1 loss of function [CLS]  contributes to tumor immune evasion is likely associated with loss of the JAK1-mediated interferon response."}
{"subject": "tumor immune evasion", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29121062.json", "snippet": " represent a potential pan-cancer adaptation to immune responses against tumors with microsatellite instability; 2) The mechanism by which JAK1  [CLS] loss of function contributes to tumor immune evasion [CLS]  is likely associated with loss of the JAK1-mediated interferon response."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "occurred", "obj_type": "Reg", "file_name": "PubMed-29121062.json", "snippet": " analyzing gene expression patterns. Recurrent frameshift mutations in JAK1 were associated with high mutation burden and microsatellite instability. These  [CLS] mutations occurred [CLS]  in multiple tumor types including endometrial, colorectal, stomach, and prostate carcinomas. Analyzing gene expression signatures in endometrial and stomach"}
{"subject": "carcinomas", "sub_type": "Disease", "rel": "ThemeOf", "object": "occurred", "obj_type": "Reg", "file_name": "PubMed-29121062.json", "snippet": " gene expression patterns. Recurrent frameshift mutations in JAK1 were associated with high mutation burden and microsatellite instability. These mutations  [CLS] occurred in multiple tumor types including endometrial, colorectal, stomach, and prostate carcinomas [CLS] . Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1 frameshift exhibited reduced expression"}
{"subject": "endometrial", "sub_type": "Disease", "rel": "ThemeOf", "object": "carcinomas", "obj_type": "Disease", "file_name": "PubMed-29121062.json", "snippet": " in JAK1 were associated with high mutation burden and microsatellite instability. These mutations occurred in multiple tumor types including  [CLS] endometrial, colorectal, stomach, and prostate carcinomas [CLS] . Analyzing gene expression signatures in endometrial and stomach adenocarcinomas revealed that tumors with a JAK1 frameshift exhibited reduced expression"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Gain of function", "obj_type": "PosReg", "file_name": "PubMed-29124309.json", "snippet": " [CLS] Gain of function of TMEM16E/ANO5 scrambling activity caused by a mutation [CLS]  associated with gnathodiaphyseal dysplasia.\nMutations in the human TMEM16E (ANO5) gene are associated both with the bone disease gnathodiaphyseal"}
{"subject": "gnathodiaphyseal dysplasia", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain of function", "obj_type": "PosReg", "file_name": "PubMed-29124309.json", "snippet": " [CLS] Gain of function of TMEM16E/ANO5 scrambling activity caused by a mutation associated with gnathodiaphyseal dysplasia [CLS] .\nMutations in the human TMEM16E (ANO5) gene are associated both with the bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260)"}
{"subject": "TMEM16E", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29124309.json", "snippet": " [CLS] TMEM16E/ANO5 scrambling activity caused by a mutation [CLS]  associated with gnathodiaphyseal dysplasia.\nMutations in the human TMEM16E (ANO5) gene are associated both with the bone disease gnathodiaphyseal"}
{"subject": "scrambling activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "Gain of function", "obj_type": "PosReg", "file_name": "PubMed-29124309.json", "snippet": " [CLS] Gain of function of TMEM16E/ANO5 scrambling activity [CLS]  caused by a mutation associated with gnathodiaphyseal dysplasia.\nMutations in the human TMEM16E (ANO5) gene are associated both with"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29124309.json", "snippet": " [CLS] Mutations in the human TMEM16E (ANO5) gene are associated [CLS]  both with the bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260) and muscle dystrophies (OMIM: 611307, 613319). However, the physiological"}
{"subject": "gnathodiaphyseal dysplasia", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29124309.json", "snippet": " TMEM16E/ANO5 scrambling activity caused by a mutation associated with gnathodiaphyseal dysplasia.\nMutations in the human TMEM16E (ANO5) gene are  [CLS] associated both with the bone disease gnathodiaphyseal dysplasia [CLS]  (GDD; OMIM: 166260) and muscle dystrophies (OMIM: 611307, 613319). However, the physiological function of TMEM16E has remained unclear. We"}
{"subject": "muscle dystrophies", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29124309.json", "snippet": " TMEM16E/ANO5 scrambling activity caused by a mutation associated with gnathodiaphyseal dysplasia.\nMutations in the human TMEM16E (ANO5) gene are  [CLS] associated both with the bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260) and muscle dystrophies [CLS]  (OMIM: 611307, 613319). However, the physiological function of TMEM16E has remained unclear. We show here that human TMEM16E, when"}
{"subject": "TMEM16E", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-29124309.json", "snippet": " [CLS] Mutations in the human TMEM16E [CLS]  (ANO5) gene are associated both with the bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260) and muscle dystrophies (OMIM: 611307,"}
{"subject": "gnathodiaphyseal dysplasia", "sub_type": "Disease", "rel": "CauseOf", "object": "bone disease", "obj_type": "Disease", "file_name": "PubMed-29124309.json", "snippet": " by a mutation associated with gnathodiaphyseal dysplasia.\nMutations in the human TMEM16E (ANO5) gene are associated both with the  [CLS] bone disease gnathodiaphyseal dysplasia [CLS]  (GDD; OMIM: 166260) and muscle dystrophies (OMIM: 611307, 613319). However, the physiological function of TMEM16E has remained unclear. We"}
{"subject": "muscle dystrophies", "sub_type": "Disease", "rel": "CauseOf", "object": "bone disease", "obj_type": "Disease", "file_name": "PubMed-29124309.json", "snippet": " by a mutation associated with gnathodiaphyseal dysplasia.\nMutations in the human TMEM16E (ANO5) gene are associated both with the  [CLS] bone disease gnathodiaphyseal dysplasia (GDD; OMIM: 166260) and muscle dystrophies [CLS]  (OMIM: 611307, 613319). However, the physiological function of TMEM16E has remained unclear. We show here that human TMEM16E, when"}
{"subject": "L. pneumophila", "sub_type": "CPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29133401.json", "snippet": " virulence phenotypes using genetic complementation studies and infection assays. Specifically, loss-of-function mutations in the gene encoding LegC4 resulted in  [CLS] enhanced L. pneumophila [CLS]  in the lungs of infected mice but not within cultured host cells, which indicates LegC4 augments bacterial clearance by"}
{"subject": "LegC4", "sub_type": "Var", "rel": "CauseOf", "object": "augments", "obj_type": "PosReg", "file_name": "PubMed-29133401.json", "snippet": " resulted in enhanced L. pneumophila in the lungs of infected mice but not within cultured host cells, which indicates  [CLS] LegC4 augments [CLS]  bacterial clearance by the host immune system. The effector proteins RavY and Lpg2505 were important for efficient replication within"}
{"subject": "bacterial clearance", "sub_type": "CPA", "rel": "ThemeOf", "object": "augments", "obj_type": "PosReg", "file_name": "PubMed-29133401.json", "snippet": " in enhanced L. pneumophila in the lungs of infected mice but not within cultured host cells, which indicates LegC4  [CLS] augments bacterial clearance [CLS]  by the host immune system. The effector proteins RavY and Lpg2505 were important for efficient replication within both mammalian"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29133401.json", "snippet": " a pool of effector mutants in parallel both in a mouse model of infection and in cultured host cells.  [CLS] Loss-of-function mutations [CLS]  in genes encoding effector proteins resulted in host-specific or broad virulence phenotypes. Screen results were validated for several effector"}
{"subject": "host-specific", "sub_type": "MPA", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29133401.json", "snippet": " a pool of effector mutants in parallel both in a mouse model of infection and in cultured host cells.  [CLS] Loss-of-function mutations in genes encoding effector proteins resulted in host-specific [CLS]  or broad virulence phenotypes. Screen results were validated for several effector mutants displaying different virulence phenotypes using genetic complementation"}
{"subject": "broad virulence phenotypes", "sub_type": "MPA", "rel": "ThemeOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29133401.json", "snippet": " a pool of effector mutants in parallel both in a mouse model of infection and in cultured host cells.  [CLS] Loss-of-function mutations in genes encoding effector proteins resulted in host-specific or broad virulence phenotypes [CLS] . Screen results were validated for several effector mutants displaying different virulence phenotypes using genetic complementation studies and infection assays."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29133401.json", "snippet": " results were validated for several effector mutants displaying different virulence phenotypes using genetic complementation studies and infection assays. Specifically,  [CLS] loss-of-function mutations [CLS]  in the gene encoding LegC4 resulted in enhanced L. pneumophila in the lungs of infected mice but not within"}
{"subject": "LegC4", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29133401.json", "snippet": " were validated for several effector mutants displaying different virulence phenotypes using genetic complementation studies and infection assays. Specifically, loss-of-function  [CLS] mutations in the gene encoding LegC4 [CLS]  resulted in enhanced L. pneumophila in the lungs of infected mice but not within cultured host cells, which indicates"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29133401.json", "snippet": " were validated for several effector mutants displaying different virulence phenotypes using genetic complementation studies and infection assays. Specifically, loss-of-function  [CLS] mutations in the gene encoding LegC4 resulted in enhanced [CLS]  L. pneumophila in the lungs of infected mice but not within cultured host cells, which indicates LegC4 augments bacterial"}
{"subject": "AKT2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Variant", "obj_type": "Var", "file_name": "PubMed-29141982.json", "snippet": " [CLS] Variant in AKT2 [CLS]  Is Associated With Reduced Insulin-Mediated Glucose Uptake in Multiple Insulin-Sensitive Tissues: A Genotype-Based Callback Positron Emission Tomography Study.\nRare"}
{"subject": "Variant", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-29141982.json", "snippet": " [CLS] Loss-of-Function Variant [CLS]  in AKT2 Is Associated With Reduced Insulin-Mediated Glucose Uptake in Multiple Insulin-Sensitive Tissues: A Genotype-Based Callback Positron Emission Tomography"}
{"subject": "Insulin-Mediated Glucose Uptake", "sub_type": "CPA", "rel": "ThemeOf", "object": "Reduced", "obj_type": "NegReg", "file_name": "PubMed-29141982.json", "snippet": " [CLS] Reduced Insulin-Mediated Glucose Uptake [CLS]  in Multiple Insulin-Sensitive Tissues: A Genotype-Based Callback Positron Emission Tomography Study.\nRare fully penetrant mutations in AKT2 are an"}
{"subject": "insulin-mediated GU", "sub_type": "MPA", "rel": "ThemeOf", "object": "influences", "obj_type": "Reg", "file_name": "PubMed-29141982.json", "snippet": " marrow (32.9%)-and increases of 16.8-19.1% in seven tested brain regions. These data demonstrate that the p.P50T substitution of AKT2  [CLS] influences insulin-mediated GU [CLS]  in multiple insulin-sensitive tissues and may explain, at least in part, the increased risk of type 2 diabetes in"}
{"subject": "AKT2", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.P50T", "obj_type": "Var", "file_name": "PubMed-29141982.json", "snippet": " adipose (29.7%), and bone marrow (32.9%)-and increases of 16.8-19.1% in seven tested brain regions. These data demonstrate that the  [CLS] p.P50T substitution of AKT2 [CLS]  influences insulin-mediated GU in multiple insulin-sensitive tissues and may explain, at least in part, the increased risk of type"}
{"subject": "Variant", "sub_type": "Var", "rel": "CauseOf", "object": "Reduced", "obj_type": "NegReg", "file_name": "PubMed-29141982.json", "snippet": " [CLS] Variant in AKT2 Is Associated With Reduced [CLS]  Insulin-Mediated Glucose Uptake in Multiple Insulin-Sensitive Tissues: A Genotype-Based Callback Positron Emission Tomography Study.\nRare fully penetrant mutations in"}
{"subject": "p.P50T", "sub_type": "Var", "rel": "CauseOf", "object": "influences", "obj_type": "Reg", "file_name": "PubMed-29141982.json", "snippet": " adipose (29.7%), and bone marrow (32.9%)-and increases of 16.8-19.1% in seven tested brain regions. These data demonstrate that the  [CLS] p.P50T substitution of AKT2 influences [CLS]  insulin-mediated GU in multiple insulin-sensitive tissues and may explain, at least in part, the increased risk of type 2"}
{"subject": "TBK1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29146049.json", "snippet": " [CLS] TBK1 variants [CLS]  in early-onset Alzheimer disease in a European cohort.\nTANK-binding kinase 1 (TBK1) loss-of-function (LoF) mutations are known to cause"}
{"subject": "early-onset Alzheimer disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-29146049.json", "snippet": " [CLS] in early-onset Alzheimer disease [CLS]  in a European cohort.\nTANK-binding kinase 1 (TBK1) loss-of-function (LoF) mutations are known to cause frontotemporal dementia (FTD) and"}
{"subject": "TBK1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29146049.json", "snippet": " [CLS] TBK1) loss-of-function (LoF) mutations [CLS]  are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), often combined with memory deficits early in"}
{"subject": "frontotemporal dementia", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29146049.json", "snippet": " [CLS] loss-of-function (LoF) mutations are known to cause frontotemporal dementia [CLS]  (FTD) and amyotrophic lateral sclerosis (ALS), often combined with memory deficits early in the disease course. We performed targeted"}
{"subject": "amyotrophic lateral sclerosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29146049.json", "snippet": " [CLS] loss-of-function (LoF) mutations are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis [CLS]  (ALS), often combined with memory deficits early in the disease course. We performed targeted resequencing of TBK1 in 1253"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-29146049.json", "snippet": " [CLS] variants in [CLS]  early-onset Alzheimer disease in a European cohort.\nTANK-binding kinase 1 (TBK1) loss-of-function (LoF) mutations are known to cause frontotemporal"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29146049.json", "snippet": " [CLS] loss-of-function (LoF) mutations [CLS]  are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), often combined with memory deficits early in"}
{"subject": "NLRP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families. Gain-of-function  [CLS] NLRP1 variants [CLS]  rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with"}
{"subject": "rs11651270", "sub_type": "Var", "rel": "CauseOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-29154202.json", "snippet": " their families. Gain-of-function NLRP1 variants rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and  [CLS] rs11651270 and rs2670660 also with [CLS]  asthma severity and total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized"}
{"subject": "rs2670660", "sub_type": "Var", "rel": "CauseOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-29154202.json", "snippet": " Gain-of-function NLRP1 variants rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and  [CLS] rs2670660 also with [CLS]  asthma severity and total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized"}
{"subject": "IgE level", "sub_type": "MPA", "rel": "ThemeOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-29154202.json", "snippet": " variants rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also  [CLS] with asthma severity and total IgE level [CLS]  in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with gain-of-function SNPs in"}
{"subject": "asthma", "sub_type": "Disease", "rel": "ThemeOf", "object": "with", "obj_type": "Reg", "file_name": "PubMed-29154202.json", "snippet": " variants rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also  [CLS] with asthma [CLS]  severity and total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that"}
{"subject": "SNPs", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " total IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with  [CLS] gain-of-function SNPs [CLS]  in NLRP1 could be more prone in activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress"}
{"subject": "NLRP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "SNPs", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with gain-of-function  [CLS] SNPs in NLRP1 [CLS]  could be more prone in activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS),"}
{"subject": "activating inflammasome", "sub_type": "MPA", "rel": "ThemeOf", "object": "prone", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " activators in humans are still unknown, however we hypothesized that individuals with gain-of-function SNPs in NLRP1 could be more  [CLS] prone in activating inflammasome [CLS]  in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to exacerbate inflammatory"}
{"subject": "SNPs", "sub_type": "Var", "rel": "CauseOf", "object": "prone", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with gain-of-function  [CLS] SNPs in NLRP1 could be more prone [CLS]  in activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute"}
{"subject": "SNPs", "sub_type": "Var", "rel": "CauseOf", "object": "exacerbate", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " IgE level in asthmatic children. NLRP1 activators in humans are still unknown, however we hypothesized that individuals with gain-of-function  [CLS] SNPs in NLRP1 could be more prone in activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to exacerbate [CLS]  inflammatory response and asthma development. Gain-of-function IL1A rs17561 resulted significantly associated with a reduced pulmonary capacity in asthmatic children."}
{"subject": "NLRP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "rs11651270", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families. Gain-of-function  [CLS] NLRP1 variants rs11651270 [CLS] , rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma"}
{"subject": "inflammatory response", "sub_type": "CPA", "rel": "ThemeOf", "object": "exacerbate", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to  [CLS] exacerbate inflammatory response [CLS]  and asthma development. Gain-of-function IL1A rs17561 resulted significantly associated with a reduced pulmonary capacity in asthmatic children. IL18 rs5744256"}
{"subject": "asthma development", "sub_type": "CPA", "rel": "ThemeOf", "object": "exacerbate", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " activating inflammasome in the presence of asthma-related cell stressors (i.e. ER stress or ROS), and this activation contribute to  [CLS] exacerbate inflammatory response and asthma development [CLS] . Gain-of-function IL1A rs17561 resulted significantly associated with a reduced pulmonary capacity in asthmatic children. IL18 rs5744256 which lead to"}
{"subject": "IL1A", "sub_type": "Gene", "rel": "ThemeOf", "object": "rs17561", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " cell stressors (i.e. ER stress or ROS), and this activation contribute to exacerbate inflammatory response and asthma development. Gain-of-function  [CLS] IL1A rs17561 [CLS]  resulted significantly associated with a reduced pulmonary capacity in asthmatic children. IL18 rs5744256 which lead to lower serum level"}
{"subject": "rs17561", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29154202.json", "snippet": " stressors (i.e. ER stress or ROS), and this activation contribute to exacerbate inflammatory response and asthma development. Gain-of-function IL1A  [CLS] rs17561 resulted significantly associated with a reduced [CLS]  pulmonary capacity in asthmatic children. IL18 rs5744256 which lead to lower serum level of IL-18 appeared to be associated"}
{"subject": "pulmonary capacity", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29154202.json", "snippet": " and this activation contribute to exacerbate inflammatory response and asthma development. Gain-of-function IL1A rs17561 resulted significantly associated with a  [CLS] reduced pulmonary capacity [CLS]  in asthmatic children. IL18 rs5744256 which lead to lower serum level of IL-18 appeared to be associated to a"}
{"subject": "IL18", "sub_type": "Gene", "rel": "ThemeOf", "object": "rs5744256", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " inflammatory response and asthma development. Gain-of-function IL1A rs17561 resulted significantly associated with a reduced pulmonary capacity in asthmatic children.  [CLS] IL18 rs5744256 [CLS]  which lead to lower serum level of IL-18 appeared to be associated to a worse response to bronchodilators. Concluding,"}
{"subject": "serum level of IL-18", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29154202.json", "snippet": " Gain-of-function IL1A rs17561 resulted significantly associated with a reduced pulmonary capacity in asthmatic children. IL18 rs5744256 which lead to  [CLS] lower serum level of IL-18 [CLS]  appeared to be associated to a worse response to bronchodilators. Concluding, this work provides evidences about the contribution of"}
{"subject": "rs5744256", "sub_type": "Var", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29154202.json", "snippet": " response and asthma development. Gain-of-function IL1A rs17561 resulted significantly associated with a reduced pulmonary capacity in asthmatic children. IL18  [CLS] rs5744256 which lead to lower [CLS]  serum level of IL-18 appeared to be associated to a worse response to bronchodilators. Concluding, this work provides evidences"}
{"subject": "NLRP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "rs12150220", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families. Gain-of-function  [CLS] NLRP1 variants rs11651270, rs12150220 [CLS]  and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families.  [CLS] Gain-of-function NLRP1 variants [CLS]  rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with"}
{"subject": "rs11651270", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families.  [CLS] Gain-of-function NLRP1 variants rs11651270 [CLS] , rs12150220 and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma"}
{"subject": "rs12150220", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families.  [CLS] Gain-of-function NLRP1 variants rs11651270, rs12150220 [CLS]  and rs2670660 resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity"}
{"subject": "rs2670660", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families.  [CLS] Gain-of-function NLRP1 variants rs11651270, rs12150220 and rs2670660 [CLS]  resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity and total"}
{"subject": "NLRP1", "sub_type": "Gene", "rel": "ThemeOf", "object": "rs2670660", "obj_type": "Var", "file_name": "PubMed-29154202.json", "snippet": " asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families. Gain-of-function  [CLS] NLRP1 variants rs11651270, rs12150220 and rs2670660 [CLS]  resulted significantly associated to asthma in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity and total"}
{"subject": "asthma", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29154202.json", "snippet": " of asthma. Selected functional polymorphisms in inflammasome genes are evaluated in a cohort of asthmatic children and their families.  [CLS] Gain-of-function NLRP1 variants rs11651270, rs12150220 and rs2670660 resulted significantly associated to asthma [CLS]  in trios (TDT) analysis; and rs11651270 and rs2670660 also with asthma severity and total IgE level in asthmatic children."}
{"subject": "MED13L", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29159987.json", "snippet": " [CLS] MED13L loss-of-function variants [CLS]  in two patients with syndromic Pierre Robin sequence.\nWe report two unrelated patients with Pierre Robin sequence (PRS) and"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29159987.json", "snippet": " [CLS] loss-of-function variants [CLS]  in two patients with syndromic Pierre Robin sequence.\nWe report two unrelated patients with Pierre Robin sequence (PRS) and"}
{"subject": "Pierre Robin sequence", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29159987.json", "snippet": " [CLS] loss-of-function variants in two patients with syndromic Pierre Robin sequence [CLS] .\nWe report two unrelated patients with Pierre Robin sequence (PRS) and a strikingly similar combination of associated features. Whole"}
{"subject": "MED13L", "sub_type": "Gene", "rel": "ThemeOf", "object": "Disruption", "obj_type": "Var", "file_name": "PubMed-29159987.json", "snippet": " the investigation of copy number variants in MED13L in the other, leading to the identification of an intragenic deletion.  [CLS] Disruption of MED13L [CLS] , encoding a component of the Mediator complex, is increasingly recognized as the cause of an intellectual disability syndrome with"}
{"subject": "Disruption", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29159987.json", "snippet": " the investigation of copy number variants in MED13L in the other, leading to the identification of an intragenic deletion.  [CLS] Disruption of MED13L, encoding a component of the Mediator complex, is increasingly recognized as the cause [CLS]  of an intellectual disability syndrome with associated facial dysmorphism. Our findings suggest that MED13L-related disorders are a possible differential"}
{"subject": "intellectual disability syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29159987.json", "snippet": " of an intragenic deletion. Disruption of MED13L, encoding a component of the Mediator complex, is increasingly recognized as the  [CLS] cause of an intellectual disability syndrome [CLS]  with associated facial dysmorphism. Our findings suggest that MED13L-related disorders are a possible differential diagnosis for syndromic PRS."}
{"subject": "facial dysmorphism", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29159987.json", "snippet": " of an intragenic deletion. Disruption of MED13L, encoding a component of the Mediator complex, is increasingly recognized as the  [CLS] cause of an intellectual disability syndrome with associated facial dysmorphism [CLS] . Our findings suggest that MED13L-related disorders are a possible differential diagnosis for syndromic PRS."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-activity", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " [CLS] Loss-of-activity-mutation [CLS]  in the cardiac chloride-bicarbonate exchanger AE3 causes short QT syndrome.\nPatients with short QT syndrome (SQTS) may present with"}
{"subject": "cardiac chloride-bicarbonate exchanger AE3", "sub_type": "MPA", "rel": "ThemeOf", "object": "Loss-of-activity", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " [CLS] Loss-of-activity-mutation in the cardiac chloride-bicarbonate exchanger AE3 [CLS]  causes short QT syndrome.\nPatients with short QT syndrome (SQTS) may present with syncope, ventricular fibrillation or sudden cardiac"}
{"subject": "short QT syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-activity", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " [CLS] Loss-of-activity-mutation in the cardiac chloride-bicarbonate exchanger AE3 causes short QT syndrome [CLS] .\nPatients with short QT syndrome (SQTS) may present with syncope, ventricular fibrillation or sudden cardiac death. Six SQTS susceptibility"}
{"subject": "missense mutation", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " sudden cardiac death. Six SQTS susceptibility genes, encoding cation channels, explain <25% of SQTS cases. Here we identify a  [CLS] missense mutation in the anion exchanger (AE3)-encoding SLC4A3 gene in two unrelated families with SQTS. The mutation causes reduced [CLS]  surface expression of AE3 and reduced membrane bicarbonate transport. Slc4a3 knockdown in zebrafish causes increased cardiac pHi, short QTc,"}
{"subject": "SLC4A3", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutation", "obj_type": "Var", "file_name": "PubMed-29167417.json", "snippet": " sudden cardiac death. Six SQTS susceptibility genes, encoding cation channels, explain <25% of SQTS cases. Here we identify a  [CLS] missense mutation in the anion exchanger (AE3)-encoding SLC4A3 [CLS]  gene in two unrelated families with SQTS. The mutation causes reduced surface expression of AE3 and reduced membrane bicarbonate"}
{"subject": "surface expression of AE3", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " a missense mutation in the anion exchanger (AE3)-encoding SLC4A3 gene in two unrelated families with SQTS. The mutation causes  [CLS] reduced surface expression of AE3 [CLS]  and reduced membrane bicarbonate transport. Slc4a3 knockdown in zebrafish causes increased cardiac pHi, short QTc, and reduced systolic duration,"}
{"subject": "missense mutation", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " sudden cardiac death. Six SQTS susceptibility genes, encoding cation channels, explain <25% of SQTS cases. Here we identify a  [CLS] missense mutation in the anion exchanger (AE3)-encoding SLC4A3 gene in two unrelated families with SQTS. The mutation causes reduced surface expression of AE3 and reduced [CLS]  membrane bicarbonate transport. Slc4a3 knockdown in zebrafish causes increased cardiac pHi, short QTc, and reduced systolic duration, which is"}
{"subject": "membrane bicarbonate transport", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29167417.json", "snippet": " exchanger (AE3)-encoding SLC4A3 gene in two unrelated families with SQTS. The mutation causes reduced surface expression of AE3 and  [CLS] reduced membrane bicarbonate transport [CLS] . Slc4a3 knockdown in zebrafish causes increased cardiac pHi, short QTc, and reduced systolic duration, which is rescued by wildtype"}
{"subject": "LDLR", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1429G>A", "obj_type": "Var", "file_name": "PubMed-29172679.json", "snippet": " in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes,  [CLS] c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR [CLS]  gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction"}
{"subject": "c.9835A>G", "sub_type": "Var", "rel": "CauseOf", "object": "deformities", "obj_type": "Reg", "file_name": "PubMed-29172679.json", "snippet": " in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to  [CLS] c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities [CLS]  showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the"}
{"subject": "functional interaction", "sub_type": "Interaction", "rel": "ThemeOf", "object": "deformities", "obj_type": "Reg", "file_name": "PubMed-29172679.json", "snippet": " in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore,  [CLS] functional interaction deformities [CLS]  showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the"}
{"subject": "c.1731G>T", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29172679.json", "snippet": " were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N),  [CLS] c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss [CLS]  and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed"}
{"subject": "c.1783C>T", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29172679.json", "snippet": " on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and  [CLS] c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss [CLS]  and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed"}
{"subject": "c.1429G>A", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29172679.json", "snippet": " in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes,  [CLS] c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss [CLS]  and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed"}
{"subject": "c.1474G>A", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29172679.json", "snippet": " (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N),  [CLS] c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss [CLS]  and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed"}
{"subject": "c.9835A>G", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29172679.json", "snippet": " in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to  [CLS] c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss [CLS]  and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed"}
{"subject": "energies in the mutated proteins", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29172679.json", "snippet": " c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant  [CLS] loss and gain of energies in the mutated proteins [CLS] . These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients"}
{"subject": "c.1731G>T", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-29172679.json", "snippet": " were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N),  [CLS] c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain [CLS]  of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be"}
{"subject": "c.1783C>T", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-29172679.json", "snippet": " on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and  [CLS] c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain [CLS]  of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be"}
{"subject": "LDLR", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1474G>A", "obj_type": "Var", "file_name": "PubMed-29172679.json", "snippet": " (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N),  [CLS] c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR [CLS]  gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction"}
{"subject": "c.1429G>A", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-29172679.json", "snippet": " in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes,  [CLS] c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain [CLS]  of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be"}
{"subject": "c.1474G>A", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-29172679.json", "snippet": " (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N),  [CLS] c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain [CLS]  of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be"}
{"subject": "c.9835A>G", "sub_type": "Var", "rel": "CauseOf", "object": "gain", "obj_type": "PosReg", "file_name": "PubMed-29172679.json", "snippet": " in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to  [CLS] c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain [CLS]  of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be"}
{"subject": "LDLR", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1731G>T", "obj_type": "Var", "file_name": "PubMed-29172679.json", "snippet": " were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N),  [CLS] c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR [CLS]  gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction"}
{"subject": "LDLR", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1783C>T", "obj_type": "Var", "file_name": "PubMed-29172679.json", "snippet": " on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and  [CLS] c.1783C>T (p.R595W) in LDLR [CLS]  gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction"}
{"subject": "APOB", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.9835A>G", "obj_type": "Var", "file_name": "PubMed-29172679.json", "snippet": " in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to  [CLS] c.9835A>G (p.S3279G) in APOB [CLS] , were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain of"}
{"subject": "c.1429G>A", "sub_type": "Var", "rel": "CauseOf", "object": "deformities", "obj_type": "Reg", "file_name": "PubMed-29172679.json", "snippet": " in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes,  [CLS] c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities [CLS]  showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the"}
{"subject": "c.1474G>A", "sub_type": "Var", "rel": "CauseOf", "object": "deformities", "obj_type": "Reg", "file_name": "PubMed-29172679.json", "snippet": " (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N),  [CLS] c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities [CLS]  showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the"}
{"subject": "c.1731G>T", "sub_type": "Var", "rel": "CauseOf", "object": "deformities", "obj_type": "Reg", "file_name": "PubMed-29172679.json", "snippet": " were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N),  [CLS] c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities [CLS]  showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the"}
{"subject": "c.1783C>T", "sub_type": "Var", "rel": "CauseOf", "object": "deformities", "obj_type": "Reg", "file_name": "PubMed-29172679.json", "snippet": " on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and  [CLS] c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities [CLS]  showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the"}
{"subject": "htpG", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29199454.json", "snippet": " P. aeruginosa, we have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394 [CLS] htpG mutant [CLS]  affects many physiological processes containing: decreased activity of the LasA protease, reduction of biofilm formation, decreased motility, and diminished"}
{"subject": "amount of rhamnolipids and pyoverdine/pyocyanin", "sub_type": "MPA", "rel": "ThemeOf", "object": "diminished", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " mutant affects many physiological processes containing: decreased activity of the LasA protease, reduction of biofilm formation, decreased motility, and  [CLS] diminished amount of rhamnolipids and pyoverdine/pyocyanin [CLS] . These defects were most evident when the \u0394htpG strain was cultured at 42\u00b0C.\nCONCLUSION: Our findings demonstrate the unexplored"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " aeruginosa, we have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG  [CLS] mutant affects many physiological processes containing: decreased [CLS]  activity of the LasA protease, reduction of biofilm formation, decreased motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG mutant affects many physiological processes containing:  [CLS] decreased activity [CLS]  of the LasA protease, reduction of biofilm formation, decreased motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects"}
{"subject": "LasA protease", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-29199454.json", "snippet": " HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG mutant affects many physiological processes containing: decreased  [CLS] activity of the LasA protease [CLS] , reduction of biofilm formation, decreased motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " aeruginosa, we have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG  [CLS] mutant affects many physiological processes containing: decreased activity of the LasA protease, reduction [CLS]  of biofilm formation, decreased motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the"}
{"subject": "biofilm formation", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " selected factors.\nRESULTS: We showed that \u0394htpG mutant affects many physiological processes containing: decreased activity of the LasA protease,  [CLS] reduction of biofilm formation [CLS] , decreased motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the \u0394htpG strain was"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " aeruginosa, we have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG  [CLS] mutant affects many physiological processes containing: decreased activity of the LasA protease, reduction of biofilm formation, decreased [CLS]  motility, and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the \u0394htpG strain was cultured"}
{"subject": "motility", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " showed that \u0394htpG mutant affects many physiological processes containing: decreased activity of the LasA protease, reduction of biofilm formation,  [CLS] decreased motility [CLS] , and diminished amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the \u0394htpG strain was cultured at"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "diminished", "obj_type": "NegReg", "file_name": "PubMed-29199454.json", "snippet": " aeruginosa, we have identified the role of HtpG in the production of selected factors.\nRESULTS: We showed that \u0394htpG  [CLS] mutant affects many physiological processes containing: decreased activity of the LasA protease, reduction of biofilm formation, decreased motility, and diminished [CLS]  amount of rhamnolipids and pyoverdine/pyocyanin. These defects were most evident when the \u0394htpG strain was cultured at 42\u00b0C.\nCONCLUSION:"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " [CLS] KMT2A variants [CLS]  involved in Wiedemann-Steiner syndrome.\nVariants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "causing", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of KMT2A  [CLS] variants are non-sense and frameshift variants causing [CLS]  a typical form of Wiedemann-Steiner syndrome. We studied KMT2A gene in a cohort of 200 patients with unexplained syndromic"}
{"subject": "Wiedemann-Steiner syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "causing", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " growing cause of intellectual disability (ID). Up to now, the majority of KMT2A variants are non-sense and frameshift variants  [CLS] causing a typical form of Wiedemann-Steiner syndrome [CLS] . We studied KMT2A gene in a cohort of 200 patients with unexplained syndromic and non-syndromic ID and identified four"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " possibly deleterious. We used primary cells from the patients and molecular approaches to determine the deleterious effects of those  [CLS] variants on KMT2A [CLS]  expression and function. For the putative splice variant c.11322-1G>A, we showed that it led to only one nucleotide deletion"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "effects", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " three missense variants, possibly deleterious. We used primary cells from the patients and molecular approaches to determine the deleterious  [CLS] effects of those variants [CLS]  on KMT2A expression and function. For the putative splice variant c.11322-1G>A, we showed that it led to only one"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "effects", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " three missense variants, possibly deleterious. We used primary cells from the patients and molecular approaches to determine the deleterious  [CLS] effects of those variants on KMT2A expression [CLS]  and function. For the putative splice variant c.11322-1G>A, we showed that it led to only one nucleotide deletion and"}
{"subject": "function", "sub_type": "MPA", "rel": "ThemeOf", "object": "effects", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " three missense variants, possibly deleterious. We used primary cells from the patients and molecular approaches to determine the deleterious  [CLS] effects of those variants on KMT2A expression and function [CLS] . For the putative splice variant c.11322-1G>A, we showed that it led to only one nucleotide deletion and loss of"}
{"subject": "c.11322-1G>A", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29203834.json", "snippet": " approaches to determine the deleterious effects of those variants on KMT2A expression and function. For the putative splice variant  [CLS] c.11322-1G>A, we showed that it led to only one nucleotide deletion and loss [CLS]  of the C-terminal part of the protein. For two studied KMT2A missense variants, c.3460C>T (p.(Arg1154Trp)) and c.8558T>G (p.(Met2853Arg)), located"}
{"subject": "C-terminal part of the protein", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29203834.json", "snippet": " and function. For the putative splice variant c.11322-1G>A, we showed that it led to only one nucleotide deletion and  [CLS] loss of the C-terminal part of the protein [CLS] . For two studied KMT2A missense variants, c.3460C>T (p.(Arg1154Trp)) and c.8558T>G (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.3460C>T", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " it led to only one nucleotide deletion and loss of the C-terminal part of the protein. For two studied  [CLS] KMT2A missense variants, c.3460C>T [CLS]  (p.(Arg1154Trp)) and c.8558T>G (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.8558T>G", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " it led to only one nucleotide deletion and loss of the C-terminal part of the protein. For two studied  [CLS] KMT2A missense variants, c.3460C>T (p.(Arg1154Trp)) and c.8558T>G [CLS]  (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we found altered KMT2A"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "involved in", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " [CLS] variants involved in [CLS]  Wiedemann-Steiner syndrome.\nVariants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up"}
{"subject": "c.8558T>G", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " deletion and loss of the C-terminal part of the protein. For two studied KMT2A missense variants, c.3460C>T (p.(Arg1154Trp)) and  [CLS] c.8558T>G (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we found altered [CLS]  KMT2A target genes expression in patient's fibroblasts compared to controls. Furthermore, we found a disturbed subcellular distribution of KMT2A"}
{"subject": "c.3460C>T", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " only one nucleotide deletion and loss of the C-terminal part of the protein. For two studied KMT2A missense variants,  [CLS] c.3460C>T (p.(Arg1154Trp)) and c.8558T>G (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we found altered [CLS]  KMT2A target genes expression in patient's fibroblasts compared to controls. Furthermore, we found a disturbed subcellular distribution of KMT2A"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " and c.8558T>G (p.(Met2853Arg)), located at the cysteine-rich CXXC domain and the transactivation domain of the protein, respectively, we found  [CLS] altered KMT2A target genes expression [CLS]  in patient's fibroblasts compared to controls. Furthermore, we found a disturbed subcellular distribution of KMT2A for the c.3460C>T mutant."}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.3460C>T", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " altered KMT2A target genes expression in patient's fibroblasts compared to controls. Furthermore, we found a disturbed subcellular distribution of  [CLS] KMT2A for the c.3460C>T [CLS]  mutant. Taken together, our results demonstrated the deleterious impact of the splice variant and of the missense variants located"}
{"subject": "c.3460C>T", "sub_type": "Var", "rel": "CauseOf", "object": "disturbed", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " protein, respectively, we found altered KMT2A target genes expression in patient's fibroblasts compared to controls. Furthermore, we found a  [CLS] disturbed subcellular distribution of KMT2A for the c.3460C>T [CLS]  mutant. Taken together, our results demonstrated the deleterious impact of the splice variant and of the missense variants located"}
{"subject": "subcellular distribution", "sub_type": "MPA", "rel": "ThemeOf", "object": "disturbed", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " protein, respectively, we found altered KMT2A target genes expression in patient's fibroblasts compared to controls. Furthermore, we found a  [CLS] disturbed subcellular distribution [CLS]  of KMT2A for the c.3460C>T mutant. Taken together, our results demonstrated the deleterious impact of the splice variant and"}
{"subject": "Wiedemann-Steiner syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "involved in", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " [CLS] involved in Wiedemann-Steiner syndrome [CLS] .\nVariants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now,"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "Variants", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " [CLS] Variants in KMT2A [CLS] , encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of"}
{"subject": "intellectual disability", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " issues of KMT2A variants involved in Wiedemann-Steiner syndrome.\nVariants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing  [CLS] cause of intellectual disability [CLS]  (ID). Up to now, the majority of KMT2A variants are non-sense and frameshift variants causing a typical form of"}
{"subject": "Variants", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29203834.json", "snippet": " [CLS] Variants in KMT2A, encoding the histone methyltransferase KMT2A, are a growing cause [CLS]  of intellectual disability (ID). Up to now, the majority of KMT2A variants are non-sense and frameshift variants causing a"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " encoding the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of  [CLS] KMT2A variants [CLS]  are non-sense and frameshift variants causing a typical form of Wiedemann-Steiner syndrome. We studied KMT2A gene in a cohort"}
{"subject": "non-sense", "sub_type": "Var", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of KMT2A  [CLS] variants are non-sense [CLS]  and frameshift variants causing a typical form of Wiedemann-Steiner syndrome. We studied KMT2A gene in a cohort of 200"}
{"subject": "frameshift", "sub_type": "Var", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29203834.json", "snippet": " the histone methyltransferase KMT2A, are a growing cause of intellectual disability (ID). Up to now, the majority of KMT2A  [CLS] variants are non-sense and frameshift [CLS]  variants causing a typical form of Wiedemann-Steiner syndrome. We studied KMT2A gene in a cohort of 200 patients with"}
{"subject": "Abnormalities", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29216801.json", "snippet": " Phenotypic Correlation by Autopsy Examination.\nThe SOX10 gene plays a vital role in neural crest cell development and migration.  [CLS] Abnormalities in SOX10 are associated [CLS]  with Waardenburg syndrome Types II and IV, and these patients have recognizable clinical features. This case report highlights the"}
{"subject": "SOX10", "sub_type": "Gene", "rel": "ThemeOf", "object": "Abnormalities", "obj_type": "Var", "file_name": "PubMed-29216801.json", "snippet": " Phenotypic Correlation by Autopsy Examination.\nThe SOX10 gene plays a vital role in neural crest cell development and migration.  [CLS] Abnormalities in SOX10 [CLS]  are associated with Waardenburg syndrome Types II and IV, and these patients have recognizable clinical features. This case report"}
{"subject": "Waardenburg syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29216801.json", "snippet": " Examination.\nThe SOX10 gene plays a vital role in neural crest cell development and migration. Abnormalities in SOX10 are  [CLS] associated with Waardenburg syndrome [CLS]  Types II and IV, and these patients have recognizable clinical features. This case report highlights the first ever reported"}
{"subject": "Types II", "sub_type": "Disease", "rel": "ThemeOf", "object": "Waardenburg syndrome", "obj_type": "Disease", "file_name": "PubMed-29216801.json", "snippet": " SOX10 gene plays a vital role in neural crest cell development and migration. Abnormalities in SOX10 are associated with  [CLS] Waardenburg syndrome Types II [CLS]  and IV, and these patients have recognizable clinical features. This case report highlights the first ever reported homozygous loss"}
{"subject": "IV", "sub_type": "Disease", "rel": "ThemeOf", "object": "Waardenburg syndrome", "obj_type": "Disease", "file_name": "PubMed-29216801.json", "snippet": " SOX10 gene plays a vital role in neural crest cell development and migration. Abnormalities in SOX10 are associated with  [CLS] Waardenburg syndrome Types II and IV [CLS] , and these patients have recognizable clinical features. This case report highlights the first ever reported homozygous loss of function"}
{"subject": "NR2F2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29222010.json", "snippet": " [CLS] NR2F2 loss-of-function mutation [CLS]  predisposes to congenital heart defect.\nCongenital heart defect (CHD) is the most common type of birth defect in humans"}
{"subject": "NR2F2", "sub_type": "Gene", "rel": "ThemeOf", "object": "synergistic transcriptional activation", "obj_type": "MPA", "file_name": "PubMed-29222010.json", "snippet": " the mutant NR2F2 protein had no transcriptional activity as compared with its wild-type counterpart. Furthermore, the mutation abrogated the  [CLS] synergistic transcriptional activation between NR2F2 [CLS]  and GATA4, another core cardiac transcription factor associated with CHD. This study firstly associates NR2F2 loss-of-function mutation with an"}
{"subject": "GATA4", "sub_type": "Gene", "rel": "ThemeOf", "object": "synergistic transcriptional activation", "obj_type": "MPA", "file_name": "PubMed-29222010.json", "snippet": " the mutant NR2F2 protein had no transcriptional activity as compared with its wild-type counterpart. Furthermore, the mutation abrogated the  [CLS] synergistic transcriptional activation between NR2F2 and GATA4 [CLS] , another core cardiac transcription factor associated with CHD. This study firstly associates NR2F2 loss-of-function mutation with an increased susceptibility"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29222010.json", "snippet": " [CLS] loss-of-function mutation [CLS]  predisposes to congenital heart defect.\nCongenital heart defect (CHD) is the most common type of birth defect in humans"}
{"subject": "congenital heart defect", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29222010.json", "snippet": " [CLS] loss-of-function mutation predisposes to congenital heart defect [CLS] .\nCongenital heart defect (CHD) is the most common type of birth defect in humans and a leading cause of"}
{"subject": "NR2F2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29222010.json", "snippet": " unrelated, ethnically-matched healthy individuals used as controls. Functional deciphers by using a dual-luciferase reporter assay system revealed that the  [CLS] mutant NR2F2 [CLS]  protein had no transcriptional activity as compared with its wild-type counterpart. Furthermore, the mutation abrogated the synergistic transcriptional activation"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "no", "obj_type": "NegReg", "file_name": "PubMed-29222010.json", "snippet": " unrelated, ethnically-matched healthy individuals used as controls. Functional deciphers by using a dual-luciferase reporter assay system revealed that the  [CLS] mutant NR2F2 protein had no [CLS]  transcriptional activity as compared with its wild-type counterpart. Furthermore, the mutation abrogated the synergistic transcriptional activation between NR2F2 and"}
{"subject": "transcriptional activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "no", "obj_type": "NegReg", "file_name": "PubMed-29222010.json", "snippet": " used as controls. Functional deciphers by using a dual-luciferase reporter assay system revealed that the mutant NR2F2 protein had  [CLS] no transcriptional activity [CLS]  as compared with its wild-type counterpart. Furthermore, the mutation abrogated the synergistic transcriptional activation between NR2F2 and GATA4, another"}
{"subject": "NR2F2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29222010.json", "snippet": " ethnically-matched healthy individuals used as controls. Functional deciphers by using a dual-luciferase reporter assay system revealed that the mutant  [CLS] NR2F2 protein had no transcriptional activity as compared with its wild-type counterpart. Furthermore, the mutation [CLS]  abrogated the synergistic transcriptional activation between NR2F2 and GATA4, another core cardiac transcription factor associated with CHD. This study"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "abrogated", "obj_type": "NegReg", "file_name": "PubMed-29222010.json", "snippet": " system revealed that the mutant NR2F2 protein had no transcriptional activity as compared with its wild-type counterpart. Furthermore, the  [CLS] mutation abrogated [CLS]  the synergistic transcriptional activation between NR2F2 and GATA4, another core cardiac transcription factor associated with CHD. This study firstly"}
{"subject": "synergistic transcriptional activation", "sub_type": "MPA", "rel": "ThemeOf", "object": "abrogated", "obj_type": "NegReg", "file_name": "PubMed-29222010.json", "snippet": " revealed that the mutant NR2F2 protein had no transcriptional activity as compared with its wild-type counterpart. Furthermore, the mutation  [CLS] abrogated the synergistic transcriptional activation [CLS]  between NR2F2 and GATA4, another core cardiac transcription factor associated with CHD. This study firstly associates NR2F2 loss-of-function mutation"}
{"subject": "FMR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "expansion of 55-200 CGG repeats", "obj_type": "Var", "file_name": "PubMed-29223504.json", "snippet": " Syndrome: RAN translation and/or RNA gain-of-function?\nFragile X-associated tremor/ataxia syndrome (FXTAS) is an inherited neurodegenerative disease caused by an  [CLS] expansion of 55-200 CGG repeats located in the FMR1 [CLS]  gene. The main clinical and neuropathological features of FXTAS are progressive intention tremor and gait ataxia associated with brain"}
{"subject": "expansion of 55-200 CGG repeats", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29223504.json", "snippet": " X Tremor Ataxia Syndrome: RAN translation and/or RNA gain-of-function?\nFragile X-associated tremor/ataxia syndrome (FXTAS) is an inherited neurodegenerative disease  [CLS] caused by an expansion of 55-200 CGG repeats [CLS]  located in the FMR1 gene. The main clinical and neuropathological features of FXTAS are progressive intention tremor and gait"}
{"subject": "Fragile X-associated tremor/ataxia syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29223504.json", "snippet": " [CLS] Fragile X-associated tremor/ataxia syndrome (FXTAS) is an inherited neurodegenerative disease caused by [CLS]  an expansion of 55-200 CGG repeats located in the FMR1 gene. The main clinical and neuropathological features of FXTAS"}
{"subject": "DCHS1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29224215.json", "snippet": " [CLS] variants in DCHS1 [CLS]  are prevalent in sporadic cases of mitral valve prolapse.\nBACKGROUND: A recent study identified DCHS1 as a causal gene"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "prevalent", "obj_type": "Reg", "file_name": "PubMed-29224215.json", "snippet": " [CLS] variants in DCHS1 are prevalent [CLS]  in sporadic cases of mitral valve prolapse.\nBACKGROUND: A recent study identified DCHS1 as a causal gene for mitral"}
{"subject": "mitral valve prolapse", "sub_type": "Disease", "rel": "ThemeOf", "object": "prevalent", "obj_type": "Reg", "file_name": "PubMed-29224215.json", "snippet": " [CLS] prevalent in sporadic cases of mitral valve prolapse [CLS] .\nBACKGROUND: A recent study identified DCHS1 as a causal gene for mitral valve prolapse. The goal of this study"}
{"subject": "DCHS1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.R2330C", "obj_type": "Var", "file_name": "PubMed-29224215.json", "snippet": " to severe organic mitral regurgitation.\nMETHODS: DNA sequencing assays were developed for two previously identified functional missense variants, namely  [CLS] p.R2330C and p.R2513H, and all 21 exons of DCHS1 [CLS] . Pathogenicity of variants was evaluated in silico.\nRESULTS: p.R2330C and p.R2513H were not identified in this cohort. Sequencing all"}
{"subject": "DCHS1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.R2513H", "obj_type": "Var", "file_name": "PubMed-29224215.json", "snippet": " organic mitral regurgitation.\nMETHODS: DNA sequencing assays were developed for two previously identified functional missense variants, namely p.R2330C and  [CLS] p.R2513H, and all 21 exons of DCHS1 [CLS] . Pathogenicity of variants was evaluated in silico.\nRESULTS: p.R2330C and p.R2513H were not identified in this cohort. Sequencing all"}
{"subject": "PSMC3IP", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutation", "obj_type": "Var", "file_name": "PubMed-29240891.json", "snippet": " [CLS] PSMC3IP Stop Gain Mutation [CLS] .\nContext: The etiology of primary ovarian insufficiency (POI) remains unknown in most cases.\nObjective: We sought to identify the"}
{"subject": "Mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Carriers", "obj_type": "Reg", "file_name": "PubMed-29240891.json", "snippet": " [CLS] Carriers of a Homozygous PSMC3IP Stop Gain Mutation [CLS] .\nContext: The etiology of primary ovarian insufficiency (POI) remains unknown in most cases.\nObjective: We sought to identify the"}
{"subject": "Azoospermia", "sub_type": "Disease", "rel": "ThemeOf", "object": "Carriers", "obj_type": "Reg", "file_name": "PubMed-29240891.json", "snippet": " [CLS] Azoospermia in Carriers [CLS]  of a Homozygous PSMC3IP Stop Gain Mutation.\nContext: The etiology of primary ovarian insufficiency (POI) remains unknown in most"}
{"subject": "Primary Ovarian Insufficiency", "sub_type": "Disease", "rel": "ThemeOf", "object": "Carriers", "obj_type": "Reg", "file_name": "PubMed-29240891.json", "snippet": " [CLS] Primary Ovarian Insufficiency and Azoospermia in Carriers [CLS]  of a Homozygous PSMC3IP Stop Gain Mutation.\nContext: The etiology of primary ovarian insufficiency (POI) remains unknown in most"}
{"subject": "c.100C>T", "sub_type": "Var", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29240891.json", "snippet": " gain mutation in exon 6 of PSMC3IP (c.489 C>G, p.Tyr163Ter) and a missense variant in exon 1 of CLPP ( [CLS] c.100C>T, p.Pro34Ser). The affected brother also carried the homozygous PSMC3IP mutation. Functional studies demonstrated mitochondrial fragmentation in cells infected with the CLPP mutation [CLS] . However, no abnormality was found in mitochondrial targeting or respiration.\nConclusions: The PSMC3IP mutation provides additional evidence that mutations"}
{"subject": "CLPP", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29240891.json", "snippet": " The affected brother also carried the homozygous PSMC3IP mutation. Functional studies demonstrated mitochondrial fragmentation in cells infected with the  [CLS] CLPP mutation [CLS] . However, no abnormality was found in mitochondrial targeting or respiration.\nConclusions: The PSMC3IP mutation provides additional evidence that mutations"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "demonstrated", "obj_type": "Reg", "file_name": "PubMed-29240891.json", "snippet": " variant in exon 1 of CLPP (c.100C>T, p.Pro34Ser). The affected brother also carried the homozygous PSMC3IP mutation. Functional studies  [CLS] demonstrated mitochondrial fragmentation in cells infected with the CLPP mutation [CLS] . However, no abnormality was found in mitochondrial targeting or respiration.\nConclusions: The PSMC3IP mutation provides additional evidence that mutations"}
{"subject": "mitochondrial fragmentation", "sub_type": "CPA", "rel": "ThemeOf", "object": "demonstrated", "obj_type": "Reg", "file_name": "PubMed-29240891.json", "snippet": " variant in exon 1 of CLPP (c.100C>T, p.Pro34Ser). The affected brother also carried the homozygous PSMC3IP mutation. Functional studies  [CLS] demonstrated mitochondrial fragmentation [CLS]  in cells infected with the CLPP mutation. However, no abnormality was found in mitochondrial targeting or respiration.\nConclusions: The"}
{"subject": "hop-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29242286.json", "snippet": " Notch signaling. We also show that HOP-1 is necessary for maximum fecundity and reproductive span. The low-fecundity phenotype of  [CLS] hop-1 mutants [CLS]  can be phenocopied by switching off glp-1/Notch function during the last stage of larval development. We propose that at"}
{"subject": "production", "sub_type": "CPA", "rel": "ThemeOf", "object": "defects", "obj_type": "NegReg", "file_name": "PubMed-29242286.json", "snippet": " dual presenilin usage switches exclusively to HOP-1, perhaps offering opportunities for differential regulation of the germline during adulthood. Additional  [CLS] defects in oocyte size and production [CLS]  rate in hop-1 and glp-1 mutants indicate that the process of oogenesis is compromised when germline Notch signaling is"}
{"subject": "oocyte size", "sub_type": "CPA", "rel": "ThemeOf", "object": "defects", "obj_type": "NegReg", "file_name": "PubMed-29242286.json", "snippet": " dual presenilin usage switches exclusively to HOP-1, perhaps offering opportunities for differential regulation of the germline during adulthood. Additional  [CLS] defects in oocyte size [CLS]  and production rate in hop-1 and glp-1 mutants indicate that the process of oogenesis is compromised when germline Notch"}
{"subject": "fecundity", "sub_type": "CPA", "rel": "ThemeOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-29242286.json", "snippet": " exclusively on HOP-1-mediated Notch signaling. We also show that HOP-1 is necessary for maximum fecundity and reproductive span. The  [CLS] low-fecundity [CLS]  phenotype of hop-1 mutants can be phenocopied by switching off glp-1/Notch function during the last stage of larval development."}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "switching off", "obj_type": "NegReg", "file_name": "PubMed-29242286.json", "snippet": " signaling. We also show that HOP-1 is necessary for maximum fecundity and reproductive span. The low-fecundity phenotype of hop-1  [CLS] mutants can be phenocopied by switching off [CLS]  glp-1/Notch function during the last stage of larval development. We propose that at the end of larval development, dual"}
{"subject": "glp-1/Notch function", "sub_type": "MPA", "rel": "ThemeOf", "object": "switching off", "obj_type": "NegReg", "file_name": "PubMed-29242286.json", "snippet": " HOP-1 is necessary for maximum fecundity and reproductive span. The low-fecundity phenotype of hop-1 mutants can be phenocopied by  [CLS] switching off glp-1/Notch function [CLS]  during the last stage of larval development. We propose that at the end of larval development, dual presenilin usage"}
{"subject": "switching off", "sub_type": "NegReg", "rel": "CauseOf", "object": "fecundity", "obj_type": "CPA", "file_name": "PubMed-29242286.json", "snippet": " exclusively on HOP-1-mediated Notch signaling. We also show that HOP-1 is necessary for maximum fecundity and reproductive span. The low- [CLS] fecundity phenotype of hop-1 mutants can be phenocopied by switching off [CLS]  glp-1/Notch function during the last stage of larval development. We propose that at the end of larval development, dual"}
{"subject": "glp-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29242286.json", "snippet": " for differential regulation of the germline during adulthood. Additional defects in oocyte size and production rate in hop-1 and  [CLS] glp-1 mutants [CLS]  indicate that the process of oogenesis is compromised when germline Notch signaling is switched off. We calculate that in"}
{"subject": "hop-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29242286.json", "snippet": " offering opportunities for differential regulation of the germline during adulthood. Additional defects in oocyte size and production rate in  [CLS] hop-1 and glp-1 mutants [CLS]  indicate that the process of oogenesis is compromised when germline Notch signaling is switched off. We calculate that in"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "defects", "obj_type": "NegReg", "file_name": "PubMed-29242286.json", "snippet": " dual presenilin usage switches exclusively to HOP-1, perhaps offering opportunities for differential regulation of the germline during adulthood. Additional  [CLS] defects in oocyte size and production rate in hop-1 and glp-1 mutants [CLS]  indicate that the process of oogenesis is compromised when germline Notch signaling is switched off. We calculate that in"}
{"subject": "lac4", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29242289.json", "snippet": " short telomeres produced a large increase in the frequency of mutations affecting the native subtelomeric \u03b2-galactosidase (LAC4) gene. All  [CLS] lac4 mutants [CLS]  examined from strains with severe telomere dysfunction underwent terminal deletion/duplication events consistent with being due to break-induced replication. In"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "underwent", "obj_type": "Reg", "file_name": "PubMed-29242289.json", "snippet": " telomeres produced a large increase in the frequency of mutations affecting the native subtelomeric \u03b2-galactosidase (LAC4) gene. All lac4  [CLS] mutants examined from strains with severe telomere dysfunction underwent [CLS]  terminal deletion/duplication events consistent with being due to break-induced replication. In contrast, although cells with mild telomere dysfunction also"}
{"subject": "terminal deletion/duplication", "sub_type": "MPA", "rel": "ThemeOf", "object": "underwent", "obj_type": "Reg", "file_name": "PubMed-29242289.json", "snippet": " of mutations affecting the native subtelomeric \u03b2-galactosidase (LAC4) gene. All lac4 mutants examined from strains with severe telomere dysfunction  [CLS] underwent terminal deletion/duplication [CLS]  events consistent with being due to break-induced replication. In contrast, although cells with mild telomere dysfunction also exhibited similar"}
{"subject": "lac4", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29242289.json", "snippet": " contrast, although cells with mild telomere dysfunction also exhibited similar terminal deletion and duplication events, up to 50% of  [CLS] lac4 mutants [CLS]  from this background unexpectedly contained base changes within the LAC4 coding region. This mutational bias for producing base changes"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "contained", "obj_type": "Reg", "file_name": "PubMed-29242289.json", "snippet": " although cells with mild telomere dysfunction also exhibited similar terminal deletion and duplication events, up to 50% of lac4  [CLS] mutants from this background unexpectedly contained [CLS]  base changes within the LAC4 coding region. This mutational bias for producing base changes demonstrates that mild telomere dysfunction"}
{"subject": "base changes", "sub_type": "MPA", "rel": "ThemeOf", "object": "contained", "obj_type": "Reg", "file_name": "PubMed-29242289.json", "snippet": " dysfunction also exhibited similar terminal deletion and duplication events, up to 50% of lac4 mutants from this background unexpectedly  [CLS] contained base changes [CLS]  within the LAC4 coding region. This mutational bias for producing base changes demonstrates that mild telomere dysfunction can be"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29255178.json", "snippet": " [CLS] loss of function variants [CLS]  in either of two genes encoding histone-modifying enzymes. We performed targeted sequencing in a cohort of 27 probands with"}
{"subject": "Kabuki syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29255178.json", "snippet": " [CLS] Kabuki syndrome is a monogenic disorder caused by loss of function [CLS]  variants in either of two genes encoding histone-modifying enzymes. We performed targeted sequencing in a cohort of 27 probands"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29255178.json", "snippet": " causative variants in the two known Kabuki syndrome genes. In 2, we identified presumptive loss of function de novo  [CLS] variants in KMT2A (missense and splice site variants), a gene that encodes another histone modifying enzyme previously exclusively associated [CLS]  with Wiedermann-Steiner syndrome. Although Kabuki syndrome is a disorder of histone modification, we also find alterations in DNA methylation"}
{"subject": "Wiedermann-Steiner syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29255178.json", "snippet": " novo variants in KMT2A (missense and splice site variants), a gene that encodes another histone modifying enzyme previously exclusively  [CLS] associated with Wiedermann-Steiner syndrome [CLS] . Although Kabuki syndrome is a disorder of histone modification, we also find alterations in DNA methylation among individuals with"}
{"subject": "KMT2A", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29255178.json", "snippet": " causative variants in the two known Kabuki syndrome genes. In 2, we identified presumptive loss of function de novo  [CLS] variants in KMT2A [CLS]  (missense and splice site variants), a gene that encodes another histone modifying enzyme previously exclusively associated with Wiedermann-Steiner syndrome."}
{"subject": "ARL13B", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29255182.json", "snippet": " [CLS] ARL13B variant [CLS]  in patients with Joubert syndrome impairs its guanine nucleotide-exchange factor activity.\nARL13B encodes for the ADP-ribosylation factor-like 13B GTPase,"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29255182.json", "snippet": " [CLS] variant in patients with Joubert syndrome impairs [CLS]  its guanine nucleotide-exchange factor activity.\nARL13B encodes for the ADP-ribosylation factor-like 13B GTPase, which is required for normal cilia"}
{"subject": "guanine nucleotide-exchange factor activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29255182.json", "snippet": " [CLS] impairs its guanine nucleotide-exchange factor activity [CLS] .\nARL13B encodes for the ADP-ribosylation factor-like 13B GTPase, which is required for normal cilia structure and Sonic hedgehog (Shh)"}
{"subject": "ARL13B", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.[223G>A]", "obj_type": "Var", "file_name": "PubMed-29255182.json", "snippet": " defects displayed by Arl13b hennin (null) cells, indicating that the variant did not disrupt either ARL13B function. In contrast,  [CLS] ARL13B-c.[223G>A] [CLS]  (p.(Gly75Arg) displayed a marked loss of ARL3 guanine nucleotide-exchange factor activity, with retention of its GTPase activities, highlighting the"}
{"subject": "c.[223G>A]", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29255182.json", "snippet": " defects displayed by Arl13b hennin (null) cells, indicating that the variant did not disrupt either ARL13B function. In contrast, ARL13B- [CLS] c.[223G>A] (p.(Gly75Arg) displayed a marked loss [CLS]  of ARL3 guanine nucleotide-exchange factor activity, with retention of its GTPase activities, highlighting the correlation between its loss of"}
{"subject": "ARL3 guanine nucleotide-exchange factor activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29255182.json", "snippet": " (null) cells, indicating that the variant did not disrupt either ARL13B function. In contrast, ARL13B-c.[223G>A] (p.(Gly75Arg) displayed a marked  [CLS] loss of ARL3 guanine nucleotide-exchange factor activity [CLS] , with retention of its GTPase activities, highlighting the correlation between its loss of function as an ARL3 guanine nucleotide-exchange"}
{"subject": "Joubert syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29255182.json", "snippet": " (null) cells, indicating that the variant did not disrupt either ARL13B function. In contrast, ARL13B-c.[223G>A] (p.(Gly75Arg) displayed a marked  [CLS] loss of ARL3 guanine nucleotide-exchange factor activity, with retention of its GTPase activities, highlighting the correlation between its loss of function as an ARL3 guanine nucleotide-exchange factor and Joubert syndrome [CLS] ."}
{"subject": "ABCC9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " [CLS] ABCC9) mutations [CLS]  in distinct structural domains result in KATP channel gain-of-function by differential mechanisms.\nThe complex disorder Cantu syndrome (CS) arises"}
{"subject": "channel activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such mutations can  [CLS] increase channel activity [CLS]  by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is altered by several"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such  [CLS] mutations can increase [CLS]  channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is altered"}
{"subject": "SUR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "D207E", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of  [CLS] SUR2: D207E [CLS]  in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions"}
{"subject": "SUR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Y985S", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of  [CLS] SUR2: D207E in the intracellular L0-linker and Y985S [CLS] , G989E, M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E,"}
{"subject": "SUR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "G989E", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of  [CLS] SUR2: D207E in the intracellular L0-linker and Y985S, G989E [CLS] , M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I,"}
{"subject": "SUR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "M1060I", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of  [CLS] SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I [CLS] , and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and"}
{"subject": "SUR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "R1154Q", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of  [CLS] SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q [CLS] /R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and"}
{"subject": "SUR2", "sub_type": "Gene", "rel": "ThemeOf", "object": "R1154W", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " study, we determined the mechanism by which KATP function is altered by several substitutions in distinct structural domains of  [CLS] SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q/R1154W [CLS]  in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and"}
{"subject": "R1154W", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29275331.json", "snippet": " increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is  [CLS] altered by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q/R1154W [CLS]  in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and"}
{"subject": "R1154Q", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29275331.json", "snippet": " increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is  [CLS] altered by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q [CLS] /R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " [CLS] mutations in distinct structural domains result in KATP channel gain-of-function [CLS]  by differential mechanisms.\nThe complex disorder Cantu syndrome (CS) arises from gain-of-function mutations in either KCNJ8 or ABCC9, the"}
{"subject": "Y985S", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29275331.json", "snippet": " increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is  [CLS] altered by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S [CLS] , G989E, M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E,"}
{"subject": "G989E", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29275331.json", "snippet": " increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is  [CLS] altered by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S, G989E [CLS] , M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I,"}
{"subject": "M1060I", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29275331.json", "snippet": " increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function is  [CLS] altered by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I [CLS] , and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and"}
{"subject": "KATP function", "sub_type": "MPA", "rel": "ThemeOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29275331.json", "snippet": " such mutations can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which  [CLS] KATP function is altered [CLS]  by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I, and"}
{"subject": "D207E", "sub_type": "Var", "rel": "CauseOf", "object": "increasing", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux assays and patch-clamp electrophysiology. Our results indicate that  [CLS] D207E increases KATP channel activity by increasing [CLS]  intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented Mg-nucleotide activation."}
{"subject": "intrinsic stability of the open state", "sub_type": "MPA", "rel": "ThemeOf", "object": "increasing", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " using macroscopic rubidium (86Rb+) efflux assays and patch-clamp electrophysiology. Our results indicate that D207E increases KATP channel activity by  [CLS] increasing intrinsic stability of the open state [CLS] , whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented Mg-nucleotide activation. We also tested the responses of"}
{"subject": "increasing", "sub_type": "PosReg", "rel": "CauseOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux assays and patch-clamp electrophysiology. Our results indicate that D207E  [CLS] increases KATP channel activity by increasing [CLS]  intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented Mg-nucleotide activation."}
{"subject": "KATP channel activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increases", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (86Rb+) efflux assays and patch-clamp electrophysiology. Our results indicate that D207E  [CLS] increases KATP channel activity [CLS]  by increasing intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented"}
{"subject": "Y981S", "sub_type": "Var", "rel": "CauseOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " indicate that D207E increases KATP channel activity by increasing intrinsic stability of the open state, whereas the cluster of  [CLS] Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented [CLS]  Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a"}
{"subject": "G985E", "sub_type": "Var", "rel": "CauseOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " indicate that D207E increases KATP channel activity by increasing intrinsic stability of the open state, whereas the cluster of Y981S/ [CLS] G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented [CLS]  Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a"}
{"subject": "KATP channel", "sub_type": "MPA", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " [CLS] KATP channel gain-of-function [CLS]  by differential mechanisms.\nThe complex disorder Cantu syndrome (CS) arises from gain-of-function mutations in either KCNJ8 or ABCC9, the"}
{"subject": "M1056I", "sub_type": "Var", "rel": "CauseOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " indicate that D207E increases KATP channel activity by increasing intrinsic stability of the open state, whereas the cluster of Y981S/G985E/ [CLS] M1056I substitutions, as well as R1150Q/R1150W, augmented [CLS]  Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a"}
{"subject": "R1150Q", "sub_type": "Var", "rel": "CauseOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " channel activity by increasing intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as  [CLS] R1150Q/R1150W, augmented [CLS]  Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a"}
{"subject": "R1150W", "sub_type": "Var", "rel": "CauseOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " channel activity by increasing intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/ [CLS] R1150W, augmented [CLS]  Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a"}
{"subject": "Mg-nucleotide activation", "sub_type": "MPA", "rel": "ThemeOf", "object": "augmented", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " activity by increasing intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W,  [CLS] augmented Mg-nucleotide activation [CLS] . We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a potential pharmacotherapy"}
{"subject": "KCNJ8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " structural domains result in KATP channel gain-of-function by differential mechanisms.\nThe complex disorder Cantu syndrome (CS) arises from gain-of-function  [CLS] mutations in either KCNJ8 [CLS]  or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate"}
{"subject": "ABCC9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " structural domains result in KATP channel gain-of-function by differential mechanisms.\nThe complex disorder Cantu syndrome (CS) arises from gain-of-function  [CLS] mutations in either KCNJ8 or ABCC9 [CLS] , the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such"}
{"subject": "Cantu syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " syndrome-associated SUR2 (ABCC9) mutations in distinct structural domains result in KATP channel gain-of-function by differential mechanisms.\nThe complex disorder  [CLS] Cantu syndrome (CS) arises from gain-of-function [CLS]  mutations in either KCNJ8 or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels,"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29275331.json", "snippet": " distinct structural domains result in KATP channel gain-of-function by differential mechanisms.\nThe complex disorder Cantu syndrome (CS) arises from  [CLS] gain-of-function mutations [CLS]  in either KCNJ8 or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively."}
{"subject": "KCNJ8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " in KATP channel gain-of-function by differential mechanisms.\nThe complex disorder Cantu syndrome (CS) arises from gain-of-function mutations in either  [CLS] KCNJ8 or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such mutations [CLS]  can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function"}
{"subject": "ABCC9", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29275331.json", "snippet": " channel gain-of-function by differential mechanisms.\nThe complex disorder Cantu syndrome (CS) arises from gain-of-function mutations in either KCNJ8 or  [CLS] ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (KATP) channels, respectively. Recent reports indicate that such mutations [CLS]  can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which KATP function"}
{"subject": "PLC3", "sub_type": "Gene", "rel": "ThemeOf", "object": "knock-down mutants", "obj_type": "Var", "file_name": "PubMed-29309666.json", "snippet": " genome encodes nine PLCs. We used a reversed-genetic approach to explore PLC's function in Arabidopsis, and report here that  [CLS] PLC3 is required for proper root development, seed germination and stomatal opening. Two independent knock-down mutants [CLS] , plc3-2 and plc3-3, were found to exhibit reduced lateral root densities by 10-20%. Mutant seeds germinated more slowly but"}
{"subject": "knock-down mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29309666.json", "snippet": " Arabidopsis, and report here that PLC3 is required for proper root development, seed germination and stomatal opening. Two independent  [CLS] knock-down mutants, plc3-2 and plc3-3, were found to exhibit reduced [CLS]  lateral root densities by 10-20%. Mutant seeds germinated more slowly but were less sensitive to ABA to prevent germination."}
{"subject": "lateral root densities", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29309666.json", "snippet": " proper root development, seed germination and stomatal opening. Two independent knock-down mutants, plc3-2 and plc3-3, were found to exhibit  [CLS] reduced lateral root densities [CLS]  by 10-20%. Mutant seeds germinated more slowly but were less sensitive to ABA to prevent germination. Guard cells of"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "slowly", "obj_type": "NegReg", "file_name": "PubMed-29309666.json", "snippet": " stomatal opening. Two independent knock-down mutants, plc3-2 and plc3-3, were found to exhibit reduced lateral root densities by 10-20%.  [CLS] Mutant seeds germinated more slowly [CLS]  but were less sensitive to ABA to prevent germination. Guard cells of plc3 were also compromised in ABA-dependent stomatal"}
{"subject": "germinated", "sub_type": "CPA", "rel": "ThemeOf", "object": "slowly", "obj_type": "NegReg", "file_name": "PubMed-29309666.json", "snippet": " Two independent knock-down mutants, plc3-2 and plc3-3, were found to exhibit reduced lateral root densities by 10-20%. Mutant seeds  [CLS] germinated more slowly [CLS]  but were less sensitive to ABA to prevent germination. Guard cells of plc3 were also compromised in ABA-dependent stomatal"}
{"subject": "plc3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29309666.json", "snippet": " ABA stimulated the formation of PIP2 in germinating seeds and guard cell-enriched leaf peels, which was significantly reduced in  [CLS] plc3 mutants [CLS] . Overexpression of PLC3 had no effect on root system architecture or seed germination, but increased the plant's tolerance to"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29309666.json", "snippet": " revealed that ABA stimulated the formation of PIP2 in germinating seeds and guard cell-enriched leaf peels, which was significantly  [CLS] reduced in plc3 mutants [CLS] . Overexpression of PLC3 had no effect on root system architecture or seed germination, but increased the plant's tolerance to"}
{"subject": "formation of PIP2", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29309666.json", "snippet": " most probably phloem companion cells, in roots, leaves and flowers. In vivo 32Pi labeling revealed that ABA stimulated the  [CLS] formation of PIP2 in germinating seeds and guard cell-enriched leaf peels, which was significantly reduced [CLS]  in plc3 mutants. Overexpression of PLC3 had no effect on root system architecture or seed germination, but increased the"}
{"subject": "N-methyl-D-aspartate glutamate receptors", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29317596.json", "snippet": " [CLS] mutations in N-methyl-D-aspartate glutamate receptors [CLS]  and their contributions to schizophrenia susceptibility.\nIn schizophrenia (SCZ) and autism spectrum disorder (ASD), the dysregulation of glutamate transmission"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29317596.json", "snippet": " [CLS] loss of function mutations [CLS]  in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility.\nIn schizophrenia (SCZ) and autism spectrum disorder (ASD), the"}
{"subject": "schizophrenia", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29317596.json", "snippet": " [CLS] loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia [CLS]  susceptibility.\nIn schizophrenia (SCZ) and autism spectrum disorder (ASD), the dysregulation of glutamate transmission through N-methyl-D-aspartate receptors (NMDARs) has"}
{"subject": "NMDARs", "sub_type": "Gene", "rel": "ThemeOf", "object": "nonsense or splice site", "obj_type": "Var", "file_name": "PubMed-29317596.json", "snippet": " be singleton. Our study gives evidence in support of the view that ultra-rare variants with loss of function (frameshift,  [CLS] nonsense or splice site) in NMDARs [CLS]  genes may contribute to possible risk of SCZ."}
{"subject": "NMDARs", "sub_type": "Gene", "rel": "ThemeOf", "object": "frameshift", "obj_type": "Var", "file_name": "PubMed-29317596.json", "snippet": " to be singleton. Our study gives evidence in support of the view that ultra-rare variants with loss of function ( [CLS] frameshift, nonsense or splice site) in NMDARs [CLS]  genes may contribute to possible risk of SCZ."}
{"subject": "frameshift", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29317596.json", "snippet": " them were revealed to be singleton. Our study gives evidence in support of the view that ultra-rare variants with  [CLS] loss of function (frameshift [CLS] , nonsense or splice site) in NMDARs genes may contribute to possible risk of SCZ."}
{"subject": "nonsense or splice site", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29317596.json", "snippet": " them were revealed to be singleton. Our study gives evidence in support of the view that ultra-rare variants with  [CLS] loss of function (frameshift, nonsense or splice site [CLS] ) in NMDARs genes may contribute to possible risk of SCZ."}
{"subject": "SCZ", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29317596.json", "snippet": " them were revealed to be singleton. Our study gives evidence in support of the view that ultra-rare variants with  [CLS] loss of function (frameshift, nonsense or splice site) in NMDARs genes may contribute to possible risk of SCZ [CLS] ."}
{"subject": "fln1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29319227.json", "snippet": " polymerase chain reaction and immunoblot analysis revealed that the transcription and translation of PEP-dependent genes were strongly inhibited in  [CLS] fln1 and trxz mutants [CLS] , indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the stability of the transcriptionally active chromosome complex and"}
{"subject": "stability of the transcriptionally active chromosome complex", "sub_type": "CPA", "rel": "ThemeOf", "object": "perturbs", "obj_type": "NegReg", "file_name": "PubMed-29319227.json", "snippet": " PEP-dependent genes were strongly inhibited in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function  [CLS] perturbs the stability of the transcriptionally active chromosome complex [CLS]  and PEP activity. These results show that OsFLN1 and HSA1/OsFLN2 contribute to chloroplast biogenesis and plant growth."}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "inhibited", "obj_type": "NegReg", "file_name": "PubMed-29319227.json", "snippet": " reverse transcription polymerase chain reaction and immunoblot analysis revealed that the transcription and translation of PEP-dependent genes were strongly  [CLS] inhibited in fln1 and trxz mutants [CLS] , indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the stability of the transcriptionally active chromosome complex and"}
{"subject": "transcription", "sub_type": "MPA", "rel": "ThemeOf", "object": "inhibited", "obj_type": "NegReg", "file_name": "PubMed-29319227.json", "snippet": " phenotype to that of the fln1 mutants. Quantitative reverse transcription polymerase chain reaction and immunoblot analysis revealed that the  [CLS] transcription and translation of PEP-dependent genes were strongly inhibited [CLS]  in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the stability of the"}
{"subject": "translation", "sub_type": "MPA", "rel": "ThemeOf", "object": "inhibited", "obj_type": "NegReg", "file_name": "PubMed-29319227.json", "snippet": " that of the fln1 mutants. Quantitative reverse transcription polymerase chain reaction and immunoblot analysis revealed that the transcription and  [CLS] translation of PEP-dependent genes were strongly inhibited [CLS]  in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the stability of the"}
{"subject": "PEP-dependent genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "translation", "obj_type": "MPA", "file_name": "PubMed-29319227.json", "snippet": " that of the fln1 mutants. Quantitative reverse transcription polymerase chain reaction and immunoblot analysis revealed that the transcription and  [CLS] translation of PEP-dependent genes [CLS]  were strongly inhibited in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the"}
{"subject": "PEP-dependent genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "transcription", "obj_type": "MPA", "file_name": "PubMed-29319227.json", "snippet": " phenotype to that of the fln1 mutants. Quantitative reverse transcription polymerase chain reaction and immunoblot analysis revealed that the  [CLS] transcription and translation of PEP-dependent genes [CLS]  were strongly inhibited in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the"}
{"subject": "inhibited", "sub_type": "NegReg", "rel": "CauseOf", "object": "perturbs", "obj_type": "NegReg", "file_name": "PubMed-29319227.json", "snippet": " reverse transcription polymerase chain reaction and immunoblot analysis revealed that the transcription and translation of PEP-dependent genes were strongly  [CLS] inhibited in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs [CLS]  the stability of the transcriptionally active chromosome complex and PEP activity. These results show that OsFLN1 and HSA1/OsFLN2 contribute"}
{"subject": "PEP", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-29319227.json", "snippet": " indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function perturbs the stability of the transcriptionally active chromosome complex and  [CLS] PEP activity [CLS] . These results show that OsFLN1 and HSA1/OsFLN2 contribute to chloroplast biogenesis and plant growth."}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "perturbs", "obj_type": "NegReg", "file_name": "PubMed-29319227.json", "snippet": " PEP-dependent genes were strongly inhibited in fln1 and trxz mutants, indicating that loss of OsFLN1, HSA1/OsFLN2, or OsTRXz function  [CLS] perturbs the stability of the transcriptionally active chromosome complex and PEP activity [CLS] . These results show that OsFLN1 and HSA1/OsFLN2 contribute to chloroplast biogenesis and plant growth."}
{"subject": "SHP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K", "obj_type": "Var", "file_name": "PubMed-29323748.json", "snippet": " [CLS] E76K in SHP2 [CLS]  promotes CAC tumorigenesis and induces EMT via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "aggravated", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " (CAC) and used the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11 [CLS] E76K conditional knock-in mice exhibited aggravated [CLS]  inflammation and increased CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced"}
{"subject": "inflammation", "sub_type": "CPA", "rel": "ThemeOf", "object": "aggravated", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited  [CLS] aggravated inflammation [CLS]  and increased CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " (CAC) and used the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11 [CLS] E76K conditional knock-in mice exhibited aggravated inflammation and increased [CLS]  CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT)"}
{"subject": "SHP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K", "obj_type": "Var", "file_name": "PubMed-29323748.json", "snippet": " relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. In vitro,  [CLS] SHP2E76K [CLS]  and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway."}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. In vitro, SHP2 [CLS] E76K and SHP2WT promoted [CLS]  malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "induced", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. In vitro, SHP2 [CLS] E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced [CLS]  epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that"}
{"subject": "malignant biological behaviors of CRC cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "promoted", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT  [CLS] promoted malignant biological behaviors of CRC cells [CLS]  and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an"}
{"subject": "epithelial-mesenchymal transition", "sub_type": "CPA", "rel": "ThemeOf", "object": "induced", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " aggravated inflammation and increased CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and  [CLS] induced epithelial-mesenchymal transition [CLS]  (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that promotes the"}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " [CLS] gain-of-function mutation E76K [CLS]  in SHP2 promotes CAC tumorigenesis and induces EMT via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein"}
{"subject": "SHP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K", "obj_type": "Var", "file_name": "PubMed-29323748.json", "snippet": " behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that  [CLS] SHP2E76K [CLS]  acts as an oncogene that promotes the tumorigenesis and metastasis of CRC."}
{"subject": "E76K", "sub_type": "Var", "rel": "CauseOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2 [CLS] E76K acts as an oncogene that promotes [CLS]  the tumorigenesis and metastasis of CRC."}
{"subject": "tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that  [CLS] promotes the tumorigenesis [CLS]  and metastasis of CRC."}
{"subject": "metastasis", "sub_type": "CPA", "rel": "ThemeOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " epithelial-mesenchymal transition (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that  [CLS] promotes the tumorigenesis and metastasis [CLS]  of CRC."}
{"subject": "CRC", "sub_type": "Disease", "rel": "ThemeOf", "object": "metastasis", "obj_type": "CPA", "file_name": "PubMed-29323748.json", "snippet": " the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that promotes the tumorigenesis and  [CLS] metastasis of CRC [CLS] ."}
{"subject": "CRC", "sub_type": "Disease", "rel": "ThemeOf", "object": "tumorigenesis", "obj_type": "CPA", "file_name": "PubMed-29323748.json", "snippet": " (EMT) via the Wnt/\u03b2-catenin signaling pathway. Together, our results showed that SHP2E76K acts as an oncogene that promotes the  [CLS] tumorigenesis and metastasis of CRC [CLS] ."}
{"subject": "tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and  [CLS] increased CAC tumorigenesis [CLS] . In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the"}
{"subject": "CAC", "sub_type": "Disease", "rel": "ThemeOf", "object": "tumorigenesis", "obj_type": "CPA", "file_name": "PubMed-29323748.json", "snippet": " HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling. Ptpn11E76K conditional knock-in mice exhibited aggravated inflammation and increased  [CLS] CAC tumorigenesis [CLS] . In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors of CRC cells and induced epithelial-mesenchymal transition (EMT) via the"}
{"subject": "CAC", "sub_type": "Disease", "rel": "ThemeOf", "object": "tumorigenesis", "obj_type": "CPA", "file_name": "PubMed-29323748.json", "snippet": " [CLS] CAC tumorigenesis [CLS]  and induces EMT via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene."}
{"subject": "tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " [CLS] promotes CAC tumorigenesis [CLS]  and induces EMT via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene."}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " [CLS] gain-of-function mutation E76K in SHP2 promotes [CLS]  CAC tumorigenesis and induces EMT via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase 11"}
{"subject": "SHP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29323748.json", "snippet": " Several gain-of-function (GOF) mutations in Ptpn11 have been identified in human hematopoietic malignancies and solid tumors. In addition, the  [CLS] mutation rate for SHP2 [CLS]  is the highest for colorectal cancer (CRC) among solid tumors. The E76K GOF mutation is the most common and"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "highest", "obj_type": "Reg", "file_name": "PubMed-29323748.json", "snippet": " Several gain-of-function (GOF) mutations in Ptpn11 have been identified in human hematopoietic malignancies and solid tumors. In addition, the  [CLS] mutation rate for SHP2 is the highest [CLS]  for colorectal cancer (CRC) among solid tumors. The E76K GOF mutation is the most common and active SHP2 mutation;"}
{"subject": "colorectal cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "highest", "obj_type": "Reg", "file_name": "PubMed-29323748.json", "snippet": " have been identified in human hematopoietic malignancies and solid tumors. In addition, the mutation rate for SHP2 is the  [CLS] highest for colorectal cancer [CLS]  (CRC) among solid tumors. The E76K GOF mutation is the most common and active SHP2 mutation; however, the pathogenic"}
{"subject": "Wnt/\u03b2-catenin signaling pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " [CLS] induces EMT via the Wnt/\u03b2-catenin signaling pathway [CLS] .\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF) mutations in Ptpn11 have been"}
{"subject": "EMT", "sub_type": "CPA", "rel": "ThemeOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " [CLS] induces EMT [CLS]  via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function (GOF)"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-29323748.json", "snippet": " [CLS] gain-of-function mutation E76K in SHP2 promotes CAC tumorigenesis and induces [CLS]  EMT via the Wnt/\u03b2-catenin signaling pathway.\nSHP2 is encoded by the protein tyrosine phosphatase 11 (Ptpn11) gene. Several gain-of-function"}
{"subject": "Ptpn11", "sub_type": "Gene", "rel": "ThemeOf", "object": "E76K", "obj_type": "Var", "file_name": "PubMed-29323748.json", "snippet": " (CAC) and used the CRC cell lines HT29 and HCT116 to determine the relationship between SHP2 and Wnt/\u03b2-catenin signaling.  [CLS] Ptpn11E76K [CLS]  conditional knock-in mice exhibited aggravated inflammation and increased CAC tumorigenesis. In vitro, SHP2E76K and SHP2WT promoted malignant biological behaviors"}
{"subject": "PIGN", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense", "obj_type": "Var", "file_name": "PubMed-29330547.json", "snippet": " pathway, have been identified in a limited number of cases with a phenotype compatible with FS. Biallelic variants in  [CLS] PIGN, typically missense [CLS]  or compound missense with truncating, also cause multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients"}
{"subject": "compound missense", "sub_type": "Var", "rel": "CauseOf", "object": "truncating", "obj_type": "MPA", "file_name": "PubMed-29330547.json", "snippet": " in a limited number of cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically missense or  [CLS] compound missense with truncating [CLS] , also cause multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients with FS with or without"}
{"subject": "truncating", "sub_type": "MPA", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29330547.json", "snippet": " number of cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically missense or compound missense with  [CLS] truncating, also cause [CLS]  multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients with FS with or without congenital diaphragmatic"}
{"subject": "PIGN", "sub_type": "Gene", "rel": "ThemeOf", "object": "compound missense", "obj_type": "Var", "file_name": "PubMed-29330547.json", "snippet": " pathway, have been identified in a limited number of cases with a phenotype compatible with FS. Biallelic variants in  [CLS] PIGN, typically missense or compound missense [CLS]  with truncating, also cause multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients with FS with"}
{"subject": "multiple congenital anomalies-hypotonia-seizures syndrome 1", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29330547.json", "snippet": " cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically missense or compound missense with truncating, also  [CLS] cause multiple congenital anomalies-hypotonia-seizures syndrome 1 [CLS]  (MCAHS1). Here we report six further patients with FS with or without congenital diaphragmatic hernia and recessive loss of"}
{"subject": "PIGN", "sub_type": "Gene", "rel": "ThemeOf", "object": "biallelic truncating variants", "obj_type": "Var", "file_name": "PubMed-29330547.json", "snippet": " fetal or neonatal period. Inheritance is presumed autosomal recessive. Although no major genetic cause has been identified for FS,  [CLS] biallelic truncating variants in PIGN [CLS] , encoding a component of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been identified in a limited number of cases with"}
{"subject": "biallelic truncating variants", "sub_type": "Var", "rel": "CauseOf", "object": "identified", "obj_type": "Reg", "file_name": "PubMed-29330547.json", "snippet": " fetal or neonatal period. Inheritance is presumed autosomal recessive. Although no major genetic cause has been identified for FS,  [CLS] biallelic truncating variants in PIGN, encoding a component of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been identified [CLS]  in a limited number of cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically missense or"}
{"subject": "FS", "sub_type": "Disease", "rel": "ThemeOf", "object": "identified", "obj_type": "Reg", "file_name": "PubMed-29330547.json", "snippet": " identified for FS, biallelic truncating variants in PIGN, encoding a component of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been  [CLS] identified in a limited number of cases with a phenotype compatible with FS [CLS] . Biallelic variants in PIGN, typically missense or compound missense with truncating, also cause multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1)."}
{"subject": "missense", "sub_type": "Var", "rel": "CauseOf", "object": "truncating", "obj_type": "MPA", "file_name": "PubMed-29330547.json", "snippet": " been identified in a limited number of cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically  [CLS] missense or compound missense with truncating [CLS] , also cause multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients with FS with or without"}
{"subject": "ANGPTL3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29334984.json", "snippet": " atherosclerotic lesion size, leading to a lower risk for dyslipidemia and CVD. Additionally, in humans, carriers with homozygous LOF  [CLS] mutations in ANGPTL3 [CLS]  have lower plasma LDL-C, TG levels and lower risk of atherosclerosis compared to the non-carriers. Here, we collect the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-29334984.json", "snippet": " the atherosclerotic lesion size, leading to a lower risk for dyslipidemia and CVD. Additionally, in humans, carriers with homozygous  [CLS] LOF mutations [CLS]  in ANGPTL3 have lower plasma LDL-C, TG levels and lower risk of atherosclerosis compared to the non-carriers. Here, we"}
{"subject": "plasma LDL-C", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29334984.json", "snippet": " to a lower risk for dyslipidemia and CVD. Additionally, in humans, carriers with homozygous LOF mutations in ANGPTL3 have  [CLS] lower plasma LDL-C [CLS] , TG levels and lower risk of atherosclerosis compared to the non-carriers. Here, we collect the latest data and results,"}
{"subject": "TG levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29334984.json", "snippet": " to a lower risk for dyslipidemia and CVD. Additionally, in humans, carriers with homozygous LOF mutations in ANGPTL3 have  [CLS] lower plasma LDL-C, TG levels [CLS]  and lower risk of atherosclerosis compared to the non-carriers. Here, we collect the latest data and results, giving a"}
{"subject": "LOF", "sub_type": "NegReg", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29334984.json", "snippet": " the atherosclerotic lesion size, leading to a lower risk for dyslipidemia and CVD. Additionally, in humans, carriers with homozygous  [CLS] LOF mutations in ANGPTL3 have lower [CLS]  plasma LDL-C, TG levels and lower risk of atherosclerosis compared to the non-carriers. Here, we collect the latest data"}
{"subject": "NT5C2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29342136.json", "snippet": " mutant-relapsed acute lymphoblastic leukaemia.\nRelapsed acute lymphoblastic leukaemia (ALL) is associated with resistance to chemotherapy and poor prognosis. Gain-of-function  [CLS] mutations in the 5'-nucleotidase, cytosolic II (NT5C2 [CLS] ) gene induce resistance to 6-mercaptopurine and are selectively present in relapsed ALL. Yet, the mechanisms involved in NT5C2 mutation-driven"}
{"subject": "depletion of the intracellular purine-nucleotide pool", "sub_type": "MPA", "rel": "ThemeOf", "object": "excess", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of NT5C2+/R367Q mutant cells is associated with  [CLS] excess export of purines to the extracellular space and depletion of the intracellular purine-nucleotide pool [CLS] . Consequently, blocking guanosine synthesis by inhibition of inosine-5'-monophosphate dehydrogenase (IMPDH) induced increased cytotoxicity against NT5C2-mutant leukaemia lymphoblasts. These results"}
{"subject": "R367Q", "sub_type": "Var", "rel": "CauseOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " leukaemia, disease progression and relapse remain unknown. Here we use a conditional-and-inducible leukaemia model to demonstrate that expression of NT5C2( [CLS] R367Q), a highly prevalent relapsed-ALL NT5C2 mutation, induces [CLS]  resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness"}
{"subject": "R367Q", "sub_type": "Var", "rel": "CauseOf", "object": "excess", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of NT5C2+/ [CLS] R367Q mutant cells is associated with excess [CLS]  export of purines to the extracellular space and depletion of the intracellular purine-nucleotide pool. Consequently, blocking guanosine synthesis by"}
{"subject": "excess", "sub_type": "PosReg", "rel": "CauseOf", "object": "loss-of-fitness", "obj_type": "NegReg", "file_name": "PubMed-29342136.json", "snippet": " induces resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The  [CLS] loss-of-fitness phenotype of NT5C2+/R367Q mutant cells is associated with excess [CLS]  export of purines to the extracellular space and depletion of the intracellular purine-nucleotide pool. Consequently, blocking guanosine synthesis by"}
{"subject": "induces", "sub_type": "PosReg", "rel": "CauseOf", "object": "relapsed-ALL", "obj_type": "Disease", "file_name": "PubMed-29342136.json", "snippet": " relapse remain unknown. Here we use a conditional-and-inducible leukaemia model to demonstrate that expression of NT5C2(R367Q), a highly prevalent  [CLS] relapsed-ALL NT5C2 mutation, induces [CLS]  resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness"}
{"subject": "NT5C2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29342136.json", "snippet": " [CLS] NT5C2 mutant [CLS] -relapsed acute lymphoblastic leukaemia.\nRelapsed acute lymphoblastic leukaemia (ALL) is associated with resistance to chemotherapy and poor prognosis. Gain-of-function mutations"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "mechanisms", "obj_type": "Reg", "file_name": "PubMed-29342136.json", "snippet": " [CLS] mechanisms in NT5C2 mutant [CLS] -relapsed acute lymphoblastic leukaemia.\nRelapsed acute lymphoblastic leukaemia (ALL) is associated with resistance to chemotherapy and poor prognosis. Gain-of-function mutations"}
{"subject": "relapsed acute lymphoblastic leukaemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "mechanisms", "obj_type": "Reg", "file_name": "PubMed-29342136.json", "snippet": " [CLS] mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia [CLS] .\nRelapsed acute lymphoblastic leukaemia (ALL) is associated with resistance to chemotherapy and poor prognosis. Gain-of-function mutations in the 5'-nucleotidase,"}
{"subject": "resistance to 6-mercaptopurine", "sub_type": "MPA", "rel": "ThemeOf", "object": "induce", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " (ALL) is associated with resistance to chemotherapy and poor prognosis. Gain-of-function mutations in the 5'-nucleotidase, cytosolic II (NT5C2) gene  [CLS] induce resistance to 6-mercaptopurine [CLS]  and are selectively present in relapsed ALL. Yet, the mechanisms involved in NT5C2 mutation-driven clonal evolution during the initiation"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " NT5C2 mutant-relapsed acute lymphoblastic leukaemia.\nRelapsed acute lymphoblastic leukaemia (ALL) is associated with resistance to chemotherapy and poor prognosis.  [CLS] Gain-of-function mutations [CLS]  in the 5'-nucleotidase, cytosolic II (NT5C2) gene induce resistance to 6-mercaptopurine and are selectively present in relapsed ALL. Yet,"}
{"subject": "Gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "induce", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " NT5C2 mutant-relapsed acute lymphoblastic leukaemia.\nRelapsed acute lymphoblastic leukaemia (ALL) is associated with resistance to chemotherapy and poor prognosis.  [CLS] Gain-of-function mutations in the 5'-nucleotidase, cytosolic II (NT5C2) gene induce [CLS]  resistance to 6-mercaptopurine and are selectively present in relapsed ALL. Yet, the mechanisms involved in NT5C2 mutation-driven clonal evolution"}
{"subject": "NT5C2", "sub_type": "Gene", "rel": "ThemeOf", "object": "R367Q", "obj_type": "Var", "file_name": "PubMed-29342136.json", "snippet": " leukaemia, disease progression and relapse remain unknown. Here we use a conditional-and-inducible leukaemia model to demonstrate that expression of NT5C2( [CLS] R367Q), a highly prevalent relapsed-ALL NT5C2 [CLS]  mutation, induces resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity."}
{"subject": "resistance to chemotherapy with 6-mercaptopurine", "sub_type": "MPA", "rel": "ThemeOf", "object": "induces", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " Here we use a conditional-and-inducible leukaemia model to demonstrate that expression of NT5C2(R367Q), a highly prevalent relapsed-ALL NT5C2 mutation,  [CLS] induces resistance to chemotherapy with 6-mercaptopurine [CLS]  at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of NT5C2+/R367Q mutant cells"}
{"subject": "NT5C2", "sub_type": "Gene", "rel": "ThemeOf", "object": "R367Q", "obj_type": "Var", "file_name": "PubMed-29342136.json", "snippet": " chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of  [CLS] NT5C2+/R367Q [CLS]  mutant cells is associated with excess export of purines to the extracellular space and depletion of the intracellular purine-nucleotide"}
{"subject": "export of purines to the extracellular space", "sub_type": "MPA", "rel": "ThemeOf", "object": "excess", "obj_type": "PosReg", "file_name": "PubMed-29342136.json", "snippet": " of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of NT5C2+/R367Q mutant cells is associated with  [CLS] excess export of purines to the extracellular space [CLS]  and depletion of the intracellular purine-nucleotide pool. Consequently, blocking guanosine synthesis by inhibition of inosine-5'-monophosphate dehydrogenase (IMPDH) induced increased"}
{"subject": "phenotype", "sub_type": "CPA", "rel": "ThemeOf", "object": "loss-of-fitness", "obj_type": "NegReg", "file_name": "PubMed-29342136.json", "snippet": " induces resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The  [CLS] loss-of-fitness phenotype [CLS]  of NT5C2+/R367Q mutant cells is associated with excess export of purines to the extracellular space and depletion of the"}
{"subject": "DOT1L", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29343685.json", "snippet": " that, in contrast to MLL-rearranged leukemia, DOT1L plays a protective role in ultraviolet radiation (UVR)-induced melanoma development. Specifically, the  [CLS] DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations [CLS]  functionally compromise DOT1L methyltransferase enzyme activity leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA"}
{"subject": "melanoma development", "sub_type": "CPA", "rel": "ThemeOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29343685.json", "snippet": " reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss  [CLS] promotes melanoma development [CLS]  in mice after exposure to UVR. Mechanistically, DOT1L facilitates DNA damage repair, with DOT1L-methylated H3K79 involvement in binding and"}
{"subject": "loss", "sub_type": "NegReg", "rel": "CauseOf", "object": "promotes", "obj_type": "PosReg", "file_name": "PubMed-29343685.json", "snippet": " to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L  [CLS] loss promotes [CLS]  melanoma development in mice after exposure to UVR. Mechanistically, DOT1L facilitates DNA damage repair, with DOT1L-methylated H3K79 involvement in"}
{"subject": "DOT1L", "sub_type": "Gene", "rel": "ThemeOf", "object": "methyltransferase enzyme", "obj_type": "Enzyme", "file_name": "PubMed-29343685.json", "snippet": " gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations functionally compromise  [CLS] DOT1L methyltransferase enzyme [CLS]  activity leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so"}
{"subject": "methyltransferase enzyme", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-29343685.json", "snippet": " is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations functionally compromise DOT1L  [CLS] methyltransferase enzyme activity [CLS]  leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that"}
{"subject": "H3K79", "sub_type": "Protein", "rel": "ThemeOf", "object": "methylation", "obj_type": "MPA", "file_name": "PubMed-29343685.json", "snippet": " region and undergoes somatic mutation in human melanoma. Specific mutations functionally compromise DOT1L methyltransferase enzyme activity leading to reduced  [CLS] H3K79 methylation [CLS] . Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss promotes melanoma development"}
{"subject": "methylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29343685.json", "snippet": " deleted region and undergoes somatic mutation in human melanoma. Specific mutations functionally compromise DOT1L methyltransferase enzyme activity leading to  [CLS] reduced H3K79 methylation [CLS] . Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss promotes melanoma development"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "compromise", "obj_type": "NegReg", "file_name": "PubMed-29343685.json", "snippet": " DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations functionally  [CLS] compromise DOT1L methyltransferase enzyme activity [CLS]  leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "compromise", "obj_type": "NegReg", "file_name": "PubMed-29343685.json", "snippet": " Specifically, the DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific  [CLS] mutations functionally compromise [CLS]  DOT1L methyltransferase enzyme activity leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is"}
{"subject": "compromise", "sub_type": "NegReg", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29343685.json", "snippet": " DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations functionally  [CLS] compromise DOT1L methyltransferase enzyme activity leading to reduced [CLS]  H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss promotes"}
{"subject": "DOT1L", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29343685.json", "snippet": " leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that  [CLS] DOT1L loss [CLS]  promotes melanoma development in mice after exposure to UVR. Mechanistically, DOT1L facilitates DNA damage repair, with DOT1L-methylated H3K79 involvement"}
{"subject": "KIF14", "sub_type": "Gene", "rel": "ThemeOf", "object": "Biallelic variants", "obj_type": "Var", "file_name": "PubMed-29343805.json", "snippet": " [CLS] Biallelic variants in KIF14 [CLS]  cause intellectual disability with microcephaly.\nKinesin proteins are critical for various cellular functions such as intracellular transport and cell"}
{"subject": "p.Asn83Ilefs*3", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29343805.json", "snippet": " parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in KIF14 were detected; two  [CLS] loss-of-function (p.Asn83Ilefs*3 [CLS]  and p.Ser1478fs), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for"}
{"subject": "p.Ser1478fs", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29343805.json", "snippet": " parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in KIF14 were detected; two  [CLS] loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs [CLS] ), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization"}
{"subject": "pathogenic", "sub_type": "CPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29343805.json", "snippet": " and microcephaly from four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely  [CLS] pathogenic variants in KIF14 were detected; two loss-of-function [CLS]  (p.Asn83Ilefs*3 and p.Ser1478fs), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required"}
{"subject": "KIF14", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Ser841Phe", "obj_type": "Var", "file_name": "PubMed-29343805.json", "snippet": " four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in  [CLS] KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs), and two missense substitutions (p.Ser841Phe [CLS]  and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting"}
{"subject": "KIF14", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Gly459Arg", "obj_type": "Var", "file_name": "PubMed-29343805.json", "snippet": " four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in  [CLS] KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs), and two missense substitutions (p.Ser841Phe and p.Gly459Arg [CLS] ). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT,"}
{"subject": "pathogenic", "sub_type": "CPA", "rel": "ThemeOf", "object": "missense substitutions", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " and microcephaly from four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely  [CLS] pathogenic variants in KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs), and two missense substitutions [CLS]  (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron"}
{"subject": "p.Ser841Phe", "sub_type": "Var", "rel": "CauseOf", "object": "missense substitutions", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " of each family, homozygosity for likely pathogenic variants in KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs), and two  [CLS] missense substitutions (p.Ser841Phe [CLS]  and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting"}
{"subject": "p.Gly459Arg", "sub_type": "Var", "rel": "CauseOf", "object": "missense substitutions", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " of each family, homozygosity for likely pathogenic variants in KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs), and two  [CLS] missense substitutions (p.Ser841Phe and p.Gly459Arg [CLS] ). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT,"}
{"subject": "intellectual disability", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " [CLS] cause intellectual disability [CLS]  with microcephaly.\nKinesin proteins are critical for various cellular functions such as intracellular transport and cell division, and many"}
{"subject": "microcephaly", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " [CLS] cause intellectual disability with microcephaly [CLS] .\nKinesin proteins are critical for various cellular functions such as intracellular transport and cell division, and many members of"}
{"subject": "Biallelic variants", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " [CLS] Biallelic variants in KIF14 cause [CLS]  intellectual disability with microcephaly.\nKinesin proteins are critical for various cellular functions such as intracellular transport and cell division,"}
{"subject": "CIT", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutated", "obj_type": "Var", "file_name": "PubMed-29343805.json", "snippet": " p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase,  [CLS] CIT, also mutated [CLS]  in microcephaly. Our results demonstrate the involvement of KIF14 in development and reveal a wide phenotypic variability ranging from"}
{"subject": "microcephaly", "sub_type": "Disease", "rel": "ThemeOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also mutated  [CLS] in microcephaly [CLS] . Our results demonstrate the involvement of KIF14 in development and reveal a wide phenotypic variability ranging from fetal lethality"}
{"subject": "mutated", "sub_type": "Var", "rel": "CauseOf", "object": "in", "obj_type": "Reg", "file_name": "PubMed-29343805.json", "snippet": " is a mitotic motor protein that is required for spindle localization of the mitotic citron rho-interacting kinase, CIT, also  [CLS] mutated in [CLS]  microcephaly. Our results demonstrate the involvement of KIF14 in development and reveal a wide phenotypic variability ranging from fetal"}
{"subject": "KIF14", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Asn83Ilefs*3", "obj_type": "Var", "file_name": "PubMed-29343805.json", "snippet": " four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in  [CLS] KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 [CLS]  and p.Ser1478fs), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for"}
{"subject": "KIF14", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Ser1478fs", "obj_type": "Var", "file_name": "PubMed-29343805.json", "snippet": " four unrelated families with parental consanguinity. In the affected individuals of each family, homozygosity for likely pathogenic variants in  [CLS] KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs [CLS] ), and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle localization"}
{"subject": "APOC3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29348120.json", "snippet": " [CLS] mutations in APOC3 [CLS]  associate with low remnant cholesterol levels and low risk of ischemic vascular disease (IVD). Because some studies show an"}
{"subject": "APOC3", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-29348120.json", "snippet": " [CLS] APOC3 Loss-of-Function Mutations [CLS] , Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation- and Meta-Analyses of 137\u2009895 Individuals.\nOBJECTIVE: Loss-of-function mutations in APOC3"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " [CLS] Loss-of-Function Mutations [CLS] , Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation- and Meta-Analyses of 137\u2009895 Individuals.\nOBJECTIVE: Loss-of-function mutations in APOC3"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " [CLS] Loss-of-function mutations [CLS]  in APOC3 associate with low remnant cholesterol levels and low risk of ischemic vascular disease (IVD). Because some studies"}
{"subject": "Loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " [CLS] Loss-of-function mutations in APOC3 associate with low [CLS]  remnant cholesterol levels and low risk of ischemic vascular disease (IVD). Because some studies show an additional association with"}
{"subject": "remnant cholesterol levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation- and Meta-Analyses of 137\u2009895 Individuals.\nOBJECTIVE: Loss-of-function mutations in APOC3 associate with  [CLS] low remnant cholesterol levels [CLS]  and low risk of ischemic vascular disease (IVD). Because some studies show an additional association with low levels of"}
{"subject": "APOC3", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " heart disease; corresponding values mediated by LDL-C were 1% and 2%.\nCONCLUSIONS: The low risk of IVD observed in  [CLS] APOC3 loss-of-function [CLS]  heterozygotes is mainly mediated by the associated low remnant cholesterol and not by low LDL-C. Furthermore, the contribution of"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " disease; corresponding values mediated by LDL-C were 1% and 2%.\nCONCLUSIONS: The low risk of IVD observed in APOC3  [CLS] loss-of-function heterozygotes is mainly mediated by the associated low [CLS]  remnant cholesterol and not by low LDL-C. Furthermore, the contribution of LDL-C to IVD risk was not masked by"}
{"subject": "remnant cholesterol", "sub_type": "MPA", "rel": "ThemeOf", "object": "low", "obj_type": "NegReg", "file_name": "PubMed-29348120.json", "snippet": " and 2%.\nCONCLUSIONS: The low risk of IVD observed in APOC3 loss-of-function heterozygotes is mainly mediated by the associated  [CLS] low remnant cholesterol [CLS]  and not by low LDL-C. Furthermore, the contribution of LDL-C to IVD risk was not masked by lipid-lowering therapy."}
{"subject": "APAF1", "sub_type": "Gene", "rel": "ThemeOf", "object": "apoptotic genes", "obj_type": "Gene", "file_name": "PubMed-29358613.json", "snippet": " [CLS] apoptotic genes APAF1 [CLS]  and CASP9 implicated in recurrent folate-resistant neural tube defects.\nNeural tube defects (NTDs) remain one of the most serious"}
{"subject": "CASP9", "sub_type": "Gene", "rel": "ThemeOf", "object": "apoptotic genes", "obj_type": "Gene", "file_name": "PubMed-29358613.json", "snippet": " [CLS] apoptotic genes APAF1 and CASP9 [CLS]  implicated in recurrent folate-resistant neural tube defects.\nNeural tube defects (NTDs) remain one of the most serious birth defects,"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29358613.json", "snippet": " in key apoptotic genes in two families with recurrent neural tube defects. Functional studies in fibroblasts indicate that these  [CLS] variants are loss-of-function [CLS] , as apoptosis is significantly reduced. This is the first report of variants in apoptotic genes contributing to neural tube"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29358613.json", "snippet": " in key apoptotic genes in two families with recurrent neural tube defects. Functional studies in fibroblasts indicate that these  [CLS] variants are loss-of-function, as apoptosis is significantly reduced [CLS] . This is the first report of variants in apoptotic genes contributing to neural tube defect risk in humans."}
{"subject": "apoptosis", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29358613.json", "snippet": " in two families with recurrent neural tube defects. Functional studies in fibroblasts indicate that these variants are loss-of-function, as  [CLS] apoptosis is significantly reduced [CLS] . This is the first report of variants in apoptotic genes contributing to neural tube defect risk in humans."}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "contributing", "obj_type": "Reg", "file_name": "PubMed-29358613.json", "snippet": " in fibroblasts indicate that these variants are loss-of-function, as apoptosis is significantly reduced. This is the first report of  [CLS] variants in apoptotic genes contributing [CLS]  to neural tube defect risk in humans."}
{"subject": "neural tube defect", "sub_type": "Disease", "rel": "ThemeOf", "object": "contributing", "obj_type": "Reg", "file_name": "PubMed-29358613.json", "snippet": " these variants are loss-of-function, as apoptosis is significantly reduced. This is the first report of variants in apoptotic genes  [CLS] contributing to neural tube defect [CLS]  risk in humans."}
{"subject": "apoptotic genes", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29358613.json", "snippet": " in fibroblasts indicate that these variants are loss-of-function, as apoptosis is significantly reduced. This is the first report of  [CLS] variants in apoptotic genes [CLS]  contributing to neural tube defect risk in humans."}
{"subject": "NHS", "sub_type": "Gene", "rel": "ThemeOf", "object": "nonsense", "obj_type": "Var", "file_name": "PubMed-29358614.json", "snippet": " dental anomalies, facial dysmorphism, and intellectual disability. Here, we identify a patient with Nance-Horan syndrome caused by a new  [CLS] nonsense NHS [CLS]  variant. In addition, the patient presented congenital diaphragmatic hernia. NHS gene expression in murine fetal diaphragm was demonstrated, suggesting"}
{"subject": "nonsense", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29358614.json", "snippet": " by bilateral congenital cataract, dental anomalies, facial dysmorphism, and intellectual disability. Here, we identify a patient with Nance-Horan syndrome  [CLS] caused by a new nonsense [CLS]  NHS variant. In addition, the patient presented congenital diaphragmatic hernia. NHS gene expression in murine fetal diaphragm was demonstrated,"}
{"subject": "Nance-Horan syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29358614.json", "snippet": " disorder characterized by bilateral congenital cataract, dental anomalies, facial dysmorphism, and intellectual disability. Here, we identify a patient with  [CLS] Nance-Horan syndrome caused by [CLS]  a new nonsense NHS variant. In addition, the patient presented congenital diaphragmatic hernia. NHS gene expression in murine fetal"}
{"subject": "congenital diaphragmatic hernia", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29358614.json", "snippet": " by bilateral congenital cataract, dental anomalies, facial dysmorphism, and intellectual disability. Here, we identify a patient with Nance-Horan syndrome  [CLS] caused by a new nonsense NHS variant. In addition, the patient presented congenital diaphragmatic hernia [CLS] . NHS gene expression in murine fetal diaphragm was demonstrated, suggesting a possible involvement of NHS in diaphragm development. Congenital"}
{"subject": "NHS", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29358614.json", "snippet": " fetal diaphragm was demonstrated, suggesting a possible involvement of NHS in diaphragm development. Congenital diaphragmatic hernia could result from  [CLS] NHS loss of function [CLS]  in pleuroperitoneal fold or in somites-derived muscle progenitor cells leading to an impairment of their cells migration."}
{"subject": "loss of function", "sub_type": "NegReg", "rel": "CauseOf", "object": "cells migration", "obj_type": "CPA", "file_name": "PubMed-29358614.json", "snippet": " diaphragm was demonstrated, suggesting a possible involvement of NHS in diaphragm development. Congenital diaphragmatic hernia could result from NHS  [CLS] loss of function in pleuroperitoneal fold or in somites-derived muscle progenitor cells leading to an impairment of their cells migration [CLS] ."}
{"subject": "cells migration", "sub_type": "CPA", "rel": "CauseOf", "object": "Congenital diaphragmatic hernia", "obj_type": "Disease", "file_name": "PubMed-29358614.json", "snippet": " hernia. NHS gene expression in murine fetal diaphragm was demonstrated, suggesting a possible involvement of NHS in diaphragm development.  [CLS] Congenital diaphragmatic hernia could result from NHS loss of function in pleuroperitoneal fold or in somites-derived muscle progenitor cells leading to an impairment of their cells migration [CLS] ."}
{"subject": "FLG", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29367526.json", "snippet": " [CLS] mutations in filaggrin (FLG [CLS] ) gene in atopic dermatitis (AD) individuals, significant attention has been paid against the skin barrier as an initial starting"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29367526.json", "snippet": " [CLS] loss-of-function mutations [CLS]  in filaggrin (FLG) gene in atopic dermatitis (AD) individuals, significant attention has been paid against the skin barrier as"}
{"subject": "atopic dermatitis", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29367526.json", "snippet": " [CLS] loss-of-function mutations in filaggrin (FLG) gene in atopic dermatitis [CLS]  (AD) individuals, significant attention has been paid against the skin barrier as an initial starting point of atopic march."}
{"subject": "TRH", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29367674.json", "snippet": " [CLS] TRH) loss of function mutations [CLS]  induce growth and behavioral defects in Daphnia magna.\nTryptophan hydroxylase (TRH) is the rate limiting enzyme in the serotonin"}
{"subject": "lacking", "sub_type": "NegReg", "rel": "CauseOf", "object": "reproduced", "obj_type": "CPA", "file_name": "PubMed-29367674.json", "snippet": " and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants  [CLS] lacking serotonin grew less and hence reproduced [CLS]  latter, produced smaller clutches of smaller offspring and responded to a greater extent to light than wild type individuals."}
{"subject": "offspring", "sub_type": "CPA", "rel": "ThemeOf", "object": "smaller", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " to selective serotonin reuptake inhibitors (SSRI). Mutants lacking serotonin grew less and hence reproduced latter, produced smaller clutches of  [CLS] smaller offspring [CLS]  and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals showed the intermediate"}
{"subject": "smaller", "sub_type": "NegReg", "rel": "ThemeOf", "object": "clutches", "obj_type": "CPA", "file_name": "PubMed-29367674.json", "snippet": " those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants lacking serotonin grew less and hence reproduced latter, produced smaller  [CLS] clutches of smaller [CLS]  offspring and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals showed the"}
{"subject": "clutches", "sub_type": "CPA", "rel": "ThemeOf", "object": "smaller", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants lacking serotonin grew less and hence reproduced latter, produced  [CLS] smaller clutches [CLS]  of smaller offspring and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+ individuals"}
{"subject": "lacking", "sub_type": "NegReg", "rel": "CauseOf", "object": "smaller", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants  [CLS] lacking serotonin grew less and hence reproduced latter, produced smaller [CLS]  clutches of smaller offspring and responded to a greater extent to light than wild type individuals. Mono-allelic indel TRH-/+"}
{"subject": "growth and behavioral defects", "sub_type": "CPA", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " [CLS] loss of function mutations induce growth and behavioral defects [CLS]  in Daphnia magna.\nTryptophan hydroxylase (TRH) is the rate limiting enzyme in the serotonin synthesis. CRISPR-Cas9 technology was used"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " [CLS] loss of function mutations [CLS]  induce growth and behavioral defects in Daphnia magna.\nTryptophan hydroxylase (TRH) is the rate limiting enzyme in the serotonin"}
{"subject": "serotonin", "sub_type": "MPA", "rel": "ThemeOf", "object": "lacking", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants  [CLS] lacking serotonin [CLS]  grew less and hence reproduced latter, produced smaller clutches of smaller offspring and responded to a greater extent to"}
{"subject": "Mutants", "sub_type": "Var", "rel": "CauseOf", "object": "lacking", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " history and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI).  [CLS] Mutants lacking [CLS]  serotonin grew less and hence reproduced latter, produced smaller clutches of smaller offspring and responded to a greater extent"}
{"subject": "lacking", "sub_type": "NegReg", "rel": "CauseOf", "object": "less", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " and behavioral responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants  [CLS] lacking serotonin grew less [CLS]  and hence reproduced latter, produced smaller clutches of smaller offspring and responded to a greater extent to light than"}
{"subject": "grew", "sub_type": "CPA", "rel": "ThemeOf", "object": "less", "obj_type": "NegReg", "file_name": "PubMed-29367674.json", "snippet": " responses of TRH-/- clones showed the anti-phenotype of those exposed to selective serotonin reuptake inhibitors (SSRI). Mutants lacking serotonin  [CLS] grew less [CLS]  and hence reproduced latter, produced smaller clutches of smaller offspring and responded to a greater extent to light than"}
{"subject": "FLT3", "sub_type": "Gene", "rel": "ThemeOf", "object": "Internal tandem duplication mutations", "obj_type": "Var", "file_name": "PubMed-29372308.json", "snippet": " [CLS] Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 [CLS]  display a higher oncogenic potential than the activation loop D835Y mutation.\nAcute myeloid leukemia (AML) remains the most common"}
{"subject": "STAT5", "sub_type": "Protein", "rel": "ThemeOf", "object": "phosphorylation", "obj_type": "MPA", "file_name": "PubMed-29372308.json", "snippet": " was also significantly higher in TKD-ITD expressing cells, compared to cells expressing D835Y/FLT3. Furthermore, TKD-ITD is capable of inducing  [CLS] phosphorylation of STAT5 [CLS] , while D835Y/FLT3 fails to induce tyrosine phosphorylation of STAT5. Other signal transduction pathways such as the RAS/ERK and the"}
{"subject": "phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "inducing", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " survival was also significantly higher in TKD-ITD expressing cells, compared to cells expressing D835Y/FLT3. Furthermore, TKD-ITD is capable of  [CLS] inducing phosphorylation [CLS]  of STAT5, while D835Y/FLT3 fails to induce tyrosine phosphorylation of STAT5. Other signal transduction pathways such as the RAS/ERK"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "prevalent", "obj_type": "Reg", "file_name": "PubMed-29372308.json", "snippet": " remains the most common form of acute leukemia among adults and accounts for a large number of leukemia-related deaths.  [CLS] Mutations in FMS-like tyrosine kinase 3 (FLT3) is one of the most prevalent [CLS]  findings in this heterogeneous disease. The major types of mutations in FLT3 can be categorized as internal tandem duplications"}
{"subject": "Acute myeloid leukemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "prevalent", "obj_type": "Reg", "file_name": "PubMed-29372308.json", "snippet": " mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation.\n [CLS] Acute myeloid leukemia (AML) remains the most common form of acute leukemia among adults and accounts for a large number of leukemia-related deaths. Mutations in FMS-like tyrosine kinase 3 (FLT3) is one of the most prevalent [CLS]  findings in this heterogeneous disease. The major types of mutations in FLT3 can be categorized as internal tandem duplications"}
{"subject": "FLT3", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-29372308.json", "snippet": " remains the most common form of acute leukemia among adults and accounts for a large number of leukemia-related deaths.  [CLS] Mutations in FMS-like tyrosine kinase 3 (FLT3 [CLS] ) is one of the most prevalent findings in this heterogeneous disease. The major types of mutations in FLT3 can"}
{"subject": "Internal tandem duplication mutations", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " [CLS] Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher [CLS]  oncogenic potential than the activation loop D835Y mutation.\nAcute myeloid leukemia (AML) remains the most common form of acute"}
{"subject": "oncogenic potential", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " [CLS] higher oncogenic potential [CLS]  than the activation loop D835Y mutation.\nAcute myeloid leukemia (AML) remains the most common form of acute leukemia among"}
{"subject": "TKD-ITD", "sub_type": "Var", "rel": "CauseOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " were indistinguishable, while Ba/F3 cells expressing D835Y/FLT3 failed to form colonies. Cell proliferation and cell survival was also significantly  [CLS] higher in TKD-ITD [CLS]  expressing cells, compared to cells expressing D835Y/FLT3. Furthermore, TKD-ITD is capable of inducing phosphorylation of STAT5, while D835Y/FLT3 fails"}
{"subject": "cell survival", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " the tyrosine kinase domain (TKD)-ITD were indistinguishable, while Ba/F3 cells expressing D835Y/FLT3 failed to form colonies. Cell proliferation and  [CLS] cell survival was also significantly higher [CLS]  in TKD-ITD expressing cells, compared to cells expressing D835Y/FLT3. Furthermore, TKD-ITD is capable of inducing phosphorylation of STAT5, while"}
{"subject": "Cell proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " receptor (JMD-ITD) or the tyrosine kinase domain (TKD)-ITD were indistinguishable, while Ba/F3 cells expressing D835Y/FLT3 failed to form colonies.  [CLS] Cell proliferation and cell survival was also significantly higher [CLS]  in TKD-ITD expressing cells, compared to cells expressing D835Y/FLT3. Furthermore, TKD-ITD is capable of inducing phosphorylation of STAT5, while"}
{"subject": "TKD-ITD", "sub_type": "Var", "rel": "CauseOf", "object": "inducing", "obj_type": "PosReg", "file_name": "PubMed-29372308.json", "snippet": " Cell proliferation and cell survival was also significantly higher in TKD-ITD expressing cells, compared to cells expressing D835Y/FLT3. Furthermore,  [CLS] TKD-ITD is capable of inducing [CLS]  phosphorylation of STAT5, while D835Y/FLT3 fails to induce tyrosine phosphorylation of STAT5. Other signal transduction pathways such as the"}
{"subject": "HJV", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29373985.json", "snippet": " that a successful biventricular assist device explant occurred 131 days after initial implant. Targeted gene sequencing revealed a loss-of-function  [CLS] mutation within the HJV [CLS]  gene, which is consistent with juvenile hemochromatosis.\nCONCLUSIONS: This rare case of a patient with juvenile hemochromatosis associated with"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29373985.json", "snippet": " such that a successful biventricular assist device explant occurred 131 days after initial implant. Targeted gene sequencing revealed a  [CLS] loss-of-function mutation [CLS]  within the HJV gene, which is consistent with juvenile hemochromatosis.\nCONCLUSIONS: This rare case of a patient with juvenile"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "juvenile hemochromatosis", "obj_type": "Disease", "file_name": "PubMed-29373985.json", "snippet": " such that a successful biventricular assist device explant occurred 131 days after initial implant. Targeted gene sequencing revealed a  [CLS] loss-of-function mutation within the HJV gene, which is consistent with juvenile hemochromatosis [CLS] .\nCONCLUSIONS: This rare case of a patient with juvenile hemochromatosis associated with a HJV mutation provides histologic evidence documenting"}
{"subject": "juvenile hemochromatosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29373985.json", "snippet": " mutation within the HJV gene, which is consistent with juvenile hemochromatosis.\nCONCLUSIONS: This rare case of a patient with  [CLS] juvenile hemochromatosis associated [CLS]  with a HJV mutation provides histologic evidence documenting the reversal of associated end-stage heart failure, requiring emergent mechanical circulatory"}
{"subject": "HJV", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29373985.json", "snippet": " which is consistent with juvenile hemochromatosis.\nCONCLUSIONS: This rare case of a patient with juvenile hemochromatosis associated with a  [CLS] HJV mutation [CLS]  provides histologic evidence documenting the reversal of associated end-stage heart failure, requiring emergent mechanical circulatory support, with iron chelation"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29373985.json", "snippet": " the HJV gene, which is consistent with juvenile hemochromatosis.\nCONCLUSIONS: This rare case of a patient with juvenile hemochromatosis  [CLS] associated with a HJV mutation [CLS]  provides histologic evidence documenting the reversal of associated end-stage heart failure, requiring emergent mechanical circulatory support, with iron chelation"}
{"subject": "TRPV1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29424270.json", "snippet": " [CLS] TRPV1 gain-of-function mutation [CLS]  impairs pain and itch sensations in mice.\nTransient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel, which"}
{"subject": "thermosensory", "sub_type": "CPA", "rel": "ThemeOf", "object": "defect", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a  [CLS] thermosensory defect [CLS] , impaired inflammatory thermal pain, and capsaicin sensitivity. We also demonstrated an attenuated behavioral response to the pruritic agent histamine"}
{"subject": "G564S", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the  [CLS] G564S mutation in mouse TRPV1 caused increased basal current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect, impaired [CLS]  inflammatory thermal pain, and capsaicin sensitivity. We also demonstrated an attenuated behavioral response to the pruritic agent histamine in"}
{"subject": "inflammatory thermal pain", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect,  [CLS] impaired inflammatory thermal pain [CLS] , and capsaicin sensitivity. We also demonstrated an attenuated behavioral response to the pruritic agent histamine in the knock-in mice."}
{"subject": "G564S", "sub_type": "Var", "rel": "CauseOf", "object": "capsaicin sensitivity", "obj_type": "CPA", "file_name": "PubMed-29424270.json", "snippet": " generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the  [CLS] G564S mutation in mouse TRPV1 caused increased basal current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect, impaired inflammatory thermal pain, and capsaicin sensitivity [CLS] . We also demonstrated an attenuated behavioral response to the pruritic agent histamine in the knock-in mice. Indeed, calcium imaging"}
{"subject": "G564S", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " imaging together with electrophysiology showed that the overactive mutant had decreased capsaicin sensitivity. Western blot analysis revealed that the  [CLS] G564S mutant reduced [CLS]  TRPV1 phosphorylation and cell membrane trafficking. Together, we have generated a mouse model with a gain-of-function mutation in Trpv1"}
{"subject": "TRPV1", "sub_type": "Protein", "rel": "ThemeOf", "object": "phosphorylation", "obj_type": "MPA", "file_name": "PubMed-29424270.json", "snippet": " electrophysiology showed that the overactive mutant had decreased capsaicin sensitivity. Western blot analysis revealed that the G564S mutant reduced  [CLS] TRPV1 phosphorylation [CLS]  and cell membrane trafficking. Together, we have generated a mouse model with a gain-of-function mutation in Trpv1 gene and"}
{"subject": "phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " with electrophysiology showed that the overactive mutant had decreased capsaicin sensitivity. Western blot analysis revealed that the G564S mutant  [CLS] reduced TRPV1 phosphorylation [CLS]  and cell membrane trafficking. Together, we have generated a mouse model with a gain-of-function mutation in Trpv1 gene and"}
{"subject": "cell membrane trafficking", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " with electrophysiology showed that the overactive mutant had decreased capsaicin sensitivity. Western blot analysis revealed that the G564S mutant  [CLS] reduced TRPV1 phosphorylation and cell membrane trafficking [CLS] . Together, we have generated a mouse model with a gain-of-function mutation in Trpv1 gene and demonstrated that the pain"}
{"subject": "Trpv1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29424270.json", "snippet": " G564S mutant reduced TRPV1 phosphorylation and cell membrane trafficking. Together, we have generated a mouse model with a gain-of-function  [CLS] mutation in Trpv1 [CLS]  gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due to a decreased"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29424270.json", "snippet": " the G564S mutant reduced TRPV1 phosphorylation and cell membrane trafficking. Together, we have generated a mouse model with a  [CLS] gain-of-function mutation [CLS]  in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due to"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29424270.json", "snippet": " [CLS] gain-of-function mutation [CLS]  impairs pain and itch sensations in mice.\nTransient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel, which"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " the G564S mutant reduced TRPV1 phosphorylation and cell membrane trafficking. Together, we have generated a mouse model with a  [CLS] gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due to a decreased [CLS]  phosphorylation level and reduced membrane localization of TRPV1."}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " the G564S mutant reduced TRPV1 phosphorylation and cell membrane trafficking. Together, we have generated a mouse model with a  [CLS] gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due to a decreased phosphorylation level and reduced [CLS]  membrane localization of TRPV1."}
{"subject": "phosphorylation level", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are impaired due to a  [CLS] decreased phosphorylation level [CLS]  and reduced membrane localization of TRPV1."}
{"subject": "TRPV1", "sub_type": "Protein", "rel": "ThemeOf", "object": "membrane localization", "obj_type": "MPA", "file_name": "PubMed-29424270.json", "snippet": " the pain and histamine-dependent itch sensations in these mice are impaired due to a decreased phosphorylation level and reduced  [CLS] membrane localization of TRPV1 [CLS] ."}
{"subject": "membrane localization", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " that the pain and histamine-dependent itch sensations in these mice are impaired due to a decreased phosphorylation level and  [CLS] reduced membrane localization [CLS]  of TRPV1."}
{"subject": "decreased", "sub_type": "NegReg", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " a gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are  [CLS] impaired due to a decreased [CLS]  phosphorylation level and reduced membrane localization of TRPV1."}
{"subject": "reduced", "sub_type": "NegReg", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " a gain-of-function mutation in Trpv1 gene and demonstrated that the pain and histamine-dependent itch sensations in these mice are  [CLS] impaired due to a decreased phosphorylation level and reduced [CLS]  membrane localization of TRPV1."}
{"subject": "pain and histamine-dependent itch sensations", "sub_type": "CPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " trafficking. Together, we have generated a mouse model with a gain-of-function mutation in Trpv1 gene and demonstrated that the  [CLS] pain and histamine-dependent itch sensations in these mice are impaired [CLS]  due to a decreased phosphorylation level and reduced membrane localization of TRPV1."}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " [CLS] gain-of-function mutation impairs [CLS]  pain and itch sensations in mice.\nTransient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel, which can"}
{"subject": "pain and itch sensations", "sub_type": "CPA", "rel": "ThemeOf", "object": "impairs", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " [CLS] impairs pain and itch sensations [CLS]  in mice.\nTransient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel, which can detect various noxious stimuli"}
{"subject": "TRPV1", "sub_type": "Gene", "rel": "ThemeOf", "object": "G564S", "obj_type": "Var", "file_name": "PubMed-29424270.json", "snippet": " generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the  [CLS] G564S mutation in mouse TRPV1 [CLS]  caused increased basal current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in"}
{"subject": "G564S", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29424270.json", "snippet": " generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the  [CLS] G564S mutation in mouse TRPV1 caused increased [CLS]  basal current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed"}
{"subject": "basal current", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29424270.json", "snippet": " G564S mutation. In the heterologous expression system, an electrophysiological study showed that the G564S mutation in mouse TRPV1 caused  [CLS] increased basal current [CLS]  and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory"}
{"subject": "G564S", "sub_type": "Var", "rel": "CauseOf", "object": "leftward shift of voltage dependence", "obj_type": "CPA", "file_name": "PubMed-29424270.json", "snippet": " generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the  [CLS] G564S mutation in mouse TRPV1 caused increased basal current and a leftward shift of voltage dependence [CLS] . Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect, impaired inflammatory thermal pain, and capsaicin"}
{"subject": "G564S", "sub_type": "Var", "rel": "CauseOf", "object": "defect", "obj_type": "NegReg", "file_name": "PubMed-29424270.json", "snippet": " generated TRPV1 knock-in mice with a G564S mutation. In the heterologous expression system, an electrophysiological study showed that the  [CLS] G564S mutation in mouse TRPV1 caused increased basal current and a leftward shift of voltage dependence. Intriguingly, using behavioral analysis, we found that knock-in mice showed a thermosensory defect [CLS] , impaired inflammatory thermal pain, and capsaicin sensitivity. We also demonstrated an attenuated behavioral response to the pruritic agent histamine"}
{"subject": "UNC45A", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Mutations in UNC45A [CLS]  Cause a Syndrome Associating Cholestasis, Diarrhea, Impaired Hearing, and Bone Fragility.\nDespite the rapid discovery of genes for rare"}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "impaired hearing", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " presenting with syndromic manifestations. Here, we have studied four affected people in three families presenting with cholestasis, congenital diarrhea,  [CLS] impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified biallelic mutations [CLS]  in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies"}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "congenital diarrhea", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " encounter individuals presenting with syndromic manifestations. Here, we have studied four affected people in three families presenting with cholestasis,  [CLS] congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified biallelic mutations [CLS]  in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies"}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cholestasis", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " to encounter individuals presenting with syndromic manifestations. Here, we have studied four affected people in three families presenting with  [CLS] cholestasis, congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified biallelic mutations [CLS]  in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies"}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " with cholestasis, congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified  [CLS] biallelic mutations in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function [CLS]  paradigm, wherein mutations attenuated or abolished protein activity with concomitant defects in gut development and function."}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "attenuated", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " with cholestasis, congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified  [CLS] biallelic mutations in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated [CLS]  or abolished protein activity with concomitant defects in gut development and function."}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "abolished", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " with cholestasis, congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified  [CLS] biallelic mutations in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated or abolished [CLS]  protein activity with concomitant defects in gut development and function."}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-29429573.json", "snippet": " Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated or abolished  [CLS] protein activity [CLS]  with concomitant defects in gut development and function."}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "abolished", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated or  [CLS] abolished protein activity [CLS]  with concomitant defects in gut development and function."}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "attenuated", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations  [CLS] attenuated or abolished protein activity [CLS]  with concomitant defects in gut development and function."}
{"subject": "gut development", "sub_type": "CPA", "rel": "CauseOf", "object": "defects", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated or abolished protein activity with concomitant  [CLS] defects in gut development [CLS]  and function."}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Loss-of-Function Mutations [CLS]  in UNC45A Cause a Syndrome Associating Cholestasis, Diarrhea, Impaired Hearing, and Bone Fragility.\nDespite the rapid discovery of genes"}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "defects", "obj_type": "NegReg", "file_name": "PubMed-29429573.json", "snippet": " with cholestasis, congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified  [CLS] biallelic mutations in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a loss-of-function paradigm, wherein mutations attenuated or abolished protein activity with concomitant defects [CLS]  in gut development and function."}
{"subject": "Loss-of-Function", "sub_type": "NegReg", "rel": "CauseOf", "object": "Syndrome", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Loss-of-Function Mutations in UNC45A Cause a Syndrome [CLS]  Associating Cholestasis, Diarrhea, Impaired Hearing, and Bone Fragility.\nDespite the rapid discovery of genes for rare genetic disorders, we"}
{"subject": "Cholestasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Syndrome", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Syndrome Associating Cholestasis [CLS] , Diarrhea, Impaired Hearing, and Bone Fragility.\nDespite the rapid discovery of genes for rare genetic disorders, we continue to"}
{"subject": "Diarrhea", "sub_type": "Disease", "rel": "ThemeOf", "object": "Syndrome", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Syndrome Associating Cholestasis, Diarrhea [CLS] , Impaired Hearing, and Bone Fragility.\nDespite the rapid discovery of genes for rare genetic disorders, we continue to encounter"}
{"subject": "Impaired Hearing", "sub_type": "Disease", "rel": "ThemeOf", "object": "Syndrome", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Syndrome Associating Cholestasis, Diarrhea, Impaired Hearing [CLS] , and Bone Fragility.\nDespite the rapid discovery of genes for rare genetic disorders, we continue to encounter individuals presenting"}
{"subject": "Bone Fragility", "sub_type": "Disease", "rel": "ThemeOf", "object": "Syndrome", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " [CLS] Syndrome Associating Cholestasis, Diarrhea, Impaired Hearing, and Bone Fragility [CLS] .\nDespite the rapid discovery of genes for rare genetic disorders, we continue to encounter individuals presenting with syndromic manifestations."}
{"subject": "UNC45A", "sub_type": "Gene", "rel": "ThemeOf", "object": "biallelic mutations", "obj_type": "Var", "file_name": "PubMed-29429573.json", "snippet": " with cholestasis, congenital diarrhea, impaired hearing, and bone fragility. Whole-exome sequencing of all affected individuals and their parents identified  [CLS] biallelic mutations in Unc-45 Myosin Chaperone A (UNC45A [CLS] ) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies of the candidate gene indicated a"}
{"subject": "biallelic mutations", "sub_type": "Var", "rel": "CauseOf", "object": "bone fragility", "obj_type": "Disease", "file_name": "PubMed-29429573.json", "snippet": " manifestations. Here, we have studied four affected people in three families presenting with cholestasis, congenital diarrhea, impaired hearing, and  [CLS] bone fragility. Whole-exome sequencing of all affected individuals and their parents identified biallelic mutations [CLS]  in Unc-45 Myosin Chaperone A (UNC45A) as a likely driver for this disorder. Subsequent in\u00a0vitro and in\u00a0vivo functional studies"}
{"subject": "PPP3CA", "sub_type": "Gene", "rel": "ThemeOf", "object": "catalytic domain mutations", "obj_type": "Var", "file_name": "PubMed-29432562.json", "snippet": " caused premature termination was also identified. Detailed clinical evaluation of the six individuals revealed clinically unexpected consequences of the  [CLS] PPP3CA mutations. First, the catalytic domain mutations [CLS]  and frameshift mutation were consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain"}
{"subject": "PPP3CA", "sub_type": "Gene", "rel": "ThemeOf", "object": "AI domain mutations", "obj_type": "Var", "file_name": "PubMed-29432562.json", "snippet": " gracile bones (severe bone slenderness and perinatal fractures). Using a yeast model system, we showed that the catalytic and  [CLS] AI domain mutations visibly result in decreased and increased calcineurin signaling, respectively. These findings indicate that different functional effects of PPP3CA [CLS]  mutations are associated with two distinct disorders and suggest that functional approaches using a simple cellular system provide a"}
{"subject": "AI domain mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29432562.json", "snippet": " gracile bones (severe bone slenderness and perinatal fractures). Using a yeast model system, we showed that the catalytic and  [CLS] AI domain mutations visibly result in decreased and increased [CLS]  calcineurin signaling, respectively. These findings indicate that different functional effects of PPP3CA mutations are associated with two distinct disorders"}
{"subject": "calcineurin signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29432562.json", "snippet": " Using a yeast model system, we showed that the catalytic and AI domain mutations visibly result in decreased and  [CLS] increased calcineurin signaling [CLS] , respectively. These findings indicate that different functional effects of PPP3CA mutations are associated with two distinct disorders and suggest"}
{"subject": "catalytic domain mutations", "sub_type": "Var", "rel": "CauseOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-29432562.json", "snippet": " also identified. Detailed clinical evaluation of the six individuals revealed clinically unexpected consequences of the PPP3CA mutations. First, the  [CLS] catalytic domain mutations and frameshift mutation were consistently found [CLS]  in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated with multiple congenital"}
{"subject": "frameshift mutation", "sub_type": "Var", "rel": "CauseOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-29432562.json", "snippet": " evaluation of the six individuals revealed clinically unexpected consequences of the PPP3CA mutations. First, the catalytic domain mutations and  [CLS] frameshift mutation were consistently found [CLS]  in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated with multiple congenital"}
{"subject": "nonsyndromic early onset epileptic encephalopathy", "sub_type": "Disease", "rel": "ThemeOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-29432562.json", "snippet": " individuals revealed clinically unexpected consequences of the PPP3CA mutations. First, the catalytic domain mutations and frameshift mutation were consistently  [CLS] found in patients with nonsyndromic early onset epileptic encephalopathy [CLS] . In contrast, the AI domain mutations were associated with multiple congenital abnormalities including craniofacial dysmorphism, arthrogryposis and short stature."}
{"subject": "PPP3CA", "sub_type": "Gene", "rel": "ThemeOf", "object": "frameshift mutation", "obj_type": "Var", "file_name": "PubMed-29432562.json", "snippet": " caused premature termination was also identified. Detailed clinical evaluation of the six individuals revealed clinically unexpected consequences of the  [CLS] PPP3CA mutations. First, the catalytic domain mutations and frameshift mutation [CLS]  were consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated"}
{"subject": "AI domain mutations", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29432562.json", "snippet": " domain mutations and frameshift mutation were consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the  [CLS] AI domain mutations were associated [CLS]  with multiple congenital abnormalities including craniofacial dysmorphism, arthrogryposis and short stature. In addition, one individual showed severe skeletal developmental"}
{"subject": "multiple congenital abnormalities", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29432562.json", "snippet": " mutation were consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were  [CLS] associated with multiple congenital abnormalities [CLS]  including craniofacial dysmorphism, arthrogryposis and short stature. In addition, one individual showed severe skeletal developmental defects, namely, severe craniosynostosis"}
{"subject": "craniofacial dysmorphism", "sub_type": "Disease", "rel": "ThemeOf", "object": "multiple congenital abnormalities", "obj_type": "Disease", "file_name": "PubMed-29432562.json", "snippet": " consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated with  [CLS] multiple congenital abnormalities including craniofacial dysmorphism [CLS] , arthrogryposis and short stature. In addition, one individual showed severe skeletal developmental defects, namely, severe craniosynostosis and gracile bones"}
{"subject": "arthrogryposis", "sub_type": "Disease", "rel": "ThemeOf", "object": "multiple congenital abnormalities", "obj_type": "Disease", "file_name": "PubMed-29432562.json", "snippet": " consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated with  [CLS] multiple congenital abnormalities including craniofacial dysmorphism, arthrogryposis [CLS]  and short stature. In addition, one individual showed severe skeletal developmental defects, namely, severe craniosynostosis and gracile bones (severe"}
{"subject": "short stature", "sub_type": "Disease", "rel": "ThemeOf", "object": "multiple congenital abnormalities", "obj_type": "Disease", "file_name": "PubMed-29432562.json", "snippet": " consistently found in patients with nonsyndromic early onset epileptic encephalopathy. In contrast, the AI domain mutations were associated with  [CLS] multiple congenital abnormalities including craniofacial dysmorphism, arthrogryposis and short stature [CLS] . In addition, one individual showed severe skeletal developmental defects, namely, severe craniosynostosis and gracile bones (severe bone slenderness and"}
{"subject": "Caenorhabditis elegans peroxidasin PXN-2", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "Loss of function", "obj_type": "NegReg", "file_name": "PubMed-29440357.json", "snippet": " development in animals. Peroxidasins are extracellular peroxidases implicated in the unique sulfilimine cross-links between type IV basement membrane collagens.  [CLS] Loss of function in the Caenorhabditis elegans peroxidasin PXN-2 [CLS]  results in fully penetrant embryonic or larval lethality. Using genetic suppressor screening, we find that the requirement for PXN-2"}
{"subject": "Loss of function", "sub_type": "NegReg", "rel": "CauseOf", "object": "fully penetrant embryonic", "obj_type": "CPA", "file_name": "PubMed-29440357.json", "snippet": " development in animals. Peroxidasins are extracellular peroxidases implicated in the unique sulfilimine cross-links between type IV basement membrane collagens.  [CLS] Loss of function in the Caenorhabditis elegans peroxidasin PXN-2 results in fully penetrant embryonic [CLS]  or larval lethality. Using genetic suppressor screening, we find that the requirement for PXN-2 in development can be bypassed"}
{"subject": "Loss of function", "sub_type": "NegReg", "rel": "CauseOf", "object": "larval lethality", "obj_type": "CPA", "file_name": "PubMed-29440357.json", "snippet": " development in animals. Peroxidasins are extracellular peroxidases implicated in the unique sulfilimine cross-links between type IV basement membrane collagens.  [CLS] Loss of function in the Caenorhabditis elegans peroxidasin PXN-2 results in fully penetrant embryonic or larval lethality [CLS] . Using genetic suppressor screening, we find that the requirement for PXN-2 in development can be bypassed by gain of"}
{"subject": "let-805", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense alterations", "obj_type": "Var", "file_name": "PubMed-29440357.json", "snippet": " protein myotactin, which suppress phenotypes of pxn-2 null mutants and of other basement membrane mutants such as F-spondin/spon-1 These  [CLS] let-805 suppressor alleles cause missense alterations [CLS]  in two pairs of FNIII repeats in the extracellular domain; they act dominantly and have no detectable phenotypes alone,"}
{"subject": "missense alterations", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29440357.json", "snippet": " phenotypes of pxn-2 null mutants and of other basement membrane mutants such as F-spondin/spon-1 These let-805 suppressor alleles cause  [CLS] missense alterations in two pairs of FNIII repeats in the extracellular domain; they act dominantly and have no detectable phenotypes alone, suggesting they cause gain of function [CLS] . We also identify suppressor missense mutations affecting basement membrane components type IV collagen (emb-9, let-2) and perlecan (unc-52), as"}
{"subject": "GTPBP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Biallelic inactivating variants", "obj_type": "Var", "file_name": "PubMed-29449720.json", "snippet": " [CLS] Biallelic inactivating variants in the GTPBP2 [CLS]  gene cause a neurodevelopmental disorder with severe intellectual disability.\nCongenital neurological disorders are genetically highly heterogeneous. Rare forms of"}
{"subject": "c.430[C>T];[C>T] p.(Arg144*)", "sub_type": "Var", "rel": "CauseOf", "object": "structural brain abnormalities", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants  [CLS] c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include structural brain abnormalities [CLS]  (e.g., agenesis of the corpus callosum, exclusive to our patients), and evidence for brain iron accumulation (exclusive to the"}
{"subject": "c.1219[C>T];[C>T] p.(Gln407*)", "sub_type": "Var", "rel": "CauseOf", "object": "structural brain abnormalities", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*),  [CLS] c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include structural brain abnormalities [CLS]  (e.g., agenesis of the corpus callosum, exclusive to our patients), and evidence for brain iron accumulation (exclusive to the"}
{"subject": "c.1408[C>T];[C>T] p.(Arg470*)", "sub_type": "Var", "rel": "CauseOf", "object": "structural brain abnormalities", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and  [CLS] c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include structural brain abnormalities [CLS]  (e.g., agenesis of the corpus callosum, exclusive to our patients), and evidence for brain iron accumulation (exclusive to the"}
{"subject": "agenesis of the corpus callosum", "sub_type": "CPA", "rel": "ThemeOf", "object": "structural brain abnormalities", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include  [CLS] structural brain abnormalities (e.g., agenesis of the corpus callosum [CLS] , exclusive to our patients), and evidence for brain iron accumulation (exclusive to the previously described family). This report confirms"}
{"subject": "brain iron accumulation", "sub_type": "CPA", "rel": "ThemeOf", "object": "structural brain abnormalities", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include  [CLS] structural brain abnormalities (e.g., agenesis of the corpus callosum, exclusive to our patients), and evidence for brain iron accumulation [CLS]  (exclusive to the previously described family). This report confirms pathogenicity of biallelic GTPBP2 inactivation and broadens the phenotypic spectrum."}
{"subject": "neurodevelopmental disorder", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29449720.json", "snippet": " [CLS] cause a neurodevelopmental disorder [CLS]  with severe intellectual disability.\nCongenital neurological disorders are genetically highly heterogeneous. Rare forms of hereditary neurological disorders are still"}
{"subject": "Biallelic inactivating variants", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29449720.json", "snippet": " [CLS] Biallelic inactivating variants in the GTPBP2 gene cause [CLS]  a neurodevelopmental disorder with severe intellectual disability.\nCongenital neurological disorders are genetically highly heterogeneous. Rare forms of hereditary neurological"}
{"subject": "GTPBP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1408[C>T];[C>T] p.(Arg470*)", "obj_type": "Var", "file_name": "PubMed-29449720.json", "snippet": " We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and  [CLS] c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2 [CLS] . Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in"}
{"subject": "GTPBP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.1219[C>T];[C>T] p.(Gln407*)", "obj_type": "Var", "file_name": "PubMed-29449720.json", "snippet": " need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*),  [CLS] c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2 [CLS] . Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in"}
{"subject": "GTPBP2", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.430[C>T];[C>T] p.(Arg144*)", "obj_type": "Var", "file_name": "PubMed-29449720.json", "snippet": " single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants  [CLS] c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2 [CLS] . Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in"}
{"subject": "c.430[C>T];[C>T] p.(Arg144*)", "sub_type": "Var", "rel": "CauseOf", "object": "non-progressive motor and cognitive impairment", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants  [CLS] c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment [CLS] , and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences"}
{"subject": "c.1219[C>T];[C>T] p.(Gln407*)", "sub_type": "Var", "rel": "CauseOf", "object": "non-progressive motor and cognitive impairment", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*),  [CLS] c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment [CLS] , and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences"}
{"subject": "c.1408[C>T];[C>T] p.(Arg470*)", "sub_type": "Var", "rel": "CauseOf", "object": "non-progressive motor and cognitive impairment", "obj_type": "CPA", "file_name": "PubMed-29449720.json", "snippet": " We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and  [CLS] c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment [CLS] , and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences"}
{"subject": "COCH", "sub_type": "Gene", "rel": "ThemeOf", "object": "Bi-allelic inactivating variants", "obj_type": "Var", "file_name": "PubMed-29449721.json", "snippet": " [CLS] Bi-allelic inactivating variants in the COCH [CLS]  gene cause autosomal recessive prelingual hearing impairment.\nPathogenic variant in COCH are a known cause of DFNA9 autosomal dominant"}
{"subject": "Bi-allelic inactivating variants", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29449721.json", "snippet": " [CLS] Bi-allelic inactivating variants in the COCH gene cause [CLS]  autosomal recessive prelingual hearing impairment.\nPathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing"}
{"subject": "autosomal recessive prelingual hearing impairment", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-29449721.json", "snippet": " [CLS] cause autosomal recessive prelingual hearing impairment [CLS] .\nPathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with"}
{"subject": "COCH", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.292C>T(p.Arg98*)", "obj_type": "Var", "file_name": "PubMed-29449721.json", "snippet": " or gain-of-function effect have been described. Here, we describe two brothers with congenital prelingual deafness and a homozygous nonsense  [CLS] c.292C>T(p.Arg98*) COCH [CLS]  variant, suggesting a loss-of-function effect. Vestibular dysfunction starting in the first decade was observed in the older patient. The"}
{"subject": "c.292C>T(p.Arg98*)", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29449721.json", "snippet": " or gain-of-function effect have been described. Here, we describe two brothers with congenital prelingual deafness and a homozygous nonsense  [CLS] c.292C>T(p.Arg98*) COCH variant, suggesting a loss-of-function [CLS]  effect. Vestibular dysfunction starting in the first decade was observed in the older patient. The heterozygous parents and sibling"}
{"subject": "Vestibular dysfunction", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29449721.json", "snippet": " described. Here, we describe two brothers with congenital prelingual deafness and a homozygous nonsense c.292C>T(p.Arg98*) COCH variant, suggesting a  [CLS] loss-of-function effect. Vestibular dysfunction [CLS]  starting in the first decade was observed in the older patient. The heterozygous parents and sibling have normal hearing"}
{"subject": "RecQ-family DNA helicase", "sub_type": "Protein", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29452565.json", "snippet": " pathways in mice synthesizing a nonfunctional mutant WRN protein.\nWerner syndrome (WS) is a premature aging disorder caused by  [CLS] mutations in a RecQ-family DNA helicase [CLS]  (WRN). Mice lacking part of the helicase domain of the WRN ortholog exhibit several phenotypic features of WS. In"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29452565.json", "snippet": " stress response pathways in mice synthesizing a nonfunctional mutant WRN protein.\nWerner syndrome (WS) is a premature aging disorder  [CLS] caused by mutations [CLS]  in a RecQ-family DNA helicase (WRN). Mice lacking part of the helicase domain of the WRN ortholog exhibit several"}
{"subject": "Werner syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused by", "obj_type": "Reg", "file_name": "PubMed-29452565.json", "snippet": " C levels modulate the lifespan and endoplasmic reticulum stress response pathways in mice synthesizing a nonfunctional mutant WRN protein.\n [CLS] Werner syndrome (WS) is a premature aging disorder caused by [CLS]  mutations in a RecQ-family DNA helicase (WRN). Mice lacking part of the helicase domain of the WRN ortholog exhibit"}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29464833.json", "snippet": " [CLS] CgPDR1 gain-of-function mutations [CLS]  lead to azole-resistance and increased adhesion in clinical Candida glabrata strains.\nRecently, Candida glabrata has emerged as a health-threatening"}
{"subject": "drug resistance", "sub_type": "MPA", "rel": "ThemeOf", "object": "conferred", "obj_type": "Reg", "file_name": "PubMed-29464833.json", "snippet": " transporter gene expression levels did not always correspond with that of the adhesin EPA1 gene. GOF mutations in CgPDR1  [CLS] conferred drug resistance [CLS]  and increased adherence in the clinical strains, possibly endowing C.\u00a0glabrata with increased viability and pathogenicity."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " Interestingly, the drug transporter gene expression levels did not always correspond with that of the adhesin EPA1 gene. GOF  [CLS] mutations in CgPDR1 conferred drug resistance and increased [CLS]  adherence in the clinical strains, possibly endowing C.\u00a0glabrata with increased viability and pathogenicity."}
{"subject": "adherence", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " did not always correspond with that of the adhesin EPA1 gene. GOF mutations in CgPDR1 conferred drug resistance and  [CLS] increased adherence [CLS]  in the clinical strains, possibly endowing C.\u00a0glabrata with increased viability and pathogenicity."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " P927S, the last being reported for the first time. CDR1, CDR2 and SNQ2 efflux pump gene expression levels were  [CLS] elevated in strains harbouring GOF mutations [CLS]  in CgPDR1, resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the"}
{"subject": "CDR1, CDR2 and SNQ2 efflux pump gene expression levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " were revealed by sequence analysis, namely G1099D, G346D, L344S and P927S, the last being reported for the first time.  [CLS] CDR1, CDR2 and SNQ2 efflux pump gene expression levels were elevated [CLS]  in strains harbouring GOF mutations in CgPDR1, resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed"}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29464833.json", "snippet": " for the first time. CDR1, CDR2 and SNQ2 efflux pump gene expression levels were elevated in strains harbouring GOF  [CLS] mutations in CgPDR1 [CLS] , resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " reported for the first time. CDR1, CDR2 and SNQ2 efflux pump gene expression levels were elevated in strains harbouring  [CLS] GOF mutations [CLS]  in CgPDR1, resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29464833.json", "snippet": " for the first time. CDR1, CDR2 and SNQ2 efflux pump gene expression levels were elevated in strains harbouring GOF  [CLS] mutations in CgPDR1, resulting in decreased [CLS]  azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1GOF mutations led"}
{"subject": "azole susceptibility", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-29464833.json", "snippet": " CDR2 and SNQ2 efflux pump gene expression levels were elevated in strains harbouring GOF mutations in CgPDR1, resulting in  [CLS] decreased azole susceptibility [CLS] . CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1GOF mutations led to increased"}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29464833.json", "snippet": " resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes.  [CLS] CgPDR1GOF mutations [CLS]  led to increased efflux pumps expression levels in a strain background independent way. Hyperactive Pdr1G1099D and Pdr1P927S displayed strain"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " [CLS] gain-of-function mutations [CLS]  lead to azole-resistance and increased adhesion in clinical Candida glabrata strains.\nRecently, Candida glabrata has emerged as a health-threatening"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " resulting in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1 [CLS] GOF mutations [CLS]  led to increased efflux pumps expression levels in a strain background independent way. Hyperactive Pdr1G1099D and Pdr1P927S displayed strain"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " in decreased azole susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1GOF  [CLS] mutations led to increased [CLS]  efflux pumps expression levels in a strain background independent way. Hyperactive Pdr1G1099D and Pdr1P927S displayed strain background-dependent increased adherence"}
{"subject": "efflux pumps expression levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " susceptibility. CgPDR1 alleles with distinct GOF mutations displayed different expression profiles for the drug-related genes. CgPDR1GOF mutations led to  [CLS] increased efflux pumps expression levels [CLS]  in a strain background independent way. Hyperactive Pdr1G1099D and Pdr1P927S displayed strain background-dependent increased adherence to host cells via"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29464833.json", "snippet": " [CLS] mutations lead to [CLS]  azole-resistance and increased adhesion in clinical Candida glabrata strains.\nRecently, Candida glabrata has emerged as a health-threatening pathogen and"}
{"subject": "azole-resistance", "sub_type": "MPA", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29464833.json", "snippet": " [CLS] lead to azole-resistance [CLS]  and increased adhesion in clinical Candida glabrata strains.\nRecently, Candida glabrata has emerged as a health-threatening pathogen and the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " [CLS] mutations lead to azole-resistance and increased [CLS]  adhesion in clinical Candida glabrata strains.\nRecently, Candida glabrata has emerged as a health-threatening pathogen and the rising resistance"}
{"subject": "adhesion", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " [CLS] increased adhesion [CLS]  in clinical Candida glabrata strains.\nRecently, Candida glabrata has emerged as a health-threatening pathogen and the rising resistance to"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29464833.json", "snippet": " transcription. Interestingly, the drug transporter gene expression levels did not always correspond with that of the adhesin EPA1 gene.  [CLS] GOF mutations [CLS]  in CgPDR1 conferred drug resistance and increased adherence in the clinical strains, possibly endowing C.\u00a0glabrata with increased viability and"}
{"subject": "CgPDR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29464833.json", "snippet": " Interestingly, the drug transporter gene expression levels did not always correspond with that of the adhesin EPA1 gene. GOF  [CLS] mutations in CgPDR1 [CLS]  conferred drug resistance and increased adherence in the clinical strains, possibly endowing C.\u00a0glabrata with increased viability and pathogenicity."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "conferred", "obj_type": "Reg", "file_name": "PubMed-29464833.json", "snippet": " Interestingly, the drug transporter gene expression levels did not always correspond with that of the adhesin EPA1 gene. GOF  [CLS] mutations in CgPDR1 conferred [CLS]  drug resistance and increased adherence in the clinical strains, possibly endowing C.\u00a0glabrata with increased viability and pathogenicity."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29478779.json", "snippet": " external genitalia, and biochemical or histological evidence of testicular tissue. We demonstrate a highly significant association between the NR2F2  [CLS] loss-of-function mutations [CLS]  and this syndromic form of DSD (p = 2.44\u00a0\u00d7 10-8). We show that COUP-TF2 is highly abundant in a"}
{"subject": "syndromic form of DSD", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29478779.json", "snippet": " external genitalia, and biochemical or histological evidence of testicular tissue. We demonstrate a highly significant association between the NR2F2  [CLS] loss-of-function mutations and this syndromic form of DSD [CLS]  (p = 2.44\u00a0\u00d7 10-8). We show that COUP-TF2 is highly abundant in a FOXL2-negative stromal cell population of the"}
{"subject": "p.Gly35Argfs\u221775", "sub_type": "Var", "rel": "ThemeOf", "object": "NR2F2", "obj_type": "Gene", "file_name": "PubMed-29478779.json", "snippet": " individuals with either unexplained virilization or with testicular/ovotesticular disorders/differences of sex development (TDSD/OTDSD). We identified heterozygous frameshift mutations in  [CLS] NR2F2, encoding COUP-TF2, in three children. One carried a c.103_109delGGCGCCC (p.Gly35Argfs\u221775 [CLS] ) mutation, while two others carried a c.97_103delCCGCCCG (p.Pro33Alafs\u221777) mutation. In two of three children the mutation was de novo."}
{"subject": "p.Pro33Alafs\u221777", "sub_type": "Var", "rel": "ThemeOf", "object": "NR2F2", "obj_type": "Gene", "file_name": "PubMed-29478779.json", "snippet": " individuals with either unexplained virilization or with testicular/ovotesticular disorders/differences of sex development (TDSD/OTDSD). We identified heterozygous frameshift mutations in  [CLS] NR2F2, encoding COUP-TF2, in three children. One carried a c.103_109delGGCGCCC (p.Gly35Argfs\u221775) mutation, while two others carried a c.97_103delCCGCCCG (p.Pro33Alafs\u221777 [CLS] ) mutation. In two of three children the mutation was de novo. All three children presented with congenital heart disease"}
{"subject": "p.Pro33Alafs\u221777", "sub_type": "Var", "rel": "CauseOf", "object": "presented with", "obj_type": "Reg", "file_name": "PubMed-29478779.json", "snippet": " in NR2F2, encoding COUP-TF2, in three children. One carried a c.103_109delGGCGCCC (p.Gly35Argfs\u221775) mutation, while two others carried a c.97_103delCCGCCCG ( [CLS] p.Pro33Alafs\u221777) mutation. In two of three children the mutation was de novo. All three children presented with [CLS]  congenital heart disease (CHD), one child with congenital diaphragmatic hernia (CDH), and two children with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)."}
{"subject": "p.Gly35Argfs\u221775", "sub_type": "Var", "rel": "CauseOf", "object": "presented with", "obj_type": "Reg", "file_name": "PubMed-29478779.json", "snippet": " sex development (TDSD/OTDSD). We identified heterozygous frameshift mutations in NR2F2, encoding COUP-TF2, in three children. One carried a c.103_109delGGCGCCC ( [CLS] p.Gly35Argfs\u221775) mutation, while two others carried a c.97_103delCCGCCCG (p.Pro33Alafs\u221777) mutation. In two of three children the mutation was de novo. All three children presented with [CLS]  congenital heart disease (CHD), one child with congenital diaphragmatic hernia (CDH), and two children with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)."}
{"subject": "congenital heart disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "presented with", "obj_type": "Reg", "file_name": "PubMed-29478779.json", "snippet": " others carried a c.97_103delCCGCCCG (p.Pro33Alafs\u221777) mutation. In two of three children the mutation was de novo. All three children  [CLS] presented with congenital heart disease [CLS]  (CHD), one child with congenital diaphragmatic hernia (CDH), and two children with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). The three children"}
{"subject": "NR2F2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29478779.json", "snippet": " of external genitalia, and biochemical or histological evidence of testicular tissue. We demonstrate a highly significant association between the  [CLS] NR2F2 loss-of-function mutations [CLS]  and this syndromic form of DSD (p = 2.44\u00a0\u00d7 10-8). We show that COUP-TF2 is highly abundant in a"}
{"subject": "ATP5F1D", "sub_type": "Gene", "rel": "ThemeOf", "object": "Biallelic Mutations", "obj_type": "Var", "file_name": "PubMed-29478781.json", "snippet": " [CLS] Biallelic Mutations in ATP5F1D [CLS] , which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.\nATP synthase, H+ transporting, mitochondrial F1 complex, \u03b4"}
{"subject": "Mendelian mitochondrial disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "leading to", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish c.245C>T (p.Pro82Leu) and c.317T>G (p.Val106Gly) in ATP5F1D as pathogenic variants  [CLS] leading to a Mendelian mitochondrial disease [CLS]  featuring episodic metabolic decompensation."}
{"subject": "missense variants", "sub_type": "Var", "rel": "CauseOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " plays an important role in coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous  [CLS] missense variants in ATP5F1D, who presented [CLS]  with episodic lethargy, metabolic acidosis, 3-methylglutaconic aciduria, and hyperammonemia. Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with recurrent metabolic"}
{"subject": "episodic lethargy", "sub_type": "MPA", "rel": "ThemeOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous missense variants in ATP5F1D, who  [CLS] presented with episodic lethargy [CLS] , metabolic acidosis, 3-methylglutaconic aciduria, and hyperammonemia. Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with recurrent metabolic decompensation starting in"}
{"subject": "metabolic acidosis", "sub_type": "MPA", "rel": "ThemeOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous missense variants in ATP5F1D, who  [CLS] presented with episodic lethargy, metabolic acidosis [CLS] , 3-methylglutaconic aciduria, and hyperammonemia. Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with recurrent metabolic decompensation starting in the neonatal"}
{"subject": "3-methylglutaconic aciduria", "sub_type": "MPA", "rel": "ThemeOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous missense variants in ATP5F1D, who  [CLS] presented with episodic lethargy, metabolic acidosis, 3-methylglutaconic aciduria [CLS] , and hyperammonemia. Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with recurrent metabolic decompensation starting in the neonatal period, and"}
{"subject": "hyperammonemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous missense variants in ATP5F1D, who  [CLS] presented with episodic lethargy, metabolic acidosis, 3-methylglutaconic aciduria, and hyperammonemia [CLS] . Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with recurrent metabolic decompensation starting in the neonatal period, and subject 2,"}
{"subject": "ATP5F1D", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense variants", "obj_type": "Var", "file_name": "PubMed-29478781.json", "snippet": " plays an important role in coupling proton translocation and ATP production. Here, we describe two individuals, each with homozygous  [CLS] missense variants in ATP5F1D [CLS] , who presented with episodic lethargy, metabolic acidosis, 3-methylglutaconic aciduria, and hyperammonemia. Subject 1, homozygous for c.245C>T (p.Pro82Leu), presented with"}
{"subject": "Biallelic Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Cause", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " [CLS] Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause [CLS]  a Metabolic Disorder.\nATP synthase, H+ transporting, mitochondrial F1 complex, \u03b4 subunit (ATP5F1D; formerly ATP5D) is a subunit of"}
{"subject": "Metabolic Disorder", "sub_type": "MPA", "rel": "ThemeOf", "object": "Cause", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " [CLS] Cause a Metabolic Disorder [CLS] .\nATP synthase, H+ transporting, mitochondrial F1 complex, \u03b4 subunit (ATP5F1D; formerly ATP5D) is a subunit of mitochondrial ATP synthase"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "rescued", "obj_type": "PosReg", "file_name": "PubMed-29478781.json", "snippet": " a phenotype that was fully rescued by wild-type human ATP5F1D. In contrast, expression of the ATP5F1D c.245C>T and c.317T>G  [CLS] variants rescued [CLS]  the head-size phenotype but recapitulated the eye and antennae defects seen in other genetic models of mitochondrial oxidative phosphorylation"}
{"subject": "head-size phenotype", "sub_type": "MPA", "rel": "ThemeOf", "object": "rescued", "obj_type": "PosReg", "file_name": "PubMed-29478781.json", "snippet": " phenotype that was fully rescued by wild-type human ATP5F1D. In contrast, expression of the ATP5F1D c.245C>T and c.317T>G variants  [CLS] rescued the head-size phenotype [CLS]  but recapitulated the eye and antennae defects seen in other genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "recapitulated", "obj_type": "NegReg", "file_name": "PubMed-29478781.json", "snippet": " a phenotype that was fully rescued by wild-type human ATP5F1D. In contrast, expression of the ATP5F1D c.245C>T and c.317T>G  [CLS] variants rescued the head-size phenotype but recapitulated [CLS]  the eye and antennae defects seen in other genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish c.245C>T (p.Pro82Leu)"}
{"subject": "eye", "sub_type": "MPA", "rel": "ThemeOf", "object": "recapitulated", "obj_type": "NegReg", "file_name": "PubMed-29478781.json", "snippet": " by wild-type human ATP5F1D. In contrast, expression of the ATP5F1D c.245C>T and c.317T>G variants rescued the head-size phenotype but  [CLS] recapitulated the eye [CLS]  and antennae defects seen in other genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish c.245C>T (p.Pro82Leu) and c.317T>G"}
{"subject": "antennae defects", "sub_type": "MPA", "rel": "ThemeOf", "object": "recapitulated", "obj_type": "NegReg", "file_name": "PubMed-29478781.json", "snippet": " by wild-type human ATP5F1D. In contrast, expression of the ATP5F1D c.245C>T and c.317T>G variants rescued the head-size phenotype but  [CLS] recapitulated the eye and antennae defects [CLS]  seen in other genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish c.245C>T (p.Pro82Leu) and c.317T>G (p.Val106Gly) in ATP5F1D"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "leading to", "obj_type": "Reg", "file_name": "PubMed-29478781.json", "snippet": " other genetic models of mitochondrial oxidative phosphorylation deficiency. Our\u00a0data establish c.245C>T (p.Pro82Leu) and c.317T>G (p.Val106Gly) in ATP5F1D as pathogenic  [CLS] variants leading to [CLS]  a Mendelian mitochondrial disease featuring episodic metabolic decompensation."}
{"subject": "Nav1.5", "sub_type": "Gene", "rel": "ThemeOf", "object": "G213D", "obj_type": "Var", "file_name": "PubMed-29506689.json", "snippet": " [CLS] Nav1.5 gain-of-function mutation (G213D [CLS] ).\nBACKGROUND: SCN5A mutations can lead to different cardiac diseases. Recently, SCN5A mutations have been linked to the clinical entity"}
{"subject": "G213D", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29506689.json", "snippet": " [CLS] gain-of-function mutation (G213D [CLS] ).\nBACKGROUND: SCN5A mutations can lead to different cardiac diseases. Recently, SCN5A mutations have been linked to the clinical entity"}
{"subject": "G213D", "sub_type": "Var", "rel": "ThemeOf", "object": "resulting in", "obj_type": "Reg", "file_name": "PubMed-29506689.json", "snippet": " revealed a missense mutation in the linker between segments 3 and 4 in domain 1 of the Nav1.5 protein,  [CLS] resulting in a glycine to aspartate substitution at position 213 (G213D [CLS] ). The phenotype co-segregated with the missense mutation. Electrophysiological studies of wild type (WT) hNav1.5 and hNav1.5_G213D expressed in CHO-K"}
{"subject": "Nav1.5", "sub_type": "Gene", "rel": "ThemeOf", "object": "G213D", "obj_type": "Var", "file_name": "PubMed-29506689.json", "snippet": " to a gain-of-function phenotype. Flecainide and amiodarone markedly reduced premature atrial and ventricular contractions in four patients.\nCONCLUSION: The  [CLS] Nav1.5_G213D [CLS]  mutation is associated with a gain-of-function phenotype, multifocal atrial and ventricular ectopy and dilated cardiomyopathy. Since patients with a"}
{"subject": "G213D", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29506689.json", "snippet": " to a gain-of-function phenotype. Flecainide and amiodarone markedly reduced premature atrial and ventricular contractions in four patients.\nCONCLUSION: The Nav1.5_ [CLS] G213D mutation is associated with a gain-of-function [CLS]  phenotype, multifocal atrial and ventricular ectopy and dilated cardiomyopathy. Since patients with a MEPPC-like phenotype may specifically benefit from"}
{"subject": "dilated cardiomyopathy", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29506689.json", "snippet": " amiodarone markedly reduced premature atrial and ventricular contractions in four patients.\nCONCLUSION: The Nav1.5_G213D mutation is associated with a  [CLS] gain-of-function phenotype, multifocal atrial and ventricular ectopy and dilated cardiomyopathy [CLS] . Since patients with a MEPPC-like phenotype may specifically benefit from Class-1 antiarrhythmic drugs or amiodarone, clinical identification of this"}
{"subject": "dilated cardiomyopathy", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29506689.json", "snippet": " [CLS] dilated cardiomyopathy caused by a Nav1.5 gain-of-function [CLS]  mutation (G213D).\nBACKGROUND: SCN5A mutations can lead to different cardiac diseases. Recently, SCN5A mutations have been linked to the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29506689.json", "snippet": " ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Nav1.5 gain-of-function mutation (G213D).\nBACKGROUND: SCN5A  [CLS] mutations can lead to [CLS]  different cardiac diseases. Recently, SCN5A mutations have been linked to the clinical entity multifocal ectopic Purkinje-related premature contractions (MEPPC)"}
{"subject": "cardiac diseases", "sub_type": "Disease", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29506689.json", "snippet": " contractions with an increased risk of dilated cardiomyopathy caused by a Nav1.5 gain-of-function mutation (G213D).\nBACKGROUND: SCN5A mutations can  [CLS] lead to different cardiac diseases [CLS] . Recently, SCN5A mutations have been linked to the clinical entity multifocal ectopic Purkinje-related premature contractions (MEPPC) characterized by ventricular"}
{"subject": "SCN5A", "sub_type": "Gene", "rel": "ThemeOf", "object": "missense mutation", "obj_type": "Var", "file_name": "PubMed-29506689.json", "snippet": " ventricular arrhythmias and dilated cardiomyopathy caused by a high frequency of ventricular ectopy was clinically assessed. Screening of the  [CLS] SCN5A gene revealed a missense mutation [CLS]  in the linker between segments 3 and 4 in domain 1 of the Nav1.5 protein, resulting in a glycine"}
{"subject": "missense mutation", "sub_type": "Var", "rel": "CauseOf", "object": "resulting in", "obj_type": "Reg", "file_name": "PubMed-29506689.json", "snippet": " cardiomyopathy caused by a high frequency of ventricular ectopy was clinically assessed. Screening of the SCN5A gene revealed a  [CLS] missense mutation in the linker between segments 3 and 4 in domain 1 of the Nav1.5 protein, resulting in [CLS]  a glycine to aspartate substitution at position 213 (G213D). The phenotype co-segregated with the missense mutation. Electrophysiological studies of"}
{"subject": "ego-3", "sub_type": "Gene", "rel": "ThemeOf", "object": "om40", "obj_type": "Var", "file_name": "PubMed-29507057.json", "snippet": " GLP-1/Notch signaling in Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3.  [CLS] ego-3(om40 [CLS] ) causes several defects in the soma and the germline, including paralysis during larval development, sterility, delayed proliferation of germline"}
{"subject": "om40", "sub_type": "Var", "rel": "CauseOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-29507057.json", "snippet": " GLP-1/Notch signaling in Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3. ego-3( [CLS] om40) causes [CLS]  several defects in the soma and the germline, including paralysis during larval development, sterility, delayed proliferation of germline stem"}
{"subject": "defects", "sub_type": "MPA", "rel": "ThemeOf", "object": "causes", "obj_type": "Reg", "file_name": "PubMed-29507057.json", "snippet": " signaling in Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3. ego-3(om40)  [CLS] causes several defects [CLS]  in the soma and the germline, including paralysis during larval development, sterility, delayed proliferation of germline stem cells, and"}
{"subject": "paralysis", "sub_type": "Disease", "rel": "ThemeOf", "object": "defects", "obj_type": "MPA", "file_name": "PubMed-29507057.json", "snippet": " Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3. ego-3(om40) causes several  [CLS] defects in the soma and the germline, including paralysis [CLS]  during larval development, sterility, delayed proliferation of germline stem cells, and ectopic germline stem cell proliferation. Whole genome sequencing"}
{"subject": "sterility", "sub_type": "Disease", "rel": "ThemeOf", "object": "defects", "obj_type": "MPA", "file_name": "PubMed-29507057.json", "snippet": " Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3. ego-3(om40) causes several  [CLS] defects in the soma and the germline, including paralysis during larval development, sterility [CLS] , delayed proliferation of germline stem cells, and ectopic germline stem cell proliferation. Whole genome sequencing identified om40 as an"}
{"subject": "delayed proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "defects", "obj_type": "MPA", "file_name": "PubMed-29507057.json", "snippet": " Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3. ego-3(om40) causes several  [CLS] defects in the soma and the germline, including paralysis during larval development, sterility, delayed proliferation [CLS]  of germline stem cells, and ectopic germline stem cell proliferation. Whole genome sequencing identified om40 as an allele of"}
{"subject": "ectopic germline stem cell proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "defects", "obj_type": "MPA", "file_name": "PubMed-29507057.json", "snippet": " Caenorhabditis elegans germline stem cells, we found a single mutation, om40, defining a gene called ego-3. ego-3(om40) causes several  [CLS] defects in the soma and the germline, including paralysis during larval development, sterility, delayed proliferation of germline stem cells, and ectopic germline stem cell proliferation [CLS] . Whole genome sequencing identified om40 as an allele of hsp-90, previously known as daf-21, which encodes the C. elegans"}
{"subject": "Platelet activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "associated", "obj_type": "Interaction", "file_name": "PubMed-29509167.json", "snippet": " or transient ischemic attack alone was also higher (hazard ratio = 3.170; 95% confidence interval, 1.281-7.849; P = 0.034).  [CLS] Platelet activity was strongly associated [CLS]  with allele *2 status (rs = 0.21, P = 0.016) but not with other genetic polymorphisms. Carriers of allele*2"}
{"subject": "allele *2 status", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Interaction", "file_name": "PubMed-29509167.json", "snippet": " alone was also higher (hazard ratio = 3.170; 95% confidence interval, 1.281-7.849; P = 0.034). Platelet activity was strongly  [CLS] associated with allele *2 status [CLS]  (rs = 0.21, P = 0.016) but not with other genetic polymorphisms. Carriers of allele*2 exhibited lower platelet response"}
{"subject": "allele", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29509167.json", "snippet": " months, 19 patients experienced major adverse clinical events. The risk of major adverse clinical events was nearly 3-fold in  [CLS] loss-of-function allele [CLS]  carriers (hazard ratio = 2.904; 95% confidence interval, 1.083-7.786; P = 0.013), whereas the risk of ischemic stroke or"}
{"subject": "allele", "sub_type": "Var", "rel": "CauseOf", "object": "major adverse clinical events", "obj_type": "MPA", "file_name": "PubMed-29509167.json", "snippet": " infarction).\nRESULTS: Over the mean follow-up of 14.9 months, 19 patients experienced major adverse clinical events. The risk of  [CLS] major adverse clinical events was nearly 3-fold in loss-of-function allele [CLS]  carriers (hazard ratio = 2.904; 95% confidence interval, 1.083-7.786; P = 0.013), whereas the risk of ischemic stroke or"}
{"subject": "allele", "sub_type": "Var", "rel": "CauseOf", "object": "ischemic stroke", "obj_type": "MPA", "file_name": "PubMed-29509167.json", "snippet": " 19 patients experienced major adverse clinical events. The risk of major adverse clinical events was nearly 3-fold in loss-of-function  [CLS] allele carriers (hazard ratio = 2.904; 95% confidence interval, 1.083-7.786; P = 0.013), whereas the risk of ischemic stroke [CLS]  or transient ischemic attack alone was also higher (hazard ratio = 3.170; 95% confidence interval, 1.281-7.849; P = 0.034)."}
{"subject": "allele", "sub_type": "Var", "rel": "CauseOf", "object": "transient ischemic attack alone", "obj_type": "MPA", "file_name": "PubMed-29509167.json", "snippet": " 19 patients experienced major adverse clinical events. The risk of major adverse clinical events was nearly 3-fold in loss-of-function  [CLS] allele carriers (hazard ratio = 2.904; 95% confidence interval, 1.083-7.786; P = 0.013), whereas the risk of ischemic stroke or transient ischemic attack alone [CLS]  was also higher (hazard ratio = 3.170; 95% confidence interval, 1.281-7.849; P = 0.034). Platelet activity was strongly associated"}
{"subject": "fama", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29513733.json", "snippet": " switch during stomatal development. Our research demonstrates that FAMA is also an essential component of B. cinerea resistance. The  [CLS] fama loss-of-function mutants [CLS]  (fama-1 and fama-2) increased susceptibility to B. cinerea infection and reduced defense-gene expression. On the contrary, transgenic lines constitutively"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29513733.json", "snippet": " during stomatal development. Our research demonstrates that FAMA is also an essential component of B. cinerea resistance. The fama  [CLS] loss-of-function mutants [CLS]  (fama-1 and fama-2) increased susceptibility to B. cinerea infection and reduced defense-gene expression. On the contrary, transgenic lines constitutively"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29513733.json", "snippet": " stomatal development. Our research demonstrates that FAMA is also an essential component of B. cinerea resistance. The fama loss-of-function  [CLS] mutants (fama-1 and fama-2) increased [CLS]  susceptibility to B. cinerea infection and reduced defense-gene expression. On the contrary, transgenic lines constitutively overexpressing FAMA showed opposite"}
{"subject": "susceptibility to B. cinerea infection", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29513733.json", "snippet": " demonstrates that FAMA is also an essential component of B. cinerea resistance. The fama loss-of-function mutants (fama-1 and fama-2)  [CLS] increased susceptibility to B. cinerea infection [CLS]  and reduced defense-gene expression. On the contrary, transgenic lines constitutively overexpressing FAMA showed opposite B. cinerea responses compared with"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29513733.json", "snippet": " stomatal development. Our research demonstrates that FAMA is also an essential component of B. cinerea resistance. The fama loss-of-function  [CLS] mutants (fama-1 and fama-2) increased susceptibility to B. cinerea infection and reduced [CLS]  defense-gene expression. On the contrary, transgenic lines constitutively overexpressing FAMA showed opposite B. cinerea responses compared with the fama"}
{"subject": "defense-gene expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29513733.json", "snippet": " component of B. cinerea resistance. The fama loss-of-function mutants (fama-1 and fama-2) increased susceptibility to B. cinerea infection and  [CLS] reduced defense-gene expression [CLS] . On the contrary, transgenic lines constitutively overexpressing FAMA showed opposite B. cinerea responses compared with the fama loss-of-function mutants."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-29514032.json", "snippet": " [CLS] caused by mutations [CLS]  in genes that regulate oxygen-dependent transcription of the gene encoding erythropoietin ( EPO). We identified a mutation in EPO"}
{"subject": "Familial erythrocytosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "caused", "obj_type": "Reg", "file_name": "PubMed-29514032.json", "snippet": " [CLS] Familial erythrocytosis with elevated erythropoietin levels is frequently caused [CLS]  by mutations in genes that regulate oxygen-dependent transcription of the gene encoding erythropoietin ( EPO). We identified a mutation"}
{"subject": "EPO", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29514032.json", "snippet": " [CLS] mutations in genes that regulate oxygen-dependent transcription of the gene encoding erythropoietin ( EPO [CLS] ). We identified a mutation in EPO that cosegregated with disease with a logarithm of the odds (LOD) score of"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "interrupts", "obj_type": "NegReg", "file_name": "PubMed-29514032.json", "snippet": " disease with a logarithm of the odds (LOD) score of 3.3 in a family with autosomal dominant erythrocytosis. This  [CLS] mutation, a single-nucleotide deletion (c.32delG), introduces a frameshift in exon 2 that interrupts [CLS]  translation of the main EPO messenger RNA (mRNA) transcript but initiates excess production of erythropoietin from what is normally"}
{"subject": "main EPO messenger RNA (mRNA) transcript", "sub_type": "MPA", "rel": "ThemeOf", "object": "interrupts", "obj_type": "NegReg", "file_name": "PubMed-29514032.json", "snippet": " a family with autosomal dominant erythrocytosis. This mutation, a single-nucleotide deletion (c.32delG), introduces a frameshift in exon 2 that  [CLS] interrupts translation of the main EPO messenger RNA (mRNA) transcript [CLS]  but initiates excess production of erythropoietin from what is normally a noncoding EPO mRNA transcribed from an alternative promoter"}
{"subject": "Fgfr2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Inactivation", "obj_type": "Var", "file_name": "PubMed-29526646.json", "snippet": " [CLS] Inactivation of Fgfr2 [CLS]  gene in mouse secondary palate mesenchymal cells leads to cleft palate.\nNumerous studies have been conducted to understand the"}
{"subject": "Inactivation", "sub_type": "Var", "rel": "CauseOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-29526646.json", "snippet": " [CLS] Inactivation of Fgfr2 gene in mouse secondary palate mesenchymal cells leads to [CLS]  cleft palate.\nNumerous studies have been conducted to understand the molecular mechanisms controlling mammalian secondary palate development such as"}
{"subject": "cleft palate", "sub_type": "Disease", "rel": "ThemeOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-29526646.json", "snippet": " [CLS] leads to cleft palate [CLS] .\nNumerous studies have been conducted to understand the molecular mechanisms controlling mammalian secondary palate development such as growth, reorientation"}
{"subject": "inactivation", "sub_type": "Var", "rel": "CauseOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-29526646.json", "snippet": " shelf initiation. Fgfr2 continues to express in palate on E12.5 and E13.5 in both epithelial and mesenchymal cells, and  [CLS] inactivation of Fgfr2 expression in mesenchymal cells using floxed Fgfr2 allele and Osr2-Cre leads to [CLS]  cleft palate at various stages including reorientation, horizontal growth and fusion. Notably, some mutant embryos displayed no sign of"}
{"subject": "cleft palate", "sub_type": "Disease", "rel": "ThemeOf", "object": "leads to", "obj_type": "Reg", "file_name": "PubMed-29526646.json", "snippet": " both epithelial and mesenchymal cells, and inactivation of Fgfr2 expression in mesenchymal cells using floxed Fgfr2 allele and Osr2-Cre  [CLS] leads to cleft palate [CLS]  at various stages including reorientation, horizontal growth and fusion. Notably, some mutant embryos displayed no sign of palate shelf"}
{"subject": "Fgfr2", "sub_type": "Gene", "rel": "ThemeOf", "object": "inactivation", "obj_type": "Var", "file_name": "PubMed-29526646.json", "snippet": " shelf initiation. Fgfr2 continues to express in palate on E12.5 and E13.5 in both epithelial and mesenchymal cells, and  [CLS] inactivation of Fgfr2 [CLS]  expression in mesenchymal cells using floxed Fgfr2 allele and Osr2-Cre leads to cleft palate at various stages including reorientation,"}
{"subject": "mib-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29531012.json", "snippet": " elegans mib-1 expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that  [CLS] mib-1 mutants [CLS]  suppress both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants, restoring anchor cell formation and a functional vulva to"}
{"subject": "oocyte production", "sub_type": "MPA", "rel": "ThemeOf", "object": "restoring", "obj_type": "PosReg", "file_name": "PubMed-29531012.json", "snippet": " vulva precursor cells. Here, we show that mib-1 mutants suppress both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants,  [CLS] restoring anchor cell formation and a functional vulva to the former and partly restoring oocyte production [CLS]  to the latter. However, suppressed hermaphrodites are only observed when grown at 25\u00b0, and they are self-sterile. This probably"}
{"subject": "mib-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29531012.json", "snippet": " recovered in the extensive Notch suppressor/enhancer screens that have identified numerous pathway components. Here, we show that C. elegans  [CLS] mib-1 null mutants [CLS]  have a spermatogenesis-defective phenotype that results in a heterogeneous mixture of arrested spermatocytes, defective spermatids, and motility-impaired spermatozoa. mib-1"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "results in", "obj_type": "Reg", "file_name": "PubMed-29531012.json", "snippet": " the extensive Notch suppressor/enhancer screens that have identified numerous pathway components. Here, we show that C. elegans mib-1 null  [CLS] mutants have a spermatogenesis-defective phenotype that results in [CLS]  a heterogeneous mixture of arrested spermatocytes, defective spermatids, and motility-impaired spermatozoa. mib-1 mutants also have chromosome segregation defects during"}
{"subject": "heterogeneous mixture of arrested spermatocytes", "sub_type": "MPA", "rel": "ThemeOf", "object": "results in", "obj_type": "Reg", "file_name": "PubMed-29531012.json", "snippet": " have identified numerous pathway components. Here, we show that C. elegans mib-1 null mutants have a spermatogenesis-defective phenotype that  [CLS] results in a heterogeneous mixture of arrested spermatocytes [CLS] , defective spermatids, and motility-impaired spermatozoa. mib-1 mutants also have chromosome segregation defects during meiosis, molecular null mutants are intrinsically"}
{"subject": "heterogeneous mixture of arrested spermatocytes", "sub_type": "MPA", "rel": "CauseOf", "object": "spermatogenesis-defective phenotype", "obj_type": "Disease", "file_name": "PubMed-29531012.json", "snippet": " suppressor/enhancer screens that have identified numerous pathway components. Here, we show that C. elegans mib-1 null mutants have a  [CLS] spermatogenesis-defective phenotype that results in a heterogeneous mixture of arrested spermatocytes [CLS] , defective spermatids, and motility-impaired spermatozoa. mib-1 mutants also have chromosome segregation defects during meiosis, molecular null mutants are intrinsically"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "suppress", "obj_type": "NegReg", "file_name": "PubMed-29531012.json", "snippet": " mib-1 expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1  [CLS] mutants suppress [CLS]  both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants, restoring anchor cell formation and a functional vulva to the"}
{"subject": "lin-12", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29531012.json", "snippet": " upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1 mutants suppress both  [CLS] lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants [CLS] , restoring anchor cell formation and a functional vulva to the former and partly restoring oocyte production to the latter."}
{"subject": "glp-1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29531012.json", "snippet": " spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1 mutants suppress both lin-12 and  [CLS] glp-1 (C. elegans Notch) gain-of-function mutants [CLS] , restoring anchor cell formation and a functional vulva to the former and partly restoring oocyte production to the latter."}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29531012.json", "snippet": " including in vulva precursor cells. Here, we show that mib-1 mutants suppress both lin-12 and glp-1 (C. elegans Notch)  [CLS] gain-of-function mutants [CLS] , restoring anchor cell formation and a functional vulva to the former and partly restoring oocyte production to the latter."}
{"subject": "mutants", "sub_type": "Var", "rel": "ThemeOf", "object": "suppress", "obj_type": "NegReg", "file_name": "PubMed-29531012.json", "snippet": " expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1 mutants  [CLS] suppress both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants [CLS] , restoring anchor cell formation and a functional vulva to the former and partly restoring oocyte production to the latter."}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "restoring", "obj_type": "PosReg", "file_name": "PubMed-29531012.json", "snippet": " mib-1 expression, while upregulated during spermatogenesis, also occurs somatically, including in vulva precursor cells. Here, we show that mib-1  [CLS] mutants suppress both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants, restoring [CLS]  anchor cell formation and a functional vulva to the former and partly restoring oocyte production to the latter. However,"}
{"subject": "anchor cell formation", "sub_type": "MPA", "rel": "ThemeOf", "object": "restoring", "obj_type": "PosReg", "file_name": "PubMed-29531012.json", "snippet": " vulva precursor cells. Here, we show that mib-1 mutants suppress both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants,  [CLS] restoring anchor cell formation [CLS]  and a functional vulva to the former and partly restoring oocyte production to the latter. However, suppressed hermaphrodites are"}
{"subject": "functional vulva", "sub_type": "MPA", "rel": "ThemeOf", "object": "restoring", "obj_type": "PosReg", "file_name": "PubMed-29531012.json", "snippet": " vulva precursor cells. Here, we show that mib-1 mutants suppress both lin-12 and glp-1 (C. elegans Notch) gain-of-function mutants,  [CLS] restoring anchor cell formation and a functional vulva [CLS]  to the former and partly restoring oocyte production to the latter. However, suppressed hermaphrodites are only observed when grown"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " [CLS] Mutations activating [CLS]  the \u03b1 subunit of heterotrimeric Gs protein are associated with a number of highly specific pathological molecular phenotypes. One"}
{"subject": "G\u03b1s", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29544460.json", "snippet": " remain well differentiated but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that gain-of-function  [CLS] mutations of G\u03b1s [CLS]  interfere with signals in the microenvironment of permissive tissues and lead to a transversal neoplastic phenotype."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "interfere", "obj_type": "NegReg", "file_name": "PubMed-29544460.json", "snippet": " remain well differentiated but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that gain-of-function  [CLS] mutations of G\u03b1s interfere [CLS]  with signals in the microenvironment of permissive tissues and lead to a transversal neoplastic phenotype."}
{"subject": "microenvironment of permissive", "sub_type": "MPA", "rel": "ThemeOf", "object": "interfere", "obj_type": "NegReg", "file_name": "PubMed-29544460.json", "snippet": " but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that gain-of-function mutations of G\u03b1s  [CLS] interfere with signals in the microenvironment of permissive [CLS]  tissues and lead to a transversal neoplastic phenotype."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29544460.json", "snippet": " remain well differentiated but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that gain-of-function  [CLS] mutations of G\u03b1s interfere with signals in the microenvironment of permissive tissues and lead to [CLS]  a transversal neoplastic phenotype."}
{"subject": "transversal neoplastic phenotype", "sub_type": "MPA", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-29544460.json", "snippet": " we propose the possibility that gain-of-function mutations of G\u03b1s interfere with signals in the microenvironment of permissive tissues and  [CLS] lead to a transversal neoplastic phenotype [CLS] ."}
{"subject": "heterotrimeric Gs protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " [CLS] activating the \u03b1 subunit of heterotrimeric Gs protein [CLS]  are associated with a number of highly specific pathological molecular phenotypes. One of the best characterized is the McCune"}
{"subject": "McCune Albright syndrome", "sub_type": "Disease", "rel": "ThemeOf", "object": "heterotrimeric Gs protein", "obj_type": "Protein", "file_name": "PubMed-29544460.json", "snippet": " [CLS] heterotrimeric Gs protein are associated with a number of highly specific pathological molecular phenotypes. One of the best characterized is the McCune Albright syndrome [CLS] . The disease presents with an increased incidence of neoplasias in specific tissues.\nMAIN BODY: A similar repertoire of neoplasms"}
{"subject": "G\u03b1s", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29544460.json", "snippet": " birth. Glands are the most \"permissive\" tissues, recently found to include the entire gastrointestinal tract. High frequency of activating  [CLS] G\u03b1s mutations [CLS]  is associated with precise diagnoses (e.g., IPMN, Pyloric gland adenoma, pituitary toxic adenoma). Typically, most neoplastic lesions, from thyroid"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " after birth. Glands are the most \"permissive\" tissues, recently found to include the entire gastrointestinal tract. High frequency of  [CLS] activating G\u03b1s mutations [CLS]  is associated with precise diagnoses (e.g., IPMN, Pyloric gland adenoma, pituitary toxic adenoma). Typically, most neoplastic lesions, from thyroid"}
{"subject": "IPMN", "sub_type": "Disease", "rel": "ThemeOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " after birth. Glands are the most \"permissive\" tissues, recently found to include the entire gastrointestinal tract. High frequency of  [CLS] activating G\u03b1s mutations is associated with precise diagnoses (e.g., IPMN [CLS] , Pyloric gland adenoma, pituitary toxic adenoma). Typically, most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may"}
{"subject": "Pyloric gland adenoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " after birth. Glands are the most \"permissive\" tissues, recently found to include the entire gastrointestinal tract. High frequency of  [CLS] activating G\u03b1s mutations is associated with precise diagnoses (e.g., IPMN, Pyloric gland adenoma [CLS] , pituitary toxic adenoma). Typically, most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may be a precursor"}
{"subject": "pituitary toxic adenoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " after birth. Glands are the most \"permissive\" tissues, recently found to include the entire gastrointestinal tract. High frequency of  [CLS] activating G\u03b1s mutations is associated with precise diagnoses (e.g., IPMN, Pyloric gland adenoma, pituitary toxic adenoma [CLS] ). Typically, most neoplastic lesions, from thyroid to pancreas, remain well differentiated but may be a precursor to aggressive cancer."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29544460.json", "snippet": " pancreas, remain well differentiated but may be a precursor to aggressive cancer.\nCONCLUSIONS: Here we propose the possibility that  [CLS] gain-of-function mutations [CLS]  of G\u03b1s interfere with signals in the microenvironment of permissive tissues and lead to a transversal neoplastic phenotype."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "responsible", "obj_type": "Reg", "file_name": "PubMed-29546444.json", "snippet": " components of the heavy panicle trait in hybrid rice remain elusive. Here, we report that the combination of loss-of-function  [CLS] mutations in Grain number 1a (Gn1a) and Grain Size 3 (GS3) is responsible [CLS]  for the heavy panicle phenotype of the elite hybrid rice restorer line Shuhui498 (R498). The null gn1a allele is"}
{"subject": "heavy panicle phenotype", "sub_type": "MPA", "rel": "ThemeOf", "object": "responsible", "obj_type": "Reg", "file_name": "PubMed-29546444.json", "snippet": " we report that the combination of loss-of-function mutations in Grain number 1a (Gn1a) and Grain Size 3 (GS3) is  [CLS] responsible for the heavy panicle phenotype [CLS]  of the elite hybrid rice restorer line Shuhui498 (R498). The null gn1a allele is the determinant factor for heavy"}
{"subject": "GS3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29546444.json", "snippet": " components of the heavy panicle trait in hybrid rice remain elusive. Here, we report that the combination of loss-of-function  [CLS] mutations in Grain number 1a (Gn1a) and Grain Size 3 (GS3 [CLS] ) is responsible for the heavy panicle phenotype of the elite hybrid rice restorer line Shuhui498 (R498). The null gn1a"}
{"subject": "Gn1a", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29546444.json", "snippet": " components of the heavy panicle trait in hybrid rice remain elusive. Here, we report that the combination of loss-of-function  [CLS] mutations in Grain number 1a (Gn1a [CLS] ) and Grain Size 3 (GS3) is responsible for the heavy panicle phenotype of the elite hybrid rice restorer line"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29546444.json", "snippet": " genetic components of the heavy panicle trait in hybrid rice remain elusive. Here, we report that the combination of  [CLS] loss-of-function mutations [CLS]  in Grain number 1a (Gn1a) and Grain Size 3 (GS3) is responsible for the heavy panicle phenotype of the"}
{"subject": "Variants", "sub_type": "Var", "rel": "CauseOf", "object": "association", "obj_type": "Interaction", "file_name": "PubMed-29562163.json", "snippet": " human genetics study to identify genetic variants associated with serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST).  [CLS] Variants that were replicated in three additional cohorts (12,527 persons) were evaluated for association [CLS]  with clinical diagnoses of chronic liver disease in DiscovEHR study participants and two independent cohorts (total of 37,173 persons)"}
{"subject": "nonalcoholic cirrhosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " with reduced levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a  [CLS] reduced risk of alcoholic liver disease (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and by 53% [95% CI, 3 to 77] among homozygotes), nonalcoholic liver disease (by 17% [95% CI, 8 to 25] among heterozygotes and by 30% [95% CI, 13 to 43] among homozygotes), alcoholic cirrhosis (by 42% [95% CI, 14 to 61] among heterozygotes and by 73% [95% CI, 15 to 91] among homozygotes), and nonalcoholic cirrhosis [CLS]  (by 26% [95% CI, 7 to 40] among heterozygotes and by 49% [95% CI, 15 to 69] among homozygotes)."}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " and by 49% [95% CI, 15 to 69] among homozygotes). Associations were confirmed in two independent cohorts. The rs72613567:TA  [CLS] variant was associated with a reduced [CLS]  risk of nonalcoholic steatohepatitis, but not steatosis, in human liver samples. The rs72613567:TA variant mitigated liver injury associated with"}
{"subject": "nonalcoholic steatohepatitis", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " 15 to 69] among homozygotes). Associations were confirmed in two independent cohorts. The rs72613567:TA variant was associated with a  [CLS] reduced risk of nonalcoholic steatohepatitis [CLS] , but not steatosis, in human liver samples. The rs72613567:TA variant mitigated liver injury associated with the risk-increasing PNPLA3 p.I148M"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "mitigated", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " variant was associated with a reduced risk of nonalcoholic steatohepatitis, but not steatosis, in human liver samples. The rs72613567:TA  [CLS] variant mitigated [CLS]  liver injury associated with the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced"}
{"subject": "liver injury", "sub_type": "Disease", "rel": "ThemeOf", "object": "mitigated", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " was associated with a reduced risk of nonalcoholic steatohepatitis, but not steatosis, in human liver samples. The rs72613567:TA variant  [CLS] mitigated liver injury [CLS]  associated with the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced enzymatic activity."}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " the risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced enzymatic activity.\nCONCLUSIONS: A  [CLS] loss-of-function variant [CLS]  in HSD17B13 was associated with a reduced risk of chronic liver disease and of progression from steatosis to steatohepatitis."}
{"subject": "HSD17B13", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29562163.json", "snippet": " risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced enzymatic activity.\nCONCLUSIONS: A loss-of-function  [CLS] variant in HSD17B13 [CLS]  was associated with a reduced risk of chronic liver disease and of progression from steatosis to steatohepatitis. (Funded by"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " risk-increasing PNPLA3 p.I148M allele and resulted in an unstable and truncated protein with reduced enzymatic activity.\nCONCLUSIONS: A loss-of-function  [CLS] variant in HSD17B13 was associated with a reduced [CLS]  risk of chronic liver disease and of progression from steatosis to steatohepatitis. (Funded by Regeneron Pharmaceuticals and others.)."}
{"subject": "chronic liver disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " an unstable and truncated protein with reduced enzymatic activity.\nCONCLUSIONS: A loss-of-function variant in HSD17B13 was associated with a  [CLS] reduced risk of chronic liver disease [CLS]  and of progression from steatosis to steatohepatitis. (Funded by Regeneron Pharmaceuticals and others.)."}
{"subject": "AST", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " A splice variant (rs72613567:TA) in HSD17B13, encoding the hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with  [CLS] reduced levels of ALT (P=4.2\u00d710-12) and AST [CLS]  (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a reduced risk of alcoholic liver disease (by 42%"}
{"subject": "chronic liver disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "association", "obj_type": "Interaction", "file_name": "PubMed-29562163.json", "snippet": " aminotransferase (ALT) and aspartate aminotransferase (AST). Variants that were replicated in three additional cohorts (12,527 persons) were evaluated for  [CLS] association with clinical diagnoses of chronic liver disease [CLS]  in DiscovEHR study participants and two independent cohorts (total of 37,173 persons) and with histopathological severity of liver disease"}
{"subject": "splice variant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " cohorts (total of 37,173 persons) and with histopathological severity of liver disease in 2391 human liver samples.\nRESULTS: A  [CLS] splice variant (rs72613567:TA) in HSD17B13, encoding the hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with reduced [CLS]  levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a reduced risk"}
{"subject": "HSD17B13", "sub_type": "Gene", "rel": "ThemeOf", "object": "splice variant", "obj_type": "Var", "file_name": "PubMed-29562163.json", "snippet": " cohorts (total of 37,173 persons) and with histopathological severity of liver disease in 2391 human liver samples.\nRESULTS: A  [CLS] splice variant (rs72613567:TA) in HSD17B13 [CLS] , encoding the hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with reduced levels of ALT (P=4.2\u00d710-12) and"}
{"subject": "ALT", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " A splice variant (rs72613567:TA) in HSD17B13, encoding the hepatic lipid droplet protein hydroxysteroid 17-beta dehydrogenase 13, was associated with  [CLS] reduced levels of ALT [CLS]  (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a reduced risk of alcoholic liver"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " 17-beta dehydrogenase 13, was associated with reduced levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this  [CLS] variant was associated with a reduced [CLS]  risk of alcoholic liver disease (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and by 53%"}
{"subject": "alcoholic liver disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " with reduced levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a  [CLS] reduced risk of alcoholic liver disease [CLS]  (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and by 53% [95% CI, 3 to 77]"}
{"subject": "nonalcoholic liver disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " with reduced levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a  [CLS] reduced risk of alcoholic liver disease (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and by 53% [95% CI, 3 to 77] among homozygotes), nonalcoholic liver disease [CLS]  (by 17% [95% CI, 8 to 25] among heterozygotes and by 30% [95% CI, 13 to 43] among homozygotes),"}
{"subject": "alcoholic cirrhosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-29562163.json", "snippet": " with reduced levels of ALT (P=4.2\u00d710-12) and AST (P=6.2\u00d710-10). Among DiscovEHR study participants, this variant was associated with a  [CLS] reduced risk of alcoholic liver disease (by 42% [95% confidence interval {CI}, 20 to 58] among heterozygotes and by 53% [95% CI, 3 to 77] among homozygotes), nonalcoholic liver disease (by 17% [95% CI, 8 to 25] among heterozygotes and by 30% [95% CI, 13 to 43] among homozygotes), alcoholic cirrhosis [CLS]  (by 42% [95% CI, 14 to 61] among heterozygotes and by 73% [95% CI, 15 to 91] among homozygotes),"}
{"subject": "CSF3R", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29572350.json", "snippet": " receptor CSF3R regulate granulopoiesis, neutrophil function, and hematopoietic stem cell mobilization. Recent studies have uncovered an oncogenic role of  [CLS] mutations in the CSF3R [CLS]  gene in many hematologic malignancies. To find additional CSF3R mutations that give rise to cell transformation, we performed a"}
{"subject": "missense mutations", "sub_type": "Var", "rel": "CauseOf", "object": "exhibit", "obj_type": "PosReg", "file_name": "PubMed-29572350.json", "snippet": " at the cell surface. Cumulatively, we have expanded the regions of the CSF3R extracellular and transmembrane domains in which  [CLS] missense mutations exhibit [CLS]  leukemogenic capacity and have further elucidated the mechanistic underpinnings that underlie altered CSF3R expression, dimerization, and signaling activation."}
{"subject": "leukemogenic", "sub_type": "Disease", "rel": "ThemeOf", "object": "exhibit", "obj_type": "PosReg", "file_name": "PubMed-29572350.json", "snippet": " cell surface. Cumulatively, we have expanded the regions of the CSF3R extracellular and transmembrane domains in which missense mutations  [CLS] exhibit leukemogenic [CLS]  capacity and have further elucidated the mechanistic underpinnings that underlie altered CSF3R expression, dimerization, and signaling activation."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "hematologic malignancies", "obj_type": "Disease", "file_name": "PubMed-29572350.json", "snippet": " receptor CSF3R regulate granulopoiesis, neutrophil function, and hematopoietic stem cell mobilization. Recent studies have uncovered an oncogenic role of  [CLS] mutations in the CSF3R gene in many hematologic malignancies [CLS] . To find additional CSF3R mutations that give rise to cell transformation, we performed a cellular transformation assay in which"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "transform", "obj_type": "Reg", "file_name": "PubMed-29572350.json", "snippet": " absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel  [CLS] mutations and determined that they transform [CLS]  cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution at"}
{"subject": "cells", "sub_type": "CPA", "rel": "ThemeOf", "object": "transform", "obj_type": "Reg", "file_name": "PubMed-29572350.json", "snippet": " clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel mutations and determined that they  [CLS] transform cells [CLS]  via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution at the"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cysteine- and disulfide bond-mediated dimerization", "obj_type": "MPA", "file_name": "PubMed-29572350.json", "snippet": " absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel  [CLS] mutations and determined that they transform cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization [CLS]  (S581C); 2) polar, noncharged amino acid substitution at the transmembrane helix dimer interface at residue Thr-640; 3) increased internalization"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "polar, noncharged amino acid substitution", "obj_type": "Var", "file_name": "PubMed-29572350.json", "snippet": " absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel  [CLS] mutations and determined that they transform cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution [CLS]  at the transmembrane helix dimer interface at residue Thr-640; 3) increased internalization by a Glu-524 substitution that mimics a"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29572350.json", "snippet": " absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel  [CLS] mutations and determined that they transform cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution at the transmembrane helix dimer interface at residue Thr-640; 3) increased [CLS]  internalization by a Glu-524 substitution that mimics a low G-CSF dose; and 4) hydrophobic amino acid substitutions in the"}
{"subject": "internalization", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29572350.json", "snippet": " bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution at the transmembrane helix dimer interface at residue Thr-640; 3)  [CLS] increased internalization [CLS]  by a Glu-524 substitution that mimics a low G-CSF dose; and 4) hydrophobic amino acid substitutions in the membrane-proximal"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "hydrophobic amino acid substitutions", "obj_type": "Var", "file_name": "PubMed-29572350.json", "snippet": " absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel  [CLS] mutations and determined that they transform cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution at the transmembrane helix dimer interface at residue Thr-640; 3) increased internalization by a Glu-524 substitution that mimics a low G-CSF dose; and 4) hydrophobic amino acid substitutions [CLS]  in the membrane-proximal residues Thr-612, Thr-615, and Thr-618. Furthermore, the change in signaling activation was related to an altered"}
{"subject": "WNT5A", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29575631.json", "snippet": " [CLS] WNT5A mutations [CLS]  in an infant with severe and atypical manifestations of Robinow syndrome.\nRobinow syndrome (RS) is a well-recognized Mendelian disorder"}
{"subject": "WNT5A", "sub_type": "Gene", "rel": "ThemeOf", "object": "homozygous frameshifting single nucleotide deletion", "obj_type": "Var", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A [CLS]  in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development"}
{"subject": "homozygous frameshifting single nucleotide deletion", "sub_type": "Var", "rel": "CauseOf", "object": "congenital diaphragmatic hernia", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia [CLS] , ambiguous genitalia, dysmorphic facies, shortened long bones, adactyly, and ventricular septal defect. The parents, who are both heterozygous for"}
{"subject": "homozygous frameshifting single nucleotide deletion", "sub_type": "Var", "rel": "CauseOf", "object": "ambiguous genitalia", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia, ambiguous genitalia [CLS] , dysmorphic facies, shortened long bones, adactyly, and ventricular septal defect. The parents, who are both heterozygous for the deletion,"}
{"subject": "homozygous frameshifting single nucleotide deletion", "sub_type": "Var", "rel": "CauseOf", "object": "ventricular septal defect", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia, ambiguous genitalia, dysmorphic facies, shortened long bones, adactyly, and ventricular septal defect [CLS] . The parents, who are both heterozygous for the deletion, appear clinically unaffected. In conjunction with published observations of Wnt5a"}
{"subject": "homozygous frameshifting single nucleotide deletion", "sub_type": "Var", "rel": "CauseOf", "object": "adactyly", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia, ambiguous genitalia, dysmorphic facies, shortened long bones, adactyly [CLS] , and ventricular septal defect. The parents, who are both heterozygous for the deletion, appear clinically unaffected. In conjunction with"}
{"subject": "homozygous frameshifting single nucleotide deletion", "sub_type": "Var", "rel": "CauseOf", "object": "shortened long bones", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia, ambiguous genitalia, dysmorphic facies, shortened long bones [CLS] , adactyly, and ventricular septal defect. The parents, who are both heterozygous for the deletion, appear clinically unaffected. In conjunction"}
{"subject": "homozygous frameshifting single nucleotide deletion", "sub_type": "Var", "rel": "CauseOf", "object": "dysmorphic facies", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " inheritance has been observed for mutations in WNT5A, DVL1, and DVL3. Through trio whole genome sequencing, we identified a  [CLS] homozygous frameshifting single nucleotide deletion in WNT5A in a previously reported, deceased infant with a unique constellation of features comprising a 46,XY disorder of sex development with multiple congenital malformations including congenital diaphragmatic hernia, ambiguous genitalia, dysmorphic facies [CLS] , shortened long bones, adactyly, and ventricular septal defect. The parents, who are both heterozygous for the deletion, appear clinically"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29575631.json", "snippet": " [CLS] loss-of-function WNT5A mutations [CLS]  in an infant with severe and atypical manifestations of Robinow syndrome.\nRobinow syndrome (RS) is a well-recognized Mendelian disorder"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Robinow syndrome.", "obj_type": "Disease", "file_name": "PubMed-29575631.json", "snippet": " [CLS] mutations in an infant with severe and atypical manifestations of Robinow syndrome. [CLS] \nRobinow syndrome (RS) is a well-recognized Mendelian disorder known to demonstrate both autosomal dominant and autosomal recessive inheritance. Typical"}
{"subject": "SYNGAP1", "sub_type": "Gene", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29580901.json", "snippet": " [CLS] SYNGAP1 loss-of-function [CLS]  variants are causally associated with intellectual disability, severe epilepsy, autism spectrum disorder and schizophrenia. While there are hundreds of"}
{"subject": "variants", "sub_type": "Var", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29580901.json", "snippet": " [CLS] loss-of-function variants [CLS]  are causally associated with intellectual disability, severe epilepsy, autism spectrum disorder and schizophrenia. While there are hundreds of genetic"}
{"subject": "intellectual disability", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29580901.json", "snippet": " [CLS] loss-of-function variants are causally associated with intellectual disability [CLS] , severe epilepsy, autism spectrum disorder and schizophrenia. While there are hundreds of genetic risk factors for neurodevelopmental disorders (NDDs),"}
{"subject": "severe epilepsy", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29580901.json", "snippet": " [CLS] loss-of-function variants are causally associated with intellectual disability, severe epilepsy [CLS] , autism spectrum disorder and schizophrenia. While there are hundreds of genetic risk factors for neurodevelopmental disorders (NDDs), this gene"}
{"subject": "autism spectrum disorder", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29580901.json", "snippet": " [CLS] loss-of-function variants are causally associated with intellectual disability, severe epilepsy, autism spectrum disorder [CLS]  and schizophrenia. While there are hundreds of genetic risk factors for neurodevelopmental disorders (NDDs), this gene is somewhat unique"}
{"subject": "schizophrenia", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29580901.json", "snippet": " [CLS] loss-of-function variants are causally associated with intellectual disability, severe epilepsy, autism spectrum disorder and schizophrenia [CLS] . While there are hundreds of genetic risk factors for neurodevelopmental disorders (NDDs), this gene is somewhat unique because of"}
{"subject": "PCSK9", "sub_type": "Var", "rel": "CauseOf", "object": "degrading", "obj_type": "NegReg", "file_name": "PubMed-29593095.json", "snippet": " unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained.\nThe proprotein convertase subtilisin/kexin type-9 ( [CLS] PCSK9) plays a central role in cardiovascular disease (CVD) by degrading [CLS]  hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF) PCSK9 variants that fail to exit the endoplasmic reticulum (ER)"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29593095.json", "snippet": " PCSK9 variants that are retained in the ER can cause ER stress and hepatic cytotoxicity. Although overexpression of these  [CLS] PCSK9 variants [CLS]  caused an accumulation in the ER of hepatocytes, UPR activation or apoptosis was not observed. Furthermore, ER retention of"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "accumulation", "obj_type": "PosReg", "file_name": "PubMed-29593095.json", "snippet": " variants that are retained in the ER can cause ER stress and hepatic cytotoxicity. Although overexpression of these PCSK9  [CLS] variants caused an accumulation [CLS]  in the ER of hepatocytes, UPR activation or apoptosis was not observed. Furthermore, ER retention of endogenous PCSK9 via"}
{"subject": "ER of hepatocytes", "sub_type": "MPA", "rel": "ThemeOf", "object": "accumulation", "obj_type": "PosReg", "file_name": "PubMed-29593095.json", "snippet": " retained in the ER can cause ER stress and hepatic cytotoxicity. Although overexpression of these PCSK9 variants caused an  [CLS] accumulation in the ER of hepatocytes [CLS] , UPR activation or apoptosis was not observed. Furthermore, ER retention of endogenous PCSK9 via splice switching also failed to"}
{"subject": "overexpression", "sub_type": "PosReg", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29593095.json", "snippet": " variety of LOF PCSK9 variants that are retained in the ER can cause ER stress and hepatic cytotoxicity. Although  [CLS] overexpression of these PCSK9 variants [CLS]  caused an accumulation in the ER of hepatocytes, UPR activation or apoptosis was not observed. Furthermore, ER retention of"}
{"subject": "hepatic low-density lipoprotein receptor", "sub_type": "MPA", "rel": "ThemeOf", "object": "degrading", "obj_type": "NegReg", "file_name": "PubMed-29593095.json", "snippet": " reticulum stress when retained.\nThe proprotein convertase subtilisin/kexin type-9 (PCSK9) plays a central role in cardiovascular disease (CVD) by  [CLS] degrading hepatic low-density lipoprotein receptor [CLS]  (LDLR). As such, loss-of-function (LOF) PCSK9 variants that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels"}
{"subject": "cardiovascular disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "hepatic low-density lipoprotein receptor", "obj_type": "MPA", "file_name": "PubMed-29593095.json", "snippet": " fail to induce endoplasmic reticulum stress when retained.\nThe proprotein convertase subtilisin/kexin type-9 (PCSK9) plays a central role in  [CLS] cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor [CLS]  (LDLR). As such, loss-of-function (LOF) PCSK9 variants that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels"}
{"subject": "PCSK9", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29593095.json", "snippet": " plays a central role in cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF)  [CLS] PCSK9 variants [CLS]  that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and lower the risk of developing CVD."}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29593095.json", "snippet": " type-9 (PCSK9) plays a central role in cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor (LDLR). As such,  [CLS] loss-of-function (LOF) PCSK9 variants [CLS]  that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and lower the risk of developing CVD."}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29593095.json", "snippet": " a central role in cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF) PCSK9  [CLS] variants that fail to exit the endoplasmic reticulum (ER) increase [CLS]  hepatic LDLR levels and lower the risk of developing CVD. The retention of misfolded protein in the ER can"}
{"subject": "hepatic LDLR levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29593095.json", "snippet": " hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF) PCSK9 variants that fail to exit the endoplasmic reticulum (ER)  [CLS] increase hepatic LDLR levels [CLS]  and lower the risk of developing CVD. The retention of misfolded protein in the ER can cause ER stress"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29593095.json", "snippet": " a central role in cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF) PCSK9  [CLS] variants that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and lower [CLS]  the risk of developing CVD. The retention of misfolded protein in the ER can cause ER stress and activate"}
{"subject": "risk of developing CVD", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29593095.json", "snippet": " As such, loss-of-function (LOF) PCSK9 variants that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and  [CLS] lower the risk of developing CVD [CLS] . The retention of misfolded protein in the ER can cause ER stress and activate the unfolded protein response (UPR)."}
{"subject": "CBL", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29600428.json", "snippet": " [CLS] CBL mutation [CLS]  and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.\nGlucocorticoid"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "prolonged", "obj_type": "PosReg", "file_name": "PubMed-29600428.json", "snippet": " were both more significantly suppressed than non-mutated cells following GC treatment in the presence of GM-CSF. A loss-of-function CBL  [CLS] mutation prolonged [CLS]  STAT5 phosphorylation after GM-CSF stimulation, which was rapidly terminated in both patient samples and GDM-1 cells. In conclusion, GC"}
{"subject": "STAT5 phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "prolonged", "obj_type": "PosReg", "file_name": "PubMed-29600428.json", "snippet": " both more significantly suppressed than non-mutated cells following GC treatment in the presence of GM-CSF. A loss-of-function CBL mutation  [CLS] prolonged STAT5 phosphorylation [CLS]  after GM-CSF stimulation, which was rapidly terminated in both patient samples and GDM-1 cells. In conclusion, GC therapy effectively"}
{"subject": "MEFV", "sub_type": "Gene", "rel": "ThemeOf", "object": "single-nucleotide variant", "obj_type": "Var", "file_name": "PubMed-29600428.json", "snippet": " [CLS] MEFV single-nucleotide variant [CLS]  are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.\nGlucocorticoid (GC) therapy occasionally relieves"}
{"subject": "single-nucleotide variant", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-29600428.json", "snippet": " [CLS] single-nucleotide variant are important genetic predictors of tumor reduction [CLS]  in glucocorticoid-treated patients with chronic myelomonocytic leukemia.\nGlucocorticoid (GC) therapy occasionally relieves tumor-related fever and promotes tumor reduction in"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-29600428.json", "snippet": " [CLS] mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction [CLS]  in glucocorticoid-treated patients with chronic myelomonocytic leukemia.\nGlucocorticoid (GC) therapy occasionally relieves tumor-related fever and promotes tumor reduction in"}
{"subject": "tumor", "sub_type": "Disease", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-29600428.json", "snippet": " [CLS] tumor reduction [CLS]  in glucocorticoid-treated patients with chronic myelomonocytic leukemia.\nGlucocorticoid (GC) therapy occasionally relieves tumor-related fever and promotes tumor reduction in"}
{"subject": "chronic myelomonocytic leukemia", "sub_type": "Disease", "rel": "ThemeOf", "object": "tumor", "obj_type": "Disease", "file_name": "PubMed-29600428.json", "snippet": " [CLS] tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia [CLS] .\nGlucocorticoid (GC) therapy occasionally relieves tumor-related fever and promotes tumor reduction in patients with chronic myelomonocytic leukemia (CMML). A"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29600428.json", "snippet": " CBL mutation, were both more significantly suppressed than non-mutated cells following GC treatment in the presence of GM-CSF. A  [CLS] loss-of-function CBL mutation [CLS]  prolonged STAT5 phosphorylation after GM-CSF stimulation, which was rapidly terminated in both patient samples and GDM-1 cells. In conclusion,"}
{"subject": "CBL", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29600428.json", "snippet": " mutation, were both more significantly suppressed than non-mutated cells following GC treatment in the presence of GM-CSF. A loss-of-function  [CLS] CBL mutation [CLS]  prolonged STAT5 phosphorylation after GM-CSF stimulation, which was rapidly terminated in both patient samples and GDM-1 cells. In conclusion,"}
{"subject": "IGF1R", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29621572.json", "snippet": " [CLS] mutation in IGF1R [CLS]  and a crosstalk between IGF1R and Wnt/\u03b2-catenin signaling pathways.\nIGF1R is a ubiquitous receptor tyrosine kinase that plays critical"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29621572.json", "snippet": " [CLS] loss-of-function mutation [CLS]  in IGF1R and a crosstalk between IGF1R and Wnt/\u03b2-catenin signaling pathways.\nIGF1R is a ubiquitous receptor tyrosine kinase that"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "crosstalk", "obj_type": "Reg", "file_name": "PubMed-29621572.json", "snippet": " [CLS] mutation in IGF1R and a crosstalk [CLS]  between IGF1R and Wnt/\u03b2-catenin signaling pathways.\nIGF1R is a ubiquitous receptor tyrosine kinase that plays critical roles in cell"}
{"subject": "Wnt/\u03b2-catenin signaling pathways", "sub_type": "Pathway", "rel": "ThemeOf", "object": "crosstalk", "obj_type": "Reg", "file_name": "PubMed-29621572.json", "snippet": " [CLS] crosstalk between IGF1R and Wnt/\u03b2-catenin signaling pathways [CLS] .\nIGF1R is a ubiquitous receptor tyrosine kinase that plays critical roles in cell proliferation, growth and survival. Clinical studies"}
{"subject": "IGF1R", "sub_type": "Gene", "rel": "ThemeOf", "object": "crosstalk", "obj_type": "Reg", "file_name": "PubMed-29621572.json", "snippet": " [CLS] crosstalk between IGF1R [CLS]  and Wnt/\u03b2-catenin signaling pathways.\nIGF1R is a ubiquitous receptor tyrosine kinase that plays critical roles in cell proliferation, growth"}
{"subject": "GRN", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29653316.json", "snippet": " [CLS] GRN) null mutation [CLS] , originating from a common founder, in multiple Belgian families with frontotemporal dementia. Here, we used data of a 10-year"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "reported", "obj_type": "Reg", "file_name": "PubMed-29653316.json", "snippet": " [CLS] reported a granulin (GRN) null mutation [CLS] , originating from a common founder, in multiple Belgian families with frontotemporal dementia. Here, we used data of a 10-year"}
{"subject": "frontotemporal dementia", "sub_type": "Disease", "rel": "ThemeOf", "object": "reported", "obj_type": "Reg", "file_name": "PubMed-29653316.json", "snippet": " [CLS] reported a granulin (GRN) null mutation, originating from a common founder, in multiple Belgian families with frontotemporal dementia [CLS] . Here, we used data of a 10-year follow-up study to describe in detail the clinical heterogeneity observed in this"}
{"subject": "MLKL", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29656768.json", "snippet": " [CLS] variant in MLKL [CLS]  confers susceptibility to ApoE \u025b4-negative Alzheimer's disease in Hong Kong Chinese population.\nAlzheimer's disease (AD) is the most common"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "susceptibility", "obj_type": "Reg", "file_name": "PubMed-29656768.json", "snippet": " [CLS] variant in MLKL confers susceptibility [CLS]  to ApoE \u025b4-negative Alzheimer's disease in Hong Kong Chinese population.\nAlzheimer's disease (AD) is the most common neurodegenerative disorders"}
{"subject": "Alzheimer's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "susceptibility", "obj_type": "Reg", "file_name": "PubMed-29656768.json", "snippet": " [CLS] susceptibility to ApoE \u025b4-negative Alzheimer's disease [CLS]  in Hong Kong Chinese population.\nAlzheimer's disease (AD) is the most common neurodegenerative disorders in the elderly. To identify"}
{"subject": "MLKL", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Q48X", "obj_type": "Var", "file_name": "PubMed-29656768.json", "snippet": " rare stop-gain variant (p.Q48X) in mixed lineage kinase domain like pseudokinase (MLKL) gene present exclusively in 6 LOAD cases.  [CLS] MLKL is expressed in neurons, and the its expression levels in the p.Q48X [CLS]  carriers were significantly lower than that in age-matched wild-type controls. The ratio of A\u03b242 to A\u03b240 significantly increased in"}
{"subject": "p.Q48X", "sub_type": "Var", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29656768.json", "snippet": " gene present exclusively in 6 LOAD cases. MLKL is expressed in neurons, and the its expression levels in the  [CLS] p.Q48X carriers were significantly lower [CLS]  than that in age-matched wild-type controls. The ratio of A\u03b242 to A\u03b240 significantly increased in MLKL knockdown cells compared"}
{"subject": "expression levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-29656768.json", "snippet": " domain like pseudokinase (MLKL) gene present exclusively in 6 LOAD cases. MLKL is expressed in neurons, and the its  [CLS] expression levels in the p.Q48X carriers were significantly lower [CLS]  than that in age-matched wild-type controls. The ratio of A\u03b242 to A\u03b240 significantly increased in MLKL knockdown cells compared"}
{"subject": "MLKL", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29656768.json", "snippet": " age-matched wild-type controls. The ratio of A\u03b242 to A\u03b240 significantly increased in MLKL knockdown cells compared to scramble controls.  [CLS] MLKL loss-of-function mutation [CLS]  might contribute to late-onset ApoE \u025b4-negative AD in the Hong Kong Chinese population."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29656768.json", "snippet": " wild-type controls. The ratio of A\u03b242 to A\u03b240 significantly increased in MLKL knockdown cells compared to scramble controls. MLKL  [CLS] loss-of-function mutation [CLS]  might contribute to late-onset ApoE \u025b4-negative AD in the Hong Kong Chinese population."}
{"subject": "AD", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29656768.json", "snippet": " wild-type controls. The ratio of A\u03b242 to A\u03b240 significantly increased in MLKL knockdown cells compared to scramble controls. MLKL  [CLS] loss-of-function mutation might contribute to late-onset ApoE \u025b4-negative AD [CLS]  in the Hong Kong Chinese population."}
{"subject": "TRPV1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Leu206Stop", "obj_type": "Var", "file_name": "PubMed-29660342.json", "snippet": " random mutagenesis was used to generate a mouse model for the analysis of the transient receptor potential vanilloid 1 ( [CLS] TRPV1) cation channel. A transversion from T\u2192A in exon 4 led to a Leu206Stop [CLS]  mutation generating a loss-of-function mutant. The TRPV1 agonist capsaicin was used to analyze functional and nociceptive parameters in\u00a0vitro and"}
{"subject": "Leu206Stop", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29660342.json", "snippet": " the transient receptor potential vanilloid 1 (TRPV1) cation channel. A transversion from T\u2192A in exon 4 led to a  [CLS] Leu206Stop mutation generating a loss-of-function [CLS]  mutant. The TRPV1 agonist capsaicin was used to analyze functional and nociceptive parameters in\u00a0vitro and in\u00a0vivo in TRPV1 Leu206Stop"}
{"subject": "TRPV1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Leu206Stop", "obj_type": "Var", "file_name": "PubMed-29660342.json", "snippet": " TRPV1 Leu206Stop mice and congenic C3HeB/FeJ controls. Capsaicin-induced [Ca2+]i changes in small diameter DRG neurons were significantly diminished in  [CLS] TRPV1 Leu206Stop [CLS]  mice and administration of capsaicin induced neither hypothermia nor nocifensive behaviour in\u00a0vivo. TRPV1 Leu206Stop mice were tested in the"}
{"subject": "Leu206Stop", "sub_type": "Var", "rel": "CauseOf", "object": "diminished", "obj_type": "NegReg", "file_name": "PubMed-29660342.json", "snippet": " in\u00a0vivo in TRPV1 Leu206Stop mice and congenic C3HeB/FeJ controls. Capsaicin-induced [Ca2+]i changes in small diameter DRG neurons were significantly  [CLS] diminished in TRPV1 Leu206Stop [CLS]  mice and administration of capsaicin induced neither hypothermia nor nocifensive behaviour in\u00a0vivo. TRPV1 Leu206Stop mice were tested in the"}
{"subject": "Capsaicin-induced [Ca2+]i", "sub_type": "MPA", "rel": "ThemeOf", "object": "diminished", "obj_type": "NegReg", "file_name": "PubMed-29660342.json", "snippet": " was used to analyze functional and nociceptive parameters in\u00a0vitro and in\u00a0vivo in TRPV1 Leu206Stop mice and congenic C3HeB/FeJ controls.  [CLS] Capsaicin-induced [Ca2+]i changes in small diameter DRG neurons were significantly diminished [CLS]  in TRPV1 Leu206Stop mice and administration of capsaicin induced neither hypothermia nor nocifensive behaviour in\u00a0vivo. TRPV1 Leu206Stop mice were"}
{"subject": "DRG neurons", "sub_type": "CPA", "rel": "ThemeOf", "object": "Capsaicin-induced [Ca2+]i", "obj_type": "MPA", "file_name": "PubMed-29660342.json", "snippet": " was used to analyze functional and nociceptive parameters in\u00a0vitro and in\u00a0vivo in TRPV1 Leu206Stop mice and congenic C3HeB/FeJ controls.  [CLS] Capsaicin-induced [Ca2+]i changes in small diameter DRG neurons [CLS]  were significantly diminished in TRPV1 Leu206Stop mice and administration of capsaicin induced neither hypothermia nor nocifensive behaviour in\u00a0vivo. TRPV1"}
{"subject": "TRPV1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Leu206Stop", "obj_type": "Var", "file_name": "PubMed-29660342.json", "snippet": " two weeks after nerve injury. In the open field test, a significant increase in spontaneous locomotion was detected in  [CLS] TRPV1 Leu206Stop [CLS]  mice as compared to wildtype controls. TRPV1 knockout mice have been reported to carry a similar phenotype regarding capsaicin-evoked"}
{"subject": "Leu206Stop", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29660342.json", "snippet": " of mononeuropathic pain and developed mechanical hypersensitivity two weeks after nerve injury. In the open field test, a significant  [CLS] increase in spontaneous locomotion was detected in TRPV1 Leu206Stop [CLS]  mice as compared to wildtype controls. TRPV1 knockout mice have been reported to carry a similar phenotype regarding capsaicin-evoked"}
{"subject": "spontaneous locomotion", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29660342.json", "snippet": " of mononeuropathic pain and developed mechanical hypersensitivity two weeks after nerve injury. In the open field test, a significant  [CLS] increase in spontaneous locomotion [CLS]  was detected in TRPV1 Leu206Stop mice as compared to wildtype controls. TRPV1 knockout mice have been reported to carry"}
{"subject": "TP53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29666004.json", "snippet": " [CLS] TP53 gain of function mutations [CLS]  in rapidly progressing solid tumors.\nRecent studies are discovering TP53 mutations with gain of function (GOF) properties that promote"}
{"subject": "p.P278S", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " 27%). Immunohistochemistry showed nuclear accumulation of p53. The third patient, a 62-year-old female with metastatic lung adenocarcinoma, had allelic  [CLS] p.P278S (GOF [CLS] ) and p.R283L (non-GOF) variants at frequencies of 61% but with null staining for p53. Germline testing for Patient 1"}
{"subject": "metastatic lung adenocarcinoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " carcinoma (allele frequencies 19% and 27%). Immunohistochemistry showed nuclear accumulation of p53. The third patient, a 62-year-old female with  [CLS] metastatic lung adenocarcinoma, had allelic p.P278S (GOF [CLS] ) and p.R283L (non-GOF) variants at frequencies of 61% but with null staining for p53. Germline testing for Patient 1"}
{"subject": "p.R283L", "sub_type": "Var", "rel": "CauseOf", "object": "non-GOF", "obj_type": "Reg", "file_name": "PubMed-29666004.json", "snippet": " nuclear accumulation of p53. The third patient, a 62-year-old female with metastatic lung adenocarcinoma, had allelic p.P278S (GOF) and  [CLS] p.R283L (non-GOF [CLS] ) variants at frequencies of 61% but with null staining for p53. Germline testing for Patient 1 confirmed wildtype TP53."}
{"subject": "metastatic lung adenocarcinoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "non-GOF", "obj_type": "Reg", "file_name": "PubMed-29666004.json", "snippet": " carcinoma (allele frequencies 19% and 27%). Immunohistochemistry showed nuclear accumulation of p53. The third patient, a 62-year-old female with  [CLS] metastatic lung adenocarcinoma, had allelic p.P278S (GOF) and p.R283L (non-GOF [CLS] ) variants at frequencies of 61% but with null staining for p53. Germline testing for Patient 1 confirmed wildtype TP53."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " [CLS] gain of function mutations [CLS]  in rapidly progressing solid tumors.\nRecent studies are discovering TP53 mutations with gain of function (GOF) properties that promote"}
{"subject": "rapidly progressing solid tumors", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " [CLS] gain of function mutations in rapidly progressing solid tumors [CLS] .\nRecent studies are discovering TP53 mutations with gain of function (GOF) properties that promote tumorigenesis via a variety of"}
{"subject": "TP53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29666004.json", "snippet": " [CLS] TP53 mutations [CLS]  with gain of function (GOF) properties that promote tumorigenesis via a variety of mechanisms. To our knowledge, all reported"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " [CLS] mutations with gain of function [CLS]  (GOF) properties that promote tumorigenesis via a variety of mechanisms. To our knowledge, all reported compound mutations are allelic."}
{"subject": "tumorigenesis", "sub_type": "CPA", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " [CLS] gain of function (GOF) properties that promote tumorigenesis [CLS]  via a variety of mechanisms. To our knowledge, all reported compound mutations are allelic. We identified two patients with"}
{"subject": "p.R273H", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " DNA was extracted from formalin-fixed, paraffin-embedded tissue and mutational analysis was performed using Ion AmpliSeq\u2122Cancer HotSpot Panel V2. Biallelic  [CLS] GOF mutations (p.R273H [CLS]  and p.R273C) were identified in a 19-year-old male with glioblastoma (allele frequencies 94% and 48%) and a 54-year-old with"}
{"subject": "p.R273C", "sub_type": "Var", "rel": "CauseOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " DNA was extracted from formalin-fixed, paraffin-embedded tissue and mutational analysis was performed using Ion AmpliSeq\u2122Cancer HotSpot Panel V2. Biallelic  [CLS] GOF mutations (p.R273H and p.R273C [CLS] ) were identified in a 19-year-old male with glioblastoma (allele frequencies 94% and 48%) and a 54-year-old with pT3 penile"}
{"subject": "glioblastoma", "sub_type": "Disease", "rel": "ThemeOf", "object": "GOF", "obj_type": "PosReg", "file_name": "PubMed-29666004.json", "snippet": " DNA was extracted from formalin-fixed, paraffin-embedded tissue and mutational analysis was performed using Ion AmpliSeq\u2122Cancer HotSpot Panel V2. Biallelic  [CLS] GOF mutations (p.R273H and p.R273C) were identified in a 19-year-old male with glioblastoma [CLS]  (allele frequencies 94% and 48%) and a 54-year-old with pT3 penile squamous cell carcinoma (allele frequencies 19% and 27%)."}
{"subject": "CDH1", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29706558.json", "snippet": " cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.\nBACKGROUND: Germline pathogenic  [CLS] variants in the E-cadherin gene (CDH1 [CLS] ) are strongly associated with the development of hereditary diffuse gastric cancer. There is a paucity of data to guide"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-29706558.json", "snippet": " cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.\nBACKGROUND: Germline pathogenic  [CLS] variants in the E-cadherin gene (CDH1) are strongly associated with [CLS]  the development of hereditary diffuse gastric cancer. There is a paucity of data to guide risk assessment and management"}
{"subject": "hereditary diffuse gastric cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated with", "obj_type": "Reg", "file_name": "PubMed-29706558.json", "snippet": " cancer without CDH1 mutation: a whole-exome sequencing study.\nBACKGROUND: Germline pathogenic variants in the E-cadherin gene (CDH1) are strongly  [CLS] associated with the development of hereditary diffuse gastric cancer [CLS] . There is a paucity of data to guide risk assessment and management of families with hereditary diffuse gastric cancer"}
{"subject": "PALB2", "sub_type": "Gene", "rel": "ThemeOf", "object": "frameshift deletion", "obj_type": "Var", "file_name": "PubMed-29706558.json", "snippet": " gastric cancer; variants were found in genes known to predispose to cancer and in lesser-studied DNA repair genes. A  [CLS] frameshift deletion in PALB2 [CLS]  was found in one member of a family with a history of gastric and breast cancer. Two different MSH2"}
{"subject": "frameshift deletion", "sub_type": "Var", "rel": "CauseOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-29706558.json", "snippet": " gastric cancer; variants were found in genes known to predispose to cancer and in lesser-studied DNA repair genes. A  [CLS] frameshift deletion in PALB2 was found [CLS]  in one member of a family with a history of gastric and breast cancer. Two different MSH2 variants were"}
{"subject": "gastric", "sub_type": "Disease", "rel": "ThemeOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-29706558.json", "snippet": " in genes known to predispose to cancer and in lesser-studied DNA repair genes. A frameshift deletion in PALB2 was  [CLS] found in one member of a family with a history of gastric [CLS]  and breast cancer. Two different MSH2 variants were identified in two unrelated affected individuals, including one frameshift insertion and"}
{"subject": "breast cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "found", "obj_type": "Reg", "file_name": "PubMed-29706558.json", "snippet": " in genes known to predispose to cancer and in lesser-studied DNA repair genes. A frameshift deletion in PALB2 was  [CLS] found in one member of a family with a history of gastric and breast cancer [CLS] . Two different MSH2 variants were identified in two unrelated affected individuals, including one frameshift insertion and one previously described"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss of function", "obj_type": "NegReg", "file_name": "PubMed-29726959.json", "snippet": " MC4R Agonist Treatment.\nContext: The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight.  [CLS] Loss of function (LoF) mutations [CLS]  in the MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1), leptin receptor (LEPR), or MC4R"}
{"subject": "POMC", "sub_type": "Gene", "rel": "ThemeOf", "object": "MC4R pathway", "obj_type": "Pathway", "file_name": "PubMed-29726959.json", "snippet": " 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF) mutations in the  [CLS] MC4R pathway, including mutations in the pro-opiomelanocortin (POMC [CLS] ), prohormone convertase 1 (PCSK1), leptin receptor (LEPR), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods:"}
{"subject": "early-onset severe obesity", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss of function", "obj_type": "NegReg", "file_name": "PubMed-29726959.json", "snippet": " MC4R Agonist Treatment.\nContext: The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight.  [CLS] Loss of function (LoF) mutations in the MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1), leptin receptor (LEPR), or MC4R genes, have been shown to cause early-onset severe obesity [CLS] .\nMethods: Through a comprehensive epidemiological analysis of known and predicted LoF variants in the POMC, PCSK1, and LEPR genes,"}
{"subject": "PCSK1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29726959.json", "snippet": " The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF)  [CLS] mutations in the MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1 [CLS] ), leptin receptor (LEPR), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological"}
{"subject": "LEPR", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29726959.json", "snippet": " The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF)  [CLS] mutations in the MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1), leptin receptor (LEPR [CLS] ), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological analysis of known"}
{"subject": "MC4R", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29726959.json", "snippet": " The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF)  [CLS] mutations in the MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1), leptin receptor (LEPR), or MC4R [CLS]  genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological analysis of known and predicted"}
{"subject": "POMC", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29726959.json", "snippet": " The hypothalamic melanocortin 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF)  [CLS] mutations in the MC4R pathway, including mutations in the pro-opiomelanocortin (POMC [CLS] ), prohormone convertase 1 (PCSK1), leptin receptor (LEPR), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods:"}
{"subject": "PCSK1", "sub_type": "Gene", "rel": "ThemeOf", "object": "MC4R pathway", "obj_type": "Pathway", "file_name": "PubMed-29726959.json", "snippet": " 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF) mutations in the  [CLS] MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1 [CLS] ), leptin receptor (LEPR), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological"}
{"subject": "LEPR", "sub_type": "Gene", "rel": "ThemeOf", "object": "MC4R pathway", "obj_type": "Pathway", "file_name": "PubMed-29726959.json", "snippet": " 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF) mutations in the  [CLS] MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1), leptin receptor (LEPR [CLS] ), or MC4R genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological analysis of known"}
{"subject": "MC4R", "sub_type": "Gene", "rel": "ThemeOf", "object": "MC4R pathway", "obj_type": "Pathway", "file_name": "PubMed-29726959.json", "snippet": " 4 receptor (MC4R) pathway serves a critical role in regulating body weight. Loss of function (LoF) mutations in the  [CLS] MC4R pathway, including mutations in the pro-opiomelanocortin (POMC), prohormone convertase 1 (PCSK1), leptin receptor (LEPR), or MC4R [CLS]  genes, have been shown to cause early-onset severe obesity.\nMethods: Through a comprehensive epidemiological analysis of known and predicted"}
{"subject": "C11orf70", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-29727693.json", "snippet": " [CLS] Mutations in C11orf70 [CLS]  Cause Primary Ciliary Dyskinesia with Randomization of Left/Right Body Asymmetry Due to Defects of Outer and Inner Dynein Arms."}
{"subject": "respiratory cilia", "sub_type": "CPA", "rel": "ThemeOf", "object": "immotility", "obj_type": "CPA", "file_name": "PubMed-29727693.json", "snippet": " from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that loss-of-function mutations in C11orf70 cause  [CLS] immotility of respiratory cilia [CLS]  and sperm flagella, respectively, as a result of the loss of axonemal outer (ODAs) and inner dynein arms (IDAs),"}
{"subject": "sperm flagella", "sub_type": "CPA", "rel": "ThemeOf", "object": "immotility", "obj_type": "CPA", "file_name": "PubMed-29727693.json", "snippet": " from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that loss-of-function mutations in C11orf70 cause  [CLS] immotility of respiratory cilia and sperm flagella [CLS] , respectively, as a result of the loss of axonemal outer (ODAs) and inner dynein arms (IDAs), indicating that C11orf70"}
{"subject": "axonemal outer", "sub_type": "Protein", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " that loss-of-function mutations in C11orf70 cause immotility of respiratory cilia and sperm flagella, respectively, as a result of the  [CLS] loss of axonemal outer [CLS]  (ODAs) and inner dynein arms (IDAs), indicating that C11orf70 is involved in cytoplasmic assembly of dynein arms. Expression analyses"}
{"subject": "inner dynein arms", "sub_type": "Protein", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " that loss-of-function mutations in C11orf70 cause immotility of respiratory cilia and sperm flagella, respectively, as a result of the  [CLS] loss of axonemal outer (ODAs) and inner dynein arms [CLS]  (IDAs), indicating that C11orf70 is involved in cytoplasmic assembly of dynein arms. Expression analyses of C11orf70 showed that C11orf70"}
{"subject": "loss", "sub_type": "NegReg", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " frame C11orf70 in PCD individuals from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that  [CLS] loss-of-function mutations in C11orf70 cause immotility of respiratory cilia and sperm flagella, respectively, as a result of the loss [CLS]  of axonemal outer (ODAs) and inner dynein arms (IDAs), indicating that C11orf70 is involved in cytoplasmic assembly of dynein"}
{"subject": "mutations", "sub_type": "Var", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " C11orf70 in PCD individuals from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that loss-of-function  [CLS] mutations in C11orf70 cause immotility of respiratory cilia and sperm flagella, respectively, as a result of the loss [CLS]  of axonemal outer (ODAs) and inner dynein arms (IDAs), indicating that C11orf70 is involved in cytoplasmic assembly of dynein"}
{"subject": "Primary Ciliary Dyskinesia", "sub_type": "Disease", "rel": "ThemeOf", "object": "Cause", "obj_type": "Reg", "file_name": "PubMed-29727693.json", "snippet": " [CLS] Cause Primary Ciliary Dyskinesia [CLS]  with Randomization of Left/Right Body Asymmetry Due to Defects of Outer and Inner Dynein Arms.\nPrimary ciliary dyskinesia (PCD)"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Defects", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " [CLS] Mutations in C11orf70 Cause Primary Ciliary Dyskinesia with Randomization of Left/Right Body Asymmetry Due to Defects [CLS]  of Outer and Inner Dynein Arms.\nPrimary ciliary dyskinesia (PCD) is characterized by chronic airway disease, male infertility, and"}
{"subject": "Outer and Inner Dynein Arms", "sub_type": "Protein", "rel": "ThemeOf", "object": "Defects", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " [CLS] Defects of Outer and Inner Dynein Arms [CLS] .\nPrimary ciliary dyskinesia (PCD) is characterized by chronic airway disease, male infertility, and randomization of the left/right body axis"}
{"subject": "Defects", "sub_type": "NegReg", "rel": "CauseOf", "object": "Cause", "obj_type": "Reg", "file_name": "PubMed-29727693.json", "snippet": " [CLS] Cause Primary Ciliary Dyskinesia with Randomization of Left/Right Body Asymmetry Due to Defects [CLS]  of Outer and Inner Dynein Arms.\nPrimary ciliary dyskinesia (PCD) is characterized by chronic airway disease, male infertility, and"}
{"subject": "C11orf70", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29727693.json", "snippet": " C11orf70 in PCD individuals from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that loss-of-function  [CLS] mutations in C11orf70 [CLS]  cause immotility of respiratory cilia and sperm flagella, respectively, as a result of the loss of axonemal outer (ODAs)"}
{"subject": "immotility", "sub_type": "CPA", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29727693.json", "snippet": " frame C11orf70 in PCD individuals from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that  [CLS] loss-of-function mutations in C11orf70 cause immotility [CLS]  of respiratory cilia and sperm flagella, respectively, as a result of the loss of axonemal outer (ODAs) and inner"}
{"subject": "MAP1B", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29738522.json", "snippet": " [CLS] variants in MAP1B [CLS]  in periventricular nodular heterotopia.\nPeriventricular nodular heterotopia (PVNH) is a malformation of cortical development commonly associated with epilepsy. We"}
{"subject": "MAP1B", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-29738522.json", "snippet": " gene-level collapsing analysis comparing cases and controls, we identified a genome-wide significant signal driven by four ultra-rare loss-of-function heterozygous  [CLS] variants in MAP1B [CLS] , including one de novo variant. In at least one instance, the MAP1B variant was inherited from a parent with"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29738522.json", "snippet": " Using a gene-level collapsing analysis comparing cases and controls, we identified a genome-wide significant signal driven by four ultra-rare  [CLS] loss-of-function heterozygous variants [CLS]  in MAP1B, including one de novo variant. In at least one instance, the MAP1B variant was inherited from a"}
{"subject": "MAP1B", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29738522.json", "snippet": " by four ultra-rare loss-of-function heterozygous variants in MAP1B, including one de novo variant. In at least one instance, the  [CLS] MAP1B variant [CLS]  was inherited from a parent with previously undiagnosed PVNH. The PVNH was frontally predominant and associated with perisylvian polymicrogyria."}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "inherited from", "obj_type": "Reg", "file_name": "PubMed-29738522.json", "snippet": " four ultra-rare loss-of-function heterozygous variants in MAP1B, including one de novo variant. In at least one instance, the MAP1B  [CLS] variant was inherited from [CLS]  a parent with previously undiagnosed PVNH. The PVNH was frontally predominant and associated with perisylvian polymicrogyria. These results implicate"}
{"subject": "PVNH", "sub_type": "Disease", "rel": "ThemeOf", "object": "inherited from", "obj_type": "Reg", "file_name": "PubMed-29738522.json", "snippet": " loss-of-function heterozygous variants in MAP1B, including one de novo variant. In at least one instance, the MAP1B variant was  [CLS] inherited from a parent with previously undiagnosed PVNH [CLS] . The PVNH was frontally predominant and associated with perisylvian polymicrogyria. These results implicate MAP1B in PVNH. More broadly, our"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " [CLS] gain-of-function variant [CLS]  in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.\nConventional protein kinase C (PKC) family members"}
{"subject": "signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " function is lost in cancer. Here, we address how a gain-of-function germline mutation in PKC\u03b1 in Alzheimer's disease (AD)  [CLS] enhances signaling [CLS]  without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this mutation results in an \u223c30% increase"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " in Alzheimer's disease (AD) enhances signaling without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this  [CLS] mutation results in an \u223c30% increase [CLS]  in the catalytic rate of the activated enzyme, with no changes in the concentrations of Ca2+ or lipid required"}
{"subject": "catalytic", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " signaling without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this mutation results in an \u223c30%  [CLS] increase in the catalytic [CLS]  rate of the activated enzyme, with no changes in the concentrations of Ca2+ or lipid required for half-maximal activation."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "decreasing", "obj_type": "NegReg", "file_name": "PubMed-29844158.json", "snippet": " no changes in the concentrations of Ca2+ or lipid required for half-maximal activation. Molecular dynamics simulations reveal that this  [CLS] mutation has both localized and allosteric effects, most notably decreasing [CLS]  the dynamics of the C-helix, a key determinant in the catalytic turnover of kinases. Consistent with this mutation not"}
{"subject": "dynamics of the C-helix", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreasing", "obj_type": "NegReg", "file_name": "PubMed-29844158.json", "snippet": " required for half-maximal activation. Molecular dynamics simulations reveal that this mutation has both localized and allosteric effects, most notably  [CLS] decreasing the dynamics of the C-helix [CLS] , a key determinant in the catalytic turnover of kinases. Consistent with this mutation not altering autoinhibitory constraints, live-cell imaging"}
{"subject": "enzyme", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29844158.json", "snippet": " not altering autoinhibitory constraints, live-cell imaging studies reveal that the basal signaling output of PKC\u03b1-M489V is unchanged. However, the  [CLS] mutant enzyme [CLS]  in cells displays increased sensitivity to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " not altering autoinhibitory constraints, live-cell imaging studies reveal that the basal signaling output of PKC\u03b1-M489V is unchanged. However, the  [CLS] mutant enzyme in cells displays increased [CLS]  sensitivity to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may"}
{"subject": "sensitivity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " imaging studies reveal that the basal signaling output of PKC\u03b1-M489V is unchanged. However, the mutant enzyme in cells displays  [CLS] increased sensitivity [CLS]  to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "interactions", "obj_type": "Interaction", "file_name": "PubMed-29844158.json", "snippet": " to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence  [CLS] protein interactions [CLS] . Finally, we show that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of"}
{"subject": "interactions", "sub_type": "Interaction", "rel": "ThemeOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29844158.json", "snippet": " sensitivity to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may  [CLS] influence protein interactions [CLS] . Finally, we show that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of"}
{"subject": "Alzheimer's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " [CLS] gain-of-function variant in Alzheimer's disease [CLS]  displays enhanced catalysis by a mechanism that evades down-regulation.\nConventional protein kinase C (PKC) family members are reversibly activated"}
{"subject": "increased", "sub_type": "PosReg", "rel": "CauseOf", "object": "influence", "obj_type": "Reg", "file_name": "PubMed-29844158.json", "snippet": " imaging studies reveal that the basal signaling output of PKC\u03b1-M489V is unchanged. However, the mutant enzyme in cells displays  [CLS] increased sensitivity to an inhibitor that is ineffective toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence [CLS]  protein interactions. Finally, we show that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in"}
{"subject": "PKC\u03b1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "M489V mutation", "obj_type": "Var", "file_name": "PubMed-29844158.json", "snippet": " of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the  [CLS] PKC\u03b1-M489V mutation [CLS] . Our results unveil how an AD-associated mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades the"}
{"subject": "M489V mutation", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " may influence protein interactions. Finally, we show that phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is  [CLS] increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation [CLS] . Our results unveil how an AD-associated mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades the"}
{"subject": "phosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence protein interactions. Finally, we show that  [CLS] phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate, is increased [CLS]  in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated mutation in PKC\u03b1"}
{"subject": "myristoylated alanine-rich C-kinase substrate", "sub_type": "MPA", "rel": "ThemeOf", "object": "phosphorylation", "obj_type": "MPA", "file_name": "PubMed-29844158.json", "snippet": " toward scaffolded PKC, suggesting the altered dynamics of the kinase domain may influence protein interactions. Finally, we show that  [CLS] phosphorylation of a key PKC substrate, myristoylated alanine-rich C-kinase substrate [CLS] , is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated mutation"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29844158.json", "snippet": " C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD- [CLS] associated mutation [CLS]  in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "AD", "sub_type": "Disease", "rel": "ThemeOf", "object": "associated", "obj_type": "Reg", "file_name": "PubMed-29844158.json", "snippet": " C-kinase substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an  [CLS] AD-associated [CLS]  mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades the cell's homeostatic down-regulation of constitutively active"}
{"subject": "PKC\u03b1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29844158.json", "snippet": " substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated  [CLS] mutation in PKC\u03b1 [CLS]  permits enhanced agonist-dependent signaling via a mechanism that evades the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "evades", "obj_type": "NegReg", "file_name": "PubMed-29844158.json", "snippet": " substrate, is increased in brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated  [CLS] mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades [CLS]  the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "homeostatic down-regulation", "sub_type": "MPA", "rel": "ThemeOf", "object": "evades", "obj_type": "NegReg", "file_name": "PubMed-29844158.json", "snippet": " PKC\u03b1-M489V mutation. Our results unveil how an AD-associated mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that  [CLS] evades the cell's homeostatic down-regulation [CLS]  of constitutively active PKC\u03b1."}
{"subject": "Protein kinase C\u03b1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-29844158.json", "snippet": " [CLS] Protein kinase C\u03b1 gain-of-function variant [CLS]  in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.\nConventional protein kinase C (PKC) family members"}
{"subject": "constitutively active PKC\u03b1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "homeostatic down-regulation", "obj_type": "MPA", "file_name": "PubMed-29844158.json", "snippet": " results unveil how an AD-associated mutation in PKC\u03b1 permits enhanced agonist-dependent signaling via a mechanism that evades the cell's  [CLS] homeostatic down-regulation of constitutively active PKC\u03b1 [CLS] ."}
{"subject": "evades", "sub_type": "NegReg", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated mutation in PKC\u03b1 permits  [CLS] enhanced agonist-dependent signaling via a mechanism that evades [CLS]  the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "agonist-dependent signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " brains of CRISPR-Cas9 genome-edited mice containing the PKC\u03b1-M489V mutation. Our results unveil how an AD-associated mutation in PKC\u03b1 permits  [CLS] enhanced agonist-dependent signaling [CLS]  via a mechanism that evades the cell's homeostatic down-regulation of constitutively active PKC\u03b1."}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " [CLS] variant in Alzheimer's disease displays enhanced [CLS]  catalysis by a mechanism that evades down-regulation.\nConventional protein kinase C (PKC) family members are reversibly activated by binding"}
{"subject": "catalysis", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " [CLS] enhanced catalysis [CLS]  by a mechanism that evades down-regulation.\nConventional protein kinase C (PKC) family members are reversibly activated by binding to"}
{"subject": "germline mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " destabilization, is one of many mechanisms by which PKC function is lost in cancer. Here, we address how a  [CLS] gain-of-function germline mutation [CLS]  in PKC\u03b1 in Alzheimer's disease (AD) enhances signaling without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate"}
{"subject": "PKC\u03b1", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "germline mutation", "obj_type": "Var", "file_name": "PubMed-29844158.json", "snippet": " is one of many mechanisms by which PKC function is lost in cancer. Here, we address how a gain-of-function  [CLS] germline mutation in PKC\u03b1 [CLS]  in Alzheimer's disease (AD) enhances signaling without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this"}
{"subject": "Alzheimer's disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " destabilization, is one of many mechanisms by which PKC function is lost in cancer. Here, we address how a  [CLS] gain-of-function germline mutation in PKC\u03b1 in Alzheimer's disease [CLS]  (AD) enhances signaling without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this mutation results in"}
{"subject": "gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "enhances", "obj_type": "PosReg", "file_name": "PubMed-29844158.json", "snippet": " destabilization, is one of many mechanisms by which PKC function is lost in cancer. Here, we address how a  [CLS] gain-of-function germline mutation in PKC\u03b1 in Alzheimer's disease (AD) enhances [CLS]  signaling without increasing vulnerability to down-regulation. Biochemical analyses of purified protein demonstrate that this mutation results in an \u223c30%"}
{"subject": "KCNJ6", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutation", "obj_type": "Var", "file_name": "PubMed-29852244.json", "snippet": " [CLS] KCNJ6 Mutation [CLS]  in a Severe Hyperkinetic Movement Disorder Phenotype.\nHere, we describe a fourth case of a human with a de"}
{"subject": "GIRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29852244.json", "snippet": " vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the  [CLS] mutant GIRK2 [CLS]  channel alone produced an aberrant basal inward current that lacked G protein activation, lost K+ selectivity and gained Ca2+"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "produced", "obj_type": "PosReg", "file_name": "PubMed-29852244.json", "snippet": " vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the  [CLS] mutant GIRK2 channel alone produced [CLS]  an aberrant basal inward current that lacked G protein activation, lost K+ selectivity and gained Ca2+ permeability. Notably, the"}
{"subject": "basal inward current", "sub_type": "MPA", "rel": "ThemeOf", "object": "produced", "obj_type": "PosReg", "file_name": "PubMed-29852244.json", "snippet": " determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone  [CLS] produced an aberrant basal inward current [CLS]  that lacked G protein activation, lost K+ selectivity and gained Ca2+ permeability. Notably, the inward current was inhibited by"}
{"subject": "produced", "sub_type": "PosReg", "rel": "CauseOf", "object": "lacked", "obj_type": "NegReg", "file_name": "PubMed-29852244.json", "snippet": " determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone  [CLS] produced an aberrant basal inward current that lacked [CLS]  G protein activation, lost K+ selectivity and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+"}
{"subject": "G protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "activation", "obj_type": "MPA", "file_name": "PubMed-29852244.json", "snippet": " of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone produced an aberrant basal inward current that lacked  [CLS] G protein activation [CLS] , lost K+ selectivity and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314,"}
{"subject": "activation", "sub_type": "MPA", "rel": "ThemeOf", "object": "lacked", "obj_type": "NegReg", "file_name": "PubMed-29852244.json", "snippet": " function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone produced an aberrant basal inward current that  [CLS] lacked G protein activation [CLS] , lost K+ selectivity and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314,"}
{"subject": "produced", "sub_type": "PosReg", "rel": "CauseOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-29852244.json", "snippet": " determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone  [CLS] produced an aberrant basal inward current that lacked G protein activation, lost [CLS]  K+ selectivity and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314, similar"}
{"subject": "K+ selectivity", "sub_type": "MPA", "rel": "ThemeOf", "object": "lost", "obj_type": "NegReg", "file_name": "PubMed-29852244.json", "snippet": " Heterologous expression of the mutant GIRK2 channel alone produced an aberrant basal inward current that lacked G protein activation,  [CLS] lost K+ selectivity [CLS]  and gained Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314, similar to the"}
{"subject": "produced", "sub_type": "PosReg", "rel": "CauseOf", "object": "gained", "obj_type": "PosReg", "file_name": "PubMed-29852244.json", "snippet": " determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone  [CLS] produced an aberrant basal inward current that lacked G protein activation, lost K+ selectivity and gained [CLS]  Ca2+ permeability. Notably, the inward current was inhibited by the Na+ channel blocker QX-314, similar to the previously reported"}
{"subject": "Ca2+ permeability", "sub_type": "MPA", "rel": "ThemeOf", "object": "gained", "obj_type": "PosReg", "file_name": "PubMed-29852244.json", "snippet": " mutant GIRK2 channel alone produced an aberrant basal inward current that lacked G protein activation, lost K+ selectivity and  [CLS] gained Ca2+ permeability [CLS] . Notably, the inward current was inhibited by the Na+ channel blocker QX-314, similar to the previously reported weaver mutation"}
{"subject": "Mutation", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29852244.json", "snippet": " [CLS] Gain-of-function KCNJ6 Mutation [CLS]  in a Severe Hyperkinetic Movement Disorder Phenotype.\nHere, we describe a fourth case of a human with a de"}
{"subject": "GIRK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Leu171Arg", "obj_type": "Var", "file_name": "PubMed-29852244.json", "snippet": " dimer containing GIRK1 and GIRK2(p.Leu171Arg) did not lead to any currents, suggesting heterotetramers are not functional. In neurons expressing  [CLS] p.Leu171Arg GIRK2 [CLS]  channels, these changes in channel properties would be expected to generate a sustained depolarization, instead of the normal G"}
{"subject": "p.Leu171Arg", "sub_type": "Var", "rel": "CauseOf", "object": "depolarization", "obj_type": "NegReg", "file_name": "PubMed-29852244.json", "snippet": " dimer containing GIRK1 and GIRK2(p.Leu171Arg) did not lead to any currents, suggesting heterotetramers are not functional. In neurons expressing  [CLS] p.Leu171Arg GIRK2 channels, these changes in channel properties would be expected to generate a sustained depolarization [CLS] , instead of the normal G protein-gated inhibitory response, which could be mitigated by expression of other GIRK subunits. The"}
{"subject": "G protein-gated inhibitory response", "sub_type": "MPA", "rel": "ThemeOf", "object": "depolarization", "obj_type": "NegReg", "file_name": "PubMed-29852244.json", "snippet": " functional. In neurons expressing p.Leu171Arg GIRK2 channels, these changes in channel properties would be expected to generate a sustained  [CLS] depolarization, instead of the normal G protein-gated inhibitory response [CLS] , which could be mitigated by expression of other GIRK subunits. The identification of the p.Leu171Arg GIRK2 mutation potentially expands"}
{"subject": "Severe Hyperkinetic Movement Disorder", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29852244.json", "snippet": " [CLS] Gain-of-function KCNJ6 Mutation in a Severe Hyperkinetic Movement Disorder [CLS]  Phenotype.\nHere, we describe a fourth case of a human with a de novo KCNJ6 (GIRK2) mutation, who presented"}
{"subject": "KCNJ6", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29852244.json", "snippet": " a Severe Hyperkinetic Movement Disorder Phenotype.\nHere, we describe a fourth case of a human with a de novo  [CLS] KCNJ6 (GIRK2) mutation [CLS] , who presented with clinical findings of severe hyperkinetic movement disorder and developmental delay, similar to the Keppen-Lubinsky syndrome but"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29852244.json", "snippet": " Hyperkinetic Movement Disorder Phenotype.\nHere, we describe a fourth case of a human with a de novo KCNJ6 (GIRK2)  [CLS] mutation, who presented [CLS]  with clinical findings of severe hyperkinetic movement disorder and developmental delay, similar to the Keppen-Lubinsky syndrome but without lipodystrophy."}
{"subject": "severe hyperkinetic movement disorder", "sub_type": "Disease", "rel": "ThemeOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29852244.json", "snippet": " Disorder Phenotype.\nHere, we describe a fourth case of a human with a de novo KCNJ6 (GIRK2) mutation, who  [CLS] presented with clinical findings of severe hyperkinetic movement disorder [CLS]  and developmental delay, similar to the Keppen-Lubinsky syndrome but without lipodystrophy. Whole-exome sequencing of the patient's DNA revealed a"}
{"subject": "developmental delay", "sub_type": "CPA", "rel": "ThemeOf", "object": "presented", "obj_type": "Reg", "file_name": "PubMed-29852244.json", "snippet": " Disorder Phenotype.\nHere, we describe a fourth case of a human with a de novo KCNJ6 (GIRK2) mutation, who  [CLS] presented with clinical findings of severe hyperkinetic movement disorder and developmental delay [CLS] , similar to the Keppen-Lubinsky syndrome but without lipodystrophy. Whole-exome sequencing of the patient's DNA revealed a heterozygous de novo"}
{"subject": "KCNJ6", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.512T>G", "obj_type": "Var", "file_name": "PubMed-29852244.json", "snippet": " Keppen-Lubinsky syndrome but without lipodystrophy. Whole-exome sequencing of the patient's DNA revealed a heterozygous de novo variant in the  [CLS] KCNJ6 (c.512T>G [CLS] , p.Leu171Arg). We conducted in vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels."}
{"subject": "KCNJ6", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Leu171Arg", "obj_type": "Var", "file_name": "PubMed-29852244.json", "snippet": " Keppen-Lubinsky syndrome but without lipodystrophy. Whole-exome sequencing of the patient's DNA revealed a heterozygous de novo variant in the  [CLS] KCNJ6 (c.512T>G, p.Leu171Arg [CLS] ). We conducted in vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous"}
{"subject": "Variants", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-29861108.json", "snippet": " [CLS] Loss-of-Function Variants [CLS]  in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.\nNext-generation sequencing is a powerful tool for the"}
{"subject": "TLK2", "sub_type": "Gene", "rel": "ThemeOf", "object": "Variants", "obj_type": "Var", "file_name": "PubMed-29861108.json", "snippet": " [CLS] Variants in TLK2 [CLS] : Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.\nNext-generation sequencing is a powerful tool for the discovery of"}
{"subject": "Distinct Neurodevelopmental Disorder", "sub_type": "Disease", "rel": "ThemeOf", "object": "Loss-of-Function", "obj_type": "NegReg", "file_name": "PubMed-29861108.json", "snippet": " [CLS] Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder [CLS] .\nNext-generation sequencing is a powerful tool for the discovery of genes related to neurodevelopmental disorders (NDDs). Here, we report"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cases", "obj_type": "Reg", "file_name": "PubMed-29889573.json", "snippet": " in tumors and has anti-inflammatory properties. The protein may be cleaved into granulins which display pro-inflammatory properties. In 2006,  [CLS] mutations in progranulin gene (GRN) that cause haploinsufficiency were found in familial cases [CLS]  of frontotemporal dementia (FTD). Patients with null mutations in GRN display very low-plasma PGRN levels; this analysis is useful"}
{"subject": "frontotemporal dementia", "sub_type": "Disease", "rel": "ThemeOf", "object": "cases", "obj_type": "Reg", "file_name": "PubMed-29889573.json", "snippet": " granulins which display pro-inflammatory properties. In 2006, mutations in progranulin gene (GRN) that cause haploinsufficiency were found in familial  [CLS] cases of frontotemporal dementia [CLS]  (FTD). Patients with null mutations in GRN display very low-plasma PGRN levels; this analysis is useful for identifying mutation"}
{"subject": "GRN", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29889573.json", "snippet": " in tumors and has anti-inflammatory properties. The protein may be cleaved into granulins which display pro-inflammatory properties. In 2006,  [CLS] mutations in progranulin gene (GRN [CLS] ) that cause haploinsufficiency were found in familial cases of frontotemporal dementia (FTD). Patients with null mutations in GRN display"}
{"subject": "Sik3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-29899451.json", "snippet": " Sleep deprivation induces cumulative phosphorylation of the brain proteome, which dissipates during sleep. Sleepy mice, owing to a gain-of-function  [CLS] mutation in the Sik3 [CLS]  gene 12 , have a constitutively high sleep need despite increased sleep amount. The brain proteome of these mice"}
{"subject": "SNIPPs", "sub_type": "Protein", "rel": "ThemeOf", "object": "phosphorylates", "obj_type": "MPA", "file_name": "PubMed-29899451.json", "snippet": " in which phosphorylation states closely parallel changes of sleep need. SLEEPY, the mutant SIK3 protein, preferentially associates with and  [CLS] phosphorylates SNIPPs [CLS] . Inhibition of SIK3 activity reduces phosphorylation of SNIPPs and slow wave activity during non-rapid-eye-movement sleep, the best known measurable"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29899451.json", "snippet": " need. Sleep deprivation induces cumulative phosphorylation of the brain proteome, which dissipates during sleep. Sleepy mice, owing to a  [CLS] gain-of-function mutation [CLS]  in the Sik3 gene 12 , have a constitutively high sleep need despite increased sleep amount. The brain proteome"}
{"subject": "hyperphosphorylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "brain proteome", "obj_type": "Protein", "file_name": "PubMed-29899451.json", "snippet": " gain-of-function mutation in the Sik3 gene 12 , have a constitutively high sleep need despite increased sleep amount. The  [CLS] brain proteome of these mice exhibits hyperphosphorylation [CLS] , similar to that seen in the brain of sleep-deprived mice. Comparison of the two models identifies 80 mostly synaptic"}
{"subject": "brain proteome", "sub_type": "Protein", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-29899451.json", "snippet": " need. Sleep deprivation induces cumulative phosphorylation of the brain proteome, which dissipates during sleep. Sleepy mice, owing to a  [CLS] gain-of-function mutation in the Sik3 gene 12 , have a constitutively high sleep need despite increased sleep amount. The brain proteome [CLS]  of these mice exhibits hyperphosphorylation, similar to that seen in the brain of sleep-deprived mice. Comparison of the two"}
{"subject": "SIK3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-29899451.json", "snippet": " identifies 80 mostly synaptic sleep-need-index phosphoproteins (SNIPPs), in which phosphorylation states closely parallel changes of sleep need. SLEEPY, the  [CLS] mutant SIK3 [CLS]  protein, preferentially associates with and phosphorylates SNIPPs. Inhibition of SIK3 activity reduces phosphorylation of SNIPPs and slow wave activity"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "SIK3", "obj_type": "Gene", "file_name": "PubMed-29899451.json", "snippet": " 80 mostly synaptic sleep-need-index phosphoproteins (SNIPPs), in which phosphorylation states closely parallel changes of sleep need. SLEEPY, the mutant  [CLS] SIK3 protein [CLS] , preferentially associates with and phosphorylates SNIPPs. Inhibition of SIK3 activity reduces phosphorylation of SNIPPs and slow wave activity during"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "preferentially", "obj_type": "PosReg", "file_name": "PubMed-29899451.json", "snippet": " identifies 80 mostly synaptic sleep-need-index phosphoproteins (SNIPPs), in which phosphorylation states closely parallel changes of sleep need. SLEEPY, the  [CLS] mutant SIK3 protein, preferentially [CLS]  associates with and phosphorylates SNIPPs. Inhibition of SIK3 activity reduces phosphorylation of SNIPPs and slow wave activity during non-rapid-eye-movement"}
{"subject": "associates with", "sub_type": "Interaction", "rel": "ThemeOf", "object": "preferentially", "obj_type": "PosReg", "file_name": "PubMed-29899451.json", "snippet": " synaptic sleep-need-index phosphoproteins (SNIPPs), in which phosphorylation states closely parallel changes of sleep need. SLEEPY, the mutant SIK3 protein,  [CLS] preferentially associates with [CLS]  and phosphorylates SNIPPs. Inhibition of SIK3 activity reduces phosphorylation of SNIPPs and slow wave activity during non-rapid-eye-movement sleep, the"}
{"subject": "phosphorylates", "sub_type": "MPA", "rel": "ThemeOf", "object": "associates with", "obj_type": "Interaction", "file_name": "PubMed-29899451.json", "snippet": " sleep-need-index phosphoproteins (SNIPPs), in which phosphorylation states closely parallel changes of sleep need. SLEEPY, the mutant SIK3 protein, preferentially  [CLS] associates with and phosphorylates [CLS]  SNIPPs. Inhibition of SIK3 activity reduces phosphorylation of SNIPPs and slow wave activity during non-rapid-eye-movement sleep, the best known"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29912901.json", "snippet": " germline mutations, the characterisation of which has refined our understanding of nephrogenesis and carcinogenesis. Here we report that germline  [CLS] loss of function mutations [CLS]  in TRIM28 predispose children to Wilms tumour. Loss of function of this transcriptional co-repressor, which has a role in"}
{"subject": "Wilms tumour", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29912901.json", "snippet": " germline mutations, the characterisation of which has refined our understanding of nephrogenesis and carcinogenesis. Here we report that germline  [CLS] loss of function mutations in TRIM28 predispose children to Wilms tumour [CLS] . Loss of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with"}
{"subject": "TRIM28", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29912901.json", "snippet": " characterisation of which has refined our understanding of nephrogenesis and carcinogenesis. Here we report that germline loss of function  [CLS] mutations in TRIM28 [CLS]  predispose children to Wilms tumour. Loss of function of this transcriptional co-repressor, which has a role in nephrogenesis, has"}
{"subject": "loss of heterozygosity", "sub_type": "Var", "rel": "CauseOf", "object": "Inactivation", "obj_type": "NegReg", "file_name": "PubMed-29912901.json", "snippet": " of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with cancer.  [CLS] Inactivation of TRIM28, either germline or somatic, occurred through inactivating mutations, loss of heterozygosity [CLS]  or epigenetic silencing. TRIM28-mutated tumours had a monomorphic epithelial histology that is uncommon for Wilms tumour. Critically, these tumours"}
{"subject": "inactivating mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Inactivation", "obj_type": "NegReg", "file_name": "PubMed-29912901.json", "snippet": " of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with cancer.  [CLS] Inactivation of TRIM28, either germline or somatic, occurred through inactivating mutations [CLS] , loss of heterozygosity or epigenetic silencing. TRIM28-mutated tumours had a monomorphic epithelial histology that is uncommon for Wilms tumour."}
{"subject": "epigenetic silencing", "sub_type": "Var", "rel": "CauseOf", "object": "Inactivation", "obj_type": "NegReg", "file_name": "PubMed-29912901.json", "snippet": " of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with cancer.  [CLS] Inactivation of TRIM28, either germline or somatic, occurred through inactivating mutations, loss of heterozygosity or epigenetic silencing [CLS] . TRIM28-mutated tumours had a monomorphic epithelial histology that is uncommon for Wilms tumour. Critically, these tumours were negative for"}
{"subject": "TRIM28", "sub_type": "Gene", "rel": "ThemeOf", "object": "Inactivation", "obj_type": "NegReg", "file_name": "PubMed-29912901.json", "snippet": " of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with cancer.  [CLS] Inactivation of TRIM28 [CLS] , either germline or somatic, occurred through inactivating mutations, loss of heterozygosity or epigenetic silencing. TRIM28-mutated tumours had a monomorphic"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " [CLS] loss of function mutations [CLS] .\nOBJECTIVE: To study the functional properties of six novel missense mutations of the NR5A1 gene encoding the steroidogenic factor"}
{"subject": "p.Q460R", "sub_type": "Var", "rel": "CauseOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R [CLS] . Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and"}
{"subject": "p.T40R", "sub_type": "Var", "rel": "CauseOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD patients six novel mutations: p.T40R [CLS] , p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed"}
{"subject": "p.R427W", "sub_type": "Var", "rel": "CauseOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E, p.R427W [CLS] , and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of"}
{"subject": "p.A351E", "sub_type": "Var", "rel": "CauseOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E [CLS] , p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss"}
{"subject": "p.G328W", "sub_type": "Var", "rel": "CauseOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W [CLS] , p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant"}
{"subject": "p.T47C", "sub_type": "Var", "rel": "CauseOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C [CLS] , p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a"}
{"subject": "p.R427W", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " molecular function.\nRESULT(S): NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E,  [CLS] p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss [CLS]  of DNA-binding and transactivation ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with"}
{"subject": "46,XY DSD", "sub_type": "Disease", "rel": "ThemeOf", "object": "identified in", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing  [CLS] identified in six 46,XY DSD [CLS]  patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was"}
{"subject": "p.A351E", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " on molecular function.\nRESULT(S): NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W,  [CLS] p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss [CLS]  of DNA-binding and transactivation ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with"}
{"subject": "p.G328W", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C,  [CLS] p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss [CLS]  of DNA-binding and transactivation ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " [CLS] NR5A1 gene in 46,XY disorders of sex development: identification of six novel loss of function mutations [CLS] .\nOBJECTIVE: To study the functional properties of six novel missense mutations of the NR5A1 gene encoding the steroidogenic factor"}
{"subject": "p.T47C", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R,  [CLS] p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss [CLS]  of DNA-binding and transactivation ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with"}
{"subject": "p.T40R", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " impact of mutations on molecular function.\nRESULT(S): NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations:  [CLS] p.T40R, p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss [CLS]  of DNA-binding and transactivation ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with"}
{"subject": "DNA-binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant  [CLS] loss of DNA-binding [CLS]  and transactivation ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with that of"}
{"subject": "transactivation", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant  [CLS] loss of DNA-binding and transactivation [CLS]  ability for all variants, except for p.Q460R, which showed a modest reduced activity compared with that of the wild-type"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " production, and possible fertility, to females with and without m\u00fcllerian structures and primary amenorrhea.\nCONCLUSION(S): We describe six novel  [CLS] mutations in NR5A1 [CLS]  gene and showed that they might affect protein structure, therefore compromising seriously the SF-1 role in regulating gonadal development."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " production, and possible fertility, to females with and without m\u00fcllerian structures and primary amenorrhea.\nCONCLUSION(S): We describe six novel  [CLS] mutations in NR5A1 gene and showed that they might affect [CLS]  protein structure, therefore compromising seriously the SF-1 role in regulating gonadal development. Clinically, we suggest that NR5A1 analysis should"}
{"subject": "protein structure", "sub_type": "MPA", "rel": "ThemeOf", "object": "affect", "obj_type": "Reg", "file_name": "PubMed-29935645.json", "snippet": " m\u00fcllerian structures and primary amenorrhea.\nCONCLUSION(S): We describe six novel mutations in NR5A1 gene and showed that they might  [CLS] affect protein structure [CLS] , therefore compromising seriously the SF-1 role in regulating gonadal development. Clinically, we suggest that NR5A1 analysis should be performed"}
{"subject": "affect", "sub_type": "Reg", "rel": "CauseOf", "object": "compromising", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " m\u00fcllerian structures and primary amenorrhea.\nCONCLUSION(S): We describe six novel mutations in NR5A1 gene and showed that they might  [CLS] affect protein structure, therefore compromising [CLS]  seriously the SF-1 role in regulating gonadal development. Clinically, we suggest that NR5A1 analysis should be performed whenever atypical"}
{"subject": "SF-1", "sub_type": "MPA", "rel": "ThemeOf", "object": "compromising", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " amenorrhea.\nCONCLUSION(S): We describe six novel mutations in NR5A1 gene and showed that they might affect protein structure, therefore  [CLS] compromising seriously the SF-1 [CLS]  role in regulating gonadal development. Clinically, we suggest that NR5A1 analysis should be performed whenever atypical sex organs are"}
{"subject": "gonadal development", "sub_type": "CPA", "rel": "ThemeOf", "object": "compromising", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " amenorrhea.\nCONCLUSION(S): We describe six novel mutations in NR5A1 gene and showed that they might affect protein structure, therefore  [CLS] compromising seriously the SF-1 role in regulating gonadal development [CLS] . Clinically, we suggest that NR5A1 analysis should be performed whenever atypical sex organs are evidenced or there is an"}
{"subject": "46,XY disorders of sex development", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss of function", "obj_type": "NegReg", "file_name": "PubMed-29935645.json", "snippet": " [CLS] 46,XY disorders of sex development: identification of six novel loss of function [CLS]  mutations.\nOBJECTIVE: To study the functional properties of six novel missense mutations of the NR5A1 gene encoding the steroidogenic"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.T40R", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S):  [CLS] NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R [CLS] , p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Q460R", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S):  [CLS] NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E, p.R427W, and p.Q460R [CLS] . Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of DNA-binding and"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.R427W", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S):  [CLS] NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E, p.R427W [CLS] , and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss of"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.A351E", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S):  [CLS] NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W, p.A351E [CLS] , p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant loss"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.G328W", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S):  [CLS] NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C, p.G328W [CLS] , p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a significant"}
{"subject": "NR5A1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.T47C", "obj_type": "Var", "file_name": "PubMed-29935645.json", "snippet": " of the NR5A1 gene. Functional studies by transactivation assays to predict the impact of mutations on molecular function.\nRESULT(S):  [CLS] NR5A1 exons sequencing identified in six 46,XY DSD patients six novel mutations: p.T40R, p.T47C [CLS] , p.G328W, p.A351E, p.R427W, and p.Q460R. Five missense variants were heterozygous, and one was homozygous (p.R427W). Functional analysis revealed a"}
{"subject": "Substitution", "sub_type": "Var", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29941455.json", "snippet": " changes in receptor parameters by using currently available structural information on the open and closed states of the GlyR.  [CLS] Substitution of six of the eight Phe residues in the ECD with Ala resulted in loss [CLS]  of function or significantly increased the EC50 and also altered the maximal response to the partial GlyR agonist taurine"}
{"subject": "function", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-29941455.json", "snippet": " states of the GlyR. Substitution of six of the eight Phe residues in the ECD with Ala resulted in  [CLS] loss of function [CLS]  or significantly increased the EC50 and also altered the maximal response to the partial GlyR agonist taurine compared with"}
{"subject": "Substitution", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29941455.json", "snippet": " changes in receptor parameters by using currently available structural information on the open and closed states of the GlyR.  [CLS] Substitution of six of the eight Phe residues in the ECD with Ala resulted in loss of function or significantly increased [CLS]  the EC50 and also altered the maximal response to the partial GlyR agonist taurine compared with glycine in those"}
{"subject": "EC50", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29941455.json", "snippet": " of six of the eight Phe residues in the ECD with Ala resulted in loss of function or significantly  [CLS] increased the EC50 [CLS]  and also altered the maximal response to the partial GlyR agonist taurine compared with glycine in those receptor variants"}
{"subject": "Substitution", "sub_type": "Var", "rel": "CauseOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29941455.json", "snippet": " changes in receptor parameters by using currently available structural information on the open and closed states of the GlyR.  [CLS] Substitution of six of the eight Phe residues in the ECD with Ala resulted in loss of function or significantly increased the EC50 and also altered [CLS]  the maximal response to the partial GlyR agonist taurine compared with glycine in those receptor variants that were functional."}
{"subject": "maximal response to the partial GlyR agonist taurine", "sub_type": "MPA", "rel": "ThemeOf", "object": "altered", "obj_type": "Reg", "file_name": "PubMed-29941455.json", "snippet": " Phe residues in the ECD with Ala resulted in loss of function or significantly increased the EC50 and also  [CLS] altered the maximal response to the partial GlyR agonist taurine [CLS]  compared with glycine in those receptor variants that were functional. Substitutions with other amino acids, combined with examination of"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-29969449.json", "snippet": " intronic features associated with its activity, and its role in development are unknown. In this study, we have generated  [CLS] loss-of-function mutants [CLS]  for the three components of the RES complex in zebrafish and showed that they are required during early development."}
{"subject": "intron splicing", "sub_type": "MPA", "rel": "ThemeOf", "object": "defect", "obj_type": "NegReg", "file_name": "PubMed-29969449.json", "snippet": " and a decrease in differentiated neurons. Transcriptomic analysis of bud13, snip1 (pml1) and rbmx2 (snu17) mutants revealed a global  [CLS] defect in intron splicing [CLS] , with strong mis-splicing of a subset of introns. We found these RES-dependent introns were short, rich in GC and"}
{"subject": "mis-splicing of a subset of introns", "sub_type": "MPA", "rel": "ThemeOf", "object": "intron splicing", "obj_type": "MPA", "file_name": "PubMed-29969449.json", "snippet": " decrease in differentiated neurons. Transcriptomic analysis of bud13, snip1 (pml1) and rbmx2 (snu17) mutants revealed a global defect in  [CLS] intron splicing, with strong mis-splicing of a subset of introns [CLS] . We found these RES-dependent introns were short, rich in GC and flanked by GC depleted exons, all of which"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-29969449.json", "snippet": " intronic features associated with its activity, and its role in development are unknown. In this study, we have generated  [CLS] loss-of-function mutants for the three components of the RES complex in zebrafish and showed that they are required during early development. The mutants showed a marked neural phenotype with increased cell death in the brain and a decrease [CLS]  in differentiated neurons. Transcriptomic analysis of bud13, snip1 (pml1) and rbmx2 (snu17) mutants revealed a global defect in intron"}
{"subject": "differentiated neurons", "sub_type": "CPA", "rel": "ThemeOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-29969449.json", "snippet": " during early development. The mutants showed a marked neural phenotype with increased cell death in the brain and a  [CLS] decrease in differentiated neurons [CLS] . Transcriptomic analysis of bud13, snip1 (pml1) and rbmx2 (snu17) mutants revealed a global defect in intron splicing, with strong"}
{"subject": "rbmx2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29969449.json", "snippet": " increased cell death in the brain and a decrease in differentiated neurons. Transcriptomic analysis of bud13, snip1 (pml1) and  [CLS] rbmx2 (snu17) mutants [CLS]  revealed a global defect in intron splicing, with strong mis-splicing of a subset of introns. We found these RES-dependent"}
{"subject": "snip1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29969449.json", "snippet": " neural phenotype with increased cell death in the brain and a decrease in differentiated neurons. Transcriptomic analysis of bud13,  [CLS] snip1 (pml1) and rbmx2 (snu17) mutants [CLS]  revealed a global defect in intron splicing, with strong mis-splicing of a subset of introns. We found these RES-dependent"}
{"subject": "bud13", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29969449.json", "snippet": " marked neural phenotype with increased cell death in the brain and a decrease in differentiated neurons. Transcriptomic analysis of  [CLS] bud13, snip1 (pml1) and rbmx2 (snu17) mutants [CLS]  revealed a global defect in intron splicing, with strong mis-splicing of a subset of introns. We found these RES-dependent"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "defect", "obj_type": "NegReg", "file_name": "PubMed-29969449.json", "snippet": " death in the brain and a decrease in differentiated neurons. Transcriptomic analysis of bud13, snip1 (pml1) and rbmx2 (snu17)  [CLS] mutants revealed a global defect [CLS]  in intron splicing, with strong mis-splicing of a subset of introns. We found these RES-dependent introns were short, rich"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutant", "obj_type": "Var", "file_name": "PubMed-29970031.json", "snippet": " [CLS] Mutant p53 [CLS]  gain of function induces HER2 over-expression in cancer cells.\nBACKGROUND: HER2 over-expression is related with a poor prognosis in"}
{"subject": "mtp53", "sub_type": "Var", "rel": "CauseOf", "object": "Higher", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " expression in cell lines. Finally, we evaluated the interaction of the p53 mutants over the HER2 receptor promoter.\nRESULTS:  [CLS] Higher HER2 expression in cell lines harboring endogenous mtp53 [CLS]  compared with wt or null expression of p53 cell lines. Transfection of p53 mutants (R248Q and R273C) in cell"}
{"subject": "HER2", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-29970031.json", "snippet": " in cell lines. Finally, we evaluated the interaction of the p53 mutants over the HER2 receptor promoter.\nRESULTS: Higher  [CLS] HER2 expression [CLS]  in cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of p53"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "Higher", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " expression in cell lines. Finally, we evaluated the interaction of the p53 mutants over the HER2 receptor promoter.\nRESULTS:  [CLS] Higher HER2 expression [CLS]  in cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of p53"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R248Q", "obj_type": "Var", "file_name": "PubMed-29970031.json", "snippet": " expression in cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of  [CLS] p53 mutants (R248Q [CLS]  and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R273C", "obj_type": "Var", "file_name": "PubMed-29970031.json", "snippet": " expression in cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of  [CLS] p53 mutants (R248Q and R273C [CLS] ) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q"}
{"subject": "R273C", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of p53 mutants (R248Q and  [CLS] R273C) in cell lines increased [CLS]  the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase"}
{"subject": "R248Q", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " cell lines harboring endogenous mtp53 compared with wt or null expression of p53 cell lines. Transfection of p53 mutants ( [CLS] R248Q and R273C) in cell lines increased [CLS]  the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase"}
{"subject": "HER2", "sub_type": "Protein", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-29970031.json", "snippet": " or null expression of p53 cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines increased the  [CLS] expression of HER2 [CLS] . Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the luciferase activity on"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " with wt or null expression of p53 cell lines. Transfection of p53 mutants (R248Q and R273C) in cell lines  [CLS] increased the expression [CLS]  of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the luciferase"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R248Q", "obj_type": "Var", "file_name": "PubMed-29970031.json", "snippet": " (R248Q and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The  [CLS] p53 mutants R248Q [CLS]  and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of H3"}
{"subject": "Mutant", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " [CLS] Mutant p53 gain of function [CLS]  induces HER2 over-expression in cancer cells.\nBACKGROUND: HER2 over-expression is related with a poor prognosis in patients with invasive"}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "R273C", "obj_type": "Var", "file_name": "PubMed-29970031.json", "snippet": " (R248Q and R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The  [CLS] p53 mutants R248Q and R273C [CLS]  significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of H3 and H4"}
{"subject": "R248Q", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants  [CLS] R248Q and R273C significantly increase [CLS]  the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding"}
{"subject": "R273C", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and  [CLS] R273C significantly increase [CLS]  the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding"}
{"subject": "luciferase", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-29970031.json", "snippet": " expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly increase the  [CLS] luciferase activity [CLS]  on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS:"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and R273C significantly  [CLS] increase the luciferase activity [CLS]  on the HER2 promoter, and both mutants also promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS:"}
{"subject": "H3", "sub_type": "Protein", "rel": "ThemeOf", "object": "binding", "obj_type": "Interaction", "file_name": "PubMed-29970031.json", "snippet": " R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of  [CLS] H3 and H4 histones binding [CLS]  in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants induce over-expression of HER2 at transcriptional"}
{"subject": "H4 histones", "sub_type": "Protein", "rel": "ThemeOf", "object": "binding", "obj_type": "Interaction", "file_name": "PubMed-29970031.json", "snippet": " R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote acetylation of H3 and  [CLS] H4 histones binding [CLS]  in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants induce over-expression of HER2 at transcriptional"}
{"subject": "binding", "sub_type": "Interaction", "rel": "ThemeOf", "object": "acetylation", "obj_type": "MPA", "file_name": "PubMed-29970031.json", "snippet": " p53 mutants R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote  [CLS] acetylation of H3 and H4 histones binding [CLS]  in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants induce over-expression of HER2 at transcriptional"}
{"subject": "acetylation", "sub_type": "MPA", "rel": "ThemeOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " The p53 mutants R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also  [CLS] promote acetylation [CLS]  of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants"}
{"subject": "R248Q", "sub_type": "Var", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " R273C) in cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants  [CLS] R248Q and R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote [CLS]  acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53"}
{"subject": "gain of function", "sub_type": "PosReg", "rel": "CauseOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-29970031.json", "snippet": " [CLS] gain of function induces [CLS]  HER2 over-expression in cancer cells.\nBACKGROUND: HER2 over-expression is related with a poor prognosis in patients with invasive breast"}
{"subject": "R273C", "sub_type": "Var", "rel": "CauseOf", "object": "promote", "obj_type": "PosReg", "file_name": "PubMed-29970031.json", "snippet": " cell lines increased the expression of HER2. Silencing of p53 mutants, decrease HER2 expression. The p53 mutants R248Q and  [CLS] R273C significantly increase the luciferase activity on the HER2 promoter, and both mutants also promote [CLS]  acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53"}
{"subject": "HER2", "sub_type": "Protein", "rel": "ThemeOf", "object": "over-expression", "obj_type": "MPA", "file_name": "PubMed-29970031.json", "snippet": " [CLS] HER2 over-expression [CLS]  in cancer cells.\nBACKGROUND: HER2 over-expression is related with a poor prognosis in patients with invasive breast cancer tumors."}
{"subject": "over-expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "induces", "obj_type": "Reg", "file_name": "PubMed-29970031.json", "snippet": " [CLS] induces HER2 over-expression [CLS]  in cancer cells.\nBACKGROUND: HER2 over-expression is related with a poor prognosis in patients with invasive breast cancer tumors."}
{"subject": "p53", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-29970031.json", "snippet": " promote acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that  [CLS] p53 mutants [CLS]  induce over-expression of HER2 at transcriptional level of the HER2 protein. Our results could have clinical implications in breast"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "induce", "obj_type": "Reg", "file_name": "PubMed-29970031.json", "snippet": " acetylation of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53  [CLS] mutants induce [CLS]  over-expression of HER2 at transcriptional level of the HER2 protein. Our results could have clinical implications in breast cancer"}
{"subject": "HER2", "sub_type": "Protein", "rel": "ThemeOf", "object": "over-expression", "obj_type": "MPA", "file_name": "PubMed-29970031.json", "snippet": " H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants induce  [CLS] over-expression of HER2 [CLS]  at transcriptional level of the HER2 protein. Our results could have clinical implications in breast cancer and other types"}
{"subject": "over-expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "induce", "obj_type": "Reg", "file_name": "PubMed-29970031.json", "snippet": " of H3 and H4 histones binding in it.\nCONCLUSIONS: These findings show for the first time that p53 mutants  [CLS] induce over-expression [CLS]  of HER2 at transcriptional level of the HER2 protein. Our results could have clinical implications in breast cancer and"}
{"subject": "SLC30A8", "sub_type": "Gene", "rel": "ThemeOf", "object": "R138X", "obj_type": "Var", "file_name": "PubMed-30038024.json", "snippet": " [CLS] SLC30A8 R138X [CLS]  loss-of-function mutation have increased insulin secretory capacity.\nSLC30A8 encodes a zinc transporter that is primarily expressed in the pancreatic"}
{"subject": "secrete insulin", "sub_type": "MPA", "rel": "ThemeOf", "object": "increasing", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " or mass. Our data suggest that the SLC30A8 R138X LOF mutation may exert beneficial effects on glucose metabolism by  [CLS] increasing the capacity of \u03b2-cells to secrete insulin [CLS]  under hyperglycemic conditions."}
{"subject": "increasing", "sub_type": "PosReg", "rel": "CauseOf", "object": "beneficial effects", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the SLC30A8 R138X LOF mutation may exert  [CLS] beneficial effects on glucose metabolism by increasing [CLS]  the capacity of \u03b2-cells to secrete insulin under hyperglycemic conditions."}
{"subject": "glucose metabolism", "sub_type": "MPA", "rel": "ThemeOf", "object": "beneficial effects", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the SLC30A8 R138X LOF mutation may exert  [CLS] beneficial effects on glucose metabolism [CLS]  by increasing the capacity of \u03b2-cells to secrete insulin under hyperglycemic conditions."}
{"subject": "R138X", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30038024.json", "snippet": " [CLS] R138X loss-of-function [CLS]  mutation have increased insulin secretory capacity.\nSLC30A8 encodes a zinc transporter that is primarily expressed in the pancreatic islets"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " [CLS] loss-of-function mutation have increased [CLS]  insulin secretory capacity.\nSLC30A8 encodes a zinc transporter that is primarily expressed in the pancreatic islets of Langerhans. In"}
{"subject": "insulin secretory capacity", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " [CLS] increased insulin secretory capacity [CLS] .\nSLC30A8 encodes a zinc transporter that is primarily expressed in the pancreatic islets of Langerhans. In \u03b2-cells it transports"}
{"subject": "R138X", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " weight, glucose tolerance, and pancreatic \u03b2-cell mass. Interestingly, in hyperglycemic conditions induced by the insulin receptor antagonist S961, the  [CLS] R138X mice showed a 50% increase [CLS]  in insulin secretion. This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the"}
{"subject": "insulin secretion", "sub_type": "MPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " \u03b2-cell mass. Interestingly, in hyperglycemic conditions induced by the insulin receptor antagonist S961, the R138X mice showed a 50%  [CLS] increase in insulin secretion [CLS] . This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the SLC30A8 R138X LOF"}
{"subject": "SLC30A8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-30038024.json", "snippet": " in insulin secretion. This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the  [CLS] SLC30A8 R138X LOF mutation [CLS]  may exert beneficial effects on glucose metabolism by increasing the capacity of \u03b2-cells to secrete insulin under hyperglycemic conditions."}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-30038024.json", "snippet": " secretion. This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the SLC30A8 R138X  [CLS] LOF mutation [CLS]  may exert beneficial effects on glucose metabolism by increasing the capacity of \u03b2-cells to secrete insulin under hyperglycemic conditions."}
{"subject": "LOF", "sub_type": "NegReg", "rel": "CauseOf", "object": "increasing", "obj_type": "PosReg", "file_name": "PubMed-30038024.json", "snippet": " secretion. This effect was not associated with enhanced \u03b2-cell proliferation or mass. Our data suggest that the SLC30A8 R138X  [CLS] LOF mutation may exert beneficial effects on glucose metabolism by increasing [CLS]  the capacity of \u03b2-cells to secrete insulin under hyperglycemic conditions."}
{"subject": "NOTCH3", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations in exon 33", "obj_type": "Var", "file_name": "PubMed-30042232.json", "snippet": "\nLateral meningocele syndrome (LMS) is a rare genetic disorder characterized by neurological complications and osteoporosis. LMS is associated with  [CLS] mutations in exon 33 of NOTCH3 [CLS]  leading to a truncated protein lacking sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function. To create"}
{"subject": "osteoblast proliferation", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the Notch3tm1.1Ecan mutation causes osteopenia despite an  [CLS] increase in osteoblast proliferation [CLS]  and function and is associated with enhanced Tnfsf11 expression in osteoblasts and osteocytes."}
{"subject": "function", "sub_type": "CPA", "rel": "ThemeOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the Notch3tm1.1Ecan mutation causes osteopenia despite an  [CLS] increase in osteoblast proliferation and function [CLS]  and is associated with enhanced Tnfsf11 expression in osteoblasts and osteocytes."}
{"subject": "Notch3tm1.1Ecan mutation", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the  [CLS] Notch3tm1.1Ecan mutation causes osteopenia despite an increase in osteoblast proliferation and function and is associated with enhanced [CLS]  Tnfsf11 expression in osteoblasts and osteocytes."}
{"subject": "Tnfsf11", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-30042232.json", "snippet": " conclusion, the Notch3tm1.1Ecan mutation causes osteopenia despite an increase in osteoblast proliferation and function and is associated with enhanced  [CLS] Tnfsf11 expression [CLS]  in osteoblasts and osteocytes."}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " In conclusion, the Notch3tm1.1Ecan mutation causes osteopenia despite an increase in osteoblast proliferation and function and is associated with  [CLS] enhanced Tnfsf11 expression [CLS]  in osteoblasts and osteocytes."}
{"subject": "Notch3tm1.1Ecan", "sub_type": "Var", "rel": "CauseOf", "object": "osteopenia", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " 6691-6696 (ACCAAG\u2192TAATGA) and verified this mutation (Notch3tm1.1Ecan ) by DNA sequencing of F1 mice. One-month-old male and female heterozygous  [CLS] Notch3tm1.1Ecan mice had cancellous and cortical bone osteopenia [CLS]  but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants"}
{"subject": "cancellous and cortical bone", "sub_type": "CPA", "rel": "ThemeOf", "object": "osteopenia", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " verified this mutation (Notch3tm1.1Ecan ) by DNA sequencing of F1 mice. One-month-old male and female heterozygous Notch3tm1.1Ecan mice had  [CLS] cancellous and cortical bone osteopenia [CLS]  but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " osteopenia but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these  [CLS] mutants revealed a 35-60% decrease in cancellous bone volume associated with a reduction [CLS]  in trabecular number and decreased connectivity. During maturation, cancellous and cortical bones were restored in female but not in"}
{"subject": "trabecular number", "sub_type": "CPA", "rel": "ThemeOf", "object": "reduction", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60% decrease in cancellous bone volume associated with a  [CLS] reduction in trabecular number [CLS]  and decreased connectivity. During maturation, cancellous and cortical bones were restored in female but not in male mice, which"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " osteopenia but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these  [CLS] mutants revealed a 35-60% decrease in cancellous bone volume associated with a reduction in trabecular number and decreased [CLS]  connectivity. During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous"}
{"subject": "mutations in exon 33", "sub_type": "Var", "rel": "CauseOf", "object": "truncated", "obj_type": "MPA", "file_name": "PubMed-30042232.json", "snippet": "\nLateral meningocele syndrome (LMS) is a rare genetic disorder characterized by neurological complications and osteoporosis. LMS is associated with  [CLS] mutations in exon 33 of NOTCH3 leading to a truncated [CLS]  protein lacking sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function. To create a mouse model reproducing"}
{"subject": "connectivity", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " of these mutants revealed a 35-60% decrease in cancellous bone volume associated with a reduction in trabecular number and  [CLS] decreased connectivity [CLS] . During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous bone"}
{"subject": "cancellous bone volume", "sub_type": "CPA", "rel": "ThemeOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60%  [CLS] decrease in cancellous bone volume [CLS]  associated with a reduction in trabecular number and decreased connectivity. During maturation, cancellous and cortical bones were restored in"}
{"subject": "reduction", "sub_type": "NegReg", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60%  [CLS] decrease in cancellous bone volume associated with a reduction [CLS]  in trabecular number and decreased connectivity. During maturation, cancellous and cortical bones were restored in female but not in"}
{"subject": "decreased", "sub_type": "NegReg", "rel": "CauseOf", "object": "decrease", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60%  [CLS] decrease in cancellous bone volume associated with a reduction in trabecular number and decreased [CLS]  connectivity. During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous"}
{"subject": "calvarial osteoblasts", "sub_type": "CPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate. Notch3tm1.1Ecan  [CLS] calvarial osteoblasts had increased [CLS]  proliferation and increased bone \u03b3-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower Tnfrsf11b levels."}
{"subject": "Notch3tm1.1Ecan", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " bone histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate.  [CLS] Notch3tm1.1Ecan calvarial osteoblasts had increased [CLS]  proliferation and increased bone \u03b3-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower Tnfrsf11b levels."}
{"subject": "Notch3tm1.1Ecan", "sub_type": "Var", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " bone histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate.  [CLS] Notch3tm1.1Ecan calvarial osteoblasts had increased proliferation and increased [CLS]  bone \u03b3-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower Tnfrsf11b levels. Tnfsf11 mRNA was"}
{"subject": "protein", "sub_type": "Protein", "rel": "ThemeOf", "object": "truncated", "obj_type": "MPA", "file_name": "PubMed-30042232.json", "snippet": " characterized by neurological complications and osteoporosis. LMS is associated with mutations in exon 33 of NOTCH3 leading to a  [CLS] truncated protein [CLS]  lacking sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function. To create a mouse model reproducing human"}
{"subject": "bone \u03b3-carboxyglutamate protein (Bglap)", "sub_type": "Protein", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " numbers and a modest increase in osteoclast surface and bone formation rate. Notch3tm1.1Ecan calvarial osteoblasts had increased proliferation and  [CLS] increased bone \u03b3-carboxyglutamate protein (Bglap) [CLS]  and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora"}
{"subject": "TNF superfamily member 11 (Tnfsf11)", "sub_type": "Gene", "rel": "ThemeOf", "object": "mRNA levels", "obj_type": "MPA", "file_name": "PubMed-30042232.json", "snippet": " osteoclast surface and bone formation rate. Notch3tm1.1Ecan calvarial osteoblasts had increased proliferation and increased bone \u03b3-carboxyglutamate protein (Bglap) and  [CLS] TNF superfamily member 11 (Tnfsf11) mRNA levels [CLS]  and lower Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages"}
{"subject": "mRNA levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " numbers and a modest increase in osteoclast surface and bone formation rate. Notch3tm1.1Ecan calvarial osteoblasts had increased proliferation and  [CLS] increased bone \u03b3-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels [CLS]  and lower Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages"}
{"subject": "Notch3tm1.1Ecan", "sub_type": "Var", "rel": "CauseOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " bone histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate.  [CLS] Notch3tm1.1Ecan calvarial osteoblasts had increased proliferation and increased bone \u03b3-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower [CLS]  Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan"}
{"subject": "Tnfrsf11b levels", "sub_type": "MPA", "rel": "ThemeOf", "object": "lower", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " osteoblasts had increased proliferation and increased bone \u03b3-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and  [CLS] lower Tnfrsf11b levels [CLS] . Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan mice revealed"}
{"subject": "truncated", "sub_type": "MPA", "rel": "CauseOf", "object": "lacking", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " characterized by neurological complications and osteoporosis. LMS is associated with mutations in exon 33 of NOTCH3 leading to a  [CLS] truncated protein lacking [CLS]  sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function. To create a mouse model reproducing human LMS-associated"}
{"subject": "sequences for NOTCH3 degradation", "sub_type": "MPA", "rel": "ThemeOf", "object": "lacking", "obj_type": "NegReg", "file_name": "PubMed-30042232.json", "snippet": " neurological complications and osteoporosis. LMS is associated with mutations in exon 33 of NOTCH3 leading to a truncated protein  [CLS] lacking sequences for NOTCH3 degradation [CLS]  and presumably causing NOTCH3 gain of function. To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9"}
{"subject": "mutations in exon 33", "sub_type": "Var", "rel": "CauseOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": "\nLateral meningocele syndrome (LMS) is a rare genetic disorder characterized by neurological complications and osteoporosis. LMS is associated with  [CLS] mutations in exon 33 of NOTCH3 leading to a truncated protein lacking sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function [CLS] . To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9 to introduce a tandem termination codon at"}
{"subject": "NOTCH3", "sub_type": "Gene", "rel": "ThemeOf", "object": "gain of function", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " mutations in exon 33 of NOTCH3 leading to a truncated protein lacking sequences for NOTCH3 degradation and presumably causing  [CLS] NOTCH3 gain of function [CLS] . To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9 to introduce a tandem termination codon at"}
{"subject": "Notch3tm1.1Ecan mutation", "sub_type": "Var", "rel": "CauseOf", "object": "osteopenia", "obj_type": "Disease", "file_name": "PubMed-30042232.json", "snippet": " macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the  [CLS] Notch3tm1.1Ecan mutation causes osteopenia [CLS]  despite an increase in osteoblast proliferation and function and is associated with enhanced Tnfsf11 expression in osteoblasts and osteocytes."}
{"subject": "Notch3tm1.1Ecan mutation", "sub_type": "Var", "rel": "CauseOf", "object": "increase", "obj_type": "PosReg", "file_name": "PubMed-30042232.json", "snippet": " macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the  [CLS] Notch3tm1.1Ecan mutation causes osteopenia despite an increase [CLS]  in osteoblast proliferation and function and is associated with enhanced Tnfsf11 expression in osteoblasts and osteocytes."}
{"subject": "ABCC8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-30068891.json", "snippet": " gain-of-function mutation in the ATP-binding cassette subfamily C member 8 (ABCC8) gene.\nGain-of-function ATP-binding cassette subfamily C member 8 ( [CLS] ABCC8) mutations [CLS]  are known to cause neonatal diabetes mellitus and maturity-onset diabetes in the young. However, the intrafamilial heterogeneous nature of"}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-30068891.json", "snippet": " of diabetes in a family with a gain-of-function mutation in the ATP-binding cassette subfamily C member 8 (ABCC8) gene.\n [CLS] Gain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations [CLS]  are known to cause neonatal diabetes mellitus and maturity-onset diabetes in the young. However, the intrafamilial heterogeneous nature of"}
{"subject": "Gain-of-function", "sub_type": "PosReg", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30068891.json", "snippet": " of diabetes in a family with a gain-of-function mutation in the ATP-binding cassette subfamily C member 8 (ABCC8) gene.\n [CLS] Gain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations are known to cause [CLS]  neonatal diabetes mellitus and maturity-onset diabetes in the young. However, the intrafamilial heterogeneous nature of diabetes caused by the"}
{"subject": "neonatal diabetes mellitus", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30068891.json", "snippet": " cassette subfamily C member 8 (ABCC8) gene.\nGain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations are known to  [CLS] cause neonatal diabetes mellitus [CLS]  and maturity-onset diabetes in the young. However, the intrafamilial heterogeneous nature of diabetes caused by the ABCC8 mutation is"}
{"subject": "maturity-onset diabetes", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30068891.json", "snippet": " cassette subfamily C member 8 (ABCC8) gene.\nGain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations are known to  [CLS] cause neonatal diabetes mellitus and maturity-onset diabetes [CLS]  in the young. However, the intrafamilial heterogeneous nature of diabetes caused by the ABCC8 mutation is not fully understood"}
{"subject": "ABCC8", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-30068891.json", "snippet": " [CLS] mutation in the ATP-binding cassette subfamily C member 8 (ABCC8 [CLS] ) gene.\nGain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations are known to cause neonatal diabetes mellitus and maturity-onset"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-30068891.json", "snippet": " [CLS] gain-of-function mutation [CLS]  in the ATP-binding cassette subfamily C member 8 (ABCC8) gene.\nGain-of-function ATP-binding cassette subfamily C member 8 (ABCC8) mutations"}
{"subject": "diabetes", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-30068891.json", "snippet": " [CLS] diabetes in a family with a gain-of-function [CLS]  mutation in the ATP-binding cassette subfamily C member 8 (ABCC8) gene.\nGain-of-function ATP-binding cassette subfamily C member 8 (ABCC8)"}
{"subject": "ERBB2", "sub_type": "Gene", "rel": "ThemeOf", "object": "point mutations", "obj_type": "Var", "file_name": "PubMed-30094493.json", "snippet": " human epidermal growth factor receptor 2 (HER2) gene mutation in bone metastases from breast cancer.\nIn addition to amplification,  [CLS] point mutations of the human epidermal growth factor receptor 2 (HER2) gene (ERBB2 [CLS] ) have been shown to activate the corresponding signaling pathway in breast cancer. The prevalence of ERBB2/HER2 mutation in bone"}
{"subject": "point mutations", "sub_type": "Var", "rel": "CauseOf", "object": "activate", "obj_type": "PosReg", "file_name": "PubMed-30094493.json", "snippet": " human epidermal growth factor receptor 2 (HER2) gene mutation in bone metastases from breast cancer.\nIn addition to amplification,  [CLS] point mutations of the human epidermal growth factor receptor 2 (HER2) gene (ERBB2) have been shown to activate [CLS]  the corresponding signaling pathway in breast cancer. The prevalence of ERBB2/HER2 mutation in bone metastasis of breast cancer and"}
{"subject": "signaling pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "activate", "obj_type": "PosReg", "file_name": "PubMed-30094493.json", "snippet": " to amplification, point mutations of the human epidermal growth factor receptor 2 (HER2) gene (ERBB2) have been shown to  [CLS] activate the corresponding signaling pathway [CLS]  in breast cancer. The prevalence of ERBB2/HER2 mutation in bone metastasis of breast cancer and the associated phenotype are"}
{"subject": "breast cancer", "sub_type": "Disease", "rel": "ThemeOf", "object": "signaling pathway", "obj_type": "Pathway", "file_name": "PubMed-30094493.json", "snippet": " mutations of the human epidermal growth factor receptor 2 (HER2) gene (ERBB2) have been shown to activate the corresponding  [CLS] signaling pathway in breast cancer [CLS] . The prevalence of ERBB2/HER2 mutation in bone metastasis of breast cancer and the associated phenotype are not known. In"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "activating", "obj_type": "PosReg", "file_name": "PubMed-30094493.json", "snippet": " with estrogen receptor gene (ESR1) mutation, conveying resistance against aromatase inhibitors, no concomitant ERBB2/HER2 mutation occurred. We conclude that  [CLS] activating HER2 mutation [CLS]  is present in about 3% of bone metastases from breast cancers, with significantly higher rates in the pleomorphic subtype"}
{"subject": "activating", "sub_type": "PosReg", "rel": "CauseOf", "object": "higher rates", "obj_type": "PosReg", "file_name": "PubMed-30094493.json", "snippet": " with estrogen receptor gene (ESR1) mutation, conveying resistance against aromatase inhibitors, no concomitant ERBB2/HER2 mutation occurred. We conclude that  [CLS] activating HER2 mutation is present in about 3% of bone metastases from breast cancers, with significantly higher rates [CLS]  in the pleomorphic subtype of lobular cancer. Since mutated cases appear to be HER2-negative by conventional testing, the opportunity"}
{"subject": "breast cancers", "sub_type": "Disease", "rel": "ThemeOf", "object": "bone metastases", "obj_type": "CPA", "file_name": "PubMed-30094493.json", "snippet": " aromatase inhibitors, no concomitant ERBB2/HER2 mutation occurred. We conclude that activating HER2 mutation is present in about 3% of  [CLS] bone metastases from breast cancers [CLS] , with significantly higher rates in the pleomorphic subtype of lobular cancer. Since mutated cases appear to be HER2-negative by"}
{"subject": "bone metastases", "sub_type": "CPA", "rel": "ThemeOf", "object": "higher rates", "obj_type": "PosReg", "file_name": "PubMed-30094493.json", "snippet": " aromatase inhibitors, no concomitant ERBB2/HER2 mutation occurred. We conclude that activating HER2 mutation is present in about 3% of  [CLS] bone metastases from breast cancers, with significantly higher rates [CLS]  in the pleomorphic subtype of lobular cancer. Since mutated cases appear to be HER2-negative by conventional testing, the opportunity"}
{"subject": "HER2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-30094493.json", "snippet": " estrogen receptor gene (ESR1) mutation, conveying resistance against aromatase inhibitors, no concomitant ERBB2/HER2 mutation occurred. We conclude that activating  [CLS] HER2 mutation [CLS]  is present in about 3% of bone metastases from breast cancers, with significantly higher rates in the pleomorphic subtype"}
{"subject": "PINK1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutant", "obj_type": "Var", "file_name": "PubMed-30185553.json", "snippet": " regulates mitochondrial Ca2+ (mito-Ca2+) homeostasis in dopaminergic (DA) neurons, and that the PD-associated PINK1 protein modulates this process. In  [CLS] PINK1 mutant [CLS]  DA neurons, the ERMCS is strengthened and mito-Ca2+ level is elevated, resulting in mitochondrial enlargement and neuronal death. Miro,"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "strengthened", "obj_type": "PosReg", "file_name": "PubMed-30185553.json", "snippet": " mitochondrial Ca2+ (mito-Ca2+) homeostasis in dopaminergic (DA) neurons, and that the PD-associated PINK1 protein modulates this process. In PINK1  [CLS] mutant DA neurons, the ERMCS is strengthened [CLS]  and mito-Ca2+ level is elevated, resulting in mitochondrial enlargement and neuronal death. Miro, a well-characterized component of the mitochondrial"}
{"subject": "mutant", "sub_type": "Var", "rel": "CauseOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-30185553.json", "snippet": " mitochondrial Ca2+ (mito-Ca2+) homeostasis in dopaminergic (DA) neurons, and that the PD-associated PINK1 protein modulates this process. In PINK1  [CLS] mutant DA neurons, the ERMCS is strengthened and mito-Ca2+ level is elevated [CLS] , resulting in mitochondrial enlargement and neuronal death. Miro, a well-characterized component of the mitochondrial trafficking machinery, mediates the effects"}
{"subject": "elevated", "sub_type": "PosReg", "rel": "CauseOf", "object": "enlargement", "obj_type": "PosReg", "file_name": "PubMed-30185553.json", "snippet": " PD-associated PINK1 protein modulates this process. In PINK1 mutant DA neurons, the ERMCS is strengthened and mito-Ca2+ level is  [CLS] elevated, resulting in mitochondrial enlargement [CLS]  and neuronal death. Miro, a well-characterized component of the mitochondrial trafficking machinery, mediates the effects of PINK1 on mito-Ca2+"}
{"subject": "ERMCS", "sub_type": "MPA", "rel": "ThemeOf", "object": "strengthened", "obj_type": "PosReg", "file_name": "PubMed-30185553.json", "snippet": " in dopaminergic (DA) neurons, and that the PD-associated PINK1 protein modulates this process. In PINK1 mutant DA neurons, the  [CLS] ERMCS is strengthened [CLS]  and mito-Ca2+ level is elevated, resulting in mitochondrial enlargement and neuronal death. Miro, a well-characterized component of the mitochondrial"}
{"subject": "mito-Ca2+ level", "sub_type": "MPA", "rel": "ThemeOf", "object": "elevated", "obj_type": "PosReg", "file_name": "PubMed-30185553.json", "snippet": " and that the PD-associated PINK1 protein modulates this process. In PINK1 mutant DA neurons, the ERMCS is strengthened and  [CLS] mito-Ca2+ level is elevated [CLS] , resulting in mitochondrial enlargement and neuronal death. Miro, a well-characterized component of the mitochondrial trafficking machinery, mediates the effects"}
{"subject": "mitochondrial", "sub_type": "MPA", "rel": "ThemeOf", "object": "enlargement", "obj_type": "PosReg", "file_name": "PubMed-30185553.json", "snippet": " modulates this process. In PINK1 mutant DA neurons, the ERMCS is strengthened and mito-Ca2+ level is elevated, resulting in  [CLS] mitochondrial enlargement [CLS]  and neuronal death. Miro, a well-characterized component of the mitochondrial trafficking machinery, mediates the effects of PINK1 on mito-Ca2+"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Variant", "obj_type": "Var", "file_name": "PubMed-30187709.json", "snippet": " [CLS] STAT1 Gain-of-Function Variant [CLS] : First Case in Korea.\nBronchiectasis is a chronic disease characterized by airway infection and inflammation, leading to permanent dilation"}
{"subject": "c.800C>T", "sub_type": "Var", "rel": "CauseOf", "object": "revealed", "obj_type": "Reg", "file_name": "PubMed-30187709.json", "snippet": " 24-year-old female presented with recurrent respiratory bacterial and nontuberculous mycobacterial infections complicated by severe bronchiectasis and CMC. Whole-exome sequencing  [CLS] revealed a c.800C>T [CLS]  (p.Ala267Val) heterozygous mutation in the STAT1 gene. Further analysis by Sanger sequencing of STAT1 from the patient and her"}
{"subject": "respiratory bacterial and nontuberculous mycobacterial infections", "sub_type": "Disease", "rel": "ThemeOf", "object": "revealed", "obj_type": "Reg", "file_name": "PubMed-30187709.json", "snippet": " various types of infections who carried a pathogenic variant of the STAT1 gene. The 24-year-old female presented with recurrent  [CLS] respiratory bacterial and nontuberculous mycobacterial infections complicated by severe bronchiectasis and CMC. Whole-exome sequencing revealed [CLS]  a c.800C>T (p.Ala267Val) heterozygous mutation in the STAT1 gene. Further analysis by Sanger sequencing of STAT1 from the patient"}
{"subject": "bronchiectasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "revealed", "obj_type": "Reg", "file_name": "PubMed-30187709.json", "snippet": " of the STAT1 gene. The 24-year-old female presented with recurrent respiratory bacterial and nontuberculous mycobacterial infections complicated by severe  [CLS] bronchiectasis and CMC. Whole-exome sequencing revealed [CLS]  a c.800C>T (p.Ala267Val) heterozygous mutation in the STAT1 gene. Further analysis by Sanger sequencing of STAT1 from the patient"}
{"subject": "CMC", "sub_type": "Disease", "rel": "ThemeOf", "object": "revealed", "obj_type": "Reg", "file_name": "PubMed-30187709.json", "snippet": " STAT1 gene. The 24-year-old female presented with recurrent respiratory bacterial and nontuberculous mycobacterial infections complicated by severe bronchiectasis and  [CLS] CMC. Whole-exome sequencing revealed [CLS]  a c.800C>T (p.Ala267Val) heterozygous mutation in the STAT1 gene. Further analysis by Sanger sequencing of STAT1 from the patient"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "alleles", "obj_type": "Var", "file_name": "PubMed-30187709.json", "snippet": " transcription 1 (STAT1) protein plays a key role in STAT signaling and immune system regulation. Heterozygotes for gain-of-function (GOF)  [CLS] alleles of the STAT1 [CLS]  gene usually display autosomal dominant chronic mucocutaneous candidiasis (CMC) and a wide range of clinical features, such as bronchiectasis."}
{"subject": "alleles", "sub_type": "Var", "rel": "CauseOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-30187709.json", "snippet": " activator of transcription 1 (STAT1) protein plays a key role in STAT signaling and immune system regulation. Heterozygotes for  [CLS] gain-of-function (GOF) alleles [CLS]  of the STAT1 gene usually display autosomal dominant chronic mucocutaneous candidiasis (CMC) and a wide range of clinical features,"}
{"subject": "autosomal dominant chronic mucocutaneous candidiasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-30187709.json", "snippet": " activator of transcription 1 (STAT1) protein plays a key role in STAT signaling and immune system regulation. Heterozygotes for  [CLS] gain-of-function (GOF) alleles of the STAT1 gene usually display autosomal dominant chronic mucocutaneous candidiasis [CLS]  (CMC) and a wide range of clinical features, such as bronchiectasis. Here, we report on a patient with CMC"}
{"subject": "bronchiectasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "gain-of-function", "obj_type": "PosReg", "file_name": "PubMed-30187709.json", "snippet": " activator of transcription 1 (STAT1) protein plays a key role in STAT signaling and immune system regulation. Heterozygotes for  [CLS] gain-of-function (GOF) alleles of the STAT1 gene usually display autosomal dominant chronic mucocutaneous candidiasis (CMC) and a wide range of clinical features, such as bronchiectasis [CLS] . Here, we report on a patient with CMC and bronchiectasis with various types of infections who carried a pathogenic"}
{"subject": "Variant", "sub_type": "Var", "rel": "CauseOf", "object": "Gain-of-Function", "obj_type": "PosReg", "file_name": "PubMed-30187709.json", "snippet": " [CLS] Gain-of-Function Variant [CLS] : First Case in Korea.\nBronchiectasis is a chronic disease characterized by airway infection and inflammation, leading to permanent dilation"}
{"subject": "Bronchiectasis", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-Function", "obj_type": "PosReg", "file_name": "PubMed-30187709.json", "snippet": " [CLS] Bronchiectasis and Recurrent Respiratory Infections with a De Novo STAT1 Gain-of-Function [CLS]  Variant: First Case in Korea.\nBronchiectasis is a chronic disease characterized by airway infection and inflammation, leading to permanent"}
{"subject": "Recurrent Respiratory Infections", "sub_type": "Disease", "rel": "ThemeOf", "object": "Gain-of-Function", "obj_type": "PosReg", "file_name": "PubMed-30187709.json", "snippet": " [CLS] Recurrent Respiratory Infections with a De Novo STAT1 Gain-of-Function [CLS]  Variant: First Case in Korea.\nBronchiectasis is a chronic disease characterized by airway infection and inflammation, leading to permanent"}
{"subject": "STAT1", "sub_type": "Gene", "rel": "ThemeOf", "object": "c.800C>T", "obj_type": "Var", "file_name": "PubMed-30187709.json", "snippet": " presented with recurrent respiratory bacterial and nontuberculous mycobacterial infections complicated by severe bronchiectasis and CMC. Whole-exome sequencing revealed a  [CLS] c.800C>T (p.Ala267Val) heterozygous mutation in the STAT1 [CLS]  gene. Further analysis by Sanger sequencing of STAT1 from the patient and her parents revealed the patient had a"}
{"subject": "SOD1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Mutations", "obj_type": "Var", "file_name": "PubMed-30296255.json", "snippet": " ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration.\n [CLS] Mutations in Cu/Zn superoxide dismutase 1 (SOD1 [CLS] ) lead to Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease that disproportionately affects glutamatergic and cholinergic motor neurons. Previous work"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-30296255.json", "snippet": " ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration.\n [CLS] Mutations in Cu/Zn superoxide dismutase 1 (SOD1) lead to [CLS]  Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease that disproportionately affects glutamatergic and cholinergic motor neurons. Previous work with SOD1"}
{"subject": "Amyotrophic Lateral Sclerosis", "sub_type": "Disease", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-30296255.json", "snippet": " and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration.\nMutations in Cu/Zn superoxide dismutase 1 (SOD1)  [CLS] lead to Amyotrophic Lateral Sclerosis [CLS]  (ALS), a neurodegenerative disease that disproportionately affects glutamatergic and cholinergic motor neurons. Previous work with SOD1 overexpression models supports"}
{"subject": "CYBC1", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutation", "obj_type": "Var", "file_name": "PubMed-30361506.json", "snippet": " [CLS] mutation leading to CYBC1 [CLS]  deficiency causes chronic granulomatous disease.\nMutations in genes encoding subunits of the phagocyte NADPH oxidase complex are recognized to"}
{"subject": "chronic granulomatous disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30361506.json", "snippet": " [CLS] loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease [CLS] .\nMutations in genes encoding subunits of the phagocyte NADPH oxidase complex are recognized to cause chronic granulomatous disease (CGD),"}
{"subject": "CYBC1", "sub_type": "Gene", "rel": "ThemeOf", "object": "p.Tyr2Ter", "obj_type": "Var", "file_name": "PubMed-30361506.json", "snippet": " main subunit (gp91phox) and results in CGD. Analyzing two brothers diagnosed with CGD we identify a homozygous loss-of-function mutation,  [CLS] p.Tyr2Ter, in CYBC1 [CLS] . Imputation of p.Tyr2Ter into 155K chip-genotyped Icelanders reveals six additional homozygotes, all with signs of CGD, manifesting as colitis,"}
{"subject": "p.Tyr2Ter", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30361506.json", "snippet": " NADPH oxidase's main subunit (gp91phox) and results in CGD. Analyzing two brothers diagnosed with CGD we identify a homozygous  [CLS] loss-of-function mutation, p.Tyr2Ter [CLS] , in CYBC1. Imputation of p.Tyr2Ter into 155K chip-genotyped Icelanders reveals six additional homozygotes, all with signs of CGD, manifesting"}
{"subject": "p.Tyr2Ter", "sub_type": "Var", "rel": "CauseOf", "object": "associates with", "obj_type": "Reg", "file_name": "PubMed-30361506.json", "snippet": " with signs of CGD, manifesting as colitis, rare infections, or a severely impaired PMA-induced neutrophil oxidative burst. Homozygosity for  [CLS] p.Tyr2Ter consequently associates with [CLS]  inflammatory bowel disease (IBD) in Iceland (P\u2009=\u20098.3\u2009\u00d7\u200910-8; OR\u2009=\u200967.6), as well as reduced height (P\u2009=\u20093.3\u2009\u00d7\u200910-4; -8.5\u2009cm). Overall, we find that"}
{"subject": "inflammatory bowel disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "associates with", "obj_type": "Reg", "file_name": "PubMed-30361506.json", "snippet": " of CGD, manifesting as colitis, rare infections, or a severely impaired PMA-induced neutrophil oxidative burst. Homozygosity for p.Tyr2Ter consequently  [CLS] associates with inflammatory bowel disease [CLS]  (IBD) in Iceland (P\u2009=\u20098.3\u2009\u00d7\u200910-8; OR\u2009=\u200967.6), as well as reduced height (P\u2009=\u20093.3\u2009\u00d7\u200910-4; -8.5\u2009cm). Overall, we find that CYBC1 deficiency results"}
{"subject": "mutation", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30361506.json", "snippet": " [CLS] loss-of-function mutation [CLS]  leading to CYBC1 deficiency causes chronic granulomatous disease.\nMutations in genes encoding subunits of the phagocyte NADPH oxidase complex"}
{"subject": "Mutations", "sub_type": "Var", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30361506.json", "snippet": " [CLS] Mutations in genes encoding subunits of the phagocyte NADPH oxidase complex are recognized to cause [CLS]  chronic granulomatous disease (CGD), a severe primary immunodeficiency. Here we describe how deficiency of CYBC1, a previously uncharacterized protein"}
{"subject": "chronic granulomatous disease", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30361506.json", "snippet": " deficiency causes chronic granulomatous disease.\nMutations in genes encoding subunits of the phagocyte NADPH oxidase complex are recognized to  [CLS] cause chronic granulomatous disease [CLS]  (CGD), a severe primary immunodeficiency. Here we describe how deficiency of CYBC1, a previously uncharacterized protein in humans (C17orf62),"}
{"subject": "single amino acid mutation", "sub_type": "Var", "rel": "CauseOf", "object": "conformational change", "obj_type": "MPA", "file_name": "PubMed-30388729.json", "snippet": " conformational change on the substrate-binding site in the ZEP. A comparative analysis of the ZEP structures suggested that the  [CLS] conformational change induced by a single amino acid mutation [CLS]  might impact the interaction between the substrate and substrate-binding site, resulting in loss of zeaxanthin epoxidase function."}
{"subject": "glycine to aspartate in a highly conserved region in the catalytic domain", "sub_type": "MPA", "rel": "ThemeOf", "object": "change", "obj_type": "Reg", "file_name": "PubMed-30388729.json", "snippet": " point mutation of the 1337th nucleotide of the ZEP sequence (a change from guanine to adenine), resulting in a  [CLS] change of glycine to aspartate in a highly conserved region in the catalytic domain [CLS] . Similar expression levels of ZEP mRNA and protein in both wild-type and zea1 were confirmed by using qRT-PCR and"}
{"subject": "ZEP", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "conformational change", "obj_type": "MPA", "file_name": "PubMed-30388729.json", "snippet": " of zea1, we observed a conformational change on the substrate-binding site in the ZEP. A comparative analysis of the  [CLS] ZEP structures suggested that the conformational change [CLS]  induced by a single amino acid mutation might impact the interaction between the substrate and substrate-binding site, resulting in"}
{"subject": "conformational change", "sub_type": "MPA", "rel": "CauseOf", "object": "impact", "obj_type": "NegReg", "file_name": "PubMed-30388729.json", "snippet": " conformational change on the substrate-binding site in the ZEP. A comparative analysis of the ZEP structures suggested that the  [CLS] conformational change induced by a single amino acid mutation might impact [CLS]  the interaction between the substrate and substrate-binding site, resulting in loss of zeaxanthin epoxidase function."}
{"subject": "interaction between the substrate and substrate-binding site", "sub_type": "Interaction", "rel": "ThemeOf", "object": "impact", "obj_type": "NegReg", "file_name": "PubMed-30388729.json", "snippet": " comparative analysis of the ZEP structures suggested that the conformational change induced by a single amino acid mutation might  [CLS] impact the interaction between the substrate and substrate-binding site [CLS] , resulting in loss of zeaxanthin epoxidase function."}
{"subject": "impact", "sub_type": "NegReg", "rel": "CauseOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-30388729.json", "snippet": " comparative analysis of the ZEP structures suggested that the conformational change induced by a single amino acid mutation might  [CLS] impact the interaction between the substrate and substrate-binding site, resulting in loss [CLS]  of zeaxanthin epoxidase function."}
{"subject": "zeaxanthin epoxidase", "sub_type": "Enzyme", "rel": "ThemeOf", "object": "function", "obj_type": "MPA", "file_name": "PubMed-30388729.json", "snippet": " a single amino acid mutation might impact the interaction between the substrate and substrate-binding site, resulting in loss of  [CLS] zeaxanthin epoxidase function [CLS] ."}
{"subject": "function", "sub_type": "MPA", "rel": "ThemeOf", "object": "loss", "obj_type": "NegReg", "file_name": "PubMed-30388729.json", "snippet": " induced by a single amino acid mutation might impact the interaction between the substrate and substrate-binding site, resulting in  [CLS] loss of zeaxanthin epoxidase function [CLS] ."}
{"subject": "ZEP", "sub_type": "Gene", "rel": "ThemeOf", "object": "point mutation", "obj_type": "Var", "file_name": "PubMed-30388729.json", "snippet": " the ZEP gene from both wild-type D. tertiolecta and the mutant. We found that the zea1 mutant has a  [CLS] point mutation of the 1337th nucleotide of the ZEP [CLS]  sequence (a change from guanine to adenine), resulting in a change of glycine to aspartate in a highly conserved"}
{"subject": "point mutation", "sub_type": "Var", "rel": "CauseOf", "object": "change", "obj_type": "Reg", "file_name": "PubMed-30388729.json", "snippet": " the ZEP gene from both wild-type D. tertiolecta and the mutant. We found that the zea1 mutant has a  [CLS] point mutation of the 1337th nucleotide of the ZEP sequence (a change from guanine to adenine), resulting in a change [CLS]  of glycine to aspartate in a highly conserved region in the catalytic domain. Similar expression levels of ZEP mRNA"}
{"subject": "LZTR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "inactivation", "obj_type": "Var", "file_name": "PubMed-30442766.json", "snippet": " of RAS ubiquitination and signaling.\nIn genetic screens aimed at understanding drug resistance mechanisms in chronic myeloid leukemia cells,  [CLS] inactivation of the cullin 3 adapter protein-encoding leucine zipper-like transcription regulator 1 (LZTR1 [CLS] ) gene led to enhanced mitogen-activated protein kinase (MAPK) pathway activity and reduced sensitivity to tyrosine kinase inhibitors. Knockdown of"}
{"subject": "Inactivation", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30442766.json", "snippet": " Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms.  [CLS] Inactivation of LZTR1 led to decreased ubiquitination and enhanced [CLS]  plasma membrane localization of endogenous KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog). We propose that LZTR1 acts as"}
{"subject": "plasma membrane localization", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30442766.json", "snippet": " gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms. Inactivation of LZTR1 led to decreased ubiquitination and  [CLS] enhanced plasma membrane localization [CLS]  of endogenous KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog). We propose that LZTR1 acts as a conserved regulator"}
{"subject": "inactivation", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30442766.json", "snippet": " of RAS ubiquitination and signaling.\nIn genetic screens aimed at understanding drug resistance mechanisms in chronic myeloid leukemia cells,  [CLS] inactivation of the cullin 3 adapter protein-encoding leucine zipper-like transcription regulator 1 (LZTR1) gene led to enhanced [CLS]  mitogen-activated protein kinase (MAPK) pathway activity and reduced sensitivity to tyrosine kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30442766.json", "snippet": " myeloid leukemia cells, inactivation of the cullin 3 adapter protein-encoding leucine zipper-like transcription regulator 1 (LZTR1) gene led to  [CLS] enhanced mitogen-activated protein kinase (MAPK) pathway activity [CLS]  and reduced sensitivity to tyrosine kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function"}
{"subject": "mitogen-activated protein kinase (MAPK) pathway", "sub_type": "Pathway", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-30442766.json", "snippet": " leukemia cells, inactivation of the cullin 3 adapter protein-encoding leucine zipper-like transcription regulator 1 (LZTR1) gene led to enhanced  [CLS] mitogen-activated protein kinase (MAPK) pathway activity [CLS]  and reduced sensitivity to tyrosine kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function"}
{"subject": "inactivation", "sub_type": "Var", "rel": "CauseOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-30442766.json", "snippet": " of RAS ubiquitination and signaling.\nIn genetic screens aimed at understanding drug resistance mechanisms in chronic myeloid leukemia cells,  [CLS] inactivation of the cullin 3 adapter protein-encoding leucine zipper-like transcription regulator 1 (LZTR1) gene led to enhanced mitogen-activated protein kinase (MAPK) pathway activity and reduced [CLS]  sensitivity to tyrosine kinase inhibitors. Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous"}
{"subject": "sensitivity to tyrosine kinase inhibitors", "sub_type": "MPA", "rel": "ThemeOf", "object": "reduced", "obj_type": "NegReg", "file_name": "PubMed-30442766.json", "snippet": " adapter protein-encoding leucine zipper-like transcription regulator 1 (LZTR1) gene led to enhanced mitogen-activated protein kinase (MAPK) pathway activity and  [CLS] reduced sensitivity to tyrosine kinase inhibitors [CLS] . Knockdown of the Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the"}
{"subject": "LZTR1", "sub_type": "Gene", "rel": "ThemeOf", "object": "Inactivation", "obj_type": "Var", "file_name": "PubMed-30442766.json", "snippet": " Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms.  [CLS] Inactivation of LZTR1 [CLS]  led to decreased ubiquitination and enhanced plasma membrane localization of endogenous KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog)."}
{"subject": "Inactivation", "sub_type": "Var", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-30442766.json", "snippet": " Drosophila LZTR1 ortholog CG3711 resulted in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms.  [CLS] Inactivation of LZTR1 led to decreased [CLS]  ubiquitination and enhanced plasma membrane localization of endogenous KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog). We propose that"}
{"subject": "ubiquitination", "sub_type": "MPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-30442766.json", "snippet": " in a Ras-dependent gain-of-function phenotype. Endogenous human LZTR1 associates with the main RAS isoforms. Inactivation of LZTR1 led to  [CLS] decreased ubiquitination [CLS]  and enhanced plasma membrane localization of endogenous KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog). We propose that LZTR1"}
{"subject": "TTN", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-30535219.json", "snippet": " participants (odds ratio [OR], 1.76 [95% CI, 1.04-2.97]). The proportion of individuals with early-onset AF who carried a LOF  [CLS] variant in TTN [CLS]  increased with an earlier age of AF onset (P value for trend, 4.92\u2009\u00d7\u200910-4), and 6.5% of individuals with AF"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "PosReg", "file_name": "PubMed-30535219.json", "snippet": " control participants (odds ratio [OR], 1.76 [95% CI, 1.04-2.97]). The proportion of individuals with early-onset AF who carried a  [CLS] LOF variant [CLS]  in TTN increased with an earlier age of AF onset (P value for trend, 4.92\u2009\u00d7\u200910-4), and 6.5% of individuals"}
{"subject": "LOF", "sub_type": "PosReg", "rel": "CauseOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30535219.json", "snippet": " control participants (odds ratio [OR], 1.76 [95% CI, 1.04-2.97]). The proportion of individuals with early-onset AF who carried a  [CLS] LOF variant in TTN increased [CLS]  with an earlier age of AF onset (P value for trend, 4.92\u2009\u00d7\u200910-4), and 6.5% of individuals with AF onset"}
{"subject": "early-onset AF", "sub_type": "Disease", "rel": "ThemeOf", "object": "increased", "obj_type": "PosReg", "file_name": "PubMed-30535219.json", "snippet": " participants compared with 1.1% in control participants (odds ratio [OR], 1.76 [95% CI, 1.04-2.97]). The proportion of individuals with  [CLS] early-onset AF who carried a LOF variant in TTN increased [CLS]  with an earlier age of AF onset (P value for trend, 4.92\u2009\u00d7\u200910-4), and 6.5% of individuals with AF onset"}
{"subject": "TTN", "sub_type": "Gene", "rel": "ThemeOf", "object": "variant", "obj_type": "Var", "file_name": "PubMed-30535219.json", "snippet": " CI, 1.19-3.92]; P\u2009=\u2009.01).\nConclusions and Relevance: In a case-control study, there was a statistically significant association between an LOF  [CLS] variant in the TTN [CLS]  gene and early-onset AF, with the variant present in a small percentage of participants with early-onset AF (the case"}
{"subject": "variant", "sub_type": "Var", "rel": "CauseOf", "object": "LOF", "obj_type": "NegReg", "file_name": "PubMed-30535219.json", "snippet": " [95% CI, 1.19-3.92]; P\u2009=\u2009.01).\nConclusions and Relevance: In a case-control study, there was a statistically significant association between an  [CLS] LOF variant [CLS]  in the TTN gene and early-onset AF, with the variant present in a small percentage of participants with early-onset"}
{"subject": "LOF", "sub_type": "NegReg", "rel": "CauseOf", "object": "significant association", "obj_type": "Reg", "file_name": "PubMed-30535219.json", "snippet": " control participants (OR, 2.16 [95% CI, 1.19-3.92]; P\u2009=\u2009.01).\nConclusions and Relevance: In a case-control study, there was a statistically  [CLS] significant association between an LOF [CLS]  variant in the TTN gene and early-onset AF, with the variant present in a small percentage of participants with"}
{"subject": "early-onset AF", "sub_type": "Disease", "rel": "ThemeOf", "object": "significant association", "obj_type": "Reg", "file_name": "PubMed-30535219.json", "snippet": " control participants (OR, 2.16 [95% CI, 1.19-3.92]; P\u2009=\u2009.01).\nConclusions and Relevance: In a case-control study, there was a statistically  [CLS] significant association between an LOF variant in the TTN gene and early-onset AF [CLS] , with the variant present in a small percentage of participants with early-onset AF (the case group). Further research is"}
{"subject": "RIG-I", "sub_type": "Gene", "rel": "ThemeOf", "object": "C268F", "obj_type": "Var", "file_name": "PubMed-30560918.json", "snippet": " autoimmunity.\nRetinoic acid inducible gene-I (RIG-I) ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in  [CLS] RIG-I (C268F [CLS]  and E373A) lead to impaired ATPase activity, thereby driving hyperactive signaling associated with autoimmune diseases. Here we report, using"}
{"subject": "H830A mutation", "sub_type": "Var", "rel": "CauseOf", "object": "restores", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " its ability to stabilize RIG-I helicase and blunts caspase activation and recruitment domains (CARD) partial opening by threefold. RIG-I  [CLS] H830A mutation restores [CLS]  Cap1-helicase engagement as well as CARDs partial opening event to a level comparable to that of 5'ppp. However, E373A"}
{"subject": "Cap1-helicase", "sub_type": "Protein", "rel": "ThemeOf", "object": "engagement", "obj_type": "MPA", "file_name": "PubMed-30560918.json", "snippet": " stabilize RIG-I helicase and blunts caspase activation and recruitment domains (CARD) partial opening by threefold. RIG-I H830A mutation restores  [CLS] Cap1-helicase engagement [CLS]  as well as CARDs partial opening event to a level comparable to that of 5'ppp. However, E373A RIG-I locks"}
{"subject": "engagement", "sub_type": "MPA", "rel": "ThemeOf", "object": "restores", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " to stabilize RIG-I helicase and blunts caspase activation and recruitment domains (CARD) partial opening by threefold. RIG-I H830A mutation  [CLS] restores Cap1-helicase engagement [CLS]  as well as CARDs partial opening event to a level comparable to that of 5'ppp. However, E373A RIG-I locks"}
{"subject": "CARDs partial opening event", "sub_type": "MPA", "rel": "ThemeOf", "object": "restores", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " to stabilize RIG-I helicase and blunts caspase activation and recruitment domains (CARD) partial opening by threefold. RIG-I H830A mutation  [CLS] restores Cap1-helicase engagement as well as CARDs partial opening event [CLS]  to a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting"}
{"subject": "RIG-I", "sub_type": "Gene", "rel": "ThemeOf", "object": "E373A", "obj_type": "Var", "file_name": "PubMed-30560918.json", "snippet": " restores Cap1-helicase engagement as well as CARDs partial opening event to a level comparable to that of 5'ppp. However,  [CLS] E373A RIG-I [CLS]  locks the receptor in an ATP-bound state, resulting in enhanced Cap1-helicase engagement and a sequential CARDs stimulation. C268F mutation"}
{"subject": "E373A", "sub_type": "Var", "rel": "CauseOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " restores Cap1-helicase engagement as well as CARDs partial opening event to a level comparable to that of 5'ppp. However,  [CLS] E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced [CLS]  Cap1-helicase engagement and a sequential CARDs stimulation. C268F mutation renders a more tethered ring architecture and results in constitutive"}
{"subject": "Cap1-helicase", "sub_type": "Protein", "rel": "ThemeOf", "object": "engagement", "obj_type": "MPA", "file_name": "PubMed-30560918.json", "snippet": " level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced  [CLS] Cap1-helicase engagement [CLS]  and a sequential CARDs stimulation. C268F mutation renders a more tethered ring architecture and results in constitutive CARDs signaling"}
{"subject": "engagement", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in  [CLS] enhanced Cap1-helicase engagement [CLS]  and a sequential CARDs stimulation. C268F mutation renders a more tethered ring architecture and results in constitutive CARDs signaling"}
{"subject": "sequential CARDs stimulation", "sub_type": "MPA", "rel": "ThemeOf", "object": "enhanced", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " a level comparable to that of 5'ppp. However, E373A RIG-I locks the receptor in an ATP-bound state, resulting in  [CLS] enhanced Cap1-helicase engagement and a sequential CARDs stimulation [CLS] . C268F mutation renders a more tethered ring architecture and results in constitutive CARDs signaling in an ATP-independent manner."}
{"subject": "C268F mutation", "sub_type": "Var", "rel": "CauseOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced Cap1-helicase engagement and a sequential CARDs stimulation.  [CLS] C268F mutation renders a more [CLS]  tethered ring architecture and results in constitutive CARDs signaling in an ATP-independent manner."}
{"subject": "RIG-I", "sub_type": "Gene", "rel": "ThemeOf", "object": "E373A", "obj_type": "Var", "file_name": "PubMed-30560918.json", "snippet": " autoimmunity.\nRetinoic acid inducible gene-I (RIG-I) ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in  [CLS] RIG-I (C268F and E373A [CLS] ) lead to impaired ATPase activity, thereby driving hyperactive signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange,"}
{"subject": "tethered ring architecture", "sub_type": "MPA", "rel": "ThemeOf", "object": "more", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " receptor in an ATP-bound state, resulting in enhanced Cap1-helicase engagement and a sequential CARDs stimulation. C268F mutation renders a  [CLS] more tethered ring architecture [CLS]  and results in constitutive CARDs signaling in an ATP-independent manner."}
{"subject": "C268F mutation", "sub_type": "Var", "rel": "CauseOf", "object": "results in", "obj_type": "Reg", "file_name": "PubMed-30560918.json", "snippet": " E373A RIG-I locks the receptor in an ATP-bound state, resulting in enhanced Cap1-helicase engagement and a sequential CARDs stimulation.  [CLS] C268F mutation renders a more tethered ring architecture and results in [CLS]  constitutive CARDs signaling in an ATP-independent manner."}
{"subject": "constitutive CARDs signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "results in", "obj_type": "Reg", "file_name": "PubMed-30560918.json", "snippet": " resulting in enhanced Cap1-helicase engagement and a sequential CARDs stimulation. C268F mutation renders a more tethered ring architecture and  [CLS] results in constitutive CARDs signaling [CLS]  in an ATP-independent manner."}
{"subject": "C268F", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-30560918.json", "snippet": "\nRetinoic acid inducible gene-I (RIG-I) ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in RIG-I ( [CLS] C268F and E373A) lead to impaired [CLS]  ATPase activity, thereby driving hyperactive signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for"}
{"subject": "E373A", "sub_type": "Var", "rel": "CauseOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-30560918.json", "snippet": " inducible gene-I (RIG-I) ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in RIG-I (C268F and  [CLS] E373A) lead to impaired [CLS]  ATPase activity, thereby driving hyperactive signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for"}
{"subject": "ATPase", "sub_type": "Protein", "rel": "ThemeOf", "object": "activity", "obj_type": "MPA", "file_name": "PubMed-30560918.json", "snippet": " immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in RIG-I (C268F and E373A) lead to impaired  [CLS] ATPase activity [CLS] , thereby driving hyperactive signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for dysregulated RIG-I"}
{"subject": "activity", "sub_type": "MPA", "rel": "ThemeOf", "object": "impaired", "obj_type": "NegReg", "file_name": "PubMed-30560918.json", "snippet": " ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in RIG-I (C268F and E373A) lead to  [CLS] impaired ATPase activity [CLS] , thereby driving hyperactive signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for dysregulated RIG-I"}
{"subject": "impaired", "sub_type": "NegReg", "rel": "CauseOf", "object": "hyperactive", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " ensures immune surveillance of viral RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in RIG-I (C268F and E373A) lead to  [CLS] impaired ATPase activity, thereby driving hyperactive [CLS]  signaling associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for dysregulated RIG-I proofreading that ultimately"}
{"subject": "signaling", "sub_type": "MPA", "rel": "ThemeOf", "object": "hyperactive", "obj_type": "PosReg", "file_name": "PubMed-30560918.json", "snippet": " RNAs bearing a 5'-triphosphate (5'ppp) moiety. Mutations in RIG-I (C268F and E373A) lead to impaired ATPase activity, thereby driving  [CLS] hyperactive signaling [CLS]  associated with autoimmune diseases. Here we report, using hydrogen/deuterium exchange, mechanistic models for dysregulated RIG-I proofreading that ultimately result"}
{"subject": "RIG-I", "sub_type": "Gene", "rel": "ThemeOf", "object": "H830A mutation", "obj_type": "Var", "file_name": "PubMed-30560918.json", "snippet": " compromises its ability to stabilize RIG-I helicase and blunts caspase activation and recruitment domains (CARD) partial opening by threefold.  [CLS] RIG-I H830A mutation [CLS]  restores Cap1-helicase engagement as well as CARDs partial opening event to a level comparable to that of 5'ppp. However,"}
{"subject": "PRLR", "sub_type": "Gene", "rel": "ThemeOf", "object": "variants", "obj_type": "Var", "file_name": "PubMed-30575453.json", "snippet": " with a complete lack of lactation after each of her two deliveries. She is a compound heterozygote for loss-of-function  [CLS] variants of PRLR [CLS] . Her unaffected parents are heterozygotes. These findings are consistent with previous work showing that mice deficient in functional Prlr"}
{"subject": "variants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30575453.json", "snippet": " associated with a complete lack of lactation after each of her two deliveries. She is a compound heterozygote for  [CLS] loss-of-function variants [CLS]  of PRLR. Her unaffected parents are heterozygotes. These findings are consistent with previous work showing that mice deficient in"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "not", "obj_type": "NegReg", "file_name": "PubMed-30575453.json", "snippet": " associated with a complete lack of lactation after each of her two deliveries. She is a compound heterozygote for  [CLS] loss-of-function variants of PRLR. Her unaffected parents are heterozygotes. These findings are consistent with previous work showing that mice deficient in functional Prlr do not [CLS]  lactate."}
{"subject": "lactate", "sub_type": "CPA", "rel": "ThemeOf", "object": "not", "obj_type": "NegReg", "file_name": "PubMed-30575453.json", "snippet": " unaffected parents are heterozygotes. These findings are consistent with previous work showing that mice deficient in functional Prlr do  [CLS] not lactate [CLS] ."}
{"subject": "not", "sub_type": "NegReg", "rel": "CauseOf", "object": "hyperprolactinemia", "obj_type": "Disease", "file_name": "PubMed-30575453.json", "snippet": " galactorrhea; however, this paradoxical phenotype is not completely understood. Here we describe a 35-year-old woman who presented with idiopathic  [CLS] hyperprolactinemia that was associated with a complete lack of lactation after each of her two deliveries. She is a compound heterozygote for loss-of-function variants of PRLR. Her unaffected parents are heterozygotes. These findings are consistent with previous work showing that mice deficient in functional Prlr do not [CLS]  lactate."}
{"subject": "Cd tolerance", "sub_type": "CPA", "rel": "ThemeOf", "object": "Enhanced", "obj_type": "PosReg", "file_name": "PubMed-30617455.json", "snippet": " Cd tolerance by repressing the expression of PC synthesis-related genes. The expression of WRKY12 was inhibited by Cd stress.  [CLS] Enhanced Cd tolerance [CLS]  was observed in the WRKY12 loss-of-function mutants, whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and"}
{"subject": "GSH1", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-30617455.json", "snippet": " Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing the  [CLS] expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of GSH1 [CLS] , GSH2, PCS1, and PCS2. Further analysis indicated that WRKY12 could directly bind to the W-box of the promoter in"}
{"subject": "GSH2", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-30617455.json", "snippet": " Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing the  [CLS] expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of GSH1, GSH2 [CLS] , PCS1, and PCS2. Further analysis indicated that WRKY12 could directly bind to the W-box of the promoter in GSH1"}
{"subject": "PCS1", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-30617455.json", "snippet": " Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing the  [CLS] expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of GSH1, GSH2, PCS1 [CLS] , and PCS2. Further analysis indicated that WRKY12 could directly bind to the W-box of the promoter in GSH1 but"}
{"subject": "PCS2", "sub_type": "Gene", "rel": "ThemeOf", "object": "expression", "obj_type": "MPA", "file_name": "PubMed-30617455.json", "snippet": " Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing the  [CLS] expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of GSH1, GSH2, PCS1, and PCS2 [CLS] . Further analysis indicated that WRKY12 could directly bind to the W-box of the promoter in GSH1 but not in"}
{"subject": "WRKY12", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutants", "obj_type": "Var", "file_name": "PubMed-30617455.json", "snippet": " PC synthesis-related genes. The expression of WRKY12 was inhibited by Cd stress. Enhanced Cd tolerance was observed in the  [CLS] WRKY12 loss-of-function mutants [CLS] , whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with"}
{"subject": "mutants", "sub_type": "Var", "rel": "CauseOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30617455.json", "snippet": " synthesis-related genes. The expression of WRKY12 was inhibited by Cd stress. Enhanced Cd tolerance was observed in the WRKY12  [CLS] loss-of-function mutants [CLS] , whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "Enhanced", "obj_type": "PosReg", "file_name": "PubMed-30617455.json", "snippet": " Cd tolerance by repressing the expression of PC synthesis-related genes. The expression of WRKY12 was inhibited by Cd stress.  [CLS] Enhanced Cd tolerance was observed in the WRKY12 loss-of-function [CLS]  mutants, whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively"}
{"subject": "WRKY12", "sub_type": "Gene", "rel": "ThemeOf", "object": "loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30617455.json", "snippet": " was observed in the WRKY12 loss-of-function mutants, whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and  [CLS] loss-of-function of WRKY12 [CLS]  were associated respectively with increased and decreased Cd accumulation by repressing or releasing the expression of the genes involved"}
{"subject": "loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "releasing", "obj_type": "PosReg", "file_name": "PubMed-30617455.json", "snippet": " was observed in the WRKY12 loss-of-function mutants, whereas increased Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and  [CLS] loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or releasing [CLS]  the expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the"}
{"subject": "expression", "sub_type": "MPA", "rel": "ThemeOf", "object": "releasing", "obj_type": "PosReg", "file_name": "PubMed-30617455.json", "snippet": " WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and decreased Cd accumulation by repressing or  [CLS] releasing the expression [CLS]  of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the expression of"}
{"subject": "releasing", "sub_type": "PosReg", "rel": "CauseOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-30617455.json", "snippet": " Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and  [CLS] decreased Cd accumulation by repressing or releasing [CLS]  the expression of the genes involved in the PC synthesis pathway. Transient expression assay showed that WRKY12 repressed the"}
{"subject": "Cd accumulation", "sub_type": "CPA", "rel": "ThemeOf", "object": "decreased", "obj_type": "NegReg", "file_name": "PubMed-30617455.json", "snippet": " Cd sensitivity was found in the WRKY12-overexpressing plants. Overexpression and loss-of-function of WRKY12 were associated respectively with increased and  [CLS] decreased Cd accumulation [CLS]  by repressing or releasing the expression of the genes involved in the PC synthesis pathway. Transient expression assay showed"}
{"subject": "QRICH2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-30683861.json", "snippet": " [CLS] mutations in QRICH2 [CLS]  cause male infertility with multiple morphological abnormalities of the sperm flagella.\nAberrant sperm flagella impair sperm motility and cause"}
{"subject": "male infertility", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " QRICH2 cause male infertility with multiple morphological abnormalities of the sperm flagella.\nAberrant sperm flagella impair sperm motility and  [CLS] cause male infertility [CLS] , yet the genes which have been identified in multiple morphological abnormalities of the flagella (MMAF) can only explain the"}
{"subject": "QRICH2", "sub_type": "Gene", "rel": "ThemeOf", "object": "mutations", "obj_type": "Var", "file_name": "PubMed-30683861.json", "snippet": " through stabilizing and enhancing the expression of proteins related to flagellar development. Our findings strongly suggest that the genetic  [CLS] mutations of human QRICH2 [CLS]  can lead to male infertility with MMAF and that QRICH2 is essential for sperm flagellar formation."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " through stabilizing and enhancing the expression of proteins related to flagellar development. Our findings strongly suggest that the genetic  [CLS] mutations of human QRICH2 can lead to [CLS]  male infertility with MMAF and that QRICH2 is essential for sperm flagellar formation."}
{"subject": "male infertility", "sub_type": "Disease", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " expression of proteins related to flagellar development. Our findings strongly suggest that the genetic mutations of human QRICH2 can  [CLS] lead to male infertility [CLS]  with MMAF and that QRICH2 is essential for sperm flagellar formation."}
{"subject": "MMAF", "sub_type": "CPA", "rel": "ThemeOf", "object": "lead to", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " expression of proteins related to flagellar development. Our findings strongly suggest that the genetic mutations of human QRICH2 can  [CLS] lead to male infertility with MMAF [CLS]  and that QRICH2 is essential for sperm flagellar formation."}
{"subject": "mutations", "sub_type": "Var", "rel": "CauseOf", "object": "Loss-of-function", "obj_type": "NegReg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] Loss-of-function mutations [CLS]  in QRICH2 cause male infertility with multiple morphological abnormalities of the sperm flagella.\nAberrant sperm flagella impair sperm motility"}
{"subject": "Loss-of-function", "sub_type": "NegReg", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] Loss-of-function mutations in QRICH2 cause [CLS]  male infertility with multiple morphological abnormalities of the sperm flagella.\nAberrant sperm flagella impair sperm motility and cause male"}
{"subject": "male infertility", "sub_type": "Disease", "rel": "ThemeOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] cause male infertility [CLS]  with multiple morphological abnormalities of the sperm flagella.\nAberrant sperm flagella impair sperm motility and cause male infertility, yet"}
{"subject": "sperm flagella", "sub_type": "CPA", "rel": "ThemeOf", "object": "Aberrant", "obj_type": "Var", "file_name": "PubMed-30683861.json", "snippet": " [CLS] Aberrant sperm flagella [CLS]  impair sperm motility and cause male infertility, yet the genes which have been identified in multiple morphological abnormalities of"}
{"subject": "Aberrant", "sub_type": "Var", "rel": "CauseOf", "object": "impair", "obj_type": "NegReg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] Aberrant sperm flagella impair [CLS]  sperm motility and cause male infertility, yet the genes which have been identified in multiple morphological abnormalities of the"}
{"subject": "sperm motility", "sub_type": "CPA", "rel": "ThemeOf", "object": "impair", "obj_type": "NegReg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] impair sperm motility [CLS]  and cause male infertility, yet the genes which have been identified in multiple morphological abnormalities of the flagella (MMAF)"}
{"subject": "impair", "sub_type": "NegReg", "rel": "CauseOf", "object": "cause", "obj_type": "Reg", "file_name": "PubMed-30683861.json", "snippet": " [CLS] impair sperm motility and cause [CLS]  male infertility, yet the genes which have been identified in multiple morphological abnormalities of the flagella (MMAF) can only"}
